data_2jzx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jzx _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.5 m120 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.952 0.406 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.7 t -136.92 150.06 26.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.748 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 2.5 t -103.51 157.7 16.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.871 0.367 . . . . 0.0 111.305 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.0 mt -152.33 174.46 13.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.993 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.9 m -142.5 133.62 25.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.776 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.404 ' CD1' ' CZ ' ' A' ' 72' ' ' PHE . 1.1 tt -136.92 123.58 29.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.161 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.493 ' NH2' ' OE1' ' A' ' 143' ' ' GLU . 2.3 mpp_? -101.24 117.07 34.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.746 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.0 mt -94.75 128.51 41.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.862 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.8 tt -123.05 120.85 34.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.496 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.418 ' HB3' ' HB ' ' A' ' 25' ' ' VAL . 0.8 OUTLIER -147.91 168.65 21.69 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.288 0.566 . . . . 0.0 111.9 -179.46 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.416 ' HB3' ' CD ' ' A' ' 23' ' ' LYS . 29.0 m-70 -74.64 140.95 44.64 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.844 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -45.48 -30.89 3.29 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.962 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.541 ' HG2' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -78.45 -49.5 13.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 117.354 0.577 . . . . 0.0 111.95 -179.077 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.541 ' N ' ' HG2' ' A' ' 23' ' ' LYS . 4.8 mt-10 -65.14 -50.78 64.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.207 0.527 . . . . 0.0 109.999 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.46 ' O ' HG12 ' A' ' 29' ' ' ILE . 7.3 p -58.72 -34.25 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.572 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.38 -41.9 98.69 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.924 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.1 p -65.88 -27.92 68.57 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.4 mm -81.21 -32.36 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.899 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 25' ' ' VAL . 3.0 mm -60.43 -42.75 92.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.342 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.08 150.39 26.8 Favored Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.317 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.406 ' C ' ' HD3' ' A' ' 32' ' ' LYS . 1.3 tppm? -61.71 145.72 51.48 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.723 -0.739 . . . . 0.0 111.34 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.411 ' CE ' ' HB3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 50.79 20.22 0.73 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.442 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.443 ' O ' HG22 ' A' ' 36' ' ' VAL . . . 51.24 13.88 1.19 Allowed Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.936 -0.649 . . . . 0.0 113.919 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.411 ' HB3' ' CE ' ' A' ' 32' ' ' LYS . 10.1 tt0 -76.79 -26.09 54.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.213 0.53 . . . . 0.0 109.808 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.13 -42.33 56.55 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.401 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -67.38 -26.57 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.624 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.93 -36.69 67.27 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.54 -34.57 72.41 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.839 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -53.46 57.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.489 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.09 -51.48 69.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.989 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -51.9 -38.43 56.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.947 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -85.95 -27.38 24.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.697 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.41 ' HB2' ' CB ' ' A' ' 71' ' ' ALA . 1.5 p -73.25 -55.26 6.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.809 0.338 . . . . 0.0 111.21 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.36 -5.27 85.36 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.443 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.452 ' O ' ' CG1' ' A' ' 47' ' ' ILE . . . -110.71 127.4 55.3 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.63 0.253 . . . . 0.0 111.197 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 9.1 tpp180 -28.19 104.3 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.452 ' CG1' ' O ' ' A' ' 45' ' ' ALA . 2.9 mt -114.73 120.37 64.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.688 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -137.01 173.82 11.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.041 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.9 mt -126.51 151.73 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.947 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.5 t -135.73 -175.28 3.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.08 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.791 179.993 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 . . . . . 0 N--CA 1.466 0.362 0 CA-C-O 120.385 0.136 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.29 133.98 37.5 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.035 0.445 . . . . 0.0 111.624 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.0 mt -140.48 119.09 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.718 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.5 mt -97.01 109.66 23.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.442 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.7 m -87.2 108.7 19.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.033 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.449 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -106.67 138.52 42.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.506 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.423 ' O ' ' HB1' ' A' ' 45' ' ' ALA . . . -145.41 132.25 20.11 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.445 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.53 166.38 16.85 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 119.549 -1.31 . . . . 0.0 113.3 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 1.9 Cg_endo -46.09 159.21 0.26 Allowed 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 123.174 2.583 . . . . 0.0 112.472 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.408 ' O ' HG23 ' A' ' 68' ' ' ILE . 13.2 t -55.99 -35.94 67.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.429 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -65.37 -51.88 57.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.093 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.28 -44.54 84.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.041 0.448 . . . . 0.0 110.872 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 65' ' ' THR . 1.2 tt -66.45 -39.39 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.878 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.53 -45.13 77.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.041 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -45.4 68.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.746 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.41 ' CB ' ' HB2' ' A' ' 43' ' ' SER . . . -54.78 -56.16 22.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.323 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.404 ' CZ ' ' CD1' ' A' ' 16' ' ' ILE . 0.6 OUTLIER -56.27 -40.09 73.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.998 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.45 -32.26 72.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.185 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.2 mtm -74.27 -46.55 40.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.196 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.43 HG13 ' N ' ' A' ' 76' ' ' ILE . 29.0 pt -61.56 -42.83 95.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.229 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.43 ' N ' HG13 ' A' ' 75' ' ' ILE . 41.0 pt -64.91 -36.45 77.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.82 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.9 -37.7 82.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.321 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -35.45 77.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.01 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.6 tp -76.34 -28.11 56.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.383 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.9 -35.98 56.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.682 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -72.39 -33.45 67.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.909 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.7 t0 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.237 -179.667 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 C--O 1.231 0.164 0 CA-C-O 120.891 0.288 . . . . 0.0 112.641 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.5 m -140.97 119.87 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.464 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 14.9 p -102.81 141.96 34.74 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.957 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.85 117.75 11.75 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -100.87 112.62 25.09 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.499 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.6 mp -99.35 162.82 12.82 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.835 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.4 t -115.76 147.75 18.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.215 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.3 m -160.38 154.36 19.46 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.046 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.37 167.53 18.39 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.386 2.057 . . . . 0.0 112.238 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.52 -34.58 78.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.479 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.1 t -69.59 -30.35 68.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.134 0.492 . . . . 0.0 109.837 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -71.92 -46.24 58.33 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.79 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.62 -46.65 75.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.756 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -54.84 -51.79 50.73 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.57 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.3 m -70.76 -40.03 72.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.771 0.32 . . . . 0.0 110.757 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.7 mt -55.27 -26.99 43.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.645 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.408 ' CG2' ' HA2' ' A' ' 117' ' ' GLY . 9.8 mt -84.29 -40.76 15.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.799 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.48 -177.19 49.47 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.497 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.5 mttp -66.36 124.13 21.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.827 0.346 . . . . 0.0 111.056 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 58.47 19.96 43.28 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.766 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.408 ' HA2' ' CG2' ' A' ' 113' ' ' ILE . . . 66.78 11.57 57.91 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.904 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 29.1 p -53.01 -38.55 62.43 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -67.78 -65.39 0.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.641 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -55.87 -34.66 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.728 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -62.3 -50.4 71.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.306 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.407 ' HG3' ' N ' ' A' ' 123' ' ' ILE . 5.8 pt-20 -64.36 -34.39 78.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.303 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.407 ' N ' ' HG3' ' A' ' 122' ' ' GLU . 15.7 mt -65.87 -53.97 32.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.226 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.47 -30.31 65.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.036 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -59.04 -45.22 91.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.982 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.2 -39.34 14.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.12 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 36.5 m -49.93 -25.84 3.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.832 0.349 . . . . 0.0 110.16 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.6 -9.25 65.58 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.929 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -108.14 164.25 12.46 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.83 0.348 . . . . 0.0 111.204 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -104.81 133.15 50.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.708 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.405 ' HB ' ' CD1' ' A' ' 146' ' ' ILE . 6.3 m -99.19 139.07 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.137 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.614 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -109.2 158.17 18.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.608 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.8 t -137.66 132.58 44.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.883 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.11 179.971 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.7 p . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.866 0.365 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.81 -48.68 2.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.698 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.493 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 16.7 mm-40 -99.45 140.39 33.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.689 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -109.97 136.79 48.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.964 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -104.3 125.93 50.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.118 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.614 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 0.5 OUTLIER -105.91 139.86 25.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.518 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.478 ' HB ' ' HB2' ' A' ' 132' ' ' GLN . 2.3 m -121.12 115.1 22.45 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.473 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.8 mp -104.39 121.78 56.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.104 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.35 145.93 44.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.021 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 154.49 -151.62 23.28 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.651 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.49 ' CG2' ' HD2' ' A' ' 152' ' ' PRO . 1.5 mp -82.41 143.85 48.75 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.49 ' HD2' ' CG2' ' A' ' 151' ' ' ILE . 79.5 Cg_exo -48.98 -34.09 28.1 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 121.933 1.756 . . . . 0.0 111.589 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -72.17 -34.64 68.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.645 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 50.7 m -69.81 -39.04 76.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.902 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 39.2 mm -66.26 -53.47 36.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.073 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 32.6 mm -57.51 -29.0 32.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.873 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -72.32 -40.82 67.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.837 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.73 -35.03 79.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.855 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.7 t -73.99 -37.73 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.169 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -71.55 -34.82 70.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.93 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -73.77 -40.65 63.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.958 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 14.8 tt -71.43 -34.46 53.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.152 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 1.5 m -68.27 -51.92 39.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.137 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 10.8 p -58.83 -40.13 79.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.273 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 50.5 t -70.62 -32.33 49.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.007 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -45.78 90.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.874 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -71.36 -47.32 57.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.89 -2.65 24.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.209 -0.451 . . . . 0.0 112.015 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.166 -0.921 . . . . 0.0 111.385 179.957 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.807 0.336 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.403 ' CG2' ' N ' ' A' ' 13' ' ' THR . 7.7 p -108.7 161.1 7.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.003 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 3.1 t -103.57 160.78 14.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.012 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.3 mt -150.61 173.75 13.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.163 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.7 m -142.47 113.23 7.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.756 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.7 tt -132.61 129.01 58.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.319 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.494 ' NH2' ' OE1' ' A' ' 143' ' ' GLU . 0.0 OUTLIER -117.98 148.61 42.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.693 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 pp -129.38 146.67 51.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.895 0.379 . . . . 0.0 111.248 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.3 tt -123.05 134.62 54.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.795 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -138.47 165.81 25.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.983 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.78 166.25 15.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.676 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.2 -36.93 94.1 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.705 -0.76 . . . . 0.0 113.022 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -78.36 -50.08 12.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.901 0.381 . . . . 0.0 111.34 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.95 -44.81 95.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.335 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.4 p -62.97 -35.98 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.794 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.16 -34.87 90.47 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.5 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.6 t -75.52 -30.17 59.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.768 0.318 . . . . 0.0 110.846 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.422 HD11 ' N ' ' A' ' 28' ' ' ILE . 4.1 mm -81.12 -36.87 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.258 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.409 HD11 ' CD ' ' A' ' 57' ' ' ARG . 30.5 mt -65.75 -42.48 92.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.337 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.58 150.9 22.29 Favored Glycine 0 N--CA 1.434 -1.489 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.122 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.437 ' C ' ' HG3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -51.22 146.61 6.47 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.739 -0.731 . . . . 0.0 111.242 179.599 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.486 ' HE3' ' HB3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 44.43 27.1 0.21 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.119 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.445 ' O ' HG21 ' A' ' 36' ' ' VAL . . . 45.37 20.2 0.31 Allowed Glycine 0 CA--C 1.522 0.529 0 C-N-CA 121.353 -0.451 . . . . 0.0 113.967 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.486 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -73.14 -25.3 60.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.327 0.564 . . . . 0.0 110.086 179.263 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.58 -42.75 64.26 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.539 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 33' ' ' GLY . 0.9 OUTLIER -67.02 -26.62 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -71.03 -36.9 72.54 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.04 -37.09 86.45 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.586 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -59.01 -53.74 54.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.419 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.9 mtm-85 -52.86 -51.14 62.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.956 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.6 -37.5 84.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.914 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.52 -35.84 63.16 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.28 -55.74 3.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.978 0.418 . . . . 0.0 111.08 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.37 10.03 54.5 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.882 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.422 ' O ' ' C ' ' A' ' 46' ' ' ARG . . . -110.77 128.38 55.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.89 0.345 . . . . 0.0 111.221 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -27.49 134.5 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.243 179.439 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.4 mt -142.22 100.57 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.705 0.288 . . . . 0.0 110.522 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -112.98 167.43 10.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.886 0.374 . . . . 0.0 111.056 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.4 mt -126.52 152.04 33.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.155 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 63.9 m -91.03 -175.05 4.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.218 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.16 -179.816 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.455 -0.201 0 CA-C-O 120.802 0.334 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.409 ' CD ' HD11 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -146.32 127.53 14.78 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.288 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.3 mt -115.0 104.58 17.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.375 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.3 mt -92.92 103.55 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.522 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 91.1 m -83.02 129.1 35.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.459 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.455 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 0.3 OUTLIER -118.21 131.3 56.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.085 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -131.29 130.92 43.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.759 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.2 164.8 14.07 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.961 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.461 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 86.9 Cg_exo -40.31 162.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.169 2.58 . . . . 0.0 113.041 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.6 m -60.17 -35.73 76.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.009 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -69.84 -51.86 29.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.081 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.04 -39.64 75.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.97 0.414 . . . . 0.0 110.85 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.23 -39.54 84.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.34 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.74 -43.13 89.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.01 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.29 -49.92 75.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.955 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.04 -56.47 21.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.27 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -57.39 -34.57 69.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.113 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.27 -42.09 99.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.124 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.06 -36.55 72.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.951 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.9 mt -62.77 -49.26 84.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.5 pt -61.21 -40.51 86.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.027 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -61.22 -39.87 91.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.685 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.43 -41.67 97.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.29 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.1 tp -74.61 -26.62 60.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.472 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -76.89 -34.62 57.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.703 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -72.21 -37.38 69.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.729 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.8 t0 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.914 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo . . . . . 0 N--CA 1.465 -0.198 0 CA-C-O 120.988 0.328 . . . . 0.0 112.839 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.2 t -140.77 122.12 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.987 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.0 p -102.62 141.13 35.95 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.461 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 147' ' ' THR . 4.6 mp -139.84 158.58 43.85 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.139 -1.801 . . . . 0.0 106.139 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.3 ttp-105 -122.84 113.33 19.0 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.912 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.09 144.6 29.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.933 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.5 t -104.43 139.08 26.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.061 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.3 m -149.06 157.22 40.17 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.04 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.24 166.56 20.84 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.421 2.081 . . . . 0.0 112.324 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.68 -34.57 75.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.384 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 p -68.97 -30.28 68.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.978 0.418 . . . . 0.0 109.926 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -50.6 52.71 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.793 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 30.9 p -70.67 -38.21 73.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.677 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -54.7 -50.45 57.67 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.475 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.2 p -77.43 -47.45 19.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.671 0.272 . . . . 0.0 111.011 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.0 mt -52.66 -26.46 13.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.925 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 41.0 mt -92.33 -37.37 8.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.943 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.93 179.47 32.83 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.423 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -67.39 124.18 22.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.873 0.368 . . . . 0.0 111.008 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.0 19.1 63.14 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.816 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 64.41 13.26 54.25 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.887 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -52.9 -50.6 63.57 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 120.775 0.322 . . . . 0.0 111.728 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.401 ' CD ' ' CD1' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -57.1 -60.83 3.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.178 -179.763 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.1 -26.92 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.456 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.6 tptp -65.06 -47.0 78.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.796 0.332 . . . . 0.0 110.892 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -73.13 -45.8 54.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.136 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.438 HD13 HG23 ' A' ' 123' ' ' ILE . 50.6 mt -62.17 -50.89 78.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.998 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -63.78 -40.55 96.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.151 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -54.99 -57.38 11.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.818 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.3 m -75.83 -43.68 44.77 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.0 m -47.95 -25.94 1.55 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.866 0.365 . . . . 0.0 110.432 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.24 -7.05 58.24 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.049 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -105.66 137.11 44.06 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.951 0.375 . . . . 0.0 110.953 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 0.0 OUTLIER -95.58 144.59 25.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.209 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.8 m -99.31 147.17 7.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.045 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 7.0 tp60 -140.22 117.77 11.52 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.6 p -96.59 116.47 38.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.051 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.795 -179.608 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 88.3 p . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.865 0.364 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 25.7 m -106.42 -64.56 1.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.359 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.494 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 10.5 mm-40 -93.92 135.73 34.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.171 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.75 166.41 14.35 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.241 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -130.2 115.75 17.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.791 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 30.5 mt -100.77 129.24 51.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.696 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.47 ' HB ' ' CB ' ' A' ' 132' ' ' GLN . 2.6 m -97.67 123.06 41.43 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.519 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 130' ' ' GLN . 2.1 pp -106.72 117.97 53.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.935 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.34 126.43 52.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.121 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 171.28 -153.28 20.08 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.592 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.491 ' CG2' ' HD2' ' A' ' 152' ' ' PRO . 1.3 mp -87.32 143.59 34.65 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 110.624 -0.139 . . . . 0.0 110.624 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.491 ' HD2' ' CG2' ' A' ' 151' ' ' ILE . 71.3 Cg_exo -49.33 -31.03 21.62 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 121.966 1.777 . . . . 0.0 111.447 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.13 -34.65 68.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.674 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 22.2 t -68.79 -50.08 53.3 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.795 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.425 HG22 HD12 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -58.39 -45.07 89.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.9 mt -63.88 -29.98 48.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.845 0.355 . . . . 0.0 110.842 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -73.65 -43.02 60.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.238 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 21.4 p -72.42 -42.87 64.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.277 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 13.3 p -60.83 -37.9 77.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.927 0.394 . . . . 0.0 111.01 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.97 -32.91 69.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.756 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -49.56 61.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.0 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 37.7 mm -66.41 -34.48 70.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.015 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 1.7 m -64.58 -48.1 76.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.978 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 11.1 p -65.48 -33.53 64.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.187 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 50.8 t -70.64 -45.14 75.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.878 0.371 . . . . 0.0 110.972 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 27.2 mtm -58.98 -33.57 70.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.847 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.56 -48.22 41.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.818 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.02 -2.55 24.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.93 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 41.2 p . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.876 -179.979 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.816 0.341 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.44 151.68 16.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.986 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 0.9 OUTLIER -103.66 142.75 33.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.039 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.2 mt -137.11 175.23 9.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.991 0.424 . . . . 0.0 111.211 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.7 m -142.4 135.97 29.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.841 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.1 tt -140.87 154.67 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.164 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.496 ' NH2' ' OE1' ' A' ' 143' ' ' GLU . 25.0 mtp180 -134.79 127.63 31.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.867 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.5 mt -113.96 147.58 38.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.8 tt -102.35 106.04 16.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.762 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.2 144.14 40.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.044 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.61 167.82 21.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.752 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.472 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -59.8 -34.66 83.49 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.769 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.86 -52.02 8.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 0.0 111.354 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -34.12 76.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.849 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.668 ' O ' HG12 ' A' ' 29' ' ' ILE . 7.4 p -71.03 -38.97 74.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.664 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.08 -35.08 90.95 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.683 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.26 -34.96 61.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.594 0.235 . . . . 0.0 111.07 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 25' ' ' VAL . 2.9 pp -80.15 -32.53 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.355 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.668 HG12 ' O ' ' A' ' 25' ' ' VAL . 12.4 mm -65.06 -58.87 5.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.7 150.54 25.29 Favored Glycine 0 N--CA 1.436 -1.354 0 CA-C-O 121.635 0.575 . . . . 0.0 112.664 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.443 ' O ' ' CD ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -61.52 146.34 48.98 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.501 -0.85 . . . . 0.0 111.441 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.443 ' CD ' ' O ' ' A' ' 31' ' ' LYS . 0.1 OUTLIER 52.56 18.89 1.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.277 179.482 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.434 ' O ' HG21 ' A' ' 36' ' ' VAL . . . 51.7 13.79 1.5 Allowed Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.956 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.412 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 5.4 tp10 -76.88 -26.27 54.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.322 0.561 . . . . 0.0 109.748 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.428 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -75.19 -40.95 58.93 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.246 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.434 HG21 ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -67.3 -26.51 36.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.243 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.57 -36.61 81.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 177.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.428 ' HB3' ' O ' ' A' ' 35' ' ' SER . 22.2 ttmm -60.36 -40.9 92.43 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.778 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.458 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 3.0 ttp -59.2 -48.46 81.55 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.38 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.2 ttp85 -55.3 -50.63 69.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.101 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -64.64 -38.51 91.25 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 39' ' ' MET . 3.1 pp20? -75.03 -35.88 61.92 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.0 p -91.04 -55.4 3.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.911 0.386 . . . . 0.0 111.105 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.12 5.86 65.45 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.248 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.487 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . . . -110.65 128.43 55.69 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.44 0.162 . . . . 0.0 110.799 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -27.61 136.91 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.001 0.521 . . . . 0.0 112.057 178.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.45 HG13 HD13 ' A' ' 61' ' ' LEU . 20.6 mt -142.19 100.68 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.73 0.3 . . . . 0.0 110.578 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -121.41 121.57 37.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.919 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -107.53 127.61 63.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.374 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.92 -174.04 0.18 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.044 179.92 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 120.687 0.28 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -145.82 155.89 43.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.006 0.431 . . . . 0.0 111.525 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.7 mt -140.64 118.7 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.339 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 mt -85.94 117.93 31.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.985 0.422 . . . . 0.0 111.622 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.9 m -108.57 101.75 10.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.467 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.476 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 15.9 tp -104.41 124.29 48.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.812 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 46' ' ' ARG . . . -126.78 131.71 51.22 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.487 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.39 166.19 16.43 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 119.686 -1.245 . . . . 0.0 113.297 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 2.9 Cg_endo -41.85 159.48 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 123.396 2.731 . . . . 0.0 112.669 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 57.0 m -60.11 -35.97 76.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.48 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -68.72 -52.07 34.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.239 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.07 -38.04 72.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.071 0.462 . . . . 0.0 110.882 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -65.18 -39.34 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.275 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.44 -45.09 92.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.886 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.2 -53.41 58.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.614 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.72 -43.74 97.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.177 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -62.02 -35.51 78.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.078 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.87 -38.78 83.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.262 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.36 -39.21 54.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.984 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 88.6 mt -62.06 -50.58 79.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.661 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.3 pp -63.87 -40.69 89.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.969 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -69.65 -29.69 67.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.455 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -35.64 81.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.076 0.465 . . . . 0.0 109.91 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.9 tp -77.39 -30.52 53.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.386 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.94 -34.05 57.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.776 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.54 -37.84 68.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.032 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.446 -179.674 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo . . . . . 0 C--O 1.232 0.195 0 CA-C-O 120.715 0.214 . . . . 0.0 112.078 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.17 103.32 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.903 0.383 . . . . 0.0 111.418 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.0 t -107.53 127.0 53.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.383 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 mt -140.03 117.76 11.63 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -103.18 112.39 25.23 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.788 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.64 149.77 26.89 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.403 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.24 145.08 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.652 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.424 ' CG1' ' HD2' ' A' ' 105' ' ' PRO . 40.1 t -142.88 144.75 30.66 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.225 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 108' ' ' GLN . 22.2 Cg_exo -65.36 165.51 22.16 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.507 2.138 . . . . 0.0 112.154 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.04 -44.22 73.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.135 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.5 m -66.7 -30.48 70.72 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.427 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -74.61 -41.42 60.46 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.434 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 55.6 m -66.28 -40.9 90.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.102 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.57 -50.71 64.79 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.161 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.3 t -70.4 -36.2 73.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.783 0.325 . . . . 0.0 110.615 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 10.7 mt -58.49 -28.32 65.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.272 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.431 ' CG2' ' HA2' ' A' ' 117' ' ' GLY . 10.9 mt -81.71 -40.29 17.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.717 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.1 -176.83 53.81 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.521 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -66.47 118.15 9.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.896 0.379 . . . . 0.0 111.185 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.99 15.38 56.0 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.015 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.431 ' HA2' ' CG2' ' A' ' 113' ' ' ILE . . . 73.06 5.08 64.6 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.006 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 1.5 m -53.13 -39.65 63.64 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 120.727 0.299 . . . . 0.0 111.719 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -64.87 -65.33 0.69 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.438 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -54.4 -35.51 31.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.393 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.5 tptm -59.26 -44.18 92.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.08 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -73.24 -40.21 64.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.329 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 88.2 mt -54.97 -53.9 29.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.216 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -31.95 69.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.892 0.377 . . . . 0.0 110.938 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -49.74 72.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.31 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.2 m -90.08 -36.94 14.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.546 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.6 m -49.89 -26.05 3.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.848 0.356 . . . . 0.0 110.364 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.3 -12.04 52.59 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.093 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -103.8 155.24 18.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.844 0.354 . . . . 0.0 111.038 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.31 127.94 53.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.054 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 147' ' ' THR . 14.4 m -99.2 138.64 23.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.861 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.679 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 5.4 tm0? -123.38 116.59 23.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.167 0.508 . . . . 0.0 112.032 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 30.8 m -103.46 130.97 52.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.363 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.929 179.675 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 79.0 p . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.798 0.332 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.01 -47.32 3.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.496 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 29.5 mt-10 -121.98 139.88 53.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.825 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.04 173.07 6.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -122.54 126.33 47.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.232 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.679 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 3.4 mp -105.48 125.0 60.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.618 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 131' ' ' VAL . 2.1 m -99.59 114.69 27.87 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.678 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 4.6 pt -106.9 114.72 46.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.411 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -119.38 132.33 55.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.768 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 167.06 -151.61 19.67 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.815 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.511 ' CG2' ' HD2' ' A' ' 152' ' ' PRO . 15.9 mt -84.85 144.46 42.02 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.511 ' HD2' ' CG2' ' A' ' 151' ' ' ILE . 73.5 Cg_exo -48.89 -33.77 26.57 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 121.988 1.792 . . . . 0.0 111.689 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -72.05 -34.75 69.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.845 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.3 m -67.97 -50.46 55.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.992 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.449 HG22 HD11 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -59.26 -47.45 90.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.134 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.6 mt -60.69 -45.9 96.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.819 0.342 . . . . 0.0 110.759 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -60.46 -35.17 75.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.663 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 9.0 t -67.03 -42.99 83.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.774 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.6 t -59.03 -37.96 71.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.022 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.97 -33.01 73.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.777 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -71.47 -46.23 60.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.827 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 50.3 mt -67.25 -34.51 69.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.979 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 1.6 m -63.93 -52.37 60.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.017 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 10.7 p -59.56 -33.3 51.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.172 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 44.0 t -70.69 -44.03 76.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.849 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.85 -33.09 71.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.855 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.59 -50.56 35.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.76 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -73.97 -2.56 24.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.069 0.461 . . . . 0.0 111.948 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 60.2 m . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.864 179.96 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.531 0.237 0 CA-C-O 120.447 0.165 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.5 p -114.27 159.18 14.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.115 0.483 . . . . 0.0 111.373 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -109.52 154.05 23.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.787 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.415 HD21 ' HA ' ' A' ' 14' ' ' LEU . 1.1 mt -144.36 169.28 18.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.054 0.454 . . . . 0.0 111.229 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.2 m -142.72 132.13 23.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.673 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.436 HD11 ' CZ ' ' A' ' 72' ' ' PHE . 2.4 tt -140.83 140.05 33.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.948 0.404 . . . . 0.0 111.326 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.497 ' NH2' ' OE1' ' A' ' 143' ' ' GLU . 1.1 mpp_? -124.48 120.32 31.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.686 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.413 HD22 ' CZ ' ' A' ' 72' ' ' PHE . 14.1 mt -99.8 119.63 38.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.118 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.3 tt -102.71 105.43 15.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.702 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.6 tpp -120.21 161.48 20.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.902 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.404 ' O ' ' CG1' ' A' ' 25' ' ' VAL . 0.3 OUTLIER -67.7 172.57 5.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.452 179.807 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.08 -40.79 99.39 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.913 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.93 -45.27 24.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.771 0.32 . . . . 0.0 111.547 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.13 -48.39 78.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.944 0.402 . . . . 0.0 110.283 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.404 ' CG1' ' O ' ' A' ' 21' ' ' HIS . 9.8 p -61.66 -35.2 65.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.852 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.94 -34.92 90.46 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.187 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 m -75.24 -26.76 59.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.879 0.371 . . . . 0.0 110.723 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.433 ' N ' HD13 ' A' ' 28' ' ' ILE . 3.9 mm -79.11 -51.48 16.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.123 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.7 mt -57.31 -42.27 79.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.514 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.03 150.84 27.3 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.137 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.412 ' O ' ' CD ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -51.59 146.05 8.16 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.058 -0.571 . . . . 0.0 111.143 179.766 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.442 ' HE3' ' HB3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 43.36 27.07 0.12 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.834 -179.65 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 45.17 21.75 0.43 Allowed Glycine 0 CA--C 1.52 0.4 0 C-N-CA 121.273 -0.489 . . . . 0.0 113.852 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.442 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -76.23 -28.84 57.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.209 0.504 . . . . 0.0 110.314 179.574 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.1 t -73.71 -41.75 62.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.488 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.405 ' HA ' ' HB2' ' A' ' 39' ' ' MET . 2.3 p -67.42 -27.34 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.2 -36.67 79.91 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 176.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.406 ' HA ' ' CG ' ' A' ' 41' ' ' GLU . 1.8 tttm -70.91 -31.8 68.53 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.241 177.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.405 ' HB2' ' HA ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -63.21 -51.04 67.89 Favored 'General case' 0 C--O 1.228 -0.047 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.463 179.52 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.0 ttt-85 -58.38 -51.57 69.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.581 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.406 ' CG ' ' HA ' ' A' ' 38' ' ' LYS . 1.4 pp20? -64.33 -37.94 89.27 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -74.69 -36.75 62.76 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.1 p -81.37 -55.65 4.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.906 0.384 . . . . 0.0 111.018 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.93 1.12 56.15 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.736 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' A' ' 46' ' ' ARG . . . -110.66 128.17 55.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.842 0.321 . . . . 0.0 111.304 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 8.3 ttm180 -27.27 140.6 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.257 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 60' ' ' THR . 12.0 mt -142.52 101.1 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.696 0.284 . . . . 0.0 110.817 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -118.38 128.77 54.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.781 0.324 . . . . 0.0 111.248 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.6 mm -92.11 151.86 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.97 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.7 m -87.16 -177.06 5.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.915 0.388 . . . . 0.0 111.268 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.111 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 120.761 0.315 . . . . 0.0 110.855 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -145.79 139.3 26.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.825 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.8 mm -105.62 109.71 28.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.024 0.44 . . . . 0.0 110.892 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.8 mt -86.49 92.83 3.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.094 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 47' ' ' ILE . 8.0 m -81.1 134.08 35.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.985 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.451 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -131.39 134.65 46.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.285 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.47 130.52 34.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.66 0.267 . . . . 0.0 110.862 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.404 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.22 164.61 13.87 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.919 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 83.6 Cg_exo -39.93 158.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 123.21 2.607 . . . . 0.0 113.238 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.407 ' O ' HG21 ' A' ' 68' ' ' ILE . 29.9 m -60.04 -35.69 75.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.87 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -63.48 -51.83 63.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.262 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.21 -40.7 77.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.057 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.407 HG21 ' O ' ' A' ' 65' ' ' THR . 0.5 OUTLIER -66.19 -39.37 84.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.18 -179.44 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.38 -48.92 79.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.227 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.73 -48.8 79.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.977 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.41 -58.75 6.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.286 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.436 ' CZ ' HD11 ' A' ' 16' ' ' ILE . 2.7 m-85 -51.84 -39.24 58.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.305 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.61 -43.93 93.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.109 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.0 ttp -72.21 -34.82 68.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.9 mt -64.29 -48.7 84.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.965 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.3 pt -62.65 -39.35 84.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.93 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.19 -36.52 82.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.718 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -42.27 93.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.335 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.5 tp -77.34 -24.94 50.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.624 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -76.86 -39.96 49.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.779 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.1 -34.01 68.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.834 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.917 -179.922 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo . . . . . 0 C--O 1.231 0.15 0 CA-C-O 120.831 0.263 . . . . 0.0 112.114 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.3 t -134.81 107.04 7.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.197 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.1 p -104.0 135.53 45.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.785 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.98 117.59 11.53 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -105.2 112.56 25.73 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.291 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.3 mt -99.37 129.97 45.61 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.049 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.3 m -103.85 143.99 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.058 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.7 m -157.94 166.2 17.04 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.09 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 108' ' ' GLN . 21.8 Cg_exo -65.97 171.32 10.17 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.609 2.206 . . . . 0.0 112.356 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.58 -34.6 78.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.623 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.3 m -67.34 -30.52 70.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.11 0.481 . . . . 0.0 109.874 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.401 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -69.41 -50.53 45.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.772 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.18 -41.52 99.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.646 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -56.55 -47.47 83.8 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.375 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.0 t -71.99 -40.5 68.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.795 0.331 . . . . 0.0 110.815 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.6 mt -54.36 -26.82 32.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.978 0.418 . . . . 0.0 110.598 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.408 ' CG2' ' HA2' ' A' ' 117' ' ' GLY . 8.2 mt -84.86 -43.18 17.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.791 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.98 -176.74 54.58 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.569 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -67.29 116.89 8.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.896 0.379 . . . . 0.0 111.079 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.57 11.82 57.7 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.999 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.408 ' HA2' ' CG2' ' A' ' 113' ' ' ILE . . . 75.64 2.58 69.88 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.995 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -52.83 -36.79 59.14 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 120.701 0.286 . . . . 0.0 111.609 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.9 mmtp -63.87 -65.27 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.192 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.39 -31.05 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.373 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.98 -46.55 88.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.038 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -73.21 -46.25 51.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.307 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 40.4 mm -54.84 -53.68 30.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.204 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -63.74 -39.92 95.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.26 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.33 -53.93 47.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.33 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.8 m -76.99 -33.47 57.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.294 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 17.8 m -52.34 -26.61 12.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.974 0.416 . . . . 0.0 110.125 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.84 -22.09 5.14 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.247 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -96.44 165.4 12.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.919 0.36 . . . . 0.0 111.073 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -105.16 138.01 42.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.694 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 27.6 m -99.11 145.07 10.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.16 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.701 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 0.7 OUTLIER -119.57 158.43 26.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.767 -179.685 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.5 p -120.74 122.13 67.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.792 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.382 -179.76 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.822 0.344 . . . . 0.0 110.834 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 15.7 m -123.35 -48.56 1.95 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.497 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 7.9 mt-10 -98.67 136.87 38.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.812 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 11.1 mtm-85 -115.6 155.3 27.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.93 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -122.43 135.98 54.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.988 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.701 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 21.9 mt -108.91 143.79 18.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.73 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.434 ' HB ' ' CB ' ' A' ' 132' ' ' GLN . 0.2 OUTLIER -113.62 116.84 30.12 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.178 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -103.78 124.5 58.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.143 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.46 146.32 44.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.171 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 149.52 -153.22 25.01 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.255 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.3 pt -87.12 156.39 54.64 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.642 0.258 . . . . 0.0 110.863 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -49.53 -34.65 34.49 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.621 2.214 . . . . 0.0 111.907 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.98 -34.66 69.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.391 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 18.6 m -70.37 -39.14 74.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.946 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 22.7 mm -72.64 -48.59 45.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.214 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.2 tt -58.21 -45.15 88.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.141 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -62.73 -36.67 83.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.707 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 3.9 t -58.22 -47.22 84.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.642 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 30.3 t -61.2 -42.09 92.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.979 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -35.59 75.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.78 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -67.24 -37.1 82.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.776 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 41.3 mt -74.02 -34.38 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.15 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 77.1 m -73.91 -45.15 52.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.076 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 11.6 p -62.36 -45.36 98.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.062 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 28.0 m -65.85 -45.6 90.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.058 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 50.8 mtp -57.6 -42.71 83.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.841 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 7.9 tt -72.55 -41.76 65.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.819 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.91 -2.67 24.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.977 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 52.6 p . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.838 179.915 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.849 0.357 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.6 t -145.39 158.35 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.144 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.14 129.49 55.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.506 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -128.84 153.4 47.48 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.175 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.5 m -135.91 112.76 10.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.502 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.6 tt -111.48 142.97 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.453 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.496 ' NH2' ' OE1' ' A' ' 143' ' ' GLU . 1.1 mpp_? -132.08 126.14 33.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.657 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.13 132.0 53.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.247 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.0 tt -102.23 136.32 42.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.632 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.99 155.39 46.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.892 0.377 . . . . 0.0 111.135 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -67.75 175.18 3.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.641 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.01 -41.96 96.69 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.91 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.66 -42.83 27.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.742 0.305 . . . . 0.0 111.677 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.56 -40.99 98.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.986 0.422 . . . . 0.0 110.537 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.495 ' O ' HG12 ' A' ' 29' ' ' ILE . 8.6 p -70.89 -32.44 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.657 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.42 -39.86 98.33 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.371 -0.919 . . . . 0.0 112.822 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.5 p -76.06 -35.49 59.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 25' ' ' VAL . 2.1 pp -79.83 -32.61 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 25' ' ' VAL . 9.8 mm -71.92 -54.58 16.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.916 0.388 . . . . 0.0 110.427 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.65 150.64 25.45 Favored Glycine 0 N--CA 1.436 -1.327 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.945 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.427 ' O ' ' CD ' ' A' ' 32' ' ' LYS . 8.3 mttm -59.67 146.54 40.77 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.478 -0.861 . . . . 0.0 111.214 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.455 ' HE3' ' HB3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 44.2 26.25 0.15 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.997 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.443 ' O ' HG23 ' A' ' 36' ' ' VAL . . . 50.88 18.63 2.91 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.685 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.455 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -75.44 -29.77 59.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.228 0.514 . . . . 0.0 109.992 179.308 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.39 -40.3 58.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.584 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -67.09 -26.25 36.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.23 -36.97 74.89 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -63.15 -37.43 87.18 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.396 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.5 ttm -59.33 -51.29 70.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.487 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -53.81 -51.35 63.79 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.159 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -59.27 -38.41 80.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.693 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.27 -20.42 34.51 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.1 t -90.44 -55.48 3.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.757 0.313 . . . . 0.0 111.554 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.53 -10.93 73.27 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.401 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.421 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . . . -110.73 128.91 55.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.588 0.232 . . . . 0.0 111.112 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.441 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.8 OUTLIER -27.01 140.12 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.204 0.602 . . . . 0.0 112.386 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 45' ' ' ALA . 25.6 mt -142.32 100.55 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.558 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.47 129.99 52.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.751 0.31 . . . . 0.0 111.011 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 3.4 mp -108.4 142.47 20.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.197 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.8 p -161.64 -170.73 2.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.922 0.392 . . . . 0.0 111.317 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.407 ' CB ' ' CD1' ' A' ' 58' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.035 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 -145.75 132.71 20.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.851 0.357 . . . . 0.0 110.885 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 46.4 mt -98.05 105.91 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.756 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.7 mp -86.07 97.61 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.212 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 62.5 m -87.49 136.83 32.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.925 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 2.1 tt -131.42 134.24 46.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.486 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -133.12 130.71 39.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.685 0.278 . . . . 0.0 111.158 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.421 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.26 164.41 13.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.707 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -40.75 161.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.019 2.479 . . . . 0.0 113.179 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.401 ' O ' HG21 ' A' ' 68' ' ' ILE . 8.5 m -60.21 -35.64 75.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.115 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 -64.73 -51.88 60.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.362 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.97 -42.4 80.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.957 0.408 . . . . 0.0 110.974 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.401 HG21 ' O ' ' A' ' 65' ' ' THR . 0.5 OUTLIER -66.3 -39.65 84.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.335 -179.334 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -46.12 90.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.061 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -51.2 70.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.991 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.37 -41.64 80.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.29 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.437 ' O ' HG13 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -60.37 -39.43 87.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.912 0.387 . . . . 0.0 110.889 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.92 -29.86 68.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.312 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -48.46 14.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.699 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 72' ' ' PHE . 0.7 OUTLIER -59.78 -39.08 78.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.288 -179.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 pp -72.48 -37.03 56.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.853 0.359 . . . . 0.0 111.012 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -65.48 -46.94 77.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.498 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.04 -35.3 74.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.012 0.434 . . . . 0.0 110.018 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.7 tp -76.58 -27.27 55.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.141 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.84 -34.13 57.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.696 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.23 -44.28 63.13 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.758 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.868 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.465 -0.187 0 CA-C-O 120.819 0.258 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.6 m -141.02 117.08 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.739 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.8 m -103.01 141.51 35.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.808 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.97 117.78 11.69 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -100.91 112.64 25.12 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.166 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.51 137.37 47.45 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.229 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.74 148.93 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.4 t -152.81 143.67 15.81 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.227 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' A' ' 108' ' ' GLN . 20.9 Cg_exo -65.78 163.16 31.65 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.45 2.1 . . . . 0.0 112.192 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.94 -34.96 76.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.666 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.4 m -70.46 -30.48 67.33 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.426 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 26.4 mm-40 -71.79 -49.48 38.37 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.435 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 2.9 t -64.49 -41.46 96.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.307 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -54.66 -51.81 49.91 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.219 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.9 -35.43 69.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.908 0.385 . . . . 0.0 110.405 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.67 -25.86 66.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.35 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.411 ' CG2' ' HA2' ' A' ' 117' ' ' GLY . 9.3 mt -84.68 -36.9 12.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.776 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.17 -178.73 16.2 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.505 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.46 129.63 40.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.883 0.373 . . . . 0.0 111.128 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 60.44 17.1 46.34 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.938 -0.648 . . . . 0.0 113.008 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.411 ' HA2' ' CG2' ' A' ' 113' ' ' ILE . . . 67.65 9.53 55.93 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.991 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 4.6 t -53.14 -35.53 59.82 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.801 0.334 . . . . 0.0 111.493 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -64.09 0.93 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.274 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.1 tt -54.11 -26.94 15.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.822 0.344 . . . . 0.0 111.253 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -48.24 66.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.943 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -73.09 -36.11 66.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.177 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 16.4 mt -67.93 -48.29 75.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.217 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.04 -48.18 59.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.303 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -54.46 -35.29 62.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.46 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 99.9 p -90.21 -35.41 15.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.706 0.289 . . . . 0.0 111.329 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.4 m -52.14 -26.09 10.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.889 0.376 . . . . 0.0 110.106 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.11 -20.18 22.39 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.936 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -108.17 167.75 9.78 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.809 0.338 . . . . 0.0 111.132 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -105.08 129.95 53.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.892 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 147' ' ' THR . 13.2 m -99.29 139.14 21.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.067 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.617 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 1.1 tt0 -125.61 116.61 22.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.174 0.511 . . . . 0.0 112.178 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.3 p -97.46 136.75 27.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.408 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.056 179.922 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.6 m . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.796 0.331 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 10.9 t -115.96 -39.77 3.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.84 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.496 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 18.3 mt-10 -127.56 136.91 52.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.826 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.5 mtt180 -113.49 171.74 7.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.73 136.41 53.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.086 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.617 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 40.0 mt -105.86 124.32 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.736 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.461 ' HB ' ' CB ' ' A' ' 132' ' ' GLN . 4.4 m -97.77 114.76 26.85 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.523 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 23.6 mt -106.34 110.47 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.421 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.36 122.7 43.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.646 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 171.09 -151.38 15.6 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.543 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.503 ' CG2' ' HD2' ' A' ' 152' ' ' PRO . 1.4 mp -80.99 144.72 55.5 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.503 ' HD2' ' CG2' ' A' ' 151' ' ' ILE . 82.6 Cg_exo -49.02 -31.04 19.52 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 121.987 1.792 . . . . 0.0 111.587 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -72.03 -34.68 69.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.727 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 66.9 m -65.08 -44.81 87.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.734 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 4.3 mt -66.03 -51.32 61.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.195 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 23.0 mt -55.89 -28.49 24.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.991 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -73.39 -41.24 63.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.942 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -67.09 -48.48 68.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.014 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 11.5 p -60.53 -38.19 77.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.248 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.33 -42.83 74.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.032 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -65.83 -49.39 68.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.036 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 17.2 tt -64.15 -45.07 97.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.197 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 12.6 t -62.54 -48.52 79.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.991 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 53.2 t -60.0 -52.69 58.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.094 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 33.2 t -62.05 -34.72 64.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.233 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 9.5 tmm? -59.9 -51.89 67.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.994 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.9 tt -58.94 -55.73 31.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.992 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.89 -2.62 24.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.072 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.901 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.882 0.372 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.407 ' CG2' ' N ' ' A' ' 13' ' ' THR . 12.5 p -116.77 166.04 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.052 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -103.13 141.96 34.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.595 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.5 mt -136.14 177.24 7.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.171 0.51 . . . . 0.0 111.447 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.2 m -141.71 113.07 7.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.557 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.63 126.47 69.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.976 0.417 . . . . 0.0 111.471 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.483 ' NH2' ' OE2' ' A' ' 143' ' ' GLU . 81.9 mtm-85 -112.57 116.31 30.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.446 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.59 119.6 37.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.237 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.8 pp -113.38 133.96 54.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.825 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.23 177.02 8.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.959 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -67.57 166.0 15.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.61 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.73 -31.96 72.9 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.925 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -78.37 -42.27 30.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.806 0.336 . . . . 0.0 111.335 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -67.79 -43.11 80.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.917 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.407 ' HA ' ' CG2' ' A' ' 28' ' ' ILE . 18.2 m -65.48 -40.39 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.314 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.91 -41.35 99.9 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.892 -0.67 . . . . 0.0 113.229 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.6 m -75.96 -35.64 59.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.721 0.296 . . . . 0.0 111.63 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.407 ' CG2' ' HA ' ' A' ' 25' ' ' VAL . 2.7 tp -76.73 -50.52 21.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.746 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 31.4 mt -60.19 -42.43 90.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.914 0.388 . . . . 0.0 110.752 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.409 ' HA3' ' CB ' ' A' ' 35' ' ' SER . . . 99.82 150.84 25.53 Favored Glycine 0 N--CA 1.435 -1.399 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.556 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.411 ' C ' ' HG3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -57.98 146.42 32.59 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.825 -0.688 . . . . 0.0 111.378 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.521 ' HD2' ' HB2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 44.01 27.04 0.17 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.956 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 50.6 19.64 3.32 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 114.512 0.565 . . . . 0.0 114.512 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.521 ' HB2' ' HD2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -76.98 -35.44 57.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.755 0.778 . . . . 0.0 109.966 179.095 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.444 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -68.81 -43.14 76.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.65 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.7 p -67.36 -27.04 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.91 -36.7 82.85 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 176.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.444 ' HB3' ' O ' ' A' ' 35' ' ' SER . 0.5 OUTLIER -69.71 -34.66 74.2 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.517 -1.219 . . . . 0.0 108.948 177.792 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -67.34 -41.22 85.56 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.101 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.4 ttp-105 -58.48 -51.35 70.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.194 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -59.76 -38.51 81.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.807 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -75.27 -36.27 61.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.693 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.7 t -73.02 -49.27 29.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.28 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.18 -8.96 78.66 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.292 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.427 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . . . -110.91 128.48 55.82 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.6 0.238 . . . . 0.0 111.156 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.8 OUTLIER -27.23 136.74 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.221 179.356 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.2 mt -142.7 100.47 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.979 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -115.88 165.84 12.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.916 0.389 . . . . 0.0 111.421 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.403 ' CG1' ' CD1' ' A' ' 59' ' ' ILE . 3.2 mp -126.47 151.74 33.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.798 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.59 -178.64 0.75 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.983 0.42 . . . . 0.0 111.4 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.421 ' CB ' ' CD1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.12 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 120.677 0.275 . . . . 0.0 110.516 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.71 127.59 15.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.857 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.421 ' CD1' ' CB ' ' A' ' 51' ' ' GLU . 19.1 mt -102.22 110.67 29.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.403 ' CD1' ' CG1' ' A' ' 49' ' ' ILE . 26.3 mm -94.62 96.38 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.088 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.0 m -76.33 139.14 40.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.795 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -131.29 133.27 45.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.267 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -133.03 129.31 37.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.79 0.328 . . . . 0.0 111.109 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.427 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.15 164.18 13.35 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.726 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 94.6 Cg_exo -42.2 161.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.106 2.537 . . . . 0.0 113.07 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.1 m -59.97 -35.72 75.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.974 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -62.42 -51.88 65.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.224 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.99 -37.64 71.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.008 0.432 . . . . 0.0 110.989 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.421 HG21 ' N ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -66.21 -39.36 84.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.194 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.421 ' N ' HG21 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -63.76 -47.28 81.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.888 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.74 -51.91 67.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.745 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.11 -58.37 8.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.315 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -49.2 -32.53 10.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.33 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.21 -41.59 81.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.11 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -75.91 -32.84 59.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.055 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.2 mt -68.11 -43.63 85.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.963 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.1 pt -67.88 -40.34 83.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.971 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.03 -41.04 95.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.443 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.3 tptt -61.87 -35.92 79.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.055 0.455 . . . . 0.0 110.048 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.7 tp -77.39 -28.15 52.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.435 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -76.69 -35.11 58.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.649 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.29 -42.75 65.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.824 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.041 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo . . . . . 0 N--CA 1.465 -0.201 0 CA-C-O 120.737 0.224 . . . . 0.0 111.938 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.7 t -140.88 111.87 3.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.347 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 16.0 m -103.41 134.28 47.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.634 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.4 mp -139.91 117.76 11.71 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 -101.98 112.5 25.16 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.132 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.1 mp -113.47 162.32 16.28 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.935 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.3 p -98.73 136.42 29.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.022 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.433 ' CG1' ' HD2' ' A' ' 105' ' ' PRO . 25.4 t -138.66 145.37 45.93 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.104 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.433 ' HD2' ' CG1' ' A' ' 104' ' ' VAL . 21.6 Cg_exo -65.99 159.92 46.85 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.475 2.116 . . . . 0.0 112.146 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.99 -34.64 75.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.5 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 m -69.48 -30.45 68.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.168 0.508 . . . . 0.0 109.771 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.34 -50.54 38.02 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.463 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 53.5 t -62.19 -43.48 98.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.381 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -53.89 -47.52 65.46 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.395 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.85 -40.31 69.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.804 0.335 . . . . 0.0 110.644 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 19.1 mt -55.97 -27.82 54.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.0 0.428 . . . . 0.0 110.486 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.415 ' CG2' ' HA2' ' A' ' 117' ' ' GLY . 28.0 mm -82.07 -39.89 16.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.582 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.66 -177.67 26.02 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.501 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -67.54 125.15 25.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.894 0.378 . . . . 0.0 111.129 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.72 13.1 58.46 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.989 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.415 ' HA2' ' CG2' ' A' ' 113' ' ' ILE . . . 70.84 7.31 61.6 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.974 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 5.2 t -53.0 -39.64 63.24 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.786 0.326 . . . . 0.0 111.695 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.33 -65.36 0.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.286 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.6 tp -55.83 -32.22 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.356 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.26 -52.3 66.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.157 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -73.08 -40.95 64.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.432 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 53.8 mt -57.24 -53.65 40.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.362 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.03 -38.25 72.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.353 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -54.84 -39.95 69.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.615 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.07 -37.55 11.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.602 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 17.2 m -49.73 -26.14 3.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.887 0.375 . . . . 0.0 110.265 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.46 -12.14 28.37 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.825 -0.702 . . . . 0.0 113.224 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -108.27 146.3 33.08 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.953 0.377 . . . . 0.0 111.299 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.16 129.52 43.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.597 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.7 m -99.28 150.38 5.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.351 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.658 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 11.4 tt0 -122.65 158.55 29.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.01 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.6 m -137.45 140.89 40.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.227 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.125 179.935 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.86 0.362 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.57 -50.56 2.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.639 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.483 ' OE2' ' NH2' ' A' ' 17' ' ' ARG . 10.1 mt-10 -115.09 137.92 51.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.679 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -109.88 176.99 4.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.909 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -110.41 130.7 55.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.166 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.658 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 0.5 OUTLIER -113.55 140.03 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.772 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.477 ' HB ' ' HB2' ' A' ' 132' ' ' GLN . 0.7 OUTLIER -115.98 114.99 25.37 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.304 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.6 pt -106.78 123.43 61.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.11 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.48 136.2 53.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.101 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 160.87 -162.88 33.88 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.513 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.7 pt -87.02 161.49 46.71 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.61 0.243 . . . . 0.0 110.95 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.4 -40.0 44.4 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.431 2.087 . . . . 0.0 112.041 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -64.69 -34.7 78.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.301 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 61.8 m -69.4 -34.02 73.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.71 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 26.6 mt -73.09 -53.34 18.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.945 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.7 mm -59.15 -28.63 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.061 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -75.17 -40.16 59.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.033 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -72.14 -38.91 69.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.183 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 12.1 p -69.98 -41.96 79.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.393 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 8.3 pttt -65.54 -38.58 90.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.039 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -64.42 -49.41 71.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.44 HG21 HD13 ' A' ' 162' ' ' ILE . 0.0 OUTLIER -64.78 -34.52 70.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.977 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 34.1 m -67.76 -43.4 79.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 54.0 t -59.6 -52.68 58.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.9 p -64.26 -30.4 50.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.021 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -59.31 -51.57 69.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.951 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 9.6 mt -70.03 -45.91 66.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.949 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -73.99 -2.48 24.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.052 0.454 . . . . 0.0 112.018 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.848 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.528 0.132 0 CA-C-O 120.989 0.423 . . . . 0.0 111.554 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 64' ' ' PRO . 20.3 t -120.56 158.26 22.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.913 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -103.77 139.34 39.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.029 -179.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.0 mt -143.02 166.1 25.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.008 0.433 . . . . 0.0 111.188 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 m -142.73 140.65 31.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.632 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.8 tt -140.87 152.51 20.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.972 0.415 . . . . 0.0 111.479 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.487 ' NH2' ' OE2' ' A' ' 143' ' ' GLU . 2.8 ttm-85 -134.99 129.68 34.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.389 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.02 135.23 51.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.947 0.403 . . . . 0.0 111.121 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.8 mp -93.32 115.0 27.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.628 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -107.87 141.02 40.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.951 0.405 . . . . 0.0 110.89 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -67.6 163.89 20.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.602 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.441 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -58.7 -45.05 95.32 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.699 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.45 -43.28 27.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.985 0.422 . . . . 0.0 110.91 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.01 -32.79 73.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.508 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.501 ' O ' HG12 ' A' ' 29' ' ' ILE . 9.8 p -76.95 -31.22 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.474 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.48 ' N ' HG12 ' A' ' 25' ' ' VAL . . . -62.36 -42.71 99.7 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.441 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.9 m -75.87 -37.24 59.12 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.669 0.271 . . . . 0.0 111.605 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.467 ' CG1' ' HA ' ' A' ' 25' ' ' VAL . 1.7 pp -76.29 -32.7 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 120.787 0.327 . . . . 0.0 111.879 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 25' ' ' VAL . 10.9 mm -70.68 -54.74 16.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.253 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.56 150.29 25.13 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-O 121.769 0.649 . . . . 0.0 113.026 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.561 ' HB3' ' HD3' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -67.13 146.37 54.33 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.413 -0.893 . . . . 0.0 111.113 179.606 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.561 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER 63.71 6.82 2.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.37 -179.603 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.459 ' O ' HG22 ' A' ' 36' ' ' VAL . . . 57.71 12.67 10.5 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 119.84 -1.171 . . . . 0.0 111.648 -178.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -76.78 -28.93 55.84 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.918 0.39 . . . . 0.0 110.091 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.33 -41.5 63.43 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.184 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -67.16 -26.38 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.552 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.98 -36.87 75.53 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.49 -37.45 86.04 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.776 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -52.45 63.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.432 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -50.56 -51.21 50.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.206 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -57.98 -38.04 75.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.72 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -75.11 -36.11 61.68 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.6 p -82.69 -55.75 4.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.846 0.355 . . . . 0.0 111.66 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.9 -5.62 66.46 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.426 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.422 ' O ' ' C ' ' A' ' 46' ' ' ARG . . . -110.67 128.83 55.86 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.688 0.28 . . . . 0.0 111.138 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 47.8 ttm-85 -27.16 137.84 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.339 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.2 mt -142.27 100.43 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.705 0.288 . . . . 0.0 110.471 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.95 171.38 7.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.724 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 6.0 mt -126.7 149.78 31.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.954 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.88 -169.3 1.96 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.911 0.386 . . . . 0.0 111.302 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.029 -179.884 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.422 ' HB2' ' N ' ' A' ' 22' ' ' GLY . 2.7 mt-10 . . . . . 0 N--CA 1.47 0.533 0 CA-C-O 120.657 0.265 . . . . 0.0 110.577 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.88 142.15 28.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.987 0.422 . . . . 0.0 111.626 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 25.5 mt -123.25 131.16 73.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.127 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.0 mt -109.24 106.12 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.87 0.367 . . . . 0.0 111.766 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 66.9 m -93.05 139.17 30.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.805 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.449 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 6.3 tt -131.5 137.26 48.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.726 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.55 132.37 37.13 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.563 0.22 . . . . 0.0 110.851 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.412 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.19 164.83 14.11 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.261 -0.971 . . . . 0.0 112.928 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 95.7 Cg_exo -42.47 159.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.986 2.457 . . . . 0.0 113.041 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.8 m -60.28 -35.69 76.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.981 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -66.34 -52.02 51.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.15 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.77 -37.64 71.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.408 HG23 ' N ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -66.36 -39.24 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.157 -179.643 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.408 ' N ' HG23 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -59.43 -51.9 67.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.842 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -43.83 88.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.587 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.48 -45.54 76.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.22 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -58.46 -50.3 74.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.207 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.0 -36.99 68.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.599 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.85 -40.0 49.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.23 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.1 mt -62.42 -51.46 72.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.652 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.22 -38.54 80.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.991 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.26 -29.59 65.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.416 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -35.33 80.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.054 0.454 . . . . 0.0 109.81 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.9 tp -76.65 -31.69 57.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.172 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -76.79 -32.85 57.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.769 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -72.25 -36.85 69.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.783 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.992 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo . . . . . 0 C--O 1.231 0.133 0 CA-C-O 120.895 0.289 . . . . 0.0 112.198 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.4 t -126.21 103.36 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.95 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 11.0 t -113.26 133.49 55.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.01 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.6 tp -139.94 117.86 11.77 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.443 ' HA ' ' O ' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -107.62 112.67 25.51 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.631 -178.684 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 28.5 mt -102.64 155.38 18.33 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.903 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.0 t -106.71 141.15 22.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.17 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.4 m -145.44 155.94 53.47 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.124 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.402 ' HG2' ' HB2' ' A' ' 108' ' ' GLN . 36.4 Cg_endo -66.64 162.86 35.23 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.552 2.168 . . . . 0.0 112.583 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.63 -34.51 69.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.502 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.1 m -67.24 -30.71 70.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.151 0.501 . . . . 0.0 109.823 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.402 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -67.58 -45.4 75.65 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.525 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 42.7 t -66.68 -49.32 66.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.63 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -49.29 -51.96 24.68 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.522 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.9 p -71.84 -40.21 69.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.765 0.317 . . . . 0.0 110.545 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.4 mt -54.93 -28.72 53.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.045 0.45 . . . . 0.0 110.246 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.413 ' CG2' ' HA2' ' A' ' 117' ' ' GLY . 17.9 mt -80.02 -44.6 22.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.552 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 76.94 -173.25 54.88 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.588 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.5 tptp -64.56 118.98 9.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.894 0.378 . . . . 0.0 111.197 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 56.85 20.32 32.65 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.987 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.413 ' HA2' ' CG2' ' A' ' 113' ' ' ILE . . . 71.8 6.98 64.62 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.988 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 30.9 p -53.1 -40.12 63.9 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 120.826 0.346 . . . . 0.0 111.707 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.26 -65.29 0.69 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.5 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -55.1 -34.29 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.581 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -60.64 -45.09 95.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.011 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -73.11 -32.37 64.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.101 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 26.7 mt -64.24 -43.38 97.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.184 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.84 -42.7 60.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.92 0.391 . . . . 0.0 111.017 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -58.83 -35.37 72.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.733 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.8 t -93.45 -45.55 7.73 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.675 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.1 m -48.37 -25.64 1.7 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.874 0.368 . . . . 0.0 110.275 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.48 -9.49 41.94 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.048 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -108.29 153.72 22.84 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.932 0.366 . . . . 0.0 111.201 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -99.7 141.29 32.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.732 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.409 ' HB ' ' CD1' ' A' ' 146' ' ' ILE . 11.4 m -99.22 157.9 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.356 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.782 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 0.1 OUTLIER -128.78 158.45 38.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.447 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.0 t -129.39 118.87 47.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.967 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.242 -179.862 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.835 0.35 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.9 t -115.49 -41.82 3.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.699 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.487 ' OE2' ' NH2' ' A' ' 17' ' ' ARG . 15.2 pt-20 -118.17 139.13 51.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.703 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -109.91 168.2 9.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.938 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.56 134.33 54.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.303 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.782 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 1.5 tt -116.37 131.94 67.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.519 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.492 ' HB ' ' CB ' ' A' ' 132' ' ' GLN . 1.0 OUTLIER -109.45 116.05 31.08 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.715 -179.554 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 4.7 tp -104.89 121.99 57.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.742 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.39 140.41 49.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.204 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 166.14 -154.29 24.76 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.355 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.405 ' HB ' ' HD2' ' A' ' 152' ' ' PRO . 1.2 pt -87.06 161.96 45.17 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.59 0.234 . . . . 0.0 110.839 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 151' ' ' ILE . 73.7 Cg_exo -49.51 -34.96 35.31 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.315 2.01 . . . . 0.0 112.209 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.06 -34.74 68.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.817 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 53.1 p -74.25 -41.15 61.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.971 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -68.73 -41.28 82.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.175 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.1 tp -69.68 -32.83 53.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.141 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -69.84 -49.22 54.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.894 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -58.61 -53.1 62.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.097 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 30.1 t -57.35 -35.53 49.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.296 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 10.5 tptp -68.32 -32.91 73.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.978 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -72.06 -38.32 69.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.033 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 36.0 mm -74.01 -34.48 39.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.2 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.17 -37.47 69.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.099 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 14.0 p -74.36 -39.68 48.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.456 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 36.0 m -69.5 -45.59 78.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.418 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 5.6 ptm -62.01 -45.93 91.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.928 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.13 -51.11 41.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.931 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -74.02 -2.53 24.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.959 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.93 0.395 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 64' ' ' PRO . 21.5 t -126.28 152.65 33.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.97 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 1.4 m -103.25 146.91 27.73 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.682 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.3 pp -158.21 139.77 13.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.531 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 62' ' ' ALA . 58.3 m -113.12 129.92 56.35 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.31 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.426 HD13 ' CE2' ' A' ' 72' ' ' PHE . 2.0 pt -112.13 163.98 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.223 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.493 ' NH2' ' OE2' ' A' ' 143' ' ' GLU . 0.9 OUTLIER -133.96 123.06 23.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.834 179.765 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.41 HD23 ' CE1' ' A' ' 72' ' ' PHE . 67.5 mt -114.58 119.87 38.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.201 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.8 128.1 55.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.723 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.42 ' HB2' ' CG1' ' A' ' 25' ' ' VAL . 0.9 OUTLIER -142.11 162.38 35.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.835 0.35 . . . . 0.0 111.208 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -70.2 163.45 26.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.888 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.19 -35.83 20.56 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.659 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -51.4 10.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.922 0.361 . . . . 0.0 111.958 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.93 -33.56 74.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.818 0.342 . . . . 0.0 110.991 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.514 ' O ' HG12 ' A' ' 29' ' ' ILE . 15.4 m -71.54 -39.96 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.083 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.406 ' N ' HG21 ' A' ' 25' ' ' VAL . . . -62.01 -35.16 91.02 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.635 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 p -75.45 -33.55 60.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.668 0.271 . . . . 0.0 111.388 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.467 HG23 ' HA ' ' A' ' 25' ' ' VAL . 1.7 tp -79.21 -47.09 22.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.451 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' ' 25' ' ' VAL . 8.1 mm -57.25 -50.25 77.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.872 0.368 . . . . 0.0 110.204 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.9 150.32 26.18 Favored Glycine 0 N--CA 1.437 -1.278 0 CA-C-O 121.747 0.637 . . . . 0.0 113.012 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.412 ' C ' ' HD3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -62.42 145.9 52.84 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.528 -0.836 . . . . 0.0 111.321 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.421 ' HG2' ' HB2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 51.36 18.89 0.69 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.461 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.493 ' O ' HG21 ' A' ' 36' ' ' VAL . . . 53.69 11.32 1.91 Allowed Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.936 -0.65 . . . . 0.0 114.26 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.421 ' HB2' ' HG2' ' A' ' 32' ' ' LYS . 4.0 tp10 -74.69 -27.2 60.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.536 0.668 . . . . 0.0 109.735 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.39 -39.84 58.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.514 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.493 HG21 ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -67.28 -26.34 35.91 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.588 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -70.66 -36.73 73.52 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -62.61 -34.73 77.62 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.936 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -43.05 81.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.711 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 44.9 mtp85 -58.1 -51.15 70.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.846 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -63.86 -38.02 89.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.037 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.84 -35.7 62.4 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 53.2 p -88.34 -55.79 3.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.937 0.399 . . . . 0.0 110.879 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.14 4.76 62.74 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.193 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.414 ' HB1' ' HA3' ' A' ' 63' ' ' GLY . . . -110.77 127.31 55.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.077 0.438 . . . . 0.0 111.317 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 45' ' ' ALA . 1.8 mpt_? -27.75 104.3 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.275 0.63 . . . . 0.0 112.551 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.8 mt -107.45 100.58 11.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.832 0.348 . . . . 0.0 110.935 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.39 169.94 8.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.256 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.416 ' CG2' ' HD2' ' A' ' 57' ' ' ARG . 13.9 mt -126.46 152.13 33.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.144 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.406 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . 33.1 t -92.12 -161.4 0.82 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.738 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 . . . . . 0 N--CA 1.463 0.189 0 CA-C-O 121.2 0.524 . . . . 0.0 112.144 -179.046 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.224 -0.246 0 CA-C-O 120.624 0.25 . . . . 0.0 110.659 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.506 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 3.0 mmt180 -144.5 136.55 26.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.874 0.368 . . . . 0.0 110.992 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 18' ' ' LEU . 4.5 mm -115.64 106.8 21.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.555 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.1 mt -85.98 94.05 4.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.882 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.0 m -80.04 101.87 8.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.138 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.28 144.79 25.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.908 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 15' ' ' THR . . . -143.76 124.71 14.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.777 0.323 . . . . 0.0 111.051 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.414 ' HA3' ' HB1' ' A' ' 45' ' ' ALA . . . 157.57 164.0 13.28 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.159 -1.02 . . . . 0.0 113.104 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.594 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 78.6 Cg_exo -41.48 160.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 123.555 2.836 . . . . 0.0 113.798 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.6 t -57.89 -35.72 71.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.135 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.37 -52.48 46.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.917 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.35 -43.32 83.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.316 0.579 . . . . 0.0 110.429 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.53 -39.4 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.842 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.85 -36.51 67.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.763 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.08 -38.94 63.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.691 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.65 -48.25 77.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.149 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.476 ' O ' HG13 ' A' ' 75' ' ' ILE . 1.2 m-85 -64.04 -43.06 96.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.78 -29.26 67.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.306 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.6 tpt -77.29 -48.3 17.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.688 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 72' ' ' PHE . 2.2 pp -59.81 -42.98 90.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.252 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.6 pt -68.76 -36.01 72.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.852 0.358 . . . . 0.0 111.017 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -62.35 -47.63 83.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.024 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -62.39 -35.22 78.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.967 0.413 . . . . 0.0 110.149 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.489 ' N ' ' HG3' ' A' ' 78' ' ' LYS . 16.2 tp -77.53 -26.18 50.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.069 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -76.95 -35.71 57.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.597 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -72.07 -38.09 69.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.778 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.863 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 N--CA 1.465 -0.164 0 CA-C-O 120.83 0.263 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.2 t -140.32 113.19 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.654 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.22 140.21 37.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.271 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 tt -139.83 117.76 11.76 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.22 112.7 25.91 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.788 -178.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.37 147.53 29.13 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.741 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.1 t -100.6 138.04 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.273 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 m -144.87 157.54 54.4 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.001 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -65.89 157.63 58.15 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.596 2.197 . . . . 0.0 112.143 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.86 -34.84 76.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.391 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.1 m -70.55 -30.3 66.99 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -70.94 -46.54 62.25 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.628 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 21.6 m -61.8 -40.03 93.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.389 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.75 -50.12 71.14 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.21 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.1 m -67.59 -38.7 84.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 0.0 110.724 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.8 mt -57.3 -27.77 62.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.476 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 12.6 mt -83.14 -34.28 11.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.786 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.63 178.55 6.27 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.558 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -67.49 132.53 47.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.818 0.342 . . . . 0.0 110.882 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.73 16.77 59.52 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.633 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 63.1 15.74 56.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.871 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 95.9 m -52.88 -43.64 66.29 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.869 0.366 . . . . 0.0 111.401 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -63.68 -58.56 6.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.129 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.6 tt -54.22 -31.44 22.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.315 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.16 -41.93 89.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.856 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -73.23 -40.2 64.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.082 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 50.2 mt -58.61 -53.42 47.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.297 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.27 -40.42 86.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.969 0.414 . . . . 0.0 111.077 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -54.54 -48.36 72.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.881 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.48 -39.02 17.94 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 18.2 m -49.37 -26.38 3.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.845 0.355 . . . . 0.0 110.333 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.42 -21.85 4.17 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.333 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -108.27 170.89 7.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.949 0.374 . . . . 0.0 111.149 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.7 130.45 44.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.705 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 36.0 m -99.26 140.52 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.164 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.63 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -109.11 158.39 17.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.197 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.5 t -137.53 134.99 46.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.181 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.077 179.933 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.792 0.33 . . . . 0.0 110.815 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 13.2 t -118.57 -46.56 2.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.887 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.493 ' OE2' ' NH2' ' A' ' 17' ' ' ARG . 3.0 mt-10 -104.07 137.74 41.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.7 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -109.97 140.84 43.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.93 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.42 153.46 17.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.17 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.63 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 74.9 mt -125.18 140.05 49.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.667 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.483 ' HB ' ' HB2' ' A' ' 132' ' ' GLN . 0.2 OUTLIER -119.07 114.93 23.26 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.409 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -104.1 121.47 55.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.109 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.39 134.71 54.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.13 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 162.13 -151.91 22.09 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.532 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.9 pt -87.0 162.06 45.07 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.57 0.224 . . . . 0.0 110.962 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.62 -32.84 29.3 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.517 2.144 . . . . 0.0 112.218 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -34.65 69.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.757 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 10.6 p -67.92 -50.29 56.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.039 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 2.7 mp -59.33 -51.52 71.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.157 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -55.84 -30.7 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.135 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -69.26 -48.0 63.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.834 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 17.7 t -61.58 -44.06 97.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.96 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.9 t -59.49 -38.95 77.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.956 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -32.86 74.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.711 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -71.71 -45.67 61.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.416 HD12 HG22 ' A' ' 162' ' ' ILE . 30.5 mm -69.92 -34.41 59.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.044 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 47.7 t -65.42 -52.4 53.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.117 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 12.3 p -61.49 -45.14 99.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.225 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 54.8 t -63.82 -40.28 88.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.914 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 32.4 mtt -56.98 -45.63 82.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.808 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 7.8 tt -65.11 -45.19 86.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.804 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.96 -2.72 25.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.902 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 39.1 p . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.887 -179.953 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.717 0.294 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 64' ' ' PRO . 11.5 t -115.09 154.98 16.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.812 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.21 131.36 55.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.693 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -130.44 158.49 39.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.148 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.2 m -141.97 133.59 26.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.749 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.8 tt -137.36 148.03 26.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.354 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.487 ' NH2' ' OE1' ' A' ' 143' ' ' GLU . 0.0 OUTLIER -129.35 131.1 46.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.709 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.58 139.22 53.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.103 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.6 pp -108.72 136.02 48.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.758 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.11 162.4 33.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.827 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.403 ' O ' ' CG1' ' A' ' 25' ' ' VAL . 3.8 m-70 -67.58 169.63 8.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.536 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.65 -44.77 96.59 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.103 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.402 ' HG2' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -78.5 -38.51 40.58 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.266 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.402 ' N ' ' HG2' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -67.69 -50.74 56.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.925 0.393 . . . . 0.0 110.655 -179.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.403 ' CG1' ' O ' ' A' ' 21' ' ' HIS . 9.8 p -63.44 -35.02 70.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.841 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.16 -34.92 90.63 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.32 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.3 m -75.38 -28.2 59.39 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.802 0.334 . . . . 0.0 110.68 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.427 HD11 ' N ' ' A' ' 28' ' ' ILE . 3.6 mm -78.84 -45.61 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.08 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.42 ' HA ' ' CG1' ' A' ' 36' ' ' VAL . 13.0 mt -60.59 -42.56 92.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.385 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.65 150.34 16.68 Favored Glycine 0 N--CA 1.435 -1.427 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.611 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.544 ' HG2' ' HG3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -58.15 145.75 35.88 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.593 -0.804 . . . . 0.0 111.588 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.544 ' HG3' ' HG2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER 45.98 27.93 0.56 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.248 -178.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.485 ' O ' HG23 ' A' ' 36' ' ' VAL . . . 47.29 17.92 0.45 Allowed Glycine 0 CA--C 1.522 0.507 0 N-CA-C 114.784 0.673 . . . . 0.0 114.784 178.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.543 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 2.7 tm-20 -75.27 -25.46 58.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.752 0.776 . . . . 0.0 109.856 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -41.87 59.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.415 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -67.24 -26.21 35.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 178.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.6 -36.75 70.94 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -62.94 -35.82 81.38 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.852 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -43.46 87.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.392 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -56.63 -51.05 70.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.131 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -61.55 -37.5 84.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.778 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -74.62 -36.48 62.94 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.5 p -92.57 -55.86 3.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.862 0.363 . . . . 0.0 111.145 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.33 0.78 50.62 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.041 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.422 ' O ' ' C ' ' A' ' 46' ' ' ARG . . . -110.76 128.16 55.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.877 0.338 . . . . 0.0 111.654 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 2.6 ttt180 -27.44 141.07 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.061 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.6 mt -142.32 100.44 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.76 0.314 . . . . 0.0 111.301 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -116.09 173.46 6.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.724 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.405 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 4.8 mt -126.5 151.97 33.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.121 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 94.3 p -83.74 -171.28 3.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.199 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.382 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 120.894 0.378 . . . . 0.0 110.782 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.405 ' NE ' ' CG2' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -145.87 135.37 23.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.54 179.266 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.1 mt -98.44 115.96 40.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.804 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.2 mt -86.62 101.21 10.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.285 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 89.2 m -90.01 138.25 31.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.94 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 7.3 tt -131.51 132.9 44.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.264 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -128.68 133.85 48.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.742 0.306 . . . . 0.0 111.12 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.28 164.46 13.72 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.754 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 82.4 Cg_exo -39.58 162.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.147 2.565 . . . . 0.0 113.29 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.4 ' O ' HG22 ' A' ' 68' ' ' ILE . 73.5 m -59.69 -35.66 74.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.29 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -64.2 -51.96 61.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.782 0.325 . . . . 0.0 111.319 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.04 -37.98 72.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.351 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -66.16 -39.48 84.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.538 -179.231 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.417 ' N ' HG22 ' A' ' 68' ' ' ILE . 0.1 OUTLIER -63.26 -49.3 74.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.366 -179.66 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.67 -47.23 82.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.117 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.04 -56.3 23.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.316 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -53.35 -42.52 66.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.339 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.27 -48.05 81.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.48 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 20.7 mmm -70.45 -33.88 71.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.178 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.6 mt -68.09 -38.26 79.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.473 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 36.6 pt -71.47 -38.44 68.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.071 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.39 -47.41 82.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.659 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.31 -36.39 83.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.947 0.403 . . . . 0.0 110.058 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.5 tp -77.58 -23.08 50.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.47 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -76.4 -49.31 17.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.99 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -72.27 -32.32 66.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.862 0.363 . . . . 0.0 111.067 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.0 t70 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.824 -179.438 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.837 0.265 . . . . 0.0 112.124 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 24.9 t -140.81 115.45 6.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.813 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 50.2 p -103.08 142.32 34.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.899 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.96 117.55 11.52 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.67 112.4 25.32 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.36 -178.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -102.14 143.17 32.3 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.928 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.411 ' CG2' ' NH1' ' A' ' 17' ' ' ARG . 31.2 m -107.82 142.93 19.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.07 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.401 ' HB ' ' CB ' ' A' ' 108' ' ' GLN . 4.4 m -159.53 157.16 26.39 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.33 172.08 9.48 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.559 2.173 . . . . 0.0 112.308 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.15 -34.64 78.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.517 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.21 -30.48 68.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.151 0.501 . . . . 0.0 109.848 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.401 ' CB ' ' HB ' ' A' ' 104' ' ' VAL . 2.2 mm100 -72.64 -49.78 29.57 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.724 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.5 m -62.94 -37.98 89.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.365 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.25 -43.25 99.62 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.249 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 83.6 p -74.49 -38.48 62.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.741 0.305 . . . . 0.0 110.655 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.7 mt -57.25 -27.95 62.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.563 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.4 mt -85.6 -36.74 11.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.847 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.59 -178.98 30.88 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.461 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.0 ttmm -66.99 123.68 20.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 0.0 111.204 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.6 15.29 57.21 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.012 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 73.58 5.1 67.28 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.955 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 31.9 p -52.92 -35.64 58.57 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.848 0.356 . . . . 0.0 111.631 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -65.53 -65.29 0.69 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.155 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -54.75 -30.05 22.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.297 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -50.4 71.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.812 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -61.22 -40.55 94.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.203 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 44.4 mm -57.09 -53.94 36.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.807 0.337 . . . . 0.0 110.907 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.62 -32.91 74.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.822 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -57.14 -52.65 64.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.569 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.02 -46.99 8.43 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 92.3 m -47.39 -25.92 1.17 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.944 0.402 . . . . 0.0 110.485 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.11 -7.54 21.9 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.355 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -108.3 141.39 40.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.996 0.398 . . . . 0.0 111.209 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -79.14 141.08 37.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.8 m -107.39 143.17 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.157 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.61 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -113.84 158.41 21.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.278 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.8 m -137.41 128.2 39.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.08 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.116 -179.955 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.974 0.416 . . . . 0.0 111.07 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 15.0 t -121.41 -40.49 2.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.567 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.487 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 9.9 mt-10 -107.27 145.76 32.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.416 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -109.86 161.48 15.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.904 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -118.51 155.0 31.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.329 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.61 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 69.7 mt -129.66 141.01 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.401 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.502 ' HB ' ' HB2' ' A' ' 132' ' ' GLN . 0.4 OUTLIER -116.41 117.42 29.9 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.432 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.1 mm -104.08 120.54 54.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.793 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.31 137.22 53.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.128 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 160.77 -151.68 22.19 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.593 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.511 ' CG2' ' HD2' ' A' ' 152' ' ' PRO . 15.4 mt -85.48 144.52 40.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.511 ' HD2' ' CG2' ' A' ' 151' ' ' ILE . 72.3 Cg_exo -48.96 -32.51 23.35 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.98 1.787 . . . . 0.0 111.552 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -72.08 -34.83 68.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.62 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 57.9 m -70.94 -39.31 72.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.61 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 40.5 mm -64.53 -50.06 77.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.909 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.9 mt -57.19 -38.39 61.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.7 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -66.24 -38.8 88.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.497 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -61.57 -45.63 93.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.591 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 32.9 t -59.97 -36.09 64.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.796 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -32.98 74.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.62 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -72.19 -31.82 66.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.887 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 29.8 mt -74.01 -36.34 44.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.077 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 1.3 m -74.01 -43.29 58.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.939 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 11.2 p -66.29 -45.76 88.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.32 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 11.8 p -61.76 -42.54 94.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.021 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -59.17 -40.03 84.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.796 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.2 tt -72.64 -43.99 62.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.78 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -73.97 -2.64 24.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.034 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 32.5 p . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.895 179.992 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.5 m120 . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.824 0.345 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.414 ' CG2' ' N ' ' A' ' 13' ' ' THR . 6.8 p -107.34 159.87 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.029 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -103.65 140.65 37.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.804 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.5 mt -131.24 171.32 13.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.027 0.441 . . . . 0.0 111.297 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.63 117.91 10.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.615 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 15.5 tt -121.51 156.66 25.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.908 0.385 . . . . 0.0 111.283 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.498 ' NH2' ' OE1' ' A' ' 143' ' ' GLU . 1.9 mtp85 -134.46 111.92 10.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.643 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.517 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 0.6 OUTLIER -89.38 145.3 25.43 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.749 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.0 tt -122.51 121.1 35.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.544 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.4 ' CB ' ' HB ' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -148.07 163.19 37.67 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.374 0.607 . . . . 0.0 112.121 -179.515 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -76.48 134.72 39.44 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.542 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -45.7 -25.47 1.5 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 121.024 -0.608 . . . . 0.0 113.556 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.38 -52.46 9.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.942 0.371 . . . . 0.0 111.609 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -71.09 -51.0 27.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.993 0.425 . . . . 0.0 110.402 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.445 ' O ' HG12 ' A' ' 29' ' ' ILE . 10.0 p -62.8 -33.9 62.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.296 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.52 -37.75 94.66 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.641 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.3 t -68.38 -28.42 67.1 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.422 HD13 ' N ' ' A' ' 28' ' ' ILE . 4.6 mm -80.59 -32.55 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.567 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 25' ' ' VAL . 3.2 mm -60.59 -45.22 97.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.902 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.448 ' HA3' ' CB ' ' A' ' 35' ' ' SER . . . 94.69 150.57 27.23 Favored Glycine 0 N--CA 1.436 -1.347 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.812 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.418 ' C ' ' HD3' ' A' ' 32' ' ' LYS . 8.0 tttm -64.4 146.31 54.68 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.571 -0.814 . . . . 0.0 111.659 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.418 ' HD3' ' C ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER 63.01 6.74 2.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.847 179.635 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.502 ' O ' HG22 ' A' ' 36' ' ' VAL . . . 59.9 7.07 5.94 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 119.822 -1.18 . . . . 0.0 111.795 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -71.8 -28.21 63.45 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.025 0.44 . . . . 0.0 109.878 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.448 ' CB ' ' HA3' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -75.03 -36.34 61.9 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.265 179.496 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -67.32 -26.56 36.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.525 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -69.88 -36.81 75.76 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -65.04 -34.78 79.25 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.844 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -46.44 84.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.616 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -58.26 -51.18 70.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.289 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.02 -38.16 90.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.203 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -74.85 -36.06 62.35 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.1 t -77.9 -47.23 19.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.898 0.38 . . . . 0.0 111.116 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.89 -8.42 76.11 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.398 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 46' ' ' ARG . . . -110.79 128.75 55.88 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.493 0.187 . . . . 0.0 111.108 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 4.5 mtt-85 -26.99 139.37 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.058 0.543 . . . . 0.0 112.038 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.1 mt -142.13 116.31 4.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.714 0.292 . . . . 0.0 111.317 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -133.68 122.07 22.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.059 0.456 . . . . 0.0 110.907 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.467 HD13 HG21 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -108.15 130.78 60.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.902 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.5 t 168.6 169.8 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.067 0.46 . . . . 0.0 111.383 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 C--N 1.333 -0.141 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.894 179.104 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 . . . . . 0 N--CA 1.465 0.301 0 CA-C-O 120.304 0.097 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.89 130.76 38.27 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.034 0.445 . . . . 0.0 111.605 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 47.6 mt -129.46 109.93 19.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.491 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.459 HG23 HD11 ' A' ' 59' ' ' ILE . 7.1 mm -85.96 94.99 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.951 0.405 . . . . 0.0 111.537 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 50.0 m -88.82 105.85 17.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.841 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.495 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 9.1 tt -107.85 136.71 47.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.621 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -133.51 133.74 42.58 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.541 0.21 . . . . 0.0 110.864 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.16 164.92 14.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.894 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 92.6 Cg_exo -41.35 162.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.04 2.494 . . . . 0.0 113.161 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.462 ' O ' HG21 ' A' ' 68' ' ' ILE . 4.1 t -60.19 -35.56 75.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.206 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -63.88 -51.81 62.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.228 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.26 -44.67 84.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.0 0.428 . . . . 0.0 111.003 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.462 HG21 ' O ' ' A' ' 65' ' ' THR . 1.5 tt -66.43 -39.42 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.666 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.27 -48.38 76.7 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.108 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.88 -48.02 78.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.899 0.38 . . . . 0.0 110.832 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.72 -40.64 80.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.423 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.406 ' O ' HG13 ' A' ' 75' ' ' ILE . 0.5 OUTLIER -61.47 -48.29 81.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.218 -179.663 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.72 -29.28 67.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.94 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.8 mmm -77.46 -48.43 17.15 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 72' ' ' PHE . 1.2 pp -61.34 -41.43 89.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.311 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.0 pt -67.8 -38.91 81.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.808 0.337 . . . . 0.0 110.907 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.22 -32.16 73.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.399 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -40.42 86.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.174 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.7 tp -77.49 -25.62 50.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.492 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -77.06 -41.48 42.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -72.11 -36.64 69.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.904 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 179.948 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.402 ' HG2' ' CA ' ' A' ' 150' ' ' GLY . 35.9 Cg_endo . . . . . 0 CA--C 1.527 0.163 0 N-CA-C 112.642 0.208 . . . . 0.0 112.642 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.6 t -137.25 111.67 9.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.913 0.387 . . . . 0.0 111.022 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 38.8 p -103.24 138.36 40.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.982 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.94 117.79 11.72 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -102.26 112.5 25.22 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.367 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.63 145.53 37.74 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.032 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.409 ' CG1' ' HB3' ' A' ' 17' ' ' ARG . 11.9 p -95.98 131.47 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.72 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.474 HG22 ' HB3' ' A' ' 108' ' ' GLN . 7.5 p -130.22 145.78 58.79 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.171 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.409 ' HD2' ' CG2' ' A' ' 104' ' ' VAL . 22.5 Cg_exo -65.62 163.4 30.34 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.537 2.158 . . . . 0.0 111.987 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.25 -39.69 78.31 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 25.8 m -69.72 -30.48 68.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.289 0.566 . . . . 0.0 109.626 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.474 ' HB3' HG22 ' A' ' 104' ' ' VAL . 0.9 OUTLIER -74.58 -49.48 21.61 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.53 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -65.47 -37.42 86.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.935 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.38 -51.46 57.56 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.041 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.3 m -72.88 -34.87 66.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.806 0.336 . . . . 0.0 110.438 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.7 mt -60.88 -29.07 69.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.129 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.438 ' CG2' ' HA2' ' A' ' 117' ' ' GLY . 12.4 mt -80.41 -37.95 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.623 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.76 -179.26 44.53 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.458 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.05 122.23 17.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.867 0.365 . . . . 0.0 111.012 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.08 11.91 56.33 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.927 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.438 ' HA2' ' CG2' ' A' ' 113' ' ' ILE . . . 72.15 6.17 64.08 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.02 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -53.16 -39.98 63.99 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -65.33 0.7 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.762 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.411 ' HB ' ' HA ' ' A' ' 113' ' ' ILE . 0.9 OUTLIER -58.03 -37.65 62.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.634 -179.356 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.3 -44.75 80.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.332 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -73.12 -39.29 65.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.313 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 24.3 mt -58.13 -53.88 39.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.264 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.0 ptt85 -67.97 -35.02 77.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.879 0.371 . . . . 0.0 111.071 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -54.92 -50.63 68.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.177 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 53.3 p -83.86 -36.1 23.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.374 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 18.2 m -50.28 -26.13 4.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.807 0.337 . . . . 0.0 110.256 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 88.84 -21.75 25.27 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.981 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -102.49 155.82 18.01 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.823 0.344 . . . . 0.0 111.152 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -105.17 132.85 50.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.023 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 147' ' ' THR . 5.6 m -99.18 138.78 22.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.895 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.679 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 0.1 OUTLIER -116.94 116.67 27.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.107 0.479 . . . . 0.0 112.04 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.9 p -100.67 140.28 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.543 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.928 179.699 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.0 p . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.796 0.331 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.5 m -117.73 -46.22 2.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.82 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.498 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 43.9 mt-10 -108.54 138.01 45.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.762 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -109.9 148.84 30.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.833 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -105.98 128.82 54.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.218 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.679 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 28.5 mm -108.6 127.25 65.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.866 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.434 ' HB ' ' HB2' ' A' ' 132' ' ' GLN . 0.2 OUTLIER -108.06 114.67 28.76 Favored 'General case' 0 N--CA 1.46 0.07 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.711 179.76 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.2 mp -104.1 117.53 49.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.409 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.91 126.07 50.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.856 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.402 ' CA ' ' HG2' ' A' ' 97' ' ' PRO . . . 171.26 -153.04 19.61 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.693 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.518 ' CG2' ' HD2' ' A' ' 152' ' ' PRO . 4.4 mt -86.98 143.3 34.86 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 110.569 -0.16 . . . . 0.0 110.569 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.518 ' HD2' ' CG2' ' A' ' 151' ' ' ILE . 6.0 Cg_endo -48.63 -34.18 26.18 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.258 1.972 . . . . 0.0 111.609 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -72.09 -34.65 68.82 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 19.2 m -68.84 -44.48 73.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.648 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 4.2 mt -60.64 -52.49 60.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.806 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 7.8 tp -56.02 -31.06 30.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.861 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -70.08 -37.07 75.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.706 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.01 -52.91 57.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.643 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 34.3 t -59.37 -31.97 47.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.773 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 7.4 ttmt -67.46 -34.45 77.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.748 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.45 -35.1 73.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.712 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 34.2 mm -73.4 -34.42 43.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.951 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 4.2 t -73.91 -46.39 44.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.043 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.24 -41.38 86.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.126 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 59.5 t -69.28 -47.54 73.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.797 0.332 . . . . 0.0 110.859 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -32.77 65.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 62.3 tp -71.91 -47.35 53.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.762 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -73.86 -2.72 24.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.081 0.467 . . . . 0.0 112.027 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 72.6 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.803 -179.994 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.761 0.315 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 64' ' ' PRO . 5.6 t -105.62 146.87 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.772 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 7.1 m -103.64 151.38 23.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.158 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.6 mt -138.32 176.21 8.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.984 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.41 125.32 16.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.901 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.4 tt -140.82 133.52 31.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.318 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.496 ' NH2' ' OE1' ' A' ' 143' ' ' GLU . 16.6 mtt180 -112.58 139.06 48.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.703 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 mp -113.74 138.82 49.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.938 0.399 . . . . 0.0 111.091 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.05 114.22 23.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.703 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.87 161.92 26.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.072 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 27.6 m170 -74.69 175.0 8.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.899 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.57 -40.77 99.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.666 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.48 -44.23 25.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.829 0.347 . . . . 0.0 111.123 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -61.92 -43.98 97.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.081 0.467 . . . . 0.0 110.281 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.491 ' O ' HG12 ' A' ' 29' ' ' ILE . 9.8 p -68.66 -30.34 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.561 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.28 -39.32 97.56 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.538 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.87 -36.2 59.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.732 0.301 . . . . 0.0 111.474 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 25' ' ' VAL . 2.0 pp -78.5 -32.47 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.491 HG12 ' O ' ' A' ' 25' ' ' VAL . 7.6 mm -70.62 -52.88 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.464 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.414 ' HA3' ' CB ' ' A' ' 35' ' ' SER . . . 99.69 150.33 25.07 Favored Glycine 0 N--CA 1.437 -1.297 0 CA-C-O 121.791 0.662 . . . . 0.0 112.967 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.488 ' C ' ' HD3' ' A' ' 32' ' ' LYS . 6.6 mttt -66.09 146.39 54.72 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.398 -0.901 . . . . 0.0 111.348 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.512 ' HE3' ' HB2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 61.59 6.9 1.65 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.583 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.533 ' O ' HG22 ' A' ' 36' ' ' VAL . . . 59.16 8.22 6.08 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.304 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.512 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 3.7 mt-10 -75.58 -30.56 59.68 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 122.402 -0.47 . . . . 0.0 109.915 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.5 ' HA ' ' HG2' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -67.91 -42.67 80.75 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.26 179.462 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -66.86 -26.16 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.548 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.18 -36.63 83.58 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.5 ' HG2' ' HA ' ' A' ' 35' ' ' SER . 41.5 mmtt -59.96 -43.3 95.13 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.579 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.42 -47.14 82.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.914 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.25 -51.05 71.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.226 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -64.35 -37.79 88.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.98 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -74.59 -36.61 63.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.9 t -90.55 -55.79 3.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.946 0.403 . . . . 0.0 110.753 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.7 10.78 61.3 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.915 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 62' ' ' ALA . . . -109.21 127.63 54.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 117.048 0.424 . . . . 0.0 111.554 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.413 ' C ' ' O ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -27.94 104.08 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.294 178.869 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 60' ' ' THR . 3.3 mt -116.02 100.62 10.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.777 0.322 . . . . 0.0 110.419 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.484 ' O ' ' HB ' ' A' ' 60' ' ' THR . 2.4 p30 -121.61 125.83 47.64 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.617 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.7 mt -100.0 142.27 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.73 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.6 m -161.68 -177.81 6.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.024 0.44 . . . . 0.0 111.552 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.306 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -145.77 127.61 15.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.926 0.393 . . . . 0.0 111.207 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.425 ' CD1' ' N ' ' A' ' 58' ' ' ILE . 2.4 mp -101.04 104.72 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.612 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.1 mp -86.43 95.1 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.411 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 47' ' ' ILE . 27.7 m -73.8 131.0 41.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.688 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.5 tt -131.59 129.64 41.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.652 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . -139.45 130.45 26.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.699 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.406 ' HA3' ' HB2' ' A' ' 45' ' ' ALA . . . 157.35 165.18 14.68 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.116 -1.04 . . . . 0.0 112.783 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 80.6 Cg_exo -39.37 154.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.135 2.557 . . . . 0.0 113.216 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.8 m -59.04 -35.35 73.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.864 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -67.03 -52.02 47.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.186 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.26 -42.93 82.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.058 0.456 . . . . 0.0 110.795 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -66.44 -39.46 84.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.172 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.52 -47.01 87.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.065 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -50.59 73.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.938 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.72 -40.68 84.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.153 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.78 -42.69 99.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.093 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.79 -39.31 88.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.167 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.9 mtt -78.04 -32.49 50.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.841 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.14 -46.15 81.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.002 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.1 pp -68.14 -37.85 78.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.223 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -65.48 -46.2 80.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.504 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -35.4 75.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.111 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.0 tp -77.57 -25.17 49.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.523 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -76.88 -43.01 37.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.912 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -72.1 -32.33 66.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.828 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.3 t70 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.983 -179.948 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo . . . . . 0 N--CA 1.461 -0.408 0 CA-C-O 120.791 0.246 . . . . 0.0 112.606 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 24.3 t -137.2 106.77 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 40.7 p -103.4 139.22 39.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.04 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.86 117.61 11.63 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.91 112.44 25.41 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.527 -178.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 40.7 mt -111.85 153.76 26.16 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.956 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.2 t -114.32 149.23 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.062 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.0 m -156.14 164.46 21.35 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.335 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -66.03 160.74 43.02 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.744 2.296 . . . . 0.0 112.113 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.98 -34.9 76.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.358 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.9 t -70.17 -30.28 67.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.201 0.524 . . . . 0.0 109.667 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -41.8 71.43 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.63 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.449 ' HA ' ' CD2' ' A' ' 112' ' ' LEU . 5.1 t -65.85 -40.8 92.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.706 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.17 -33.47 87.32 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.885 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.6 p -77.32 -50.78 12.07 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 121.115 -0.234 . . . . 0.0 111.312 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.449 ' CD2' ' HA ' ' A' ' 109' ' ' CYS . 2.7 pp -55.66 -25.78 41.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.054 0.455 . . . . 0.0 110.009 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.407 ' O ' ' HA2' ' A' ' 117' ' ' GLY . 51.2 mt -77.03 -39.31 29.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.224 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.41 -177.86 39.37 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.527 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.53 121.73 16.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.857 0.361 . . . . 0.0 111.128 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.85 12.37 56.88 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.08 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 113' ' ' ILE . . . 72.99 4.97 63.95 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.034 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 2.2 m -52.94 -42.64 65.65 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 120.791 0.329 . . . . 0.0 111.828 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -65.34 0.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.564 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.2 tt -58.99 -30.59 43.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.647 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 7.6 tppt? -60.07 -44.83 94.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.105 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -73.28 -41.66 63.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.464 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 34.5 mm -62.7 -53.78 42.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.583 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.4 mmt85 -67.82 -42.72 81.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.398 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.61 -40.77 69.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.222 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 91.3 p -85.32 -36.75 20.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.758 0.313 . . . . 0.0 111.101 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 31.0 m -50.49 -26.09 4.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.929 0.395 . . . . 0.0 110.249 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.48 -9.15 62.49 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.026 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -108.03 154.32 21.83 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.857 0.36 . . . . 0.0 111.212 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -105.14 139.75 39.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.407 ' HB ' ' CG2' ' A' ' 146' ' ' ILE . 1.2 m -99.16 157.96 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.035 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.578 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 3.4 tp60 -138.59 116.81 11.84 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.269 0.557 . . . . 0.0 112.347 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.65 131.22 45.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.305 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.079 179.915 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.869 0.366 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 24.5 m -118.91 -41.87 2.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.614 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.496 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 37.5 mt-10 -134.15 138.9 45.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.76 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.24 165.29 13.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.952 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.28 138.98 53.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.233 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.578 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 35.5 mt -114.21 131.63 65.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.824 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.446 ' HB ' ' CB ' ' A' ' 132' ' ' GLN . 1.0 OUTLIER -106.17 115.06 29.58 Favored 'General case' 0 N--CA 1.46 0.065 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.689 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.2 mp -103.89 118.7 51.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.452 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.55 134.5 55.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.758 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 163.35 -151.58 21.22 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.777 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 152' ' ' PRO . 3.7 mt -78.2 144.74 67.5 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' A' ' 151' ' ' ILE . 5.7 Cg_endo -48.4 -39.87 36.06 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.134 1.889 . . . . 0.0 111.322 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -66.63 -34.68 78.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 18.3 m -68.44 -32.26 72.16 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.625 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 29.5 mm -76.35 -49.0 25.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.119 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.4 mm -55.81 -36.38 43.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.989 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -75.03 -36.72 61.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.826 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 4.8 t -68.16 -38.45 82.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.905 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 10.3 p -70.82 -32.17 48.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.065 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.3 -34.68 75.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.872 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.41 -49.37 34.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.776 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.491 HG23 HD12 ' A' ' 162' ' ' ILE . 0.0 OUTLIER -63.15 -44.08 99.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.947 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 1.7 m -58.95 -44.61 91.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.831 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 53.4 t -58.48 -52.59 57.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.02 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.8 t -57.9 -41.25 79.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.18 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -59.69 -37.48 78.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.971 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 7.6 tt -67.46 -55.87 11.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.88 -2.63 24.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.01 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 18.4 p . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.372 -0.823 . . . . 0.0 111.152 179.999 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.722 0.296 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -118.08 163.97 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.97 0.414 . . . . 0.0 111.347 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.74 128.31 52.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.288 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -124.26 151.43 44.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.237 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.2 m -141.66 118.78 11.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.519 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.4 tt -119.96 147.21 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.931 0.396 . . . . 0.0 111.408 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.486 ' NH2' ' OE2' ' A' ' 143' ' ' GLU . 2.4 mpp_? -131.04 112.08 12.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.524 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.51 134.74 51.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.224 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -104.36 122.36 45.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.562 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -124.71 159.51 30.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.144 0.497 . . . . 0.0 111.436 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.89 142.15 49.52 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.427 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -43.98 -32.2 2.26 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 121.018 -0.611 . . . . 0.0 113.801 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.37 -52.03 9.2 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.18 -50.55 67.69 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.027 0.442 . . . . 0.0 110.309 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.6 p -58.88 -36.04 59.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.956 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.37 -36.13 92.66 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.39 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.1 m -72.48 -29.53 63.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.96 0.41 . . . . 0.0 110.212 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.404 HD11 ' N ' ' A' ' 28' ' ' ILE . 4.9 mm -81.14 -32.59 12.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.699 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.419 ' HA ' ' CG1' ' A' ' 36' ' ' VAL . 14.2 mt -64.14 -42.59 96.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.156 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.4 150.96 26.14 Favored Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.293 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.432 ' C ' ' HG3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -58.08 146.39 33.28 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.772 -0.714 . . . . 0.0 111.259 179.824 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.479 ' HD2' ' HB2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 44.58 26.75 0.2 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.221 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.542 ' O ' HG21 ' A' ' 36' ' ' VAL . . . 49.25 16.17 0.8 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 114.391 0.517 . . . . 0.0 114.391 178.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 4.0 mt-10 -72.09 -35.01 69.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.677 0.739 . . . . 0.0 109.872 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.9 t -68.41 -39.86 81.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.102 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.542 HG21 ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -66.8 -26.1 36.26 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -36.45 79.91 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 34' ' ' GLU . 8.8 mmtt -63.28 -41.22 98.98 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.597 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.54 -49.48 76.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.169 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -58.34 -51.66 68.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.682 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -64.91 -38.4 90.84 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -75.06 -35.97 61.83 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.5 p -82.27 -55.33 4.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.83 0.347 . . . . 0.0 111.041 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.41 -7.89 64.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.544 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.443 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . . . -104.28 127.94 51.99 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 122.781 -0.246 . . . . 0.0 111.012 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 4.5 mmt180 -27.36 139.39 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.101 0.56 . . . . 0.0 112.213 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.6 mt -142.24 100.59 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.723 0.297 . . . . 0.0 111.008 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.34 132.6 50.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.04 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.9 mt -90.24 151.77 3.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.081 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.87 -175.12 3.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.043 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.055 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 . . . . . 0 N--CA 1.467 0.415 0 CA-C-O 120.593 0.235 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -140.24 143.61 36.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.008 0.432 . . . . 0.0 111.375 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.2 mt -140.53 115.45 6.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.599 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.5 mt -86.18 110.13 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.976 0.417 . . . . 0.0 111.43 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 49.6 m -103.15 101.84 11.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.64 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.503 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 6.5 tt -104.69 133.85 48.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.753 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . -125.55 137.42 53.93 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.443 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.49 165.57 15.44 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 119.847 -1.168 . . . . 0.0 113.007 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -50.5 161.96 1.07 Allowed 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.906 2.404 . . . . 0.0 112.337 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.406 ' O ' HG22 ' A' ' 68' ' ' ILE . 18.2 m -56.85 -35.96 69.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.559 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -63.8 -51.81 63.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.788 0.328 . . . . 0.0 111.3 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.24 -37.47 72.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.198 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 65' ' ' THR . 0.1 OUTLIER -66.21 -39.34 84.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.376 -179.301 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.67 -50.91 70.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.032 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.76 -49.71 76.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.886 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.31 -50.85 70.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.27 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -52.78 -42.51 65.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.095 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.98 -37.13 78.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.108 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -76.32 -37.63 57.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.949 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 46.0 mt -64.11 -50.6 76.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.846 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -62.17 -37.42 78.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.143 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -65.0 -47.64 76.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.741 0.305 . . . . 0.0 110.513 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.36 -35.42 80.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.174 0.511 . . . . 0.0 109.781 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.0 tp -77.67 -22.99 49.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.486 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -76.08 -41.75 49.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.841 0.353 . . . . 0.0 110.9 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.23 -45.44 60.22 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.036 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.681 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo . . . . . 0 N--CA 1.463 -0.315 0 CA-C-O 120.937 0.307 . . . . 0.0 112.701 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.431 ' O ' HG12 ' A' ' 98' ' ' VAL . 7.2 p -140.92 116.21 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.505 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.08 131.85 49.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.133 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.6 mt -139.92 117.67 11.63 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -103.09 112.57 25.48 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.567 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.4 mp -99.46 151.01 21.6 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.842 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.9 t -107.26 149.28 10.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.241 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.8 m -156.01 161.69 28.96 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.133 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 108' ' ' GLN . 21.4 Cg_exo -65.69 162.15 35.75 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.748 2.298 . . . . 0.0 112.216 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.13 -34.64 76.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.639 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.25 -30.52 69.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.086 0.469 . . . . 0.0 109.823 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.43 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -68.85 -46.19 69.15 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.678 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -67.57 -37.48 82.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.419 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.22 -49.68 70.48 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.312 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.9 m -77.28 -35.22 55.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.839 0.352 . . . . 0.0 110.803 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.9 mt -57.66 -29.67 64.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.62 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 27.7 mm -87.12 -38.71 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.807 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.4 -179.38 36.66 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.453 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.34 124.73 23.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.874 0.369 . . . . 0.0 111.054 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.41 16.07 57.85 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.882 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 68.16 10.6 59.77 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.965 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -52.93 -39.86 63.16 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.823 0.344 . . . . 0.0 111.547 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.67 -65.27 0.7 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.224 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.13 -28.86 21.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.437 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -64.69 -49.36 71.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.094 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.5 -38.99 74.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.34 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 27.8 mt -57.52 -53.93 37.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.116 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.47 -30.52 64.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.912 0.387 . . . . 0.0 110.998 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.97 -44.73 82.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.131 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.4 m -93.12 -37.53 12.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.506 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.5 m -49.83 -26.25 3.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.809 0.337 . . . . 0.0 110.234 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 82.9 -16.55 26.56 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.229 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -100.87 166.54 10.79 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.937 0.368 . . . . 0.0 111.195 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -105.23 133.82 49.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.952 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 147' ' ' THR . 14.0 m -101.93 139.48 22.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.905 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.622 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 0.4 OUTLIER -129.47 116.72 19.39 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.6 m -99.26 132.74 44.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.277 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.995 179.92 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 56.1 p . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.84 0.353 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 28.3 m -115.59 -47.17 2.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.811 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.486 ' OE2' ' NH2' ' A' ' 17' ' ' ARG . 10.9 mt-10 -116.2 147.03 41.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.792 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.03 174.43 5.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.893 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -136.44 129.9 31.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.402 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.622 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 3.9 mp -100.13 125.4 53.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.741 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.463 ' HB ' ' HB2' ' A' ' 132' ' ' GLN . 0.3 OUTLIER -96.92 114.82 26.47 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.743 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.04 113.48 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.183 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.44 131.16 56.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.086 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 165.49 -158.4 31.25 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.49 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.405 HD13 ' CB ' ' A' ' 154' ' ' SER . 0.7 OUTLIER -87.76 163.74 37.09 Favored Pre-proline 0 C--N 1.33 -0.272 0 O-C-N 122.858 -0.201 . . . . 0.0 110.637 179.534 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.403 ' HD2' ' CB ' ' A' ' 151' ' ' ILE . 6.9 Cg_endo -49.59 -36.59 40.92 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.428 2.085 . . . . 0.0 111.77 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -63.54 -34.61 78.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.038 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.405 ' CB ' HD13 ' A' ' 151' ' ' ILE . 4.2 m -70.45 -37.14 74.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.591 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 36.8 mm -67.53 -51.72 48.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.937 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.9 mm -58.85 -28.24 37.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.056 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -70.6 -57.02 5.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.521 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 6.8 p -61.01 -47.54 86.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.519 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 13.4 p -57.01 -36.56 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.809 0.338 . . . . 0.0 111.166 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.48 -33.05 68.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.827 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.56 -39.81 67.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.978 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 6.4 tp -74.05 -34.51 38.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.032 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 2.3 t -70.81 -47.35 59.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.071 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.81 -45.36 98.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.08 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 28.5 m -69.27 -42.64 81.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.062 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 4.5 tpp -64.53 -37.43 87.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.958 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.44 -57.5 7.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.92 -2.49 24.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.029 0.442 . . . . 0.0 112.026 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.875 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.763 0.316 . . . . 0.0 111.307 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -113.03 -70.65 0.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.952 0.406 . . . . 0.0 110.649 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.7 t -136.92 150.06 26.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.748 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 2.5 t -103.51 157.7 16.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.871 0.367 . . . . 0.0 111.305 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.0 mt -152.33 174.46 13.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.993 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.9 m -142.5 133.62 25.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.776 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.404 ' CD1' ' CZ ' ' A' ' 72' ' ' PHE . 1.1 tt -136.92 123.58 29.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.161 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.493 ' NH2' ' OE1' ' A' ' 143' ' ' GLU . 2.3 mpp_? -101.24 117.07 34.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.746 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.0 mt -94.75 128.51 41.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.862 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.8 tt -123.05 120.85 34.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.496 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.418 ' HB3' ' HB ' ' A' ' 25' ' ' VAL . 0.8 OUTLIER -147.91 168.65 21.69 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.288 0.566 . . . . 0.0 111.9 -179.46 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.532 ' HA ' ' O ' ' A' ' 55' ' ' PRO . 29.0 m-70 -74.64 140.95 44.64 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.844 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -45.48 -30.89 3.29 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.962 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.541 ' HG2' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -78.45 -49.5 13.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 117.354 0.577 . . . . 0.0 111.95 -179.077 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.541 ' N ' ' HG2' ' A' ' 23' ' ' LYS . 4.8 mt-10 -65.14 -50.78 64.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.207 0.527 . . . . 0.0 109.999 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.46 ' O ' HG12 ' A' ' 29' ' ' ILE . 7.3 p -58.72 -34.25 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.572 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.38 -41.9 98.69 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.924 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.1 p -65.88 -27.92 68.57 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.4 mm -81.21 -32.36 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.899 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 25' ' ' VAL . 3.0 mm -60.43 -42.75 92.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.342 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.08 150.39 26.8 Favored Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.317 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.406 ' C ' ' HD3' ' A' ' 32' ' ' LYS . 1.3 tppm? -61.71 145.72 51.48 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.723 -0.739 . . . . 0.0 111.34 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.411 ' CE ' ' HB3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 50.79 20.22 0.73 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.442 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.443 ' O ' HG22 ' A' ' 36' ' ' VAL . . . 51.24 13.88 1.19 Allowed Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.936 -0.649 . . . . 0.0 113.919 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.411 ' HB3' ' CE ' ' A' ' 32' ' ' LYS . 10.1 tt0 -76.79 -26.09 54.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.213 0.53 . . . . 0.0 109.808 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.13 -42.33 56.55 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.401 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -67.38 -26.57 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.624 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.93 -36.69 67.27 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.54 -34.57 72.41 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.839 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -53.46 57.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.489 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.09 -51.48 69.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.989 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -51.9 -38.43 56.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.947 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -85.95 -27.38 24.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.697 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.41 ' HB2' ' CB ' ' A' ' 71' ' ' ALA . 1.5 p -73.25 -55.26 6.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.809 0.338 . . . . 0.0 111.21 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.36 -5.27 85.36 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.443 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.452 ' O ' ' CG1' ' A' ' 47' ' ' ILE . . . -110.71 127.4 55.3 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.63 0.253 . . . . 0.0 111.197 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 9.1 tpp180 -28.19 104.3 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.452 ' CG1' ' O ' ' A' ' 45' ' ' ALA . 2.9 mt -114.73 120.37 64.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.688 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -137.01 173.82 11.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.041 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.9 mt -126.51 151.73 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.947 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.5 t -135.73 -175.28 3.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.08 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -81.73 -165.85 1.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.791 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . 166.72 83.24 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.75 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -52.97 -23.02 6.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.105 0.478 . . . . 0.0 110.301 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.47 ' CB ' ' HD3' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -93.48 -64.24 0.14 Allowed Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.549 -179.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.532 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 61.3 Cg_endo -82.82 -34.73 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.576 2.184 . . . . 0.0 112.349 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 52' ' ' GLY . 3.1 mm-40 93.56 -33.13 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.163 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.29 133.98 37.5 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.035 0.445 . . . . 0.0 111.624 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.0 mt -140.48 119.09 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.718 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.5 mt -97.01 109.66 23.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.442 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.7 m -87.2 108.7 19.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.033 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.449 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -106.67 138.52 42.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.506 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.423 ' O ' ' HB1' ' A' ' 45' ' ' ALA . . . -145.41 132.25 20.11 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.445 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.53 166.38 16.85 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 119.549 -1.31 . . . . 0.0 113.3 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 1.9 Cg_endo -46.09 159.21 0.26 Allowed 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 123.174 2.583 . . . . 0.0 112.472 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.408 ' O ' HG23 ' A' ' 68' ' ' ILE . 13.2 t -55.99 -35.94 67.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.429 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -65.37 -51.88 57.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.093 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.28 -44.54 84.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.041 0.448 . . . . 0.0 110.872 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 65' ' ' THR . 1.2 tt -66.45 -39.39 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.878 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.53 -45.13 77.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.041 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -45.4 68.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.746 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.41 ' CB ' ' HB2' ' A' ' 43' ' ' SER . . . -54.78 -56.16 22.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.323 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.404 ' CZ ' ' CD1' ' A' ' 16' ' ' ILE . 0.6 OUTLIER -56.27 -40.09 73.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.998 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.45 -32.26 72.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.185 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.2 mtm -74.27 -46.55 40.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.196 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.43 HG13 ' N ' ' A' ' 76' ' ' ILE . 29.0 pt -61.56 -42.83 95.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.229 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.43 ' N ' HG13 ' A' ' 75' ' ' ILE . 41.0 pt -64.91 -36.45 77.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.82 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.9 -37.7 82.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.321 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -35.45 77.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.01 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.6 tp -76.34 -28.11 56.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.383 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.9 -35.98 56.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.682 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -72.39 -33.45 67.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.909 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -68.78 -55.3 11.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.237 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -55.53 -39.42 53.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.321 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.51 38.94 1.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.847 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.82 17.12 11.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.236 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.1 m 63.87 80.77 0.22 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.815 0.34 . . . . 0.0 110.777 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 5.4 tpt -58.82 121.25 10.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.946 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.56 33.87 2.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -160.64 178.01 9.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.84 165.99 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.2 t -126.15 93.83 3.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.951 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 62.23 148.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.08 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.65 -38.16 3.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.205 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 62.4 29.33 17.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.96 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.14 71.59 79.28 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.9 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.548 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 50.6 Cg_exo -52.98 -47.27 28.44 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.709 2.273 . . . . 0.0 112.91 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 96' ' ' PRO . 45.7 Cg_endo -69.31 -167.66 0.22 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.095 1.863 . . . . 0.0 112.641 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.5 m -140.97 119.87 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.464 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 14.9 p -102.81 141.96 34.74 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.957 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.85 117.75 11.75 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -100.87 112.62 25.09 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.499 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.6 mp -99.35 162.82 12.82 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.835 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.4 t -115.76 147.75 18.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.215 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.3 m -160.38 154.36 19.46 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.046 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.37 167.53 18.39 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.386 2.057 . . . . 0.0 112.238 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.52 -34.58 78.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.479 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.1 t -69.59 -30.35 68.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.134 0.492 . . . . 0.0 109.837 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -71.92 -46.24 58.33 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.79 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.62 -46.65 75.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.756 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -54.84 -51.79 50.73 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.57 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.3 m -70.76 -40.03 72.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.771 0.32 . . . . 0.0 110.757 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.7 mt -55.27 -26.99 43.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.645 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.408 ' CG2' ' HA2' ' A' ' 117' ' ' GLY . 9.8 mt -84.29 -40.76 15.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.799 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.48 -177.19 49.47 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.497 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.5 mttp -66.36 124.13 21.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.827 0.346 . . . . 0.0 111.056 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 58.47 19.96 43.28 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.766 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.408 ' HA2' ' CG2' ' A' ' 113' ' ' ILE . . . 66.78 11.57 57.91 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.904 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 29.1 p -53.01 -38.55 62.43 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -67.78 -65.39 0.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.641 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -55.87 -34.66 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.728 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -62.3 -50.4 71.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.306 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.407 ' HG3' ' N ' ' A' ' 123' ' ' ILE . 5.8 pt-20 -64.36 -34.39 78.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.303 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.407 ' N ' ' HG3' ' A' ' 122' ' ' GLU . 15.7 mt -65.87 -53.97 32.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.226 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.47 -30.31 65.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.036 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -59.04 -45.22 91.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.982 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.2 -39.34 14.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.12 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 36.5 m -49.93 -25.84 3.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.832 0.349 . . . . 0.0 110.16 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.6 -9.25 65.58 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.929 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -108.14 164.25 12.46 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.83 0.348 . . . . 0.0 111.204 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -104.81 133.15 50.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.708 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.405 ' HB ' ' CD1' ' A' ' 146' ' ' ILE . 6.3 m -99.19 139.07 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.137 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.614 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -109.2 158.17 18.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.608 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.8 t -137.66 132.58 44.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.883 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.74 161.14 26.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.11 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -78.66 -156.49 9.56 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.479 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -177.16 66.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.95 0.405 . . . . 0.0 110.915 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -63.77 108.18 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.826 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.7 mp 61.03 166.7 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.852 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.02 76.54 0.85 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.563 2.176 . . . . 0.0 112.227 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -135.41 -45.77 0.69 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.0 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.7 p -64.0 143.17 58.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.963 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.81 -48.68 2.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.698 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.493 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 16.7 mm-40 -99.45 140.39 33.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.689 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -109.97 136.79 48.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.964 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -104.3 125.93 50.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.118 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.614 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 0.5 OUTLIER -105.91 139.86 25.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.518 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.478 ' HB ' ' HB2' ' A' ' 132' ' ' GLN . 2.3 m -121.12 115.1 22.45 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.473 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.8 mp -104.39 121.78 56.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.104 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.35 145.93 44.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.021 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 154.49 -151.62 23.28 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.651 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.49 ' CG2' ' HD2' ' A' ' 152' ' ' PRO . 1.5 mp -82.41 143.85 48.75 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.49 ' HD2' ' CG2' ' A' ' 151' ' ' ILE . 79.5 Cg_exo -48.98 -34.09 28.1 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 121.933 1.756 . . . . 0.0 111.589 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -72.17 -34.64 68.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.645 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 50.7 m -69.81 -39.04 76.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.902 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 39.2 mm -66.26 -53.47 36.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.073 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 32.6 mm -57.51 -29.0 32.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.873 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -72.32 -40.82 67.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.837 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.73 -35.03 79.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.855 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.7 t -73.99 -37.73 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.169 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -71.55 -34.82 70.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.93 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -73.77 -40.65 63.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.958 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 14.8 tt -71.43 -34.46 53.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.152 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 1.5 m -68.27 -51.92 39.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.137 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 10.8 p -58.83 -40.13 79.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.273 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 50.5 t -70.62 -32.33 49.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.007 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -45.78 90.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.874 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -71.36 -47.32 57.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.89 -2.65 24.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.209 -0.451 . . . . 0.0 112.015 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.166 -0.921 . . . . 0.0 111.385 179.957 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.903 0.382 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -109.94 -71.22 0.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.837 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.403 ' CG2' ' N ' ' A' ' 13' ' ' THR . 7.7 p -108.7 161.1 7.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.003 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 3.1 t -103.57 160.78 14.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.012 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.3 mt -150.61 173.75 13.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.163 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.7 m -142.47 113.23 7.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.756 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.7 tt -132.61 129.01 58.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.319 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.494 ' NH2' ' OE1' ' A' ' 143' ' ' GLU . 0.0 OUTLIER -117.98 148.61 42.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.693 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 pp -129.38 146.67 51.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.895 0.379 . . . . 0.0 111.248 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.3 tt -123.05 134.62 54.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.795 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -138.47 165.81 25.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.983 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.78 166.25 15.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.676 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.2 -36.93 94.1 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.705 -0.76 . . . . 0.0 113.022 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -78.36 -50.08 12.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.901 0.381 . . . . 0.0 111.34 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.95 -44.81 95.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.335 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.4 p -62.97 -35.98 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.794 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.16 -34.87 90.47 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.5 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.6 t -75.52 -30.17 59.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.768 0.318 . . . . 0.0 110.846 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.422 HD11 ' N ' ' A' ' 28' ' ' ILE . 4.1 mm -81.12 -36.87 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.258 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.409 HD11 ' CD ' ' A' ' 57' ' ' ARG . 30.5 mt -65.75 -42.48 92.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.337 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.58 150.9 22.29 Favored Glycine 0 N--CA 1.434 -1.489 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.122 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.437 ' C ' ' HG3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -51.22 146.61 6.47 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.739 -0.731 . . . . 0.0 111.242 179.599 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.486 ' HE3' ' HB3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 44.43 27.1 0.21 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.119 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.445 ' O ' HG21 ' A' ' 36' ' ' VAL . . . 45.37 20.2 0.31 Allowed Glycine 0 CA--C 1.522 0.529 0 C-N-CA 121.353 -0.451 . . . . 0.0 113.967 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.486 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -73.14 -25.3 60.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.327 0.564 . . . . 0.0 110.086 179.263 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.58 -42.75 64.26 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.539 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 33' ' ' GLY . 0.9 OUTLIER -67.02 -26.62 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -71.03 -36.9 72.54 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.04 -37.09 86.45 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.586 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -59.01 -53.74 54.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.419 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.9 mtm-85 -52.86 -51.14 62.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.956 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.6 -37.5 84.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.914 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.52 -35.84 63.16 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.28 -55.74 3.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.978 0.418 . . . . 0.0 111.08 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.37 10.03 54.5 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.882 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.422 ' O ' ' C ' ' A' ' 46' ' ' ARG . . . -110.77 128.38 55.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.89 0.345 . . . . 0.0 111.221 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -27.49 134.5 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.243 179.439 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.4 mt -142.22 100.57 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.705 0.288 . . . . 0.0 110.522 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -112.98 167.43 10.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.886 0.374 . . . . 0.0 111.056 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.4 mt -126.52 152.04 33.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.155 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 63.9 m -91.03 -175.05 4.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.218 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -62.43 -168.45 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.16 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.85 -72.84 2.19 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.386 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 44.12 29.37 0.34 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.052 0.453 . . . . 0.0 110.558 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.485 ' CB ' ' CD ' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -151.25 -68.48 0.02 OUTLIER Pre-proline 0 N--CA 1.454 -0.266 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.09 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 54' ' ' CYS . 86.5 Cg_endo -77.4 -35.41 1.64 Allowed 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.037 1.825 . . . . 0.0 110.937 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -146.34 161.05 41.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.583 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.409 ' CD ' HD11 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -146.32 127.53 14.78 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.288 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.3 mt -115.0 104.58 17.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.375 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.3 mt -92.92 103.55 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.522 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 91.1 m -83.02 129.1 35.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.459 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.455 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 0.3 OUTLIER -118.21 131.3 56.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.085 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -131.29 130.92 43.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.759 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.2 164.8 14.07 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.961 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.461 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 86.9 Cg_exo -40.31 162.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.169 2.58 . . . . 0.0 113.041 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.6 m -60.17 -35.73 76.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.009 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -69.84 -51.86 29.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.081 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.04 -39.64 75.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.97 0.414 . . . . 0.0 110.85 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.23 -39.54 84.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.34 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.74 -43.13 89.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.01 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.29 -49.92 75.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.955 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.04 -56.47 21.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.27 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -57.39 -34.57 69.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.113 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.27 -42.09 99.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.124 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.06 -36.55 72.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.951 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.9 mt -62.77 -49.26 84.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.5 pt -61.21 -40.51 86.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.027 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -61.22 -39.87 91.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.685 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.43 -41.67 97.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.29 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.1 tp -74.61 -26.62 60.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.472 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -76.89 -34.62 57.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.703 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -72.21 -37.38 69.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.729 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -59.33 -33.36 71.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.914 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 12.3 mt -68.36 -41.32 83.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.993 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.6 t -99.69 31.52 3.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.912 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.97 -31.51 11.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.5 p -164.83 141.56 5.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 2.7 ptm -154.14 115.02 4.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.945 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.1 m -71.32 -66.0 0.68 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.003 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -143.01 166.58 24.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.89 -79.05 0.43 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.92 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 47.76 88.62 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.188 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 61.62 -165.31 0.23 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.069 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -157.89 92.02 1.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.032 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.0 p -72.22 -28.23 63.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.132 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.1 64.07 59.68 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.03 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.452 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 33.9 Cg_exo -58.56 -46.33 24.71 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.55 2.167 . . . . 0.0 112.884 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 96' ' ' PRO . 84.6 Cg_endo -79.12 -163.81 0.24 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.371 2.047 . . . . 0.0 112.839 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.2 t -140.77 122.12 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.987 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.0 p -102.62 141.13 35.95 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.461 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 147' ' ' THR . 4.6 mp -139.84 158.58 43.85 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.139 -1.801 . . . . 0.0 106.139 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.3 ttp-105 -122.84 113.33 19.0 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.912 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.09 144.6 29.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.933 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.5 t -104.43 139.08 26.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.061 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.3 m -149.06 157.22 40.17 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.04 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.24 166.56 20.84 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.421 2.081 . . . . 0.0 112.324 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.68 -34.57 75.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.384 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 p -68.97 -30.28 68.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.978 0.418 . . . . 0.0 109.926 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -50.6 52.71 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.793 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 30.9 p -70.67 -38.21 73.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.677 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -54.7 -50.45 57.67 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.475 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.2 p -77.43 -47.45 19.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.671 0.272 . . . . 0.0 111.011 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.0 mt -52.66 -26.46 13.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.925 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 41.0 mt -92.33 -37.37 8.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.943 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.93 179.47 32.83 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.423 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -67.39 124.18 22.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.873 0.368 . . . . 0.0 111.008 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.0 19.1 63.14 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.816 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 64.41 13.26 54.25 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.887 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -52.9 -50.6 63.57 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 120.775 0.322 . . . . 0.0 111.728 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.401 ' CD ' ' CD1' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -57.1 -60.83 3.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.178 -179.763 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.1 -26.92 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.456 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.6 tptp -65.06 -47.0 78.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.796 0.332 . . . . 0.0 110.892 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -73.13 -45.8 54.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.136 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.438 HD13 HG23 ' A' ' 123' ' ' ILE . 50.6 mt -62.17 -50.89 78.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.998 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -63.78 -40.55 96.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.151 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -54.99 -57.38 11.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.818 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.3 m -75.83 -43.68 44.77 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.0 m -47.95 -25.94 1.55 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.866 0.365 . . . . 0.0 110.432 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.24 -7.05 58.24 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.049 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -105.66 137.11 44.06 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.951 0.375 . . . . 0.0 110.953 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 0.0 OUTLIER -95.58 144.59 25.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.209 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.8 m -99.31 147.17 7.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.045 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 7.0 tp60 -140.22 117.77 11.52 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.6 p -96.59 116.47 38.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.051 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.22 135.01 35.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.795 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 49.78 -178.69 0.02 OUTLIER Glycine 0 CA--C 1.518 0.228 0 CA-C-N 115.968 -0.56 . . . . 0.0 113.387 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.3 p30 174.37 41.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.926 0.393 . . . . 0.0 110.484 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 19.6 mtp -56.09 166.87 0.7 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.127 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.52 164.59 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.837 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -50.78 -25.21 14.84 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.483 2.122 . . . . 0.0 112.189 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 177.29 104.72 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.639 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 88.3 p -57.77 -174.09 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.997 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 25.7 m -106.42 -64.56 1.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.359 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.494 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 10.5 mm-40 -93.92 135.73 34.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.171 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.75 166.41 14.35 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.241 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -130.2 115.75 17.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.791 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 30.5 mt -100.77 129.24 51.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.696 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.47 ' HB ' ' CB ' ' A' ' 132' ' ' GLN . 2.6 m -97.67 123.06 41.43 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.519 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 130' ' ' GLN . 2.1 pp -106.72 117.97 53.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.935 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.34 126.43 52.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.121 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 171.28 -153.28 20.08 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.592 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.491 ' CG2' ' HD2' ' A' ' 152' ' ' PRO . 1.3 mp -87.32 143.59 34.65 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 110.624 -0.139 . . . . 0.0 110.624 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.491 ' HD2' ' CG2' ' A' ' 151' ' ' ILE . 71.3 Cg_exo -49.33 -31.03 21.62 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 121.966 1.777 . . . . 0.0 111.447 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.13 -34.65 68.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.674 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 22.2 t -68.79 -50.08 53.3 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.795 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.425 HG22 HD12 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -58.39 -45.07 89.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.9 mt -63.88 -29.98 48.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.845 0.355 . . . . 0.0 110.842 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -73.65 -43.02 60.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.238 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 21.4 p -72.42 -42.87 64.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.277 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 13.3 p -60.83 -37.9 77.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.927 0.394 . . . . 0.0 111.01 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.97 -32.91 69.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.756 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -49.56 61.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.0 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 37.7 mm -66.41 -34.48 70.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.015 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 1.7 m -64.58 -48.1 76.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.978 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 11.1 p -65.48 -33.53 64.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.187 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 50.8 t -70.64 -45.14 75.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.878 0.371 . . . . 0.0 110.972 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 27.2 mtm -58.98 -33.57 70.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.847 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.56 -48.22 41.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.818 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.02 -2.55 24.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.93 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 41.2 p . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.876 -179.979 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 120.762 0.315 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 -104.54 -77.88 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.854 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.44 151.68 16.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.986 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 0.9 OUTLIER -103.66 142.75 33.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.039 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.2 mt -137.11 175.23 9.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.991 0.424 . . . . 0.0 111.211 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.7 m -142.4 135.97 29.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.841 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.1 tt -140.87 154.67 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.164 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.496 ' NH2' ' OE1' ' A' ' 143' ' ' GLU . 25.0 mtp180 -134.79 127.63 31.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.867 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.5 mt -113.96 147.58 38.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.8 tt -102.35 106.04 16.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.762 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.2 144.14 40.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.044 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.445 ' HA ' ' O ' ' A' ' 55' ' ' PRO . 0.2 OUTLIER -76.61 167.82 21.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.752 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.472 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -59.8 -34.66 83.49 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.769 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.86 -52.02 8.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 0.0 111.354 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -34.12 76.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.849 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.668 ' O ' HG12 ' A' ' 29' ' ' ILE . 7.4 p -71.03 -38.97 74.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.664 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.08 -35.08 90.95 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.683 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.26 -34.96 61.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.594 0.235 . . . . 0.0 111.07 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 25' ' ' VAL . 2.9 pp -80.15 -32.53 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.355 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.668 HG12 ' O ' ' A' ' 25' ' ' VAL . 12.4 mm -65.06 -58.87 5.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.7 150.54 25.29 Favored Glycine 0 N--CA 1.436 -1.354 0 CA-C-O 121.635 0.575 . . . . 0.0 112.664 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.443 ' O ' ' CD ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -61.52 146.34 48.98 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.501 -0.85 . . . . 0.0 111.441 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.443 ' CD ' ' O ' ' A' ' 31' ' ' LYS . 0.1 OUTLIER 52.56 18.89 1.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.277 179.482 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.434 ' O ' HG21 ' A' ' 36' ' ' VAL . . . 51.7 13.79 1.5 Allowed Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.956 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.412 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 5.4 tp10 -76.88 -26.27 54.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.322 0.561 . . . . 0.0 109.748 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.428 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -75.19 -40.95 58.93 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.246 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.434 HG21 ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -67.3 -26.51 36.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.243 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.57 -36.61 81.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 177.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.428 ' HB3' ' O ' ' A' ' 35' ' ' SER . 22.2 ttmm -60.36 -40.9 92.43 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.778 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.458 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 3.0 ttp -59.2 -48.46 81.55 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.38 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.2 ttp85 -55.3 -50.63 69.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.101 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -64.64 -38.51 91.25 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 39' ' ' MET . 3.1 pp20? -75.03 -35.88 61.92 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.0 p -91.04 -55.4 3.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.911 0.386 . . . . 0.0 111.105 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.12 5.86 65.45 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.248 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.487 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . . . -110.65 128.43 55.69 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.44 0.162 . . . . 0.0 110.799 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -27.61 136.91 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.001 0.521 . . . . 0.0 112.057 178.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.45 HG13 HD13 ' A' ' 61' ' ' LEU . 20.6 mt -142.19 100.68 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.73 0.3 . . . . 0.0 110.578 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -121.41 121.57 37.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.919 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -107.53 127.61 63.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.374 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.92 -174.04 0.18 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 61.44 173.25 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.044 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 149.76 -76.94 0.24 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.942 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.4 m120 53.97 24.61 4.76 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.461 ' CB ' ' CD ' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -164.41 -65.16 0.01 OUTLIER Pre-proline 0 N--CA 1.453 -0.295 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.562 -179.494 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 56' ' ' GLU . 78.0 Cg_endo -79.58 -33.21 1.35 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.395 2.063 . . . . 0.0 111.254 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.553 ' CB ' ' O ' ' A' ' 55' ' ' PRO . 1.8 mt-10 113.14 -35.42 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.739 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -145.82 155.89 43.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.006 0.431 . . . . 0.0 111.525 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.7 mt -140.64 118.7 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.339 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 mt -85.94 117.93 31.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.985 0.422 . . . . 0.0 111.622 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.9 m -108.57 101.75 10.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.467 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.476 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 15.9 tp -104.41 124.29 48.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.812 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 46' ' ' ARG . . . -126.78 131.71 51.22 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.487 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.39 166.19 16.43 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 119.686 -1.245 . . . . 0.0 113.297 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 2.9 Cg_endo -41.85 159.48 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 123.396 2.731 . . . . 0.0 112.669 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 57.0 m -60.11 -35.97 76.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.48 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -68.72 -52.07 34.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.239 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.07 -38.04 72.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.071 0.462 . . . . 0.0 110.882 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -65.18 -39.34 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.275 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.44 -45.09 92.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.886 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.2 -53.41 58.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.614 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.72 -43.74 97.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.177 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -62.02 -35.51 78.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.078 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.87 -38.78 83.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.262 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.36 -39.21 54.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.984 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 88.6 mt -62.06 -50.58 79.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.661 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.3 pp -63.87 -40.69 89.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.969 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -69.65 -29.69 67.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.455 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -35.64 81.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.076 0.465 . . . . 0.0 109.91 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.9 tp -77.39 -30.52 53.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.386 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.94 -34.05 57.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.776 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.54 -37.84 68.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.032 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -71.71 -51.17 24.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.446 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.7 pp -53.79 -42.97 54.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.55 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.48 112.29 1.94 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.935 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.12 -51.17 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.819 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.07 30.19 3.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.955 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 1.3 mtt -126.91 -43.17 1.7 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.901 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.2 -22.74 33.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.063 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 70.0 -65.8 0.3 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.955 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.94 56.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.838 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.0 t -138.24 36.71 2.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.937 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -158.35 154.4 26.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.038 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -171.4 36.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.192 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.3 m -119.84 -48.43 2.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.911 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.1 ttp180 63.9 119.49 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.879 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -74.31 170.48 20.1 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.423 2.082 . . . . 0.0 112.339 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.71 -166.71 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.597 2.198 . . . . 0.0 112.078 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.17 103.32 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.903 0.383 . . . . 0.0 111.418 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.0 t -107.53 127.0 53.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.383 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 mt -140.03 117.76 11.63 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -103.18 112.39 25.23 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.788 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.64 149.77 26.89 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.403 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.24 145.08 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.652 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.424 ' CG1' ' HD2' ' A' ' 105' ' ' PRO . 40.1 t -142.88 144.75 30.66 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.225 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 108' ' ' GLN . 22.2 Cg_exo -65.36 165.51 22.16 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.507 2.138 . . . . 0.0 112.154 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.04 -44.22 73.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.135 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.5 m -66.7 -30.48 70.72 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.427 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -74.61 -41.42 60.46 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.434 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 55.6 m -66.28 -40.9 90.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.102 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.57 -50.71 64.79 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.161 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.3 t -70.4 -36.2 73.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.783 0.325 . . . . 0.0 110.615 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 10.7 mt -58.49 -28.32 65.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.272 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.431 ' CG2' ' HA2' ' A' ' 117' ' ' GLY . 10.9 mt -81.71 -40.29 17.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.717 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.1 -176.83 53.81 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.521 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -66.47 118.15 9.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.896 0.379 . . . . 0.0 111.185 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.99 15.38 56.0 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.015 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.431 ' HA2' ' CG2' ' A' ' 113' ' ' ILE . . . 73.06 5.08 64.6 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.006 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 1.5 m -53.13 -39.65 63.64 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 120.727 0.299 . . . . 0.0 111.719 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -64.87 -65.33 0.69 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.438 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -54.4 -35.51 31.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.393 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.5 tptm -59.26 -44.18 92.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.08 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -73.24 -40.21 64.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.329 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 88.2 mt -54.97 -53.9 29.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.216 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -31.95 69.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.892 0.377 . . . . 0.0 110.938 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -49.74 72.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.31 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.2 m -90.08 -36.94 14.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.546 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.6 m -49.89 -26.05 3.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.848 0.356 . . . . 0.0 110.364 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.3 -12.04 52.59 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.093 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -103.8 155.24 18.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.844 0.354 . . . . 0.0 111.038 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.31 127.94 53.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.054 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 147' ' ' THR . 14.4 m -99.2 138.64 23.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.861 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.679 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 5.4 tm0? -123.38 116.59 23.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.167 0.508 . . . . 0.0 112.032 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 30.8 m -103.46 130.97 52.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.363 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.2 160.71 30.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.929 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.97 173.27 35.36 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.6 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -150.47 -46.6 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.865 0.364 . . . . 0.0 110.76 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 2.4 tpt 62.65 92.49 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.081 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.8 mp 58.81 163.34 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.964 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -55.93 91.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.57 2.18 . . . . 0.0 112.249 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -134.02 -68.05 0.57 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.887 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 79.0 p -62.76 166.19 5.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.882 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.01 -47.32 3.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.496 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 29.5 mt-10 -121.98 139.88 53.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.825 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.04 173.07 6.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -122.54 126.33 47.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.232 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.679 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 3.4 mp -105.48 125.0 60.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.618 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 131' ' ' VAL . 2.1 m -99.59 114.69 27.87 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.678 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 4.6 pt -106.9 114.72 46.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.411 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -119.38 132.33 55.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.768 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 167.06 -151.61 19.67 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.815 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.511 ' CG2' ' HD2' ' A' ' 152' ' ' PRO . 15.9 mt -84.85 144.46 42.02 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.511 ' HD2' ' CG2' ' A' ' 151' ' ' ILE . 73.5 Cg_exo -48.89 -33.77 26.57 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 121.988 1.792 . . . . 0.0 111.689 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -72.05 -34.75 69.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.845 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.3 m -67.97 -50.46 55.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.992 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.449 HG22 HD11 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -59.26 -47.45 90.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.134 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.6 mt -60.69 -45.9 96.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.819 0.342 . . . . 0.0 110.759 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -60.46 -35.17 75.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.663 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 9.0 t -67.03 -42.99 83.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.774 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.6 t -59.03 -37.96 71.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.022 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.97 -33.01 73.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.777 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -71.47 -46.23 60.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.827 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 50.3 mt -67.25 -34.51 69.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.979 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 1.6 m -63.93 -52.37 60.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.017 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 10.7 p -59.56 -33.3 51.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.172 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 44.0 t -70.69 -44.03 76.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.849 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.85 -33.09 71.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.855 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.59 -50.56 35.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.76 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -73.97 -2.56 24.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.069 0.461 . . . . 0.0 111.948 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 60.2 m . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.864 179.96 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.4 tttm . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.839 0.352 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -55.07 -84.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.15 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.5 p -114.27 159.18 14.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.115 0.483 . . . . 0.0 111.373 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -109.52 154.05 23.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.787 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.415 HD21 ' HA ' ' A' ' 14' ' ' LEU . 1.1 mt -144.36 169.28 18.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.054 0.454 . . . . 0.0 111.229 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.2 m -142.72 132.13 23.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.673 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.436 HD11 ' CZ ' ' A' ' 72' ' ' PHE . 2.4 tt -140.83 140.05 33.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.948 0.404 . . . . 0.0 111.326 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.497 ' NH2' ' OE1' ' A' ' 143' ' ' GLU . 1.1 mpp_? -124.48 120.32 31.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.686 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.413 HD22 ' CZ ' ' A' ' 72' ' ' PHE . 14.1 mt -99.8 119.63 38.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.118 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.3 tt -102.71 105.43 15.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.702 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.6 tpp -120.21 161.48 20.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.902 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.404 ' O ' ' CG1' ' A' ' 25' ' ' VAL . 0.3 OUTLIER -67.7 172.57 5.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.452 179.807 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.08 -40.79 99.39 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.913 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.93 -45.27 24.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.771 0.32 . . . . 0.0 111.547 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.13 -48.39 78.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.944 0.402 . . . . 0.0 110.283 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.404 ' CG1' ' O ' ' A' ' 21' ' ' HIS . 9.8 p -61.66 -35.2 65.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.852 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.94 -34.92 90.46 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.187 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 m -75.24 -26.76 59.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.879 0.371 . . . . 0.0 110.723 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.433 ' N ' HD13 ' A' ' 28' ' ' ILE . 3.9 mm -79.11 -51.48 16.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.123 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.7 mt -57.31 -42.27 79.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.514 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.03 150.84 27.3 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.137 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.412 ' O ' ' CD ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -51.59 146.05 8.16 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.058 -0.571 . . . . 0.0 111.143 179.766 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.442 ' HE3' ' HB3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 43.36 27.07 0.12 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.834 -179.65 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 45.17 21.75 0.43 Allowed Glycine 0 CA--C 1.52 0.4 0 C-N-CA 121.273 -0.489 . . . . 0.0 113.852 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.442 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -76.23 -28.84 57.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.209 0.504 . . . . 0.0 110.314 179.574 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.1 t -73.71 -41.75 62.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.488 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.405 ' HA ' ' HB2' ' A' ' 39' ' ' MET . 2.3 p -67.42 -27.34 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.2 -36.67 79.91 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 176.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.406 ' HA ' ' CG ' ' A' ' 41' ' ' GLU . 1.8 tttm -70.91 -31.8 68.53 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.241 177.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.405 ' HB2' ' HA ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -63.21 -51.04 67.89 Favored 'General case' 0 C--O 1.228 -0.047 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.463 179.52 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.0 ttt-85 -58.38 -51.57 69.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.581 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.406 ' CG ' ' HA ' ' A' ' 38' ' ' LYS . 1.4 pp20? -64.33 -37.94 89.27 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -74.69 -36.75 62.76 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.1 p -81.37 -55.65 4.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.906 0.384 . . . . 0.0 111.018 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.93 1.12 56.15 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.736 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' A' ' 46' ' ' ARG . . . -110.66 128.17 55.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.842 0.321 . . . . 0.0 111.304 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 8.3 ttm180 -27.27 140.6 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.257 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 60' ' ' THR . 12.0 mt -142.52 101.1 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.696 0.284 . . . . 0.0 110.817 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -118.38 128.77 54.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.781 0.324 . . . . 0.0 111.248 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.6 mm -92.11 151.86 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.97 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.7 m -87.16 -177.06 5.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.915 0.388 . . . . 0.0 111.268 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.15 -166.01 0.28 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.111 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.62 -76.94 1.38 Allowed Glycine 0 CA--C 1.51 -0.231 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.296 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 48.67 27.6 1.56 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.982 0.42 . . . . 0.0 110.348 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.481 ' CB ' ' CD ' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -149.96 -68.37 0.02 OUTLIER Pre-proline 0 N--CA 1.454 -0.241 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.378 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.481 ' CD ' ' CB ' ' A' ' 54' ' ' CYS . 92.0 Cg_endo -73.22 -32.35 8.46 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.838 1.692 . . . . 0.0 110.323 178.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.34 170.29 2.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.855 -178.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -145.79 139.3 26.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.825 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.8 mm -105.62 109.71 28.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.024 0.44 . . . . 0.0 110.892 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.8 mt -86.49 92.83 3.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.094 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 47' ' ' ILE . 8.0 m -81.1 134.08 35.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.985 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.451 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -131.39 134.65 46.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.285 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.47 130.52 34.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.66 0.267 . . . . 0.0 110.862 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.404 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.22 164.61 13.87 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.919 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 83.6 Cg_exo -39.93 158.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 123.21 2.607 . . . . 0.0 113.238 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.407 ' O ' HG21 ' A' ' 68' ' ' ILE . 29.9 m -60.04 -35.69 75.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.87 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -63.48 -51.83 63.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.262 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.21 -40.7 77.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.057 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.407 HG21 ' O ' ' A' ' 65' ' ' THR . 0.5 OUTLIER -66.19 -39.37 84.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.18 -179.44 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.38 -48.92 79.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.227 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.73 -48.8 79.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.977 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.41 -58.75 6.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.286 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.436 ' CZ ' HD11 ' A' ' 16' ' ' ILE . 2.7 m-85 -51.84 -39.24 58.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.305 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.61 -43.93 93.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.109 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.0 ttp -72.21 -34.82 68.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.9 mt -64.29 -48.7 84.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.965 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.3 pt -62.65 -39.35 84.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.93 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.19 -36.52 82.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.718 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -42.27 93.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.335 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.5 tp -77.34 -24.94 50.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.624 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -76.86 -39.96 49.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.779 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.1 -34.01 68.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.834 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.77 -55.23 35.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.917 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -66.08 -39.87 85.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.222 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.5 t 54.39 24.14 4.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.268 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 57.94 46.64 16.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.97 0.414 . . . . 0.0 110.873 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.8 m 63.66 93.68 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.651 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -54.58 -26.84 34.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.207 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.3 t -135.83 -55.19 0.77 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.13 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 177.76 174.35 0.52 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.94 0.4 . . . . 0.0 110.87 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.0 149.29 51.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.864 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.7 p -100.49 39.1 1.4 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.891 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -96.09 -69.0 0.77 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.093 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -165.38 -58.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.165 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.1 m -160.52 -70.78 0.07 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.959 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.8 139.54 20.25 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -77.38 114.02 3.66 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.514 2.143 . . . . 0.0 112.399 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.91 164.37 31.96 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.419 2.08 . . . . 0.0 112.114 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.3 t -134.81 107.04 7.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.197 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.1 p -104.0 135.53 45.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.785 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.98 117.59 11.53 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -105.2 112.56 25.73 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.291 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.3 mt -99.37 129.97 45.61 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.049 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.3 m -103.85 143.99 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.058 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.7 m -157.94 166.2 17.04 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.09 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 108' ' ' GLN . 21.8 Cg_exo -65.97 171.32 10.17 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.609 2.206 . . . . 0.0 112.356 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.58 -34.6 78.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.623 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.3 m -67.34 -30.52 70.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.11 0.481 . . . . 0.0 109.874 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.401 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -69.41 -50.53 45.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.772 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.18 -41.52 99.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.646 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -56.55 -47.47 83.8 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.375 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.0 t -71.99 -40.5 68.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.795 0.331 . . . . 0.0 110.815 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.6 mt -54.36 -26.82 32.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.978 0.418 . . . . 0.0 110.598 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.408 ' CG2' ' HA2' ' A' ' 117' ' ' GLY . 8.2 mt -84.86 -43.18 17.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.791 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.98 -176.74 54.58 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.569 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -67.29 116.89 8.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.896 0.379 . . . . 0.0 111.079 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.57 11.82 57.7 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.999 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.408 ' HA2' ' CG2' ' A' ' 113' ' ' ILE . . . 75.64 2.58 69.88 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.995 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -52.83 -36.79 59.14 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 120.701 0.286 . . . . 0.0 111.609 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.9 mmtp -63.87 -65.27 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.192 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.39 -31.05 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.373 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.98 -46.55 88.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.038 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -73.21 -46.25 51.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.307 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 40.4 mm -54.84 -53.68 30.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.204 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -63.74 -39.92 95.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.26 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.33 -53.93 47.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.33 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.8 m -76.99 -33.47 57.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.294 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 17.8 m -52.34 -26.61 12.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.974 0.416 . . . . 0.0 110.125 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.84 -22.09 5.14 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.247 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -96.44 165.4 12.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.919 0.36 . . . . 0.0 111.073 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -105.16 138.01 42.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.694 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 27.6 m -99.11 145.07 10.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.16 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.701 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 0.7 OUTLIER -119.57 158.43 26.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.767 -179.685 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.5 p -120.74 122.13 67.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.792 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -73.33 148.83 43.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.382 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -72.28 97.65 0.77 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.421 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -150.17 -45.15 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.873 0.368 . . . . 0.0 110.79 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 6.3 ttm 61.12 160.32 0.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.487 ' N ' ' CD ' ' A' ' 139' ' ' PRO . 0.3 OUTLIER -80.26 -46.14 1.38 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.172 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 138' ' ' LEU . 49.3 Cg_exo -55.8 -27.88 64.4 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.413 2.076 . . . . 0.0 112.26 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.85 -77.86 0.49 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.858 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.5 t -83.02 -168.69 2.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.834 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 15.7 m -123.35 -48.56 1.95 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.497 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 7.9 mt-10 -98.67 136.87 38.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.812 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 11.1 mtm-85 -115.6 155.3 27.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.93 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -122.43 135.98 54.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.988 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.701 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 21.9 mt -108.91 143.79 18.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.73 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.434 ' HB ' ' CB ' ' A' ' 132' ' ' GLN . 0.2 OUTLIER -113.62 116.84 30.12 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.178 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -103.78 124.5 58.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.143 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.46 146.32 44.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.171 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 149.52 -153.22 25.01 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.255 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.3 pt -87.12 156.39 54.64 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.642 0.258 . . . . 0.0 110.863 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -49.53 -34.65 34.49 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.621 2.214 . . . . 0.0 111.907 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.98 -34.66 69.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.391 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 18.6 m -70.37 -39.14 74.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.946 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 22.7 mm -72.64 -48.59 45.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.214 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.2 tt -58.21 -45.15 88.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.141 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -62.73 -36.67 83.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.707 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 3.9 t -58.22 -47.22 84.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.642 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 30.3 t -61.2 -42.09 92.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.979 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -35.59 75.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.78 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -67.24 -37.1 82.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.776 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 41.3 mt -74.02 -34.38 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.15 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 77.1 m -73.91 -45.15 52.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.076 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 11.6 p -62.36 -45.36 98.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.062 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 28.0 m -65.85 -45.6 90.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.058 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 50.8 mtp -57.6 -42.71 83.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.841 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 7.9 tt -72.55 -41.76 65.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.819 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.91 -2.67 24.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.977 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 52.6 p . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.838 179.915 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.807 0.337 . . . . 0.0 111.182 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -134.44 76.66 1.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.921 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.6 t -145.39 158.35 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.144 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.14 129.49 55.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.506 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -128.84 153.4 47.48 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.175 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.5 m -135.91 112.76 10.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.502 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.6 tt -111.48 142.97 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.453 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.496 ' NH2' ' OE1' ' A' ' 143' ' ' GLU . 1.1 mpp_? -132.08 126.14 33.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.657 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.13 132.0 53.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.247 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.0 tt -102.23 136.32 42.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.632 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.99 155.39 46.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.892 0.377 . . . . 0.0 111.135 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -67.75 175.18 3.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.641 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.01 -41.96 96.69 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.91 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.66 -42.83 27.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.742 0.305 . . . . 0.0 111.677 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.56 -40.99 98.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.986 0.422 . . . . 0.0 110.537 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.495 ' O ' HG12 ' A' ' 29' ' ' ILE . 8.6 p -70.89 -32.44 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.657 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.42 -39.86 98.33 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.371 -0.919 . . . . 0.0 112.822 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.5 p -76.06 -35.49 59.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 25' ' ' VAL . 2.1 pp -79.83 -32.61 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 25' ' ' VAL . 9.8 mm -71.92 -54.58 16.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.916 0.388 . . . . 0.0 110.427 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.65 150.64 25.45 Favored Glycine 0 N--CA 1.436 -1.327 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.945 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.427 ' O ' ' CD ' ' A' ' 32' ' ' LYS . 8.3 mttm -59.67 146.54 40.77 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.478 -0.861 . . . . 0.0 111.214 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.455 ' HE3' ' HB3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 44.2 26.25 0.15 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.997 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.443 ' O ' HG23 ' A' ' 36' ' ' VAL . . . 50.88 18.63 2.91 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.685 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.455 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -75.44 -29.77 59.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.228 0.514 . . . . 0.0 109.992 179.308 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.39 -40.3 58.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.584 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -67.09 -26.25 36.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.23 -36.97 74.89 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -63.15 -37.43 87.18 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.396 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.5 ttm -59.33 -51.29 70.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.487 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -53.81 -51.35 63.79 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.159 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -59.27 -38.41 80.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.693 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.27 -20.42 34.51 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.1 t -90.44 -55.48 3.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.757 0.313 . . . . 0.0 111.554 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.53 -10.93 73.27 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.401 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.421 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . . . -110.73 128.91 55.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.588 0.232 . . . . 0.0 111.112 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.441 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.8 OUTLIER -27.01 140.12 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.204 0.602 . . . . 0.0 112.386 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 45' ' ' ALA . 25.6 mt -142.32 100.55 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.558 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.47 129.99 52.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.751 0.31 . . . . 0.0 111.011 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 3.4 mp -108.4 142.47 20.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.197 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.8 p -161.64 -170.73 2.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.922 0.392 . . . . 0.0 111.317 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.407 ' CB ' ' CD1' ' A' ' 58' ' ' ILE . 0.3 OUTLIER 66.29 131.15 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.035 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.76 -66.38 0.63 Allowed Glycine 0 CA--C 1.508 -0.375 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.69 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 45.48 25.92 0.27 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.93 0.395 . . . . 0.0 110.565 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.493 ' CB ' ' CD ' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -151.47 -70.13 0.02 OUTLIER Pre-proline 0 N--CA 1.452 -0.375 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.868 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.493 ' CD ' ' CB ' ' A' ' 54' ' ' CYS . 66.5 Cg_endo -81.12 -33.14 0.81 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.157 1.905 . . . . 0.0 110.954 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.64 170.22 17.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.297 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 -145.75 132.71 20.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.851 0.357 . . . . 0.0 110.885 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 46.4 mt -98.05 105.91 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.756 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.7 mp -86.07 97.61 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.212 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 62.5 m -87.49 136.83 32.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.925 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 2.1 tt -131.42 134.24 46.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.486 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -133.12 130.71 39.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.685 0.278 . . . . 0.0 111.158 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.421 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.26 164.41 13.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.707 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -40.75 161.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.019 2.479 . . . . 0.0 113.179 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.401 ' O ' HG21 ' A' ' 68' ' ' ILE . 8.5 m -60.21 -35.64 75.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.115 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 -64.73 -51.88 60.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.362 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.97 -42.4 80.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.957 0.408 . . . . 0.0 110.974 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.401 HG21 ' O ' ' A' ' 65' ' ' THR . 0.5 OUTLIER -66.3 -39.65 84.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.335 -179.334 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -46.12 90.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.061 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -51.2 70.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.991 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.37 -41.64 80.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.29 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.437 ' O ' HG13 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -60.37 -39.43 87.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.912 0.387 . . . . 0.0 110.889 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.92 -29.86 68.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.312 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -48.46 14.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.699 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 72' ' ' PHE . 0.7 OUTLIER -59.78 -39.08 78.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.288 -179.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 pp -72.48 -37.03 56.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.853 0.359 . . . . 0.0 111.012 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -65.48 -46.94 77.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.498 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.04 -35.3 74.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.012 0.434 . . . . 0.0 110.018 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.7 tp -76.58 -27.27 55.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.141 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.84 -34.13 57.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.696 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.23 -44.28 63.13 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.758 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.3 -51.38 69.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.868 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 28.8 mm -72.11 -30.62 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.939 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.2 t -107.34 48.0 0.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.758 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 m -91.22 14.36 14.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.233 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.83 -14.68 13.04 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.239 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 12.8 mmt 61.41 75.33 0.41 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.846 0.355 . . . . 0.0 110.9 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.2 m -152.77 164.66 37.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.845 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -127.75 162.75 25.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.1 -178.08 3.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.913 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 m -103.72 -58.85 1.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.904 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -148.16 31.19 0.84 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.026 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.33 -72.15 0.72 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.074 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 63.88 35.14 11.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.909 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.7 ptt-85 -141.34 71.17 26.99 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.891 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.05 147.33 54.37 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.611 2.207 . . . . 0.0 112.24 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.14 116.55 4.2 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.51 2.14 . . . . 0.0 112.546 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.6 m -141.02 117.08 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.739 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.8 m -103.01 141.51 35.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.808 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.97 117.78 11.69 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -100.91 112.64 25.12 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.166 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.51 137.37 47.45 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.229 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.74 148.93 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.4 t -152.81 143.67 15.81 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.227 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' A' ' 108' ' ' GLN . 20.9 Cg_exo -65.78 163.16 31.65 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.45 2.1 . . . . 0.0 112.192 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.94 -34.96 76.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.666 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.4 m -70.46 -30.48 67.33 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.426 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 26.4 mm-40 -71.79 -49.48 38.37 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.435 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 2.9 t -64.49 -41.46 96.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.307 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -54.66 -51.81 49.91 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.219 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.9 -35.43 69.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.908 0.385 . . . . 0.0 110.405 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.67 -25.86 66.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.35 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.411 ' CG2' ' HA2' ' A' ' 117' ' ' GLY . 9.3 mt -84.68 -36.9 12.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.776 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.17 -178.73 16.2 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.505 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.46 129.63 40.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.883 0.373 . . . . 0.0 111.128 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 60.44 17.1 46.34 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.938 -0.648 . . . . 0.0 113.008 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.411 ' HA2' ' CG2' ' A' ' 113' ' ' ILE . . . 67.65 9.53 55.93 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.991 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 4.6 t -53.14 -35.53 59.82 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.801 0.334 . . . . 0.0 111.493 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -64.09 0.93 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.274 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.1 tt -54.11 -26.94 15.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.822 0.344 . . . . 0.0 111.253 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -48.24 66.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.943 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -73.09 -36.11 66.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.177 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 16.4 mt -67.93 -48.29 75.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.217 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.04 -48.18 59.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.303 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -54.46 -35.29 62.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.46 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 99.9 p -90.21 -35.41 15.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.706 0.289 . . . . 0.0 111.329 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.4 m -52.14 -26.09 10.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.889 0.376 . . . . 0.0 110.106 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.11 -20.18 22.39 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.936 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -108.17 167.75 9.78 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.809 0.338 . . . . 0.0 111.132 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -105.08 129.95 53.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.892 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 147' ' ' THR . 13.2 m -99.29 139.14 21.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.067 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.617 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 1.1 tt0 -125.61 116.61 22.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.174 0.511 . . . . 0.0 112.178 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.3 p -97.46 136.75 27.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.408 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.55 161.11 10.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.056 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.59 155.58 53.37 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.635 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -170.67 32.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.1 mtt -101.8 26.39 7.52 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.298 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.424 ' CB ' ' HD3' ' A' ' 139' ' ' PRO . 0.2 OUTLIER -177.71 -53.48 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.043 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.424 ' HD3' ' CB ' ' A' ' 138' ' ' LEU . 35.9 Cg_exo -59.83 -35.89 92.67 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.341 2.028 . . . . 0.0 112.094 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 63.98 103.19 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.85 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.6 m -120.48 -170.67 2.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.928 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 10.9 t -115.96 -39.77 3.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.84 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.496 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 18.3 mt-10 -127.56 136.91 52.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.826 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.5 mtt180 -113.49 171.74 7.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.73 136.41 53.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.086 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.617 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 40.0 mt -105.86 124.32 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.736 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.461 ' HB ' ' CB ' ' A' ' 132' ' ' GLN . 4.4 m -97.77 114.76 26.85 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.523 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 23.6 mt -106.34 110.47 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.421 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.36 122.7 43.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.646 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 171.09 -151.38 15.6 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.543 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.503 ' CG2' ' HD2' ' A' ' 152' ' ' PRO . 1.4 mp -80.99 144.72 55.5 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.503 ' HD2' ' CG2' ' A' ' 151' ' ' ILE . 82.6 Cg_exo -49.02 -31.04 19.52 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 121.987 1.792 . . . . 0.0 111.587 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -72.03 -34.68 69.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.727 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 66.9 m -65.08 -44.81 87.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.734 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 4.3 mt -66.03 -51.32 61.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.195 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 23.0 mt -55.89 -28.49 24.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.991 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -73.39 -41.24 63.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.942 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -67.09 -48.48 68.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.014 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 11.5 p -60.53 -38.19 77.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.248 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.33 -42.83 74.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.032 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -65.83 -49.39 68.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.036 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 17.2 tt -64.15 -45.07 97.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.197 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 12.6 t -62.54 -48.52 79.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.991 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 53.2 t -60.0 -52.69 58.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.094 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 33.2 t -62.05 -34.72 64.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.233 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 9.5 tmm? -59.9 -51.89 67.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.994 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.9 tt -58.94 -55.73 31.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.992 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.89 -2.62 24.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.072 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.901 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.806 0.336 . . . . 0.0 111.202 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -89.51 77.17 7.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.407 ' CG2' ' N ' ' A' ' 13' ' ' THR . 12.5 p -116.77 166.04 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.052 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -103.13 141.96 34.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.595 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.5 mt -136.14 177.24 7.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.171 0.51 . . . . 0.0 111.447 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.2 m -141.71 113.07 7.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.557 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.63 126.47 69.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.976 0.417 . . . . 0.0 111.471 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.483 ' NH2' ' OE2' ' A' ' 143' ' ' GLU . 81.9 mtm-85 -112.57 116.31 30.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.446 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.59 119.6 37.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.237 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.8 pp -113.38 133.96 54.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.825 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.23 177.02 8.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.959 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -67.57 166.0 15.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.61 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.73 -31.96 72.9 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.925 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -78.37 -42.27 30.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.806 0.336 . . . . 0.0 111.335 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -67.79 -43.11 80.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.917 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.407 ' HA ' ' CG2' ' A' ' 28' ' ' ILE . 18.2 m -65.48 -40.39 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.314 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.91 -41.35 99.9 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.892 -0.67 . . . . 0.0 113.229 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.6 m -75.96 -35.64 59.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.721 0.296 . . . . 0.0 111.63 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.407 ' CG2' ' HA ' ' A' ' 25' ' ' VAL . 2.7 tp -76.73 -50.52 21.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.746 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 31.4 mt -60.19 -42.43 90.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.914 0.388 . . . . 0.0 110.752 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.409 ' HA3' ' CB ' ' A' ' 35' ' ' SER . . . 99.82 150.84 25.53 Favored Glycine 0 N--CA 1.435 -1.399 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.556 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.411 ' C ' ' HG3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -57.98 146.42 32.59 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.825 -0.688 . . . . 0.0 111.378 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.521 ' HD2' ' HB2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 44.01 27.04 0.17 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.956 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 50.6 19.64 3.32 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 114.512 0.565 . . . . 0.0 114.512 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.521 ' HB2' ' HD2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -76.98 -35.44 57.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.755 0.778 . . . . 0.0 109.966 179.095 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.444 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -68.81 -43.14 76.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.65 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.7 p -67.36 -27.04 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.91 -36.7 82.85 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 176.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.444 ' HB3' ' O ' ' A' ' 35' ' ' SER . 0.5 OUTLIER -69.71 -34.66 74.2 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.517 -1.219 . . . . 0.0 108.948 177.792 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -67.34 -41.22 85.56 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.101 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.4 ttp-105 -58.48 -51.35 70.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.194 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -59.76 -38.51 81.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.807 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -75.27 -36.27 61.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.693 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.7 t -73.02 -49.27 29.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.28 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.18 -8.96 78.66 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.292 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.427 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . . . -110.91 128.48 55.82 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.6 0.238 . . . . 0.0 111.156 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.8 OUTLIER -27.23 136.74 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.221 179.356 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.2 mt -142.7 100.47 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.979 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -115.88 165.84 12.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.916 0.389 . . . . 0.0 111.421 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.403 ' CG1' ' CD1' ' A' ' 59' ' ' ILE . 3.2 mp -126.47 151.74 33.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.798 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.59 -178.64 0.75 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.983 0.42 . . . . 0.0 111.4 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.421 ' CB ' ' CD1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER 66.12 134.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.12 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.39 -75.67 0.14 Allowed Glycine 0 CA--C 1.508 -0.351 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.675 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.3 m120 54.62 21.86 3.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.874 0.368 . . . . 0.0 110.038 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.482 ' CB ' ' CD ' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -148.31 -68.66 0.02 OUTLIER Pre-proline 0 N--CA 1.452 -0.356 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.937 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.482 ' CD ' ' CB ' ' A' ' 54' ' ' CYS . 80.5 Cg_endo -80.23 -34.55 0.81 Allowed 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.096 1.864 . . . . 0.0 111.158 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.82 176.96 8.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.516 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.71 127.59 15.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.857 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.421 ' CD1' ' CB ' ' A' ' 51' ' ' GLU . 19.1 mt -102.22 110.67 29.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.403 ' CD1' ' CG1' ' A' ' 49' ' ' ILE . 26.3 mm -94.62 96.38 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.088 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.0 m -76.33 139.14 40.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.795 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -131.29 133.27 45.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.267 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -133.03 129.31 37.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.79 0.328 . . . . 0.0 111.109 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.427 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.15 164.18 13.35 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.726 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 94.6 Cg_exo -42.2 161.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.106 2.537 . . . . 0.0 113.07 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.1 m -59.97 -35.72 75.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.974 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -62.42 -51.88 65.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.224 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.99 -37.64 71.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.008 0.432 . . . . 0.0 110.989 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.421 HG21 ' N ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -66.21 -39.36 84.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.194 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.421 ' N ' HG21 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -63.76 -47.28 81.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.888 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.74 -51.91 67.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.745 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.11 -58.37 8.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.315 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -49.2 -32.53 10.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.33 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.21 -41.59 81.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.11 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -75.91 -32.84 59.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.055 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.2 mt -68.11 -43.63 85.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.963 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.1 pt -67.88 -40.34 83.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.971 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.03 -41.04 95.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.443 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.3 tptt -61.87 -35.92 79.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.055 0.455 . . . . 0.0 110.048 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.7 tp -77.39 -28.15 52.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.435 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -76.69 -35.11 58.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.649 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.29 -42.75 65.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.824 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.81 -50.14 75.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.041 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.4 mt -62.05 -52.89 54.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.935 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.9 t 61.29 -80.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.109 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.3 p -101.52 -22.32 14.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.087 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 70.66 95.57 0.07 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.879 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -68.62 -29.84 68.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.904 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.06 87.48 3.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.867 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -121.69 143.47 49.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.914 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.5 t -152.48 -46.9 0.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.813 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.3 p -150.78 -47.03 0.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.865 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -148.35 98.36 2.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.194 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -165.33 75.21 0.24 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.927 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.6 p -138.08 -43.7 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.29 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.456 ' CB ' ' HD3' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -157.48 -59.8 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.516 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.462 ' N ' ' CD ' ' A' ' 97' ' ' PRO . 58.9 Cg_exo -50.44 -45.88 32.13 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.087 1.858 . . . . 0.0 112.632 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 10.2 Cg_exo -71.62 116.6 4.76 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.465 2.11 . . . . 0.0 111.938 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.7 t -140.88 111.87 3.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.347 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 16.0 m -103.41 134.28 47.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.634 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.4 mp -139.91 117.76 11.71 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 -101.98 112.5 25.16 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.132 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.1 mp -113.47 162.32 16.28 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.935 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.3 p -98.73 136.42 29.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.022 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.433 ' CG1' ' HD2' ' A' ' 105' ' ' PRO . 25.4 t -138.66 145.37 45.93 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.104 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.433 ' HD2' ' CG1' ' A' ' 104' ' ' VAL . 21.6 Cg_exo -65.99 159.92 46.85 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.475 2.116 . . . . 0.0 112.146 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.99 -34.64 75.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.5 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 m -69.48 -30.45 68.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.168 0.508 . . . . 0.0 109.771 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.34 -50.54 38.02 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.463 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 53.5 t -62.19 -43.48 98.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.381 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -53.89 -47.52 65.46 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.395 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.85 -40.31 69.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.804 0.335 . . . . 0.0 110.644 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 19.1 mt -55.97 -27.82 54.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.0 0.428 . . . . 0.0 110.486 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.415 ' CG2' ' HA2' ' A' ' 117' ' ' GLY . 28.0 mm -82.07 -39.89 16.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.582 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.66 -177.67 26.02 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.501 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -67.54 125.15 25.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.894 0.378 . . . . 0.0 111.129 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.72 13.1 58.46 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.989 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.415 ' HA2' ' CG2' ' A' ' 113' ' ' ILE . . . 70.84 7.31 61.6 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.974 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 5.2 t -53.0 -39.64 63.24 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.786 0.326 . . . . 0.0 111.695 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.33 -65.36 0.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.286 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.6 tp -55.83 -32.22 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.356 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.26 -52.3 66.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.157 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -73.08 -40.95 64.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.432 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 53.8 mt -57.24 -53.65 40.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.362 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.03 -38.25 72.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.353 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -54.84 -39.95 69.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.615 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.07 -37.55 11.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.602 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 17.2 m -49.73 -26.14 3.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.887 0.375 . . . . 0.0 110.265 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.46 -12.14 28.37 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.825 -0.702 . . . . 0.0 113.224 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -108.27 146.3 33.08 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.953 0.377 . . . . 0.0 111.299 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.16 129.52 43.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.597 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.7 m -99.28 150.38 5.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.351 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.658 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 11.4 tt0 -122.65 158.55 29.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.01 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.6 m -137.45 140.89 40.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.227 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.75 161.14 24.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.125 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -78.62 -166.38 30.0 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.642 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -139.29 -42.35 0.46 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.706 0.289 . . . . 0.0 110.982 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 16.9 mtp 69.6 -167.57 0.17 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.817 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.532 ' N ' ' HD2' ' A' ' 139' ' ' PRO . 1.3 tp -50.63 -53.69 43.63 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.25 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 138' ' ' LEU . 35.5 Cg_endo -64.21 -160.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.214 1.943 . . . . 0.0 111.904 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -163.1 99.02 0.95 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.116 0.484 . . . . 0.0 110.768 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.1 -169.05 0.25 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.93 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.57 -50.56 2.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.639 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.483 ' OE2' ' NH2' ' A' ' 17' ' ' ARG . 10.1 mt-10 -115.09 137.92 51.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.679 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -109.88 176.99 4.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.909 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -110.41 130.7 55.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.166 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.658 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 0.5 OUTLIER -113.55 140.03 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.772 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.477 ' HB ' ' HB2' ' A' ' 132' ' ' GLN . 0.7 OUTLIER -115.98 114.99 25.37 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.304 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.6 pt -106.78 123.43 61.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.11 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.48 136.2 53.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.101 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 160.87 -162.88 33.88 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.513 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.7 pt -87.02 161.49 46.71 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.61 0.243 . . . . 0.0 110.95 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.4 -40.0 44.4 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.431 2.087 . . . . 0.0 112.041 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -64.69 -34.7 78.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.301 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 61.8 m -69.4 -34.02 73.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.71 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 26.6 mt -73.09 -53.34 18.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.945 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.7 mm -59.15 -28.63 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.061 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -75.17 -40.16 59.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.033 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -72.14 -38.91 69.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.183 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 12.1 p -69.98 -41.96 79.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.393 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 8.3 pttt -65.54 -38.58 90.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.039 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -64.42 -49.41 71.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.44 HG21 HD13 ' A' ' 162' ' ' ILE . 0.0 OUTLIER -64.78 -34.52 70.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.977 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 34.1 m -67.76 -43.4 79.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 54.0 t -59.6 -52.68 58.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.9 p -64.26 -30.4 50.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.021 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -59.31 -51.57 69.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.951 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 9.6 mt -70.03 -45.91 66.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.949 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -73.99 -2.48 24.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.052 0.454 . . . . 0.0 112.018 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.848 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 120.822 0.344 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 43.04 60.64 2.43 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.554 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 64' ' ' PRO . 20.3 t -120.56 158.26 22.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.913 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -103.77 139.34 39.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.029 -179.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.0 mt -143.02 166.1 25.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.008 0.433 . . . . 0.0 111.188 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 m -142.73 140.65 31.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.632 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.8 tt -140.87 152.51 20.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.972 0.415 . . . . 0.0 111.479 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.487 ' NH2' ' OE2' ' A' ' 143' ' ' GLU . 2.8 ttm-85 -134.99 129.68 34.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.389 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.02 135.23 51.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.947 0.403 . . . . 0.0 111.121 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.8 mp -93.32 115.0 27.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.628 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -107.87 141.02 40.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.951 0.405 . . . . 0.0 110.89 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.424 ' HA ' ' O ' ' A' ' 55' ' ' PRO . 1.4 t-80 -67.6 163.89 20.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.602 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.441 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -58.7 -45.05 95.32 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.699 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.45 -43.28 27.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.985 0.422 . . . . 0.0 110.91 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.01 -32.79 73.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.508 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.501 ' O ' HG12 ' A' ' 29' ' ' ILE . 9.8 p -76.95 -31.22 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.474 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.48 ' N ' HG12 ' A' ' 25' ' ' VAL . . . -62.36 -42.71 99.7 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.441 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.9 m -75.87 -37.24 59.12 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.669 0.271 . . . . 0.0 111.605 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.467 ' CG1' ' HA ' ' A' ' 25' ' ' VAL . 1.7 pp -76.29 -32.7 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 120.787 0.327 . . . . 0.0 111.879 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 25' ' ' VAL . 10.9 mm -70.68 -54.74 16.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.253 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.56 150.29 25.13 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-O 121.769 0.649 . . . . 0.0 113.026 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.561 ' HB3' ' HD3' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -67.13 146.37 54.33 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.413 -0.893 . . . . 0.0 111.113 179.606 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.561 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER 63.71 6.82 2.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.37 -179.603 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.459 ' O ' HG22 ' A' ' 36' ' ' VAL . . . 57.71 12.67 10.5 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 119.84 -1.171 . . . . 0.0 111.648 -178.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -76.78 -28.93 55.84 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.918 0.39 . . . . 0.0 110.091 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.33 -41.5 63.43 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.184 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -67.16 -26.38 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.552 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.98 -36.87 75.53 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.49 -37.45 86.04 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.776 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -52.45 63.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.432 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -50.56 -51.21 50.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.206 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -57.98 -38.04 75.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.72 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -75.11 -36.11 61.68 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.6 p -82.69 -55.75 4.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.846 0.355 . . . . 0.0 111.66 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.9 -5.62 66.46 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.426 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.422 ' O ' ' C ' ' A' ' 46' ' ' ARG . . . -110.67 128.83 55.86 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.688 0.28 . . . . 0.0 111.138 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 47.8 ttm-85 -27.16 137.84 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.339 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.2 mt -142.27 100.43 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.705 0.288 . . . . 0.0 110.471 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.95 171.38 7.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.724 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 6.0 mt -126.7 149.78 31.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.954 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.88 -169.3 1.96 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.911 0.386 . . . . 0.0 111.302 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -75.41 -160.21 0.12 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.029 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -151.64 -71.92 0.01 OUTLIER Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.021 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.3 m120 58.39 19.07 6.07 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.495 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -167.4 -66.26 0.01 OUTLIER Pre-proline 0 N--CA 1.452 -0.351 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.475 -179.755 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.558 ' O ' ' CB ' ' A' ' 56' ' ' GLU . 64.0 Cg_endo -81.75 -33.18 0.68 Allowed 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.384 2.056 . . . . 0.0 111.493 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.558 ' CB ' ' O ' ' A' ' 55' ' ' PRO . 2.7 mt-10 110.48 -43.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.577 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.88 142.15 28.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.987 0.422 . . . . 0.0 111.626 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 25.5 mt -123.25 131.16 73.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.127 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.0 mt -109.24 106.12 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.87 0.367 . . . . 0.0 111.766 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 66.9 m -93.05 139.17 30.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.805 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.449 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 6.3 tt -131.5 137.26 48.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.726 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.55 132.37 37.13 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.563 0.22 . . . . 0.0 110.851 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.412 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.19 164.83 14.11 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.261 -0.971 . . . . 0.0 112.928 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 95.7 Cg_exo -42.47 159.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.986 2.457 . . . . 0.0 113.041 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.8 m -60.28 -35.69 76.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.981 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -66.34 -52.02 51.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.15 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.77 -37.64 71.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.408 HG23 ' N ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -66.36 -39.24 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.157 -179.643 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.408 ' N ' HG23 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -59.43 -51.9 67.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.842 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -43.83 88.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.587 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.48 -45.54 76.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.22 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -58.46 -50.3 74.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.207 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.0 -36.99 68.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.599 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.85 -40.0 49.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.23 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.1 mt -62.42 -51.46 72.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.652 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.22 -38.54 80.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.991 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.26 -29.59 65.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.416 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -35.33 80.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.054 0.454 . . . . 0.0 109.81 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.9 tp -76.65 -31.69 57.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.172 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -76.79 -32.85 57.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.769 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -72.25 -36.85 69.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.783 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.98 -54.97 31.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.992 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 15.9 pt -56.83 -42.7 78.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.195 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.24 -176.03 6.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.962 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.9 p 79.88 -55.81 0.38 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.941 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.2 114.27 6.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.939 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.54 -177.81 4.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.866 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.9 m -114.92 157.06 23.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.926 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -60.95 -32.8 72.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.902 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.7 m -65.42 155.56 35.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.06 153.88 19.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.848 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -90.12 -61.53 1.66 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.102 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -160.51 -78.48 0.05 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.166 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.18 97.42 0.27 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.864 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.6 tpp85 63.92 126.11 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.92 107.94 0.84 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.463 2.108 . . . . 0.0 112.167 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -69.82 162.96 40.09 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.672 2.248 . . . . 0.0 112.198 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.4 t -126.21 103.36 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.95 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 11.0 t -113.26 133.49 55.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.01 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.6 tp -139.94 117.86 11.77 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.443 ' HA ' ' O ' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -107.62 112.67 25.51 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.631 -178.684 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 28.5 mt -102.64 155.38 18.33 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.903 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.0 t -106.71 141.15 22.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.17 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.4 m -145.44 155.94 53.47 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.124 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.402 ' HG2' ' HB2' ' A' ' 108' ' ' GLN . 36.4 Cg_endo -66.64 162.86 35.23 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.552 2.168 . . . . 0.0 112.583 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.63 -34.51 69.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.502 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.1 m -67.24 -30.71 70.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.151 0.501 . . . . 0.0 109.823 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.402 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -67.58 -45.4 75.65 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.525 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 42.7 t -66.68 -49.32 66.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.63 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -49.29 -51.96 24.68 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.522 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.9 p -71.84 -40.21 69.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.765 0.317 . . . . 0.0 110.545 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.4 mt -54.93 -28.72 53.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.045 0.45 . . . . 0.0 110.246 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.413 ' CG2' ' HA2' ' A' ' 117' ' ' GLY . 17.9 mt -80.02 -44.6 22.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.552 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 76.94 -173.25 54.88 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.588 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.5 tptp -64.56 118.98 9.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.894 0.378 . . . . 0.0 111.197 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 56.85 20.32 32.65 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.987 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.413 ' HA2' ' CG2' ' A' ' 113' ' ' ILE . . . 71.8 6.98 64.62 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.988 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 30.9 p -53.1 -40.12 63.9 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 120.826 0.346 . . . . 0.0 111.707 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.26 -65.29 0.69 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.5 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -55.1 -34.29 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.581 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -60.64 -45.09 95.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.011 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -73.11 -32.37 64.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.101 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 26.7 mt -64.24 -43.38 97.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.184 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.84 -42.7 60.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.92 0.391 . . . . 0.0 111.017 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -58.83 -35.37 72.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.733 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.8 t -93.45 -45.55 7.73 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.675 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.1 m -48.37 -25.64 1.7 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.874 0.368 . . . . 0.0 110.275 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.48 -9.49 41.94 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.048 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -108.29 153.72 22.84 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.932 0.366 . . . . 0.0 111.201 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -99.7 141.29 32.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.732 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.409 ' HB ' ' CD1' ' A' ' 146' ' ' ILE . 11.4 m -99.22 157.9 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.356 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.782 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 0.1 OUTLIER -128.78 158.45 38.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.447 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.0 t -129.39 118.87 47.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.967 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.69 161.11 29.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.242 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -78.43 105.59 2.2 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.454 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -156.53 -44.3 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.823 0.344 . . . . 0.0 111.024 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 65.65 172.1 0.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.808 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.43 ' N ' ' CD ' ' A' ' 139' ' ' PRO . 0.2 OUTLIER -88.06 -51.15 0.41 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.974 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 138' ' ' LEU . 33.5 Cg_exo -57.87 -28.86 84.24 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.495 2.13 . . . . 0.0 112.327 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -85.82 -80.71 0.22 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.999 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.28 -168.75 2.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.913 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.9 t -115.49 -41.82 3.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.699 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.487 ' OE2' ' NH2' ' A' ' 17' ' ' ARG . 15.2 pt-20 -118.17 139.13 51.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.703 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -109.91 168.2 9.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.938 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.56 134.33 54.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.303 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.782 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 1.5 tt -116.37 131.94 67.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.519 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.492 ' HB ' ' CB ' ' A' ' 132' ' ' GLN . 1.0 OUTLIER -109.45 116.05 31.08 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.715 -179.554 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 4.7 tp -104.89 121.99 57.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.742 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.39 140.41 49.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.204 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 166.14 -154.29 24.76 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.355 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.405 ' HB ' ' HD2' ' A' ' 152' ' ' PRO . 1.2 pt -87.06 161.96 45.17 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.59 0.234 . . . . 0.0 110.839 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 151' ' ' ILE . 73.7 Cg_exo -49.51 -34.96 35.31 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.315 2.01 . . . . 0.0 112.209 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.06 -34.74 68.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.817 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 53.1 p -74.25 -41.15 61.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.971 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -68.73 -41.28 82.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.175 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.1 tp -69.68 -32.83 53.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.141 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -69.84 -49.22 54.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.894 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -58.61 -53.1 62.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.097 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 30.1 t -57.35 -35.53 49.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.296 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 10.5 tptp -68.32 -32.91 73.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.978 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -72.06 -38.32 69.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.033 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 36.0 mm -74.01 -34.48 39.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.2 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.17 -37.47 69.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.099 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 14.0 p -74.36 -39.68 48.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.456 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 36.0 m -69.5 -45.59 78.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.418 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 5.6 ptm -62.01 -45.93 91.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.928 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.13 -51.11 41.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.931 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -74.02 -2.53 24.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.959 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.855 0.359 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -142.63 50.46 1.46 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 64' ' ' PRO . 21.5 t -126.28 152.65 33.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.97 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 1.4 m -103.25 146.91 27.73 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.682 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.3 pp -158.21 139.77 13.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.531 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 62' ' ' ALA . 58.3 m -113.12 129.92 56.35 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.31 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.426 HD13 ' CE2' ' A' ' 72' ' ' PHE . 2.0 pt -112.13 163.98 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.223 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.493 ' NH2' ' OE2' ' A' ' 143' ' ' GLU . 0.9 OUTLIER -133.96 123.06 23.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.834 179.765 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.41 HD23 ' CE1' ' A' ' 72' ' ' PHE . 67.5 mt -114.58 119.87 38.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.201 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.8 128.1 55.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.723 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.42 ' HB2' ' CG1' ' A' ' 25' ' ' VAL . 0.9 OUTLIER -142.11 162.38 35.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.835 0.35 . . . . 0.0 111.208 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -70.2 163.45 26.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.888 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.19 -35.83 20.56 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.659 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -51.4 10.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.922 0.361 . . . . 0.0 111.958 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.93 -33.56 74.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.818 0.342 . . . . 0.0 110.991 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.514 ' O ' HG12 ' A' ' 29' ' ' ILE . 15.4 m -71.54 -39.96 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.083 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.406 ' N ' HG21 ' A' ' 25' ' ' VAL . . . -62.01 -35.16 91.02 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.635 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 p -75.45 -33.55 60.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.668 0.271 . . . . 0.0 111.388 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.467 HG23 ' HA ' ' A' ' 25' ' ' VAL . 1.7 tp -79.21 -47.09 22.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.451 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' ' 25' ' ' VAL . 8.1 mm -57.25 -50.25 77.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.872 0.368 . . . . 0.0 110.204 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.9 150.32 26.18 Favored Glycine 0 N--CA 1.437 -1.278 0 CA-C-O 121.747 0.637 . . . . 0.0 113.012 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.412 ' C ' ' HD3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -62.42 145.9 52.84 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.528 -0.836 . . . . 0.0 111.321 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.421 ' HG2' ' HB2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 51.36 18.89 0.69 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.461 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.493 ' O ' HG21 ' A' ' 36' ' ' VAL . . . 53.69 11.32 1.91 Allowed Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.936 -0.65 . . . . 0.0 114.26 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.421 ' HB2' ' HG2' ' A' ' 32' ' ' LYS . 4.0 tp10 -74.69 -27.2 60.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.536 0.668 . . . . 0.0 109.735 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.39 -39.84 58.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.514 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.493 HG21 ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -67.28 -26.34 35.91 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.588 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -70.66 -36.73 73.52 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -62.61 -34.73 77.62 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.936 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -43.05 81.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.711 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 44.9 mtp85 -58.1 -51.15 70.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.846 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -63.86 -38.02 89.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.037 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.84 -35.7 62.4 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 53.2 p -88.34 -55.79 3.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.937 0.399 . . . . 0.0 110.879 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.14 4.76 62.74 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.193 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.414 ' HB1' ' HA3' ' A' ' 63' ' ' GLY . . . -110.77 127.31 55.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.077 0.438 . . . . 0.0 111.317 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 45' ' ' ALA . 1.8 mpt_? -27.75 104.3 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.275 0.63 . . . . 0.0 112.551 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.8 mt -107.45 100.58 11.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.832 0.348 . . . . 0.0 110.935 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.39 169.94 8.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.256 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.416 ' CG2' ' HD2' ' A' ' 57' ' ' ARG . 13.9 mt -126.46 152.13 33.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.144 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.406 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . 33.1 t -92.12 -161.4 0.82 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.738 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -69.3 176.84 3.09 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.2 0.524 . . . . 0.0 112.144 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.598 ' O ' ' O ' ' A' ' 56' ' ' GLU . . . 51.79 109.65 0.01 OUTLIER Glycine 0 CA--C 1.505 -0.546 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.311 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -105.2 37.54 2.16 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 176.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.496 ' CB ' ' CD ' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -154.58 -66.26 0.02 OUTLIER Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 115.08 -0.964 . . . . 0.0 113.303 -177.361 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 54' ' ' CYS . 36.8 Cg_endo -59.45 -34.74 97.22 Favored 'Trans proline' 0 CA--C 1.508 -0.819 0 C-N-CA 122.427 2.085 . . . . 0.0 110.446 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.598 ' O ' ' O ' ' A' ' 52' ' ' GLY . 0.2 OUTLIER -174.52 167.17 3.9 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.659 -178.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.506 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 3.0 mmt180 -144.5 136.55 26.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.874 0.368 . . . . 0.0 110.992 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 18' ' ' LEU . 4.5 mm -115.64 106.8 21.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.555 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.1 mt -85.98 94.05 4.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.882 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.0 m -80.04 101.87 8.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.138 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.28 144.79 25.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.908 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 15' ' ' THR . . . -143.76 124.71 14.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.777 0.323 . . . . 0.0 111.051 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.414 ' HA3' ' HB1' ' A' ' 45' ' ' ALA . . . 157.57 164.0 13.28 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.159 -1.02 . . . . 0.0 113.104 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.594 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 78.6 Cg_exo -41.48 160.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 123.555 2.836 . . . . 0.0 113.798 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.6 t -57.89 -35.72 71.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.135 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.37 -52.48 46.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.917 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.35 -43.32 83.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.316 0.579 . . . . 0.0 110.429 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.53 -39.4 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.842 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.85 -36.51 67.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.763 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.08 -38.94 63.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.691 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.65 -48.25 77.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.149 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.476 ' O ' HG13 ' A' ' 75' ' ' ILE . 1.2 m-85 -64.04 -43.06 96.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.78 -29.26 67.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.306 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.6 tpt -77.29 -48.3 17.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.688 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 72' ' ' PHE . 2.2 pp -59.81 -42.98 90.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.252 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.6 pt -68.76 -36.01 72.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.852 0.358 . . . . 0.0 111.017 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -62.35 -47.63 83.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.024 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -62.39 -35.22 78.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.967 0.413 . . . . 0.0 110.149 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.489 ' N ' ' HG3' ' A' ' 78' ' ' LYS . 16.2 tp -77.53 -26.18 50.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.069 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -76.95 -35.71 57.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.597 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -72.07 -38.09 69.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.778 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.89 -35.87 71.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.863 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.6 mt -74.01 -34.99 40.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.082 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.5 m -97.49 38.02 1.31 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.935 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 m -89.41 5.07 46.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.352 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 70.43 39.02 1.27 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.91 0.386 . . . . 0.0 110.533 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 4.2 mtp -68.93 71.31 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.983 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.3 t -96.83 73.56 2.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.8 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -163.4 -49.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 64.6 p -69.48 -169.85 0.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.906 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.1 p -129.01 173.3 10.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.945 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -146.19 -175.77 4.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.054 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -99.34 -42.52 6.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.131 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 m 179.88 -71.08 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.898 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.22 95.23 9.38 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.08 110.97 2.32 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.541 2.16 . . . . 0.0 112.189 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.19 -167.5 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.514 2.143 . . . . 0.0 112.521 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.2 t -140.32 113.19 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.654 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.22 140.21 37.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.271 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 tt -139.83 117.76 11.76 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.22 112.7 25.91 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.788 -178.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.37 147.53 29.13 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.741 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.1 t -100.6 138.04 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.273 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 m -144.87 157.54 54.4 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.001 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -65.89 157.63 58.15 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.596 2.197 . . . . 0.0 112.143 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.86 -34.84 76.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.391 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.1 m -70.55 -30.3 66.99 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -70.94 -46.54 62.25 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.628 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 21.6 m -61.8 -40.03 93.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.389 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.75 -50.12 71.14 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.21 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.1 m -67.59 -38.7 84.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 0.0 110.724 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.8 mt -57.3 -27.77 62.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.476 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 12.6 mt -83.14 -34.28 11.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.786 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.63 178.55 6.27 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.558 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -67.49 132.53 47.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.818 0.342 . . . . 0.0 110.882 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.73 16.77 59.52 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.633 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 63.1 15.74 56.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.871 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 95.9 m -52.88 -43.64 66.29 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.869 0.366 . . . . 0.0 111.401 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -63.68 -58.56 6.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.129 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.6 tt -54.22 -31.44 22.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.315 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.16 -41.93 89.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.856 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -73.23 -40.2 64.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.082 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 50.2 mt -58.61 -53.42 47.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.297 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.27 -40.42 86.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.969 0.414 . . . . 0.0 111.077 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -54.54 -48.36 72.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.881 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.48 -39.02 17.94 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 18.2 m -49.37 -26.38 3.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.845 0.355 . . . . 0.0 110.333 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.42 -21.85 4.17 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.333 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -108.27 170.89 7.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.949 0.374 . . . . 0.0 111.149 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.7 130.45 44.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.705 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 36.0 m -99.26 140.52 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.164 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.63 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -109.11 158.39 17.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.197 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.5 t -137.53 134.99 46.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.181 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.99 134.27 36.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.077 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -80.32 131.49 10.55 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.562 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.405 ' HB3' ' CB ' ' A' ' 141' ' ' SER . 46.5 m-20 -157.93 26.75 0.27 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.049 0.452 . . . . 0.0 109.788 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 35.1 mtm -93.96 52.22 1.62 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.97 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.434 ' N ' ' HD2' ' A' ' 139' ' ' PRO . 0.2 OUTLIER -176.13 -61.19 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.519 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 138' ' ' LEU . 15.0 Cg_endo -55.58 -90.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.392 2.061 . . . . 0.0 112.391 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -178.95 15.62 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.405 ' CB ' ' HB3' ' A' ' 136' ' ' ASP . 0.1 OUTLIER -62.29 163.02 8.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.792 0.33 . . . . 0.0 110.815 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 13.2 t -118.57 -46.56 2.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.887 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.493 ' OE2' ' NH2' ' A' ' 17' ' ' ARG . 3.0 mt-10 -104.07 137.74 41.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.7 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -109.97 140.84 43.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.93 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.42 153.46 17.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.17 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.63 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 74.9 mt -125.18 140.05 49.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.667 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.483 ' HB ' ' HB2' ' A' ' 132' ' ' GLN . 0.2 OUTLIER -119.07 114.93 23.26 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.409 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -104.1 121.47 55.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.109 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.39 134.71 54.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.13 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 162.13 -151.91 22.09 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.532 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.9 pt -87.0 162.06 45.07 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.57 0.224 . . . . 0.0 110.962 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.62 -32.84 29.3 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.517 2.144 . . . . 0.0 112.218 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -34.65 69.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.757 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 10.6 p -67.92 -50.29 56.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.039 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 2.7 mp -59.33 -51.52 71.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.157 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -55.84 -30.7 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.135 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -69.26 -48.0 63.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.834 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 17.7 t -61.58 -44.06 97.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.96 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.9 t -59.49 -38.95 77.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.956 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -32.86 74.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.711 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -71.71 -45.67 61.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.416 HD12 HG22 ' A' ' 162' ' ' ILE . 30.5 mm -69.92 -34.41 59.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.044 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 47.7 t -65.42 -52.4 53.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.117 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 12.3 p -61.49 -45.14 99.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.225 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 54.8 t -63.82 -40.28 88.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.914 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 32.4 mtt -56.98 -45.63 82.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.808 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 7.8 tt -65.11 -45.19 86.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.804 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.96 -2.72 25.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.902 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 39.1 p . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.887 -179.953 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.949 0.404 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -156.64 -78.81 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.819 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 64' ' ' PRO . 11.5 t -115.09 154.98 16.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.812 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.21 131.36 55.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.693 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -130.44 158.49 39.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.148 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.2 m -141.97 133.59 26.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.749 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.8 tt -137.36 148.03 26.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.354 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.487 ' NH2' ' OE1' ' A' ' 143' ' ' GLU . 0.0 OUTLIER -129.35 131.1 46.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.709 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.58 139.22 53.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.103 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.6 pp -108.72 136.02 48.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.758 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.11 162.4 33.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.827 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.403 ' O ' ' CG1' ' A' ' 25' ' ' VAL . 3.8 m-70 -67.58 169.63 8.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.536 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.65 -44.77 96.59 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.103 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.402 ' HG2' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -78.5 -38.51 40.58 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.266 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.402 ' N ' ' HG2' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -67.69 -50.74 56.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.925 0.393 . . . . 0.0 110.655 -179.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.403 ' CG1' ' O ' ' A' ' 21' ' ' HIS . 9.8 p -63.44 -35.02 70.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.841 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.16 -34.92 90.63 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.32 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.3 m -75.38 -28.2 59.39 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.802 0.334 . . . . 0.0 110.68 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.427 HD11 ' N ' ' A' ' 28' ' ' ILE . 3.6 mm -78.84 -45.61 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.08 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.42 ' HA ' ' CG1' ' A' ' 36' ' ' VAL . 13.0 mt -60.59 -42.56 92.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.385 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.65 150.34 16.68 Favored Glycine 0 N--CA 1.435 -1.427 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.611 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.544 ' HG2' ' HG3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -58.15 145.75 35.88 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.593 -0.804 . . . . 0.0 111.588 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.544 ' HG3' ' HG2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER 45.98 27.93 0.56 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.248 -178.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.485 ' O ' HG23 ' A' ' 36' ' ' VAL . . . 47.29 17.92 0.45 Allowed Glycine 0 CA--C 1.522 0.507 0 N-CA-C 114.784 0.673 . . . . 0.0 114.784 178.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.543 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 2.7 tm-20 -75.27 -25.46 58.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.752 0.776 . . . . 0.0 109.856 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -41.87 59.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.415 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -67.24 -26.21 35.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 178.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.6 -36.75 70.94 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -62.94 -35.82 81.38 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.852 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -43.46 87.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.392 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -56.63 -51.05 70.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.131 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -61.55 -37.5 84.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.778 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -74.62 -36.48 62.94 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.5 p -92.57 -55.86 3.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.862 0.363 . . . . 0.0 111.145 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.33 0.78 50.62 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.041 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.422 ' O ' ' C ' ' A' ' 46' ' ' ARG . . . -110.76 128.16 55.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.877 0.338 . . . . 0.0 111.654 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 2.6 ttt180 -27.44 141.07 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.061 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.6 mt -142.32 100.44 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.76 0.314 . . . . 0.0 111.301 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -116.09 173.46 6.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.724 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.405 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 4.8 mt -126.5 151.97 33.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.121 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 94.3 p -83.74 -171.28 3.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.199 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.07 -167.51 0.51 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.382 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.56 -77.29 0.83 Allowed Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.313 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 48.79 27.47 1.58 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.828 0.346 . . . . 0.0 110.397 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.487 ' CB ' ' CD ' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -150.47 -68.17 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.571 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 54' ' ' CYS . 91.2 Cg_endo -74.46 -32.07 6.61 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.809 1.673 . . . . 0.0 110.366 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.71 172.18 1.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.782 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.405 ' NE ' ' CG2' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -145.87 135.37 23.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.54 179.266 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.1 mt -98.44 115.96 40.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.804 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.2 mt -86.62 101.21 10.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.285 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 89.2 m -90.01 138.25 31.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.94 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 7.3 tt -131.51 132.9 44.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.264 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -128.68 133.85 48.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.742 0.306 . . . . 0.0 111.12 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.28 164.46 13.72 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.754 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 82.4 Cg_exo -39.58 162.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.147 2.565 . . . . 0.0 113.29 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.4 ' O ' HG22 ' A' ' 68' ' ' ILE . 73.5 m -59.69 -35.66 74.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.29 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -64.2 -51.96 61.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.782 0.325 . . . . 0.0 111.319 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.04 -37.98 72.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.351 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -66.16 -39.48 84.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.538 -179.231 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.417 ' N ' HG22 ' A' ' 68' ' ' ILE . 0.1 OUTLIER -63.26 -49.3 74.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.366 -179.66 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.67 -47.23 82.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.117 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.04 -56.3 23.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.316 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -53.35 -42.52 66.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.339 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.27 -48.05 81.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.48 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 20.7 mmm -70.45 -33.88 71.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.178 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.6 mt -68.09 -38.26 79.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.473 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 36.6 pt -71.47 -38.44 68.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.071 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.39 -47.41 82.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.659 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.31 -36.39 83.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.947 0.403 . . . . 0.0 110.058 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.5 tp -77.58 -23.08 50.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.47 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.418 ' O ' HG23 ' A' ' 83' ' ' ILE . 21.0 tt0 -76.4 -49.31 17.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.99 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -72.27 -32.32 66.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.862 0.363 . . . . 0.0 111.067 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -57.96 -32.72 68.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.824 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.499 ' CG2' ' N ' ' A' ' 84' ' ' SER . 0.6 OUTLIER -53.5 -49.6 53.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.938 0.399 . . . . 0.0 111.631 -179.214 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.499 ' N ' ' CG2' ' A' ' 83' ' ' ILE . 0.3 OUTLIER 177.93 -155.28 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.625 -179.662 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.4 p -139.55 30.82 2.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.876 0.37 . . . . 0.0 110.898 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.34 -169.26 0.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.839 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 10.0 mtp -80.19 -177.96 6.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.935 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.2 t -84.5 -169.84 2.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.931 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -121.31 -176.53 3.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 t -92.78 80.85 4.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.913 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.0 m -121.18 -46.61 2.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.85 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -144.69 175.17 10.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.102 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.29 -39.42 90.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.081 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.4 t 56.02 73.26 0.44 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.954 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.411 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 0.7 OUTLIER -72.27 -60.91 2.0 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.951 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 95' ' ' ARG . 59.8 Cg_endo -72.29 109.79 2.81 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.585 2.19 . . . . 0.0 112.353 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.7 -41.88 3.95 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.671 2.247 . . . . 0.0 112.124 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 24.9 t -140.81 115.45 6.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.813 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 50.2 p -103.08 142.32 34.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.899 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.96 117.55 11.52 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.67 112.4 25.32 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.36 -178.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -102.14 143.17 32.3 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.928 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.411 ' CG2' ' NH1' ' A' ' 17' ' ' ARG . 31.2 m -107.82 142.93 19.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.07 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.401 ' HB ' ' CB ' ' A' ' 108' ' ' GLN . 4.4 m -159.53 157.16 26.39 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.33 172.08 9.48 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.559 2.173 . . . . 0.0 112.308 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.15 -34.64 78.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.517 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.21 -30.48 68.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.151 0.501 . . . . 0.0 109.848 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.401 ' CB ' ' HB ' ' A' ' 104' ' ' VAL . 2.2 mm100 -72.64 -49.78 29.57 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.724 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.5 m -62.94 -37.98 89.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.365 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.25 -43.25 99.62 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.249 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 83.6 p -74.49 -38.48 62.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.741 0.305 . . . . 0.0 110.655 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.7 mt -57.25 -27.95 62.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.563 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.4 mt -85.6 -36.74 11.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.847 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.59 -178.98 30.88 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.461 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.0 ttmm -66.99 123.68 20.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 0.0 111.204 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.6 15.29 57.21 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.012 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 73.58 5.1 67.28 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.955 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 31.9 p -52.92 -35.64 58.57 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.848 0.356 . . . . 0.0 111.631 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -65.53 -65.29 0.69 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.155 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -54.75 -30.05 22.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.297 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -50.4 71.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.812 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -61.22 -40.55 94.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.203 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 44.4 mm -57.09 -53.94 36.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.807 0.337 . . . . 0.0 110.907 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.62 -32.91 74.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.822 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -57.14 -52.65 64.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.569 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.02 -46.99 8.43 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 92.3 m -47.39 -25.92 1.17 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.944 0.402 . . . . 0.0 110.485 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.11 -7.54 21.9 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.355 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -108.3 141.39 40.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.996 0.398 . . . . 0.0 111.209 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -79.14 141.08 37.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.8 m -107.39 143.17 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.157 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.61 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -113.84 158.41 21.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.278 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.8 m -137.41 128.2 39.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.08 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.79 161.06 31.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.116 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -84.25 -142.76 5.52 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.607 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -126.34 -20.86 4.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.696 0.284 . . . . 0.0 111.145 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 9.2 mtp 66.14 -177.89 0.19 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.844 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.461 ' HB2' ' HD3' ' A' ' 139' ' ' PRO . 1.1 mp -83.5 -49.52 0.71 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.178 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.461 ' HD3' ' HB2' ' A' ' 138' ' ' LEU . 37.6 Cg_exo -60.06 -20.06 59.06 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.375 2.05 . . . . 0.0 112.387 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 71.19 105.37 0.06 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.052 0.453 . . . . 0.0 110.692 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.93 -171.5 3.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.07 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 15.0 t -121.41 -40.49 2.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.567 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.487 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 9.9 mt-10 -107.27 145.76 32.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.416 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -109.86 161.48 15.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.904 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -118.51 155.0 31.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.329 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.61 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 69.7 mt -129.66 141.01 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.401 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.502 ' HB ' ' HB2' ' A' ' 132' ' ' GLN . 0.4 OUTLIER -116.41 117.42 29.9 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.432 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.1 mm -104.08 120.54 54.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.793 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.31 137.22 53.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.128 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 160.77 -151.68 22.19 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.593 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.511 ' CG2' ' HD2' ' A' ' 152' ' ' PRO . 15.4 mt -85.48 144.52 40.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.511 ' HD2' ' CG2' ' A' ' 151' ' ' ILE . 72.3 Cg_exo -48.96 -32.51 23.35 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.98 1.787 . . . . 0.0 111.552 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -72.08 -34.83 68.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.62 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 57.9 m -70.94 -39.31 72.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.61 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 40.5 mm -64.53 -50.06 77.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.909 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.9 mt -57.19 -38.39 61.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.7 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -66.24 -38.8 88.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.497 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -61.57 -45.63 93.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.591 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 32.9 t -59.97 -36.09 64.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.796 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -32.98 74.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.62 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -72.19 -31.82 66.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.887 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 29.8 mt -74.01 -36.34 44.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.077 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 1.3 m -74.01 -43.29 58.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.939 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 11.2 p -66.29 -45.76 88.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.32 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 11.8 p -61.76 -42.54 94.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.021 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -59.17 -40.03 84.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.796 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.2 tt -72.64 -43.99 62.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.78 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -73.97 -2.64 24.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.034 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 32.5 p . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.895 179.992 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.827 0.346 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -101.78 -76.64 0.57 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.842 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.414 ' CG2' ' N ' ' A' ' 13' ' ' THR . 6.8 p -107.34 159.87 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.029 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -103.65 140.65 37.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.804 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.5 mt -131.24 171.32 13.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.027 0.441 . . . . 0.0 111.297 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.63 117.91 10.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.615 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 15.5 tt -121.51 156.66 25.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.908 0.385 . . . . 0.0 111.283 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.498 ' NH2' ' OE1' ' A' ' 143' ' ' GLU . 1.9 mtp85 -134.46 111.92 10.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.643 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.517 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 0.6 OUTLIER -89.38 145.3 25.43 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.749 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.445 ' HG ' ' CB ' ' A' ' 55' ' ' PRO . 7.0 tt -122.51 121.1 35.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.544 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.4 ' CB ' ' HB ' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -148.07 163.19 37.67 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.374 0.607 . . . . 0.0 112.121 -179.515 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.514 ' HA ' ' O ' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -76.48 134.72 39.44 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.542 179.545 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -45.7 -25.47 1.5 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 121.024 -0.608 . . . . 0.0 113.556 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.38 -52.46 9.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.942 0.371 . . . . 0.0 111.609 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -71.09 -51.0 27.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.993 0.425 . . . . 0.0 110.402 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.445 ' O ' HG12 ' A' ' 29' ' ' ILE . 10.0 p -62.8 -33.9 62.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.296 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.52 -37.75 94.66 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.641 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.3 t -68.38 -28.42 67.1 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.422 HD13 ' N ' ' A' ' 28' ' ' ILE . 4.6 mm -80.59 -32.55 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.567 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 25' ' ' VAL . 3.2 mm -60.59 -45.22 97.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.902 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.448 ' HA3' ' CB ' ' A' ' 35' ' ' SER . . . 94.69 150.57 27.23 Favored Glycine 0 N--CA 1.436 -1.347 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.812 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.418 ' C ' ' HD3' ' A' ' 32' ' ' LYS . 8.0 tttm -64.4 146.31 54.68 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.571 -0.814 . . . . 0.0 111.659 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.418 ' HD3' ' C ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER 63.01 6.74 2.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.847 179.635 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.502 ' O ' HG22 ' A' ' 36' ' ' VAL . . . 59.9 7.07 5.94 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 119.822 -1.18 . . . . 0.0 111.795 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -71.8 -28.21 63.45 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.025 0.44 . . . . 0.0 109.878 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.448 ' CB ' ' HA3' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -75.03 -36.34 61.9 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.265 179.496 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -67.32 -26.56 36.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.525 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -69.88 -36.81 75.76 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -65.04 -34.78 79.25 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.844 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -46.44 84.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.616 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -58.26 -51.18 70.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.289 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.02 -38.16 90.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.203 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -74.85 -36.06 62.35 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.1 t -77.9 -47.23 19.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.898 0.38 . . . . 0.0 111.116 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.89 -8.42 76.11 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.398 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 46' ' ' ARG . . . -110.79 128.75 55.88 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.493 0.187 . . . . 0.0 111.108 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 4.5 mtt-85 -26.99 139.37 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.058 0.543 . . . . 0.0 112.038 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.1 mt -142.13 116.31 4.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.714 0.292 . . . . 0.0 111.317 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -133.68 122.07 22.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.059 0.456 . . . . 0.0 110.907 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.467 HD13 HG21 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -108.15 130.78 60.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.902 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.5 t 168.6 169.8 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.067 0.46 . . . . 0.0 111.383 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 67.06 162.33 0.17 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.894 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 54' ' ' CYS . . . 128.4 84.7 0.44 Allowed Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.812 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.37 41.5 0.47 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.483 ' H ' ' C ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -162.59 -63.95 0.01 OUTLIER Pre-proline 0 N--CA 1.449 -0.507 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.835 -179.016 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.514 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 76.7 Cg_endo -78.84 -32.41 1.99 Allowed 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.522 2.148 . . . . 0.0 111.252 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 55' ' ' PRO . 1.9 mt-10 92.21 -31.75 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.204 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.89 130.76 38.27 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.034 0.445 . . . . 0.0 111.605 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 47.6 mt -129.46 109.93 19.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.491 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.459 HG23 HD11 ' A' ' 59' ' ' ILE . 7.1 mm -85.96 94.99 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.951 0.405 . . . . 0.0 111.537 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 50.0 m -88.82 105.85 17.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.841 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.495 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 9.1 tt -107.85 136.71 47.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.621 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -133.51 133.74 42.58 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.541 0.21 . . . . 0.0 110.864 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.16 164.92 14.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.894 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 92.6 Cg_exo -41.35 162.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.04 2.494 . . . . 0.0 113.161 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.462 ' O ' HG21 ' A' ' 68' ' ' ILE . 4.1 t -60.19 -35.56 75.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.206 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -63.88 -51.81 62.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.228 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.26 -44.67 84.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.0 0.428 . . . . 0.0 111.003 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.462 HG21 ' O ' ' A' ' 65' ' ' THR . 1.5 tt -66.43 -39.42 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.666 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.27 -48.38 76.7 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.108 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.88 -48.02 78.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.899 0.38 . . . . 0.0 110.832 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.72 -40.64 80.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.423 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.406 ' O ' HG13 ' A' ' 75' ' ' ILE . 0.5 OUTLIER -61.47 -48.29 81.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.218 -179.663 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.72 -29.28 67.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.94 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.8 mmm -77.46 -48.43 17.15 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 72' ' ' PHE . 1.2 pp -61.34 -41.43 89.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.311 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.0 pt -67.8 -38.91 81.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.808 0.337 . . . . 0.0 110.907 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.22 -32.16 73.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.399 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -40.42 86.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.174 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.7 tp -77.49 -25.62 50.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.492 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -77.06 -41.48 42.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -72.11 -36.64 69.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.904 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.2 -53.4 57.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.401 HD13 HG22 ' A' ' 83' ' ' ILE . 15.0 pt -54.27 -43.61 62.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.358 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.69 -30.98 71.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.939 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 35.9 t -118.59 37.75 3.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.896 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.8 t -162.14 126.13 3.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.959 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 2.0 mtt -86.38 -178.01 6.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 95.3 m 57.07 85.34 0.08 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.936 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -156.57 -45.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.896 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.4 m 63.31 85.29 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.1 t -143.17 128.54 18.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.894 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 60.84 39.87 16.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.025 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -111.61 31.02 6.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.064 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -172.94 -41.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.889 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.433 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -173.9 -63.64 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.181 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 95' ' ' ARG . 10.2 Cg_endo -51.61 104.37 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.718 2.279 . . . . 0.0 112.438 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 95' ' ' ARG . 35.9 Cg_endo -68.08 -68.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.324 2.016 . . . . 0.0 112.642 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.6 t -137.25 111.67 9.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.913 0.387 . . . . 0.0 111.022 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 38.8 p -103.24 138.36 40.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.982 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.94 117.79 11.72 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -102.26 112.5 25.22 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.367 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.63 145.53 37.74 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.032 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.409 ' CG1' ' HB3' ' A' ' 17' ' ' ARG . 11.9 p -95.98 131.47 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.72 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.474 HG22 ' HB3' ' A' ' 108' ' ' GLN . 7.5 p -130.22 145.78 58.79 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.171 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.409 ' HD2' ' CG2' ' A' ' 104' ' ' VAL . 22.5 Cg_exo -65.62 163.4 30.34 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.537 2.158 . . . . 0.0 111.987 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.25 -39.69 78.31 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 25.8 m -69.72 -30.48 68.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.289 0.566 . . . . 0.0 109.626 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.474 ' HB3' HG22 ' A' ' 104' ' ' VAL . 0.9 OUTLIER -74.58 -49.48 21.61 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.53 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -65.47 -37.42 86.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.935 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.38 -51.46 57.56 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.041 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.3 m -72.88 -34.87 66.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.806 0.336 . . . . 0.0 110.438 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.7 mt -60.88 -29.07 69.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.129 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.438 ' CG2' ' HA2' ' A' ' 117' ' ' GLY . 12.4 mt -80.41 -37.95 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.623 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.76 -179.26 44.53 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.458 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.05 122.23 17.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.867 0.365 . . . . 0.0 111.012 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.08 11.91 56.33 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.927 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.438 ' HA2' ' CG2' ' A' ' 113' ' ' ILE . . . 72.15 6.17 64.08 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.02 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -53.16 -39.98 63.99 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -65.33 0.7 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.762 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.411 ' HB ' ' HA ' ' A' ' 113' ' ' ILE . 0.9 OUTLIER -58.03 -37.65 62.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.634 -179.356 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.3 -44.75 80.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.332 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -73.12 -39.29 65.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.313 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 24.3 mt -58.13 -53.88 39.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.264 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.0 ptt85 -67.97 -35.02 77.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.879 0.371 . . . . 0.0 111.071 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -54.92 -50.63 68.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.177 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 53.3 p -83.86 -36.1 23.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.374 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 18.2 m -50.28 -26.13 4.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.807 0.337 . . . . 0.0 110.256 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 88.84 -21.75 25.27 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.981 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -102.49 155.82 18.01 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.823 0.344 . . . . 0.0 111.152 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -105.17 132.85 50.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.023 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 147' ' ' THR . 5.6 m -99.18 138.78 22.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.895 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.679 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 0.1 OUTLIER -116.94 116.67 27.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.107 0.479 . . . . 0.0 112.04 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.9 p -100.67 140.28 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.543 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.21 161.36 30.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.928 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.98 -123.34 0.01 OUTLIER Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.721 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.93 20.79 1.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.686 0.279 . . . . 0.0 111.188 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 5.7 mmt 51.83 179.79 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.911 0.386 . . . . 0.0 111.212 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.414 ' CB ' ' HD3' ' A' ' 139' ' ' PRO . 0.2 OUTLIER -92.14 -50.79 0.29 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.26 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.414 ' HD3' ' CB ' ' A' ' 138' ' ' LEU . 2.0 Cg_endo -84.96 39.36 0.73 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.039 2.493 . . . . 0.0 112.699 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 63.27 103.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.079 0.466 . . . . 0.0 110.861 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.0 p -77.06 159.37 29.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.828 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.5 m -117.73 -46.22 2.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.82 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.498 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 43.9 mt-10 -108.54 138.01 45.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.762 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -109.9 148.84 30.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.833 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -105.98 128.82 54.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.218 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.679 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 28.5 mm -108.6 127.25 65.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.866 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.434 ' HB ' ' HB2' ' A' ' 132' ' ' GLN . 0.2 OUTLIER -108.06 114.67 28.76 Favored 'General case' 0 N--CA 1.46 0.07 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.711 179.76 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.2 mp -104.1 117.53 49.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.409 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.91 126.07 50.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.856 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.402 ' CA ' ' HG2' ' A' ' 97' ' ' PRO . . . 171.26 -153.04 19.61 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.693 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.518 ' CG2' ' HD2' ' A' ' 152' ' ' PRO . 4.4 mt -86.98 143.3 34.86 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 110.569 -0.16 . . . . 0.0 110.569 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.518 ' HD2' ' CG2' ' A' ' 151' ' ' ILE . 6.0 Cg_endo -48.63 -34.18 26.18 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.258 1.972 . . . . 0.0 111.609 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -72.09 -34.65 68.82 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 19.2 m -68.84 -44.48 73.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.648 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 4.2 mt -60.64 -52.49 60.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.806 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 7.8 tp -56.02 -31.06 30.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.861 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -70.08 -37.07 75.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.706 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.01 -52.91 57.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.643 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 34.3 t -59.37 -31.97 47.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.773 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 7.4 ttmt -67.46 -34.45 77.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.748 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.45 -35.1 73.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.712 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 34.2 mm -73.4 -34.42 43.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.951 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 4.2 t -73.91 -46.39 44.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.043 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.24 -41.38 86.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.126 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 59.5 t -69.28 -47.54 73.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.797 0.332 . . . . 0.0 110.859 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -32.77 65.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 62.3 tp -71.91 -47.35 53.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.762 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -73.86 -2.72 24.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.081 0.467 . . . . 0.0 112.027 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 72.6 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.803 -179.994 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.816 0.341 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -176.31 83.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.95 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 64' ' ' PRO . 5.6 t -105.62 146.87 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.772 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 7.1 m -103.64 151.38 23.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.158 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.6 mt -138.32 176.21 8.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.984 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.41 125.32 16.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.901 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.4 tt -140.82 133.52 31.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.318 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.496 ' NH2' ' OE1' ' A' ' 143' ' ' GLU . 16.6 mtt180 -112.58 139.06 48.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.703 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 mp -113.74 138.82 49.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.938 0.399 . . . . 0.0 111.091 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.05 114.22 23.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.703 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.87 161.92 26.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.072 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 27.6 m170 -74.69 175.0 8.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.899 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.57 -40.77 99.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.666 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.48 -44.23 25.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.829 0.347 . . . . 0.0 111.123 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -61.92 -43.98 97.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.081 0.467 . . . . 0.0 110.281 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.491 ' O ' HG12 ' A' ' 29' ' ' ILE . 9.8 p -68.66 -30.34 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.561 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.28 -39.32 97.56 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.538 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.87 -36.2 59.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.732 0.301 . . . . 0.0 111.474 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 25' ' ' VAL . 2.0 pp -78.5 -32.47 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.491 HG12 ' O ' ' A' ' 25' ' ' VAL . 7.6 mm -70.62 -52.88 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.464 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.414 ' HA3' ' CB ' ' A' ' 35' ' ' SER . . . 99.69 150.33 25.07 Favored Glycine 0 N--CA 1.437 -1.297 0 CA-C-O 121.791 0.662 . . . . 0.0 112.967 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.488 ' C ' ' HD3' ' A' ' 32' ' ' LYS . 6.6 mttt -66.09 146.39 54.72 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.398 -0.901 . . . . 0.0 111.348 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.512 ' HE3' ' HB2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 61.59 6.9 1.65 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.583 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.533 ' O ' HG22 ' A' ' 36' ' ' VAL . . . 59.16 8.22 6.08 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.304 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.512 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 3.7 mt-10 -75.58 -30.56 59.68 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 122.402 -0.47 . . . . 0.0 109.915 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.5 ' HA ' ' HG2' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -67.91 -42.67 80.75 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.26 179.462 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -66.86 -26.16 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.548 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.18 -36.63 83.58 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.5 ' HG2' ' HA ' ' A' ' 35' ' ' SER . 41.5 mmtt -59.96 -43.3 95.13 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.579 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.42 -47.14 82.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.914 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.25 -51.05 71.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.226 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -64.35 -37.79 88.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.98 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -74.59 -36.61 63.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.9 t -90.55 -55.79 3.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.946 0.403 . . . . 0.0 110.753 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.7 10.78 61.3 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.915 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 62' ' ' ALA . . . -109.21 127.63 54.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 117.048 0.424 . . . . 0.0 111.554 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.413 ' C ' ' O ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -27.94 104.08 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.294 178.869 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 60' ' ' THR . 3.3 mt -116.02 100.62 10.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.777 0.322 . . . . 0.0 110.419 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.484 ' O ' ' HB ' ' A' ' 60' ' ' THR . 2.4 p30 -121.61 125.83 47.64 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.617 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.7 mt -100.0 142.27 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.73 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.6 m -161.68 -177.81 6.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.024 0.44 . . . . 0.0 111.552 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 64.68 134.81 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.306 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.56 -77.09 0.09 OUTLIER Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.929 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.7 m120 57.9 19.02 5.42 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -178.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.509 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -148.01 -69.16 0.02 OUTLIER Pre-proline 0 N--CA 1.452 -0.37 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.871 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.509 ' HD3' ' HB3' ' A' ' 54' ' ' CYS . 68.1 Cg_endo -81.5 -34.88 0.48 Allowed 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.128 1.885 . . . . 0.0 111.255 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.16 167.25 22.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.247 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -145.77 127.61 15.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.926 0.393 . . . . 0.0 111.207 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.425 ' CD1' ' N ' ' A' ' 58' ' ' ILE . 2.4 mp -101.04 104.72 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.612 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.1 mp -86.43 95.1 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.411 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 47' ' ' ILE . 27.7 m -73.8 131.0 41.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.688 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.5 tt -131.59 129.64 41.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.652 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . -139.45 130.45 26.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.699 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.406 ' HA3' ' HB2' ' A' ' 45' ' ' ALA . . . 157.35 165.18 14.68 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.116 -1.04 . . . . 0.0 112.783 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 80.6 Cg_exo -39.37 154.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.135 2.557 . . . . 0.0 113.216 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.8 m -59.04 -35.35 73.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.864 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -67.03 -52.02 47.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.186 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.26 -42.93 82.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.058 0.456 . . . . 0.0 110.795 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -66.44 -39.46 84.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.172 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.52 -47.01 87.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.065 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -50.59 73.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.938 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.72 -40.68 84.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.153 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.78 -42.69 99.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.093 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.79 -39.31 88.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.167 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.9 mtt -78.04 -32.49 50.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.841 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.14 -46.15 81.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.002 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.1 pp -68.14 -37.85 78.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.223 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -65.48 -46.2 80.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.504 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -35.4 75.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.111 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.0 tp -77.57 -25.17 49.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.523 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -76.88 -43.01 37.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.912 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -72.1 -32.33 66.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.828 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -59.95 -42.4 93.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.983 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 22.6 mt -64.37 -30.89 51.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.043 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.95 55.36 0.93 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.923 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.6 p -161.43 -45.9 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.97 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 84.3 p -85.55 -31.07 22.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.926 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 9.4 mtt -75.07 -175.81 2.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 51.8 m -107.37 70.09 0.77 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -156.09 126.8 6.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.867 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.25 -50.19 2.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.7 m -88.34 -66.35 0.92 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.984 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.59 102.63 5.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.045 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -167.96 80.66 0.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.216 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.4 t -96.43 13.51 27.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.168 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.47 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 5.4 mpt_? 49.04 58.06 18.08 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.476 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.47 ' HD3' ' N ' ' A' ' 95' ' ' ARG . 36.6 Cg_exo -58.75 -48.3 15.32 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.357 2.038 . . . . 0.0 112.403 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.457 ' HD3' ' HB2' ' A' ' 96' ' ' PRO . 83.1 Cg_endo -85.88 117.76 1.7 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.719 2.279 . . . . 0.0 112.606 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 24.3 t -137.2 106.77 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 40.7 p -103.4 139.22 39.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.04 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.86 117.61 11.63 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.91 112.44 25.41 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.527 -178.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 40.7 mt -111.85 153.76 26.16 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.956 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.2 t -114.32 149.23 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.062 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.0 m -156.14 164.46 21.35 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.335 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -66.03 160.74 43.02 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.744 2.296 . . . . 0.0 112.113 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.98 -34.9 76.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.358 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.9 t -70.17 -30.28 67.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.201 0.524 . . . . 0.0 109.667 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -41.8 71.43 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.63 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.449 ' HA ' ' CD2' ' A' ' 112' ' ' LEU . 5.1 t -65.85 -40.8 92.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.706 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.17 -33.47 87.32 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.885 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.6 p -77.32 -50.78 12.07 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 121.115 -0.234 . . . . 0.0 111.312 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.449 ' CD2' ' HA ' ' A' ' 109' ' ' CYS . 2.7 pp -55.66 -25.78 41.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.054 0.455 . . . . 0.0 110.009 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.407 ' O ' ' HA2' ' A' ' 117' ' ' GLY . 51.2 mt -77.03 -39.31 29.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.224 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.41 -177.86 39.37 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.527 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.53 121.73 16.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.857 0.361 . . . . 0.0 111.128 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.85 12.37 56.88 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.08 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 113' ' ' ILE . . . 72.99 4.97 63.95 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.034 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 2.2 m -52.94 -42.64 65.65 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 120.791 0.329 . . . . 0.0 111.828 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -65.34 0.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.564 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.2 tt -58.99 -30.59 43.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.647 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 7.6 tppt? -60.07 -44.83 94.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.105 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -73.28 -41.66 63.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.464 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 34.5 mm -62.7 -53.78 42.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.583 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.4 mmt85 -67.82 -42.72 81.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.398 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.61 -40.77 69.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.222 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 91.3 p -85.32 -36.75 20.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.758 0.313 . . . . 0.0 111.101 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 31.0 m -50.49 -26.09 4.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.929 0.395 . . . . 0.0 110.249 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.48 -9.15 62.49 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.026 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -108.03 154.32 21.83 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.857 0.36 . . . . 0.0 111.212 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -105.14 139.75 39.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.407 ' HB ' ' CG2' ' A' ' 146' ' ' ILE . 1.2 m -99.16 157.96 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.035 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.578 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 3.4 tp60 -138.59 116.81 11.84 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.269 0.557 . . . . 0.0 112.347 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.65 131.22 45.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.305 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.08 161.22 13.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.079 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -58.68 -111.51 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.633 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.86 28.6 0.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.72 12.45 25.56 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.499 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.423 ' CB ' ' HD3' ' A' ' 139' ' ' PRO . 0.0 OUTLIER 165.32 -60.8 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.34 179.784 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.423 ' HD3' ' CB ' ' A' ' 138' ' ' LEU . 86.1 Cg_endo -80.58 68.48 8.31 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.707 2.272 . . . . 0.0 112.434 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -174.42 -40.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.886 0.374 . . . . 0.0 111.082 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.6 t -48.58 -53.63 17.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.951 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 24.5 m -118.91 -41.87 2.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.614 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.496 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 37.5 mt-10 -134.15 138.9 45.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.76 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.24 165.29 13.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.952 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.28 138.98 53.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.233 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.578 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 35.5 mt -114.21 131.63 65.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.824 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.446 ' HB ' ' CB ' ' A' ' 132' ' ' GLN . 1.0 OUTLIER -106.17 115.06 29.58 Favored 'General case' 0 N--CA 1.46 0.065 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.689 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.2 mp -103.89 118.7 51.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.452 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.55 134.5 55.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.758 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 163.35 -151.58 21.22 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.777 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 152' ' ' PRO . 3.7 mt -78.2 144.74 67.5 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' A' ' 151' ' ' ILE . 5.7 Cg_endo -48.4 -39.87 36.06 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.134 1.889 . . . . 0.0 111.322 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -66.63 -34.68 78.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 18.3 m -68.44 -32.26 72.16 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.625 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 29.5 mm -76.35 -49.0 25.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.119 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.4 mm -55.81 -36.38 43.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.989 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -75.03 -36.72 61.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.826 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 4.8 t -68.16 -38.45 82.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.905 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 10.3 p -70.82 -32.17 48.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.065 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.3 -34.68 75.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.872 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.41 -49.37 34.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.776 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.491 HG23 HD12 ' A' ' 162' ' ' ILE . 0.0 OUTLIER -63.15 -44.08 99.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.947 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 1.7 m -58.95 -44.61 91.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.831 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 53.4 t -58.48 -52.59 57.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.02 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.8 t -57.9 -41.25 79.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.18 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -59.69 -37.48 78.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.971 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 7.6 tt -67.46 -55.87 11.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.88 -2.63 24.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.01 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 18.4 p . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.372 -0.823 . . . . 0.0 111.152 179.999 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.801 0.334 . . . . 0.0 111.195 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -158.49 -78.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.937 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -118.08 163.97 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.97 0.414 . . . . 0.0 111.347 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.74 128.31 52.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.288 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -124.26 151.43 44.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.237 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.2 m -141.66 118.78 11.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.519 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.4 tt -119.96 147.21 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.931 0.396 . . . . 0.0 111.408 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.486 ' NH2' ' OE2' ' A' ' 143' ' ' GLU . 2.4 mpp_? -131.04 112.08 12.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.524 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.51 134.74 51.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.224 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -104.36 122.36 45.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.562 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -124.71 159.51 30.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.144 0.497 . . . . 0.0 111.436 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.521 ' HA ' ' O ' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -71.89 142.15 49.52 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.427 179.659 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -43.98 -32.2 2.26 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 121.018 -0.611 . . . . 0.0 113.801 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.37 -52.03 9.2 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.18 -50.55 67.69 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.027 0.442 . . . . 0.0 110.309 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.6 p -58.88 -36.04 59.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.956 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.37 -36.13 92.66 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.39 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.1 m -72.48 -29.53 63.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.96 0.41 . . . . 0.0 110.212 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.404 HD11 ' N ' ' A' ' 28' ' ' ILE . 4.9 mm -81.14 -32.59 12.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.699 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.419 ' HA ' ' CG1' ' A' ' 36' ' ' VAL . 14.2 mt -64.14 -42.59 96.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.156 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.4 150.96 26.14 Favored Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.293 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.432 ' C ' ' HG3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -58.08 146.39 33.28 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.772 -0.714 . . . . 0.0 111.259 179.824 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.479 ' HD2' ' HB2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 44.58 26.75 0.2 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.221 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.542 ' O ' HG21 ' A' ' 36' ' ' VAL . . . 49.25 16.17 0.8 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 114.391 0.517 . . . . 0.0 114.391 178.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 4.0 mt-10 -72.09 -35.01 69.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.677 0.739 . . . . 0.0 109.872 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.9 t -68.41 -39.86 81.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.102 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.542 HG21 ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -66.8 -26.1 36.26 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -36.45 79.91 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 34' ' ' GLU . 8.8 mmtt -63.28 -41.22 98.98 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.597 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.54 -49.48 76.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.169 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -58.34 -51.66 68.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.682 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -64.91 -38.4 90.84 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -75.06 -35.97 61.83 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.5 p -82.27 -55.33 4.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.83 0.347 . . . . 0.0 111.041 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.41 -7.89 64.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.544 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.443 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . . . -104.28 127.94 51.99 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 122.781 -0.246 . . . . 0.0 111.012 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 4.5 mmt180 -27.36 139.39 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.101 0.56 . . . . 0.0 112.213 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.6 mt -142.24 100.59 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.723 0.297 . . . . 0.0 111.008 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.34 132.6 50.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.04 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.9 mt -90.24 151.77 3.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.081 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.87 -175.12 3.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.043 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.62 -166.41 0.98 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.055 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . 162.25 84.75 0.05 OUTLIER Glycine 0 C--O 1.227 -0.315 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.653 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -55.14 -21.6 13.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.069 0.461 . . . . 0.0 110.339 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.445 ' CB ' ' CD ' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -93.16 -63.52 0.16 Allowed Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.675 -179.664 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.521 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 64.5 Cg_endo -81.79 -33.48 0.63 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.635 2.223 . . . . 0.0 112.321 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.505 ' CB ' ' O ' ' A' ' 55' ' ' PRO . 2.6 mt-10 95.83 -35.0 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.85 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -140.24 143.61 36.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.008 0.432 . . . . 0.0 111.375 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.2 mt -140.53 115.45 6.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.599 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.5 mt -86.18 110.13 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.976 0.417 . . . . 0.0 111.43 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 49.6 m -103.15 101.84 11.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.64 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.503 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 6.5 tt -104.69 133.85 48.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.753 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . -125.55 137.42 53.93 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.443 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.49 165.57 15.44 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 119.847 -1.168 . . . . 0.0 113.007 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -50.5 161.96 1.07 Allowed 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.906 2.404 . . . . 0.0 112.337 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.406 ' O ' HG22 ' A' ' 68' ' ' ILE . 18.2 m -56.85 -35.96 69.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.559 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -63.8 -51.81 63.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.788 0.328 . . . . 0.0 111.3 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.24 -37.47 72.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.198 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 65' ' ' THR . 0.1 OUTLIER -66.21 -39.34 84.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.376 -179.301 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.67 -50.91 70.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.032 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.76 -49.71 76.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.886 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.31 -50.85 70.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.27 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -52.78 -42.51 65.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.095 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.98 -37.13 78.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.108 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -76.32 -37.63 57.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.949 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 46.0 mt -64.11 -50.6 76.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.846 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -62.17 -37.42 78.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.143 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -65.0 -47.64 76.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.741 0.305 . . . . 0.0 110.513 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.36 -35.42 80.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.174 0.511 . . . . 0.0 109.781 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.467 ' O ' ' HB ' ' A' ' 83' ' ' ILE . 13.0 tp -77.67 -22.99 49.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.486 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -76.08 -41.75 49.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.841 0.353 . . . . 0.0 110.9 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.23 -45.44 60.22 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.036 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.9 -50.39 64.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.681 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 84' ' ' SER . 2.6 tt -53.63 -47.22 61.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.128 0.489 . . . . 0.0 111.261 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.468 ' N ' ' CG2' ' A' ' 83' ' ' ILE . 28.8 t 62.96 -79.35 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.302 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.99 11.04 9.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.656 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.445 ' HA ' ' CG1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER 74.01 -64.59 0.38 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.831 0.348 . . . . 0.0 110.818 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 1.2 mtp -166.6 138.72 3.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.921 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.77 80.76 1.85 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.798 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -57.4 -30.35 64.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.019 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 94.0 p -166.74 -60.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.83 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.16 102.03 2.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -151.61 110.24 3.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.071 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -149.07 33.63 0.74 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.08 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 60.5 m -88.04 -44.17 11.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.953 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -168.57 88.36 0.65 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.74 110.73 1.96 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.615 2.21 . . . . 0.0 112.12 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -83.48 170.02 12.0 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.661 2.24 . . . . 0.0 112.701 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.431 ' O ' HG12 ' A' ' 98' ' ' VAL . 7.2 p -140.92 116.21 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.505 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.08 131.85 49.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.133 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.6 mt -139.92 117.67 11.63 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -103.09 112.57 25.48 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.567 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.4 mp -99.46 151.01 21.6 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.842 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.9 t -107.26 149.28 10.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.241 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.8 m -156.01 161.69 28.96 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.133 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 108' ' ' GLN . 21.4 Cg_exo -65.69 162.15 35.75 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.748 2.298 . . . . 0.0 112.216 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.13 -34.64 76.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.639 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.25 -30.52 69.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.086 0.469 . . . . 0.0 109.823 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.43 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -68.85 -46.19 69.15 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.678 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -67.57 -37.48 82.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.419 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.22 -49.68 70.48 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.312 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.9 m -77.28 -35.22 55.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.839 0.352 . . . . 0.0 110.803 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.9 mt -57.66 -29.67 64.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.62 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 27.7 mm -87.12 -38.71 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.807 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.4 -179.38 36.66 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.453 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.34 124.73 23.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.874 0.369 . . . . 0.0 111.054 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.41 16.07 57.85 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.882 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 68.16 10.6 59.77 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.965 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -52.93 -39.86 63.16 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.823 0.344 . . . . 0.0 111.547 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.67 -65.27 0.7 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.224 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.13 -28.86 21.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.437 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -64.69 -49.36 71.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.094 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.5 -38.99 74.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.34 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 27.8 mt -57.52 -53.93 37.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.116 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.47 -30.52 64.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.912 0.387 . . . . 0.0 110.998 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.97 -44.73 82.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.131 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.4 m -93.12 -37.53 12.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.506 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.5 m -49.83 -26.25 3.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.809 0.337 . . . . 0.0 110.234 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 82.9 -16.55 26.56 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.229 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -100.87 166.54 10.79 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.937 0.368 . . . . 0.0 111.195 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -105.23 133.82 49.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.952 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 147' ' ' THR . 14.0 m -101.93 139.48 22.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.905 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.622 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 0.4 OUTLIER -129.47 116.72 19.39 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.6 m -99.26 132.74 44.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.277 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.25 160.05 5.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.995 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -89.08 -117.03 1.51 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.537 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 32.7 p-10 -161.71 31.03 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.822 0.344 . . . . 0.0 110.416 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.7 ptp -72.42 64.06 0.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.855 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -173.04 172.05 1.66 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.598 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.64 63.27 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.72 2.28 . . . . 0.0 112.323 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 64.69 103.73 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 56.1 p -80.4 165.52 22.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.787 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 28.3 m -115.59 -47.17 2.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.811 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.486 ' OE2' ' NH2' ' A' ' 17' ' ' ARG . 10.9 mt-10 -116.2 147.03 41.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.792 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.03 174.43 5.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.893 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -136.44 129.9 31.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.402 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.622 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 3.9 mp -100.13 125.4 53.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.741 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.463 ' HB ' ' HB2' ' A' ' 132' ' ' GLN . 0.3 OUTLIER -96.92 114.82 26.47 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.743 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.04 113.48 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.183 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.44 131.16 56.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.086 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 165.49 -158.4 31.25 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.49 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.405 HD13 ' CB ' ' A' ' 154' ' ' SER . 0.7 OUTLIER -87.76 163.74 37.09 Favored Pre-proline 0 C--N 1.33 -0.272 0 O-C-N 122.858 -0.201 . . . . 0.0 110.637 179.534 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.403 ' HD2' ' CB ' ' A' ' 151' ' ' ILE . 6.9 Cg_endo -49.59 -36.59 40.92 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.428 2.085 . . . . 0.0 111.77 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -63.54 -34.61 78.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.038 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.405 ' CB ' HD13 ' A' ' 151' ' ' ILE . 4.2 m -70.45 -37.14 74.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.591 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 36.8 mm -67.53 -51.72 48.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.937 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.9 mm -58.85 -28.24 37.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.056 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -70.6 -57.02 5.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.521 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 6.8 p -61.01 -47.54 86.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.519 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 13.4 p -57.01 -36.56 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.809 0.338 . . . . 0.0 111.166 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.48 -33.05 68.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.827 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.56 -39.81 67.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.978 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 6.4 tp -74.05 -34.51 38.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.032 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 2.3 t -70.81 -47.35 59.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.071 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.81 -45.36 98.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.08 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 28.5 m -69.27 -42.64 81.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.062 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 4.5 tpp -64.53 -37.43 87.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.958 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.44 -57.5 7.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.92 -2.49 24.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.029 0.442 . . . . 0.0 112.026 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.875 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.5 m120 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.952 0.406 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.7 t -136.92 150.06 26.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.748 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 2.5 t -103.51 157.7 16.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.871 0.367 . . . . 0.0 111.305 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.44 ' HA ' HD23 ' A' ' 14' ' ' LEU . 4.0 mt -152.33 174.46 13.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.993 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.9 m -142.5 133.62 25.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.776 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.887 HG22 HD11 ' A' ' 68' ' ' ILE . 1.1 tt -136.92 123.58 29.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.161 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.493 ' NH2' ' OE1' ' A' ' 143' ' ' GLU . 2.3 mpp_? -101.24 117.07 34.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.746 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.513 ' O ' HG23 ' A' ' 58' ' ' ILE . 96.0 mt -94.75 128.51 41.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.862 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.485 ' C ' HD23 ' A' ' 19' ' ' LEU . 6.8 tt -123.05 120.85 34.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.496 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.446 ' HB3' ' HB ' ' A' ' 25' ' ' VAL . 0.8 OUTLIER -147.91 168.65 21.69 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.288 0.566 . . . . 0.0 111.9 -179.46 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.906 ' O ' HG12 ' A' ' 25' ' ' VAL . 29.0 m-70 -74.64 140.95 44.64 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.844 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -45.48 -30.89 3.29 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.962 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.536 ' HG2' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -78.45 -49.5 13.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 117.354 0.577 . . . . 0.0 111.95 -179.077 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.536 ' N ' ' HG2' ' A' ' 23' ' ' LYS . 4.8 mt-10 -65.14 -50.78 64.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.207 0.527 . . . . 0.0 109.999 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.907 HG11 ' CB ' ' A' ' 57' ' ' ARG . 7.3 p -58.72 -34.25 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.572 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.38 -41.9 98.69 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.924 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.1 p -65.88 -27.92 68.57 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.4 mm -81.21 -32.36 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.899 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.77 HD11 HG22 ' A' ' 25' ' ' VAL . 3.0 mm -60.43 -42.75 92.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.342 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.08 150.39 26.8 Favored Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.317 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.401 ' O ' ' CD ' ' A' ' 32' ' ' LYS . 1.3 tppm? -61.71 145.72 51.48 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.723 -0.739 . . . . 0.0 111.34 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.435 ' HG2' ' HB2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 50.79 20.22 0.73 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.442 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 51.24 13.88 1.19 Allowed Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.936 -0.649 . . . . 0.0 113.919 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.435 ' HB2' ' HG2' ' A' ' 32' ' ' LYS . 10.1 tt0 -76.79 -26.09 54.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.213 0.53 . . . . 0.0 109.808 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.13 -42.33 56.55 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.401 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.603 HG13 ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.38 -26.57 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.624 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.93 -36.69 67.27 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.54 -34.57 72.41 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.839 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -53.46 57.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.489 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.09 -51.48 69.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.989 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -51.9 -38.43 56.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.947 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -85.95 -27.38 24.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.697 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.938 ' HB2' ' HB2' ' A' ' 71' ' ' ALA . 1.5 p -73.25 -55.26 6.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.809 0.338 . . . . 0.0 111.21 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.36 -5.27 85.36 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.443 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.507 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -110.71 127.4 55.3 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.63 0.253 . . . . 0.0 111.197 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 9.1 tpp180 -28.19 104.3 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.452 ' CG1' ' O ' ' A' ' 45' ' ' ALA . 2.9 mt -114.73 120.37 64.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.688 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -137.01 173.82 11.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.041 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.9 mt -126.51 151.73 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.947 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.5 t -135.73 -175.28 3.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.08 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.791 179.993 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 . . . . . 0 N--CA 1.466 0.362 0 CA-C-O 120.385 0.136 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.907 ' CB ' HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -136.29 133.98 37.5 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.035 0.445 . . . . 0.0 111.624 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.513 HG23 ' O ' ' A' ' 18' ' ' LEU . 31.0 mt -140.48 119.09 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.718 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.5 mt -97.01 109.66 23.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.442 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.7 m -87.2 108.7 19.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.033 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -106.67 138.52 42.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.506 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.507 ' O ' ' HB1' ' A' ' 45' ' ' ALA . . . -145.41 132.25 20.11 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.45 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.53 166.38 16.85 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 119.549 -1.31 . . . . 0.0 113.3 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 1.9 Cg_endo -46.09 159.21 0.26 Allowed 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 123.174 2.583 . . . . 0.0 112.472 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.43 ' O ' HG22 ' A' ' 68' ' ' ILE . 13.2 t -55.99 -35.94 67.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.429 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -65.37 -51.88 57.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.093 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.476 ' CB ' ' HB2' ' A' ' 45' ' ' ALA . . . -57.28 -44.54 84.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.041 0.448 . . . . 0.0 110.872 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.887 HD11 HG22 ' A' ' 16' ' ' ILE . 1.2 tt -66.45 -39.39 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.878 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.53 -45.13 77.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.041 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -45.4 68.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.746 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.938 ' HB2' ' HB2' ' A' ' 43' ' ' SER . . . -54.78 -56.16 22.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.323 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.558 ' O ' HG23 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -56.27 -40.09 73.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.998 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.45 -32.26 72.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.185 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.2 mtm -74.27 -46.55 40.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.196 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.451 HG13 ' N ' ' A' ' 76' ' ' ILE . 29.0 pt -61.56 -42.83 95.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.229 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 72' ' ' PHE . 41.0 pt -64.91 -36.45 77.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.82 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.401 ' N ' HG13 ' A' ' 76' ' ' ILE . 0.9 OUTLIER -67.9 -37.7 82.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.321 179.578 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -35.45 77.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.01 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.6 tp -76.34 -28.11 56.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.383 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.9 -35.98 56.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.682 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -72.39 -33.45 67.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.909 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.7 t0 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.237 -179.667 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 C--O 1.231 0.164 0 CA-C-O 120.891 0.288 . . . . 0.0 112.641 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 150' ' ' GLY . 4.5 m -140.97 119.87 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.464 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.7 HG22 ' HB2' ' A' ' 149' ' ' ALA . 14.9 p -102.81 141.96 34.74 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.957 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.473 HD12 ' CD1' ' A' ' 102' ' ' LEU . 0.2 OUTLIER -139.85 117.75 11.75 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.919 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -100.87 112.62 25.09 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.499 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.577 HD12 ' N ' ' A' ' 102' ' ' LEU . 5.6 mp -99.35 162.82 12.82 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.835 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.571 ' O ' HG13 ' A' ' 104' ' ' VAL . 21.4 t -115.76 147.75 18.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.215 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 103' ' ' VAL . 4.3 m -160.38 154.36 19.46 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.046 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.37 167.53 18.39 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.386 2.057 . . . . 0.0 112.238 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.52 -34.58 78.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.479 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.1 t -69.59 -30.35 68.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.134 0.492 . . . . 0.0 109.837 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -71.92 -46.24 58.33 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.79 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.403 ' O ' HD12 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -66.62 -46.65 75.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.756 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -54.84 -51.79 50.73 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.57 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.3 m -70.76 -40.03 72.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.771 0.32 . . . . 0.0 110.757 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.7 mt -55.27 -26.99 43.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.645 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.589 HG22 ' HA2' ' A' ' 117' ' ' GLY . 9.8 mt -84.29 -40.76 15.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.799 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.48 -177.19 49.47 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.497 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.5 mttp -66.36 124.13 21.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.827 0.346 . . . . 0.0 111.056 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 58.47 19.96 43.28 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.766 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.589 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 66.78 11.57 57.91 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.904 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 29.1 p -53.01 -38.55 62.43 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.589 ' HD2' HD11 ' A' ' 123' ' ' ILE . 4.8 tmtt? -67.78 -65.39 0.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.641 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.822 ' HA ' HD12 ' A' ' 123' ' ' ILE . 1.0 OUTLIER -55.87 -34.66 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.728 -179.327 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -62.3 -50.4 71.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.306 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 123' ' ' ILE . 5.8 pt-20 -64.36 -34.39 78.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.303 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.822 HD12 ' HA ' ' A' ' 120' ' ' ILE . 15.7 mt -65.87 -53.97 32.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.226 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.47 -30.31 65.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.036 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -59.04 -45.22 91.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.982 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.2 -39.34 14.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.12 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 36.5 m -49.93 -25.84 3.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.832 0.349 . . . . 0.0 110.16 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.6 -9.25 65.58 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.929 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.678 ' HB1' ' O ' ' A' ' 149' ' ' ALA . . . -108.14 164.25 12.46 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.83 0.348 . . . . 0.0 111.204 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -104.81 133.15 50.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.708 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.897 ' HB ' HD11 ' A' ' 146' ' ' ILE . 6.3 m -99.19 139.07 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.137 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.622 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -109.2 158.17 18.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.608 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.8 t -137.66 132.58 44.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.883 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.11 179.971 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.7 p . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.866 0.365 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.81 -48.68 2.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.698 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.493 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 16.7 mm-40 -99.45 140.39 33.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.689 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -109.97 136.79 48.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.964 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -104.3 125.93 50.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.118 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.897 HD11 ' HB ' ' A' ' 131' ' ' VAL . 0.5 OUTLIER -105.91 139.86 25.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.518 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.531 ' HB ' ' HB2' ' A' ' 132' ' ' GLN . 2.3 m -121.12 115.1 22.45 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.473 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.8 mp -104.39 121.78 56.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.104 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.7 ' HB2' HG22 ' A' ' 99' ' ' THR . . . -118.35 145.93 44.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.021 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.644 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 154.49 -151.62 23.28 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.651 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.506 ' CG2' ' HD2' ' A' ' 152' ' ' PRO . 1.5 mp -82.41 143.85 48.75 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.506 ' HD2' ' CG2' ' A' ' 151' ' ' ILE . 79.5 Cg_exo -48.98 -34.09 28.1 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 121.933 1.756 . . . . 0.0 111.589 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -72.17 -34.64 68.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.645 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 50.7 m -69.81 -39.04 76.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.902 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.47 ' O ' HG23 ' A' ' 159' ' ' VAL . 39.2 mm -66.26 -53.47 36.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.073 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.554 HD11 HD13 ' A' ' 76' ' ' ILE . 32.6 mm -57.51 -29.0 32.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.873 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -72.32 -40.82 67.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.837 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' CYS . . . . . 0.422 ' O ' HG22 ' A' ' 162' ' ' ILE . 0.5 OUTLIER -65.73 -35.03 79.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.855 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 155' ' ' ILE . 24.7 t -73.99 -37.73 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.169 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -71.55 -34.82 70.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.93 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.78 ' O ' HG23 ' A' ' 165' ' ' VAL . 7.0 mm100 -73.77 -40.65 63.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.958 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.422 HG22 ' O ' ' A' ' 158' ' ' CYS . 14.8 tt -71.43 -34.46 53.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.152 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 1.5 m -68.27 -51.92 39.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.137 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 10.8 p -58.83 -40.13 79.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.273 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 161' ' ' GLN . 50.5 t -70.62 -32.33 49.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.007 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -45.78 90.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.874 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -71.36 -47.32 57.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.89 -2.65 24.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.209 -0.451 . . . . 0.0 112.015 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.166 -0.921 . . . . 0.0 111.385 179.957 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.807 0.336 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.65 HG11 HD21 ' A' ' 167' ' ' LEU . 7.7 p -108.7 161.1 7.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.003 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.54 ' N ' HG22 ' A' ' 12' ' ' VAL . 3.1 t -103.57 160.78 14.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.012 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.478 ' HA ' HD23 ' A' ' 14' ' ' LEU . 4.3 mt -150.61 173.75 13.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.163 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.7 m -142.47 113.23 7.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.756 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.805 HG22 HD11 ' A' ' 68' ' ' ILE . 16.7 tt -132.61 129.01 58.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.319 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.75 ' O ' HD23 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -117.98 148.61 42.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.693 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 pp -129.38 146.67 51.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.895 0.379 . . . . 0.0 111.248 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.648 HD23 ' N ' ' A' ' 20' ' ' MET . 7.3 tt -123.05 134.62 54.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.795 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.648 ' N ' HD23 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -138.47 165.81 25.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.983 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.557 ' O ' HG12 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -67.78 166.25 15.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.676 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.2 -36.93 94.1 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.705 -0.76 . . . . 0.0 113.022 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -78.36 -50.08 12.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.901 0.381 . . . . 0.0 111.34 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.95 -44.81 95.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.335 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.796 HG22 HD11 ' A' ' 29' ' ' ILE . 6.4 p -62.97 -35.98 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.794 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.16 -34.87 90.47 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.5 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.6 t -75.52 -30.17 59.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.768 0.318 . . . . 0.0 110.846 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.524 ' CG2' HG23 ' A' ' 75' ' ' ILE . 4.1 mm -81.12 -36.87 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.258 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.796 HD11 HG22 ' A' ' 25' ' ' VAL . 30.5 mt -65.75 -42.48 92.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.337 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.42 ' HA3' ' HB2' ' A' ' 35' ' ' SER . . . 88.58 150.9 22.29 Favored Glycine 0 N--CA 1.434 -1.489 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.122 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.433 ' O ' ' CD ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -51.22 146.61 6.47 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.739 -0.731 . . . . 0.0 111.242 179.599 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.503 ' HE3' ' HB3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 44.43 27.1 0.21 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.119 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 45.37 20.2 0.31 Allowed Glycine 0 CA--C 1.522 0.529 0 C-N-CA 121.353 -0.451 . . . . 0.0 113.967 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.503 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -73.14 -25.3 60.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.327 0.564 . . . . 0.0 110.086 179.263 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.42 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -72.58 -42.75 64.26 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.539 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.663 HG13 ' HA ' ' A' ' 29' ' ' ILE . 0.9 OUTLIER -67.02 -26.62 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.871 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -71.03 -36.9 72.54 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.04 -37.09 86.45 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.586 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -59.01 -53.74 54.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.419 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.402 ' HA ' HD12 ' A' ' 47' ' ' ILE . 17.9 mtm-85 -52.86 -51.14 62.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.956 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.6 -37.5 84.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.914 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.52 -35.84 63.16 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.426 ' CB ' ' HB2' ' A' ' 71' ' ' ALA . 0.3 OUTLIER -93.28 -55.74 3.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.978 0.418 . . . . 0.0 111.08 -179.644 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.37 10.03 54.5 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.882 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.483 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -110.77 128.38 55.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.89 0.345 . . . . 0.0 111.221 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -27.49 134.5 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.243 179.439 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.406 HG13 ' HG ' ' A' ' 61' ' ' LEU . 10.4 mt -142.22 100.57 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.705 0.288 . . . . 0.0 110.522 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -112.98 167.43 10.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.886 0.374 . . . . 0.0 111.056 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.541 HG21 ' NE ' ' A' ' 57' ' ' ARG . 3.4 mt -126.52 152.04 33.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.155 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 63.9 m -91.03 -175.05 4.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.218 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.16 -179.816 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.455 -0.201 0 CA-C-O 120.802 0.334 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.791 ' HB2' HG21 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -146.32 127.53 14.78 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.288 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.639 HG12 HD12 ' A' ' 19' ' ' LEU . 17.3 mt -115.0 104.58 17.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.375 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.3 mt -92.92 103.55 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.522 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 91.1 m -83.02 129.1 35.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.459 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.794 HD22 HG13 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -118.21 131.3 56.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.085 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.483 ' O ' ' HB1' ' A' ' 45' ' ' ALA . . . -131.29 130.92 43.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.759 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.2 164.8 14.07 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.961 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 86.9 Cg_exo -40.31 162.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.169 2.58 . . . . 0.0 113.041 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.453 ' O ' HG22 ' A' ' 68' ' ' ILE . 9.6 m -60.17 -35.73 76.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.009 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -69.84 -51.86 29.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.081 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.04 -39.64 75.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.97 0.414 . . . . 0.0 110.85 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.805 HD11 HG22 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -66.23 -39.54 84.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.34 -179.469 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.74 -43.13 89.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.01 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.29 -49.92 75.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.955 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.426 ' HB2' ' CB ' ' A' ' 43' ' ' SER . . . -58.04 -56.47 21.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.27 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.933 ' HA ' HD12 ' A' ' 75' ' ' ILE . 2.6 m-85 -57.39 -34.57 69.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.113 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.27 -42.09 99.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.124 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.06 -36.55 72.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.951 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.933 HD12 ' HA ' ' A' ' 72' ' ' PHE . 14.9 mt -62.77 -49.26 84.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.4 HG13 ' N ' ' A' ' 77' ' ' ASP . 24.5 pt -61.21 -40.51 86.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.027 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.4 ' N ' HG13 ' A' ' 76' ' ' ILE . 1.1 t0 -61.22 -39.87 91.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.685 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.43 -41.67 97.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.29 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.411 HD21 HG11 ' A' ' 98' ' ' VAL . 18.1 tp -74.61 -26.62 60.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.472 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -76.89 -34.62 57.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.703 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -72.21 -37.38 69.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.729 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.8 t0 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.914 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo . . . . . 0 N--CA 1.465 -0.198 0 CA-C-O 120.988 0.328 . . . . 0.0 112.839 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.411 HG11 HD21 ' A' ' 79' ' ' LEU . 21.2 t -140.77 122.12 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.987 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.855 HG22 ' CB ' ' A' ' 149' ' ' ALA . 5.0 p -102.62 141.13 35.95 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.461 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 147' ' ' THR . 4.6 mp -139.84 158.58 43.85 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.139 -1.801 . . . . 0.0 106.139 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.584 ' HG2' ' HB1' ' A' ' 145' ' ' ALA . 8.3 ttp-105 -122.84 113.33 19.0 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.912 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.75 HD23 ' O ' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -101.09 144.6 29.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.933 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.5 t -104.43 139.08 26.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.061 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.3 m -149.06 157.22 40.17 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.04 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.24 166.56 20.84 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.421 2.081 . . . . 0.0 112.324 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.68 -34.57 75.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.384 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 p -68.97 -30.28 68.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.978 0.418 . . . . 0.0 109.926 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -50.6 52.71 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.793 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.474 ' O ' HD12 ' A' ' 113' ' ' ILE . 30.9 p -70.67 -38.21 73.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.677 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -54.7 -50.45 57.67 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.475 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.2 p -77.43 -47.45 19.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.671 0.272 . . . . 0.0 111.011 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.872 ' CD2' HD12 ' A' ' 162' ' ' ILE . 29.0 mt -52.66 -26.46 13.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.925 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.487 HG22 ' HA2' ' A' ' 117' ' ' GLY . 41.0 mt -92.33 -37.37 8.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.943 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.93 179.47 32.83 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.423 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -67.39 124.18 22.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.873 0.368 . . . . 0.0 111.008 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.0 19.1 63.14 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.816 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.487 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 64.41 13.26 54.25 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.887 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -52.9 -50.6 63.57 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 120.775 0.322 . . . . 0.0 111.728 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.734 ' HD2' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -57.1 -60.83 3.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.178 -179.763 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.645 HD13 ' O ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -56.1 -26.92 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.456 -179.766 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.6 tptp -65.06 -47.0 78.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.796 0.332 . . . . 0.0 110.892 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -73.13 -45.8 54.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.136 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.734 HD11 ' HD2' ' A' ' 119' ' ' LYS . 50.6 mt -62.17 -50.89 78.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.998 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -63.78 -40.55 96.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.151 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -54.99 -57.38 11.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.818 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.3 m -75.83 -43.68 44.77 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.422 HG21 ' HB3' ' A' ' 158' ' ' CYS . 25.0 m -47.95 -25.94 1.55 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.866 0.365 . . . . 0.0 110.432 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.24 -7.05 58.24 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.049 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -105.66 137.11 44.06 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.951 0.375 . . . . 0.0 110.953 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.41 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 0.0 OUTLIER -95.58 144.59 25.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.209 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.465 ' CG2' HD11 ' A' ' 120' ' ' ILE . 4.8 m -99.31 147.17 7.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.045 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 7.0 tp60 -140.22 117.77 11.52 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.555 HG23 ' CG ' ' A' ' 144' ' ' ARG . 11.6 p -96.59 116.47 38.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.051 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.795 -179.608 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 88.3 p . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.865 0.364 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 25.7 m -106.42 -64.56 1.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.359 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.494 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 10.5 mm-40 -93.92 135.73 34.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.171 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.555 ' CG ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -121.75 166.41 14.35 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.241 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.584 ' HB1' ' HG2' ' A' ' 101' ' ' ARG . . . -130.2 115.75 17.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.791 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 30.5 mt -100.77 129.24 51.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.696 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.457 ' HB ' ' CB ' ' A' ' 132' ' ' GLN . 2.6 m -97.67 123.06 41.43 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.519 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.795 ' O ' HD12 ' A' ' 148' ' ' ILE . 2.1 pp -106.72 117.97 53.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.935 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.855 ' CB ' HG22 ' A' ' 99' ' ' THR . . . -118.34 126.43 52.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.121 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 171.28 -153.28 20.08 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.592 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.518 HG22 ' HD2' ' A' ' 152' ' ' PRO . 1.3 mp -87.32 143.59 34.65 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 110.624 -0.139 . . . . 0.0 110.624 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.518 ' HD2' HG22 ' A' ' 151' ' ' ILE . 71.3 Cg_exo -49.33 -31.03 21.62 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 121.966 1.777 . . . . 0.0 111.447 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.13 -34.65 68.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.674 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 22.2 t -68.79 -50.08 53.3 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.795 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.612 HD13 ' C ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -58.39 -45.07 89.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.451 HD12 ' O ' ' A' ' 152' ' ' PRO . 27.9 mt -63.88 -29.98 48.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.845 0.355 . . . . 0.0 110.842 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -73.65 -43.02 60.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.238 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' CYS . . . . . 0.422 ' HB3' HG21 ' A' ' 127' ' ' THR . 21.4 p -72.42 -42.87 64.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.277 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.423 HG12 ' HA ' ' A' ' 156' ' ' ILE . 13.3 p -60.83 -37.9 77.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.927 0.394 . . . . 0.0 111.01 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.97 -32.91 69.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.756 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.874 ' O ' HG23 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -67.86 -49.56 61.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.0 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.872 HD12 ' CD2' ' A' ' 112' ' ' LEU . 37.7 mm -66.41 -34.48 70.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.015 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 1.7 m -64.58 -48.1 76.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.978 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 161' ' ' GLN . 11.1 p -65.48 -33.53 64.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.187 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 161' ' ' GLN . 50.8 t -70.64 -45.14 75.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.878 0.371 . . . . 0.0 110.972 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 27.2 mtm -58.98 -33.57 70.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.847 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.65 HD21 HG11 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -72.56 -48.22 41.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.818 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.02 -2.55 24.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.93 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 41.2 p . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.876 -179.979 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.816 0.341 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.44 151.68 16.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.986 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 0.9 OUTLIER -103.66 142.75 33.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.039 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.494 ' HA ' HD23 ' A' ' 14' ' ' LEU . 4.2 mt -137.11 175.23 9.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.991 0.424 . . . . 0.0 111.211 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.7 m -142.4 135.97 29.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.841 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.558 HG22 HD11 ' A' ' 68' ' ' ILE . 14.1 tt -140.87 154.67 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.164 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.496 ' NH2' ' OE1' ' A' ' 143' ' ' GLU . 25.0 mtp180 -134.79 127.63 31.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.867 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.474 HD11 ' CZ ' ' A' ' 72' ' ' PHE . 52.5 mt -113.96 147.58 38.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.568 HD23 ' O ' ' A' ' 19' ' ' LEU . 6.8 tt -102.35 106.04 16.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.762 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.2 144.14 40.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.044 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.547 ' O ' HG12 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -76.61 167.82 21.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.752 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.424 ' C ' HG12 ' A' ' 25' ' ' VAL . . . -59.8 -34.66 83.49 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.769 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.86 -52.02 8.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 0.0 111.354 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -34.12 76.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.849 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.685 ' O ' HG12 ' A' ' 29' ' ' ILE . 7.4 p -71.03 -38.97 74.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.664 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.08 -35.08 90.95 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.683 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.26 -34.96 61.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.594 0.235 . . . . 0.0 111.07 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.638 HD12 ' N ' ' A' ' 29' ' ' ILE . 2.9 pp -80.15 -32.53 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.355 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.768 ' HA ' HG13 ' A' ' 36' ' ' VAL . 12.4 mm -65.06 -58.87 5.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.7 150.54 25.29 Favored Glycine 0 N--CA 1.436 -1.354 0 CA-C-O 121.635 0.575 . . . . 0.0 112.664 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.443 ' O ' ' CD ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -61.52 146.34 48.98 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.501 -0.85 . . . . 0.0 111.441 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.454 ' HG2' ' H ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER 52.56 18.89 1.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.277 179.482 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.412 ' O ' HG23 ' A' ' 36' ' ' VAL . . . 51.7 13.79 1.5 Allowed Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.956 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.454 ' H ' ' HG2' ' A' ' 32' ' ' LYS . 5.4 tp10 -76.88 -26.27 54.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.322 0.561 . . . . 0.0 109.748 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.445 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -75.19 -40.95 58.93 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.246 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.768 HG13 ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.3 -26.51 36.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.243 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.57 -36.61 81.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 177.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 35' ' ' SER . 22.2 ttmm -60.36 -40.9 92.43 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.778 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.502 ' HE2' HG21 ' A' ' 47' ' ' ILE . 3.0 ttp -59.2 -48.46 81.55 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.38 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.2 ttp85 -55.3 -50.63 69.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.101 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -64.64 -38.51 91.25 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 39' ' ' MET . 3.1 pp20? -75.03 -35.88 61.92 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.742 ' HB3' ' HB2' ' A' ' 71' ' ' ALA . 37.0 p -91.04 -55.4 3.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.911 0.386 . . . . 0.0 111.105 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.12 5.86 65.45 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.248 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.832 ' HB3' HD11 ' A' ' 61' ' ' LEU . . . -110.65 128.43 55.69 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.44 0.162 . . . . 0.0 110.799 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.572 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -27.61 136.91 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.001 0.521 . . . . 0.0 112.057 178.921 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.502 HG21 ' HE2' ' A' ' 39' ' ' MET . 20.6 mt -142.19 100.68 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.73 0.3 . . . . 0.0 110.578 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -121.41 121.57 37.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.919 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -107.53 127.61 63.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.374 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.404 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER 178.92 -174.04 0.18 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.044 179.92 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 120.687 0.28 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.616 ' CD ' HG11 ' A' ' 25' ' ' VAL . 2.0 mpt_? -145.82 155.89 43.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.006 0.431 . . . . 0.0 111.525 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.404 ' HB ' ' O ' ' A' ' 50' ' ' SER . 19.7 mt -140.64 118.7 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.339 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 mt -85.94 117.93 31.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.985 0.422 . . . . 0.0 111.622 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.9 m -108.57 101.75 10.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.467 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.832 HD11 ' HB3' ' A' ' 45' ' ' ALA . 15.9 tp -104.41 124.29 48.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.812 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.508 ' HB3' ' HB2' ' A' ' 46' ' ' ARG . . . -126.78 131.71 51.22 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.495 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.39 166.19 16.43 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 119.686 -1.245 . . . . 0.0 113.297 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 2.9 Cg_endo -41.85 159.48 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 123.396 2.731 . . . . 0.0 112.669 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.466 ' O ' HG22 ' A' ' 68' ' ' ILE . 57.0 m -60.11 -35.97 76.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.48 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -68.72 -52.07 34.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.239 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.07 -38.04 72.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.071 0.462 . . . . 0.0 110.882 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.558 HD11 HG22 ' A' ' 16' ' ' ILE . 0.5 OUTLIER -65.18 -39.34 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.275 -179.376 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.44 -45.09 92.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.886 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.2 -53.41 58.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.614 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.742 ' HB2' ' HB3' ' A' ' 43' ' ' SER . . . -60.72 -43.74 97.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.177 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.474 ' CZ ' HD11 ' A' ' 18' ' ' LEU . 0.7 OUTLIER -62.02 -35.51 78.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.078 -179.834 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.87 -38.78 83.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.262 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.36 -39.21 54.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.984 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 88.6 mt -62.06 -50.58 79.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.661 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.499 HD12 ' N ' ' A' ' 77' ' ' ASP . 2.3 pp -63.87 -40.69 89.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.969 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.499 ' N ' HD12 ' A' ' 76' ' ' ILE . 3.0 m-20 -69.65 -29.69 67.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.455 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -35.64 81.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.076 0.465 . . . . 0.0 109.91 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.9 tp -77.39 -30.52 53.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.386 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.94 -34.05 57.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.776 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.54 -37.84 68.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.032 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.446 -179.674 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo . . . . . 0 C--O 1.232 0.195 0 CA-C-O 120.715 0.214 . . . . 0.0 112.078 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.422 HG21 ' HG3' ' A' ' 152' ' ' PRO . 21.3 t -125.17 103.32 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.903 0.383 . . . . 0.0 111.418 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.0 t -107.53 127.0 53.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.383 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 mt -140.03 117.76 11.63 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -103.18 112.39 25.23 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.788 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.64 149.77 26.89 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.403 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.24 145.08 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.652 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.653 HG23 HD13 ' A' ' 146' ' ' ILE . 40.1 t -142.88 144.75 30.66 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.225 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.446 ' HD2' ' CG1' ' A' ' 104' ' ' VAL . 22.2 Cg_exo -65.36 165.51 22.16 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.507 2.138 . . . . 0.0 112.154 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' A' ' 142' ' ' THR . . . -69.04 -44.22 73.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.135 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.5 m -66.7 -30.48 70.72 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.419 ' HB3' ' CG1' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -74.61 -41.42 60.46 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.434 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 55.6 m -66.28 -40.9 90.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.102 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.57 -50.71 64.79 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.161 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.3 t -70.4 -36.2 73.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.783 0.325 . . . . 0.0 110.615 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.52 HD21 HG23 ' A' ' 162' ' ' ILE . 10.7 mt -58.49 -28.32 65.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.272 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.585 HG22 ' HA2' ' A' ' 117' ' ' GLY . 10.9 mt -81.71 -40.29 17.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.717 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.1 -176.83 53.81 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.521 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -66.47 118.15 9.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.896 0.379 . . . . 0.0 111.185 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.99 15.38 56.0 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.015 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.585 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 73.06 5.08 64.6 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.006 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 1.5 m -53.13 -39.65 63.64 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 120.727 0.299 . . . . 0.0 111.719 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -64.87 -65.33 0.69 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.438 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.405 ' HB ' ' HA ' ' A' ' 113' ' ' ILE . 0.5 OUTLIER -54.4 -35.51 31.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.393 -179.674 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.5 tptm -59.26 -44.18 92.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.08 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -73.24 -40.21 64.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.329 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 88.2 mt -54.97 -53.9 29.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.216 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -31.95 69.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.892 0.377 . . . . 0.0 110.938 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -49.74 72.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.31 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.2 m -90.08 -36.94 14.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.546 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.6 m -49.89 -26.05 3.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.848 0.356 . . . . 0.0 110.364 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.3 -12.04 52.59 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.093 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -103.8 155.24 18.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.844 0.354 . . . . 0.0 111.038 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.31 127.94 53.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.054 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 147' ' ' THR . 14.4 m -99.2 138.64 23.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.861 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.69 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 5.4 tm0? -123.38 116.59 23.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.167 0.508 . . . . 0.0 112.032 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.484 HG12 HG13 ' A' ' 146' ' ' ILE . 30.8 m -103.46 130.97 52.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.363 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.929 179.675 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 79.0 p . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.798 0.332 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.419 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.2 OUTLIER -112.01 -47.32 3.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.496 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 29.5 mt-10 -121.98 139.88 53.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.825 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.04 173.07 6.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -122.54 126.33 47.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.232 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.69 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 3.4 mp -105.48 125.0 60.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.618 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 131' ' ' VAL . 2.1 m -99.59 114.69 27.87 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.678 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.923 HD12 HG12 ' A' ' 155' ' ' ILE . 4.6 pt -106.9 114.72 46.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.411 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -119.38 132.33 55.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.768 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 167.06 -151.61 19.67 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.815 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.532 ' CG2' ' HD2' ' A' ' 152' ' ' PRO . 15.9 mt -84.85 144.46 42.02 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.532 ' HD2' ' CG2' ' A' ' 151' ' ' ILE . 73.5 Cg_exo -48.89 -33.77 26.57 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 121.988 1.792 . . . . 0.0 111.689 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -72.05 -34.75 69.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.845 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.3 m -67.97 -50.46 55.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.992 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.923 HG12 HD12 ' A' ' 148' ' ' ILE . 0.0 OUTLIER -59.26 -47.45 90.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.134 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.472 ' N ' HG23 ' A' ' 155' ' ' ILE . 33.6 mt -60.69 -45.9 96.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.819 0.342 . . . . 0.0 110.759 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -60.46 -35.17 75.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.663 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 9.0 t -67.03 -42.99 83.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.774 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 155' ' ' ILE . 21.6 t -59.03 -37.96 71.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.022 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.97 -33.01 73.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.777 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.893 ' O ' HG23 ' A' ' 165' ' ' VAL . 26.1 tp60 -71.47 -46.23 60.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.827 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.631 HG22 ' SD ' ' A' ' 166' ' ' MET . 50.3 mt -67.25 -34.51 69.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.979 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 1.6 m -63.93 -52.37 60.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.017 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 161' ' ' GLN . 10.7 p -59.56 -33.3 51.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.172 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 161' ' ' GLN . 44.0 t -70.69 -44.03 76.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.849 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.631 ' SD ' HG22 ' A' ' 162' ' ' ILE . 0.0 OUTLIER -59.85 -33.09 71.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.855 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.59 -50.56 35.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.76 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -73.97 -2.56 24.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.069 0.461 . . . . 0.0 111.948 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 169' ' ' THR . 60.2 m . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.864 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.495 ' N ' ' ND2' ' A' ' 11' ' ' ASN . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.237 0 CA-C-O 120.447 0.165 . . . . 0.0 111.15 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.613 HG11 ' CD1' ' A' ' 167' ' ' LEU . 7.5 p -114.27 159.18 14.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.115 0.483 . . . . 0.0 111.373 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.522 ' N ' HG22 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -109.52 154.05 23.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.787 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' A' ' 14' ' ' LEU . 1.1 mt -144.36 169.28 18.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.054 0.454 . . . . 0.0 111.229 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.2 m -142.72 132.13 23.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.673 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.808 HG22 HD11 ' A' ' 68' ' ' ILE . 2.4 tt -140.83 140.05 33.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.948 0.404 . . . . 0.0 111.326 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.712 ' HG3' HG23 ' A' ' 60' ' ' THR . 1.1 mpp_? -124.48 120.32 31.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.686 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.572 HD21 ' CZ ' ' A' ' 72' ' ' PHE . 14.1 mt -99.8 119.63 38.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.118 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.567 ' C ' HD23 ' A' ' 19' ' ' LEU . 8.3 tt -102.71 105.43 15.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.702 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.6 tpp -120.21 161.48 20.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.902 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.618 ' O ' HG12 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -67.7 172.57 5.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.452 179.807 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.08 -40.79 99.39 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.913 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.93 -45.27 24.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.771 0.32 . . . . 0.0 111.547 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.13 -48.39 78.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.944 0.402 . . . . 0.0 110.283 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.755 HG22 HD11 ' A' ' 29' ' ' ILE . 9.8 p -61.66 -35.2 65.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.852 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.94 -34.92 90.46 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.187 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 m -75.24 -26.76 59.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.879 0.371 . . . . 0.0 110.723 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.456 HG23 HG23 ' A' ' 75' ' ' ILE . 3.9 mm -79.11 -51.48 16.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.123 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.755 HD11 HG22 ' A' ' 25' ' ' VAL . 8.7 mt -57.31 -42.27 79.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.514 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.03 150.84 27.3 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.137 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.416 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -51.59 146.05 8.16 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.058 -0.571 . . . . 0.0 111.143 179.766 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.454 ' HE3' ' HB3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 43.36 27.07 0.12 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.834 -179.65 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.45 ' O ' HG12 ' A' ' 36' ' ' VAL . . . 45.17 21.75 0.43 Allowed Glycine 0 CA--C 1.52 0.4 0 C-N-CA 121.273 -0.489 . . . . 0.0 113.852 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.454 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -76.23 -28.84 57.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.209 0.504 . . . . 0.0 110.314 179.574 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.1 t -73.71 -41.75 62.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.488 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 33' ' ' GLY . 2.3 p -67.42 -27.34 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.2 -36.67 79.91 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 176.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.414 ' HA ' ' CG ' ' A' ' 41' ' ' GLU . 1.8 tttm -70.91 -31.8 68.53 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.241 177.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.409 ' HB2' ' HA ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -63.21 -51.04 67.89 Favored 'General case' 0 C--O 1.228 -0.047 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.463 179.52 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.0 ttt-85 -58.38 -51.57 69.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.581 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.414 ' CG ' ' HA ' ' A' ' 38' ' ' LYS . 1.4 pp20? -64.33 -37.94 89.27 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -74.69 -36.75 62.76 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.853 ' CB ' ' HB2' ' A' ' 71' ' ' ALA . 83.1 p -81.37 -55.65 4.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.906 0.384 . . . . 0.0 111.018 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.93 1.12 56.15 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.736 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -110.66 128.17 55.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.842 0.321 . . . . 0.0 111.304 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.566 ' HB3' ' HB3' ' A' ' 62' ' ' ALA . 8.3 ttm180 -27.27 140.6 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.257 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 60' ' ' THR . 12.0 mt -142.52 101.1 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.696 0.284 . . . . 0.0 110.817 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -118.38 128.77 54.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.781 0.324 . . . . 0.0 111.248 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.61 HG21 ' HD3' ' A' ' 57' ' ' ARG . 9.6 mm -92.11 151.86 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.97 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.7 m -87.16 -177.06 5.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.915 0.388 . . . . 0.0 111.268 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.111 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 120.761 0.315 . . . . 0.0 110.855 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.741 ' HB2' HG21 ' A' ' 25' ' ' VAL . 1.5 mtt180 -145.79 139.3 26.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.825 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.419 ' CD1' HD12 ' A' ' 19' ' ' LEU . 6.8 mm -105.62 109.71 28.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.024 0.44 . . . . 0.0 110.892 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.672 HD11 HG23 ' A' ' 25' ' ' VAL . 3.8 mt -86.49 92.83 3.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.094 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.712 HG23 ' HG3' ' A' ' 17' ' ' ARG . 8.0 m -81.1 134.08 35.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.985 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -131.39 134.65 46.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.285 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.566 ' HB3' ' HB3' ' A' ' 46' ' ' ARG . . . -135.47 130.52 34.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.66 0.267 . . . . 0.0 110.862 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.407 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.22 164.61 13.87 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.919 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.475 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 83.6 Cg_exo -39.93 158.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 123.21 2.607 . . . . 0.0 113.238 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.46 ' O ' HG22 ' A' ' 68' ' ' ILE . 29.9 m -60.04 -35.69 75.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.87 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -63.48 -51.83 63.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.262 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.21 -40.7 77.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.057 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.808 HD11 HG22 ' A' ' 16' ' ' ILE . 0.5 OUTLIER -66.19 -39.37 84.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.18 -179.44 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.38 -48.92 79.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.227 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.73 -48.8 79.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.977 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.853 ' HB2' ' CB ' ' A' ' 43' ' ' SER . . . -57.41 -58.75 6.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.286 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.838 ' HA ' HD12 ' A' ' 75' ' ' ILE . 2.7 m-85 -51.84 -39.24 58.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.305 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.61 -43.93 93.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.109 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.0 ttp -72.21 -34.82 68.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.838 HD12 ' HA ' ' A' ' 72' ' ' PHE . 20.9 mt -64.29 -48.7 84.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.965 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.3 pt -62.65 -39.35 84.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.93 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.19 -36.52 82.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.718 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -42.27 93.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.335 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.5 tp -77.34 -24.94 50.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.624 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -76.86 -39.96 49.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.779 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.1 -34.01 68.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.834 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.917 -179.922 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo . . . . . 0 C--O 1.231 0.15 0 CA-C-O 120.831 0.263 . . . . 0.0 112.114 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.497 HG21 ' HD3' ' A' ' 152' ' ' PRO . 19.3 t -134.81 107.04 7.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.197 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.1 p -104.0 135.53 45.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.785 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.585 ' O ' HG22 ' A' ' 148' ' ' ILE . 0.5 OUTLIER -139.98 117.59 11.53 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 178.812 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.485 ' HE ' HD22 ' A' ' 19' ' ' LEU . 18.9 ttp180 -105.2 112.56 25.73 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.291 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.3 mt -99.37 129.97 45.61 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.049 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.893 HG12 ' HB2' ' A' ' 145' ' ' ALA . 21.3 m -103.85 143.99 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.058 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 103' ' ' VAL . 12.7 m -157.94 166.2 17.04 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.09 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.402 ' CD ' ' HB ' ' A' ' 104' ' ' VAL . 21.8 Cg_exo -65.97 171.32 10.17 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.609 2.206 . . . . 0.0 112.356 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 142' ' ' THR . . . -63.58 -34.6 78.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.623 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.3 m -67.34 -30.52 70.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.11 0.481 . . . . 0.0 109.874 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.402 ' CB ' ' HB ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -69.41 -50.53 45.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.772 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.18 -41.52 99.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.646 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -56.55 -47.47 83.8 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.375 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.0 t -71.99 -40.5 68.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.795 0.331 . . . . 0.0 110.815 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.876 HD21 HG23 ' A' ' 162' ' ' ILE . 12.6 mt -54.36 -26.82 32.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.978 0.418 . . . . 0.0 110.598 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.641 HG22 ' HA2' ' A' ' 117' ' ' GLY . 8.2 mt -84.86 -43.18 17.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.791 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.98 -176.74 54.58 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.569 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -67.29 116.89 8.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.896 0.379 . . . . 0.0 111.079 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.57 11.82 57.7 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.999 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.641 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 75.64 2.58 69.88 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.995 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -52.83 -36.79 59.14 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 120.701 0.286 . . . . 0.0 111.609 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.9 mmtp -63.87 -65.27 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.192 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.39 -31.05 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.373 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.98 -46.55 88.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.038 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -73.21 -46.25 51.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.307 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.55 HG23 ' HG2' ' A' ' 161' ' ' GLN . 40.4 mm -54.84 -53.68 30.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.204 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -63.74 -39.92 95.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.26 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.33 -53.93 47.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.33 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.8 m -76.99 -33.47 57.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.294 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.441 HG22 ' H ' ' A' ' 129' ' ' ALA . 17.8 m -52.34 -26.61 12.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.974 0.416 . . . . 0.0 110.125 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.84 -22.09 5.14 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.247 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.643 ' HB3' HD11 ' A' ' 148' ' ' ILE . . . -96.44 165.4 12.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.919 0.36 . . . . 0.0 111.073 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 11.2 mm100 -105.16 138.01 42.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.694 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 27.6 m -99.11 145.07 10.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.16 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.708 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 0.7 OUTLIER -119.57 158.43 26.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.767 -179.685 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 133' ' ' VAL . 11.5 p -120.74 122.13 67.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.792 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.382 -179.76 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.822 0.344 . . . . 0.0 110.834 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.568 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 15.7 m -123.35 -48.56 1.95 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.497 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 7.9 mt-10 -98.67 136.87 38.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.812 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 11.1 mtm-85 -115.6 155.3 27.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.93 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.893 ' HB2' HG12 ' A' ' 103' ' ' VAL . . . -122.43 135.98 54.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.988 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.708 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 21.9 mt -108.91 143.79 18.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.73 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' A' ' 132' ' ' GLN . 0.2 OUTLIER -113.62 116.84 30.12 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.178 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.674 HD13 ' SG ' ' A' ' 158' ' ' CYS . 1.0 OUTLIER -103.78 124.5 58.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.143 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.613 ' O ' ' HB1' ' A' ' 129' ' ' ALA . . . -118.46 146.32 44.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.171 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 149.52 -153.22 25.01 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.255 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.745 HD12 ' HB2' ' A' ' 153' ' ' GLN . 1.3 pt -87.12 156.39 54.64 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.642 0.258 . . . . 0.0 110.863 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.497 ' HD3' HG21 ' A' ' 98' ' ' VAL . 7.4 Cg_endo -49.53 -34.65 34.49 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.621 2.214 . . . . 0.0 111.907 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.745 ' HB2' HD12 ' A' ' 151' ' ' ILE . 0.3 OUTLIER -71.98 -34.66 69.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.391 179.457 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.574 ' HB3' ' HB2' ' A' ' 129' ' ' ALA . 18.6 m -70.37 -39.14 74.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.946 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.533 HD12 HG23 ' A' ' 148' ' ' ILE . 22.7 mm -72.64 -48.59 45.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.214 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.491 HG23 ' N ' ' A' ' 157' ' ' GLU . 20.2 tt -58.21 -45.15 88.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.141 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.491 ' N ' HG23 ' A' ' 156' ' ' ILE . 10.7 pt-20 -62.73 -36.67 83.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.707 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' CYS . . . . . 0.674 ' SG ' HD13 ' A' ' 148' ' ' ILE . 3.9 t -58.22 -47.22 84.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.642 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 30.3 t -61.2 -42.09 92.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.979 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.415 ' O ' HG12 ' A' ' 164' ' ' VAL . 0.2 OUTLIER -60.05 -35.59 75.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.78 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.561 ' O ' HG22 ' A' ' 165' ' ' VAL . 1.1 mp0 -67.24 -37.1 82.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.776 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.876 HG23 HD21 ' A' ' 112' ' ' LEU . 41.3 mt -74.02 -34.38 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.15 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 77.1 m -73.91 -45.15 52.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.076 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.489 HG13 ' N ' ' A' ' 165' ' ' VAL . 11.6 p -62.36 -45.36 98.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.062 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.621 ' O ' HG23 ' A' ' 169' ' ' THR . 28.0 m -65.85 -45.6 90.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.058 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.49 ' N ' HG23 ' A' ' 165' ' ' VAL . 50.8 mtp -57.6 -42.71 83.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.841 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.613 ' CD1' HG11 ' A' ' 12' ' ' VAL . 7.9 tt -72.55 -41.76 65.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.819 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.91 -2.67 24.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.977 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 165' ' ' VAL . 52.6 p . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.838 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.849 0.357 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.495 HG11 HD11 ' A' ' 167' ' ' LEU . 21.6 t -145.39 158.35 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.144 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.706 ' O ' HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -109.14 129.49 55.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.506 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.706 HD22 ' O ' ' A' ' 13' ' ' THR . 4.3 mm? -128.84 153.4 47.48 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.175 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 61' ' ' LEU . 25.5 m -135.91 112.76 10.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.502 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.904 HG22 HD11 ' A' ' 68' ' ' ILE . 1.6 tt -111.48 142.97 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.453 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.496 ' NH2' ' OE1' ' A' ' 143' ' ' GLU . 1.1 mpp_? -132.08 126.14 33.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.657 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.452 ' O ' HD12 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -125.13 132.0 53.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.247 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.738 HD21 ' HB2' ' A' ' 56' ' ' GLU . 7.0 tt -102.23 136.32 42.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.632 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.636 ' N ' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -129.99 155.39 46.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.892 0.377 . . . . 0.0 111.135 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.649 ' O ' HG12 ' A' ' 25' ' ' VAL . 11.6 m170 -67.75 175.18 3.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.641 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.01 -41.96 96.69 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.91 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.66 -42.83 27.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.742 0.305 . . . . 0.0 111.677 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.56 -40.99 98.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.986 0.422 . . . . 0.0 110.537 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.724 HG22 HG13 ' A' ' 29' ' ' ILE . 8.6 p -70.89 -32.44 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.657 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.42 -39.86 98.33 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.371 -0.919 . . . . 0.0 112.822 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.5 p -76.06 -35.49 59.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 25' ' ' VAL . 2.1 pp -79.83 -32.61 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.724 HG13 HG22 ' A' ' 25' ' ' VAL . 9.8 mm -71.92 -54.58 16.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.916 0.388 . . . . 0.0 110.427 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.411 ' HA3' ' CB ' ' A' ' 35' ' ' SER . . . 99.65 150.64 25.45 Favored Glycine 0 N--CA 1.436 -1.327 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.945 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.427 ' O ' ' CD ' ' A' ' 32' ' ' LYS . 8.3 mttm -59.67 146.54 40.77 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.478 -0.861 . . . . 0.0 111.214 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.461 ' HE3' ' HB3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 44.2 26.25 0.15 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.997 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.405 ' O ' HG23 ' A' ' 36' ' ' VAL . . . 50.88 18.63 2.91 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.685 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.461 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -75.44 -29.77 59.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.228 0.514 . . . . 0.0 109.992 179.308 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.411 ' CB ' ' HA3' ' A' ' 30' ' ' GLY . 0.3 OUTLIER -75.39 -40.3 58.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.584 179.589 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.709 HG13 ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.09 -26.25 36.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.23 -36.97 74.89 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -63.15 -37.43 87.18 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.396 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.684 ' HE3' HG12 ' A' ' 36' ' ' VAL . 2.5 ttm -59.33 -51.29 70.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.487 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.503 ' HA ' HD12 ' A' ' 47' ' ' ILE . 6.0 mtp180 -53.81 -51.35 63.79 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.159 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -59.27 -38.41 80.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.693 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.27 -20.42 34.51 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.71 ' HB2' ' HB2' ' A' ' 71' ' ' ALA . 11.1 t -90.44 -55.48 3.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.757 0.313 . . . . 0.0 111.554 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.53 -10.93 73.27 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.401 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.81 ' HB3' HD21 ' A' ' 61' ' ' LEU . . . -110.73 128.91 55.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.588 0.232 . . . . 0.0 111.112 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.8 OUTLIER -27.01 140.12 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.204 0.602 . . . . 0.0 112.386 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 40' ' ' ARG . 25.6 mt -142.32 100.55 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.558 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.47 129.99 52.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.751 0.31 . . . . 0.0 111.011 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 3.4 mp -108.4 142.47 20.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.197 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.8 p -161.64 -170.73 2.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.922 0.392 . . . . 0.0 111.317 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.648 ' HG3' HD12 ' A' ' 58' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.035 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.738 ' HB2' HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.668 ' HB2' HG21 ' A' ' 25' ' ' VAL . 4.3 mtm180 -145.75 132.71 20.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.851 0.357 . . . . 0.0 110.885 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.648 HD12 ' HG3' ' A' ' 51' ' ' GLU . 46.4 mt -98.05 105.91 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.756 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.452 HD12 ' O ' ' A' ' 18' ' ' LEU . 3.7 mp -86.07 97.61 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.212 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.443 HG23 ' HG3' ' A' ' 17' ' ' ARG . 62.5 m -87.49 136.83 32.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.925 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.81 HD21 ' HB3' ' A' ' 45' ' ' ALA . 2.1 tt -131.42 134.24 46.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.486 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.412 ' O ' ' HB1' ' A' ' 45' ' ' ALA . . . -133.12 130.71 39.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.685 0.278 . . . . 0.0 111.158 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.426 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.26 164.41 13.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.707 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 86.7 Cg_exo -40.75 161.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.019 2.479 . . . . 0.0 113.179 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.456 ' O ' HG22 ' A' ' 68' ' ' ILE . 8.5 m -60.21 -35.64 75.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.115 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 -64.73 -51.88 60.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.362 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.46 ' CB ' ' HB2' ' A' ' 45' ' ' ALA . . . -56.97 -42.4 80.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.957 0.408 . . . . 0.0 110.974 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.904 HD11 HG22 ' A' ' 16' ' ' ILE . 0.5 OUTLIER -66.3 -39.65 84.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.335 -179.334 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -46.12 90.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.061 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -51.2 70.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.991 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.71 ' HB2' ' HB2' ' A' ' 43' ' ' SER . . . -57.37 -41.64 80.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.29 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.439 ' O ' HG13 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -60.37 -39.43 87.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.912 0.387 . . . . 0.0 110.889 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.92 -29.86 68.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.312 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -48.46 14.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.699 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 72' ' ' PHE . 0.7 OUTLIER -59.78 -39.08 78.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.288 -179.597 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 pp -72.48 -37.03 56.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.853 0.359 . . . . 0.0 111.012 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -65.48 -46.94 77.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.498 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.04 -35.3 74.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.012 0.434 . . . . 0.0 110.018 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.7 tp -76.58 -27.27 55.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.141 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.84 -34.13 57.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.696 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.23 -44.28 63.13 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.758 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.868 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.465 -0.187 0 CA-C-O 120.819 0.258 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.873 HG23 HD11 ' A' ' 155' ' ' ILE . 3.6 m -141.02 117.08 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.739 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 148' ' ' ILE . 17.8 m -103.01 141.51 35.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.808 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.97 117.78 11.69 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -100.91 112.64 25.12 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.166 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.701 HD11 HD11 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -109.51 137.37 47.45 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.229 -179.524 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.74 148.93 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.447 HG12 ' HB2' ' A' ' 108' ' ' GLN . 23.4 t -152.81 143.67 15.81 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.227 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.419 ' HD2' ' CG1' ' A' ' 104' ' ' VAL . 20.9 Cg_exo -65.78 163.16 31.65 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.45 2.1 . . . . 0.0 112.192 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.94 -34.96 76.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.666 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.4 m -70.46 -30.48 67.33 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.447 ' HB2' HG12 ' A' ' 104' ' ' VAL . 26.4 mm-40 -71.79 -49.48 38.37 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.435 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.449 ' O ' HD12 ' A' ' 113' ' ' ILE . 2.9 t -64.49 -41.46 96.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.307 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -54.66 -51.81 49.91 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.219 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.9 -35.43 69.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.908 0.385 . . . . 0.0 110.405 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.67 -25.86 66.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.35 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.504 HG22 ' HA2' ' A' ' 117' ' ' GLY . 9.3 mt -84.68 -36.9 12.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.776 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.17 -178.73 16.2 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.505 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.46 129.63 40.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.883 0.373 . . . . 0.0 111.128 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 60.44 17.1 46.34 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.938 -0.648 . . . . 0.0 113.008 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.504 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 67.65 9.53 55.93 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.991 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 4.6 t -53.14 -35.53 59.82 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.801 0.334 . . . . 0.0 111.493 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.422 ' HG3' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -67.95 -64.09 0.93 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.274 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.4 ' HB ' ' HA ' ' A' ' 113' ' ' ILE . 9.1 tt -54.11 -26.94 15.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.822 0.344 . . . . 0.0 111.253 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -48.24 66.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.943 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -73.09 -36.11 66.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.177 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.422 HD11 ' HG3' ' A' ' 119' ' ' LYS . 16.4 mt -67.93 -48.29 75.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.217 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.04 -48.18 59.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.303 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -54.46 -35.29 62.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.46 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 99.9 p -90.21 -35.41 15.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.706 0.289 . . . . 0.0 111.329 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.4 m -52.14 -26.09 10.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.889 0.376 . . . . 0.0 110.106 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.11 -20.18 22.39 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.936 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -108.17 167.75 9.78 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.809 0.338 . . . . 0.0 111.132 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -105.08 129.95 53.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.892 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 147' ' ' THR . 13.2 m -99.29 139.14 21.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.067 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.627 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 1.1 tt0 -125.61 116.61 22.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.174 0.511 . . . . 0.0 112.178 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.3 p -97.46 136.75 27.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.408 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.056 179.922 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.6 m . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.796 0.331 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 10.9 t -115.96 -39.77 3.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.84 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.496 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 18.3 mt-10 -127.56 136.91 52.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.826 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.5 mtt180 -113.49 171.74 7.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.73 136.41 53.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.086 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.627 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 40.0 mt -105.86 124.32 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.736 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.452 ' HB ' ' CB ' ' A' ' 132' ' ' GLN . 4.4 m -97.77 114.76 26.85 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.523 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 99' ' ' THR . 23.6 mt -106.34 110.47 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.421 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.36 122.7 43.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.646 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 171.09 -151.38 15.6 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.543 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.527 ' CG2' ' HD2' ' A' ' 152' ' ' PRO . 1.4 mp -80.99 144.72 55.5 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.683 ' HA ' HD12 ' A' ' 155' ' ' ILE . 82.6 Cg_exo -49.02 -31.04 19.52 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 121.987 1.792 . . . . 0.0 111.587 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -72.03 -34.68 69.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.727 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 66.9 m -65.08 -44.81 87.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.734 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.873 HD11 HG23 ' A' ' 98' ' ' VAL . 4.3 mt -66.03 -51.32 61.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.195 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 23.0 mt -55.89 -28.49 24.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.991 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -73.39 -41.24 63.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.942 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' CYS . . . . . 0.512 ' O ' HG22 ' A' ' 162' ' ' ILE . 0.6 OUTLIER -67.09 -48.48 68.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.014 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 11.5 p -60.53 -38.19 77.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.248 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.646 ' O ' HG23 ' A' ' 164' ' ' VAL . 0.5 OUTLIER -69.33 -42.83 74.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.032 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.77 ' O ' HG23 ' A' ' 165' ' ' VAL . 1.8 mt-30 -65.83 -49.39 68.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.036 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.512 HG22 ' O ' ' A' ' 158' ' ' CYS . 17.2 tt -64.15 -45.07 97.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.197 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' CYS . . . . . 0.485 ' N ' HG23 ' A' ' 162' ' ' ILE . 12.6 t -62.54 -48.52 79.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.991 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 160' ' ' LYS . 53.2 t -60.0 -52.69 58.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.094 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 161' ' ' GLN . 33.2 t -62.05 -34.72 64.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.233 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 9.5 tmm? -59.9 -51.89 67.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.994 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.505 HD12 HD21 ' A' ' 14' ' ' LEU . 4.9 tt -58.94 -55.73 31.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.992 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.89 -2.62 24.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.072 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.901 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.714 HD21 ' N ' ' A' ' 11' ' ' ASN . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.882 0.372 . . . . 0.0 110.859 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.584 HG22 ' N ' ' A' ' 13' ' ' THR . 12.5 p -116.77 166.04 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.052 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.584 ' N ' HG22 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -103.13 141.96 34.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.595 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.5 mt -136.14 177.24 7.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.171 0.51 . . . . 0.0 111.447 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.2 m -141.71 113.07 7.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.557 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.777 HG22 HD11 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -111.63 126.47 69.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.976 0.417 . . . . 0.0 111.471 -179.601 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.711 ' CG ' HG23 ' A' ' 60' ' ' THR . 81.9 mtm-85 -112.57 116.31 30.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.446 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.52 HD12 ' CE ' ' A' ' 20' ' ' MET . 0.4 OUTLIER -114.59 119.6 37.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.237 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.428 HD11 ' HE ' ' A' ' 101' ' ' ARG . 1.8 pp -113.38 133.96 54.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.825 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.541 ' HB2' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -135.23 177.02 8.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.959 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.836 ' O ' HG22 ' A' ' 25' ' ' VAL . 6.8 m-70 -67.57 166.0 15.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.61 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.73 -31.96 72.9 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.925 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -78.37 -42.27 30.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.806 0.336 . . . . 0.0 111.335 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.58 ' O ' HG22 ' A' ' 28' ' ' ILE . 14.6 mt-10 -67.79 -43.11 80.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.917 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 21' ' ' HIS . 18.2 m -65.48 -40.39 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.314 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.91 -41.35 99.9 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.892 -0.67 . . . . 0.0 113.229 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.6 m -75.96 -35.64 59.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.721 0.296 . . . . 0.0 111.63 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.58 HG22 ' O ' ' A' ' 24' ' ' GLU . 2.7 tp -76.73 -50.52 21.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.746 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.538 ' N ' HG23 ' A' ' 28' ' ' ILE . 31.4 mt -60.19 -42.43 90.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.914 0.388 . . . . 0.0 110.752 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.422 ' HA3' ' CB ' ' A' ' 35' ' ' SER . . . 99.82 150.84 25.53 Favored Glycine 0 N--CA 1.435 -1.399 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.556 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.409 ' O ' ' CD ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -57.98 146.42 32.59 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.825 -0.688 . . . . 0.0 111.378 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.532 ' HD2' ' HB2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 44.01 27.04 0.17 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.956 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 50.6 19.64 3.32 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 114.512 0.565 . . . . 0.0 114.512 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.532 ' HB2' ' HD2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -76.98 -35.44 57.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.755 0.778 . . . . 0.0 109.966 179.095 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -68.81 -43.14 76.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.65 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.7 p -67.36 -27.04 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.91 -36.7 82.85 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 176.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 35' ' ' SER . 0.5 OUTLIER -69.71 -34.66 74.2 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.517 -1.219 . . . . 0.0 108.948 177.792 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -67.34 -41.22 85.56 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.101 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.476 ' HA ' HD12 ' A' ' 47' ' ' ILE . 4.4 ttp-105 -58.48 -51.35 70.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.194 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -59.76 -38.51 81.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.807 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -75.27 -36.27 61.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.693 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.691 ' HB2' ' HB2' ' A' ' 71' ' ' ALA . 19.7 t -73.02 -49.27 29.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.28 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.18 -8.96 78.66 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.292 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.46 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . . . -110.91 128.48 55.82 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.6 0.238 . . . . 0.0 111.156 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.616 ' HB2' ' HB3' ' A' ' 62' ' ' ALA . 0.8 OUTLIER -27.23 136.74 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.221 179.356 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 40' ' ' ARG . 4.2 mt -142.7 100.47 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.979 178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -115.88 165.84 12.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.916 0.389 . . . . 0.0 111.421 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.617 HG23 HD13 ' A' ' 59' ' ' ILE . 3.2 mp -126.47 151.74 33.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.798 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.59 -178.64 0.75 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.983 0.42 . . . . 0.0 111.4 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.663 ' CB ' HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.12 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 120.677 0.275 . . . . 0.0 110.516 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.518 ' HB2' HG21 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -145.71 127.59 15.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.857 179.523 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.663 HD12 ' CB ' ' A' ' 51' ' ' GLU . 19.1 mt -102.22 110.67 29.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.617 HD13 HG23 ' A' ' 49' ' ' ILE . 26.3 mm -94.62 96.38 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.088 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.711 HG23 ' CG ' ' A' ' 17' ' ' ARG . 6.0 m -76.33 139.14 40.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.795 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -131.29 133.27 45.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.267 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.616 ' HB3' ' HB2' ' A' ' 46' ' ' ARG . . . -133.03 129.31 37.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.79 0.328 . . . . 0.0 111.109 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.431 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.15 164.18 13.35 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.726 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 94.6 Cg_exo -42.2 161.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.106 2.537 . . . . 0.0 113.07 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.496 ' O ' HG22 ' A' ' 68' ' ' ILE . 34.1 m -59.97 -35.72 75.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.974 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -62.42 -51.88 65.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.224 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.46 ' CB ' ' HB2' ' A' ' 45' ' ' ALA . . . -56.99 -37.64 71.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.008 0.432 . . . . 0.0 110.989 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.777 HD11 HG22 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -66.21 -39.36 84.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.194 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -47.28 81.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.888 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.74 -51.91 67.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.745 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.691 ' HB2' ' HB2' ' A' ' 43' ' ' SER . . . -56.11 -58.37 8.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.315 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.624 ' HA ' HD12 ' A' ' 75' ' ' ILE . 0.9 OUTLIER -49.2 -32.53 10.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.33 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.21 -41.59 81.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.11 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -75.91 -32.84 59.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.055 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.624 HD12 ' HA ' ' A' ' 72' ' ' PHE . 18.2 mt -68.11 -43.63 85.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.963 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 72' ' ' PHE . 23.1 pt -67.88 -40.34 83.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.971 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.401 ' N ' HG13 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -65.03 -41.04 95.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.443 179.836 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.3 tptt -61.87 -35.92 79.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.055 0.455 . . . . 0.0 110.048 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.7 tp -77.39 -28.15 52.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.435 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -76.69 -35.11 58.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.649 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.29 -42.75 65.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.824 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.041 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo . . . . . 0 N--CA 1.465 -0.201 0 CA-C-O 120.737 0.224 . . . . 0.0 111.938 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.685 HG12 HD11 ' A' ' 100' ' ' LEU . 19.7 t -140.88 111.87 3.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.347 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 16.0 m -103.41 134.28 47.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.634 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.685 HD11 HG12 ' A' ' 98' ' ' VAL . 5.4 mp -139.91 117.76 11.71 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.428 ' HE ' HD11 ' A' ' 19' ' ' LEU . 6.3 ttp180 -101.98 112.5 25.16 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.132 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.505 ' O ' HG22 ' A' ' 146' ' ' ILE . 8.1 mp -113.47 162.32 16.28 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.935 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.407 HG12 ' CB ' ' A' ' 17' ' ' ARG . 11.3 p -98.73 136.42 29.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.022 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.457 ' CG1' ' HD2' ' A' ' 105' ' ' PRO . 25.4 t -138.66 145.37 45.93 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.104 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.457 ' HD2' ' CG1' ' A' ' 104' ' ' VAL . 21.6 Cg_exo -65.99 159.92 46.85 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.475 2.116 . . . . 0.0 112.146 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.99 -34.64 75.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.5 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 m -69.48 -30.45 68.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.168 0.508 . . . . 0.0 109.771 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.411 ' HB3' ' CG1' ' A' ' 104' ' ' VAL . 0.7 OUTLIER -70.34 -50.54 38.02 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.463 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.411 ' O ' HG12 ' A' ' 113' ' ' ILE . 53.5 t -62.19 -43.48 98.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.381 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -53.89 -47.52 65.46 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.395 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.85 -40.31 69.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.804 0.335 . . . . 0.0 110.644 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 112' ' ' LEU . 19.1 mt -55.97 -27.82 54.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.0 0.428 . . . . 0.0 110.486 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.431 ' CG2' ' HA2' ' A' ' 117' ' ' GLY . 28.0 mm -82.07 -39.89 16.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.582 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.66 -177.67 26.02 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.501 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -67.54 125.15 25.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.894 0.378 . . . . 0.0 111.129 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.72 13.1 58.46 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.989 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.431 ' HA2' ' CG2' ' A' ' 113' ' ' ILE . . . 70.84 7.31 61.6 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.974 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 5.2 t -53.0 -39.64 63.24 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.786 0.326 . . . . 0.0 111.695 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.863 ' HD2' HD11 ' A' ' 123' ' ' ILE . 0.6 OUTLIER -61.33 -65.36 0.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.286 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.73 HD11 HG21 ' A' ' 131' ' ' VAL . 1.6 tp -55.83 -32.22 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.356 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.26 -52.3 66.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.157 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -73.08 -40.95 64.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.432 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.863 HD11 ' HD2' ' A' ' 119' ' ' LYS . 53.8 mt -57.24 -53.65 40.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.362 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.03 -38.25 72.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.353 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -54.84 -39.95 69.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.615 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.07 -37.55 11.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.602 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 17.2 m -49.73 -26.14 3.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.887 0.375 . . . . 0.0 110.265 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.46 -12.14 28.37 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.825 -0.702 . . . . 0.0 113.224 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.589 ' HB2' ' HB3' ' A' ' 154' ' ' SER . . . -108.27 146.3 33.08 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.953 0.377 . . . . 0.0 111.299 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.16 129.52 43.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.597 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.986 HG12 HG22 ' A' ' 148' ' ' ILE . 6.7 m -99.28 150.38 5.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.351 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.66 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 11.4 tt0 -122.65 158.55 29.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.01 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.6 m -137.45 140.89 40.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.227 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.125 179.935 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.86 0.362 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.57 -50.56 2.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.639 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.483 ' OE2' ' NH2' ' A' ' 17' ' ' ARG . 10.1 mt-10 -115.09 137.92 51.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.679 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -109.88 176.99 4.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.909 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -110.41 130.7 55.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.166 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.859 HD11 ' HB ' ' A' ' 131' ' ' VAL . 0.5 OUTLIER -113.55 140.03 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.772 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.503 ' HB ' ' HB2' ' A' ' 132' ' ' GLN . 0.7 OUTLIER -115.98 114.99 25.37 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.304 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.986 HG22 HG12 ' A' ' 131' ' ' VAL . 1.6 pt -106.78 123.43 61.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.11 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.48 136.2 53.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.101 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 160.87 -162.88 33.88 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.513 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.8 HD12 ' HB2' ' A' ' 153' ' ' GLN . 2.7 pt -87.02 161.49 46.71 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.61 0.243 . . . . 0.0 110.95 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.476 ' HA ' HD12 ' A' ' 155' ' ' ILE . 74.8 Cg_exo -49.4 -40.0 44.4 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.431 2.087 . . . . 0.0 112.041 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.8 ' HB2' HD12 ' A' ' 151' ' ' ILE . 3.1 mm-40 -64.69 -34.7 78.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.301 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.589 ' HB3' ' HB2' ' A' ' 129' ' ' ALA . 61.8 m -69.4 -34.02 73.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.71 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 152' ' ' PRO . 26.6 mt -73.09 -53.34 18.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.945 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.447 ' HA ' HG12 ' A' ' 159' ' ' VAL . 37.7 mm -59.15 -28.63 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.061 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -75.17 -40.16 59.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.033 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -72.14 -38.91 69.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.183 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.447 HG12 ' HA ' ' A' ' 156' ' ' ILE . 12.1 p -69.98 -41.96 79.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.393 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.614 ' O ' HG23 ' A' ' 164' ' ' VAL . 8.3 pttt -65.54 -38.58 90.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.039 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -64.42 -49.41 71.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.768 HD13 ' O ' ' A' ' 162' ' ' ILE . 0.0 OUTLIER -64.78 -34.52 70.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.977 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 34.1 m -67.76 -43.4 79.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 160' ' ' LYS . 54.0 t -59.6 -52.68 58.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.9 p -64.26 -30.4 50.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.021 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -59.31 -51.57 69.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.951 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.557 HD22 HG21 ' A' ' 12' ' ' VAL . 9.6 mt -70.03 -45.91 66.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.949 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -73.99 -2.48 24.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.052 0.454 . . . . 0.0 112.018 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.848 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.528 0.132 0 CA-C-O 120.989 0.423 . . . . 0.0 111.554 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 13' ' ' THR . 20.3 t -120.56 158.26 22.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.913 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -103.77 139.34 39.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.029 -179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 14' ' ' LEU . 2.0 mt -143.02 166.1 25.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.008 0.433 . . . . 0.0 111.188 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 m -142.73 140.65 31.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.632 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.691 HG22 HD11 ' A' ' 68' ' ' ILE . 17.8 tt -140.87 152.51 20.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.972 0.415 . . . . 0.0 111.479 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.487 ' NH2' ' OE2' ' A' ' 143' ' ' GLU . 2.8 ttm-85 -134.99 129.68 34.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.389 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.02 135.23 51.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.947 0.403 . . . . 0.0 111.121 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.545 HD12 HG23 ' A' ' 58' ' ' ILE . 1.8 mp -93.32 115.0 27.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.628 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -107.87 141.02 40.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.951 0.405 . . . . 0.0 110.89 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.432 ' O ' HG12 ' A' ' 25' ' ' VAL . 1.4 t-80 -67.6 163.89 20.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.602 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.518 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -58.7 -45.05 95.32 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.699 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.45 -43.28 27.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.985 0.422 . . . . 0.0 110.91 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.77 ' O ' HG23 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -62.01 -32.79 73.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.508 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.698 HG22 HG13 ' A' ' 29' ' ' ILE . 9.8 p -76.95 -31.22 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.474 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.36 -42.71 99.7 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.441 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.9 m -75.87 -37.24 59.12 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.669 0.271 . . . . 0.0 111.605 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.77 HG23 ' O ' ' A' ' 24' ' ' GLU . 1.7 pp -76.29 -32.7 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 120.787 0.327 . . . . 0.0 111.879 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.769 ' HA ' HG13 ' A' ' 36' ' ' VAL . 10.9 mm -70.68 -54.74 16.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.253 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.406 ' HA3' ' CB ' ' A' ' 35' ' ' SER . . . 99.56 150.29 25.13 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-O 121.769 0.649 . . . . 0.0 113.026 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.58 ' HB3' ' HD3' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -67.13 146.37 54.33 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.413 -0.893 . . . . 0.0 111.113 179.606 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.58 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER 63.71 6.82 2.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.37 -179.603 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.444 ' O ' HG23 ' A' ' 36' ' ' VAL . . . 57.71 12.67 10.5 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 119.84 -1.171 . . . . 0.0 111.648 -178.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -76.78 -28.93 55.84 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.918 0.39 . . . . 0.0 110.091 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.406 ' CB ' ' HA3' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -73.33 -41.5 63.43 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.184 179.567 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.769 HG13 ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.16 -26.38 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.552 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.98 -36.87 75.53 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.49 -37.45 86.04 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.776 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.483 ' HE3' ' HA ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -62.14 -52.45 63.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.432 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.515 ' HG2' HD12 ' A' ' 47' ' ' ILE . 39.9 mtm180 -50.56 -51.21 50.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.206 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -57.98 -38.04 75.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.72 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -75.11 -36.11 61.68 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.862 ' HB2' ' HB2' ' A' ' 71' ' ' ALA . 79.6 p -82.69 -55.75 4.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.846 0.355 . . . . 0.0 111.66 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.9 -5.62 66.46 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.426 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.753 ' HB3' HD21 ' A' ' 61' ' ' LEU . . . -110.67 128.83 55.86 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.688 0.28 . . . . 0.0 111.138 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 47.8 ttm-85 -27.16 137.84 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.339 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.515 HD12 ' HG2' ' A' ' 40' ' ' ARG . 12.2 mt -142.27 100.43 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.705 0.288 . . . . 0.0 110.471 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.95 171.38 7.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.724 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 58' ' ' ILE . 6.0 mt -126.7 149.78 31.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.954 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.88 -169.3 1.96 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.911 0.386 . . . . 0.0 111.302 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.029 -179.884 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.429 ' HB2' ' N ' ' A' ' 22' ' ' GLY . 2.7 mt-10 . . . . . 0 N--CA 1.47 0.533 0 CA-C-O 120.657 0.265 . . . . 0.0 110.577 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.548 ' HB2' HG11 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -145.88 142.15 28.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.987 0.422 . . . . 0.0 111.626 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.545 HG23 HD12 ' A' ' 19' ' ' LEU . 25.5 mt -123.25 131.16 73.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.127 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.714 HD11 HD11 ' A' ' 28' ' ' ILE . 30.0 mt -109.24 106.12 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.87 0.367 . . . . 0.0 111.766 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 66.9 m -93.05 139.17 30.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.805 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.753 HD21 ' HB3' ' A' ' 45' ' ' ALA . 6.3 tt -131.5 137.26 48.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.726 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.719 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -135.55 132.37 37.13 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.563 0.22 . . . . 0.0 110.851 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.421 ' HA3' ' HB1' ' A' ' 45' ' ' ALA . . . 157.19 164.83 14.11 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.261 -0.971 . . . . 0.0 112.928 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 95.7 Cg_exo -42.47 159.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.986 2.457 . . . . 0.0 113.041 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.472 ' O ' HG22 ' A' ' 68' ' ' ILE . 35.8 m -60.28 -35.69 76.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.981 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -66.34 -52.02 51.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.15 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.77 -37.64 71.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.691 HD11 HG22 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -66.36 -39.24 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.157 -179.643 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.43 -51.9 67.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.842 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -43.83 88.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.587 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.862 ' HB2' ' HB2' ' A' ' 43' ' ' SER . . . -55.48 -45.54 76.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.22 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.464 ' CE1' HD13 ' A' ' 16' ' ' ILE . 1.2 m-85 -58.46 -50.3 74.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.207 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.0 -36.99 68.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.599 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.85 -40.0 49.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.23 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 72' ' ' PHE . 12.1 mt -62.42 -51.46 72.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.652 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.22 -38.54 80.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.991 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.26 -29.59 65.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.416 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -35.33 80.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.054 0.454 . . . . 0.0 109.81 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.9 tp -76.65 -31.69 57.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.172 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -76.79 -32.85 57.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.769 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -72.25 -36.85 69.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.783 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.992 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo . . . . . 0 C--O 1.231 0.133 0 CA-C-O 120.895 0.289 . . . . 0.0 112.198 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.4 t -126.21 103.36 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.95 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 11.0 t -113.26 133.49 55.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.01 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.76 ' HB3' HD11 ' A' ' 155' ' ' ILE . 6.6 tp -139.94 117.86 11.77 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.722 ' HB3' HG23 ' A' ' 147' ' ' THR . 0.0 OUTLIER -107.62 112.67 25.51 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.631 -178.684 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.616 HD21 HD21 ' A' ' 100' ' ' LEU . 28.5 mt -102.64 155.38 18.33 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.903 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.465 HG13 ' O ' ' A' ' 144' ' ' ARG . 17.0 t -106.71 141.15 22.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.17 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.405 ' HB ' ' CB ' ' A' ' 108' ' ' GLN . 6.4 m -145.44 155.94 53.47 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.124 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.64 162.86 35.23 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.552 2.168 . . . . 0.0 112.583 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.63 -34.51 69.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.502 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.1 m -67.24 -30.71 70.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.151 0.501 . . . . 0.0 109.823 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.405 ' CB ' ' HB ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -67.58 -45.4 75.65 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.525 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.509 ' SG ' HD11 ' A' ' 113' ' ' ILE . 42.7 t -66.68 -49.32 66.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.63 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -49.29 -51.96 24.68 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.522 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.9 p -71.84 -40.21 69.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.765 0.317 . . . . 0.0 110.545 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.723 HD21 HD12 ' A' ' 162' ' ' ILE . 7.4 mt -54.93 -28.72 53.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.045 0.45 . . . . 0.0 110.246 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.509 HD11 ' SG ' ' A' ' 109' ' ' CYS . 17.9 mt -80.02 -44.6 22.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.552 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 76.94 -173.25 54.88 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.588 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.5 tptp -64.56 118.98 9.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.894 0.378 . . . . 0.0 111.197 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 56.85 20.32 32.65 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.987 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.459 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 71.8 6.98 64.62 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.988 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 30.9 p -53.1 -40.12 63.9 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 120.826 0.346 . . . . 0.0 111.707 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.84 ' HD2' HD11 ' A' ' 123' ' ' ILE . 0.7 OUTLIER -65.26 -65.29 0.69 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.5 -179.474 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.884 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.6 OUTLIER -55.1 -34.29 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.581 -179.509 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -60.64 -45.09 95.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.011 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -73.11 -32.37 64.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.101 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.884 HD12 ' HA ' ' A' ' 120' ' ' ILE . 26.7 mt -64.24 -43.38 97.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.184 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.84 -42.7 60.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.92 0.391 . . . . 0.0 111.017 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -58.83 -35.37 72.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.733 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.8 t -93.45 -45.55 7.73 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.675 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.1 m -48.37 -25.64 1.7 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.874 0.368 . . . . 0.0 110.275 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.48 -9.49 41.94 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.048 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.569 ' HB1' ' O ' ' A' ' 149' ' ' ALA . . . -108.29 153.72 22.84 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.932 0.366 . . . . 0.0 111.201 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -99.7 141.29 32.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.732 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.709 ' HB ' HD11 ' A' ' 146' ' ' ILE . 11.4 m -99.22 157.9 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.356 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.789 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 0.1 OUTLIER -128.78 158.45 38.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.447 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.511 HG22 HH21 ' A' ' 144' ' ' ARG . 21.0 t -129.39 118.87 47.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.967 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.242 -179.862 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.835 0.35 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.9 t -115.49 -41.82 3.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.699 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.487 ' OE2' ' NH2' ' A' ' 17' ' ' ARG . 15.2 pt-20 -118.17 139.13 51.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.703 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.511 HH21 HG22 ' A' ' 133' ' ' VAL . 5.4 ptm180 -109.91 168.2 9.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.938 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.56 134.33 54.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.303 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.789 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 1.5 tt -116.37 131.94 67.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.519 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.722 HG23 ' HB3' ' A' ' 101' ' ' ARG . 1.0 OUTLIER -109.45 116.05 31.08 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.715 -179.554 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.58 HG23 HD12 ' A' ' 155' ' ' ILE . 4.7 tp -104.89 121.99 57.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.742 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.569 ' O ' ' HB1' ' A' ' 129' ' ' ALA . . . -118.39 140.41 49.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.204 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 166.14 -154.29 24.76 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.355 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.553 HD12 ' HB2' ' A' ' 153' ' ' GLN . 1.2 pt -87.06 161.96 45.17 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.59 0.234 . . . . 0.0 110.839 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.509 ' O ' HG22 ' A' ' 156' ' ' ILE . 73.7 Cg_exo -49.51 -34.96 35.31 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.315 2.01 . . . . 0.0 112.209 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.553 ' HB2' HD12 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -72.06 -34.74 68.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.817 179.736 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 53.1 p -74.25 -41.15 61.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.971 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.76 HD11 ' HB3' ' A' ' 100' ' ' LEU . 0.7 OUTLIER -68.73 -41.28 82.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.175 -179.841 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.509 HG22 ' O ' ' A' ' 152' ' ' PRO . 1.1 tp -69.68 -32.83 53.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.141 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -69.84 -49.22 54.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.894 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -58.61 -53.1 62.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.097 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.744 HG23 ' O ' ' A' ' 155' ' ' ILE . 30.1 t -57.35 -35.53 49.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.296 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 10.5 tptp -68.32 -32.91 73.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.978 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.645 ' O ' HG13 ' A' ' 165' ' ' VAL . 29.6 mt-30 -72.06 -38.32 69.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.033 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.723 HD12 HD21 ' A' ' 112' ' ' LEU . 36.0 mm -74.01 -34.48 39.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.2 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.17 -37.47 69.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.099 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 14.0 p -74.36 -39.68 48.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.456 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.645 HG13 ' O ' ' A' ' 161' ' ' GLN . 36.0 m -69.5 -45.59 78.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.418 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.477 ' N ' HG23 ' A' ' 165' ' ' VAL . 5.6 ptm -62.01 -45.93 91.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.928 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.13 -51.11 41.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.931 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -74.02 -2.53 24.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.959 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.93 0.395 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.642 HG21 HD21 ' A' ' 167' ' ' LEU . 21.5 t -126.28 152.65 33.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.97 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 1.4 m -103.25 146.91 27.73 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.682 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.57 HD21 ' HA ' ' A' ' 65' ' ' THR . 2.3 pp -158.21 139.77 13.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.531 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.588 HG23 ' O ' ' A' ' 61' ' ' LEU . 58.3 m -113.12 129.92 56.35 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.31 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.616 HG12 HD11 ' A' ' 68' ' ' ILE . 2.0 pt -112.13 163.98 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.223 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.493 ' NH2' ' OE2' ' A' ' 143' ' ' GLU . 0.9 OUTLIER -133.96 123.06 23.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.834 179.765 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.472 HD21 ' CZ ' ' A' ' 72' ' ' PHE . 67.5 mt -114.58 119.87 38.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.201 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.856 HD12 ' O ' ' A' ' 101' ' ' ARG . 0.2 OUTLIER -115.8 128.1 55.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.723 179.699 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.79 ' HB2' HG12 ' A' ' 25' ' ' VAL . 0.9 OUTLIER -142.11 162.38 35.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.835 0.35 . . . . 0.0 111.208 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.811 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.9 OUTLIER -70.2 163.45 26.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.888 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.415 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -49.19 -35.83 20.56 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.659 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -51.4 10.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.922 0.361 . . . . 0.0 111.958 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.4 ' HB3' ' HB3' ' A' ' 20' ' ' MET . 0.3 OUTLIER -61.93 -33.56 74.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.818 0.342 . . . . 0.0 110.991 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.811 HG13 ' O ' ' A' ' 21' ' ' HIS . 15.4 m -71.54 -39.96 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.083 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.01 -35.16 91.02 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.635 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 p -75.45 -33.55 60.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.668 0.271 . . . . 0.0 111.388 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.812 HD11 HG22 ' A' ' 75' ' ' ILE . 1.7 tp -79.21 -47.09 22.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.451 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.733 ' HA ' HG13 ' A' ' 36' ' ' VAL . 8.1 mm -57.25 -50.25 77.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.872 0.368 . . . . 0.0 110.204 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.41 ' HA3' ' HB3' ' A' ' 35' ' ' SER . . . 97.9 150.32 26.18 Favored Glycine 0 N--CA 1.437 -1.278 0 CA-C-O 121.747 0.637 . . . . 0.0 113.012 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.401 ' O ' ' CD ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -62.42 145.9 52.84 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.528 -0.836 . . . . 0.0 111.321 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.465 ' HG2' ' HB2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 51.36 18.89 0.69 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.461 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.491 ' O ' HG23 ' A' ' 36' ' ' VAL . . . 53.69 11.32 1.91 Allowed Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.936 -0.65 . . . . 0.0 114.26 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.465 ' HB2' ' HG2' ' A' ' 32' ' ' LYS . 4.0 tp10 -74.69 -27.2 60.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.536 0.668 . . . . 0.0 109.735 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.41 ' HB3' ' HA3' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -75.39 -39.84 58.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.514 179.434 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.733 HG13 ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.28 -26.34 35.91 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.588 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -70.66 -36.73 73.52 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -62.61 -34.73 77.62 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.936 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -43.05 81.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.711 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 44.9 mtp85 -58.1 -51.15 70.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.846 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -63.86 -38.02 89.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.037 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.84 -35.7 62.4 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.507 ' CB ' ' HB2' ' A' ' 71' ' ' ALA . 53.2 p -88.34 -55.79 3.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.937 0.399 . . . . 0.0 110.879 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.14 4.76 62.74 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.193 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.49 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -110.77 127.31 55.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.077 0.438 . . . . 0.0 111.317 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.789 ' HB2' ' HB3' ' A' ' 62' ' ' ALA . 1.8 mpt_? -27.75 104.3 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.275 0.63 . . . . 0.0 112.551 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.8 mt -107.45 100.58 11.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.832 0.348 . . . . 0.0 110.935 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.39 169.94 8.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.256 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.567 HG21 ' HD2' ' A' ' 57' ' ' ARG . 13.9 mt -126.46 152.13 33.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.144 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.451 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . 33.1 t -92.12 -161.4 0.82 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.738 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 . . . . . 0 N--CA 1.463 0.189 0 CA-C-O 121.2 0.524 . . . . 0.0 112.144 -179.046 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.224 -0.246 0 CA-C-O 120.624 0.25 . . . . 0.0 110.659 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.567 ' HD2' HG21 ' A' ' 49' ' ' ILE . 3.0 mmt180 -144.5 136.55 26.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.874 0.368 . . . . 0.0 110.992 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.845 HD12 HD23 ' A' ' 19' ' ' LEU . 4.5 mm -115.64 106.8 21.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.555 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.1 mt -85.98 94.05 4.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.882 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.0 m -80.04 101.87 8.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.138 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.588 ' O ' HG23 ' A' ' 15' ' ' THR . 0.1 OUTLIER -91.28 144.79 25.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.908 179.322 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.789 ' HB3' ' HB2' ' A' ' 46' ' ' ARG . . . -143.76 124.71 14.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.777 0.323 . . . . 0.0 111.051 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.57 164.0 13.28 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.159 -1.02 . . . . 0.0 113.104 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.563 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 78.6 Cg_exo -41.48 160.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 123.555 2.836 . . . . 0.0 113.798 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.57 ' HA ' HD21 ' A' ' 14' ' ' LEU . 13.6 t -57.89 -35.72 71.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.135 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.37 -52.48 46.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.917 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.35 -43.32 83.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.316 0.579 . . . . 0.0 110.429 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.616 HD11 HG12 ' A' ' 16' ' ' ILE . 0.5 OUTLIER -66.53 -39.4 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.842 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.85 -36.51 67.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.763 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.08 -38.94 63.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.691 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.507 ' HB2' ' CB ' ' A' ' 43' ' ' SER . . . -63.65 -48.25 77.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.149 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.575 ' CE2' HD13 ' A' ' 16' ' ' ILE . 1.2 m-85 -64.04 -43.06 96.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.473 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -68.78 -29.26 67.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.306 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.6 tpt -77.29 -48.3 17.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.688 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.812 HG22 HD11 ' A' ' 28' ' ' ILE . 2.2 pp -59.81 -42.98 90.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.252 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.597 HG23 ' CD1' ' A' ' 75' ' ' ILE . 18.6 pt -68.76 -36.01 72.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.852 0.358 . . . . 0.0 111.017 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -62.35 -47.63 83.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.024 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.486 ' HG3' ' N ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -62.39 -35.22 78.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.967 0.413 . . . . 0.0 110.149 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.486 ' N ' ' HG3' ' A' ' 78' ' ' LYS . 16.2 tp -77.53 -26.18 50.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.069 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -76.95 -35.71 57.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.597 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -72.07 -38.09 69.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.778 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.863 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 N--CA 1.465 -0.164 0 CA-C-O 120.83 0.263 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.751 ' HB ' HD11 ' A' ' 155' ' ' ILE . 21.2 t -140.32 113.19 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.654 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.588 ' CG2' HG22 ' A' ' 147' ' ' THR . 0.7 OUTLIER -103.22 140.21 37.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.271 -179.556 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.623 HD12 HG21 ' A' ' 155' ' ' ILE . 1.1 tt -139.83 117.76 11.76 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.856 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -105.22 112.7 25.91 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.788 -178.266 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.538 HD23 ' N ' ' A' ' 103' ' ' VAL . 0.8 OUTLIER -106.37 147.53 29.13 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.741 179.834 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.836 ' CG2' HD11 ' A' ' 19' ' ' LEU . 11.1 t -100.6 138.04 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.273 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.445 HG23 ' SG ' ' A' ' 109' ' ' CYS . 2.6 m -144.87 157.54 54.4 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.001 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -65.89 157.63 58.15 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.596 2.197 . . . . 0.0 112.143 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 142' ' ' THR . . . -68.86 -34.84 76.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.391 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.1 m -70.55 -30.3 66.99 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -70.94 -46.54 62.25 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.628 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.445 ' SG ' HG23 ' A' ' 104' ' ' VAL . 21.6 m -61.8 -40.03 93.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.389 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.75 -50.12 71.14 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.21 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.1 m -67.59 -38.7 84.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 0.0 110.724 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.8 mt -57.3 -27.77 62.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.476 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.568 HG22 ' HA2' ' A' ' 117' ' ' GLY . 12.6 mt -83.14 -34.28 11.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.786 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.63 178.55 6.27 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.558 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -67.49 132.53 47.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.818 0.342 . . . . 0.0 110.882 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.73 16.77 59.52 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.633 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.568 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 63.1 15.74 56.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.871 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 95.9 m -52.88 -43.64 66.29 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.869 0.366 . . . . 0.0 111.401 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -63.68 -58.56 6.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.129 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.499 ' HA ' HD12 ' A' ' 123' ' ' ILE . 1.6 tt -54.22 -31.44 22.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.315 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.16 -41.93 89.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.856 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -73.23 -40.2 64.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.082 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.499 HD12 ' HA ' ' A' ' 120' ' ' ILE . 50.2 mt -58.61 -53.42 47.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.297 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.794 ' HG3' HG22 ' A' ' 131' ' ' VAL . 0.2 OUTLIER -67.27 -40.42 86.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.969 0.414 . . . . 0.0 111.077 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -54.54 -48.36 72.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.881 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.48 -39.02 17.94 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.466 HG21 HD11 ' A' ' 148' ' ' ILE . 18.2 m -49.37 -26.38 3.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.845 0.355 . . . . 0.0 110.333 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.42 -21.85 4.17 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.333 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.713 ' HB1' ' O ' ' A' ' 149' ' ' ALA . . . -108.27 170.89 7.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.949 0.374 . . . . 0.0 111.149 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.7 130.45 44.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.705 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.794 HG22 ' HG3' ' A' ' 124' ' ' ARG . 36.0 m -99.26 140.52 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.164 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.786 ' O ' HG23 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -109.11 158.39 17.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.197 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.5 t -137.53 134.99 46.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.181 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.401 ' HB3' ' H ' ' A' ' 145' ' ' ALA . . . . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.077 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.792 0.33 . . . . 0.0 110.815 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.669 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 13.2 t -118.57 -46.56 2.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.887 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.493 ' OE2' ' NH2' ' A' ' 17' ' ' ARG . 3.0 mt-10 -104.07 137.74 41.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.7 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -109.97 140.84 43.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.93 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.401 ' H ' ' HB3' ' A' ' 134' ' ' ALA . . . -96.42 153.46 17.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.17 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.786 HG23 ' O ' ' A' ' 132' ' ' GLN . 74.9 mt -125.18 140.05 49.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.667 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.588 HG22 ' CG2' ' A' ' 99' ' ' THR . 0.2 OUTLIER -119.07 114.93 23.26 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.409 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.52 HD13 ' HB2' ' A' ' 158' ' ' CYS . 0.6 OUTLIER -104.1 121.47 55.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.109 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.713 ' O ' ' HB1' ' A' ' 129' ' ' ALA . . . -118.39 134.71 54.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.13 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 162.13 -151.91 22.09 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.532 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.814 ' O ' HD12 ' A' ' 155' ' ' ILE . 2.9 pt -87.0 162.06 45.07 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.57 0.224 . . . . 0.0 110.962 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 151' ' ' ILE . 72.7 Cg_exo -49.62 -32.84 29.3 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.517 2.144 . . . . 0.0 112.218 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.517 ' HB2' HD12 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -71.91 -34.65 69.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.757 179.662 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.617 ' HB2' ' HB2' ' A' ' 129' ' ' ALA . 10.6 p -67.92 -50.29 56.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.039 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.814 HD12 ' O ' ' A' ' 151' ' ' ILE . 2.7 mp -59.33 -51.52 71.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.157 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -55.84 -30.7 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.135 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -69.26 -48.0 63.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.834 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' CYS . . . . . 0.52 ' HB2' HD13 ' A' ' 148' ' ' ILE . 17.7 t -61.58 -44.06 97.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.96 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 155' ' ' ILE . 59.9 t -59.49 -38.95 77.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.956 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -32.86 74.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.711 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.779 ' O ' HG23 ' A' ' 165' ' ' VAL . 2.0 tt0 -71.71 -45.67 61.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 30.5 mm -69.92 -34.41 59.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.044 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 47.7 t -65.42 -52.4 53.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.117 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.471 HG13 ' N ' ' A' ' 165' ' ' VAL . 12.3 p -61.49 -45.14 99.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.225 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.779 HG23 ' O ' ' A' ' 161' ' ' GLN . 54.8 t -63.82 -40.28 88.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.914 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 32.4 mtt -56.98 -45.63 82.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.808 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.642 HD21 HG21 ' A' ' 12' ' ' VAL . 7.8 tt -65.11 -45.19 86.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.804 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.96 -2.72 25.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.902 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 165' ' ' VAL . 39.1 p . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.887 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.717 0.294 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.827 HG21 HD11 ' A' ' 167' ' ' LEU . 11.5 t -115.09 154.98 16.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.812 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.767 ' C ' HD22 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -109.21 131.36 55.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.693 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.767 HD22 ' C ' ' A' ' 13' ' ' THR . 4.3 mm? -130.44 158.49 39.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.148 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.2 m -141.97 133.59 26.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.749 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.629 HG22 HD11 ' A' ' 68' ' ' ILE . 3.8 tt -137.36 148.03 26.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.354 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.487 ' NH2' ' OE1' ' A' ' 143' ' ' GLU . 0.0 OUTLIER -129.35 131.1 46.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.709 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.411 ' O ' HG23 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -121.58 139.22 53.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.103 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.732 HD23 HG13 ' A' ' 103' ' ' VAL . 2.6 pp -108.72 136.02 48.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.758 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.11 162.4 33.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.827 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.73 ' O ' HG12 ' A' ' 25' ' ' VAL . 3.8 m-70 -67.58 169.63 8.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.536 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.65 -44.77 96.59 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.103 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.5 -38.51 40.58 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.69 -50.74 56.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.925 0.393 . . . . 0.0 110.655 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.747 HG23 HD11 ' A' ' 59' ' ' ILE . 9.8 p -63.44 -35.02 70.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.841 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.16 -34.92 90.63 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.32 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.3 m -75.38 -28.2 59.39 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.802 0.334 . . . . 0.0 110.68 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.431 ' N ' HD13 ' A' ' 28' ' ' ILE . 3.6 mm -78.84 -45.61 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.08 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.754 ' HA ' HG13 ' A' ' 36' ' ' VAL . 13.0 mt -60.59 -42.56 92.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.385 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.65 150.34 16.68 Favored Glycine 0 N--CA 1.435 -1.427 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.611 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.567 ' HG2' ' HG3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -58.15 145.75 35.88 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.593 -0.804 . . . . 0.0 111.588 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.571 ' HE3' ' HB3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 45.98 27.93 0.56 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.248 -178.895 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.436 ' O ' HG23 ' A' ' 36' ' ' VAL . . . 47.29 17.92 0.45 Allowed Glycine 0 CA--C 1.522 0.507 0 N-CA-C 114.784 0.673 . . . . 0.0 114.784 178.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.571 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 2.7 tm-20 -75.27 -25.46 58.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.752 0.776 . . . . 0.0 109.856 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -41.87 59.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.415 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.754 HG13 ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.24 -26.21 35.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 178.852 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.6 -36.75 70.94 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -62.94 -35.82 81.38 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.852 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.401 ' HA ' ' CE ' ' A' ' 39' ' ' MET . 0.0 OUTLIER -65.96 -43.46 87.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.392 179.603 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -56.63 -51.05 70.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.131 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -61.55 -37.5 84.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.778 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -74.62 -36.48 62.94 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.897 ' CB ' ' HB2' ' A' ' 71' ' ' ALA . 94.5 p -92.57 -55.86 3.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.862 0.363 . . . . 0.0 111.145 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.33 0.78 50.62 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.041 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.491 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . . . -110.76 128.16 55.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.877 0.338 . . . . 0.0 111.654 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 2.6 ttt180 -27.44 141.07 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.061 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.416 HG12 HD12 ' A' ' 61' ' ' LEU . 13.6 mt -142.32 100.44 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.76 0.314 . . . . 0.0 111.301 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -116.09 173.46 6.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.724 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.824 HG21 ' NE ' ' A' ' 57' ' ' ARG . 4.8 mt -126.5 151.97 33.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.121 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 94.3 p -83.74 -171.28 3.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.199 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.382 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 120.894 0.378 . . . . 0.0 110.782 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.824 ' NE ' HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -145.87 135.37 23.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.54 179.266 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.411 HG23 ' O ' ' A' ' 18' ' ' LEU . 26.1 mt -98.44 115.96 40.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.804 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.747 HD11 HG23 ' A' ' 25' ' ' VAL . 3.2 mt -86.62 101.21 10.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.285 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.405 ' CG2' ' HD3' ' A' ' 17' ' ' ARG . 89.2 m -90.01 138.25 31.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.94 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.675 HD22 HG13 ' A' ' 68' ' ' ILE . 7.3 tt -131.51 132.9 44.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.264 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.463 ' O ' ' HB1' ' A' ' 45' ' ' ALA . . . -128.68 133.85 48.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.742 0.306 . . . . 0.0 111.12 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.28 164.46 13.72 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.754 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.424 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 82.4 Cg_exo -39.58 162.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.147 2.565 . . . . 0.0 113.29 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.514 ' O ' HG22 ' A' ' 68' ' ' ILE . 73.5 m -59.69 -35.66 74.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.29 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -64.2 -51.96 61.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.782 0.325 . . . . 0.0 111.319 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.491 ' CB ' ' HB2' ' A' ' 45' ' ' ALA . . . -57.04 -37.98 72.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.351 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.675 HG13 HD22 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -66.16 -39.48 84.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.538 -179.231 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.26 -49.3 74.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.366 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.67 -47.23 82.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.117 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.897 ' HB2' ' CB ' ' A' ' 43' ' ' SER . . . -58.04 -56.3 23.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.316 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.412 ' HA ' HD12 ' A' ' 75' ' ' ILE . 0.4 OUTLIER -53.35 -42.52 66.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.339 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.27 -48.05 81.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.48 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 20.7 mmm -70.45 -33.88 71.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.178 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 72' ' ' PHE . 17.6 mt -68.09 -38.26 79.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.473 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.415 HG13 ' N ' ' A' ' 77' ' ' ASP . 36.6 pt -71.47 -38.44 68.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.071 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.415 ' N ' HG13 ' A' ' 76' ' ' ILE . 0.7 OUTLIER -63.39 -47.41 82.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.659 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.31 -36.39 83.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.947 0.403 . . . . 0.0 110.058 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.5 tp -77.58 -23.08 50.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.47 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -76.4 -49.31 17.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.99 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -72.27 -32.32 66.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.862 0.363 . . . . 0.0 111.067 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.0 t70 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.824 -179.438 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.837 0.265 . . . . 0.0 112.124 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.54 HG21 ' HG3' ' A' ' 152' ' ' PRO . 24.9 t -140.81 115.45 6.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.813 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 50.2 p -103.08 142.32 34.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.899 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.446 HD23 HD21 ' A' ' 102' ' ' LEU . 0.5 OUTLIER -139.96 117.55 11.52 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 178.656 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.534 ' HD2' HG23 ' A' ' 147' ' ' THR . 0.1 OUTLIER -103.67 112.4 25.32 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.36 -178.579 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.446 HD21 HD23 ' A' ' 100' ' ' LEU . 4.5 mm? -102.14 143.17 32.3 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.928 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.732 HG13 HD23 ' A' ' 19' ' ' LEU . 31.2 m -107.82 142.93 19.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.07 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.556 HG13 ' O ' ' A' ' 103' ' ' VAL . 4.4 m -159.53 157.16 26.39 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.33 172.08 9.48 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.559 2.173 . . . . 0.0 112.308 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.15 -34.64 78.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.517 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.21 -30.48 68.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.151 0.501 . . . . 0.0 109.848 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.41 ' CB ' ' HB ' ' A' ' 104' ' ' VAL . 2.2 mm100 -72.64 -49.78 29.57 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.724 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.5 m -62.94 -37.98 89.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.365 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.25 -43.25 99.62 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.249 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 83.6 p -74.49 -38.48 62.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.741 0.305 . . . . 0.0 110.655 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.7 mt -57.25 -27.95 62.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.563 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.606 HG22 ' HA2' ' A' ' 117' ' ' GLY . 10.4 mt -85.6 -36.74 11.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.847 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.59 -178.98 30.88 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.461 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.0 ttmm -66.99 123.68 20.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 0.0 111.204 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.6 15.29 57.21 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.012 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.606 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 73.58 5.1 67.28 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.955 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 31.9 p -52.92 -35.64 58.57 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.848 0.356 . . . . 0.0 111.631 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -65.53 -65.29 0.69 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.155 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.877 HD11 HG21 ' A' ' 131' ' ' VAL . 0.5 OUTLIER -54.75 -30.05 22.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.297 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -50.4 71.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.812 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -61.22 -40.55 94.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.203 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.775 HG23 ' OE1' ' A' ' 161' ' ' GLN . 44.4 mm -57.09 -53.94 36.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.807 0.337 . . . . 0.0 110.907 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.62 -32.91 74.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.822 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -57.14 -52.65 64.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.569 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.02 -46.99 8.43 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.583 HG21 ' SG ' ' A' ' 158' ' ' CYS . 92.3 m -47.39 -25.92 1.17 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.944 0.402 . . . . 0.0 110.485 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.11 -7.54 21.9 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.355 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -108.3 141.39 40.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.996 0.398 . . . . 0.0 111.209 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -79.14 141.08 37.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.877 HG21 HD11 ' A' ' 120' ' ' ILE . 34.8 m -107.39 143.17 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.157 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.805 ' O ' HG23 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -113.84 158.41 21.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.278 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.8 m -137.41 128.2 39.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.08 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.116 -179.955 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.974 0.416 . . . . 0.0 111.07 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.546 HG23 ' HG3' ' A' ' 143' ' ' GLU . 15.0 t -121.41 -40.49 2.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.567 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.546 ' HG3' HG23 ' A' ' 142' ' ' THR . 9.9 mt-10 -107.27 145.76 32.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.416 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -109.86 161.48 15.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.904 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -118.51 155.0 31.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.329 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.805 HG23 ' O ' ' A' ' 132' ' ' GLN . 69.7 mt -129.66 141.01 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.401 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 132' ' ' GLN . 0.4 OUTLIER -116.41 117.42 29.9 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.432 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.834 HD12 HG12 ' A' ' 131' ' ' VAL . 8.1 mm -104.08 120.54 54.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.793 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.31 137.22 53.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.128 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 160.77 -151.68 22.19 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.593 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.529 ' CG2' ' HD2' ' A' ' 152' ' ' PRO . 15.4 mt -85.48 144.52 40.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.54 ' HG3' HG21 ' A' ' 98' ' ' VAL . 72.3 Cg_exo -48.96 -32.51 23.35 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.98 1.787 . . . . 0.0 111.552 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -72.08 -34.83 68.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.62 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 57.9 m -70.94 -39.31 72.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.61 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.406 ' O ' HG23 ' A' ' 159' ' ' VAL . 40.5 mm -64.53 -50.06 77.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.909 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.9 mt -57.19 -38.39 61.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.7 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -66.24 -38.8 88.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.497 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' CYS . . . . . 0.583 ' SG ' HG21 ' A' ' 127' ' ' THR . 0.9 OUTLIER -61.57 -45.63 93.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.591 179.669 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.472 ' HA ' HD12 ' A' ' 162' ' ' ILE . 32.9 t -59.97 -36.09 64.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.796 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.437 ' O ' HG12 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -64.41 -32.98 74.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.62 179.771 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.775 ' OE1' HG23 ' A' ' 123' ' ' ILE . 47.4 mt-30 -72.19 -31.82 66.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.887 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 159' ' ' VAL . 29.8 mt -74.01 -36.34 44.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.077 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 1.3 m -74.01 -43.29 58.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.939 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.496 HG13 ' N ' ' A' ' 165' ' ' VAL . 11.2 p -66.29 -45.76 88.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.32 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 161' ' ' GLN . 11.8 p -61.76 -42.54 94.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.021 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.437 ' N ' HG13 ' A' ' 165' ' ' VAL . 0.3 OUTLIER -59.17 -40.03 84.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.796 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.827 HD11 HG21 ' A' ' 12' ' ' VAL . 1.2 tt -72.64 -43.99 62.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.78 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -73.97 -2.64 24.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.034 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 165' ' ' VAL . 32.5 p . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.895 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.5 m120 . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.824 0.345 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.82 ' CG1' HD13 ' A' ' 167' ' ' LEU . 6.8 p -107.34 159.87 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.029 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.524 ' N ' HG22 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -103.65 140.65 37.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.804 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.441 ' HA ' HD23 ' A' ' 14' ' ' LEU . 3.5 mt -131.24 171.32 13.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.027 0.441 . . . . 0.0 111.297 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.623 HG23 ' HB2' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -142.63 117.91 10.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.615 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.823 HG22 HD11 ' A' ' 68' ' ' ILE . 15.5 tt -121.51 156.66 25.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.908 0.385 . . . . 0.0 111.283 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.637 ' HG3' HG23 ' A' ' 60' ' ' THR . 1.9 mtp85 -134.46 111.92 10.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.643 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.543 HD13 HD12 ' A' ' 102' ' ' LEU . 0.6 OUTLIER -89.38 145.3 25.43 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.749 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.0 tt -122.51 121.1 35.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.544 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.409 ' CB ' ' HB ' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -148.07 163.19 37.67 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.374 0.607 . . . . 0.0 112.121 -179.515 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.93 ' O ' HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -76.48 134.72 39.44 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.542 179.545 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -45.7 -25.47 1.5 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 121.024 -0.608 . . . . 0.0 113.556 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.38 -52.46 9.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.942 0.371 . . . . 0.0 111.609 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -71.09 -51.0 27.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.993 0.425 . . . . 0.0 110.402 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.93 HG12 ' O ' ' A' ' 21' ' ' HIS . 10.0 p -62.8 -33.9 62.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.296 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.52 -37.75 94.66 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.641 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.3 t -68.38 -28.42 67.1 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.421 ' N ' HD13 ' A' ' 28' ' ' ILE . 4.6 mm -80.59 -32.55 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.567 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.617 HD11 HG22 ' A' ' 25' ' ' VAL . 3.2 mm -60.59 -45.22 97.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.902 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.46 ' HA3' ' CB ' ' A' ' 35' ' ' SER . . . 94.69 150.57 27.23 Favored Glycine 0 N--CA 1.436 -1.347 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.812 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.419 ' C ' ' HD3' ' A' ' 32' ' ' LYS . 8.0 tttm -64.4 146.31 54.68 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.571 -0.814 . . . . 0.0 111.659 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.419 ' HD3' ' C ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER 63.01 6.74 2.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.847 179.635 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.529 ' O ' HG23 ' A' ' 36' ' ' VAL . . . 59.9 7.07 5.94 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 119.822 -1.18 . . . . 0.0 111.795 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.402 ' HB2' ' CE ' ' A' ' 32' ' ' LYS . 1.5 tm-20 -71.8 -28.21 63.45 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.025 0.44 . . . . 0.0 109.878 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.46 ' CB ' ' HA3' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -75.03 -36.34 61.9 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.265 179.496 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -67.32 -26.56 36.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.525 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -69.88 -36.81 75.76 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -65.04 -34.78 79.25 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.844 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.409 ' HE3' ' HA ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -64.16 -46.44 84.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.616 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.479 ' HA ' HD12 ' A' ' 47' ' ' ILE . 53.5 mtt180 -58.26 -51.18 70.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.289 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.02 -38.16 90.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.203 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -74.85 -36.06 62.35 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.713 ' HB2' ' HB2' ' A' ' 71' ' ' ALA . 12.1 t -77.9 -47.23 19.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.898 0.38 . . . . 0.0 111.116 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.89 -8.42 76.11 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.398 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.665 ' HB3' HD21 ' A' ' 61' ' ' LEU . . . -110.79 128.75 55.88 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.493 0.187 . . . . 0.0 111.108 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 4.5 mtt-85 -26.99 139.37 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.058 0.543 . . . . 0.0 112.038 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 40' ' ' ARG . 11.1 mt -142.13 116.31 4.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.714 0.292 . . . . 0.0 111.317 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -133.68 122.07 22.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.059 0.456 . . . . 0.0 110.907 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.887 ' HB ' HD13 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -108.15 130.78 60.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.902 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.5 t 168.6 169.8 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.067 0.46 . . . . 0.0 111.383 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.4 ' HB3' HD12 ' A' ' 58' ' ' ILE . 3.9 tt0 . . . . . 0 C--N 1.333 -0.141 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.894 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 . . . . . 0 N--CA 1.465 0.301 0 CA-C-O 120.304 0.097 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.822 ' CB ' HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -133.89 130.76 38.27 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.034 0.445 . . . . 0.0 111.605 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 47.6 mt -129.46 109.93 19.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.491 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.887 HD13 ' HB ' ' A' ' 49' ' ' ILE . 7.1 mm -85.96 94.99 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.951 0.405 . . . . 0.0 111.537 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.637 HG23 ' HG3' ' A' ' 17' ' ' ARG . 50.0 m -88.82 105.85 17.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.841 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.753 HD22 HG13 ' A' ' 68' ' ' ILE . 9.1 tt -107.85 136.71 47.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.621 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.623 ' HB2' HG23 ' A' ' 15' ' ' THR . . . -133.51 133.74 42.58 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.541 0.21 . . . . 0.0 110.864 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.16 164.92 14.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.894 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 92.6 Cg_exo -41.35 162.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.04 2.494 . . . . 0.0 113.161 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.469 ' O ' HG22 ' A' ' 68' ' ' ILE . 4.1 t -60.19 -35.56 75.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.206 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -63.88 -51.81 62.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.228 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.458 ' CB ' ' HB2' ' A' ' 45' ' ' ALA . . . -57.26 -44.67 84.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.0 0.428 . . . . 0.0 111.003 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.823 HD11 HG22 ' A' ' 16' ' ' ILE . 1.5 tt -66.43 -39.42 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.666 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.27 -48.38 76.7 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.108 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.88 -48.02 78.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.899 0.38 . . . . 0.0 110.832 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.713 ' HB2' ' HB2' ' A' ' 43' ' ' SER . . . -57.72 -40.64 80.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.423 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.477 ' O ' HG23 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -61.47 -48.29 81.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.218 -179.663 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.406 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -68.72 -29.28 67.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.94 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.8 mmm -77.46 -48.43 17.15 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 72' ' ' PHE . 1.2 pp -61.34 -41.43 89.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.311 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.477 HG23 ' O ' ' A' ' 72' ' ' PHE . 26.0 pt -67.8 -38.91 81.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.808 0.337 . . . . 0.0 110.907 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.22 -32.16 73.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.399 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -40.42 86.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.174 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.7 tp -77.49 -25.62 50.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.492 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -77.06 -41.48 42.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -72.11 -36.64 69.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.904 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 179.948 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.432 ' HG2' ' CA ' ' A' ' 150' ' ' GLY . 35.9 Cg_endo . . . . . 0 CA--C 1.527 0.163 0 N-CA-C 112.642 0.208 . . . . 0.0 112.642 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.6 t -137.25 111.67 9.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.913 0.387 . . . . 0.0 111.022 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.641 HG22 ' HB2' ' A' ' 149' ' ' ALA . 38.8 p -103.24 138.36 40.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.982 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.94 117.79 11.72 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.409 ' HB3' HG23 ' A' ' 147' ' ' THR . 4.1 ptp180 -102.26 112.5 25.22 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.367 -178.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.543 HD12 HD13 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -110.63 145.53 37.74 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.032 -179.646 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.419 ' CG1' ' HB3' ' A' ' 17' ' ' ARG . 11.9 p -95.98 131.47 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.72 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.473 HG23 ' HD2' ' A' ' 105' ' ' PRO . 7.5 p -130.22 145.78 58.79 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.171 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.473 ' HD2' HG23 ' A' ' 104' ' ' VAL . 22.5 Cg_exo -65.62 163.4 30.34 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.537 2.158 . . . . 0.0 111.987 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 142' ' ' THR . . . -69.25 -39.69 78.31 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 25.8 m -69.72 -30.48 68.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.289 0.566 . . . . 0.0 109.626 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.471 ' HB3' HG22 ' A' ' 104' ' ' VAL . 0.9 OUTLIER -74.58 -49.48 21.61 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.53 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.478 ' O ' HD12 ' A' ' 113' ' ' ILE . 1.8 t -65.47 -37.42 86.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.935 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.38 -51.46 57.56 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.041 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.3 m -72.88 -34.87 66.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.806 0.336 . . . . 0.0 110.438 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.516 ' CD2' HD12 ' A' ' 162' ' ' ILE . 9.7 mt -60.88 -29.07 69.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.129 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.532 HG22 ' HA2' ' A' ' 117' ' ' GLY . 12.4 mt -80.41 -37.95 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.623 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.76 -179.26 44.53 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.458 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.05 122.23 17.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.867 0.365 . . . . 0.0 111.012 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.08 11.91 56.33 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.927 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.532 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 72.15 6.17 64.08 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.02 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -53.16 -39.98 63.99 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.691 ' HD2' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -63.23 -65.33 0.7 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.762 -179.234 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.813 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.9 OUTLIER -58.03 -37.65 62.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.634 -179.356 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.3 -44.75 80.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.332 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -73.12 -39.29 65.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.313 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.813 HD12 ' HA ' ' A' ' 120' ' ' ILE . 24.3 mt -58.13 -53.88 39.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.264 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.0 ptt85 -67.97 -35.02 77.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.879 0.371 . . . . 0.0 111.071 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -54.92 -50.63 68.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.177 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 53.3 p -83.86 -36.1 23.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.374 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.515 HG21 ' SG ' ' A' ' 158' ' ' CYS . 18.2 m -50.28 -26.13 4.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.807 0.337 . . . . 0.0 110.256 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 88.84 -21.75 25.27 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.981 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -102.49 155.82 18.01 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.823 0.344 . . . . 0.0 111.152 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -105.17 132.85 50.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.023 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.523 HG12 HG13 ' A' ' 148' ' ' ILE . 5.6 m -99.18 138.78 22.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.895 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.697 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 0.1 OUTLIER -116.94 116.67 27.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.107 0.479 . . . . 0.0 112.04 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.9 p -100.67 140.28 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.543 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.928 179.699 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.0 p . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.796 0.331 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.471 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 1.5 m -117.73 -46.22 2.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.82 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.498 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 43.9 mt-10 -108.54 138.01 45.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.762 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -109.9 148.84 30.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.833 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -105.98 128.82 54.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.218 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.697 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 28.5 mm -108.6 127.25 65.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.866 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' A' ' 132' ' ' GLN . 0.2 OUTLIER -108.06 114.67 28.76 Favored 'General case' 0 N--CA 1.46 0.07 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.711 179.76 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.523 HG13 HG12 ' A' ' 131' ' ' VAL . 3.2 mp -104.1 117.53 49.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.409 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.641 ' HB2' HG22 ' A' ' 99' ' ' THR . . . -118.91 126.07 50.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.856 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.432 ' CA ' ' HG2' ' A' ' 97' ' ' PRO . . . 171.26 -153.04 19.61 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.693 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.532 HG23 ' HD2' ' A' ' 152' ' ' PRO . 4.4 mt -86.98 143.3 34.86 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 110.569 -0.16 . . . . 0.0 110.569 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.876 ' HA ' HD12 ' A' ' 155' ' ' ILE . 6.0 Cg_endo -48.63 -34.18 26.18 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.258 1.972 . . . . 0.0 111.609 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.436 ' O ' HG22 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -72.09 -34.65 68.82 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.653 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 19.2 m -68.84 -44.48 73.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.648 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.876 HD12 ' HA ' ' A' ' 152' ' ' PRO . 4.2 mt -60.64 -52.49 60.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.806 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 153' ' ' GLN . 7.8 tp -56.02 -31.06 30.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.861 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -70.08 -37.07 75.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.706 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' CYS . . . . . 0.515 ' SG ' HG21 ' A' ' 127' ' ' THR . 0.5 OUTLIER -64.01 -52.91 57.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.643 179.724 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 34.3 t -59.37 -31.97 47.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.773 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 7.4 ttmt -67.46 -34.45 77.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.748 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.79 ' O ' HG23 ' A' ' 165' ' ' VAL . 0.3 OUTLIER -70.45 -35.1 73.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.712 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.516 HD12 ' CD2' ' A' ' 112' ' ' LEU . 34.2 mm -73.4 -34.42 43.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.951 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 4.2 t -73.91 -46.39 44.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.043 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.24 -41.38 86.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.126 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' ' 161' ' ' GLN . 59.5 t -69.28 -47.54 73.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.797 0.332 . . . . 0.0 110.859 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -32.77 65.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.82 HD13 ' CG1' ' A' ' 12' ' ' VAL . 62.3 tp -71.91 -47.35 53.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.762 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -73.86 -2.72 24.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.081 0.467 . . . . 0.0 112.027 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 72.6 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.803 -179.994 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.761 0.315 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 64' ' ' PRO . 5.6 t -105.62 146.87 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.772 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 7.1 m -103.64 151.38 23.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.158 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' A' ' 14' ' ' LEU . 4.6 mt -138.32 176.21 8.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.984 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.41 125.32 16.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.901 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 1.043 HG22 HD11 ' A' ' 68' ' ' ILE . 7.4 tt -140.82 133.52 31.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.318 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.496 ' NH2' ' OE1' ' A' ' 143' ' ' GLU . 16.6 mtt180 -112.58 139.06 48.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.703 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.419 HD23 HD11 ' A' ' 100' ' ' LEU . 3.5 mp -113.74 138.82 49.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.938 0.399 . . . . 0.0 111.091 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.05 114.22 23.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.703 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.87 161.92 26.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.072 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.579 ' O ' HG12 ' A' ' 25' ' ' VAL . 27.6 m170 -74.69 175.0 8.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.899 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.57 -40.77 99.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.666 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.48 -44.23 25.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.829 0.347 . . . . 0.0 111.123 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.42 ' O ' HG23 ' A' ' 28' ' ' ILE . 42.4 mt-10 -61.92 -43.98 97.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.081 0.467 . . . . 0.0 110.281 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.758 HG21 ' CB ' ' A' ' 57' ' ' ARG . 9.8 p -68.66 -30.34 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.561 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.28 -39.32 97.56 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.538 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.87 -36.2 59.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.732 0.301 . . . . 0.0 111.474 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 25' ' ' VAL . 2.0 pp -78.5 -32.47 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.683 ' HA ' HG13 ' A' ' 36' ' ' VAL . 7.6 mm -70.62 -52.88 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.464 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.426 ' HA3' ' CB ' ' A' ' 35' ' ' SER . . . 99.69 150.33 25.07 Favored Glycine 0 N--CA 1.437 -1.297 0 CA-C-O 121.791 0.662 . . . . 0.0 112.967 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.49 ' C ' ' HD3' ' A' ' 32' ' ' LYS . 6.6 mttt -66.09 146.39 54.72 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.398 -0.901 . . . . 0.0 111.348 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.529 ' HE3' ' HB2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 61.59 6.9 1.65 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.583 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.52 ' O ' HG23 ' A' ' 36' ' ' VAL . . . 59.16 8.22 6.08 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.304 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.529 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 3.7 mt-10 -75.58 -30.56 59.68 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 122.402 -0.47 . . . . 0.0 109.915 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.526 ' HA ' ' HG2' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -67.91 -42.67 80.75 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.26 179.462 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.683 HG13 ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -66.86 -26.16 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.548 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.18 -36.63 83.58 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.526 ' HG2' ' HA ' ' A' ' 35' ' ' SER . 41.5 mmtt -59.96 -43.3 95.13 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.579 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.42 -47.14 82.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.914 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.25 -51.05 71.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.226 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -64.35 -37.79 88.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.98 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -74.59 -36.61 63.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.872 ' HB2' ' HB2' ' A' ' 71' ' ' ALA . 46.9 t -90.55 -55.79 3.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.946 0.403 . . . . 0.0 110.753 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.7 10.78 61.3 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.915 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.649 ' HB3' HD21 ' A' ' 61' ' ' LEU . . . -109.21 127.63 54.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 117.048 0.424 . . . . 0.0 111.554 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.545 ' HB2' ' HB3' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -27.94 104.08 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.294 178.869 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 60' ' ' THR . 3.3 mt -116.02 100.62 10.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.777 0.322 . . . . 0.0 110.419 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.483 ' O ' ' HB ' ' A' ' 60' ' ' THR . 2.4 p30 -121.61 125.83 47.64 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.617 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.7 mt -100.0 142.27 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.73 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.6 m -161.68 -177.81 6.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.024 0.44 . . . . 0.0 111.552 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.799 ' CB ' HD13 ' A' ' 58' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.306 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.758 ' CB ' HG21 ' A' ' 25' ' ' VAL . 6.3 mtt180 -145.77 127.61 15.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.926 0.393 . . . . 0.0 111.207 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.799 HD13 ' CB ' ' A' ' 51' ' ' GLU . 2.4 mp -101.04 104.72 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.612 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.1 mp -86.43 95.1 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.411 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 47' ' ' ILE . 27.7 m -73.8 131.0 41.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.688 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.649 HD21 ' HB3' ' A' ' 45' ' ' ALA . 1.5 tt -131.59 129.64 41.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.652 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.553 ' O ' ' HB1' ' A' ' 45' ' ' ALA . . . -139.45 130.45 26.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.699 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.35 165.18 14.68 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.116 -1.04 . . . . 0.0 112.783 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 80.6 Cg_exo -39.37 154.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.135 2.557 . . . . 0.0 113.216 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.425 ' O ' HG22 ' A' ' 68' ' ' ILE . 3.8 m -59.04 -35.35 73.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.864 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -67.03 -52.02 47.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.186 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.26 -42.93 82.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.058 0.456 . . . . 0.0 110.795 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 1.043 HD11 HG22 ' A' ' 16' ' ' ILE . 1.0 OUTLIER -66.44 -39.46 84.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.172 -179.515 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.52 -47.01 87.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.065 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -50.59 73.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.938 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.872 ' HB2' ' HB2' ' A' ' 43' ' ' SER . . . -58.72 -40.68 84.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.153 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.78 -42.69 99.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.093 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.79 -39.31 88.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.167 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.9 mtt -78.04 -32.49 50.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.841 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.14 -46.15 81.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.002 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.1 pp -68.14 -37.85 78.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.223 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -65.48 -46.2 80.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.504 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -35.4 75.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.111 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.0 tp -77.57 -25.17 49.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.523 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -76.88 -43.01 37.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.912 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -72.1 -32.33 66.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.828 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.3 t70 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.983 -179.948 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo . . . . . 0 N--CA 1.461 -0.408 0 CA-C-O 120.791 0.246 . . . . 0.0 112.606 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.653 HG21 ' HD3' ' A' ' 152' ' ' PRO . 24.3 t -137.2 106.77 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.482 HG22 ' HB2' ' A' ' 149' ' ' ALA . 40.7 p -103.4 139.22 39.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.04 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.419 HD11 HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -139.86 117.61 11.63 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.681 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.91 112.44 25.41 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.527 -178.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.708 HD22 HD11 ' A' ' 16' ' ' ILE . 40.7 mt -111.85 153.76 26.16 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.956 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 104' ' ' VAL . 21.2 t -114.32 149.23 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.062 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.963 HG11 HD11 ' A' ' 162' ' ' ILE . 6.0 m -156.14 164.46 21.35 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.335 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -66.03 160.74 43.02 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.744 2.296 . . . . 0.0 112.113 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.98 -34.9 76.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.358 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.9 t -70.17 -30.28 67.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.201 0.524 . . . . 0.0 109.667 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.559 ' NE2' HD23 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -70.72 -41.8 71.43 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.63 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.6 ' HA ' HD21 ' A' ' 112' ' ' LEU . 5.1 t -65.85 -40.8 92.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.706 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.17 -33.47 87.32 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.885 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.6 p -77.32 -50.78 12.07 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 121.115 -0.234 . . . . 0.0 111.312 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.625 HD12 HG13 ' A' ' 113' ' ' ILE . 2.7 pp -55.66 -25.78 41.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.054 0.455 . . . . 0.0 110.009 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.625 HG13 HD12 ' A' ' 112' ' ' LEU . 51.2 mt -77.03 -39.31 29.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.224 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.41 -177.86 39.37 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.527 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.53 121.73 16.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.857 0.361 . . . . 0.0 111.128 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.85 12.37 56.88 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.08 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.415 ' HA2' ' CG2' ' A' ' 113' ' ' ILE . . . 72.99 4.97 63.95 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.034 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 2.2 m -52.94 -42.64 65.65 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 120.791 0.329 . . . . 0.0 111.828 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -65.34 0.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.564 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.2 tt -58.99 -30.59 43.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.647 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 7.6 tppt? -60.07 -44.83 94.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.105 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -73.28 -41.66 63.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.464 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.409 HD12 ' NE2' ' A' ' 161' ' ' GLN . 34.5 mm -62.7 -53.78 42.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.583 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.4 mmt85 -67.82 -42.72 81.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.398 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.61 -40.77 69.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.222 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 91.3 p -85.32 -36.75 20.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.758 0.313 . . . . 0.0 111.101 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 31.0 m -50.49 -26.09 4.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.929 0.395 . . . . 0.0 110.249 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.48 -9.15 62.49 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.026 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -108.03 154.32 21.83 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.857 0.36 . . . . 0.0 111.212 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 1.9 mt-30 -105.14 139.75 39.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.41 ' HB ' ' CG2' ' A' ' 146' ' ' ILE . 1.2 m -99.16 157.96 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.035 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.593 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 3.4 tp60 -138.59 116.81 11.84 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.269 0.557 . . . . 0.0 112.347 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.65 131.22 45.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.305 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.079 179.915 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.869 0.366 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 24.5 m -118.91 -41.87 2.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.614 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.496 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 37.5 mt-10 -134.15 138.9 45.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.76 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.24 165.29 13.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.952 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.28 138.98 53.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.233 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.593 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 35.5 mt -114.21 131.63 65.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.824 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.435 ' HB ' ' CB ' ' A' ' 132' ' ' GLN . 1.0 OUTLIER -106.17 115.06 29.58 Favored 'General case' 0 N--CA 1.46 0.065 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.689 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 130' ' ' GLN . 3.2 mp -103.89 118.7 51.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.452 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.482 ' HB2' HG22 ' A' ' 99' ' ' THR . . . -118.55 134.5 55.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.758 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 163.35 -151.58 21.22 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.777 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.578 HG23 ' HD2' ' A' ' 152' ' ' PRO . 3.7 mt -78.2 144.74 67.5 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.653 ' HD3' HG21 ' A' ' 98' ' ' VAL . 5.7 Cg_endo -48.4 -39.87 36.06 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.134 1.889 . . . . 0.0 111.322 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -66.63 -34.68 78.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 18.3 m -68.44 -32.26 72.16 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.625 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 29.5 mm -76.35 -49.0 25.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.119 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.42 ' O ' HG12 ' A' ' 159' ' ' VAL . 33.4 mm -55.81 -36.38 43.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.989 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -75.03 -36.72 61.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.826 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 4.8 t -68.16 -38.45 82.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.905 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.445 ' HA ' HG22 ' A' ' 162' ' ' ILE . 10.3 p -70.82 -32.17 48.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.065 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.76 ' O ' HG23 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -69.3 -34.68 75.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.872 179.869 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.59 ' O ' HG23 ' A' ' 165' ' ' VAL . 0.8 OUTLIER -72.41 -49.37 34.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.776 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.963 HD11 HG11 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -63.15 -44.08 99.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.947 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 163' ' ' CYS . . . . . 0.477 ' N ' HG23 ' A' ' 162' ' ' ILE . 1.7 m -58.95 -44.61 91.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.831 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 160' ' ' LYS . 53.4 t -58.48 -52.59 57.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.02 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 161' ' ' GLN . 21.8 t -57.9 -41.25 79.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.18 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -59.69 -37.48 78.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.971 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 7.6 tt -67.46 -55.87 11.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.88 -2.63 24.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.01 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 18.4 p . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.372 -0.823 . . . . 0.0 111.152 179.999 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.722 0.296 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.563 HG22 ' N ' ' A' ' 13' ' ' THR . 12.0 p -118.08 163.97 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.97 0.414 . . . . 0.0 111.347 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.638 ' O ' HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -104.74 128.31 52.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.288 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.638 HD22 ' O ' ' A' ' 13' ' ' THR . 1.9 mm? -124.26 151.43 44.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.237 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.2 m -141.66 118.78 11.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.519 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.838 HD11 HD23 ' A' ' 102' ' ' LEU . 12.4 tt -119.96 147.21 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.931 0.396 . . . . 0.0 111.408 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.658 ' HG3' HG23 ' A' ' 60' ' ' THR . 2.4 mpp_? -131.04 112.08 12.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.524 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.685 HD12 ' CE ' ' A' ' 20' ' ' MET . 0.5 OUTLIER -109.51 134.74 51.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.224 -179.605 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.563 HD23 HG23 ' A' ' 103' ' ' VAL . 1.0 OUTLIER -104.36 122.36 45.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.562 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.685 ' CE ' HD12 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -124.71 159.51 30.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.144 0.497 . . . . 0.0 111.436 -179.621 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.86 ' O ' HG12 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -71.89 142.15 49.52 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.427 179.659 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.415 ' HA2' ' HG3' ' A' ' 57' ' ' ARG . . . -43.98 -32.2 2.26 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 121.018 -0.611 . . . . 0.0 113.801 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.41 ' HG3' ' HB3' ' A' ' 21' ' ' HIS . 0.0 OUTLIER -78.37 -52.03 9.2 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -179.255 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.18 -50.55 67.69 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.027 0.442 . . . . 0.0 110.309 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.86 HG12 ' O ' ' A' ' 21' ' ' HIS . 11.6 p -58.88 -36.04 59.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.956 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.701 ' HA2' HD12 ' A' ' 29' ' ' ILE . . . -62.37 -36.13 92.66 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.39 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.1 m -72.48 -29.53 63.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.96 0.41 . . . . 0.0 110.212 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.402 HD13 ' N ' ' A' ' 28' ' ' ILE . 4.9 mm -81.14 -32.59 12.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.699 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.735 HD11 HG22 ' A' ' 25' ' ' VAL . 14.2 mt -64.14 -42.59 96.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.156 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.4 150.96 26.14 Favored Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.293 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.431 ' C ' ' HG3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -58.08 146.39 33.28 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.772 -0.714 . . . . 0.0 111.259 179.824 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.496 ' HD2' ' HB2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 44.58 26.75 0.2 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.221 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.52 ' O ' HG23 ' A' ' 36' ' ' VAL . . . 49.25 16.17 0.8 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 114.391 0.517 . . . . 0.0 114.391 178.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.546 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 4.0 mt-10 -72.09 -35.01 69.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.677 0.739 . . . . 0.0 109.872 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.9 t -68.41 -39.86 81.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.102 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.684 HG13 ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -66.8 -26.1 36.26 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.946 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -36.45 79.91 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.546 ' HG2' ' O ' ' A' ' 34' ' ' GLU . 8.8 mmtt -63.28 -41.22 98.98 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.597 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.54 -49.48 76.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.169 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.583 ' HG2' HD12 ' A' ' 47' ' ' ILE . 1.7 mtt180 -58.34 -51.66 68.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.682 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -64.91 -38.4 90.84 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -75.06 -35.97 61.83 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.798 ' CB ' ' HB2' ' A' ' 71' ' ' ALA . 83.5 p -82.27 -55.33 4.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.83 0.347 . . . . 0.0 111.041 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.41 -7.89 64.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.544 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.565 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . . . -104.28 127.94 51.99 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 122.781 -0.246 . . . . 0.0 111.012 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 4.5 mmt180 -27.36 139.39 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.101 0.56 . . . . 0.0 112.213 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.583 HD12 ' HG2' ' A' ' 40' ' ' ARG . 11.6 mt -142.24 100.59 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.723 0.297 . . . . 0.0 111.008 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.34 132.6 50.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.04 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.9 mt -90.24 151.77 3.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.081 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.87 -175.12 3.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.043 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.055 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 . . . . . 0 N--CA 1.467 0.415 0 CA-C-O 120.593 0.235 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.697 ' HB2' HG11 ' A' ' 25' ' ' VAL . 3.3 mtp180 -140.24 143.61 36.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.008 0.432 . . . . 0.0 111.375 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.2 mt -140.53 115.45 6.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.599 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.5 mt -86.18 110.13 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.976 0.417 . . . . 0.0 111.43 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.658 HG23 ' HG3' ' A' ' 17' ' ' ARG . 49.6 m -103.15 101.84 11.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.64 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.57 HD22 HG13 ' A' ' 68' ' ' ILE . 6.5 tt -104.69 133.85 48.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.753 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.478 ' O ' ' HB1' ' A' ' 45' ' ' ALA . . . -125.55 137.42 53.93 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.45 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.49 165.57 15.44 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 119.847 -1.168 . . . . 0.0 113.007 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -50.5 161.96 1.07 Allowed 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.906 2.404 . . . . 0.0 112.337 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.496 ' O ' HG22 ' A' ' 68' ' ' ILE . 18.2 m -56.85 -35.96 69.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.559 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -63.8 -51.81 63.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.788 0.328 . . . . 0.0 111.3 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.565 ' CB ' ' HB2' ' A' ' 45' ' ' ALA . . . -57.24 -37.47 72.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.198 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.57 HG13 HD22 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -66.21 -39.34 84.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.376 -179.301 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.67 -50.91 70.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.032 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.76 -49.71 76.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.886 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.798 ' HB2' ' CB ' ' A' ' 43' ' ' SER . . . -56.31 -50.85 70.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.27 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.454 ' HA ' HD12 ' A' ' 75' ' ' ILE . 0.7 OUTLIER -52.78 -42.51 65.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.095 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.98 -37.13 78.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.108 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -76.32 -37.63 57.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.949 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 72' ' ' PHE . 46.0 mt -64.11 -50.6 76.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.846 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -62.17 -37.42 78.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.143 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -65.0 -47.64 76.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.741 0.305 . . . . 0.0 110.513 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.36 -35.42 80.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.174 0.511 . . . . 0.0 109.781 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.0 tp -77.67 -22.99 49.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.486 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -76.08 -41.75 49.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.841 0.353 . . . . 0.0 110.9 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.23 -45.44 60.22 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.036 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.681 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo . . . . . 0 N--CA 1.463 -0.315 0 CA-C-O 120.937 0.307 . . . . 0.0 112.701 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.839 HG12 ' O ' ' A' ' 150' ' ' GLY . 7.2 p -140.92 116.21 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.505 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.664 ' O ' HD23 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -103.08 131.85 49.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.133 -179.556 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.664 HD23 ' O ' ' A' ' 99' ' ' THR . 27.6 mt -139.92 117.67 11.63 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.54 ' HG2' ' HB1' ' A' ' 145' ' ' ALA . 28.2 ttm180 -103.09 112.57 25.48 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.567 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.838 HD23 HD11 ' A' ' 16' ' ' ILE . 1.4 mp -99.46 151.01 21.6 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.842 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.563 HG23 HD23 ' A' ' 19' ' ' LEU . 25.9 t -107.26 149.28 10.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.241 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.8 m -156.01 161.69 28.96 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.133 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.432 ' HD2' ' HB2' ' A' ' 108' ' ' GLN . 21.4 Cg_exo -65.69 162.15 35.75 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.748 2.298 . . . . 0.0 112.216 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.13 -34.64 76.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.639 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.25 -30.52 69.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.086 0.469 . . . . 0.0 109.823 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.432 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -68.85 -46.19 69.15 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.678 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.405 ' O ' HG12 ' A' ' 113' ' ' ILE . 0.8 OUTLIER -67.57 -37.48 82.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.419 179.554 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.22 -49.68 70.48 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.312 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.9 m -77.28 -35.22 55.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.839 0.352 . . . . 0.0 110.803 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.71 HD21 ' CD1' ' A' ' 162' ' ' ILE . 9.9 mt -57.66 -29.67 64.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.62 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.408 ' HA ' ' HB ' ' A' ' 120' ' ' ILE . 27.7 mm -87.12 -38.71 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.807 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.4 -179.38 36.66 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.453 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.34 124.73 23.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.874 0.369 . . . . 0.0 111.054 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.41 16.07 57.85 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.882 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.407 ' HA2' ' CG2' ' A' ' 113' ' ' ILE . . . 68.16 10.6 59.77 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.965 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -52.93 -39.86 63.16 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.823 0.344 . . . . 0.0 111.547 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.67 -65.27 0.7 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.224 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.891 HD11 HG21 ' A' ' 131' ' ' VAL . 0.0 OUTLIER -55.13 -28.86 21.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.437 -179.668 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -64.69 -49.36 71.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.094 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.5 -38.99 74.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.34 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 120' ' ' ILE . 27.8 mt -57.52 -53.93 37.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.116 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.435 ' HG2' HD13 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -72.47 -30.52 64.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.912 0.387 . . . . 0.0 110.998 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.97 -44.73 82.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.131 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.4 m -93.12 -37.53 12.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.506 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.5 m -49.83 -26.25 3.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.809 0.337 . . . . 0.0 110.234 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 82.9 -16.55 26.56 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.229 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.801 ' HB2' ' HB3' ' A' ' 154' ' ' SER . . . -100.87 166.54 10.79 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.937 0.368 . . . . 0.0 111.195 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -105.23 133.82 49.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.952 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.891 HG21 HD11 ' A' ' 120' ' ' ILE . 14.0 m -101.93 139.48 22.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.905 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.633 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 0.4 OUTLIER -129.47 116.72 19.39 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.6 m -99.26 132.74 44.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.277 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.995 179.92 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 56.1 p . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.84 0.353 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 28.3 m -115.59 -47.17 2.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.811 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.486 ' OE2' ' NH2' ' A' ' 17' ' ' ARG . 10.9 mt-10 -116.2 147.03 41.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.792 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.03 174.43 5.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.893 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.54 ' HB1' ' HG2' ' A' ' 101' ' ' ARG . . . -136.44 129.9 31.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.402 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.633 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 3.9 mp -100.13 125.4 53.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.741 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.566 HG22 HG22 ' A' ' 99' ' ' THR . 0.3 OUTLIER -96.92 114.82 26.47 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.743 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 148' ' ' ILE . 1.0 OUTLIER -106.04 113.48 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.183 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.611 ' HB2' HG23 ' A' ' 99' ' ' THR . . . -118.44 131.16 56.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.086 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.839 ' O ' HG12 ' A' ' 98' ' ' VAL . . . 165.49 -158.4 31.25 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.49 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.598 HG22 ' HD2' ' A' ' 152' ' ' PRO . 0.7 OUTLIER -87.76 163.74 37.09 Favored Pre-proline 0 C--N 1.33 -0.272 0 O-C-N 122.858 -0.201 . . . . 0.0 110.637 179.534 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.598 ' HD2' HG22 ' A' ' 151' ' ' ILE . 6.9 Cg_endo -49.59 -36.59 40.92 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.428 2.085 . . . . 0.0 111.77 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.44 ' HB2' HD13 ' A' ' 151' ' ' ILE . 7.8 mm100 -63.54 -34.61 78.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.038 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.801 ' HB3' ' HB2' ' A' ' 129' ' ' ALA . 4.2 m -70.45 -37.14 74.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.591 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.491 ' O ' HG12 ' A' ' 159' ' ' VAL . 36.8 mm -67.53 -51.72 48.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.937 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.9 mm -58.85 -28.24 37.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.056 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -70.6 -57.02 5.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.521 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 6.8 p -61.01 -47.54 86.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.519 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 155' ' ' ILE . 13.4 p -57.01 -36.56 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.809 0.338 . . . . 0.0 111.166 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.413 ' O ' HG12 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -71.48 -33.05 68.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.827 179.914 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.623 ' O ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -72.56 -39.81 67.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.978 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.71 ' CD1' HD21 ' A' ' 112' ' ' LEU . 6.4 tp -74.05 -34.51 38.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.032 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 2.3 t -70.81 -47.35 59.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.071 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.483 HG13 ' N ' ' A' ' 165' ' ' VAL . 12.4 p -61.81 -45.36 98.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.08 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.623 HG22 ' O ' ' A' ' 161' ' ' GLN . 28.5 m -69.27 -42.64 81.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.062 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.473 ' HG2' HD11 ' A' ' 14' ' ' LEU . 4.5 tpp -64.53 -37.43 87.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.958 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.44 -57.5 7.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.92 -2.49 24.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.029 0.442 . . . . 0.0 112.026 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.875 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.763 0.316 . . . . 0.0 111.307 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -113.03 -70.65 0.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.952 0.406 . . . . 0.0 110.649 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.7 t -136.92 150.06 26.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.748 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 2.5 t -103.51 157.7 16.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.871 0.367 . . . . 0.0 111.305 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.44 ' HA ' HD23 ' A' ' 14' ' ' LEU . 4.0 mt -152.33 174.46 13.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.993 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.9 m -142.5 133.62 25.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.776 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.887 HG22 HD11 ' A' ' 68' ' ' ILE . 1.1 tt -136.92 123.58 29.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.161 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.493 ' NH2' ' OE1' ' A' ' 143' ' ' GLU . 2.3 mpp_? -101.24 117.07 34.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.746 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.513 ' O ' HG23 ' A' ' 58' ' ' ILE . 96.0 mt -94.75 128.51 41.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.862 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.503 HD21 ' HB3' ' A' ' 55' ' ' PRO . 6.8 tt -123.05 120.85 34.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.496 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.446 ' HB3' ' HB ' ' A' ' 25' ' ' VAL . 0.8 OUTLIER -147.91 168.65 21.69 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.288 0.566 . . . . 0.0 111.9 -179.46 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.906 ' O ' HG12 ' A' ' 25' ' ' VAL . 29.0 m-70 -74.64 140.95 44.64 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.844 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -45.48 -30.89 3.29 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.962 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.536 ' HG2' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -78.45 -49.5 13.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 117.354 0.577 . . . . 0.0 111.95 -179.077 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.536 ' N ' ' HG2' ' A' ' 23' ' ' LYS . 4.8 mt-10 -65.14 -50.78 64.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.207 0.527 . . . . 0.0 109.999 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.907 HG11 ' CB ' ' A' ' 57' ' ' ARG . 7.3 p -58.72 -34.25 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.572 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.38 -41.9 98.69 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.924 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.1 p -65.88 -27.92 68.57 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.4 mm -81.21 -32.36 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.899 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.77 HD11 HG22 ' A' ' 25' ' ' VAL . 3.0 mm -60.43 -42.75 92.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.342 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.08 150.39 26.8 Favored Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.317 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.401 ' O ' ' CD ' ' A' ' 32' ' ' LYS . 1.3 tppm? -61.71 145.72 51.48 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.723 -0.739 . . . . 0.0 111.34 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.435 ' HG2' ' HB2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 50.79 20.22 0.73 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.442 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 51.24 13.88 1.19 Allowed Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.936 -0.649 . . . . 0.0 113.919 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.435 ' HB2' ' HG2' ' A' ' 32' ' ' LYS . 10.1 tt0 -76.79 -26.09 54.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.213 0.53 . . . . 0.0 109.808 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.13 -42.33 56.55 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.401 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.603 HG13 ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.38 -26.57 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.624 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.93 -36.69 67.27 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.54 -34.57 72.41 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.839 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -53.46 57.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.489 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.09 -51.48 69.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.989 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -51.9 -38.43 56.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.947 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -85.95 -27.38 24.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.697 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.938 ' HB2' ' HB2' ' A' ' 71' ' ' ALA . 1.5 p -73.25 -55.26 6.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.809 0.338 . . . . 0.0 111.21 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.36 -5.27 85.36 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.443 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.507 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -110.71 127.4 55.3 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.63 0.253 . . . . 0.0 111.197 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 9.1 tpp180 -28.19 104.3 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.452 ' CG1' ' O ' ' A' ' 45' ' ' ALA . 2.9 mt -114.73 120.37 64.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.688 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -137.01 173.82 11.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.041 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.9 mt -126.51 151.73 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.947 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.5 t -135.73 -175.28 3.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.08 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -81.73 -165.85 1.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.791 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . 166.72 83.24 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.75 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -52.97 -23.02 6.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.105 0.478 . . . . 0.0 110.301 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.489 ' CB ' ' HD3' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -93.48 -64.24 0.14 Allowed Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.549 -179.843 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.546 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 61.3 Cg_endo -82.82 -34.73 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.576 2.184 . . . . 0.0 112.349 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 52' ' ' GLY . 3.1 mm-40 93.56 -33.13 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.163 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.907 ' CB ' HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -136.29 133.98 37.5 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.035 0.445 . . . . 0.0 111.624 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.513 HG23 ' O ' ' A' ' 18' ' ' LEU . 31.0 mt -140.48 119.09 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.718 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.5 mt -97.01 109.66 23.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.442 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.7 m -87.2 108.7 19.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.033 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -106.67 138.52 42.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.506 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.507 ' O ' ' HB1' ' A' ' 45' ' ' ALA . . . -145.41 132.25 20.11 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.45 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.53 166.38 16.85 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 119.549 -1.31 . . . . 0.0 113.3 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 1.9 Cg_endo -46.09 159.21 0.26 Allowed 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 123.174 2.583 . . . . 0.0 112.472 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.43 ' O ' HG22 ' A' ' 68' ' ' ILE . 13.2 t -55.99 -35.94 67.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.429 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -65.37 -51.88 57.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.093 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.476 ' CB ' ' HB2' ' A' ' 45' ' ' ALA . . . -57.28 -44.54 84.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.041 0.448 . . . . 0.0 110.872 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.887 HD11 HG22 ' A' ' 16' ' ' ILE . 1.2 tt -66.45 -39.39 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.878 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.53 -45.13 77.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.041 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -45.4 68.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.746 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.938 ' HB2' ' HB2' ' A' ' 43' ' ' SER . . . -54.78 -56.16 22.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.323 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.558 ' O ' HG23 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -56.27 -40.09 73.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.998 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.45 -32.26 72.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.185 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.2 mtm -74.27 -46.55 40.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.196 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.451 HG13 ' N ' ' A' ' 76' ' ' ILE . 29.0 pt -61.56 -42.83 95.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.229 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 72' ' ' PHE . 41.0 pt -64.91 -36.45 77.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.82 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.401 ' N ' HG13 ' A' ' 76' ' ' ILE . 0.9 OUTLIER -67.9 -37.7 82.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.321 179.578 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -35.45 77.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.01 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.6 tp -76.34 -28.11 56.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.383 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.9 -35.98 56.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.682 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -72.39 -33.45 67.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.909 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -68.78 -55.3 11.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.237 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -55.53 -39.42 53.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.321 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.51 38.94 1.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.847 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.82 17.12 11.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.236 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.1 m 63.87 80.77 0.22 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.815 0.34 . . . . 0.0 110.777 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 5.4 tpt -58.82 121.25 10.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.946 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.56 33.87 2.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -160.64 178.01 9.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.84 165.99 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.509 ' O ' HG23 ' A' ' 91' ' ' THR . 5.2 t -126.15 93.83 3.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.951 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 62.23 148.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.08 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.65 -38.16 3.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.205 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 62.4 29.33 17.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.96 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.14 71.59 79.28 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.9 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.571 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 50.6 Cg_exo -52.98 -47.27 28.44 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.709 2.273 . . . . 0.0 112.91 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 96' ' ' PRO . 45.7 Cg_endo -69.31 -167.66 0.22 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.095 1.863 . . . . 0.0 112.641 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 150' ' ' GLY . 4.5 m -140.97 119.87 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.464 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.7 HG22 ' HB2' ' A' ' 149' ' ' ALA . 14.9 p -102.81 141.96 34.74 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.957 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.473 HD12 ' CD1' ' A' ' 102' ' ' LEU . 0.2 OUTLIER -139.85 117.75 11.75 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -100.87 112.62 25.09 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.499 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.577 HD12 ' N ' ' A' ' 102' ' ' LEU . 5.6 mp -99.35 162.82 12.82 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.835 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.571 ' O ' HG13 ' A' ' 104' ' ' VAL . 21.4 t -115.76 147.75 18.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.215 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 103' ' ' VAL . 4.3 m -160.38 154.36 19.46 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.046 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.37 167.53 18.39 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.386 2.057 . . . . 0.0 112.238 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.52 -34.58 78.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.479 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.1 t -69.59 -30.35 68.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.134 0.492 . . . . 0.0 109.837 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -71.92 -46.24 58.33 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.79 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.403 ' O ' HD12 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -66.62 -46.65 75.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.756 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -54.84 -51.79 50.73 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.57 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.3 m -70.76 -40.03 72.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.771 0.32 . . . . 0.0 110.757 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.7 mt -55.27 -26.99 43.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.645 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.589 HG22 ' HA2' ' A' ' 117' ' ' GLY . 9.8 mt -84.29 -40.76 15.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.799 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.48 -177.19 49.47 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.497 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.5 mttp -66.36 124.13 21.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.827 0.346 . . . . 0.0 111.056 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 58.47 19.96 43.28 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.766 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.589 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 66.78 11.57 57.91 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.904 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 29.1 p -53.01 -38.55 62.43 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.589 ' HD2' HD11 ' A' ' 123' ' ' ILE . 4.8 tmtt? -67.78 -65.39 0.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.641 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.822 ' HA ' HD12 ' A' ' 123' ' ' ILE . 1.0 OUTLIER -55.87 -34.66 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.728 -179.327 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -62.3 -50.4 71.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.306 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 123' ' ' ILE . 5.8 pt-20 -64.36 -34.39 78.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.303 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.822 HD12 ' HA ' ' A' ' 120' ' ' ILE . 15.7 mt -65.87 -53.97 32.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.226 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.47 -30.31 65.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.036 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -59.04 -45.22 91.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.982 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.2 -39.34 14.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.12 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 36.5 m -49.93 -25.84 3.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.832 0.349 . . . . 0.0 110.16 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.6 -9.25 65.58 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.929 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.678 ' HB1' ' O ' ' A' ' 149' ' ' ALA . . . -108.14 164.25 12.46 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.83 0.348 . . . . 0.0 111.204 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -104.81 133.15 50.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.708 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.897 ' HB ' HD11 ' A' ' 146' ' ' ILE . 6.3 m -99.19 139.07 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.137 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.622 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -109.2 158.17 18.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.608 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.8 t -137.66 132.58 44.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.883 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.74 161.14 26.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.11 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -78.66 -156.49 9.56 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.479 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -177.16 66.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.95 0.405 . . . . 0.0 110.915 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -63.77 108.18 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.826 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.7 mp 61.03 166.7 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.852 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.02 76.54 0.85 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.563 2.176 . . . . 0.0 112.227 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -135.41 -45.77 0.69 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.0 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.7 p -64.0 143.17 58.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.963 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.81 -48.68 2.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.698 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.493 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 16.7 mm-40 -99.45 140.39 33.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.689 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -109.97 136.79 48.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.964 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -104.3 125.93 50.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.118 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.897 HD11 ' HB ' ' A' ' 131' ' ' VAL . 0.5 OUTLIER -105.91 139.86 25.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.518 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.531 ' HB ' ' HB2' ' A' ' 132' ' ' GLN . 2.3 m -121.12 115.1 22.45 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.473 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.8 mp -104.39 121.78 56.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.104 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.7 ' HB2' HG22 ' A' ' 99' ' ' THR . . . -118.35 145.93 44.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.021 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.644 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 154.49 -151.62 23.28 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.651 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.506 ' CG2' ' HD2' ' A' ' 152' ' ' PRO . 1.5 mp -82.41 143.85 48.75 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.506 ' HD2' ' CG2' ' A' ' 151' ' ' ILE . 79.5 Cg_exo -48.98 -34.09 28.1 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 121.933 1.756 . . . . 0.0 111.589 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -72.17 -34.64 68.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.645 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 50.7 m -69.81 -39.04 76.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.902 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.47 ' O ' HG23 ' A' ' 159' ' ' VAL . 39.2 mm -66.26 -53.47 36.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.073 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.554 HD11 HD13 ' A' ' 76' ' ' ILE . 32.6 mm -57.51 -29.0 32.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.873 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -72.32 -40.82 67.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.837 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' CYS . . . . . 0.422 ' O ' HG22 ' A' ' 162' ' ' ILE . 0.5 OUTLIER -65.73 -35.03 79.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.855 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 155' ' ' ILE . 24.7 t -73.99 -37.73 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.169 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -71.55 -34.82 70.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.93 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.78 ' O ' HG23 ' A' ' 165' ' ' VAL . 7.0 mm100 -73.77 -40.65 63.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.958 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.422 HG22 ' O ' ' A' ' 158' ' ' CYS . 14.8 tt -71.43 -34.46 53.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.152 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 1.5 m -68.27 -51.92 39.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.137 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 10.8 p -58.83 -40.13 79.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.273 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 161' ' ' GLN . 50.5 t -70.62 -32.33 49.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.007 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -45.78 90.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.874 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -71.36 -47.32 57.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.89 -2.65 24.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.209 -0.451 . . . . 0.0 112.015 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.166 -0.921 . . . . 0.0 111.385 179.957 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.903 0.382 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -109.94 -71.22 0.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.837 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.65 HG11 HD21 ' A' ' 167' ' ' LEU . 7.7 p -108.7 161.1 7.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.003 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.54 ' N ' HG22 ' A' ' 12' ' ' VAL . 3.1 t -103.57 160.78 14.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.012 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.478 ' HA ' HD23 ' A' ' 14' ' ' LEU . 4.3 mt -150.61 173.75 13.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.163 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.7 m -142.47 113.23 7.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.756 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.805 HG22 HD11 ' A' ' 68' ' ' ILE . 16.7 tt -132.61 129.01 58.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.319 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.75 ' O ' HD23 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -117.98 148.61 42.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.693 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 pp -129.38 146.67 51.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.895 0.379 . . . . 0.0 111.248 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.648 HD23 ' N ' ' A' ' 20' ' ' MET . 7.3 tt -123.05 134.62 54.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.795 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.648 ' N ' HD23 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -138.47 165.81 25.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.983 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.557 ' O ' HG12 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -67.78 166.25 15.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.676 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.2 -36.93 94.1 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.705 -0.76 . . . . 0.0 113.022 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -78.36 -50.08 12.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.901 0.381 . . . . 0.0 111.34 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.95 -44.81 95.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.335 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.796 HG22 HD11 ' A' ' 29' ' ' ILE . 6.4 p -62.97 -35.98 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.794 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.16 -34.87 90.47 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.5 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.6 t -75.52 -30.17 59.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.768 0.318 . . . . 0.0 110.846 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.524 ' CG2' HG23 ' A' ' 75' ' ' ILE . 4.1 mm -81.12 -36.87 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.258 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.796 HD11 HG22 ' A' ' 25' ' ' VAL . 30.5 mt -65.75 -42.48 92.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.337 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.42 ' HA3' ' HB2' ' A' ' 35' ' ' SER . . . 88.58 150.9 22.29 Favored Glycine 0 N--CA 1.434 -1.489 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.122 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.433 ' O ' ' CD ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -51.22 146.61 6.47 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.739 -0.731 . . . . 0.0 111.242 179.599 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.503 ' HE3' ' HB3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 44.43 27.1 0.21 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.119 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 45.37 20.2 0.31 Allowed Glycine 0 CA--C 1.522 0.529 0 C-N-CA 121.353 -0.451 . . . . 0.0 113.967 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.503 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -73.14 -25.3 60.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.327 0.564 . . . . 0.0 110.086 179.263 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.42 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -72.58 -42.75 64.26 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.539 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.663 HG13 ' HA ' ' A' ' 29' ' ' ILE . 0.9 OUTLIER -67.02 -26.62 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.871 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -71.03 -36.9 72.54 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.04 -37.09 86.45 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.586 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -59.01 -53.74 54.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.419 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.402 ' HA ' HD12 ' A' ' 47' ' ' ILE . 17.9 mtm-85 -52.86 -51.14 62.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.956 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.6 -37.5 84.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.914 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.52 -35.84 63.16 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.426 ' CB ' ' HB2' ' A' ' 71' ' ' ALA . 0.3 OUTLIER -93.28 -55.74 3.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.978 0.418 . . . . 0.0 111.08 -179.644 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.37 10.03 54.5 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.882 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.483 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -110.77 128.38 55.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.89 0.345 . . . . 0.0 111.221 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -27.49 134.5 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.243 179.439 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.406 HG13 ' HG ' ' A' ' 61' ' ' LEU . 10.4 mt -142.22 100.57 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.705 0.288 . . . . 0.0 110.522 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -112.98 167.43 10.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.886 0.374 . . . . 0.0 111.056 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.541 HG21 ' NE ' ' A' ' 57' ' ' ARG . 3.4 mt -126.52 152.04 33.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.155 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 63.9 m -91.03 -175.05 4.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.218 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -62.43 -168.45 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.16 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.85 -72.84 2.19 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.386 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 44.12 29.37 0.34 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.052 0.453 . . . . 0.0 110.558 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.508 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -151.25 -68.48 0.02 OUTLIER Pre-proline 0 N--CA 1.454 -0.266 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.09 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' A' ' 54' ' ' CYS . 86.5 Cg_endo -77.4 -35.41 1.64 Allowed 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.037 1.825 . . . . 0.0 110.937 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -146.34 161.05 41.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.583 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.791 ' HB2' HG21 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -146.32 127.53 14.78 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.288 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.639 HG12 HD12 ' A' ' 19' ' ' LEU . 17.3 mt -115.0 104.58 17.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.375 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.3 mt -92.92 103.55 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.522 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 91.1 m -83.02 129.1 35.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.459 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.794 HD22 HG13 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -118.21 131.3 56.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.085 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.483 ' O ' ' HB1' ' A' ' 45' ' ' ALA . . . -131.29 130.92 43.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.759 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.2 164.8 14.07 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.961 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 86.9 Cg_exo -40.31 162.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.169 2.58 . . . . 0.0 113.041 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.453 ' O ' HG22 ' A' ' 68' ' ' ILE . 9.6 m -60.17 -35.73 76.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.009 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -69.84 -51.86 29.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.081 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.04 -39.64 75.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.97 0.414 . . . . 0.0 110.85 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.805 HD11 HG22 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -66.23 -39.54 84.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.34 -179.469 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.74 -43.13 89.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.01 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.29 -49.92 75.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.955 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.426 ' HB2' ' CB ' ' A' ' 43' ' ' SER . . . -58.04 -56.47 21.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.27 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.933 ' HA ' HD12 ' A' ' 75' ' ' ILE . 2.6 m-85 -57.39 -34.57 69.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.113 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.27 -42.09 99.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.124 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.06 -36.55 72.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.951 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.933 HD12 ' HA ' ' A' ' 72' ' ' PHE . 14.9 mt -62.77 -49.26 84.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.4 HG13 ' N ' ' A' ' 77' ' ' ASP . 24.5 pt -61.21 -40.51 86.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.027 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.4 ' N ' HG13 ' A' ' 76' ' ' ILE . 1.1 t0 -61.22 -39.87 91.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.685 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.43 -41.67 97.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.29 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.411 HD21 HG11 ' A' ' 98' ' ' VAL . 18.1 tp -74.61 -26.62 60.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.472 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.689 ' HA ' HD12 ' A' ' 83' ' ' ILE . 1.7 mt-10 -76.89 -34.62 57.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.703 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -72.21 -37.38 69.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.729 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -59.33 -33.36 71.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.914 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.689 HD12 ' HA ' ' A' ' 80' ' ' GLU . 12.3 mt -68.36 -41.32 83.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.993 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.6 t -99.69 31.52 3.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.912 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.97 -31.51 11.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.5 p -164.83 141.56 5.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 2.7 ptm -154.14 115.02 4.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.945 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.1 m -71.32 -66.0 0.68 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.003 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -143.01 166.58 24.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.89 -79.05 0.43 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.92 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 47.76 88.62 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.188 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 61.62 -165.31 0.23 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.069 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -157.89 92.02 1.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.032 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.0 p -72.22 -28.23 63.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.132 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.4 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -135.1 64.07 59.68 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.03 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.479 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 33.9 Cg_exo -58.56 -46.33 24.71 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.55 2.167 . . . . 0.0 112.884 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 96' ' ' PRO . 84.6 Cg_endo -79.12 -163.81 0.24 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.371 2.047 . . . . 0.0 112.839 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.411 HG11 HD21 ' A' ' 79' ' ' LEU . 21.2 t -140.77 122.12 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.987 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.855 HG22 ' CB ' ' A' ' 149' ' ' ALA . 5.0 p -102.62 141.13 35.95 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.461 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 147' ' ' THR . 4.6 mp -139.84 158.58 43.85 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.139 -1.801 . . . . 0.0 106.139 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.584 ' HG2' ' HB1' ' A' ' 145' ' ' ALA . 8.3 ttp-105 -122.84 113.33 19.0 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.912 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.75 HD23 ' O ' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -101.09 144.6 29.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.933 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.5 t -104.43 139.08 26.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.061 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.3 m -149.06 157.22 40.17 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.04 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.24 166.56 20.84 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.421 2.081 . . . . 0.0 112.324 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.68 -34.57 75.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.384 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 p -68.97 -30.28 68.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.978 0.418 . . . . 0.0 109.926 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -50.6 52.71 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.793 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.474 ' O ' HD12 ' A' ' 113' ' ' ILE . 30.9 p -70.67 -38.21 73.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.677 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -54.7 -50.45 57.67 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.475 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.2 p -77.43 -47.45 19.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.671 0.272 . . . . 0.0 111.011 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.872 ' CD2' HD12 ' A' ' 162' ' ' ILE . 29.0 mt -52.66 -26.46 13.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.925 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.487 HG22 ' HA2' ' A' ' 117' ' ' GLY . 41.0 mt -92.33 -37.37 8.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.943 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.93 179.47 32.83 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.423 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -67.39 124.18 22.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.873 0.368 . . . . 0.0 111.008 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.0 19.1 63.14 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.816 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.487 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 64.41 13.26 54.25 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.887 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -52.9 -50.6 63.57 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 120.775 0.322 . . . . 0.0 111.728 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.734 ' HD2' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -57.1 -60.83 3.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.178 -179.763 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.645 HD13 ' O ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -56.1 -26.92 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.456 -179.766 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.6 tptp -65.06 -47.0 78.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.796 0.332 . . . . 0.0 110.892 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -73.13 -45.8 54.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.136 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.734 HD11 ' HD2' ' A' ' 119' ' ' LYS . 50.6 mt -62.17 -50.89 78.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.998 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -63.78 -40.55 96.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.151 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -54.99 -57.38 11.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.818 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.3 m -75.83 -43.68 44.77 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.422 HG21 ' HB3' ' A' ' 158' ' ' CYS . 25.0 m -47.95 -25.94 1.55 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.866 0.365 . . . . 0.0 110.432 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.24 -7.05 58.24 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.049 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -105.66 137.11 44.06 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.951 0.375 . . . . 0.0 110.953 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.41 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 0.0 OUTLIER -95.58 144.59 25.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.209 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.465 ' CG2' HD11 ' A' ' 120' ' ' ILE . 4.8 m -99.31 147.17 7.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.045 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 7.0 tp60 -140.22 117.77 11.52 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.555 HG23 ' CG ' ' A' ' 144' ' ' ARG . 11.6 p -96.59 116.47 38.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.051 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.22 135.01 35.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.795 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 49.78 -178.69 0.02 OUTLIER Glycine 0 CA--C 1.518 0.228 0 CA-C-N 115.968 -0.56 . . . . 0.0 113.387 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.3 p30 174.37 41.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.926 0.393 . . . . 0.0 110.484 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 19.6 mtp -56.09 166.87 0.7 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.127 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.52 164.59 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.837 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -50.78 -25.21 14.84 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.483 2.122 . . . . 0.0 112.189 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 177.29 104.72 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.639 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 88.3 p -57.77 -174.09 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.997 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 25.7 m -106.42 -64.56 1.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.359 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.494 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 10.5 mm-40 -93.92 135.73 34.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.171 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.555 ' CG ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -121.75 166.41 14.35 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.241 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.584 ' HB1' ' HG2' ' A' ' 101' ' ' ARG . . . -130.2 115.75 17.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.791 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 30.5 mt -100.77 129.24 51.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.696 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.457 ' HB ' ' CB ' ' A' ' 132' ' ' GLN . 2.6 m -97.67 123.06 41.43 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.519 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.795 ' O ' HD12 ' A' ' 148' ' ' ILE . 2.1 pp -106.72 117.97 53.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.935 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.855 ' CB ' HG22 ' A' ' 99' ' ' THR . . . -118.34 126.43 52.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.121 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 171.28 -153.28 20.08 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.592 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.518 HG22 ' HD2' ' A' ' 152' ' ' PRO . 1.3 mp -87.32 143.59 34.65 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 110.624 -0.139 . . . . 0.0 110.624 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.518 ' HD2' HG22 ' A' ' 151' ' ' ILE . 71.3 Cg_exo -49.33 -31.03 21.62 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 121.966 1.777 . . . . 0.0 111.447 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.13 -34.65 68.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.674 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 22.2 t -68.79 -50.08 53.3 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.795 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.612 HD13 ' C ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -58.39 -45.07 89.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.451 HD12 ' O ' ' A' ' 152' ' ' PRO . 27.9 mt -63.88 -29.98 48.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.845 0.355 . . . . 0.0 110.842 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -73.65 -43.02 60.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.238 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' CYS . . . . . 0.422 ' HB3' HG21 ' A' ' 127' ' ' THR . 21.4 p -72.42 -42.87 64.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.277 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.423 HG12 ' HA ' ' A' ' 156' ' ' ILE . 13.3 p -60.83 -37.9 77.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.927 0.394 . . . . 0.0 111.01 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.97 -32.91 69.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.756 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.874 ' O ' HG23 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -67.86 -49.56 61.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.0 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.872 HD12 ' CD2' ' A' ' 112' ' ' LEU . 37.7 mm -66.41 -34.48 70.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.015 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 1.7 m -64.58 -48.1 76.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.978 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 161' ' ' GLN . 11.1 p -65.48 -33.53 64.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.187 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 161' ' ' GLN . 50.8 t -70.64 -45.14 75.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.878 0.371 . . . . 0.0 110.972 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 27.2 mtm -58.98 -33.57 70.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.847 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.65 HD21 HG11 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -72.56 -48.22 41.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.818 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.02 -2.55 24.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.93 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 41.2 p . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.876 -179.979 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 120.762 0.315 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 -104.54 -77.88 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.854 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.44 151.68 16.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.986 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 0.9 OUTLIER -103.66 142.75 33.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.039 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.494 ' HA ' HD23 ' A' ' 14' ' ' LEU . 4.2 mt -137.11 175.23 9.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.991 0.424 . . . . 0.0 111.211 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.7 m -142.4 135.97 29.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.841 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.558 HG22 HD11 ' A' ' 68' ' ' ILE . 14.1 tt -140.87 154.67 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.164 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.496 ' NH2' ' OE1' ' A' ' 143' ' ' GLU . 25.0 mtp180 -134.79 127.63 31.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.867 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.474 HD11 ' CZ ' ' A' ' 72' ' ' PHE . 52.5 mt -113.96 147.58 38.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.595 HD21 ' HB3' ' A' ' 55' ' ' PRO . 6.8 tt -102.35 106.04 16.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.762 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.2 144.14 40.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.044 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.547 ' O ' HG12 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -76.61 167.82 21.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.752 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.424 ' C ' HG12 ' A' ' 25' ' ' VAL . . . -59.8 -34.66 83.49 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.769 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.86 -52.02 8.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 0.0 111.354 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -34.12 76.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.849 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.685 ' O ' HG12 ' A' ' 29' ' ' ILE . 7.4 p -71.03 -38.97 74.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.664 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.08 -35.08 90.95 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.683 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.26 -34.96 61.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.594 0.235 . . . . 0.0 111.07 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.638 HD12 ' N ' ' A' ' 29' ' ' ILE . 2.9 pp -80.15 -32.53 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.355 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.768 ' HA ' HG13 ' A' ' 36' ' ' VAL . 12.4 mm -65.06 -58.87 5.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.7 150.54 25.29 Favored Glycine 0 N--CA 1.436 -1.354 0 CA-C-O 121.635 0.575 . . . . 0.0 112.664 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.443 ' O ' ' CD ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -61.52 146.34 48.98 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.501 -0.85 . . . . 0.0 111.441 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.454 ' HG2' ' H ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER 52.56 18.89 1.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.277 179.482 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.412 ' O ' HG23 ' A' ' 36' ' ' VAL . . . 51.7 13.79 1.5 Allowed Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.956 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.454 ' H ' ' HG2' ' A' ' 32' ' ' LYS . 5.4 tp10 -76.88 -26.27 54.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.322 0.561 . . . . 0.0 109.748 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.445 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -75.19 -40.95 58.93 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.246 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.768 HG13 ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.3 -26.51 36.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.243 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.57 -36.61 81.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 177.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 35' ' ' SER . 22.2 ttmm -60.36 -40.9 92.43 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.778 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.502 ' HE2' HG21 ' A' ' 47' ' ' ILE . 3.0 ttp -59.2 -48.46 81.55 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.38 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.2 ttp85 -55.3 -50.63 69.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.101 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -64.64 -38.51 91.25 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 39' ' ' MET . 3.1 pp20? -75.03 -35.88 61.92 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.742 ' HB3' ' HB2' ' A' ' 71' ' ' ALA . 37.0 p -91.04 -55.4 3.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.911 0.386 . . . . 0.0 111.105 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.12 5.86 65.45 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.248 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.832 ' HB3' HD11 ' A' ' 61' ' ' LEU . . . -110.65 128.43 55.69 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.44 0.162 . . . . 0.0 110.799 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.572 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -27.61 136.91 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.001 0.521 . . . . 0.0 112.057 178.921 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.502 HG21 ' HE2' ' A' ' 39' ' ' MET . 20.6 mt -142.19 100.68 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.73 0.3 . . . . 0.0 110.578 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -121.41 121.57 37.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.919 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -107.53 127.61 63.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.374 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.404 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER 178.92 -174.04 0.18 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 61.44 173.25 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.044 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.47 ' HA2' HD11 ' A' ' 58' ' ' ILE . . . 149.76 -76.94 0.24 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.942 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.4 m120 53.97 24.61 4.76 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.476 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -164.41 -65.16 0.01 OUTLIER Pre-proline 0 N--CA 1.453 -0.295 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.562 -179.494 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.595 ' HB3' HD21 ' A' ' 19' ' ' LEU . 78.0 Cg_endo -79.58 -33.21 1.35 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.395 2.063 . . . . 0.0 111.254 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.553 ' CB ' ' O ' ' A' ' 55' ' ' PRO . 1.8 mt-10 113.14 -35.42 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.739 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.616 ' CD ' HG11 ' A' ' 25' ' ' VAL . 2.0 mpt_? -145.82 155.89 43.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.006 0.431 . . . . 0.0 111.525 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.47 HD11 ' HA2' ' A' ' 52' ' ' GLY . 19.7 mt -140.64 118.7 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.339 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 mt -85.94 117.93 31.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.985 0.422 . . . . 0.0 111.622 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.9 m -108.57 101.75 10.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.467 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.832 HD11 ' HB3' ' A' ' 45' ' ' ALA . 15.9 tp -104.41 124.29 48.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.812 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.508 ' HB3' ' HB2' ' A' ' 46' ' ' ARG . . . -126.78 131.71 51.22 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.495 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.39 166.19 16.43 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 119.686 -1.245 . . . . 0.0 113.297 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 2.9 Cg_endo -41.85 159.48 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 123.396 2.731 . . . . 0.0 112.669 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.466 ' O ' HG22 ' A' ' 68' ' ' ILE . 57.0 m -60.11 -35.97 76.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.48 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -68.72 -52.07 34.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.239 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.07 -38.04 72.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.071 0.462 . . . . 0.0 110.882 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.558 HD11 HG22 ' A' ' 16' ' ' ILE . 0.5 OUTLIER -65.18 -39.34 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.275 -179.376 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.44 -45.09 92.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.886 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.2 -53.41 58.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.614 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.742 ' HB2' ' HB3' ' A' ' 43' ' ' SER . . . -60.72 -43.74 97.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.177 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.474 ' CZ ' HD11 ' A' ' 18' ' ' LEU . 0.7 OUTLIER -62.02 -35.51 78.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.078 -179.834 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.87 -38.78 83.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.262 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.36 -39.21 54.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.984 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 88.6 mt -62.06 -50.58 79.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.661 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.499 HD12 ' N ' ' A' ' 77' ' ' ASP . 2.3 pp -63.87 -40.69 89.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.969 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.499 ' N ' HD12 ' A' ' 76' ' ' ILE . 3.0 m-20 -69.65 -29.69 67.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.455 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -35.64 81.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.076 0.465 . . . . 0.0 109.91 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.9 tp -77.39 -30.52 53.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.386 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.94 -34.05 57.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.776 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.408 ' HA ' ' HB2' ' A' ' 85' ' ' SER . 0.0 OUTLIER -72.54 -37.84 68.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.032 179.896 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -71.71 -51.17 24.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.446 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.7 pp -53.79 -42.97 54.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.55 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.48 112.29 1.94 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.935 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.408 ' HB2' ' HA ' ' A' ' 81' ' ' GLU . 0.3 OUTLIER 179.12 -51.17 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.819 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.07 30.19 3.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.955 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 1.3 mtt -126.91 -43.17 1.7 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.901 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.404 ' O ' HG22 ' A' ' 91' ' ' THR . 0.9 OUTLIER -83.2 -22.74 33.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.063 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 70.0 -65.8 0.3 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.955 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.94 56.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.838 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 88' ' ' THR . 9.0 t -138.24 36.71 2.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.937 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -158.35 154.4 26.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.038 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -171.4 36.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.192 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.3 m -119.84 -48.43 2.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.911 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.1 ttp180 63.9 119.49 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.879 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -74.31 170.48 20.1 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.423 2.082 . . . . 0.0 112.339 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.71 -166.71 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.597 2.198 . . . . 0.0 112.078 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.422 HG21 ' HG3' ' A' ' 152' ' ' PRO . 21.3 t -125.17 103.32 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.903 0.383 . . . . 0.0 111.418 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.0 t -107.53 127.0 53.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.383 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 mt -140.03 117.76 11.63 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -103.18 112.39 25.23 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.788 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.64 149.77 26.89 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.403 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.24 145.08 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.652 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.653 HG23 HD13 ' A' ' 146' ' ' ILE . 40.1 t -142.88 144.75 30.66 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.225 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.446 ' HD2' ' CG1' ' A' ' 104' ' ' VAL . 22.2 Cg_exo -65.36 165.51 22.16 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.507 2.138 . . . . 0.0 112.154 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' A' ' 142' ' ' THR . . . -69.04 -44.22 73.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.135 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.5 m -66.7 -30.48 70.72 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.419 ' HB3' ' CG1' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -74.61 -41.42 60.46 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.434 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 55.6 m -66.28 -40.9 90.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.102 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.57 -50.71 64.79 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.161 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.3 t -70.4 -36.2 73.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.783 0.325 . . . . 0.0 110.615 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.52 HD21 HG23 ' A' ' 162' ' ' ILE . 10.7 mt -58.49 -28.32 65.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.272 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.585 HG22 ' HA2' ' A' ' 117' ' ' GLY . 10.9 mt -81.71 -40.29 17.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.717 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.1 -176.83 53.81 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.521 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -66.47 118.15 9.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.896 0.379 . . . . 0.0 111.185 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.99 15.38 56.0 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.015 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.585 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 73.06 5.08 64.6 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.006 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 1.5 m -53.13 -39.65 63.64 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 120.727 0.299 . . . . 0.0 111.719 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -64.87 -65.33 0.69 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.438 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.405 ' HB ' ' HA ' ' A' ' 113' ' ' ILE . 0.5 OUTLIER -54.4 -35.51 31.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.393 -179.674 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.5 tptm -59.26 -44.18 92.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.08 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -73.24 -40.21 64.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.329 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 88.2 mt -54.97 -53.9 29.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.216 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -31.95 69.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.892 0.377 . . . . 0.0 110.938 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -49.74 72.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.31 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.2 m -90.08 -36.94 14.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.546 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.6 m -49.89 -26.05 3.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.848 0.356 . . . . 0.0 110.364 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.3 -12.04 52.59 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.093 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -103.8 155.24 18.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.844 0.354 . . . . 0.0 111.038 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.31 127.94 53.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.054 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 147' ' ' THR . 14.4 m -99.2 138.64 23.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.861 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.69 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 5.4 tm0? -123.38 116.59 23.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.167 0.508 . . . . 0.0 112.032 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.484 HG12 HG13 ' A' ' 146' ' ' ILE . 30.8 m -103.46 130.97 52.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.363 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.2 160.71 30.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.929 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.97 173.27 35.36 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.6 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -150.47 -46.6 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.865 0.364 . . . . 0.0 110.76 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 2.4 tpt 62.65 92.49 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.081 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.8 mp 58.81 163.34 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.964 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -55.93 91.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.57 2.18 . . . . 0.0 112.249 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -134.02 -68.05 0.57 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.887 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 79.0 p -62.76 166.19 5.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.882 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.419 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.2 OUTLIER -112.01 -47.32 3.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.496 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 29.5 mt-10 -121.98 139.88 53.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.825 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.04 173.07 6.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -122.54 126.33 47.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.232 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.69 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 3.4 mp -105.48 125.0 60.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.618 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 131' ' ' VAL . 2.1 m -99.59 114.69 27.87 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.678 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.923 HD12 HG12 ' A' ' 155' ' ' ILE . 4.6 pt -106.9 114.72 46.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.411 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -119.38 132.33 55.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.768 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 167.06 -151.61 19.67 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.815 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.532 ' CG2' ' HD2' ' A' ' 152' ' ' PRO . 15.9 mt -84.85 144.46 42.02 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.532 ' HD2' ' CG2' ' A' ' 151' ' ' ILE . 73.5 Cg_exo -48.89 -33.77 26.57 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 121.988 1.792 . . . . 0.0 111.689 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -72.05 -34.75 69.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.845 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.3 m -67.97 -50.46 55.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.992 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.923 HG12 HD12 ' A' ' 148' ' ' ILE . 0.0 OUTLIER -59.26 -47.45 90.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.134 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.472 ' N ' HG23 ' A' ' 155' ' ' ILE . 33.6 mt -60.69 -45.9 96.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.819 0.342 . . . . 0.0 110.759 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -60.46 -35.17 75.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.663 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 9.0 t -67.03 -42.99 83.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.774 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 155' ' ' ILE . 21.6 t -59.03 -37.96 71.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.022 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.97 -33.01 73.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.777 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.893 ' O ' HG23 ' A' ' 165' ' ' VAL . 26.1 tp60 -71.47 -46.23 60.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.827 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.631 HG22 ' SD ' ' A' ' 166' ' ' MET . 50.3 mt -67.25 -34.51 69.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.979 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 1.6 m -63.93 -52.37 60.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.017 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 161' ' ' GLN . 10.7 p -59.56 -33.3 51.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.172 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 161' ' ' GLN . 44.0 t -70.69 -44.03 76.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.849 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.631 ' SD ' HG22 ' A' ' 162' ' ' ILE . 0.0 OUTLIER -59.85 -33.09 71.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.855 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.59 -50.56 35.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.76 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -73.97 -2.56 24.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.069 0.461 . . . . 0.0 111.948 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 169' ' ' THR . 60.2 m . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.864 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.4 tttm . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.839 0.352 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -55.07 -84.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.15 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.613 HG11 ' CD1' ' A' ' 167' ' ' LEU . 7.5 p -114.27 159.18 14.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.115 0.483 . . . . 0.0 111.373 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.522 ' N ' HG22 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -109.52 154.05 23.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.787 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' A' ' 14' ' ' LEU . 1.1 mt -144.36 169.28 18.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.054 0.454 . . . . 0.0 111.229 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.2 m -142.72 132.13 23.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.673 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.808 HG22 HD11 ' A' ' 68' ' ' ILE . 2.4 tt -140.83 140.05 33.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.948 0.404 . . . . 0.0 111.326 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.712 ' HG3' HG23 ' A' ' 60' ' ' THR . 1.1 mpp_? -124.48 120.32 31.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.686 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.572 HD21 ' CZ ' ' A' ' 72' ' ' PHE . 14.1 mt -99.8 119.63 38.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.118 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.567 ' C ' HD23 ' A' ' 19' ' ' LEU . 8.3 tt -102.71 105.43 15.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.702 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.6 tpp -120.21 161.48 20.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.902 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.618 ' O ' HG12 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -67.7 172.57 5.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.452 179.807 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.08 -40.79 99.39 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.913 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.93 -45.27 24.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.771 0.32 . . . . 0.0 111.547 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.13 -48.39 78.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.944 0.402 . . . . 0.0 110.283 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.755 HG22 HD11 ' A' ' 29' ' ' ILE . 9.8 p -61.66 -35.2 65.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.852 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.94 -34.92 90.46 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.187 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 m -75.24 -26.76 59.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.879 0.371 . . . . 0.0 110.723 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.456 HG23 HG23 ' A' ' 75' ' ' ILE . 3.9 mm -79.11 -51.48 16.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.123 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.755 HD11 HG22 ' A' ' 25' ' ' VAL . 8.7 mt -57.31 -42.27 79.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.514 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.03 150.84 27.3 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.137 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.416 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -51.59 146.05 8.16 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.058 -0.571 . . . . 0.0 111.143 179.766 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.454 ' HE3' ' HB3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 43.36 27.07 0.12 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.834 -179.65 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.45 ' O ' HG12 ' A' ' 36' ' ' VAL . . . 45.17 21.75 0.43 Allowed Glycine 0 CA--C 1.52 0.4 0 C-N-CA 121.273 -0.489 . . . . 0.0 113.852 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.454 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -76.23 -28.84 57.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.209 0.504 . . . . 0.0 110.314 179.574 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.1 t -73.71 -41.75 62.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.488 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 33' ' ' GLY . 2.3 p -67.42 -27.34 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.2 -36.67 79.91 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 176.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.414 ' HA ' ' CG ' ' A' ' 41' ' ' GLU . 1.8 tttm -70.91 -31.8 68.53 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.241 177.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.409 ' HB2' ' HA ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -63.21 -51.04 67.89 Favored 'General case' 0 C--O 1.228 -0.047 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.463 179.52 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.0 ttt-85 -58.38 -51.57 69.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.581 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.414 ' CG ' ' HA ' ' A' ' 38' ' ' LYS . 1.4 pp20? -64.33 -37.94 89.27 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -74.69 -36.75 62.76 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.853 ' CB ' ' HB2' ' A' ' 71' ' ' ALA . 83.1 p -81.37 -55.65 4.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.906 0.384 . . . . 0.0 111.018 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.93 1.12 56.15 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.736 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -110.66 128.17 55.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.842 0.321 . . . . 0.0 111.304 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.566 ' HB3' ' HB3' ' A' ' 62' ' ' ALA . 8.3 ttm180 -27.27 140.6 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.257 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 60' ' ' THR . 12.0 mt -142.52 101.1 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.696 0.284 . . . . 0.0 110.817 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -118.38 128.77 54.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.781 0.324 . . . . 0.0 111.248 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.61 HG21 ' HD3' ' A' ' 57' ' ' ARG . 9.6 mm -92.11 151.86 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.97 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.7 m -87.16 -177.06 5.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.915 0.388 . . . . 0.0 111.268 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.15 -166.01 0.28 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.111 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.62 -76.94 1.38 Allowed Glycine 0 CA--C 1.51 -0.231 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.296 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.5 t30 48.67 27.6 1.56 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.982 0.42 . . . . 0.0 110.348 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.507 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -149.96 -68.37 0.02 OUTLIER Pre-proline 0 N--CA 1.454 -0.241 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.378 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.507 ' HD3' ' HB3' ' A' ' 54' ' ' CYS . 92.0 Cg_endo -73.22 -32.35 8.46 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.838 1.692 . . . . 0.0 110.323 178.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.34 170.29 2.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.855 -178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.741 ' HB2' HG21 ' A' ' 25' ' ' VAL . 1.5 mtt180 -145.79 139.3 26.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.825 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.419 ' CD1' HD12 ' A' ' 19' ' ' LEU . 6.8 mm -105.62 109.71 28.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.024 0.44 . . . . 0.0 110.892 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.672 HD11 HG23 ' A' ' 25' ' ' VAL . 3.8 mt -86.49 92.83 3.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.094 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.712 HG23 ' HG3' ' A' ' 17' ' ' ARG . 8.0 m -81.1 134.08 35.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.985 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -131.39 134.65 46.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.285 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.566 ' HB3' ' HB3' ' A' ' 46' ' ' ARG . . . -135.47 130.52 34.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.66 0.267 . . . . 0.0 110.862 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.407 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.22 164.61 13.87 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.919 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.475 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 83.6 Cg_exo -39.93 158.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 123.21 2.607 . . . . 0.0 113.238 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.46 ' O ' HG22 ' A' ' 68' ' ' ILE . 29.9 m -60.04 -35.69 75.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.87 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -63.48 -51.83 63.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.262 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.21 -40.7 77.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.057 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.808 HD11 HG22 ' A' ' 16' ' ' ILE . 0.5 OUTLIER -66.19 -39.37 84.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.18 -179.44 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.38 -48.92 79.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.227 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.73 -48.8 79.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.977 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.853 ' HB2' ' CB ' ' A' ' 43' ' ' SER . . . -57.41 -58.75 6.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.286 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.838 ' HA ' HD12 ' A' ' 75' ' ' ILE . 2.7 m-85 -51.84 -39.24 58.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.305 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.61 -43.93 93.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.109 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.0 ttp -72.21 -34.82 68.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.838 HD12 ' HA ' ' A' ' 72' ' ' PHE . 20.9 mt -64.29 -48.7 84.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.965 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.3 pt -62.65 -39.35 84.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.93 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.19 -36.52 82.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.718 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -42.27 93.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.335 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.5 tp -77.34 -24.94 50.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.624 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -76.86 -39.96 49.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.779 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.1 -34.01 68.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.834 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.77 -55.23 35.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.917 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.575 HD12 ' H ' ' A' ' 85' ' ' SER . 0.8 OUTLIER -66.08 -39.87 85.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.222 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.5 t 54.39 24.14 4.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.268 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.575 ' H ' HD12 ' A' ' 83' ' ' ILE . 0.2 OUTLIER 57.94 46.64 16.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.97 0.414 . . . . 0.0 110.873 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.8 m 63.66 93.68 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.651 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -54.58 -26.84 34.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.207 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.459 HG23 ' H ' ' A' ' 89' ' ' ASN . 1.3 t -135.83 -55.19 0.77 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.13 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.459 ' H ' HG23 ' A' ' 88' ' ' THR . 0.6 OUTLIER 177.76 174.35 0.52 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.94 0.4 . . . . 0.0 110.87 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.0 149.29 51.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.864 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.7 p -100.49 39.1 1.4 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.891 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -96.09 -69.0 0.77 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.093 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -165.38 -58.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.165 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.1 m -160.52 -70.78 0.07 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.959 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.8 139.54 20.25 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.403 ' HA ' ' HD2' ' A' ' 97' ' ' PRO . 77.2 Cg_endo -77.38 114.02 3.66 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.514 2.143 . . . . 0.0 112.399 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 96' ' ' PRO . 43.2 Cg_endo -67.91 164.37 31.96 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.419 2.08 . . . . 0.0 112.114 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.497 HG21 ' HD3' ' A' ' 152' ' ' PRO . 19.3 t -134.81 107.04 7.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.197 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.1 p -104.0 135.53 45.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.785 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.585 ' O ' HG22 ' A' ' 148' ' ' ILE . 0.5 OUTLIER -139.98 117.59 11.53 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 178.812 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.485 ' HE ' HD22 ' A' ' 19' ' ' LEU . 18.9 ttp180 -105.2 112.56 25.73 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.291 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.3 mt -99.37 129.97 45.61 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.049 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.893 HG12 ' HB2' ' A' ' 145' ' ' ALA . 21.3 m -103.85 143.99 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.058 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 103' ' ' VAL . 12.7 m -157.94 166.2 17.04 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.09 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.402 ' CD ' ' HB ' ' A' ' 104' ' ' VAL . 21.8 Cg_exo -65.97 171.32 10.17 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.609 2.206 . . . . 0.0 112.356 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 142' ' ' THR . . . -63.58 -34.6 78.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.623 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.3 m -67.34 -30.52 70.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.11 0.481 . . . . 0.0 109.874 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.402 ' CB ' ' HB ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -69.41 -50.53 45.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.772 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.18 -41.52 99.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.646 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -56.55 -47.47 83.8 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.375 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.0 t -71.99 -40.5 68.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.795 0.331 . . . . 0.0 110.815 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.876 HD21 HG23 ' A' ' 162' ' ' ILE . 12.6 mt -54.36 -26.82 32.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.978 0.418 . . . . 0.0 110.598 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.641 HG22 ' HA2' ' A' ' 117' ' ' GLY . 8.2 mt -84.86 -43.18 17.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.791 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.98 -176.74 54.58 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.569 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -67.29 116.89 8.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.896 0.379 . . . . 0.0 111.079 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.57 11.82 57.7 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.999 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.641 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 75.64 2.58 69.88 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.995 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -52.83 -36.79 59.14 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 120.701 0.286 . . . . 0.0 111.609 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.9 mmtp -63.87 -65.27 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.192 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.39 -31.05 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.373 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.98 -46.55 88.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.038 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -73.21 -46.25 51.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.307 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.55 HG23 ' HG2' ' A' ' 161' ' ' GLN . 40.4 mm -54.84 -53.68 30.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.204 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -63.74 -39.92 95.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.26 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.33 -53.93 47.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.33 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.8 m -76.99 -33.47 57.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.294 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.441 HG22 ' H ' ' A' ' 129' ' ' ALA . 17.8 m -52.34 -26.61 12.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.974 0.416 . . . . 0.0 110.125 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.84 -22.09 5.14 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.247 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.643 ' HB3' HD11 ' A' ' 148' ' ' ILE . . . -96.44 165.4 12.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.919 0.36 . . . . 0.0 111.073 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 11.2 mm100 -105.16 138.01 42.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.694 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 27.6 m -99.11 145.07 10.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.16 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.708 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 0.7 OUTLIER -119.57 158.43 26.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.767 -179.685 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 133' ' ' VAL . 11.5 p -120.74 122.13 67.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.792 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -73.33 148.83 43.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.382 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -72.28 97.65 0.77 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.421 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -150.17 -45.15 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.873 0.368 . . . . 0.0 110.79 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 6.3 ttm 61.12 160.32 0.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.487 ' N ' ' CD ' ' A' ' 139' ' ' PRO . 0.3 OUTLIER -80.26 -46.14 1.38 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.172 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 138' ' ' LEU . 49.3 Cg_exo -55.8 -27.88 64.4 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.413 2.076 . . . . 0.0 112.26 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.85 -77.86 0.49 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.858 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.5 t -83.02 -168.69 2.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.834 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.568 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 15.7 m -123.35 -48.56 1.95 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.497 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 7.9 mt-10 -98.67 136.87 38.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.812 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 11.1 mtm-85 -115.6 155.3 27.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.93 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.893 ' HB2' HG12 ' A' ' 103' ' ' VAL . . . -122.43 135.98 54.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.988 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.708 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 21.9 mt -108.91 143.79 18.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.73 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' A' ' 132' ' ' GLN . 0.2 OUTLIER -113.62 116.84 30.12 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.178 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.674 HD13 ' SG ' ' A' ' 158' ' ' CYS . 1.0 OUTLIER -103.78 124.5 58.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.143 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.613 ' O ' ' HB1' ' A' ' 129' ' ' ALA . . . -118.46 146.32 44.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.171 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 149.52 -153.22 25.01 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.255 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.745 HD12 ' HB2' ' A' ' 153' ' ' GLN . 1.3 pt -87.12 156.39 54.64 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.642 0.258 . . . . 0.0 110.863 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.497 ' HD3' HG21 ' A' ' 98' ' ' VAL . 7.4 Cg_endo -49.53 -34.65 34.49 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.621 2.214 . . . . 0.0 111.907 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.745 ' HB2' HD12 ' A' ' 151' ' ' ILE . 0.3 OUTLIER -71.98 -34.66 69.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.391 179.457 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.574 ' HB3' ' HB2' ' A' ' 129' ' ' ALA . 18.6 m -70.37 -39.14 74.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.946 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.533 HD12 HG23 ' A' ' 148' ' ' ILE . 22.7 mm -72.64 -48.59 45.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.214 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.491 HG23 ' N ' ' A' ' 157' ' ' GLU . 20.2 tt -58.21 -45.15 88.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.141 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.491 ' N ' HG23 ' A' ' 156' ' ' ILE . 10.7 pt-20 -62.73 -36.67 83.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.707 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' CYS . . . . . 0.674 ' SG ' HD13 ' A' ' 148' ' ' ILE . 3.9 t -58.22 -47.22 84.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.642 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 30.3 t -61.2 -42.09 92.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.979 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.415 ' O ' HG12 ' A' ' 164' ' ' VAL . 0.2 OUTLIER -60.05 -35.59 75.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.78 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.561 ' O ' HG22 ' A' ' 165' ' ' VAL . 1.1 mp0 -67.24 -37.1 82.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.776 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.876 HG23 HD21 ' A' ' 112' ' ' LEU . 41.3 mt -74.02 -34.38 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.15 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 77.1 m -73.91 -45.15 52.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.076 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.489 HG13 ' N ' ' A' ' 165' ' ' VAL . 11.6 p -62.36 -45.36 98.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.062 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.621 ' O ' HG23 ' A' ' 169' ' ' THR . 28.0 m -65.85 -45.6 90.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.058 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.49 ' N ' HG23 ' A' ' 165' ' ' VAL . 50.8 mtp -57.6 -42.71 83.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.841 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.613 ' CD1' HG11 ' A' ' 12' ' ' VAL . 7.9 tt -72.55 -41.76 65.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.819 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.91 -2.67 24.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.977 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 165' ' ' VAL . 52.6 p . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.838 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.807 0.337 . . . . 0.0 111.182 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -134.44 76.66 1.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.921 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.495 HG11 HD11 ' A' ' 167' ' ' LEU . 21.6 t -145.39 158.35 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.144 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.706 ' O ' HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -109.14 129.49 55.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.506 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.706 HD22 ' O ' ' A' ' 13' ' ' THR . 4.3 mm? -128.84 153.4 47.48 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.175 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 61' ' ' LEU . 25.5 m -135.91 112.76 10.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.502 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.904 HG22 HD11 ' A' ' 68' ' ' ILE . 1.6 tt -111.48 142.97 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.453 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.496 ' NH2' ' OE1' ' A' ' 143' ' ' GLU . 1.1 mpp_? -132.08 126.14 33.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.657 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.452 ' O ' HD12 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -125.13 132.0 53.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.247 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.738 HD21 ' HB2' ' A' ' 56' ' ' GLU . 7.0 tt -102.23 136.32 42.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.632 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.636 ' N ' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -129.99 155.39 46.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.892 0.377 . . . . 0.0 111.135 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.649 ' O ' HG12 ' A' ' 25' ' ' VAL . 11.6 m170 -67.75 175.18 3.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.641 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.01 -41.96 96.69 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.91 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.66 -42.83 27.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.742 0.305 . . . . 0.0 111.677 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.56 -40.99 98.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.986 0.422 . . . . 0.0 110.537 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.724 HG22 HG13 ' A' ' 29' ' ' ILE . 8.6 p -70.89 -32.44 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.657 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.42 -39.86 98.33 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.371 -0.919 . . . . 0.0 112.822 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.5 p -76.06 -35.49 59.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 25' ' ' VAL . 2.1 pp -79.83 -32.61 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.724 HG13 HG22 ' A' ' 25' ' ' VAL . 9.8 mm -71.92 -54.58 16.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.916 0.388 . . . . 0.0 110.427 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.411 ' HA3' ' CB ' ' A' ' 35' ' ' SER . . . 99.65 150.64 25.45 Favored Glycine 0 N--CA 1.436 -1.327 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.945 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.427 ' O ' ' CD ' ' A' ' 32' ' ' LYS . 8.3 mttm -59.67 146.54 40.77 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.478 -0.861 . . . . 0.0 111.214 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.461 ' HE3' ' HB3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 44.2 26.25 0.15 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.997 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.405 ' O ' HG23 ' A' ' 36' ' ' VAL . . . 50.88 18.63 2.91 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.685 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.461 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -75.44 -29.77 59.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.228 0.514 . . . . 0.0 109.992 179.308 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.411 ' CB ' ' HA3' ' A' ' 30' ' ' GLY . 0.3 OUTLIER -75.39 -40.3 58.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.584 179.589 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.709 HG13 ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.09 -26.25 36.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.23 -36.97 74.89 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -63.15 -37.43 87.18 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.396 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.684 ' HE3' HG12 ' A' ' 36' ' ' VAL . 2.5 ttm -59.33 -51.29 70.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.487 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.503 ' HA ' HD12 ' A' ' 47' ' ' ILE . 6.0 mtp180 -53.81 -51.35 63.79 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.159 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -59.27 -38.41 80.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.693 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.27 -20.42 34.51 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.71 ' HB2' ' HB2' ' A' ' 71' ' ' ALA . 11.1 t -90.44 -55.48 3.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.757 0.313 . . . . 0.0 111.554 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.53 -10.93 73.27 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.401 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.81 ' HB3' HD21 ' A' ' 61' ' ' LEU . . . -110.73 128.91 55.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.588 0.232 . . . . 0.0 111.112 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.8 OUTLIER -27.01 140.12 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.204 0.602 . . . . 0.0 112.386 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 40' ' ' ARG . 25.6 mt -142.32 100.55 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.558 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.47 129.99 52.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.751 0.31 . . . . 0.0 111.011 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 3.4 mp -108.4 142.47 20.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.197 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.8 p -161.64 -170.73 2.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.922 0.392 . . . . 0.0 111.317 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.648 ' HG3' HD12 ' A' ' 58' ' ' ILE . 0.3 OUTLIER 66.29 131.15 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.035 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.76 -66.38 0.63 Allowed Glycine 0 CA--C 1.508 -0.375 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.69 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 45.48 25.92 0.27 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.93 0.395 . . . . 0.0 110.565 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.535 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -151.47 -70.13 0.02 OUTLIER Pre-proline 0 N--CA 1.452 -0.375 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.868 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 54' ' ' CYS . 66.5 Cg_endo -81.12 -33.14 0.81 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.157 1.905 . . . . 0.0 110.954 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.738 ' HB2' HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -147.64 170.22 17.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.297 -179.552 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.668 ' HB2' HG21 ' A' ' 25' ' ' VAL . 4.3 mtm180 -145.75 132.71 20.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.851 0.357 . . . . 0.0 110.885 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.648 HD12 ' HG3' ' A' ' 51' ' ' GLU . 46.4 mt -98.05 105.91 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.756 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.452 HD12 ' O ' ' A' ' 18' ' ' LEU . 3.7 mp -86.07 97.61 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.212 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.443 HG23 ' HG3' ' A' ' 17' ' ' ARG . 62.5 m -87.49 136.83 32.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.925 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.81 HD21 ' HB3' ' A' ' 45' ' ' ALA . 2.1 tt -131.42 134.24 46.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.486 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.412 ' O ' ' HB1' ' A' ' 45' ' ' ALA . . . -133.12 130.71 39.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.685 0.278 . . . . 0.0 111.158 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.426 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.26 164.41 13.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.707 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 86.7 Cg_exo -40.75 161.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.019 2.479 . . . . 0.0 113.179 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.456 ' O ' HG22 ' A' ' 68' ' ' ILE . 8.5 m -60.21 -35.64 75.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.115 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 -64.73 -51.88 60.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.362 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.46 ' CB ' ' HB2' ' A' ' 45' ' ' ALA . . . -56.97 -42.4 80.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.957 0.408 . . . . 0.0 110.974 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.904 HD11 HG22 ' A' ' 16' ' ' ILE . 0.5 OUTLIER -66.3 -39.65 84.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.335 -179.334 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -46.12 90.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.061 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -51.2 70.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.991 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.71 ' HB2' ' HB2' ' A' ' 43' ' ' SER . . . -57.37 -41.64 80.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.29 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.439 ' O ' HG13 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -60.37 -39.43 87.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.912 0.387 . . . . 0.0 110.889 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.92 -29.86 68.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.312 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -48.46 14.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.699 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 72' ' ' PHE . 0.7 OUTLIER -59.78 -39.08 78.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.288 -179.597 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 pp -72.48 -37.03 56.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.853 0.359 . . . . 0.0 111.012 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -65.48 -46.94 77.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.498 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.04 -35.3 74.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.012 0.434 . . . . 0.0 110.018 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.7 tp -76.58 -27.27 55.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.141 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.84 -34.13 57.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.696 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.23 -44.28 63.13 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.758 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.3 -51.38 69.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.868 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 28.8 mm -72.11 -30.62 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.939 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.2 t -107.34 48.0 0.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.758 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 m -91.22 14.36 14.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.233 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.83 -14.68 13.04 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.239 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 12.8 mmt 61.41 75.33 0.41 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.846 0.355 . . . . 0.0 110.9 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.2 m -152.77 164.66 37.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.845 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -127.75 162.75 25.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.1 -178.08 3.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.913 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 m -103.72 -58.85 1.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.904 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -148.16 31.19 0.84 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.026 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.33 -72.15 0.72 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.074 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 63.88 35.14 11.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.909 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.7 ptt-85 -141.34 71.17 26.99 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.891 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.05 147.33 54.37 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.611 2.207 . . . . 0.0 112.24 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.14 116.55 4.2 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.51 2.14 . . . . 0.0 112.546 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.873 HG23 HD11 ' A' ' 155' ' ' ILE . 3.6 m -141.02 117.08 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.739 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 148' ' ' ILE . 17.8 m -103.01 141.51 35.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.808 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.97 117.78 11.69 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -100.91 112.64 25.12 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.166 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.701 HD11 HD11 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -109.51 137.37 47.45 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.229 -179.524 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.74 148.93 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.447 HG12 ' HB2' ' A' ' 108' ' ' GLN . 23.4 t -152.81 143.67 15.81 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.227 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.419 ' HD2' ' CG1' ' A' ' 104' ' ' VAL . 20.9 Cg_exo -65.78 163.16 31.65 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.45 2.1 . . . . 0.0 112.192 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.94 -34.96 76.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.666 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.4 m -70.46 -30.48 67.33 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.447 ' HB2' HG12 ' A' ' 104' ' ' VAL . 26.4 mm-40 -71.79 -49.48 38.37 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.435 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.449 ' O ' HD12 ' A' ' 113' ' ' ILE . 2.9 t -64.49 -41.46 96.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.307 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -54.66 -51.81 49.91 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.219 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.9 -35.43 69.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.908 0.385 . . . . 0.0 110.405 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.67 -25.86 66.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.35 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.504 HG22 ' HA2' ' A' ' 117' ' ' GLY . 9.3 mt -84.68 -36.9 12.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.776 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.17 -178.73 16.2 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.505 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.46 129.63 40.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.883 0.373 . . . . 0.0 111.128 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 60.44 17.1 46.34 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.938 -0.648 . . . . 0.0 113.008 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.504 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 67.65 9.53 55.93 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.991 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 4.6 t -53.14 -35.53 59.82 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.801 0.334 . . . . 0.0 111.493 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.422 ' HG3' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -67.95 -64.09 0.93 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.274 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.4 ' HB ' ' HA ' ' A' ' 113' ' ' ILE . 9.1 tt -54.11 -26.94 15.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.822 0.344 . . . . 0.0 111.253 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -48.24 66.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.943 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -73.09 -36.11 66.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.177 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.422 HD11 ' HG3' ' A' ' 119' ' ' LYS . 16.4 mt -67.93 -48.29 75.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.217 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.04 -48.18 59.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.303 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -54.46 -35.29 62.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.46 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 99.9 p -90.21 -35.41 15.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.706 0.289 . . . . 0.0 111.329 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.4 m -52.14 -26.09 10.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.889 0.376 . . . . 0.0 110.106 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.11 -20.18 22.39 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.936 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -108.17 167.75 9.78 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.809 0.338 . . . . 0.0 111.132 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -105.08 129.95 53.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.892 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 147' ' ' THR . 13.2 m -99.29 139.14 21.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.067 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.627 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 1.1 tt0 -125.61 116.61 22.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.174 0.511 . . . . 0.0 112.178 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.3 p -97.46 136.75 27.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.408 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.55 161.11 10.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.056 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.59 155.58 53.37 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.635 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -170.67 32.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.1 mtt -101.8 26.39 7.52 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.298 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.427 ' CB ' ' HD3' ' A' ' 139' ' ' PRO . 0.2 OUTLIER -177.71 -53.48 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.043 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.427 ' HD3' ' CB ' ' A' ' 138' ' ' LEU . 35.9 Cg_exo -59.83 -35.89 92.67 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.341 2.028 . . . . 0.0 112.094 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 63.98 103.19 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.85 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.6 m -120.48 -170.67 2.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.928 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 10.9 t -115.96 -39.77 3.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.84 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.496 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 18.3 mt-10 -127.56 136.91 52.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.826 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.5 mtt180 -113.49 171.74 7.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.73 136.41 53.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.086 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.627 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 40.0 mt -105.86 124.32 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.736 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.452 ' HB ' ' CB ' ' A' ' 132' ' ' GLN . 4.4 m -97.77 114.76 26.85 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.523 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 99' ' ' THR . 23.6 mt -106.34 110.47 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.421 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.36 122.7 43.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.646 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 171.09 -151.38 15.6 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.543 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.527 ' CG2' ' HD2' ' A' ' 152' ' ' PRO . 1.4 mp -80.99 144.72 55.5 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.683 ' HA ' HD12 ' A' ' 155' ' ' ILE . 82.6 Cg_exo -49.02 -31.04 19.52 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 121.987 1.792 . . . . 0.0 111.587 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -72.03 -34.68 69.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.727 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 66.9 m -65.08 -44.81 87.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.734 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.873 HD11 HG23 ' A' ' 98' ' ' VAL . 4.3 mt -66.03 -51.32 61.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.195 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 23.0 mt -55.89 -28.49 24.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.991 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -73.39 -41.24 63.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.942 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' CYS . . . . . 0.512 ' O ' HG22 ' A' ' 162' ' ' ILE . 0.6 OUTLIER -67.09 -48.48 68.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.014 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 11.5 p -60.53 -38.19 77.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.248 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.646 ' O ' HG23 ' A' ' 164' ' ' VAL . 0.5 OUTLIER -69.33 -42.83 74.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.032 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.77 ' O ' HG23 ' A' ' 165' ' ' VAL . 1.8 mt-30 -65.83 -49.39 68.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.036 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.512 HG22 ' O ' ' A' ' 158' ' ' CYS . 17.2 tt -64.15 -45.07 97.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.197 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' CYS . . . . . 0.485 ' N ' HG23 ' A' ' 162' ' ' ILE . 12.6 t -62.54 -48.52 79.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.991 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 160' ' ' LYS . 53.2 t -60.0 -52.69 58.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.094 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 161' ' ' GLN . 33.2 t -62.05 -34.72 64.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.233 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 9.5 tmm? -59.9 -51.89 67.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.994 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.505 HD12 HD21 ' A' ' 14' ' ' LEU . 4.9 tt -58.94 -55.73 31.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.992 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.89 -2.62 24.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.072 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.901 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.806 0.336 . . . . 0.0 111.202 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -89.51 77.17 7.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.584 HG22 ' N ' ' A' ' 13' ' ' THR . 12.5 p -116.77 166.04 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.052 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.584 ' N ' HG22 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -103.13 141.96 34.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.595 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.5 mt -136.14 177.24 7.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.171 0.51 . . . . 0.0 111.447 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.2 m -141.71 113.07 7.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.557 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.777 HG22 HD11 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -111.63 126.47 69.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.976 0.417 . . . . 0.0 111.471 -179.601 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.711 ' CG ' HG23 ' A' ' 60' ' ' THR . 81.9 mtm-85 -112.57 116.31 30.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.446 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.52 HD12 ' CE ' ' A' ' 20' ' ' MET . 0.4 OUTLIER -114.59 119.6 37.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.237 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.428 HD11 ' HE ' ' A' ' 101' ' ' ARG . 1.8 pp -113.38 133.96 54.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.825 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.541 ' HB2' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -135.23 177.02 8.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.959 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.836 ' O ' HG22 ' A' ' 25' ' ' VAL . 6.8 m-70 -67.57 166.0 15.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.61 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.73 -31.96 72.9 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.925 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -78.37 -42.27 30.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.806 0.336 . . . . 0.0 111.335 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.58 ' O ' HG22 ' A' ' 28' ' ' ILE . 14.6 mt-10 -67.79 -43.11 80.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.917 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 21' ' ' HIS . 18.2 m -65.48 -40.39 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.314 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.91 -41.35 99.9 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.892 -0.67 . . . . 0.0 113.229 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.6 m -75.96 -35.64 59.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.721 0.296 . . . . 0.0 111.63 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.58 HG22 ' O ' ' A' ' 24' ' ' GLU . 2.7 tp -76.73 -50.52 21.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.746 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.538 ' N ' HG23 ' A' ' 28' ' ' ILE . 31.4 mt -60.19 -42.43 90.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.914 0.388 . . . . 0.0 110.752 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.422 ' HA3' ' CB ' ' A' ' 35' ' ' SER . . . 99.82 150.84 25.53 Favored Glycine 0 N--CA 1.435 -1.399 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.556 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.409 ' O ' ' CD ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -57.98 146.42 32.59 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.825 -0.688 . . . . 0.0 111.378 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.532 ' HD2' ' HB2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 44.01 27.04 0.17 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.956 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 50.6 19.64 3.32 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 114.512 0.565 . . . . 0.0 114.512 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.532 ' HB2' ' HD2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -76.98 -35.44 57.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.755 0.778 . . . . 0.0 109.966 179.095 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -68.81 -43.14 76.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.65 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.7 p -67.36 -27.04 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.91 -36.7 82.85 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 176.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 35' ' ' SER . 0.5 OUTLIER -69.71 -34.66 74.2 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.517 -1.219 . . . . 0.0 108.948 177.792 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -67.34 -41.22 85.56 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.101 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.476 ' HA ' HD12 ' A' ' 47' ' ' ILE . 4.4 ttp-105 -58.48 -51.35 70.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.194 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -59.76 -38.51 81.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.807 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -75.27 -36.27 61.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.693 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.691 ' HB2' ' HB2' ' A' ' 71' ' ' ALA . 19.7 t -73.02 -49.27 29.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.28 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.18 -8.96 78.66 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.292 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.46 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . . . -110.91 128.48 55.82 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.6 0.238 . . . . 0.0 111.156 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.616 ' HB2' ' HB3' ' A' ' 62' ' ' ALA . 0.8 OUTLIER -27.23 136.74 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.221 179.356 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 40' ' ' ARG . 4.2 mt -142.7 100.47 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.979 178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -115.88 165.84 12.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.916 0.389 . . . . 0.0 111.421 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.617 HG23 HD13 ' A' ' 59' ' ' ILE . 3.2 mp -126.47 151.74 33.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.798 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.59 -178.64 0.75 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.983 0.42 . . . . 0.0 111.4 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.663 ' CB ' HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER 66.12 134.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.12 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.39 -75.67 0.14 Allowed Glycine 0 CA--C 1.508 -0.351 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.675 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.3 m120 54.62 21.86 3.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.874 0.368 . . . . 0.0 110.038 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.502 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -148.31 -68.66 0.02 OUTLIER Pre-proline 0 N--CA 1.452 -0.356 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.937 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.502 ' HD3' ' HB3' ' A' ' 54' ' ' CYS . 80.5 Cg_endo -80.23 -34.55 0.81 Allowed 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.096 1.864 . . . . 0.0 111.158 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.82 176.96 8.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.516 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.518 ' HB2' HG21 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -145.71 127.59 15.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.857 179.523 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.663 HD12 ' CB ' ' A' ' 51' ' ' GLU . 19.1 mt -102.22 110.67 29.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.617 HD13 HG23 ' A' ' 49' ' ' ILE . 26.3 mm -94.62 96.38 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.088 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.711 HG23 ' CG ' ' A' ' 17' ' ' ARG . 6.0 m -76.33 139.14 40.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.795 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -131.29 133.27 45.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.267 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.616 ' HB3' ' HB2' ' A' ' 46' ' ' ARG . . . -133.03 129.31 37.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.79 0.328 . . . . 0.0 111.109 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.431 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.15 164.18 13.35 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.726 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 94.6 Cg_exo -42.2 161.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.106 2.537 . . . . 0.0 113.07 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.496 ' O ' HG22 ' A' ' 68' ' ' ILE . 34.1 m -59.97 -35.72 75.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.974 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -62.42 -51.88 65.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.224 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.46 ' CB ' ' HB2' ' A' ' 45' ' ' ALA . . . -56.99 -37.64 71.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.008 0.432 . . . . 0.0 110.989 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.777 HD11 HG22 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -66.21 -39.36 84.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.194 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -47.28 81.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.888 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.74 -51.91 67.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.745 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.691 ' HB2' ' HB2' ' A' ' 43' ' ' SER . . . -56.11 -58.37 8.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.315 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.624 ' HA ' HD12 ' A' ' 75' ' ' ILE . 0.9 OUTLIER -49.2 -32.53 10.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.33 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.21 -41.59 81.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.11 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -75.91 -32.84 59.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.055 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.624 HD12 ' HA ' ' A' ' 72' ' ' PHE . 18.2 mt -68.11 -43.63 85.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.963 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 72' ' ' PHE . 23.1 pt -67.88 -40.34 83.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.971 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.401 ' N ' HG13 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -65.03 -41.04 95.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.443 179.836 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.3 tptt -61.87 -35.92 79.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.055 0.455 . . . . 0.0 110.048 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.7 tp -77.39 -28.15 52.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.435 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -76.69 -35.11 58.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.649 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.29 -42.75 65.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.824 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.81 -50.14 75.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.041 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.526 HG23 ' HA ' ' A' ' 86' ' ' SER . 41.4 mt -62.05 -52.89 54.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.935 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.9 t 61.29 -80.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.109 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.3 p -101.52 -22.32 14.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.087 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.526 ' HA ' HG23 ' A' ' 83' ' ' ILE . 0.2 OUTLIER 70.66 95.57 0.07 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.879 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -68.62 -29.84 68.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.904 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.06 87.48 3.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.867 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -121.69 143.47 49.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.914 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.5 t -152.48 -46.9 0.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.813 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.3 p -150.78 -47.03 0.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.865 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -148.35 98.36 2.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.194 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -165.33 75.21 0.24 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.927 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.6 p -138.08 -43.7 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.29 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.471 ' CB ' ' HD3' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -157.48 -59.8 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.516 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.568 ' HA ' HG22 ' A' ' 151' ' ' ILE . 58.9 Cg_exo -50.44 -45.88 32.13 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.087 1.858 . . . . 0.0 112.632 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 10.2 Cg_exo -71.62 116.6 4.76 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.465 2.11 . . . . 0.0 111.938 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.685 HG12 HD11 ' A' ' 100' ' ' LEU . 19.7 t -140.88 111.87 3.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.347 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 16.0 m -103.41 134.28 47.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.634 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.685 HD11 HG12 ' A' ' 98' ' ' VAL . 5.4 mp -139.91 117.76 11.71 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.428 ' HE ' HD11 ' A' ' 19' ' ' LEU . 6.3 ttp180 -101.98 112.5 25.16 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.132 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.505 ' O ' HG22 ' A' ' 146' ' ' ILE . 8.1 mp -113.47 162.32 16.28 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.935 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.407 HG12 ' CB ' ' A' ' 17' ' ' ARG . 11.3 p -98.73 136.42 29.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.022 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.457 ' CG1' ' HD2' ' A' ' 105' ' ' PRO . 25.4 t -138.66 145.37 45.93 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.104 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.457 ' HD2' ' CG1' ' A' ' 104' ' ' VAL . 21.6 Cg_exo -65.99 159.92 46.85 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.475 2.116 . . . . 0.0 112.146 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.99 -34.64 75.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.5 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 m -69.48 -30.45 68.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.168 0.508 . . . . 0.0 109.771 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.411 ' HB3' ' CG1' ' A' ' 104' ' ' VAL . 0.7 OUTLIER -70.34 -50.54 38.02 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.463 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.411 ' O ' HG12 ' A' ' 113' ' ' ILE . 53.5 t -62.19 -43.48 98.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.381 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -53.89 -47.52 65.46 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.395 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.85 -40.31 69.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.804 0.335 . . . . 0.0 110.644 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 112' ' ' LEU . 19.1 mt -55.97 -27.82 54.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.0 0.428 . . . . 0.0 110.486 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.431 ' CG2' ' HA2' ' A' ' 117' ' ' GLY . 28.0 mm -82.07 -39.89 16.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.582 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.66 -177.67 26.02 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.501 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -67.54 125.15 25.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.894 0.378 . . . . 0.0 111.129 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.72 13.1 58.46 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.989 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.431 ' HA2' ' CG2' ' A' ' 113' ' ' ILE . . . 70.84 7.31 61.6 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.974 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 5.2 t -53.0 -39.64 63.24 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.786 0.326 . . . . 0.0 111.695 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.863 ' HD2' HD11 ' A' ' 123' ' ' ILE . 0.6 OUTLIER -61.33 -65.36 0.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.286 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.73 HD11 HG21 ' A' ' 131' ' ' VAL . 1.6 tp -55.83 -32.22 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.356 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.26 -52.3 66.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.157 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -73.08 -40.95 64.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.432 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.863 HD11 ' HD2' ' A' ' 119' ' ' LYS . 53.8 mt -57.24 -53.65 40.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.362 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.03 -38.25 72.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.353 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -54.84 -39.95 69.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.615 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.07 -37.55 11.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.602 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 17.2 m -49.73 -26.14 3.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.887 0.375 . . . . 0.0 110.265 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.46 -12.14 28.37 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.825 -0.702 . . . . 0.0 113.224 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.589 ' HB2' ' HB3' ' A' ' 154' ' ' SER . . . -108.27 146.3 33.08 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.953 0.377 . . . . 0.0 111.299 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.16 129.52 43.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.597 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.986 HG12 HG22 ' A' ' 148' ' ' ILE . 6.7 m -99.28 150.38 5.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.351 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.66 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 11.4 tt0 -122.65 158.55 29.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.01 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.6 m -137.45 140.89 40.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.227 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.75 161.14 24.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.125 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -78.62 -166.38 30.0 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.642 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -139.29 -42.35 0.46 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.706 0.289 . . . . 0.0 110.982 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 16.9 mtp 69.6 -167.57 0.17 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.817 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.547 ' N ' ' HD2' ' A' ' 139' ' ' PRO . 1.3 tp -50.63 -53.69 43.63 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.25 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 138' ' ' LEU . 35.5 Cg_endo -64.21 -160.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.214 1.943 . . . . 0.0 111.904 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -163.1 99.02 0.95 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.116 0.484 . . . . 0.0 110.768 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.1 -169.05 0.25 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.93 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.57 -50.56 2.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.639 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.483 ' OE2' ' NH2' ' A' ' 17' ' ' ARG . 10.1 mt-10 -115.09 137.92 51.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.679 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -109.88 176.99 4.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.909 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -110.41 130.7 55.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.166 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.859 HD11 ' HB ' ' A' ' 131' ' ' VAL . 0.5 OUTLIER -113.55 140.03 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.772 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.503 ' HB ' ' HB2' ' A' ' 132' ' ' GLN . 0.7 OUTLIER -115.98 114.99 25.37 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.304 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.986 HG22 HG12 ' A' ' 131' ' ' VAL . 1.6 pt -106.78 123.43 61.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.11 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.48 136.2 53.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.101 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 160.87 -162.88 33.88 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.513 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.8 HD12 ' HB2' ' A' ' 153' ' ' GLN . 2.7 pt -87.02 161.49 46.71 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.61 0.243 . . . . 0.0 110.95 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.476 ' HA ' HD12 ' A' ' 155' ' ' ILE . 74.8 Cg_exo -49.4 -40.0 44.4 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.431 2.087 . . . . 0.0 112.041 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.8 ' HB2' HD12 ' A' ' 151' ' ' ILE . 3.1 mm-40 -64.69 -34.7 78.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.301 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.589 ' HB3' ' HB2' ' A' ' 129' ' ' ALA . 61.8 m -69.4 -34.02 73.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.71 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 152' ' ' PRO . 26.6 mt -73.09 -53.34 18.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.945 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.447 ' HA ' HG12 ' A' ' 159' ' ' VAL . 37.7 mm -59.15 -28.63 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.061 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -75.17 -40.16 59.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.033 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -72.14 -38.91 69.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.183 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.447 HG12 ' HA ' ' A' ' 156' ' ' ILE . 12.1 p -69.98 -41.96 79.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.393 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.614 ' O ' HG23 ' A' ' 164' ' ' VAL . 8.3 pttt -65.54 -38.58 90.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.039 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -64.42 -49.41 71.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.768 HD13 ' O ' ' A' ' 162' ' ' ILE . 0.0 OUTLIER -64.78 -34.52 70.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.977 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 34.1 m -67.76 -43.4 79.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 160' ' ' LYS . 54.0 t -59.6 -52.68 58.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.9 p -64.26 -30.4 50.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.021 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -59.31 -51.57 69.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.951 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.557 HD22 HG21 ' A' ' 12' ' ' VAL . 9.6 mt -70.03 -45.91 66.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.949 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -73.99 -2.48 24.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.052 0.454 . . . . 0.0 112.018 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.848 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 120.822 0.344 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 43.04 60.64 2.43 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.554 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 13' ' ' THR . 20.3 t -120.56 158.26 22.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.913 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -103.77 139.34 39.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.029 -179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 14' ' ' LEU . 2.0 mt -143.02 166.1 25.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.008 0.433 . . . . 0.0 111.188 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 m -142.73 140.65 31.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.632 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.691 HG22 HD11 ' A' ' 68' ' ' ILE . 17.8 tt -140.87 152.51 20.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.972 0.415 . . . . 0.0 111.479 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.487 ' NH2' ' OE2' ' A' ' 143' ' ' GLU . 2.8 ttm-85 -134.99 129.68 34.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.389 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.02 135.23 51.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.947 0.403 . . . . 0.0 111.121 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.545 HD12 HG23 ' A' ' 58' ' ' ILE . 1.8 mp -93.32 115.0 27.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.628 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -107.87 141.02 40.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.951 0.405 . . . . 0.0 110.89 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.437 ' HA ' ' O ' ' A' ' 55' ' ' PRO . 1.4 t-80 -67.6 163.89 20.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.602 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.518 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -58.7 -45.05 95.32 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.699 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.45 -43.28 27.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.985 0.422 . . . . 0.0 110.91 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.77 ' O ' HG23 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -62.01 -32.79 73.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.508 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.698 HG22 HG13 ' A' ' 29' ' ' ILE . 9.8 p -76.95 -31.22 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.474 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.36 -42.71 99.7 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.441 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.9 m -75.87 -37.24 59.12 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.669 0.271 . . . . 0.0 111.605 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.77 HG23 ' O ' ' A' ' 24' ' ' GLU . 1.7 pp -76.29 -32.7 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 120.787 0.327 . . . . 0.0 111.879 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.769 ' HA ' HG13 ' A' ' 36' ' ' VAL . 10.9 mm -70.68 -54.74 16.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.253 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.406 ' HA3' ' CB ' ' A' ' 35' ' ' SER . . . 99.56 150.29 25.13 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-O 121.769 0.649 . . . . 0.0 113.026 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.58 ' HB3' ' HD3' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -67.13 146.37 54.33 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.413 -0.893 . . . . 0.0 111.113 179.606 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.58 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER 63.71 6.82 2.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.37 -179.603 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.444 ' O ' HG23 ' A' ' 36' ' ' VAL . . . 57.71 12.67 10.5 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 119.84 -1.171 . . . . 0.0 111.648 -178.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -76.78 -28.93 55.84 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.918 0.39 . . . . 0.0 110.091 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.406 ' CB ' ' HA3' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -73.33 -41.5 63.43 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.184 179.567 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.769 HG13 ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.16 -26.38 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.552 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.98 -36.87 75.53 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.49 -37.45 86.04 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.776 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.483 ' HE3' ' HA ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -62.14 -52.45 63.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.432 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.515 ' HG2' HD12 ' A' ' 47' ' ' ILE . 39.9 mtm180 -50.56 -51.21 50.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.206 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -57.98 -38.04 75.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.72 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -75.11 -36.11 61.68 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.862 ' HB2' ' HB2' ' A' ' 71' ' ' ALA . 79.6 p -82.69 -55.75 4.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.846 0.355 . . . . 0.0 111.66 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.9 -5.62 66.46 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.426 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.753 ' HB3' HD21 ' A' ' 61' ' ' LEU . . . -110.67 128.83 55.86 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.688 0.28 . . . . 0.0 111.138 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 47.8 ttm-85 -27.16 137.84 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.339 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.515 HD12 ' HG2' ' A' ' 40' ' ' ARG . 12.2 mt -142.27 100.43 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.705 0.288 . . . . 0.0 110.471 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.95 171.38 7.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.724 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 58' ' ' ILE . 6.0 mt -126.7 149.78 31.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.954 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.88 -169.3 1.96 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.911 0.386 . . . . 0.0 111.302 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -75.41 -160.21 0.12 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.029 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -151.64 -71.92 0.01 OUTLIER Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.021 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.3 m120 58.39 19.07 6.07 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.529 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -167.4 -66.26 0.01 OUTLIER Pre-proline 0 N--CA 1.452 -0.351 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.475 -179.755 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.558 ' O ' ' CB ' ' A' ' 56' ' ' GLU . 64.0 Cg_endo -81.75 -33.18 0.68 Allowed 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.384 2.056 . . . . 0.0 111.493 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.558 ' CB ' ' O ' ' A' ' 55' ' ' PRO . 2.7 mt-10 110.48 -43.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.577 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.548 ' HB2' HG11 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -145.88 142.15 28.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.987 0.422 . . . . 0.0 111.626 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.545 HG23 HD12 ' A' ' 19' ' ' LEU . 25.5 mt -123.25 131.16 73.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.127 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.714 HD11 HD11 ' A' ' 28' ' ' ILE . 30.0 mt -109.24 106.12 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.87 0.367 . . . . 0.0 111.766 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 66.9 m -93.05 139.17 30.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.805 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.753 HD21 ' HB3' ' A' ' 45' ' ' ALA . 6.3 tt -131.5 137.26 48.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.726 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.719 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -135.55 132.37 37.13 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.563 0.22 . . . . 0.0 110.851 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.421 ' HA3' ' HB1' ' A' ' 45' ' ' ALA . . . 157.19 164.83 14.11 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.261 -0.971 . . . . 0.0 112.928 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 95.7 Cg_exo -42.47 159.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.986 2.457 . . . . 0.0 113.041 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.472 ' O ' HG22 ' A' ' 68' ' ' ILE . 35.8 m -60.28 -35.69 76.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.981 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -66.34 -52.02 51.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.15 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.77 -37.64 71.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.691 HD11 HG22 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -66.36 -39.24 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.157 -179.643 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.43 -51.9 67.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.842 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -43.83 88.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.587 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.862 ' HB2' ' HB2' ' A' ' 43' ' ' SER . . . -55.48 -45.54 76.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.22 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.464 ' CE1' HD13 ' A' ' 16' ' ' ILE . 1.2 m-85 -58.46 -50.3 74.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.207 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.0 -36.99 68.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.599 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.85 -40.0 49.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.23 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 72' ' ' PHE . 12.1 mt -62.42 -51.46 72.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.652 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.22 -38.54 80.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.991 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.26 -29.59 65.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.416 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -35.33 80.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.054 0.454 . . . . 0.0 109.81 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.9 tp -76.65 -31.69 57.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.172 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -76.79 -32.85 57.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.769 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -72.25 -36.85 69.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.783 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.98 -54.97 31.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.992 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 15.9 pt -56.83 -42.7 78.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.195 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.24 -176.03 6.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.962 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.9 p 79.88 -55.81 0.38 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.941 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.2 114.27 6.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.939 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.54 -177.81 4.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.866 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.9 m -114.92 157.06 23.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.926 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -60.95 -32.8 72.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.902 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.7 m -65.42 155.56 35.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.06 153.88 19.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.848 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -90.12 -61.53 1.66 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.102 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -160.51 -78.48 0.05 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.166 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.18 97.42 0.27 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.864 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.6 tpp85 63.92 126.11 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.92 107.94 0.84 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.463 2.108 . . . . 0.0 112.167 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -69.82 162.96 40.09 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.672 2.248 . . . . 0.0 112.198 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.4 t -126.21 103.36 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.95 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 11.0 t -113.26 133.49 55.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.01 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.76 ' HB3' HD11 ' A' ' 155' ' ' ILE . 6.6 tp -139.94 117.86 11.77 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.722 ' HB3' HG23 ' A' ' 147' ' ' THR . 0.0 OUTLIER -107.62 112.67 25.51 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.631 -178.684 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.616 HD21 HD21 ' A' ' 100' ' ' LEU . 28.5 mt -102.64 155.38 18.33 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.903 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.465 HG13 ' O ' ' A' ' 144' ' ' ARG . 17.0 t -106.71 141.15 22.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.17 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.405 ' HB ' ' CB ' ' A' ' 108' ' ' GLN . 6.4 m -145.44 155.94 53.47 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.124 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.64 162.86 35.23 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.552 2.168 . . . . 0.0 112.583 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.63 -34.51 69.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.502 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.1 m -67.24 -30.71 70.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.151 0.501 . . . . 0.0 109.823 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.405 ' CB ' ' HB ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -67.58 -45.4 75.65 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.525 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.509 ' SG ' HD11 ' A' ' 113' ' ' ILE . 42.7 t -66.68 -49.32 66.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.63 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -49.29 -51.96 24.68 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.522 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.9 p -71.84 -40.21 69.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.765 0.317 . . . . 0.0 110.545 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.723 HD21 HD12 ' A' ' 162' ' ' ILE . 7.4 mt -54.93 -28.72 53.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.045 0.45 . . . . 0.0 110.246 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.509 HD11 ' SG ' ' A' ' 109' ' ' CYS . 17.9 mt -80.02 -44.6 22.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.552 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 76.94 -173.25 54.88 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.588 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.5 tptp -64.56 118.98 9.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.894 0.378 . . . . 0.0 111.197 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 56.85 20.32 32.65 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.987 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.459 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 71.8 6.98 64.62 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.988 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 30.9 p -53.1 -40.12 63.9 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 120.826 0.346 . . . . 0.0 111.707 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.84 ' HD2' HD11 ' A' ' 123' ' ' ILE . 0.7 OUTLIER -65.26 -65.29 0.69 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.5 -179.474 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.884 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.6 OUTLIER -55.1 -34.29 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.581 -179.509 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -60.64 -45.09 95.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.011 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -73.11 -32.37 64.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.101 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.884 HD12 ' HA ' ' A' ' 120' ' ' ILE . 26.7 mt -64.24 -43.38 97.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.184 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.84 -42.7 60.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.92 0.391 . . . . 0.0 111.017 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -58.83 -35.37 72.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.733 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.8 t -93.45 -45.55 7.73 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.675 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.1 m -48.37 -25.64 1.7 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.874 0.368 . . . . 0.0 110.275 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.48 -9.49 41.94 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.048 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.569 ' HB1' ' O ' ' A' ' 149' ' ' ALA . . . -108.29 153.72 22.84 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.932 0.366 . . . . 0.0 111.201 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -99.7 141.29 32.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.732 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.709 ' HB ' HD11 ' A' ' 146' ' ' ILE . 11.4 m -99.22 157.9 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.356 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.789 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 0.1 OUTLIER -128.78 158.45 38.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.447 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.511 HG22 HH21 ' A' ' 144' ' ' ARG . 21.0 t -129.39 118.87 47.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.967 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.69 161.11 29.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.242 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -78.43 105.59 2.2 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.454 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -156.53 -44.3 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.823 0.344 . . . . 0.0 111.024 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 65.65 172.1 0.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.808 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.527 ' N ' HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -88.06 -51.15 0.41 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.974 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 138' ' ' LEU . 33.5 Cg_exo -57.87 -28.86 84.24 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.495 2.13 . . . . 0.0 112.327 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -85.82 -80.71 0.22 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.999 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.28 -168.75 2.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.913 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.9 t -115.49 -41.82 3.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.699 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.487 ' OE2' ' NH2' ' A' ' 17' ' ' ARG . 15.2 pt-20 -118.17 139.13 51.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.703 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.511 HH21 HG22 ' A' ' 133' ' ' VAL . 5.4 ptm180 -109.91 168.2 9.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.938 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.56 134.33 54.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.303 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.789 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 1.5 tt -116.37 131.94 67.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.519 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.722 HG23 ' HB3' ' A' ' 101' ' ' ARG . 1.0 OUTLIER -109.45 116.05 31.08 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.715 -179.554 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.58 HG23 HD12 ' A' ' 155' ' ' ILE . 4.7 tp -104.89 121.99 57.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.742 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.569 ' O ' ' HB1' ' A' ' 129' ' ' ALA . . . -118.39 140.41 49.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.204 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 166.14 -154.29 24.76 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.355 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.553 HD12 ' HB2' ' A' ' 153' ' ' GLN . 1.2 pt -87.06 161.96 45.17 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.59 0.234 . . . . 0.0 110.839 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.509 ' O ' HG22 ' A' ' 156' ' ' ILE . 73.7 Cg_exo -49.51 -34.96 35.31 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.315 2.01 . . . . 0.0 112.209 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.553 ' HB2' HD12 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -72.06 -34.74 68.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.817 179.736 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 53.1 p -74.25 -41.15 61.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.971 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.76 HD11 ' HB3' ' A' ' 100' ' ' LEU . 0.7 OUTLIER -68.73 -41.28 82.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.175 -179.841 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.509 HG22 ' O ' ' A' ' 152' ' ' PRO . 1.1 tp -69.68 -32.83 53.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.141 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -69.84 -49.22 54.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.894 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -58.61 -53.1 62.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.097 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.744 HG23 ' O ' ' A' ' 155' ' ' ILE . 30.1 t -57.35 -35.53 49.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.296 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 10.5 tptp -68.32 -32.91 73.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.978 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.645 ' O ' HG13 ' A' ' 165' ' ' VAL . 29.6 mt-30 -72.06 -38.32 69.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.033 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.723 HD12 HD21 ' A' ' 112' ' ' LEU . 36.0 mm -74.01 -34.48 39.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.2 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.17 -37.47 69.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.099 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 14.0 p -74.36 -39.68 48.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.456 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.645 HG13 ' O ' ' A' ' 161' ' ' GLN . 36.0 m -69.5 -45.59 78.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.418 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.477 ' N ' HG23 ' A' ' 165' ' ' VAL . 5.6 ptm -62.01 -45.93 91.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.928 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.13 -51.11 41.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.931 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -74.02 -2.53 24.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.959 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.591 ' HD2' HG21 ' A' ' 65' ' ' THR . 8.0 mmtt . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.855 0.359 . . . . 0.0 111.236 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -142.63 50.46 1.46 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.642 HG21 HD21 ' A' ' 167' ' ' LEU . 21.5 t -126.28 152.65 33.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.97 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 1.4 m -103.25 146.91 27.73 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.682 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.57 HD21 ' HA ' ' A' ' 65' ' ' THR . 2.3 pp -158.21 139.77 13.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.531 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.588 HG23 ' O ' ' A' ' 61' ' ' LEU . 58.3 m -113.12 129.92 56.35 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.31 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.616 HG12 HD11 ' A' ' 68' ' ' ILE . 2.0 pt -112.13 163.98 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.223 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.493 ' NH2' ' OE2' ' A' ' 143' ' ' GLU . 0.9 OUTLIER -133.96 123.06 23.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.834 179.765 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.472 HD21 ' CZ ' ' A' ' 72' ' ' PHE . 67.5 mt -114.58 119.87 38.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.201 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.856 HD12 ' O ' ' A' ' 101' ' ' ARG . 0.2 OUTLIER -115.8 128.1 55.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.723 179.699 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.79 ' HB2' HG12 ' A' ' 25' ' ' VAL . 0.9 OUTLIER -142.11 162.38 35.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.835 0.35 . . . . 0.0 111.208 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.811 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.9 OUTLIER -70.2 163.45 26.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.888 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.415 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -49.19 -35.83 20.56 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.659 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -51.4 10.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.922 0.361 . . . . 0.0 111.958 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.4 ' HB3' ' HB3' ' A' ' 20' ' ' MET . 0.3 OUTLIER -61.93 -33.56 74.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.818 0.342 . . . . 0.0 110.991 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.811 HG13 ' O ' ' A' ' 21' ' ' HIS . 15.4 m -71.54 -39.96 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.083 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.01 -35.16 91.02 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.635 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 p -75.45 -33.55 60.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.668 0.271 . . . . 0.0 111.388 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.812 HD11 HG22 ' A' ' 75' ' ' ILE . 1.7 tp -79.21 -47.09 22.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.451 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.733 ' HA ' HG13 ' A' ' 36' ' ' VAL . 8.1 mm -57.25 -50.25 77.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.872 0.368 . . . . 0.0 110.204 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.41 ' HA3' ' HB3' ' A' ' 35' ' ' SER . . . 97.9 150.32 26.18 Favored Glycine 0 N--CA 1.437 -1.278 0 CA-C-O 121.747 0.637 . . . . 0.0 113.012 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.401 ' O ' ' CD ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -62.42 145.9 52.84 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.528 -0.836 . . . . 0.0 111.321 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.465 ' HG2' ' HB2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 51.36 18.89 0.69 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.461 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.491 ' O ' HG23 ' A' ' 36' ' ' VAL . . . 53.69 11.32 1.91 Allowed Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.936 -0.65 . . . . 0.0 114.26 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.465 ' HB2' ' HG2' ' A' ' 32' ' ' LYS . 4.0 tp10 -74.69 -27.2 60.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.536 0.668 . . . . 0.0 109.735 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.41 ' HB3' ' HA3' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -75.39 -39.84 58.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.514 179.434 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.733 HG13 ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.28 -26.34 35.91 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.588 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -70.66 -36.73 73.52 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -62.61 -34.73 77.62 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.936 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -43.05 81.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.711 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 44.9 mtp85 -58.1 -51.15 70.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.846 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -63.86 -38.02 89.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.037 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.84 -35.7 62.4 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.507 ' CB ' ' HB2' ' A' ' 71' ' ' ALA . 53.2 p -88.34 -55.79 3.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.937 0.399 . . . . 0.0 110.879 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.14 4.76 62.74 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.193 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.49 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -110.77 127.31 55.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.077 0.438 . . . . 0.0 111.317 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.789 ' HB2' ' HB3' ' A' ' 62' ' ' ALA . 1.8 mpt_? -27.75 104.3 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.275 0.63 . . . . 0.0 112.551 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.8 mt -107.45 100.58 11.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.832 0.348 . . . . 0.0 110.935 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.39 169.94 8.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.256 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.567 HG21 ' HD2' ' A' ' 57' ' ' ARG . 13.9 mt -126.46 152.13 33.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.144 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.451 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . 33.1 t -92.12 -161.4 0.82 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.738 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -69.3 176.84 3.09 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.2 0.524 . . . . 0.0 112.144 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.598 ' O ' ' O ' ' A' ' 56' ' ' GLU . . . 51.79 109.65 0.01 OUTLIER Glycine 0 CA--C 1.505 -0.546 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.311 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.418 ' HA ' ' CD ' ' A' ' 57' ' ' ARG . 7.6 p-10 -105.2 37.54 2.16 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 176.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.496 ' CB ' ' CD ' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -154.58 -66.26 0.02 OUTLIER Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 115.08 -0.964 . . . . 0.0 113.303 -177.361 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 54' ' ' CYS . 36.8 Cg_endo -59.45 -34.74 97.22 Favored 'Trans proline' 0 CA--C 1.508 -0.819 0 C-N-CA 122.427 2.085 . . . . 0.0 110.446 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.598 ' O ' ' O ' ' A' ' 52' ' ' GLY . 0.2 OUTLIER -174.52 167.17 3.9 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.659 -178.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.567 ' HD2' HG21 ' A' ' 49' ' ' ILE . 3.0 mmt180 -144.5 136.55 26.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.874 0.368 . . . . 0.0 110.992 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.845 HD12 HD23 ' A' ' 19' ' ' LEU . 4.5 mm -115.64 106.8 21.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.555 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.1 mt -85.98 94.05 4.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.882 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.0 m -80.04 101.87 8.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.138 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.588 ' O ' HG23 ' A' ' 15' ' ' THR . 0.1 OUTLIER -91.28 144.79 25.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.908 179.322 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.789 ' HB3' ' HB2' ' A' ' 46' ' ' ARG . . . -143.76 124.71 14.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.777 0.323 . . . . 0.0 111.051 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.57 164.0 13.28 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.159 -1.02 . . . . 0.0 113.104 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.563 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 78.6 Cg_exo -41.48 160.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 123.555 2.836 . . . . 0.0 113.798 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.591 HG21 ' HD2' ' A' ' 10' ' ' LYS . 13.6 t -57.89 -35.72 71.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.135 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.37 -52.48 46.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.917 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.35 -43.32 83.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.316 0.579 . . . . 0.0 110.429 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.616 HD11 HG12 ' A' ' 16' ' ' ILE . 0.5 OUTLIER -66.53 -39.4 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.842 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.85 -36.51 67.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.763 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.08 -38.94 63.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.691 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.507 ' HB2' ' CB ' ' A' ' 43' ' ' SER . . . -63.65 -48.25 77.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.149 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.575 ' CE2' HD13 ' A' ' 16' ' ' ILE . 1.2 m-85 -64.04 -43.06 96.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.473 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -68.78 -29.26 67.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.306 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.6 tpt -77.29 -48.3 17.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.688 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.812 HG22 HD11 ' A' ' 28' ' ' ILE . 2.2 pp -59.81 -42.98 90.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.252 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.597 HG23 ' CD1' ' A' ' 75' ' ' ILE . 18.6 pt -68.76 -36.01 72.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.852 0.358 . . . . 0.0 111.017 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -62.35 -47.63 83.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.024 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.486 ' HG3' ' N ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -62.39 -35.22 78.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.967 0.413 . . . . 0.0 110.149 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.486 ' N ' ' HG3' ' A' ' 78' ' ' LYS . 16.2 tp -77.53 -26.18 50.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.069 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -76.95 -35.71 57.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.597 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -72.07 -38.09 69.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.778 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.89 -35.87 71.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.863 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.6 mt -74.01 -34.99 40.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.082 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.5 m -97.49 38.02 1.31 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.935 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 m -89.41 5.07 46.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.352 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 70.43 39.02 1.27 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.91 0.386 . . . . 0.0 110.533 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 4.2 mtp -68.93 71.31 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.983 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.3 t -96.83 73.56 2.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.8 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -163.4 -49.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 64.6 p -69.48 -169.85 0.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.906 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.1 p -129.01 173.3 10.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.945 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -146.19 -175.77 4.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.054 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -99.34 -42.52 6.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.131 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 m 179.88 -71.08 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.898 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.22 95.23 9.38 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.08 110.97 2.32 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.541 2.16 . . . . 0.0 112.189 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.19 -167.5 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.514 2.143 . . . . 0.0 112.521 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.751 ' HB ' HD11 ' A' ' 155' ' ' ILE . 21.2 t -140.32 113.19 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.654 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.588 ' CG2' HG22 ' A' ' 147' ' ' THR . 0.7 OUTLIER -103.22 140.21 37.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.271 -179.556 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.623 HD12 HG21 ' A' ' 155' ' ' ILE . 1.1 tt -139.83 117.76 11.76 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.856 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -105.22 112.7 25.91 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.788 -178.266 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.538 HD23 ' N ' ' A' ' 103' ' ' VAL . 0.8 OUTLIER -106.37 147.53 29.13 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.741 179.834 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.836 ' CG2' HD11 ' A' ' 19' ' ' LEU . 11.1 t -100.6 138.04 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.273 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.445 HG23 ' SG ' ' A' ' 109' ' ' CYS . 2.6 m -144.87 157.54 54.4 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.001 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -65.89 157.63 58.15 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.596 2.197 . . . . 0.0 112.143 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 142' ' ' THR . . . -68.86 -34.84 76.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.391 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.1 m -70.55 -30.3 66.99 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -70.94 -46.54 62.25 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.628 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.445 ' SG ' HG23 ' A' ' 104' ' ' VAL . 21.6 m -61.8 -40.03 93.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.389 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.75 -50.12 71.14 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.21 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.1 m -67.59 -38.7 84.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 0.0 110.724 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.8 mt -57.3 -27.77 62.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.476 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.568 HG22 ' HA2' ' A' ' 117' ' ' GLY . 12.6 mt -83.14 -34.28 11.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.786 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.63 178.55 6.27 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.558 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -67.49 132.53 47.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.818 0.342 . . . . 0.0 110.882 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.73 16.77 59.52 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.633 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.568 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 63.1 15.74 56.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.871 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 95.9 m -52.88 -43.64 66.29 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.869 0.366 . . . . 0.0 111.401 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -63.68 -58.56 6.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.129 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.499 ' HA ' HD12 ' A' ' 123' ' ' ILE . 1.6 tt -54.22 -31.44 22.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.315 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.16 -41.93 89.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.856 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -73.23 -40.2 64.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.082 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.499 HD12 ' HA ' ' A' ' 120' ' ' ILE . 50.2 mt -58.61 -53.42 47.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.297 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.794 ' HG3' HG22 ' A' ' 131' ' ' VAL . 0.2 OUTLIER -67.27 -40.42 86.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.969 0.414 . . . . 0.0 111.077 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -54.54 -48.36 72.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.881 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.48 -39.02 17.94 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.466 HG21 HD11 ' A' ' 148' ' ' ILE . 18.2 m -49.37 -26.38 3.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.845 0.355 . . . . 0.0 110.333 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.42 -21.85 4.17 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.333 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.713 ' HB1' ' O ' ' A' ' 149' ' ' ALA . . . -108.27 170.89 7.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.949 0.374 . . . . 0.0 111.149 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.7 130.45 44.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.705 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.794 HG22 ' HG3' ' A' ' 124' ' ' ARG . 36.0 m -99.26 140.52 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.164 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.786 ' O ' HG23 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -109.11 158.39 17.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.197 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.5 t -137.53 134.99 46.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.181 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.401 ' HB3' ' H ' ' A' ' 145' ' ' ALA . . . -79.99 134.27 36.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.077 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -80.32 131.49 10.55 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.562 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.401 ' HB3' ' CB ' ' A' ' 141' ' ' SER . 46.5 m-20 -157.93 26.75 0.27 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.049 0.452 . . . . 0.0 109.788 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 35.1 mtm -93.96 52.22 1.62 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.97 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.443 ' N ' ' HD2' ' A' ' 139' ' ' PRO . 0.2 OUTLIER -176.13 -61.19 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.519 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 138' ' ' LEU . 15.0 Cg_endo -55.58 -90.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.392 2.061 . . . . 0.0 112.391 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -178.95 15.62 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.401 ' CB ' ' HB3' ' A' ' 136' ' ' ASP . 0.1 OUTLIER -62.29 163.02 8.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.792 0.33 . . . . 0.0 110.815 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.669 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 13.2 t -118.57 -46.56 2.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.887 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.493 ' OE2' ' NH2' ' A' ' 17' ' ' ARG . 3.0 mt-10 -104.07 137.74 41.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.7 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -109.97 140.84 43.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.93 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.401 ' H ' ' HB3' ' A' ' 134' ' ' ALA . . . -96.42 153.46 17.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.17 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.786 HG23 ' O ' ' A' ' 132' ' ' GLN . 74.9 mt -125.18 140.05 49.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.667 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.588 HG22 ' CG2' ' A' ' 99' ' ' THR . 0.2 OUTLIER -119.07 114.93 23.26 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.409 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.52 HD13 ' HB2' ' A' ' 158' ' ' CYS . 0.6 OUTLIER -104.1 121.47 55.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.109 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.713 ' O ' ' HB1' ' A' ' 129' ' ' ALA . . . -118.39 134.71 54.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.13 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 162.13 -151.91 22.09 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.532 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.814 ' O ' HD12 ' A' ' 155' ' ' ILE . 2.9 pt -87.0 162.06 45.07 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.57 0.224 . . . . 0.0 110.962 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 151' ' ' ILE . 72.7 Cg_exo -49.62 -32.84 29.3 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.517 2.144 . . . . 0.0 112.218 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.517 ' HB2' HD12 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -71.91 -34.65 69.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.757 179.662 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.617 ' HB2' ' HB2' ' A' ' 129' ' ' ALA . 10.6 p -67.92 -50.29 56.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.039 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.814 HD12 ' O ' ' A' ' 151' ' ' ILE . 2.7 mp -59.33 -51.52 71.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.157 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -55.84 -30.7 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.135 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -69.26 -48.0 63.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.834 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' CYS . . . . . 0.52 ' HB2' HD13 ' A' ' 148' ' ' ILE . 17.7 t -61.58 -44.06 97.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.96 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 155' ' ' ILE . 59.9 t -59.49 -38.95 77.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.956 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -32.86 74.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.711 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.779 ' O ' HG23 ' A' ' 165' ' ' VAL . 2.0 tt0 -71.71 -45.67 61.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 30.5 mm -69.92 -34.41 59.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.044 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 47.7 t -65.42 -52.4 53.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.117 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.471 HG13 ' N ' ' A' ' 165' ' ' VAL . 12.3 p -61.49 -45.14 99.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.225 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.779 HG23 ' O ' ' A' ' 161' ' ' GLN . 54.8 t -63.82 -40.28 88.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.914 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 32.4 mtt -56.98 -45.63 82.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.808 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.642 HD21 HG21 ' A' ' 12' ' ' VAL . 7.8 tt -65.11 -45.19 86.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.804 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.96 -2.72 25.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.902 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 165' ' ' VAL . 39.1 p . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.887 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.949 0.404 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -156.64 -78.81 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.819 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.827 HG21 HD11 ' A' ' 167' ' ' LEU . 11.5 t -115.09 154.98 16.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.812 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.767 ' C ' HD22 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -109.21 131.36 55.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.693 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.767 HD22 ' C ' ' A' ' 13' ' ' THR . 4.3 mm? -130.44 158.49 39.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.148 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.2 m -141.97 133.59 26.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.749 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.629 HG22 HD11 ' A' ' 68' ' ' ILE . 3.8 tt -137.36 148.03 26.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.354 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.487 ' NH2' ' OE1' ' A' ' 143' ' ' GLU . 0.0 OUTLIER -129.35 131.1 46.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.709 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.411 ' O ' HG23 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -121.58 139.22 53.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.103 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.732 HD23 HG13 ' A' ' 103' ' ' VAL . 2.6 pp -108.72 136.02 48.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.758 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.11 162.4 33.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.827 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.73 ' O ' HG12 ' A' ' 25' ' ' VAL . 3.8 m-70 -67.58 169.63 8.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.536 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.65 -44.77 96.59 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.103 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.5 -38.51 40.58 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.69 -50.74 56.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.925 0.393 . . . . 0.0 110.655 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.747 HG23 HD11 ' A' ' 59' ' ' ILE . 9.8 p -63.44 -35.02 70.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.841 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.16 -34.92 90.63 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.32 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.3 m -75.38 -28.2 59.39 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.802 0.334 . . . . 0.0 110.68 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.431 ' N ' HD13 ' A' ' 28' ' ' ILE . 3.6 mm -78.84 -45.61 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.08 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.754 ' HA ' HG13 ' A' ' 36' ' ' VAL . 13.0 mt -60.59 -42.56 92.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.385 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.65 150.34 16.68 Favored Glycine 0 N--CA 1.435 -1.427 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.611 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.567 ' HG2' ' HG3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -58.15 145.75 35.88 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.593 -0.804 . . . . 0.0 111.588 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.571 ' HE3' ' HB3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 45.98 27.93 0.56 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.248 -178.895 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.436 ' O ' HG23 ' A' ' 36' ' ' VAL . . . 47.29 17.92 0.45 Allowed Glycine 0 CA--C 1.522 0.507 0 N-CA-C 114.784 0.673 . . . . 0.0 114.784 178.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.571 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 2.7 tm-20 -75.27 -25.46 58.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.752 0.776 . . . . 0.0 109.856 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -41.87 59.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.415 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.754 HG13 ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.24 -26.21 35.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 178.852 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.6 -36.75 70.94 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -62.94 -35.82 81.38 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.852 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.401 ' HA ' ' CE ' ' A' ' 39' ' ' MET . 0.0 OUTLIER -65.96 -43.46 87.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.392 179.603 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -56.63 -51.05 70.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.131 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -61.55 -37.5 84.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.778 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -74.62 -36.48 62.94 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.897 ' CB ' ' HB2' ' A' ' 71' ' ' ALA . 94.5 p -92.57 -55.86 3.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.862 0.363 . . . . 0.0 111.145 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.33 0.78 50.62 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.041 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.491 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . . . -110.76 128.16 55.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.877 0.338 . . . . 0.0 111.654 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 2.6 ttt180 -27.44 141.07 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.061 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.416 HG12 HD12 ' A' ' 61' ' ' LEU . 13.6 mt -142.32 100.44 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.76 0.314 . . . . 0.0 111.301 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -116.09 173.46 6.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.724 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.824 HG21 ' NE ' ' A' ' 57' ' ' ARG . 4.8 mt -126.5 151.97 33.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.121 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 94.3 p -83.74 -171.28 3.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.199 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.07 -167.51 0.51 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.382 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.56 -77.29 0.83 Allowed Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.313 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.3 t30 48.79 27.47 1.58 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.828 0.346 . . . . 0.0 110.397 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.515 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -150.47 -68.17 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.571 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.515 ' HD3' ' HB3' ' A' ' 54' ' ' CYS . 91.2 Cg_endo -74.46 -32.07 6.61 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.809 1.673 . . . . 0.0 110.366 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.71 172.18 1.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.782 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.824 ' NE ' HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -145.87 135.37 23.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.54 179.266 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.411 HG23 ' O ' ' A' ' 18' ' ' LEU . 26.1 mt -98.44 115.96 40.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.804 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.747 HD11 HG23 ' A' ' 25' ' ' VAL . 3.2 mt -86.62 101.21 10.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.285 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.405 ' CG2' ' HD3' ' A' ' 17' ' ' ARG . 89.2 m -90.01 138.25 31.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.94 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.675 HD22 HG13 ' A' ' 68' ' ' ILE . 7.3 tt -131.51 132.9 44.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.264 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.463 ' O ' ' HB1' ' A' ' 45' ' ' ALA . . . -128.68 133.85 48.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.742 0.306 . . . . 0.0 111.12 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.28 164.46 13.72 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.754 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.424 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 82.4 Cg_exo -39.58 162.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.147 2.565 . . . . 0.0 113.29 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.514 ' O ' HG22 ' A' ' 68' ' ' ILE . 73.5 m -59.69 -35.66 74.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.29 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -64.2 -51.96 61.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.782 0.325 . . . . 0.0 111.319 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.491 ' CB ' ' HB2' ' A' ' 45' ' ' ALA . . . -57.04 -37.98 72.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.351 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.675 HG13 HD22 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -66.16 -39.48 84.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.538 -179.231 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.26 -49.3 74.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.366 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.67 -47.23 82.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.117 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.897 ' HB2' ' CB ' ' A' ' 43' ' ' SER . . . -58.04 -56.3 23.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.316 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.412 ' HA ' HD12 ' A' ' 75' ' ' ILE . 0.4 OUTLIER -53.35 -42.52 66.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.339 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.27 -48.05 81.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.48 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 20.7 mmm -70.45 -33.88 71.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.178 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 72' ' ' PHE . 17.6 mt -68.09 -38.26 79.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.473 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.415 HG13 ' N ' ' A' ' 77' ' ' ASP . 36.6 pt -71.47 -38.44 68.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.071 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.415 ' N ' HG13 ' A' ' 76' ' ' ILE . 0.7 OUTLIER -63.39 -47.41 82.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.659 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.31 -36.39 83.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.947 0.403 . . . . 0.0 110.058 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.5 tp -77.58 -23.08 50.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.47 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.535 ' O ' HG22 ' A' ' 83' ' ' ILE . 21.0 tt0 -76.4 -49.31 17.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.99 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -72.27 -32.32 66.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.862 0.363 . . . . 0.0 111.067 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -57.96 -32.72 68.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.824 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 80' ' ' GLU . 0.6 OUTLIER -53.5 -49.6 53.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.938 0.399 . . . . 0.0 111.631 -179.214 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.51 ' N ' HG23 ' A' ' 83' ' ' ILE . 0.3 OUTLIER 177.93 -155.28 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.625 -179.662 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.4 p -139.55 30.82 2.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.876 0.37 . . . . 0.0 110.898 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.34 -169.26 0.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.839 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 10.0 mtp -80.19 -177.96 6.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.935 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.2 t -84.5 -169.84 2.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.931 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -121.31 -176.53 3.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 t -92.78 80.85 4.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.913 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.0 m -121.18 -46.61 2.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.85 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -144.69 175.17 10.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.102 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.29 -39.42 90.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.081 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.4 t 56.02 73.26 0.44 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.954 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.411 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 0.7 OUTLIER -72.27 -60.91 2.0 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.951 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.455 ' HB3' ' HB1' ' A' ' 149' ' ' ALA . 59.8 Cg_endo -72.29 109.79 2.81 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.585 2.19 . . . . 0.0 112.353 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.7 -41.88 3.95 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.671 2.247 . . . . 0.0 112.124 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.54 HG21 ' HG3' ' A' ' 152' ' ' PRO . 24.9 t -140.81 115.45 6.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.813 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 50.2 p -103.08 142.32 34.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.899 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.446 HD23 HD21 ' A' ' 102' ' ' LEU . 0.5 OUTLIER -139.96 117.55 11.52 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 178.656 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.534 ' HD2' HG23 ' A' ' 147' ' ' THR . 0.1 OUTLIER -103.67 112.4 25.32 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.36 -178.579 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.446 HD21 HD23 ' A' ' 100' ' ' LEU . 4.5 mm? -102.14 143.17 32.3 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.928 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.732 HG13 HD23 ' A' ' 19' ' ' LEU . 31.2 m -107.82 142.93 19.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.07 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.556 HG13 ' O ' ' A' ' 103' ' ' VAL . 4.4 m -159.53 157.16 26.39 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.33 172.08 9.48 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.559 2.173 . . . . 0.0 112.308 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.15 -34.64 78.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.517 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.21 -30.48 68.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.151 0.501 . . . . 0.0 109.848 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.41 ' CB ' ' HB ' ' A' ' 104' ' ' VAL . 2.2 mm100 -72.64 -49.78 29.57 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.724 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.5 m -62.94 -37.98 89.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.365 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.25 -43.25 99.62 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.249 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 83.6 p -74.49 -38.48 62.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.741 0.305 . . . . 0.0 110.655 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.7 mt -57.25 -27.95 62.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.563 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.606 HG22 ' HA2' ' A' ' 117' ' ' GLY . 10.4 mt -85.6 -36.74 11.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.847 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.59 -178.98 30.88 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.461 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.0 ttmm -66.99 123.68 20.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 0.0 111.204 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.6 15.29 57.21 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.012 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.606 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 73.58 5.1 67.28 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.955 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 31.9 p -52.92 -35.64 58.57 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.848 0.356 . . . . 0.0 111.631 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -65.53 -65.29 0.69 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.155 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.877 HD11 HG21 ' A' ' 131' ' ' VAL . 0.5 OUTLIER -54.75 -30.05 22.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.297 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -50.4 71.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.812 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -61.22 -40.55 94.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.203 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.775 HG23 ' OE1' ' A' ' 161' ' ' GLN . 44.4 mm -57.09 -53.94 36.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.807 0.337 . . . . 0.0 110.907 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.62 -32.91 74.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.822 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -57.14 -52.65 64.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.569 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.02 -46.99 8.43 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.583 HG21 ' SG ' ' A' ' 158' ' ' CYS . 92.3 m -47.39 -25.92 1.17 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.944 0.402 . . . . 0.0 110.485 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.11 -7.54 21.9 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.355 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -108.3 141.39 40.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.996 0.398 . . . . 0.0 111.209 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -79.14 141.08 37.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.877 HG21 HD11 ' A' ' 120' ' ' ILE . 34.8 m -107.39 143.17 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.157 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.805 ' O ' HG23 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -113.84 158.41 21.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.278 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.8 m -137.41 128.2 39.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.08 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.79 161.06 31.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.116 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -84.25 -142.76 5.52 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.607 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -126.34 -20.86 4.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.696 0.284 . . . . 0.0 111.145 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 9.2 mtp 66.14 -177.89 0.19 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.844 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.477 ' HB2' ' HD3' ' A' ' 139' ' ' PRO . 1.1 mp -83.5 -49.52 0.71 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.178 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.477 ' HD3' ' HB2' ' A' ' 138' ' ' LEU . 37.6 Cg_exo -60.06 -20.06 59.06 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.375 2.05 . . . . 0.0 112.387 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 71.19 105.37 0.06 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.052 0.453 . . . . 0.0 110.692 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.93 -171.5 3.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.07 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.546 HG23 ' HG3' ' A' ' 143' ' ' GLU . 15.0 t -121.41 -40.49 2.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.567 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.546 ' HG3' HG23 ' A' ' 142' ' ' THR . 9.9 mt-10 -107.27 145.76 32.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.416 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -109.86 161.48 15.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.904 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -118.51 155.0 31.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.329 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.805 HG23 ' O ' ' A' ' 132' ' ' GLN . 69.7 mt -129.66 141.01 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.401 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 132' ' ' GLN . 0.4 OUTLIER -116.41 117.42 29.9 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.432 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.834 HD12 HG12 ' A' ' 131' ' ' VAL . 8.1 mm -104.08 120.54 54.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.793 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.455 ' HB1' ' HB3' ' A' ' 96' ' ' PRO . . . -118.31 137.22 53.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.128 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 160.77 -151.68 22.19 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.593 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.529 ' CG2' ' HD2' ' A' ' 152' ' ' PRO . 15.4 mt -85.48 144.52 40.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.54 ' HG3' HG21 ' A' ' 98' ' ' VAL . 72.3 Cg_exo -48.96 -32.51 23.35 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.98 1.787 . . . . 0.0 111.552 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -72.08 -34.83 68.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.62 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 57.9 m -70.94 -39.31 72.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.61 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.406 ' O ' HG23 ' A' ' 159' ' ' VAL . 40.5 mm -64.53 -50.06 77.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.909 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.9 mt -57.19 -38.39 61.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.7 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -66.24 -38.8 88.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.497 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' CYS . . . . . 0.583 ' SG ' HG21 ' A' ' 127' ' ' THR . 0.9 OUTLIER -61.57 -45.63 93.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.591 179.669 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.472 ' HA ' HD12 ' A' ' 162' ' ' ILE . 32.9 t -59.97 -36.09 64.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.796 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.437 ' O ' HG12 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -64.41 -32.98 74.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.62 179.771 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.775 ' OE1' HG23 ' A' ' 123' ' ' ILE . 47.4 mt-30 -72.19 -31.82 66.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.887 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 159' ' ' VAL . 29.8 mt -74.01 -36.34 44.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.077 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 1.3 m -74.01 -43.29 58.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.939 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.496 HG13 ' N ' ' A' ' 165' ' ' VAL . 11.2 p -66.29 -45.76 88.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.32 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 161' ' ' GLN . 11.8 p -61.76 -42.54 94.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.021 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.437 ' N ' HG13 ' A' ' 165' ' ' VAL . 0.3 OUTLIER -59.17 -40.03 84.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.796 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.827 HD11 HG21 ' A' ' 12' ' ' VAL . 1.2 tt -72.64 -43.99 62.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.78 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -73.97 -2.64 24.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.034 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 165' ' ' VAL . 32.5 p . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.895 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.827 0.346 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -101.78 -76.64 0.57 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.842 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.82 ' CG1' HD13 ' A' ' 167' ' ' LEU . 6.8 p -107.34 159.87 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.029 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.524 ' N ' HG22 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -103.65 140.65 37.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.804 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.441 ' HA ' HD23 ' A' ' 14' ' ' LEU . 3.5 mt -131.24 171.32 13.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.027 0.441 . . . . 0.0 111.297 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.623 HG23 ' HB2' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -142.63 117.91 10.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.615 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.823 HG22 HD11 ' A' ' 68' ' ' ILE . 15.5 tt -121.51 156.66 25.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.908 0.385 . . . . 0.0 111.283 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.637 ' HG3' HG23 ' A' ' 60' ' ' THR . 1.9 mtp85 -134.46 111.92 10.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.643 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.543 HD13 HD12 ' A' ' 102' ' ' LEU . 0.6 OUTLIER -89.38 145.3 25.43 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.749 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.443 ' HG ' ' CB ' ' A' ' 55' ' ' PRO . 7.0 tt -122.51 121.1 35.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.544 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.409 ' CB ' ' HB ' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -148.07 163.19 37.67 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.374 0.607 . . . . 0.0 112.121 -179.515 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.93 ' O ' HG12 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -76.48 134.72 39.44 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.542 179.545 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -45.7 -25.47 1.5 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 121.024 -0.608 . . . . 0.0 113.556 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.38 -52.46 9.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.942 0.371 . . . . 0.0 111.609 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -71.09 -51.0 27.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.993 0.425 . . . . 0.0 110.402 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.93 HG12 ' O ' ' A' ' 21' ' ' HIS . 10.0 p -62.8 -33.9 62.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.296 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.52 -37.75 94.66 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.641 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.3 t -68.38 -28.42 67.1 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.421 ' N ' HD13 ' A' ' 28' ' ' ILE . 4.6 mm -80.59 -32.55 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.567 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.617 HD11 HG22 ' A' ' 25' ' ' VAL . 3.2 mm -60.59 -45.22 97.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.902 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.46 ' HA3' ' CB ' ' A' ' 35' ' ' SER . . . 94.69 150.57 27.23 Favored Glycine 0 N--CA 1.436 -1.347 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.812 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.419 ' C ' ' HD3' ' A' ' 32' ' ' LYS . 8.0 tttm -64.4 146.31 54.68 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.571 -0.814 . . . . 0.0 111.659 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.419 ' HD3' ' C ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER 63.01 6.74 2.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.847 179.635 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.529 ' O ' HG23 ' A' ' 36' ' ' VAL . . . 59.9 7.07 5.94 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 119.822 -1.18 . . . . 0.0 111.795 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.402 ' HB2' ' CE ' ' A' ' 32' ' ' LYS . 1.5 tm-20 -71.8 -28.21 63.45 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.025 0.44 . . . . 0.0 109.878 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.46 ' CB ' ' HA3' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -75.03 -36.34 61.9 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.265 179.496 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -67.32 -26.56 36.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.525 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -69.88 -36.81 75.76 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -65.04 -34.78 79.25 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.844 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.409 ' HE3' ' HA ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -64.16 -46.44 84.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.616 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.479 ' HA ' HD12 ' A' ' 47' ' ' ILE . 53.5 mtt180 -58.26 -51.18 70.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.289 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.02 -38.16 90.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.203 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -74.85 -36.06 62.35 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.713 ' HB2' ' HB2' ' A' ' 71' ' ' ALA . 12.1 t -77.9 -47.23 19.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.898 0.38 . . . . 0.0 111.116 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.89 -8.42 76.11 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.398 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.665 ' HB3' HD21 ' A' ' 61' ' ' LEU . . . -110.79 128.75 55.88 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.493 0.187 . . . . 0.0 111.108 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 4.5 mtt-85 -26.99 139.37 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.058 0.543 . . . . 0.0 112.038 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 40' ' ' ARG . 11.1 mt -142.13 116.31 4.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.714 0.292 . . . . 0.0 111.317 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -133.68 122.07 22.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.059 0.456 . . . . 0.0 110.907 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.887 ' HB ' HD13 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -108.15 130.78 60.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.902 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.5 t 168.6 169.8 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.067 0.46 . . . . 0.0 111.383 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.4 ' HB3' HD12 ' A' ' 58' ' ' ILE . 3.9 tt0 67.06 162.33 0.17 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.894 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 54' ' ' CYS . . . 128.4 84.7 0.44 Allowed Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.812 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.37 41.5 0.47 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.498 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -162.59 -63.95 0.01 OUTLIER Pre-proline 0 N--CA 1.449 -0.507 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.835 -179.016 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.527 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 76.7 Cg_endo -78.84 -32.41 1.99 Allowed 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.522 2.148 . . . . 0.0 111.252 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 55' ' ' PRO . 1.9 mt-10 92.21 -31.75 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.204 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.822 ' CB ' HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -133.89 130.76 38.27 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.034 0.445 . . . . 0.0 111.605 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 47.6 mt -129.46 109.93 19.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.491 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.887 HD13 ' HB ' ' A' ' 49' ' ' ILE . 7.1 mm -85.96 94.99 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.951 0.405 . . . . 0.0 111.537 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.637 HG23 ' HG3' ' A' ' 17' ' ' ARG . 50.0 m -88.82 105.85 17.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.841 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.753 HD22 HG13 ' A' ' 68' ' ' ILE . 9.1 tt -107.85 136.71 47.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.621 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.623 ' HB2' HG23 ' A' ' 15' ' ' THR . . . -133.51 133.74 42.58 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.541 0.21 . . . . 0.0 110.864 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.16 164.92 14.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.894 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 92.6 Cg_exo -41.35 162.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.04 2.494 . . . . 0.0 113.161 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.469 ' O ' HG22 ' A' ' 68' ' ' ILE . 4.1 t -60.19 -35.56 75.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.206 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -63.88 -51.81 62.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.228 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.458 ' CB ' ' HB2' ' A' ' 45' ' ' ALA . . . -57.26 -44.67 84.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.0 0.428 . . . . 0.0 111.003 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.823 HD11 HG22 ' A' ' 16' ' ' ILE . 1.5 tt -66.43 -39.42 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.666 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.27 -48.38 76.7 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.108 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.88 -48.02 78.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.899 0.38 . . . . 0.0 110.832 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.713 ' HB2' ' HB2' ' A' ' 43' ' ' SER . . . -57.72 -40.64 80.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.423 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.477 ' O ' HG23 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -61.47 -48.29 81.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.218 -179.663 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.406 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -68.72 -29.28 67.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.94 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.8 mmm -77.46 -48.43 17.15 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 72' ' ' PHE . 1.2 pp -61.34 -41.43 89.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.311 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.477 HG23 ' O ' ' A' ' 72' ' ' PHE . 26.0 pt -67.8 -38.91 81.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.808 0.337 . . . . 0.0 110.907 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.22 -32.16 73.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.399 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -40.42 86.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.174 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.7 tp -77.49 -25.62 50.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.492 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -77.06 -41.48 42.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -72.11 -36.64 69.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.904 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.2 -53.4 57.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 15.0 pt -54.27 -43.61 62.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.358 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.69 -30.98 71.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.939 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 35.9 t -118.59 37.75 3.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.896 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.8 t -162.14 126.13 3.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.959 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 2.0 mtt -86.38 -178.01 6.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 95.3 m 57.07 85.34 0.08 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.936 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.688 ' OD1' HG22 ' A' ' 91' ' ' THR . 1.4 p30 -156.57 -45.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.896 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.4 m 63.31 85.29 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.688 HG22 ' OD1' ' A' ' 89' ' ' ASN . 6.1 t -143.17 128.54 18.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.894 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 60.84 39.87 16.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.025 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -111.61 31.02 6.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.064 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -172.94 -41.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.889 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.439 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -173.9 -63.64 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.181 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 95' ' ' ARG . 10.2 Cg_endo -51.61 104.37 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.718 2.279 . . . . 0.0 112.438 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.432 ' HG2' ' CA ' ' A' ' 150' ' ' GLY . 35.9 Cg_endo -68.08 -68.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.324 2.016 . . . . 0.0 112.642 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.6 t -137.25 111.67 9.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.913 0.387 . . . . 0.0 111.022 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.641 HG22 ' HB2' ' A' ' 149' ' ' ALA . 38.8 p -103.24 138.36 40.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.982 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.94 117.79 11.72 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.409 ' HB3' HG23 ' A' ' 147' ' ' THR . 4.1 ptp180 -102.26 112.5 25.22 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.367 -178.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.543 HD12 HD13 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -110.63 145.53 37.74 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.032 -179.646 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.419 ' CG1' ' HB3' ' A' ' 17' ' ' ARG . 11.9 p -95.98 131.47 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.72 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.473 HG23 ' HD2' ' A' ' 105' ' ' PRO . 7.5 p -130.22 145.78 58.79 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.171 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.473 ' HD2' HG23 ' A' ' 104' ' ' VAL . 22.5 Cg_exo -65.62 163.4 30.34 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.537 2.158 . . . . 0.0 111.987 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 142' ' ' THR . . . -69.25 -39.69 78.31 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 25.8 m -69.72 -30.48 68.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.289 0.566 . . . . 0.0 109.626 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.471 ' HB3' HG22 ' A' ' 104' ' ' VAL . 0.9 OUTLIER -74.58 -49.48 21.61 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.53 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.478 ' O ' HD12 ' A' ' 113' ' ' ILE . 1.8 t -65.47 -37.42 86.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.935 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.38 -51.46 57.56 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.041 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.3 m -72.88 -34.87 66.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.806 0.336 . . . . 0.0 110.438 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.516 ' CD2' HD12 ' A' ' 162' ' ' ILE . 9.7 mt -60.88 -29.07 69.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.129 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.532 HG22 ' HA2' ' A' ' 117' ' ' GLY . 12.4 mt -80.41 -37.95 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.623 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.76 -179.26 44.53 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.458 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.05 122.23 17.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.867 0.365 . . . . 0.0 111.012 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.08 11.91 56.33 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.927 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.532 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 72.15 6.17 64.08 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.02 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -53.16 -39.98 63.99 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.691 ' HD2' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -63.23 -65.33 0.7 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.762 -179.234 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.813 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.9 OUTLIER -58.03 -37.65 62.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.634 -179.356 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.3 -44.75 80.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.332 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -73.12 -39.29 65.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.313 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.813 HD12 ' HA ' ' A' ' 120' ' ' ILE . 24.3 mt -58.13 -53.88 39.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.264 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.0 ptt85 -67.97 -35.02 77.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.879 0.371 . . . . 0.0 111.071 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -54.92 -50.63 68.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.177 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 53.3 p -83.86 -36.1 23.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.374 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.515 HG21 ' SG ' ' A' ' 158' ' ' CYS . 18.2 m -50.28 -26.13 4.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.807 0.337 . . . . 0.0 110.256 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 88.84 -21.75 25.27 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.981 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -102.49 155.82 18.01 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.823 0.344 . . . . 0.0 111.152 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -105.17 132.85 50.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.023 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.523 HG12 HG13 ' A' ' 148' ' ' ILE . 5.6 m -99.18 138.78 22.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.895 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.697 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 0.1 OUTLIER -116.94 116.67 27.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.107 0.479 . . . . 0.0 112.04 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.9 p -100.67 140.28 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.543 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.21 161.36 30.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.928 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.98 -123.34 0.01 OUTLIER Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.721 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.93 20.79 1.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.686 0.279 . . . . 0.0 111.188 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 5.7 mmt 51.83 179.79 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.911 0.386 . . . . 0.0 111.212 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.413 ' N ' ' CD ' ' A' ' 139' ' ' PRO . 0.2 OUTLIER -92.14 -50.79 0.29 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.26 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 138' ' ' LEU . 2.0 Cg_endo -84.96 39.36 0.73 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.039 2.493 . . . . 0.0 112.699 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 63.27 103.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.079 0.466 . . . . 0.0 110.861 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.0 p -77.06 159.37 29.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.828 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.471 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 1.5 m -117.73 -46.22 2.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.82 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.498 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 43.9 mt-10 -108.54 138.01 45.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.762 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -109.9 148.84 30.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.833 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -105.98 128.82 54.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.218 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.697 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 28.5 mm -108.6 127.25 65.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.866 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' A' ' 132' ' ' GLN . 0.2 OUTLIER -108.06 114.67 28.76 Favored 'General case' 0 N--CA 1.46 0.07 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.711 179.76 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.523 HG13 HG12 ' A' ' 131' ' ' VAL . 3.2 mp -104.1 117.53 49.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.409 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.641 ' HB2' HG22 ' A' ' 99' ' ' THR . . . -118.91 126.07 50.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.856 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.432 ' CA ' ' HG2' ' A' ' 97' ' ' PRO . . . 171.26 -153.04 19.61 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.693 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.532 HG23 ' HD2' ' A' ' 152' ' ' PRO . 4.4 mt -86.98 143.3 34.86 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 110.569 -0.16 . . . . 0.0 110.569 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.876 ' HA ' HD12 ' A' ' 155' ' ' ILE . 6.0 Cg_endo -48.63 -34.18 26.18 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.258 1.972 . . . . 0.0 111.609 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.436 ' O ' HG22 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -72.09 -34.65 68.82 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.653 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 19.2 m -68.84 -44.48 73.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.648 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.876 HD12 ' HA ' ' A' ' 152' ' ' PRO . 4.2 mt -60.64 -52.49 60.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.806 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 153' ' ' GLN . 7.8 tp -56.02 -31.06 30.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.861 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -70.08 -37.07 75.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.706 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' CYS . . . . . 0.515 ' SG ' HG21 ' A' ' 127' ' ' THR . 0.5 OUTLIER -64.01 -52.91 57.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.643 179.724 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 34.3 t -59.37 -31.97 47.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.773 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 7.4 ttmt -67.46 -34.45 77.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.748 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.79 ' O ' HG23 ' A' ' 165' ' ' VAL . 0.3 OUTLIER -70.45 -35.1 73.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.712 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.516 HD12 ' CD2' ' A' ' 112' ' ' LEU . 34.2 mm -73.4 -34.42 43.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.951 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 4.2 t -73.91 -46.39 44.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.043 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.24 -41.38 86.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.126 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' ' 161' ' ' GLN . 59.5 t -69.28 -47.54 73.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.797 0.332 . . . . 0.0 110.859 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -32.77 65.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.82 HD13 ' CG1' ' A' ' 12' ' ' VAL . 62.3 tp -71.91 -47.35 53.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.762 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -73.86 -2.72 24.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.081 0.467 . . . . 0.0 112.027 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 72.6 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.803 -179.994 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.816 0.341 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -176.31 83.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.95 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 64' ' ' PRO . 5.6 t -105.62 146.87 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.772 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 7.1 m -103.64 151.38 23.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.158 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' A' ' 14' ' ' LEU . 4.6 mt -138.32 176.21 8.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.984 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.41 125.32 16.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.901 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 1.043 HG22 HD11 ' A' ' 68' ' ' ILE . 7.4 tt -140.82 133.52 31.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.318 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.496 ' NH2' ' OE1' ' A' ' 143' ' ' GLU . 16.6 mtt180 -112.58 139.06 48.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.703 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.419 HD23 HD11 ' A' ' 100' ' ' LEU . 3.5 mp -113.74 138.82 49.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.938 0.399 . . . . 0.0 111.091 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.05 114.22 23.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.703 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.87 161.92 26.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.072 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.579 ' O ' HG12 ' A' ' 25' ' ' VAL . 27.6 m170 -74.69 175.0 8.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.899 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.57 -40.77 99.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.666 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.48 -44.23 25.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.829 0.347 . . . . 0.0 111.123 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.42 ' O ' HG23 ' A' ' 28' ' ' ILE . 42.4 mt-10 -61.92 -43.98 97.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.081 0.467 . . . . 0.0 110.281 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.758 HG21 ' CB ' ' A' ' 57' ' ' ARG . 9.8 p -68.66 -30.34 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.561 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.28 -39.32 97.56 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.538 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.87 -36.2 59.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.732 0.301 . . . . 0.0 111.474 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 25' ' ' VAL . 2.0 pp -78.5 -32.47 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.683 ' HA ' HG13 ' A' ' 36' ' ' VAL . 7.6 mm -70.62 -52.88 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.464 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.426 ' HA3' ' CB ' ' A' ' 35' ' ' SER . . . 99.69 150.33 25.07 Favored Glycine 0 N--CA 1.437 -1.297 0 CA-C-O 121.791 0.662 . . . . 0.0 112.967 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.49 ' C ' ' HD3' ' A' ' 32' ' ' LYS . 6.6 mttt -66.09 146.39 54.72 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.398 -0.901 . . . . 0.0 111.348 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.529 ' HE3' ' HB2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 61.59 6.9 1.65 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.583 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.52 ' O ' HG23 ' A' ' 36' ' ' VAL . . . 59.16 8.22 6.08 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.304 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.529 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 3.7 mt-10 -75.58 -30.56 59.68 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 122.402 -0.47 . . . . 0.0 109.915 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.526 ' HA ' ' HG2' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -67.91 -42.67 80.75 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.26 179.462 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.683 HG13 ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -66.86 -26.16 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.548 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.18 -36.63 83.58 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.526 ' HG2' ' HA ' ' A' ' 35' ' ' SER . 41.5 mmtt -59.96 -43.3 95.13 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.579 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.42 -47.14 82.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.914 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.25 -51.05 71.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.226 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -64.35 -37.79 88.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.98 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -74.59 -36.61 63.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.872 ' HB2' ' HB2' ' A' ' 71' ' ' ALA . 46.9 t -90.55 -55.79 3.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.946 0.403 . . . . 0.0 110.753 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.7 10.78 61.3 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.915 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.649 ' HB3' HD21 ' A' ' 61' ' ' LEU . . . -109.21 127.63 54.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 117.048 0.424 . . . . 0.0 111.554 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.545 ' HB2' ' HB3' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -27.94 104.08 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.294 178.869 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 60' ' ' THR . 3.3 mt -116.02 100.62 10.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.777 0.322 . . . . 0.0 110.419 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.483 ' O ' ' HB ' ' A' ' 60' ' ' THR . 2.4 p30 -121.61 125.83 47.64 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.617 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.7 mt -100.0 142.27 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.73 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.6 m -161.68 -177.81 6.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.024 0.44 . . . . 0.0 111.552 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.799 ' CB ' HD13 ' A' ' 58' ' ' ILE . 0.4 OUTLIER 64.68 134.81 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.306 179.88 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.56 -77.09 0.09 OUTLIER Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.929 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 57.9 19.02 5.42 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -178.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.548 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -148.01 -69.16 0.02 OUTLIER Pre-proline 0 N--CA 1.452 -0.37 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.871 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 54' ' ' CYS . 68.1 Cg_endo -81.5 -34.88 0.48 Allowed 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.128 1.885 . . . . 0.0 111.255 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.16 167.25 22.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.247 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.758 ' CB ' HG21 ' A' ' 25' ' ' VAL . 6.3 mtt180 -145.77 127.61 15.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.926 0.393 . . . . 0.0 111.207 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.799 HD13 ' CB ' ' A' ' 51' ' ' GLU . 2.4 mp -101.04 104.72 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.612 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.1 mp -86.43 95.1 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.411 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 47' ' ' ILE . 27.7 m -73.8 131.0 41.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.688 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.649 HD21 ' HB3' ' A' ' 45' ' ' ALA . 1.5 tt -131.59 129.64 41.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.652 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.553 ' O ' ' HB1' ' A' ' 45' ' ' ALA . . . -139.45 130.45 26.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.699 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.35 165.18 14.68 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.116 -1.04 . . . . 0.0 112.783 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 80.6 Cg_exo -39.37 154.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.135 2.557 . . . . 0.0 113.216 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.425 ' O ' HG22 ' A' ' 68' ' ' ILE . 3.8 m -59.04 -35.35 73.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.864 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -67.03 -52.02 47.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.186 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.26 -42.93 82.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.058 0.456 . . . . 0.0 110.795 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 1.043 HD11 HG22 ' A' ' 16' ' ' ILE . 1.0 OUTLIER -66.44 -39.46 84.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.172 -179.515 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.52 -47.01 87.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.065 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -50.59 73.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.938 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.872 ' HB2' ' HB2' ' A' ' 43' ' ' SER . . . -58.72 -40.68 84.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.153 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.78 -42.69 99.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.093 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.79 -39.31 88.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.167 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.9 mtt -78.04 -32.49 50.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.841 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.14 -46.15 81.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.002 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.1 pp -68.14 -37.85 78.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.223 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -65.48 -46.2 80.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.504 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -35.4 75.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.111 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.0 tp -77.57 -25.17 49.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.523 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -76.88 -43.01 37.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.912 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -72.1 -32.33 66.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.828 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -59.95 -42.4 93.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.983 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 22.6 mt -64.37 -30.89 51.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.043 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.95 55.36 0.93 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.923 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.6 p -161.43 -45.9 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.97 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 84.3 p -85.55 -31.07 22.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.926 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 9.4 mtt -75.07 -175.81 2.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 51.8 m -107.37 70.09 0.77 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -156.09 126.8 6.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.867 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.25 -50.19 2.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.7 m -88.34 -66.35 0.92 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.984 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.59 102.63 5.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.045 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -167.96 80.66 0.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.216 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.4 t -96.43 13.51 27.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.168 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.486 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 5.4 mpt_? 49.04 58.06 18.08 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.476 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.486 ' HD3' ' N ' ' A' ' 95' ' ' ARG . 36.6 Cg_exo -58.75 -48.3 15.32 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.357 2.038 . . . . 0.0 112.403 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 83.1 Cg_endo -85.88 117.76 1.7 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.719 2.279 . . . . 0.0 112.606 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.653 HG21 ' HD3' ' A' ' 152' ' ' PRO . 24.3 t -137.2 106.77 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.482 HG22 ' HB2' ' A' ' 149' ' ' ALA . 40.7 p -103.4 139.22 39.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.04 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.419 HD11 HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -139.86 117.61 11.63 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.681 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.91 112.44 25.41 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.527 -178.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.708 HD22 HD11 ' A' ' 16' ' ' ILE . 40.7 mt -111.85 153.76 26.16 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.956 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 104' ' ' VAL . 21.2 t -114.32 149.23 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.062 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.963 HG11 HD11 ' A' ' 162' ' ' ILE . 6.0 m -156.14 164.46 21.35 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.335 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -66.03 160.74 43.02 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.744 2.296 . . . . 0.0 112.113 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.98 -34.9 76.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.358 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.9 t -70.17 -30.28 67.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.201 0.524 . . . . 0.0 109.667 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.559 ' NE2' HD23 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -70.72 -41.8 71.43 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.63 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.6 ' HA ' HD21 ' A' ' 112' ' ' LEU . 5.1 t -65.85 -40.8 92.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.706 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.17 -33.47 87.32 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.885 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.6 p -77.32 -50.78 12.07 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 121.115 -0.234 . . . . 0.0 111.312 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.625 HD12 HG13 ' A' ' 113' ' ' ILE . 2.7 pp -55.66 -25.78 41.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.054 0.455 . . . . 0.0 110.009 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.625 HG13 HD12 ' A' ' 112' ' ' LEU . 51.2 mt -77.03 -39.31 29.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.224 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.41 -177.86 39.37 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.527 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.53 121.73 16.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.857 0.361 . . . . 0.0 111.128 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.85 12.37 56.88 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.08 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.415 ' HA2' ' CG2' ' A' ' 113' ' ' ILE . . . 72.99 4.97 63.95 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.034 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 2.2 m -52.94 -42.64 65.65 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 120.791 0.329 . . . . 0.0 111.828 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -65.34 0.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.564 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.2 tt -58.99 -30.59 43.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.647 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 7.6 tppt? -60.07 -44.83 94.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.105 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -73.28 -41.66 63.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.464 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.409 HD12 ' NE2' ' A' ' 161' ' ' GLN . 34.5 mm -62.7 -53.78 42.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.583 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.4 mmt85 -67.82 -42.72 81.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.398 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.61 -40.77 69.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.222 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 91.3 p -85.32 -36.75 20.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.758 0.313 . . . . 0.0 111.101 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 31.0 m -50.49 -26.09 4.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.929 0.395 . . . . 0.0 110.249 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.48 -9.15 62.49 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.026 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -108.03 154.32 21.83 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.857 0.36 . . . . 0.0 111.212 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 1.9 mt-30 -105.14 139.75 39.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.41 ' HB ' ' CG2' ' A' ' 146' ' ' ILE . 1.2 m -99.16 157.96 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.035 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.593 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 3.4 tp60 -138.59 116.81 11.84 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.269 0.557 . . . . 0.0 112.347 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.65 131.22 45.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.305 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.08 161.22 13.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.079 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -58.68 -111.51 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.633 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.86 28.6 0.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.72 ' O ' HD12 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -93.72 12.45 25.56 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.499 -179.504 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.72 HD12 ' O ' ' A' ' 137' ' ' MET . 0.0 OUTLIER 165.32 -60.8 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.34 179.784 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.443 ' HD3' ' CB ' ' A' ' 138' ' ' LEU . 86.1 Cg_endo -80.58 68.48 8.31 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.707 2.272 . . . . 0.0 112.434 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -174.42 -40.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.886 0.374 . . . . 0.0 111.082 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.6 t -48.58 -53.63 17.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.951 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 24.5 m -118.91 -41.87 2.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.614 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.496 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 37.5 mt-10 -134.15 138.9 45.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.76 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.24 165.29 13.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.952 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.28 138.98 53.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.233 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.593 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 35.5 mt -114.21 131.63 65.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.824 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.435 ' HB ' ' CB ' ' A' ' 132' ' ' GLN . 1.0 OUTLIER -106.17 115.06 29.58 Favored 'General case' 0 N--CA 1.46 0.065 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.689 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 130' ' ' GLN . 3.2 mp -103.89 118.7 51.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.452 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.482 ' HB2' HG22 ' A' ' 99' ' ' THR . . . -118.55 134.5 55.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.758 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 163.35 -151.58 21.22 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.777 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.578 HG23 ' HD2' ' A' ' 152' ' ' PRO . 3.7 mt -78.2 144.74 67.5 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.653 ' HD3' HG21 ' A' ' 98' ' ' VAL . 5.7 Cg_endo -48.4 -39.87 36.06 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.134 1.889 . . . . 0.0 111.322 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -66.63 -34.68 78.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 18.3 m -68.44 -32.26 72.16 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.625 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 29.5 mm -76.35 -49.0 25.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.119 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.42 ' O ' HG12 ' A' ' 159' ' ' VAL . 33.4 mm -55.81 -36.38 43.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.989 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -75.03 -36.72 61.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.826 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 4.8 t -68.16 -38.45 82.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.905 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.445 ' HA ' HG22 ' A' ' 162' ' ' ILE . 10.3 p -70.82 -32.17 48.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.065 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.76 ' O ' HG23 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -69.3 -34.68 75.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.872 179.869 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.59 ' O ' HG23 ' A' ' 165' ' ' VAL . 0.8 OUTLIER -72.41 -49.37 34.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.776 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.963 HD11 HG11 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -63.15 -44.08 99.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.947 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 163' ' ' CYS . . . . . 0.477 ' N ' HG23 ' A' ' 162' ' ' ILE . 1.7 m -58.95 -44.61 91.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.831 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 160' ' ' LYS . 53.4 t -58.48 -52.59 57.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.02 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 161' ' ' GLN . 21.8 t -57.9 -41.25 79.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.18 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -59.69 -37.48 78.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.971 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 7.6 tt -67.46 -55.87 11.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.88 -2.63 24.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.01 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 18.4 p . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.372 -0.823 . . . . 0.0 111.152 179.999 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.801 0.334 . . . . 0.0 111.195 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -158.49 -78.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.937 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.563 HG22 ' N ' ' A' ' 13' ' ' THR . 12.0 p -118.08 163.97 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.97 0.414 . . . . 0.0 111.347 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.638 ' O ' HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -104.74 128.31 52.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.288 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.638 HD22 ' O ' ' A' ' 13' ' ' THR . 1.9 mm? -124.26 151.43 44.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.237 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.2 m -141.66 118.78 11.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.519 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.838 HD11 HD23 ' A' ' 102' ' ' LEU . 12.4 tt -119.96 147.21 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.931 0.396 . . . . 0.0 111.408 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.658 ' HG3' HG23 ' A' ' 60' ' ' THR . 2.4 mpp_? -131.04 112.08 12.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.524 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.685 HD12 ' CE ' ' A' ' 20' ' ' MET . 0.5 OUTLIER -109.51 134.74 51.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.224 -179.605 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.563 HD23 HG23 ' A' ' 103' ' ' VAL . 1.0 OUTLIER -104.36 122.36 45.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.562 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.685 ' CE ' HD12 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -124.71 159.51 30.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.144 0.497 . . . . 0.0 111.436 -179.621 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.86 ' O ' HG12 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -71.89 142.15 49.52 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.427 179.659 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.415 ' HA2' ' HG3' ' A' ' 57' ' ' ARG . . . -43.98 -32.2 2.26 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 121.018 -0.611 . . . . 0.0 113.801 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.41 ' HG3' ' HB3' ' A' ' 21' ' ' HIS . 0.0 OUTLIER -78.37 -52.03 9.2 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -179.255 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.18 -50.55 67.69 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.027 0.442 . . . . 0.0 110.309 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.86 HG12 ' O ' ' A' ' 21' ' ' HIS . 11.6 p -58.88 -36.04 59.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.956 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.701 ' HA2' HD12 ' A' ' 29' ' ' ILE . . . -62.37 -36.13 92.66 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.39 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.1 m -72.48 -29.53 63.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.96 0.41 . . . . 0.0 110.212 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.402 HD13 ' N ' ' A' ' 28' ' ' ILE . 4.9 mm -81.14 -32.59 12.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.699 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.735 HD11 HG22 ' A' ' 25' ' ' VAL . 14.2 mt -64.14 -42.59 96.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.156 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.4 150.96 26.14 Favored Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.293 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.431 ' C ' ' HG3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -58.08 146.39 33.28 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.772 -0.714 . . . . 0.0 111.259 179.824 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.496 ' HD2' ' HB2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 44.58 26.75 0.2 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.221 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.52 ' O ' HG23 ' A' ' 36' ' ' VAL . . . 49.25 16.17 0.8 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 114.391 0.517 . . . . 0.0 114.391 178.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.546 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 4.0 mt-10 -72.09 -35.01 69.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.677 0.739 . . . . 0.0 109.872 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.9 t -68.41 -39.86 81.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.102 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.684 HG13 ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -66.8 -26.1 36.26 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.946 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -36.45 79.91 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.546 ' HG2' ' O ' ' A' ' 34' ' ' GLU . 8.8 mmtt -63.28 -41.22 98.98 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.597 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.54 -49.48 76.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.169 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.583 ' HG2' HD12 ' A' ' 47' ' ' ILE . 1.7 mtt180 -58.34 -51.66 68.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.682 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -64.91 -38.4 90.84 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -75.06 -35.97 61.83 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.798 ' CB ' ' HB2' ' A' ' 71' ' ' ALA . 83.5 p -82.27 -55.33 4.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.83 0.347 . . . . 0.0 111.041 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.41 -7.89 64.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.544 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.565 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . . . -104.28 127.94 51.99 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 122.781 -0.246 . . . . 0.0 111.012 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 4.5 mmt180 -27.36 139.39 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.101 0.56 . . . . 0.0 112.213 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.583 HD12 ' HG2' ' A' ' 40' ' ' ARG . 11.6 mt -142.24 100.59 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.723 0.297 . . . . 0.0 111.008 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.34 132.6 50.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.04 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.9 mt -90.24 151.77 3.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.081 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.87 -175.12 3.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.043 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.62 -166.41 0.98 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.055 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.469 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . 162.25 84.75 0.05 OUTLIER Glycine 0 C--O 1.227 -0.315 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.653 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -55.14 -21.6 13.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.069 0.461 . . . . 0.0 110.339 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.461 ' CB ' ' HD3' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -93.16 -63.52 0.16 Allowed Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.675 -179.664 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.533 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 64.5 Cg_endo -81.79 -33.48 0.63 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.635 2.223 . . . . 0.0 112.321 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.505 ' CB ' ' O ' ' A' ' 55' ' ' PRO . 2.6 mt-10 95.83 -35.0 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.85 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.697 ' HB2' HG11 ' A' ' 25' ' ' VAL . 3.3 mtp180 -140.24 143.61 36.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.008 0.432 . . . . 0.0 111.375 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.2 mt -140.53 115.45 6.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.599 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.5 mt -86.18 110.13 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.976 0.417 . . . . 0.0 111.43 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.658 HG23 ' HG3' ' A' ' 17' ' ' ARG . 49.6 m -103.15 101.84 11.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.64 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.57 HD22 HG13 ' A' ' 68' ' ' ILE . 6.5 tt -104.69 133.85 48.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.753 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.478 ' O ' ' HB1' ' A' ' 45' ' ' ALA . . . -125.55 137.42 53.93 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.45 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.49 165.57 15.44 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 119.847 -1.168 . . . . 0.0 113.007 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -50.5 161.96 1.07 Allowed 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.906 2.404 . . . . 0.0 112.337 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.496 ' O ' HG22 ' A' ' 68' ' ' ILE . 18.2 m -56.85 -35.96 69.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.559 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -63.8 -51.81 63.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.788 0.328 . . . . 0.0 111.3 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.565 ' CB ' ' HB2' ' A' ' 45' ' ' ALA . . . -57.24 -37.47 72.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.198 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.57 HG13 HD22 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -66.21 -39.34 84.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.376 -179.301 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.67 -50.91 70.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.032 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.76 -49.71 76.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.886 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.798 ' HB2' ' CB ' ' A' ' 43' ' ' SER . . . -56.31 -50.85 70.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.27 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.454 ' HA ' HD12 ' A' ' 75' ' ' ILE . 0.7 OUTLIER -52.78 -42.51 65.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.095 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.98 -37.13 78.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.108 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -76.32 -37.63 57.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.949 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 72' ' ' PHE . 46.0 mt -64.11 -50.6 76.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.846 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -62.17 -37.42 78.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.143 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -65.0 -47.64 76.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.741 0.305 . . . . 0.0 110.513 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.36 -35.42 80.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.174 0.511 . . . . 0.0 109.781 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.481 ' O ' ' HB ' ' A' ' 83' ' ' ILE . 13.0 tp -77.67 -22.99 49.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.486 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -76.08 -41.75 49.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.841 0.353 . . . . 0.0 110.9 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.23 -45.44 60.22 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.036 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.9 -50.39 64.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.681 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 79' ' ' LEU . 2.6 tt -53.63 -47.22 61.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.128 0.489 . . . . 0.0 111.261 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.468 ' N ' ' CG2' ' A' ' 83' ' ' ILE . 28.8 t 62.96 -79.35 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.302 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.99 11.04 9.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.656 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.451 ' HA ' ' CG1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER 74.01 -64.59 0.38 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.831 0.348 . . . . 0.0 110.818 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 1.2 mtp -166.6 138.72 3.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.921 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.77 80.76 1.85 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.798 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -57.4 -30.35 64.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.019 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 94.0 p -166.74 -60.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.83 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.16 102.03 2.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -151.61 110.24 3.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.071 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -149.07 33.63 0.74 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.08 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 60.5 m -88.04 -44.17 11.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.953 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -168.57 88.36 0.65 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.74 110.73 1.96 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.615 2.21 . . . . 0.0 112.12 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -83.48 170.02 12.0 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.661 2.24 . . . . 0.0 112.701 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.839 HG12 ' O ' ' A' ' 150' ' ' GLY . 7.2 p -140.92 116.21 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.505 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.664 ' O ' HD23 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -103.08 131.85 49.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.133 -179.556 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.664 HD23 ' O ' ' A' ' 99' ' ' THR . 27.6 mt -139.92 117.67 11.63 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.54 ' HG2' ' HB1' ' A' ' 145' ' ' ALA . 28.2 ttm180 -103.09 112.57 25.48 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.567 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.838 HD23 HD11 ' A' ' 16' ' ' ILE . 1.4 mp -99.46 151.01 21.6 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.842 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.563 HG23 HD23 ' A' ' 19' ' ' LEU . 25.9 t -107.26 149.28 10.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.241 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.8 m -156.01 161.69 28.96 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.133 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.432 ' HD2' ' HB2' ' A' ' 108' ' ' GLN . 21.4 Cg_exo -65.69 162.15 35.75 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.748 2.298 . . . . 0.0 112.216 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.13 -34.64 76.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.639 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.25 -30.52 69.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.086 0.469 . . . . 0.0 109.823 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.432 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -68.85 -46.19 69.15 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.678 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.405 ' O ' HG12 ' A' ' 113' ' ' ILE . 0.8 OUTLIER -67.57 -37.48 82.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.419 179.554 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.22 -49.68 70.48 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.312 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.9 m -77.28 -35.22 55.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.839 0.352 . . . . 0.0 110.803 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.71 HD21 ' CD1' ' A' ' 162' ' ' ILE . 9.9 mt -57.66 -29.67 64.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.62 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.408 ' HA ' ' HB ' ' A' ' 120' ' ' ILE . 27.7 mm -87.12 -38.71 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.807 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.4 -179.38 36.66 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.453 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.34 124.73 23.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.874 0.369 . . . . 0.0 111.054 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.41 16.07 57.85 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.882 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.407 ' HA2' ' CG2' ' A' ' 113' ' ' ILE . . . 68.16 10.6 59.77 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.965 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -52.93 -39.86 63.16 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.823 0.344 . . . . 0.0 111.547 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.67 -65.27 0.7 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.224 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.891 HD11 HG21 ' A' ' 131' ' ' VAL . 0.0 OUTLIER -55.13 -28.86 21.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.437 -179.668 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -64.69 -49.36 71.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.094 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.5 -38.99 74.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.34 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 120' ' ' ILE . 27.8 mt -57.52 -53.93 37.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.116 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.435 ' HG2' HD13 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -72.47 -30.52 64.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.912 0.387 . . . . 0.0 110.998 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.97 -44.73 82.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.131 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.4 m -93.12 -37.53 12.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.506 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.5 m -49.83 -26.25 3.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.809 0.337 . . . . 0.0 110.234 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 82.9 -16.55 26.56 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.229 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.801 ' HB2' ' HB3' ' A' ' 154' ' ' SER . . . -100.87 166.54 10.79 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.937 0.368 . . . . 0.0 111.195 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -105.23 133.82 49.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.952 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.891 HG21 HD11 ' A' ' 120' ' ' ILE . 14.0 m -101.93 139.48 22.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.905 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.633 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 0.4 OUTLIER -129.47 116.72 19.39 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.6 m -99.26 132.74 44.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.277 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.25 160.05 5.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.995 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -89.08 -117.03 1.51 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.537 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 32.7 p-10 -161.71 31.03 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.822 0.344 . . . . 0.0 110.416 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.544 ' O ' HD12 ' A' ' 138' ' ' LEU . 3.7 ptp -72.42 64.06 0.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.855 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.544 HD12 ' O ' ' A' ' 137' ' ' MET . 0.2 OUTLIER -173.04 172.05 1.66 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.598 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.64 63.27 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.72 2.28 . . . . 0.0 112.323 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 64.69 103.73 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 56.1 p -80.4 165.52 22.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.787 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 28.3 m -115.59 -47.17 2.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.811 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.486 ' OE2' ' NH2' ' A' ' 17' ' ' ARG . 10.9 mt-10 -116.2 147.03 41.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.792 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.03 174.43 5.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.893 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.54 ' HB1' ' HG2' ' A' ' 101' ' ' ARG . . . -136.44 129.9 31.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.402 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.633 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 3.9 mp -100.13 125.4 53.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.741 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.566 HG22 HG22 ' A' ' 99' ' ' THR . 0.3 OUTLIER -96.92 114.82 26.47 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.743 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 148' ' ' ILE . 1.0 OUTLIER -106.04 113.48 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.183 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.611 ' HB2' HG23 ' A' ' 99' ' ' THR . . . -118.44 131.16 56.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.086 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.839 ' O ' HG12 ' A' ' 98' ' ' VAL . . . 165.49 -158.4 31.25 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.49 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.598 HG22 ' HD2' ' A' ' 152' ' ' PRO . 0.7 OUTLIER -87.76 163.74 37.09 Favored Pre-proline 0 C--N 1.33 -0.272 0 O-C-N 122.858 -0.201 . . . . 0.0 110.637 179.534 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.598 ' HD2' HG22 ' A' ' 151' ' ' ILE . 6.9 Cg_endo -49.59 -36.59 40.92 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.428 2.085 . . . . 0.0 111.77 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.44 ' HB2' HD13 ' A' ' 151' ' ' ILE . 7.8 mm100 -63.54 -34.61 78.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.038 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.801 ' HB3' ' HB2' ' A' ' 129' ' ' ALA . 4.2 m -70.45 -37.14 74.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.591 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.491 ' O ' HG12 ' A' ' 159' ' ' VAL . 36.8 mm -67.53 -51.72 48.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.937 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.9 mm -58.85 -28.24 37.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.056 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -70.6 -57.02 5.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.521 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 6.8 p -61.01 -47.54 86.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.519 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 155' ' ' ILE . 13.4 p -57.01 -36.56 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.809 0.338 . . . . 0.0 111.166 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.413 ' O ' HG12 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -71.48 -33.05 68.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.827 179.914 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.623 ' O ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -72.56 -39.81 67.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.978 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.71 ' CD1' HD21 ' A' ' 112' ' ' LEU . 6.4 tp -74.05 -34.51 38.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.032 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 2.3 t -70.81 -47.35 59.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.071 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.483 HG13 ' N ' ' A' ' 165' ' ' VAL . 12.4 p -61.81 -45.36 98.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.08 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.623 HG22 ' O ' ' A' ' 161' ' ' GLN . 28.5 m -69.27 -42.64 81.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.062 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.473 ' HG2' HD11 ' A' ' 14' ' ' LEU . 4.5 tpp -64.53 -37.43 87.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.958 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.44 -57.5 7.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.92 -2.49 24.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.029 0.442 . . . . 0.0 112.026 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.875 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.5 m120 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.952 0.406 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.7 t -136.92 150.06 26.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.748 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 2.5 t -103.51 157.7 16.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.871 0.367 . . . . 0.0 111.305 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.44 ' HA ' HD23 ' A' ' 14' ' ' LEU . 4.0 mt -152.33 174.46 13.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.993 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.9 m -142.5 133.62 25.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.776 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.887 HG22 HD11 ' A' ' 68' ' ' ILE . 1.1 tt -136.92 123.58 29.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.161 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.493 ' NH2' ' OE1' ' A' ' 143' ' ' GLU . 2.3 mpp_? -101.24 117.07 34.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.746 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.513 ' O ' HG23 ' A' ' 58' ' ' ILE . 96.0 mt -94.75 128.51 41.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.862 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.485 ' C ' HD23 ' A' ' 19' ' ' LEU . 6.8 tt -123.05 120.85 34.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.496 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.446 ' HB3' ' HB ' ' A' ' 25' ' ' VAL . 0.8 OUTLIER -147.91 168.65 21.69 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.288 0.566 . . . . 0.0 111.9 -179.46 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.906 ' O ' HG12 ' A' ' 25' ' ' VAL . 29.0 m-70 -74.64 140.95 44.64 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.844 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -45.48 -30.89 3.29 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.962 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.536 ' HG2' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -78.45 -49.5 13.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 117.354 0.577 . . . . 0.0 111.95 -179.077 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.536 ' N ' ' HG2' ' A' ' 23' ' ' LYS . 4.8 mt-10 -65.14 -50.78 64.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.207 0.527 . . . . 0.0 109.999 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.907 HG11 ' CB ' ' A' ' 57' ' ' ARG . 7.3 p -58.72 -34.25 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.572 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.38 -41.9 98.69 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.924 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.1 p -65.88 -27.92 68.57 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.4 mm -81.21 -32.36 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.899 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.77 HD11 HG22 ' A' ' 25' ' ' VAL . 3.0 mm -60.43 -42.75 92.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.342 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.08 150.39 26.8 Favored Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.317 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.401 ' O ' ' CD ' ' A' ' 32' ' ' LYS . 1.3 tppm? -61.71 145.72 51.48 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.723 -0.739 . . . . 0.0 111.34 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.435 ' HG2' ' HB2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 50.79 20.22 0.73 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.442 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 51.24 13.88 1.19 Allowed Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.936 -0.649 . . . . 0.0 113.919 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.435 ' HB2' ' HG2' ' A' ' 32' ' ' LYS . 10.1 tt0 -76.79 -26.09 54.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.213 0.53 . . . . 0.0 109.808 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.13 -42.33 56.55 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.401 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.603 HG13 ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.38 -26.57 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.93 -36.69 67.27 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.54 -34.57 72.41 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.839 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -53.46 57.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.489 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.09 -51.48 69.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.989 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -51.9 -38.43 56.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.947 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -85.95 -27.38 24.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.697 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.938 ' HB2' ' HB2' ' A' ' 71' ' ' ALA . 1.5 p -73.25 -55.26 6.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.809 0.338 . . . . 0.0 111.21 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.36 -5.27 85.36 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.443 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.507 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -110.71 127.4 55.3 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.63 0.253 . . . . 0.0 111.197 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 9.1 tpp180 -28.19 104.3 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.452 ' CG1' ' O ' ' A' ' 45' ' ' ALA . 2.9 mt -114.73 120.37 64.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.688 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -137.01 173.82 11.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.041 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.9 mt -126.51 151.73 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.947 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.5 t -135.73 -175.28 3.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.08 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.791 179.993 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 . . . . . 0 N--CA 1.466 0.362 0 CA-C-O 120.385 0.136 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.907 ' CB ' HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -136.29 133.98 37.5 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.035 0.445 . . . . 0.0 111.624 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.513 HG23 ' O ' ' A' ' 18' ' ' LEU . 31.0 mt -140.48 119.09 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.718 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.5 mt -97.01 109.66 23.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.442 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.7 m -87.2 108.7 19.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.033 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -106.67 138.52 42.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.506 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.507 ' O ' ' HB1' ' A' ' 45' ' ' ALA . . . -145.41 132.25 20.11 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.45 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.53 166.38 16.85 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 119.549 -1.31 . . . . 0.0 113.3 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 1.9 Cg_endo -46.09 159.21 0.26 Allowed 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 123.174 2.583 . . . . 0.0 112.472 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.43 ' O ' HG22 ' A' ' 68' ' ' ILE . 13.2 t -55.99 -35.94 67.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.429 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -65.37 -51.88 57.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.093 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.476 ' CB ' ' HB2' ' A' ' 45' ' ' ALA . . . -57.28 -44.54 84.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.041 0.448 . . . . 0.0 110.872 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.887 HD11 HG22 ' A' ' 16' ' ' ILE . 1.2 tt -66.45 -39.39 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.878 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.53 -45.13 77.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.041 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -45.4 68.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.746 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.938 ' HB2' ' HB2' ' A' ' 43' ' ' SER . . . -54.78 -56.16 22.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.323 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.558 ' O ' HG23 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -56.27 -40.09 73.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.998 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.45 -32.26 72.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.185 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.2 mtm -74.27 -46.55 40.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.196 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.451 HG13 ' N ' ' A' ' 76' ' ' ILE . 29.0 pt -61.56 -42.83 95.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.229 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 72' ' ' PHE . 41.0 pt -64.91 -36.45 77.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.82 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.401 ' N ' HG13 ' A' ' 76' ' ' ILE . 0.9 OUTLIER -67.9 -37.7 82.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.321 179.578 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -35.45 77.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.01 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.6 tp -76.34 -28.11 56.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.383 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.9 -35.98 56.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.682 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -72.39 -33.45 67.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.909 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.7 t0 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.237 -179.667 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 C--O 1.231 0.164 0 CA-C-O 120.891 0.288 . . . . 0.0 112.641 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 150' ' ' GLY . 4.5 m -140.97 119.87 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.464 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.7 HG22 ' HB2' ' A' ' 149' ' ' ALA . 14.9 p -102.81 141.96 34.74 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.957 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.473 HD12 ' CD1' ' A' ' 102' ' ' LEU . 0.2 OUTLIER -139.85 117.75 11.75 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -100.87 112.62 25.09 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.499 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.577 HD12 ' N ' ' A' ' 102' ' ' LEU . 5.6 mp -99.35 162.82 12.82 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.835 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.571 ' O ' HG13 ' A' ' 104' ' ' VAL . 21.4 t -115.76 147.75 18.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.215 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 103' ' ' VAL . 4.3 m -160.38 154.36 19.46 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.046 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.37 167.53 18.39 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.386 2.057 . . . . 0.0 112.238 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.52 -34.58 78.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.479 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.1 t -69.59 -30.35 68.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.134 0.492 . . . . 0.0 109.837 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -71.92 -46.24 58.33 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.79 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.403 ' O ' HD12 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -66.62 -46.65 75.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.756 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -54.84 -51.79 50.73 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.57 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.3 m -70.76 -40.03 72.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.771 0.32 . . . . 0.0 110.757 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.7 mt -55.27 -26.99 43.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.645 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.589 HG22 ' HA2' ' A' ' 117' ' ' GLY . 9.8 mt -84.29 -40.76 15.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.799 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.48 -177.19 49.47 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.497 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.5 mttp -66.36 124.13 21.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.827 0.346 . . . . 0.0 111.056 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 58.47 19.96 43.28 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.766 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.589 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 66.78 11.57 57.91 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.904 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 29.1 p -53.01 -38.55 62.43 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.589 ' HD2' HD11 ' A' ' 123' ' ' ILE . 4.8 tmtt? -67.78 -65.39 0.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.641 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.822 ' HA ' HD12 ' A' ' 123' ' ' ILE . 1.0 OUTLIER -55.87 -34.66 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.728 -179.327 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -62.3 -50.4 71.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.306 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 123' ' ' ILE . 5.8 pt-20 -64.36 -34.39 78.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.303 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.822 HD12 ' HA ' ' A' ' 120' ' ' ILE . 15.7 mt -65.87 -53.97 32.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.226 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.47 -30.31 65.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.036 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -59.04 -45.22 91.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.982 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.2 -39.34 14.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.12 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 36.5 m -49.93 -25.84 3.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.832 0.349 . . . . 0.0 110.16 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.6 -9.25 65.58 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.929 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.678 ' HB1' ' O ' ' A' ' 149' ' ' ALA . . . -108.14 164.25 12.46 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.83 0.348 . . . . 0.0 111.204 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -104.81 133.15 50.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.708 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.897 ' HB ' HD11 ' A' ' 146' ' ' ILE . 6.3 m -99.19 139.07 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.137 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.622 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -109.2 158.17 18.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.608 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.8 t -137.66 132.58 44.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.883 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.11 179.971 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.7 p . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.866 0.365 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.81 -48.68 2.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.698 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.493 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 16.7 mm-40 -99.45 140.39 33.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.689 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -109.97 136.79 48.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.964 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -104.3 125.93 50.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.118 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.897 HD11 ' HB ' ' A' ' 131' ' ' VAL . 0.5 OUTLIER -105.91 139.86 25.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.518 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.531 ' HB ' ' HB2' ' A' ' 132' ' ' GLN . 2.3 m -121.12 115.1 22.45 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.473 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.8 mp -104.39 121.78 56.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.104 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.7 ' HB2' HG22 ' A' ' 99' ' ' THR . . . -118.35 145.93 44.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.021 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.644 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 154.49 -151.62 23.28 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.651 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.506 ' CG2' ' HD2' ' A' ' 152' ' ' PRO . 1.5 mp -82.41 143.85 48.75 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.506 ' HD2' ' CG2' ' A' ' 151' ' ' ILE . 79.5 Cg_exo -48.98 -34.09 28.1 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 121.933 1.756 . . . . 0.0 111.589 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -72.17 -34.64 68.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.645 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 50.7 m -69.81 -39.04 76.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.902 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.47 ' O ' HG23 ' A' ' 159' ' ' VAL . 39.2 mm -66.26 -53.47 36.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.073 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.554 HD11 HD13 ' A' ' 76' ' ' ILE . 32.6 mm -57.51 -29.0 32.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.873 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -72.32 -40.82 67.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.837 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . 0.422 ' O ' HG22 ' A' ' 162' ' ' ILE . 0.5 OUTLIER -65.73 -35.03 79.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.855 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 155' ' ' ILE . 24.7 t -73.99 -37.73 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.169 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -71.55 -34.82 70.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.93 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.78 ' O ' HG23 ' A' ' 165' ' ' VAL . 7.0 mm100 -73.77 -40.65 63.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.958 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.422 HG22 ' O ' ' A' ' 158' ' ' CYS . 14.8 tt -71.43 -34.46 53.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.152 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 1.5 m -68.27 -51.92 39.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.137 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 10.8 p -58.83 -40.13 79.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.273 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 161' ' ' GLN . 50.5 t -70.62 -32.33 49.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.007 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -45.78 90.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.874 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -71.36 -47.32 57.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.89 -2.65 24.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.209 -0.451 . . . . 0.0 112.015 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.166 -0.921 . . . . 0.0 111.385 179.957 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.807 0.336 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.65 HG11 HD21 ' A' ' 167' ' ' LEU . 7.7 p -108.7 161.1 7.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.003 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.54 ' N ' HG22 ' A' ' 12' ' ' VAL . 3.1 t -103.57 160.78 14.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.012 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.478 ' HA ' HD23 ' A' ' 14' ' ' LEU . 4.3 mt -150.61 173.75 13.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.163 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.7 m -142.47 113.23 7.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.756 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.805 HG22 HD11 ' A' ' 68' ' ' ILE . 16.7 tt -132.61 129.01 58.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.319 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.75 ' O ' HD23 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -117.98 148.61 42.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.693 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 pp -129.38 146.67 51.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.895 0.379 . . . . 0.0 111.248 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.648 HD23 ' N ' ' A' ' 20' ' ' MET . 7.3 tt -123.05 134.62 54.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.795 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.648 ' N ' HD23 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -138.47 165.81 25.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.983 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.557 ' O ' HG12 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -67.78 166.25 15.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.676 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.2 -36.93 94.1 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.705 -0.76 . . . . 0.0 113.022 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -78.36 -50.08 12.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.901 0.381 . . . . 0.0 111.34 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.95 -44.81 95.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.335 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.796 HG22 HD11 ' A' ' 29' ' ' ILE . 6.4 p -62.97 -35.98 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.794 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.16 -34.87 90.47 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.5 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.6 t -75.52 -30.17 59.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.768 0.318 . . . . 0.0 110.846 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.524 ' CG2' HG23 ' A' ' 75' ' ' ILE . 4.1 mm -81.12 -36.87 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.258 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.796 HD11 HG22 ' A' ' 25' ' ' VAL . 30.5 mt -65.75 -42.48 92.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.337 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.42 ' HA3' ' HB2' ' A' ' 35' ' ' SER . . . 88.58 150.9 22.29 Favored Glycine 0 N--CA 1.434 -1.489 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.122 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.433 ' O ' ' CD ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -51.22 146.61 6.47 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.739 -0.731 . . . . 0.0 111.242 179.599 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.503 ' HE3' ' HB3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 44.43 27.1 0.21 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.119 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 45.37 20.2 0.31 Allowed Glycine 0 CA--C 1.522 0.529 0 C-N-CA 121.353 -0.451 . . . . 0.0 113.967 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.503 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -73.14 -25.3 60.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.327 0.564 . . . . 0.0 110.086 179.263 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.42 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -72.58 -42.75 64.26 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.539 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.663 HG13 ' HA ' ' A' ' 29' ' ' ILE . 0.9 OUTLIER -67.02 -26.62 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -71.03 -36.9 72.54 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.04 -37.09 86.45 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.586 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -59.01 -53.74 54.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.419 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.402 ' HA ' HD12 ' A' ' 47' ' ' ILE . 17.9 mtm-85 -52.86 -51.14 62.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.956 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.6 -37.5 84.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.914 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.52 -35.84 63.16 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.426 ' CB ' ' HB2' ' A' ' 71' ' ' ALA . 0.3 OUTLIER -93.28 -55.74 3.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.978 0.418 . . . . 0.0 111.08 -179.644 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.37 10.03 54.5 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.882 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.483 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -110.77 128.38 55.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.89 0.345 . . . . 0.0 111.221 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -27.49 134.5 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.243 179.439 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.406 HG13 ' HG ' ' A' ' 61' ' ' LEU . 10.4 mt -142.22 100.57 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.705 0.288 . . . . 0.0 110.522 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -112.98 167.43 10.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.886 0.374 . . . . 0.0 111.056 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.541 HG21 ' NE ' ' A' ' 57' ' ' ARG . 3.4 mt -126.52 152.04 33.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.155 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 63.9 m -91.03 -175.05 4.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.218 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.16 -179.816 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.455 -0.201 0 CA-C-O 120.802 0.334 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.791 ' HB2' HG21 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -146.32 127.53 14.78 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.288 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.639 HG12 HD12 ' A' ' 19' ' ' LEU . 17.3 mt -115.0 104.58 17.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.375 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.3 mt -92.92 103.55 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.522 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 91.1 m -83.02 129.1 35.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.459 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.794 HD22 HG13 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -118.21 131.3 56.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.085 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.483 ' O ' ' HB1' ' A' ' 45' ' ' ALA . . . -131.29 130.92 43.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.759 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.2 164.8 14.07 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.961 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 86.9 Cg_exo -40.31 162.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.169 2.58 . . . . 0.0 113.041 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.453 ' O ' HG22 ' A' ' 68' ' ' ILE . 9.6 m -60.17 -35.73 76.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.009 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -69.84 -51.86 29.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.081 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.04 -39.64 75.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.97 0.414 . . . . 0.0 110.85 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.805 HD11 HG22 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -66.23 -39.54 84.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.34 -179.469 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.74 -43.13 89.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.01 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.29 -49.92 75.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.955 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.426 ' HB2' ' CB ' ' A' ' 43' ' ' SER . . . -58.04 -56.47 21.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.27 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.933 ' HA ' HD12 ' A' ' 75' ' ' ILE . 2.6 m-85 -57.39 -34.57 69.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.113 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.27 -42.09 99.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.124 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.06 -36.55 72.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.951 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.933 HD12 ' HA ' ' A' ' 72' ' ' PHE . 14.9 mt -62.77 -49.26 84.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.4 HG13 ' N ' ' A' ' 77' ' ' ASP . 24.5 pt -61.21 -40.51 86.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.027 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.4 ' N ' HG13 ' A' ' 76' ' ' ILE . 1.1 t0 -61.22 -39.87 91.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.685 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.43 -41.67 97.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.29 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.411 HD21 HG11 ' A' ' 98' ' ' VAL . 18.1 tp -74.61 -26.62 60.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.472 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -76.89 -34.62 57.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.703 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -72.21 -37.38 69.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.729 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.8 t0 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.914 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo . . . . . 0 N--CA 1.465 -0.198 0 CA-C-O 120.988 0.328 . . . . 0.0 112.839 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.411 HG11 HD21 ' A' ' 79' ' ' LEU . 21.2 t -140.77 122.12 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.987 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.855 HG22 ' CB ' ' A' ' 149' ' ' ALA . 5.0 p -102.62 141.13 35.95 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.461 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 147' ' ' THR . 4.6 mp -139.84 158.58 43.85 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.139 -1.801 . . . . 0.0 106.139 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.584 ' HG2' ' HB1' ' A' ' 145' ' ' ALA . 8.3 ttp-105 -122.84 113.33 19.0 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.912 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.75 HD23 ' O ' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -101.09 144.6 29.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.933 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.5 t -104.43 139.08 26.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.061 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.3 m -149.06 157.22 40.17 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.04 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.24 166.56 20.84 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.421 2.081 . . . . 0.0 112.324 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.68 -34.57 75.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.384 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 p -68.97 -30.28 68.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.978 0.418 . . . . 0.0 109.926 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -50.6 52.71 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.793 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.474 ' O ' HD12 ' A' ' 113' ' ' ILE . 30.9 p -70.67 -38.21 73.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.677 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -54.7 -50.45 57.67 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.475 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.2 p -77.43 -47.45 19.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.671 0.272 . . . . 0.0 111.011 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.872 ' CD2' HD12 ' A' ' 162' ' ' ILE . 29.0 mt -52.66 -26.46 13.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.925 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.487 HG22 ' HA2' ' A' ' 117' ' ' GLY . 41.0 mt -92.33 -37.37 8.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.943 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.93 179.47 32.83 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.423 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -67.39 124.18 22.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.873 0.368 . . . . 0.0 111.008 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.0 19.1 63.14 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.816 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.487 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 64.41 13.26 54.25 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.887 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -52.9 -50.6 63.57 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 120.775 0.322 . . . . 0.0 111.728 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.734 ' HD2' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -57.1 -60.83 3.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.178 -179.763 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.645 HD13 ' O ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -56.1 -26.92 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.456 -179.766 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.6 tptp -65.06 -47.0 78.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.796 0.332 . . . . 0.0 110.892 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -73.13 -45.8 54.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.136 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.734 HD11 ' HD2' ' A' ' 119' ' ' LYS . 50.6 mt -62.17 -50.89 78.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.998 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -63.78 -40.55 96.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.151 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -54.99 -57.38 11.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.818 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.3 m -75.83 -43.68 44.77 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.422 HG21 ' HB3' ' A' ' 158' ' ' CYS . 25.0 m -47.95 -25.94 1.55 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.866 0.365 . . . . 0.0 110.432 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.24 -7.05 58.24 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.049 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -105.66 137.11 44.06 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.951 0.375 . . . . 0.0 110.953 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.41 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 0.0 OUTLIER -95.58 144.59 25.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.209 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.465 ' CG2' HD11 ' A' ' 120' ' ' ILE . 4.8 m -99.31 147.17 7.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.045 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 7.0 tp60 -140.22 117.77 11.52 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.555 HG23 ' CG ' ' A' ' 144' ' ' ARG . 11.6 p -96.59 116.47 38.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.051 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.795 -179.608 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 88.3 p . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.865 0.364 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 25.7 m -106.42 -64.56 1.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.359 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.494 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 10.5 mm-40 -93.92 135.73 34.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.171 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.555 ' CG ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -121.75 166.41 14.35 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.241 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.584 ' HB1' ' HG2' ' A' ' 101' ' ' ARG . . . -130.2 115.75 17.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.791 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 30.5 mt -100.77 129.24 51.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.696 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.457 ' HB ' ' CB ' ' A' ' 132' ' ' GLN . 2.6 m -97.67 123.06 41.43 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.519 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.795 ' O ' HD12 ' A' ' 148' ' ' ILE . 2.1 pp -106.72 117.97 53.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.935 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.855 ' CB ' HG22 ' A' ' 99' ' ' THR . . . -118.34 126.43 52.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.121 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 171.28 -153.28 20.08 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.592 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.518 HG22 ' HD2' ' A' ' 152' ' ' PRO . 1.3 mp -87.32 143.59 34.65 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 110.624 -0.139 . . . . 0.0 110.624 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.518 ' HD2' HG22 ' A' ' 151' ' ' ILE . 71.3 Cg_exo -49.33 -31.03 21.62 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 121.966 1.777 . . . . 0.0 111.447 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.13 -34.65 68.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.674 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 22.2 t -68.79 -50.08 53.3 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.795 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.612 HD13 ' C ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -58.39 -45.07 89.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.451 HD12 ' O ' ' A' ' 152' ' ' PRO . 27.9 mt -63.88 -29.98 48.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.845 0.355 . . . . 0.0 110.842 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -73.65 -43.02 60.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.238 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . 0.422 ' HB3' HG21 ' A' ' 127' ' ' THR . 21.4 p -72.42 -42.87 64.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.277 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.423 HG12 ' HA ' ' A' ' 156' ' ' ILE . 13.3 p -60.83 -37.9 77.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.927 0.394 . . . . 0.0 111.01 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.97 -32.91 69.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.756 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.874 ' O ' HG23 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -67.86 -49.56 61.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.0 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.872 HD12 ' CD2' ' A' ' 112' ' ' LEU . 37.7 mm -66.41 -34.48 70.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.015 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 1.7 m -64.58 -48.1 76.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.978 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 161' ' ' GLN . 11.1 p -65.48 -33.53 64.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.187 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 161' ' ' GLN . 50.8 t -70.64 -45.14 75.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.878 0.371 . . . . 0.0 110.972 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 27.2 mtm -58.98 -33.57 70.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.847 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.65 HD21 HG11 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -72.56 -48.22 41.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.818 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.02 -2.55 24.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.93 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 41.2 p . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.876 -179.979 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.816 0.341 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.44 151.68 16.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.986 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 0.9 OUTLIER -103.66 142.75 33.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.039 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.494 ' HA ' HD23 ' A' ' 14' ' ' LEU . 4.2 mt -137.11 175.23 9.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.991 0.424 . . . . 0.0 111.211 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.7 m -142.4 135.97 29.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.841 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.558 HG22 HD11 ' A' ' 68' ' ' ILE . 14.1 tt -140.87 154.67 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.164 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.496 ' NH2' ' OE1' ' A' ' 143' ' ' GLU . 25.0 mtp180 -134.79 127.63 31.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.867 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.474 HD11 ' CZ ' ' A' ' 72' ' ' PHE . 52.5 mt -113.96 147.58 38.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.568 HD23 ' O ' ' A' ' 19' ' ' LEU . 6.8 tt -102.35 106.04 16.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.762 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.2 144.14 40.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.044 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.547 ' O ' HG12 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -76.61 167.82 21.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.752 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.424 ' C ' HG12 ' A' ' 25' ' ' VAL . . . -59.8 -34.66 83.49 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.769 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.86 -52.02 8.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 0.0 111.354 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -34.12 76.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.849 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.685 ' O ' HG12 ' A' ' 29' ' ' ILE . 7.4 p -71.03 -38.97 74.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.664 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.08 -35.08 90.95 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.683 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.26 -34.96 61.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.594 0.235 . . . . 0.0 111.07 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.638 HD12 ' N ' ' A' ' 29' ' ' ILE . 2.9 pp -80.15 -32.53 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.355 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.768 ' HA ' HG13 ' A' ' 36' ' ' VAL . 12.4 mm -65.06 -58.87 5.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.7 150.54 25.29 Favored Glycine 0 N--CA 1.436 -1.354 0 CA-C-O 121.635 0.575 . . . . 0.0 112.664 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.443 ' O ' ' CD ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -61.52 146.34 48.98 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.501 -0.85 . . . . 0.0 111.441 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.454 ' HG2' ' H ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER 52.56 18.89 1.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.277 179.482 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.412 ' O ' HG23 ' A' ' 36' ' ' VAL . . . 51.7 13.79 1.5 Allowed Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.956 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.454 ' H ' ' HG2' ' A' ' 32' ' ' LYS . 5.4 tp10 -76.88 -26.27 54.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.322 0.561 . . . . 0.0 109.748 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.445 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -75.19 -40.95 58.93 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.246 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.768 HG13 ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.3 -26.51 36.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.243 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.57 -36.61 81.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 177.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 35' ' ' SER . 22.2 ttmm -60.36 -40.9 92.43 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.778 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.502 ' HE2' HG21 ' A' ' 47' ' ' ILE . 3.0 ttp -59.2 -48.46 81.55 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.38 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.2 ttp85 -55.3 -50.63 69.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.101 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -64.64 -38.51 91.25 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 39' ' ' MET . 3.1 pp20? -75.03 -35.88 61.92 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.742 ' HB3' ' HB2' ' A' ' 71' ' ' ALA . 37.0 p -91.04 -55.4 3.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.911 0.386 . . . . 0.0 111.105 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.12 5.86 65.45 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.248 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.832 ' HB3' HD11 ' A' ' 61' ' ' LEU . . . -110.65 128.43 55.69 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.44 0.162 . . . . 0.0 110.799 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.572 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -27.61 136.91 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.001 0.521 . . . . 0.0 112.057 178.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.502 HG21 ' HE2' ' A' ' 39' ' ' MET . 20.6 mt -142.19 100.68 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.73 0.3 . . . . 0.0 110.578 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -121.41 121.57 37.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.919 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -107.53 127.61 63.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.374 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.404 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER 178.92 -174.04 0.18 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.044 179.92 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 120.687 0.28 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.616 ' CD ' HG11 ' A' ' 25' ' ' VAL . 2.0 mpt_? -145.82 155.89 43.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.006 0.431 . . . . 0.0 111.525 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.404 ' HB ' ' O ' ' A' ' 50' ' ' SER . 19.7 mt -140.64 118.7 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.339 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 mt -85.94 117.93 31.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.985 0.422 . . . . 0.0 111.622 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.9 m -108.57 101.75 10.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.467 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.832 HD11 ' HB3' ' A' ' 45' ' ' ALA . 15.9 tp -104.41 124.29 48.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.812 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.508 ' HB3' ' HB2' ' A' ' 46' ' ' ARG . . . -126.78 131.71 51.22 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.495 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.39 166.19 16.43 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 119.686 -1.245 . . . . 0.0 113.297 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 2.9 Cg_endo -41.85 159.48 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 123.396 2.731 . . . . 0.0 112.669 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.466 ' O ' HG22 ' A' ' 68' ' ' ILE . 57.0 m -60.11 -35.97 76.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.48 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -68.72 -52.07 34.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.239 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.07 -38.04 72.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.071 0.462 . . . . 0.0 110.882 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.558 HD11 HG22 ' A' ' 16' ' ' ILE . 0.5 OUTLIER -65.18 -39.34 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.275 -179.376 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.44 -45.09 92.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.886 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.2 -53.41 58.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.614 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.742 ' HB2' ' HB3' ' A' ' 43' ' ' SER . . . -60.72 -43.74 97.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.177 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.474 ' CZ ' HD11 ' A' ' 18' ' ' LEU . 0.7 OUTLIER -62.02 -35.51 78.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.078 -179.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.87 -38.78 83.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.262 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.36 -39.21 54.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.984 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 88.6 mt -62.06 -50.58 79.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.661 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.499 HD12 ' N ' ' A' ' 77' ' ' ASP . 2.3 pp -63.87 -40.69 89.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.969 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.499 ' N ' HD12 ' A' ' 76' ' ' ILE . 3.0 m-20 -69.65 -29.69 67.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.455 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -35.64 81.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.076 0.465 . . . . 0.0 109.91 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.9 tp -77.39 -30.52 53.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.386 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.94 -34.05 57.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.776 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.54 -37.84 68.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.032 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.446 -179.674 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo . . . . . 0 C--O 1.232 0.195 0 CA-C-O 120.715 0.214 . . . . 0.0 112.078 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.422 HG21 ' HG3' ' A' ' 152' ' ' PRO . 21.3 t -125.17 103.32 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.903 0.383 . . . . 0.0 111.418 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.0 t -107.53 127.0 53.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.383 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 mt -140.03 117.76 11.63 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -103.18 112.39 25.23 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.788 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.64 149.77 26.89 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.403 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.24 145.08 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.652 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.653 HG23 HD13 ' A' ' 146' ' ' ILE . 40.1 t -142.88 144.75 30.66 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.225 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.446 ' HD2' ' CG1' ' A' ' 104' ' ' VAL . 22.2 Cg_exo -65.36 165.51 22.16 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.507 2.138 . . . . 0.0 112.154 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' A' ' 142' ' ' THR . . . -69.04 -44.22 73.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.135 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.5 m -66.7 -30.48 70.72 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.419 ' HB3' ' CG1' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -74.61 -41.42 60.46 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.434 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 55.6 m -66.28 -40.9 90.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.102 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.57 -50.71 64.79 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.161 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.3 t -70.4 -36.2 73.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.783 0.325 . . . . 0.0 110.615 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.52 HD21 HG23 ' A' ' 162' ' ' ILE . 10.7 mt -58.49 -28.32 65.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.272 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.585 HG22 ' HA2' ' A' ' 117' ' ' GLY . 10.9 mt -81.71 -40.29 17.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.717 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.1 -176.83 53.81 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.521 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -66.47 118.15 9.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.896 0.379 . . . . 0.0 111.185 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.99 15.38 56.0 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.015 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.585 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 73.06 5.08 64.6 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.006 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 1.5 m -53.13 -39.65 63.64 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 120.727 0.299 . . . . 0.0 111.719 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -64.87 -65.33 0.69 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.438 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.405 ' HB ' ' HA ' ' A' ' 113' ' ' ILE . 0.5 OUTLIER -54.4 -35.51 31.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.393 -179.674 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.5 tptm -59.26 -44.18 92.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.08 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -73.24 -40.21 64.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.329 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 88.2 mt -54.97 -53.9 29.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.216 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -31.95 69.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.892 0.377 . . . . 0.0 110.938 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -49.74 72.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.31 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.2 m -90.08 -36.94 14.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.546 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.6 m -49.89 -26.05 3.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.848 0.356 . . . . 0.0 110.364 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.3 -12.04 52.59 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.093 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -103.8 155.24 18.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.844 0.354 . . . . 0.0 111.038 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.31 127.94 53.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.054 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 147' ' ' THR . 14.4 m -99.2 138.64 23.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.861 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.69 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 5.4 tm0? -123.38 116.59 23.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.167 0.508 . . . . 0.0 112.032 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.484 HG12 HG13 ' A' ' 146' ' ' ILE . 30.8 m -103.46 130.97 52.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.363 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.929 179.675 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 79.0 p . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.798 0.332 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.419 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.2 OUTLIER -112.01 -47.32 3.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.496 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 29.5 mt-10 -121.98 139.88 53.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.825 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.04 173.07 6.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -122.54 126.33 47.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.232 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.69 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 3.4 mp -105.48 125.0 60.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.618 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 131' ' ' VAL . 2.1 m -99.59 114.69 27.87 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.678 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.923 HD12 HG12 ' A' ' 155' ' ' ILE . 4.6 pt -106.9 114.72 46.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.411 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -119.38 132.33 55.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.768 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 167.06 -151.61 19.67 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.815 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.532 ' CG2' ' HD2' ' A' ' 152' ' ' PRO . 15.9 mt -84.85 144.46 42.02 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.532 ' HD2' ' CG2' ' A' ' 151' ' ' ILE . 73.5 Cg_exo -48.89 -33.77 26.57 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 121.988 1.792 . . . . 0.0 111.689 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -72.05 -34.75 69.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.845 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.3 m -67.97 -50.46 55.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.992 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.923 HG12 HD12 ' A' ' 148' ' ' ILE . 0.0 OUTLIER -59.26 -47.45 90.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.134 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.472 ' N ' HG23 ' A' ' 155' ' ' ILE . 33.6 mt -60.69 -45.9 96.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.819 0.342 . . . . 0.0 110.759 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -60.46 -35.17 75.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.663 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 9.0 t -67.03 -42.99 83.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.774 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 155' ' ' ILE . 21.6 t -59.03 -37.96 71.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.022 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.97 -33.01 73.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.777 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.893 ' O ' HG23 ' A' ' 165' ' ' VAL . 26.1 tp60 -71.47 -46.23 60.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.827 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.631 HG22 ' SD ' ' A' ' 166' ' ' MET . 50.3 mt -67.25 -34.51 69.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.979 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 1.6 m -63.93 -52.37 60.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.017 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 161' ' ' GLN . 10.7 p -59.56 -33.3 51.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.172 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 161' ' ' GLN . 44.0 t -70.69 -44.03 76.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.849 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.631 ' SD ' HG22 ' A' ' 162' ' ' ILE . 0.0 OUTLIER -59.85 -33.09 71.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.855 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.59 -50.56 35.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.76 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -73.97 -2.56 24.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.069 0.461 . . . . 0.0 111.948 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 169' ' ' THR . 60.2 m . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.864 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.531 0.237 0 CA-C-O 120.447 0.165 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.613 HG11 ' CD1' ' A' ' 167' ' ' LEU . 7.5 p -114.27 159.18 14.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.115 0.483 . . . . 0.0 111.373 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.522 ' N ' HG22 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -109.52 154.05 23.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.787 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' A' ' 14' ' ' LEU . 1.1 mt -144.36 169.28 18.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.054 0.454 . . . . 0.0 111.229 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.2 m -142.72 132.13 23.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.673 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.808 HG22 HD11 ' A' ' 68' ' ' ILE . 2.4 tt -140.83 140.05 33.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.948 0.404 . . . . 0.0 111.326 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.712 ' HG3' HG23 ' A' ' 60' ' ' THR . 1.1 mpp_? -124.48 120.32 31.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.686 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.572 HD21 ' CZ ' ' A' ' 72' ' ' PHE . 14.1 mt -99.8 119.63 38.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.118 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.567 ' C ' HD23 ' A' ' 19' ' ' LEU . 8.3 tt -102.71 105.43 15.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.702 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.6 tpp -120.21 161.48 20.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.902 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.618 ' O ' HG12 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -67.7 172.57 5.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.452 179.807 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.08 -40.79 99.39 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.913 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.93 -45.27 24.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.771 0.32 . . . . 0.0 111.547 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.13 -48.39 78.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.944 0.402 . . . . 0.0 110.283 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.755 HG22 HD11 ' A' ' 29' ' ' ILE . 9.8 p -61.66 -35.2 65.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.852 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.94 -34.92 90.46 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.187 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 m -75.24 -26.76 59.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.879 0.371 . . . . 0.0 110.723 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.456 HG23 HG23 ' A' ' 75' ' ' ILE . 3.9 mm -79.11 -51.48 16.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.123 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.755 HD11 HG22 ' A' ' 25' ' ' VAL . 8.7 mt -57.31 -42.27 79.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.514 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.03 150.84 27.3 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.137 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.416 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -51.59 146.05 8.16 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.058 -0.571 . . . . 0.0 111.143 179.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.454 ' HE3' ' HB3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 43.36 27.07 0.12 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.834 -179.65 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.45 ' O ' HG12 ' A' ' 36' ' ' VAL . . . 45.17 21.75 0.43 Allowed Glycine 0 CA--C 1.52 0.4 0 C-N-CA 121.273 -0.489 . . . . 0.0 113.852 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.454 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -76.23 -28.84 57.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.209 0.504 . . . . 0.0 110.314 179.574 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.1 t -73.71 -41.75 62.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.488 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 33' ' ' GLY . 2.3 p -67.42 -27.34 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.2 -36.67 79.91 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 176.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.414 ' HA ' ' CG ' ' A' ' 41' ' ' GLU . 1.8 tttm -70.91 -31.8 68.53 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.241 177.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.409 ' HB2' ' HA ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -63.21 -51.04 67.89 Favored 'General case' 0 C--O 1.228 -0.047 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.463 179.52 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.0 ttt-85 -58.38 -51.57 69.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.581 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.414 ' CG ' ' HA ' ' A' ' 38' ' ' LYS . 1.4 pp20? -64.33 -37.94 89.27 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -74.69 -36.75 62.76 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.853 ' CB ' ' HB2' ' A' ' 71' ' ' ALA . 83.1 p -81.37 -55.65 4.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.906 0.384 . . . . 0.0 111.018 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.93 1.12 56.15 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.736 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -110.66 128.17 55.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.842 0.321 . . . . 0.0 111.304 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.566 ' HB3' ' HB3' ' A' ' 62' ' ' ALA . 8.3 ttm180 -27.27 140.6 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.257 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 60' ' ' THR . 12.0 mt -142.52 101.1 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.696 0.284 . . . . 0.0 110.817 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -118.38 128.77 54.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.781 0.324 . . . . 0.0 111.248 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.61 HG21 ' HD3' ' A' ' 57' ' ' ARG . 9.6 mm -92.11 151.86 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.97 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.7 m -87.16 -177.06 5.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.915 0.388 . . . . 0.0 111.268 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.111 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 120.761 0.315 . . . . 0.0 110.855 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.741 ' HB2' HG21 ' A' ' 25' ' ' VAL . 1.5 mtt180 -145.79 139.3 26.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.825 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.419 ' CD1' HD12 ' A' ' 19' ' ' LEU . 6.8 mm -105.62 109.71 28.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.024 0.44 . . . . 0.0 110.892 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.672 HD11 HG23 ' A' ' 25' ' ' VAL . 3.8 mt -86.49 92.83 3.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.094 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.712 HG23 ' HG3' ' A' ' 17' ' ' ARG . 8.0 m -81.1 134.08 35.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.985 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -131.39 134.65 46.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.285 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.566 ' HB3' ' HB3' ' A' ' 46' ' ' ARG . . . -135.47 130.52 34.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.66 0.267 . . . . 0.0 110.862 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.407 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.22 164.61 13.87 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.919 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.475 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 83.6 Cg_exo -39.93 158.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 123.21 2.607 . . . . 0.0 113.238 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.46 ' O ' HG22 ' A' ' 68' ' ' ILE . 29.9 m -60.04 -35.69 75.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.87 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -63.48 -51.83 63.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.262 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.21 -40.7 77.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.057 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.808 HD11 HG22 ' A' ' 16' ' ' ILE . 0.5 OUTLIER -66.19 -39.37 84.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.18 -179.44 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.38 -48.92 79.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.227 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.73 -48.8 79.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.977 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.853 ' HB2' ' CB ' ' A' ' 43' ' ' SER . . . -57.41 -58.75 6.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.286 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.838 ' HA ' HD12 ' A' ' 75' ' ' ILE . 2.7 m-85 -51.84 -39.24 58.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.305 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.61 -43.93 93.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.109 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.0 ttp -72.21 -34.82 68.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.838 HD12 ' HA ' ' A' ' 72' ' ' PHE . 20.9 mt -64.29 -48.7 84.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.965 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.3 pt -62.65 -39.35 84.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.93 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.19 -36.52 82.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.718 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -42.27 93.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.335 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.5 tp -77.34 -24.94 50.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.624 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -76.86 -39.96 49.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.779 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.1 -34.01 68.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.834 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.917 -179.922 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo . . . . . 0 C--O 1.231 0.15 0 CA-C-O 120.831 0.263 . . . . 0.0 112.114 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.497 HG21 ' HD3' ' A' ' 152' ' ' PRO . 19.3 t -134.81 107.04 7.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.197 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.1 p -104.0 135.53 45.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.785 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.585 ' O ' HG22 ' A' ' 148' ' ' ILE . 0.5 OUTLIER -139.98 117.59 11.53 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 178.812 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.485 ' HE ' HD22 ' A' ' 19' ' ' LEU . 18.9 ttp180 -105.2 112.56 25.73 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.291 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.3 mt -99.37 129.97 45.61 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.049 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.893 HG12 ' HB2' ' A' ' 145' ' ' ALA . 21.3 m -103.85 143.99 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.058 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 103' ' ' VAL . 12.7 m -157.94 166.2 17.04 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.09 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.402 ' CD ' ' HB ' ' A' ' 104' ' ' VAL . 21.8 Cg_exo -65.97 171.32 10.17 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.609 2.206 . . . . 0.0 112.356 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 142' ' ' THR . . . -63.58 -34.6 78.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.623 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.3 m -67.34 -30.52 70.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.11 0.481 . . . . 0.0 109.874 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.402 ' CB ' ' HB ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -69.41 -50.53 45.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.772 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.18 -41.52 99.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.646 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -56.55 -47.47 83.8 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.375 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.0 t -71.99 -40.5 68.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.795 0.331 . . . . 0.0 110.815 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.876 HD21 HG23 ' A' ' 162' ' ' ILE . 12.6 mt -54.36 -26.82 32.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.978 0.418 . . . . 0.0 110.598 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.641 HG22 ' HA2' ' A' ' 117' ' ' GLY . 8.2 mt -84.86 -43.18 17.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.791 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.98 -176.74 54.58 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.569 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -67.29 116.89 8.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.896 0.379 . . . . 0.0 111.079 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.57 11.82 57.7 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.999 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.641 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 75.64 2.58 69.88 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.995 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -52.83 -36.79 59.14 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 120.701 0.286 . . . . 0.0 111.609 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.9 mmtp -63.87 -65.27 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.192 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.39 -31.05 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.373 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.98 -46.55 88.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.038 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -73.21 -46.25 51.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.307 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.55 HG23 ' HG2' ' A' ' 161' ' ' GLN . 40.4 mm -54.84 -53.68 30.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.204 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -63.74 -39.92 95.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.26 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.33 -53.93 47.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.33 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.8 m -76.99 -33.47 57.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.294 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.441 HG22 ' H ' ' A' ' 129' ' ' ALA . 17.8 m -52.34 -26.61 12.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.974 0.416 . . . . 0.0 110.125 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.84 -22.09 5.14 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.247 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.643 ' HB3' HD11 ' A' ' 148' ' ' ILE . . . -96.44 165.4 12.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.919 0.36 . . . . 0.0 111.073 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 11.2 mm100 -105.16 138.01 42.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.694 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 27.6 m -99.11 145.07 10.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.16 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.708 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 0.7 OUTLIER -119.57 158.43 26.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.767 -179.685 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 133' ' ' VAL . 11.5 p -120.74 122.13 67.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.792 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.382 -179.76 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.822 0.344 . . . . 0.0 110.834 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.568 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 15.7 m -123.35 -48.56 1.95 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.497 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 7.9 mt-10 -98.67 136.87 38.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.812 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 11.1 mtm-85 -115.6 155.3 27.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.93 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.893 ' HB2' HG12 ' A' ' 103' ' ' VAL . . . -122.43 135.98 54.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.988 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.708 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 21.9 mt -108.91 143.79 18.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.73 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' A' ' 132' ' ' GLN . 0.2 OUTLIER -113.62 116.84 30.12 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.178 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.674 HD13 ' SG ' ' A' ' 158' ' ' CYS . 1.0 OUTLIER -103.78 124.5 58.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.143 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.613 ' O ' ' HB1' ' A' ' 129' ' ' ALA . . . -118.46 146.32 44.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.171 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 149.52 -153.22 25.01 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.255 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.745 HD12 ' HB2' ' A' ' 153' ' ' GLN . 1.3 pt -87.12 156.39 54.64 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.642 0.258 . . . . 0.0 110.863 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.497 ' HD3' HG21 ' A' ' 98' ' ' VAL . 7.4 Cg_endo -49.53 -34.65 34.49 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.621 2.214 . . . . 0.0 111.907 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.745 ' HB2' HD12 ' A' ' 151' ' ' ILE . 0.3 OUTLIER -71.98 -34.66 69.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.391 179.457 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.574 ' HB3' ' HB2' ' A' ' 129' ' ' ALA . 18.6 m -70.37 -39.14 74.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.946 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.533 HD12 HG23 ' A' ' 148' ' ' ILE . 22.7 mm -72.64 -48.59 45.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.214 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.491 HG23 ' N ' ' A' ' 157' ' ' GLU . 20.2 tt -58.21 -45.15 88.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.141 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.491 ' N ' HG23 ' A' ' 156' ' ' ILE . 10.7 pt-20 -62.73 -36.67 83.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.707 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . 0.674 ' SG ' HD13 ' A' ' 148' ' ' ILE . 3.9 t -58.22 -47.22 84.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.642 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 30.3 t -61.2 -42.09 92.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.979 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.415 ' O ' HG12 ' A' ' 164' ' ' VAL . 0.2 OUTLIER -60.05 -35.59 75.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.78 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.561 ' O ' HG22 ' A' ' 165' ' ' VAL . 1.1 mp0 -67.24 -37.1 82.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.776 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.876 HG23 HD21 ' A' ' 112' ' ' LEU . 41.3 mt -74.02 -34.38 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.15 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 77.1 m -73.91 -45.15 52.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.076 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.489 HG13 ' N ' ' A' ' 165' ' ' VAL . 11.6 p -62.36 -45.36 98.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.062 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.621 ' O ' HG23 ' A' ' 169' ' ' THR . 28.0 m -65.85 -45.6 90.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.058 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.49 ' N ' HG23 ' A' ' 165' ' ' VAL . 50.8 mtp -57.6 -42.71 83.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.841 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.613 ' CD1' HG11 ' A' ' 12' ' ' VAL . 7.9 tt -72.55 -41.76 65.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.819 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.91 -2.67 24.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.977 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 165' ' ' VAL . 52.6 p . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.838 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.849 0.357 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.495 HG11 HD11 ' A' ' 167' ' ' LEU . 21.6 t -145.39 158.35 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.144 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.706 ' O ' HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -109.14 129.49 55.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.506 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.706 HD22 ' O ' ' A' ' 13' ' ' THR . 4.3 mm? -128.84 153.4 47.48 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.175 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 61' ' ' LEU . 25.5 m -135.91 112.76 10.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.502 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.904 HG22 HD11 ' A' ' 68' ' ' ILE . 1.6 tt -111.48 142.97 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.453 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.496 ' NH2' ' OE1' ' A' ' 143' ' ' GLU . 1.1 mpp_? -132.08 126.14 33.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.657 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.452 ' O ' HD12 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -125.13 132.0 53.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.247 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.738 HD21 ' HB2' ' A' ' 56' ' ' GLU . 7.0 tt -102.23 136.32 42.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.632 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.636 ' N ' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -129.99 155.39 46.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.892 0.377 . . . . 0.0 111.135 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.649 ' O ' HG12 ' A' ' 25' ' ' VAL . 11.6 m170 -67.75 175.18 3.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.641 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.01 -41.96 96.69 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.91 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.66 -42.83 27.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.742 0.305 . . . . 0.0 111.677 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.56 -40.99 98.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.986 0.422 . . . . 0.0 110.537 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.724 HG22 HG13 ' A' ' 29' ' ' ILE . 8.6 p -70.89 -32.44 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.657 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.42 -39.86 98.33 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.371 -0.919 . . . . 0.0 112.822 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.5 p -76.06 -35.49 59.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 25' ' ' VAL . 2.1 pp -79.83 -32.61 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.724 HG13 HG22 ' A' ' 25' ' ' VAL . 9.8 mm -71.92 -54.58 16.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.916 0.388 . . . . 0.0 110.427 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.411 ' HA3' ' CB ' ' A' ' 35' ' ' SER . . . 99.65 150.64 25.45 Favored Glycine 0 N--CA 1.436 -1.327 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.945 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.427 ' O ' ' CD ' ' A' ' 32' ' ' LYS . 8.3 mttm -59.67 146.54 40.77 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.478 -0.861 . . . . 0.0 111.214 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.461 ' HE3' ' HB3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 44.2 26.25 0.15 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.997 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.405 ' O ' HG23 ' A' ' 36' ' ' VAL . . . 50.88 18.63 2.91 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.685 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.461 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -75.44 -29.77 59.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.228 0.514 . . . . 0.0 109.992 179.308 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.411 ' CB ' ' HA3' ' A' ' 30' ' ' GLY . 0.3 OUTLIER -75.39 -40.3 58.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.584 179.589 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.709 HG13 ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.09 -26.25 36.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.23 -36.97 74.89 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -63.15 -37.43 87.18 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.396 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.684 ' HE3' HG12 ' A' ' 36' ' ' VAL . 2.5 ttm -59.33 -51.29 70.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.487 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.503 ' HA ' HD12 ' A' ' 47' ' ' ILE . 6.0 mtp180 -53.81 -51.35 63.79 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.159 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -59.27 -38.41 80.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.693 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.27 -20.42 34.51 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.71 ' HB2' ' HB2' ' A' ' 71' ' ' ALA . 11.1 t -90.44 -55.48 3.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.757 0.313 . . . . 0.0 111.554 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.53 -10.93 73.27 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.401 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.81 ' HB3' HD21 ' A' ' 61' ' ' LEU . . . -110.73 128.91 55.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.588 0.232 . . . . 0.0 111.112 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.8 OUTLIER -27.01 140.12 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.204 0.602 . . . . 0.0 112.386 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 40' ' ' ARG . 25.6 mt -142.32 100.55 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.558 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.47 129.99 52.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.751 0.31 . . . . 0.0 111.011 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 3.4 mp -108.4 142.47 20.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.197 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.8 p -161.64 -170.73 2.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.922 0.392 . . . . 0.0 111.317 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.648 ' HG3' HD12 ' A' ' 58' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.035 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.738 ' HB2' HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.668 ' HB2' HG21 ' A' ' 25' ' ' VAL . 4.3 mtm180 -145.75 132.71 20.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.851 0.357 . . . . 0.0 110.885 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.648 HD12 ' HG3' ' A' ' 51' ' ' GLU . 46.4 mt -98.05 105.91 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.756 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.452 HD12 ' O ' ' A' ' 18' ' ' LEU . 3.7 mp -86.07 97.61 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.212 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.443 HG23 ' HG3' ' A' ' 17' ' ' ARG . 62.5 m -87.49 136.83 32.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.925 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.81 HD21 ' HB3' ' A' ' 45' ' ' ALA . 2.1 tt -131.42 134.24 46.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.486 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.412 ' O ' ' HB1' ' A' ' 45' ' ' ALA . . . -133.12 130.71 39.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.685 0.278 . . . . 0.0 111.158 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.426 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.26 164.41 13.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.707 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 86.7 Cg_exo -40.75 161.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.019 2.479 . . . . 0.0 113.179 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.456 ' O ' HG22 ' A' ' 68' ' ' ILE . 8.5 m -60.21 -35.64 75.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.115 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 -64.73 -51.88 60.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.362 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.46 ' CB ' ' HB2' ' A' ' 45' ' ' ALA . . . -56.97 -42.4 80.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.957 0.408 . . . . 0.0 110.974 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.904 HD11 HG22 ' A' ' 16' ' ' ILE . 0.5 OUTLIER -66.3 -39.65 84.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.335 -179.334 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -46.12 90.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.061 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -51.2 70.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.991 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.71 ' HB2' ' HB2' ' A' ' 43' ' ' SER . . . -57.37 -41.64 80.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.29 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.439 ' O ' HG13 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -60.37 -39.43 87.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.912 0.387 . . . . 0.0 110.889 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.92 -29.86 68.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.312 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -48.46 14.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.699 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 72' ' ' PHE . 0.7 OUTLIER -59.78 -39.08 78.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.288 -179.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 pp -72.48 -37.03 56.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.853 0.359 . . . . 0.0 111.012 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -65.48 -46.94 77.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.498 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.04 -35.3 74.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.012 0.434 . . . . 0.0 110.018 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.7 tp -76.58 -27.27 55.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.141 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.84 -34.13 57.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.696 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.23 -44.28 63.13 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.758 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.868 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.465 -0.187 0 CA-C-O 120.819 0.258 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.873 HG23 HD11 ' A' ' 155' ' ' ILE . 3.6 m -141.02 117.08 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.739 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 148' ' ' ILE . 17.8 m -103.01 141.51 35.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.808 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.97 117.78 11.69 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -100.91 112.64 25.12 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.166 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.701 HD11 HD11 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -109.51 137.37 47.45 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.229 -179.524 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.74 148.93 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.447 HG12 ' HB2' ' A' ' 108' ' ' GLN . 23.4 t -152.81 143.67 15.81 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.227 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.419 ' HD2' ' CG1' ' A' ' 104' ' ' VAL . 20.9 Cg_exo -65.78 163.16 31.65 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.45 2.1 . . . . 0.0 112.192 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.94 -34.96 76.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.666 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.4 m -70.46 -30.48 67.33 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.447 ' HB2' HG12 ' A' ' 104' ' ' VAL . 26.4 mm-40 -71.79 -49.48 38.37 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.435 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.449 ' O ' HD12 ' A' ' 113' ' ' ILE . 2.9 t -64.49 -41.46 96.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.307 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -54.66 -51.81 49.91 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.219 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.9 -35.43 69.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.908 0.385 . . . . 0.0 110.405 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.67 -25.86 66.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.35 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.504 HG22 ' HA2' ' A' ' 117' ' ' GLY . 9.3 mt -84.68 -36.9 12.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.776 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.17 -178.73 16.2 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.505 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.46 129.63 40.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.883 0.373 . . . . 0.0 111.128 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 60.44 17.1 46.34 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.938 -0.648 . . . . 0.0 113.008 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.504 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 67.65 9.53 55.93 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.991 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 4.6 t -53.14 -35.53 59.82 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.801 0.334 . . . . 0.0 111.493 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.422 ' HG3' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -67.95 -64.09 0.93 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.274 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.4 ' HB ' ' HA ' ' A' ' 113' ' ' ILE . 9.1 tt -54.11 -26.94 15.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.822 0.344 . . . . 0.0 111.253 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -48.24 66.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.943 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -73.09 -36.11 66.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.177 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.422 HD11 ' HG3' ' A' ' 119' ' ' LYS . 16.4 mt -67.93 -48.29 75.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.217 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.04 -48.18 59.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.303 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -54.46 -35.29 62.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.46 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 99.9 p -90.21 -35.41 15.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.706 0.289 . . . . 0.0 111.329 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.4 m -52.14 -26.09 10.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.889 0.376 . . . . 0.0 110.106 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.11 -20.18 22.39 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.936 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -108.17 167.75 9.78 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.809 0.338 . . . . 0.0 111.132 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -105.08 129.95 53.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.892 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 147' ' ' THR . 13.2 m -99.29 139.14 21.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.067 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.627 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 1.1 tt0 -125.61 116.61 22.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.174 0.511 . . . . 0.0 112.178 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.3 p -97.46 136.75 27.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.408 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.056 179.922 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.6 m . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.796 0.331 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 10.9 t -115.96 -39.77 3.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.84 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.496 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 18.3 mt-10 -127.56 136.91 52.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.826 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.5 mtt180 -113.49 171.74 7.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.73 136.41 53.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.086 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.627 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 40.0 mt -105.86 124.32 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.736 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.452 ' HB ' ' CB ' ' A' ' 132' ' ' GLN . 4.4 m -97.77 114.76 26.85 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.523 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 99' ' ' THR . 23.6 mt -106.34 110.47 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.421 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.36 122.7 43.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.646 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 171.09 -151.38 15.6 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.543 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.527 ' CG2' ' HD2' ' A' ' 152' ' ' PRO . 1.4 mp -80.99 144.72 55.5 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.683 ' HA ' HD12 ' A' ' 155' ' ' ILE . 82.6 Cg_exo -49.02 -31.04 19.52 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 121.987 1.792 . . . . 0.0 111.587 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -72.03 -34.68 69.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.727 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 66.9 m -65.08 -44.81 87.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.734 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.873 HD11 HG23 ' A' ' 98' ' ' VAL . 4.3 mt -66.03 -51.32 61.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.195 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 23.0 mt -55.89 -28.49 24.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.991 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -73.39 -41.24 63.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.942 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . 0.512 ' O ' HG22 ' A' ' 162' ' ' ILE . 0.6 OUTLIER -67.09 -48.48 68.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.014 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 11.5 p -60.53 -38.19 77.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.248 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.646 ' O ' HG23 ' A' ' 164' ' ' VAL . 0.5 OUTLIER -69.33 -42.83 74.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.032 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.77 ' O ' HG23 ' A' ' 165' ' ' VAL . 1.8 mt-30 -65.83 -49.39 68.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.036 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.512 HG22 ' O ' ' A' ' 158' ' ' CYS . 17.2 tt -64.15 -45.07 97.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.197 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' CYS . . . . . 0.485 ' N ' HG23 ' A' ' 162' ' ' ILE . 12.6 t -62.54 -48.52 79.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.991 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 160' ' ' LYS . 53.2 t -60.0 -52.69 58.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.094 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 161' ' ' GLN . 33.2 t -62.05 -34.72 64.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.233 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 9.5 tmm? -59.9 -51.89 67.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.994 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.505 HD12 HD21 ' A' ' 14' ' ' LEU . 4.9 tt -58.94 -55.73 31.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.992 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.89 -2.62 24.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.072 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.901 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.882 0.372 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.584 HG22 ' N ' ' A' ' 13' ' ' THR . 12.5 p -116.77 166.04 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.052 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.584 ' N ' HG22 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -103.13 141.96 34.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.595 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.5 mt -136.14 177.24 7.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.171 0.51 . . . . 0.0 111.447 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.2 m -141.71 113.07 7.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.557 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.777 HG22 HD11 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -111.63 126.47 69.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.976 0.417 . . . . 0.0 111.471 -179.601 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.711 ' CG ' HG23 ' A' ' 60' ' ' THR . 81.9 mtm-85 -112.57 116.31 30.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.446 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.52 HD12 ' CE ' ' A' ' 20' ' ' MET . 0.4 OUTLIER -114.59 119.6 37.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.237 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.428 HD11 ' HE ' ' A' ' 101' ' ' ARG . 1.8 pp -113.38 133.96 54.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.825 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.541 ' HB2' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -135.23 177.02 8.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.959 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.836 ' O ' HG22 ' A' ' 25' ' ' VAL . 6.8 m-70 -67.57 166.0 15.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.61 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.73 -31.96 72.9 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.925 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -78.37 -42.27 30.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.806 0.336 . . . . 0.0 111.335 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.58 ' O ' HG22 ' A' ' 28' ' ' ILE . 14.6 mt-10 -67.79 -43.11 80.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.917 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 21' ' ' HIS . 18.2 m -65.48 -40.39 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.314 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.91 -41.35 99.9 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.892 -0.67 . . . . 0.0 113.229 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.6 m -75.96 -35.64 59.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.721 0.296 . . . . 0.0 111.63 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.58 HG22 ' O ' ' A' ' 24' ' ' GLU . 2.7 tp -76.73 -50.52 21.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.746 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.538 ' N ' HG23 ' A' ' 28' ' ' ILE . 31.4 mt -60.19 -42.43 90.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.914 0.388 . . . . 0.0 110.752 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.422 ' HA3' ' CB ' ' A' ' 35' ' ' SER . . . 99.82 150.84 25.53 Favored Glycine 0 N--CA 1.435 -1.399 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.556 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.409 ' O ' ' CD ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -57.98 146.42 32.59 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.825 -0.688 . . . . 0.0 111.378 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.532 ' HD2' ' HB2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 44.01 27.04 0.17 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.956 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 50.6 19.64 3.32 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 114.512 0.565 . . . . 0.0 114.512 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.532 ' HB2' ' HD2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -76.98 -35.44 57.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.755 0.778 . . . . 0.0 109.966 179.095 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -68.81 -43.14 76.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.65 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.7 p -67.36 -27.04 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.91 -36.7 82.85 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 176.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 35' ' ' SER . 0.5 OUTLIER -69.71 -34.66 74.2 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.517 -1.219 . . . . 0.0 108.948 177.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -67.34 -41.22 85.56 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.101 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.476 ' HA ' HD12 ' A' ' 47' ' ' ILE . 4.4 ttp-105 -58.48 -51.35 70.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.194 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -59.76 -38.51 81.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.807 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -75.27 -36.27 61.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.693 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.691 ' HB2' ' HB2' ' A' ' 71' ' ' ALA . 19.7 t -73.02 -49.27 29.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.28 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.18 -8.96 78.66 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.292 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.46 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . . . -110.91 128.48 55.82 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.6 0.238 . . . . 0.0 111.156 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.616 ' HB2' ' HB3' ' A' ' 62' ' ' ALA . 0.8 OUTLIER -27.23 136.74 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.221 179.356 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 40' ' ' ARG . 4.2 mt -142.7 100.47 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.979 178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -115.88 165.84 12.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.916 0.389 . . . . 0.0 111.421 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.617 HG23 HD13 ' A' ' 59' ' ' ILE . 3.2 mp -126.47 151.74 33.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.798 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.59 -178.64 0.75 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.983 0.42 . . . . 0.0 111.4 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.663 ' CB ' HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.12 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 120.677 0.275 . . . . 0.0 110.516 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.518 ' HB2' HG21 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -145.71 127.59 15.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.857 179.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.663 HD12 ' CB ' ' A' ' 51' ' ' GLU . 19.1 mt -102.22 110.67 29.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.617 HD13 HG23 ' A' ' 49' ' ' ILE . 26.3 mm -94.62 96.38 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.088 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.711 HG23 ' CG ' ' A' ' 17' ' ' ARG . 6.0 m -76.33 139.14 40.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.795 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -131.29 133.27 45.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.267 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.616 ' HB3' ' HB2' ' A' ' 46' ' ' ARG . . . -133.03 129.31 37.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.79 0.328 . . . . 0.0 111.109 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.431 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.15 164.18 13.35 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.726 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 94.6 Cg_exo -42.2 161.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.106 2.537 . . . . 0.0 113.07 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.496 ' O ' HG22 ' A' ' 68' ' ' ILE . 34.1 m -59.97 -35.72 75.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.974 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -62.42 -51.88 65.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.224 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.46 ' CB ' ' HB2' ' A' ' 45' ' ' ALA . . . -56.99 -37.64 71.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.008 0.432 . . . . 0.0 110.989 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.777 HD11 HG22 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -66.21 -39.36 84.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.194 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -47.28 81.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.888 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.74 -51.91 67.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.745 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.691 ' HB2' ' HB2' ' A' ' 43' ' ' SER . . . -56.11 -58.37 8.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.315 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.624 ' HA ' HD12 ' A' ' 75' ' ' ILE . 0.9 OUTLIER -49.2 -32.53 10.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.33 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.21 -41.59 81.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.11 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -75.91 -32.84 59.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.055 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.624 HD12 ' HA ' ' A' ' 72' ' ' PHE . 18.2 mt -68.11 -43.63 85.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.963 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 72' ' ' PHE . 23.1 pt -67.88 -40.34 83.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.971 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.401 ' N ' HG13 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -65.03 -41.04 95.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.443 179.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.3 tptt -61.87 -35.92 79.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.055 0.455 . . . . 0.0 110.048 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.7 tp -77.39 -28.15 52.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.435 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -76.69 -35.11 58.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.649 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.29 -42.75 65.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.824 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.041 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo . . . . . 0 N--CA 1.465 -0.201 0 CA-C-O 120.737 0.224 . . . . 0.0 111.938 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.685 HG12 HD11 ' A' ' 100' ' ' LEU . 19.7 t -140.88 111.87 3.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.347 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 16.0 m -103.41 134.28 47.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.634 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.685 HD11 HG12 ' A' ' 98' ' ' VAL . 5.4 mp -139.91 117.76 11.71 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.428 ' HE ' HD11 ' A' ' 19' ' ' LEU . 6.3 ttp180 -101.98 112.5 25.16 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.132 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.505 ' O ' HG22 ' A' ' 146' ' ' ILE . 8.1 mp -113.47 162.32 16.28 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.935 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.407 HG12 ' CB ' ' A' ' 17' ' ' ARG . 11.3 p -98.73 136.42 29.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.022 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.457 ' CG1' ' HD2' ' A' ' 105' ' ' PRO . 25.4 t -138.66 145.37 45.93 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.104 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.457 ' HD2' ' CG1' ' A' ' 104' ' ' VAL . 21.6 Cg_exo -65.99 159.92 46.85 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.475 2.116 . . . . 0.0 112.146 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.99 -34.64 75.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.5 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 m -69.48 -30.45 68.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.168 0.508 . . . . 0.0 109.771 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.411 ' HB3' ' CG1' ' A' ' 104' ' ' VAL . 0.7 OUTLIER -70.34 -50.54 38.02 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.463 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.411 ' O ' HG12 ' A' ' 113' ' ' ILE . 53.5 t -62.19 -43.48 98.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.381 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -53.89 -47.52 65.46 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.395 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.85 -40.31 69.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.804 0.335 . . . . 0.0 110.644 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 112' ' ' LEU . 19.1 mt -55.97 -27.82 54.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.0 0.428 . . . . 0.0 110.486 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.431 ' CG2' ' HA2' ' A' ' 117' ' ' GLY . 28.0 mm -82.07 -39.89 16.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.582 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.66 -177.67 26.02 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.501 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -67.54 125.15 25.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.894 0.378 . . . . 0.0 111.129 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.72 13.1 58.46 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.989 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.431 ' HA2' ' CG2' ' A' ' 113' ' ' ILE . . . 70.84 7.31 61.6 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.974 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 5.2 t -53.0 -39.64 63.24 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.786 0.326 . . . . 0.0 111.695 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.863 ' HD2' HD11 ' A' ' 123' ' ' ILE . 0.6 OUTLIER -61.33 -65.36 0.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.286 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.73 HD11 HG21 ' A' ' 131' ' ' VAL . 1.6 tp -55.83 -32.22 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.356 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.26 -52.3 66.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.157 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -73.08 -40.95 64.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.432 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.863 HD11 ' HD2' ' A' ' 119' ' ' LYS . 53.8 mt -57.24 -53.65 40.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.362 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.03 -38.25 72.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.353 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -54.84 -39.95 69.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.615 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.07 -37.55 11.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.602 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 17.2 m -49.73 -26.14 3.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.887 0.375 . . . . 0.0 110.265 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.46 -12.14 28.37 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.825 -0.702 . . . . 0.0 113.224 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.589 ' HB2' ' HB3' ' A' ' 154' ' ' SER . . . -108.27 146.3 33.08 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.953 0.377 . . . . 0.0 111.299 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.16 129.52 43.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.597 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.986 HG12 HG22 ' A' ' 148' ' ' ILE . 6.7 m -99.28 150.38 5.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.351 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.66 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 11.4 tt0 -122.65 158.55 29.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.01 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.6 m -137.45 140.89 40.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.227 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.125 179.935 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.86 0.362 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.57 -50.56 2.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.639 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.483 ' OE2' ' NH2' ' A' ' 17' ' ' ARG . 10.1 mt-10 -115.09 137.92 51.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.679 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -109.88 176.99 4.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.909 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -110.41 130.7 55.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.166 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.859 HD11 ' HB ' ' A' ' 131' ' ' VAL . 0.5 OUTLIER -113.55 140.03 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.772 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.503 ' HB ' ' HB2' ' A' ' 132' ' ' GLN . 0.7 OUTLIER -115.98 114.99 25.37 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.304 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.986 HG22 HG12 ' A' ' 131' ' ' VAL . 1.6 pt -106.78 123.43 61.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.11 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.48 136.2 53.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.101 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 160.87 -162.88 33.88 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.513 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.8 HD12 ' HB2' ' A' ' 153' ' ' GLN . 2.7 pt -87.02 161.49 46.71 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.61 0.243 . . . . 0.0 110.95 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.476 ' HA ' HD12 ' A' ' 155' ' ' ILE . 74.8 Cg_exo -49.4 -40.0 44.4 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.431 2.087 . . . . 0.0 112.041 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.8 ' HB2' HD12 ' A' ' 151' ' ' ILE . 3.1 mm-40 -64.69 -34.7 78.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.301 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.589 ' HB3' ' HB2' ' A' ' 129' ' ' ALA . 61.8 m -69.4 -34.02 73.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.71 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 152' ' ' PRO . 26.6 mt -73.09 -53.34 18.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.945 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.447 ' HA ' HG12 ' A' ' 159' ' ' VAL . 37.7 mm -59.15 -28.63 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.061 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -75.17 -40.16 59.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.033 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -72.14 -38.91 69.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.183 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.447 HG12 ' HA ' ' A' ' 156' ' ' ILE . 12.1 p -69.98 -41.96 79.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.393 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.614 ' O ' HG23 ' A' ' 164' ' ' VAL . 8.3 pttt -65.54 -38.58 90.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.039 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -64.42 -49.41 71.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.768 HD13 ' O ' ' A' ' 162' ' ' ILE . 0.0 OUTLIER -64.78 -34.52 70.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.977 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 34.1 m -67.76 -43.4 79.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 160' ' ' LYS . 54.0 t -59.6 -52.68 58.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.9 p -64.26 -30.4 50.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.021 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -59.31 -51.57 69.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.951 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.557 HD22 HG21 ' A' ' 12' ' ' VAL . 9.6 mt -70.03 -45.91 66.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.949 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -73.99 -2.48 24.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.052 0.454 . . . . 0.0 112.018 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.848 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.528 0.132 0 CA-C-O 120.989 0.423 . . . . 0.0 111.554 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 13' ' ' THR . 20.3 t -120.56 158.26 22.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.913 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -103.77 139.34 39.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.029 -179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 14' ' ' LEU . 2.0 mt -143.02 166.1 25.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.008 0.433 . . . . 0.0 111.188 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 m -142.73 140.65 31.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.632 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.691 HG22 HD11 ' A' ' 68' ' ' ILE . 17.8 tt -140.87 152.51 20.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.972 0.415 . . . . 0.0 111.479 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.487 ' NH2' ' OE2' ' A' ' 143' ' ' GLU . 2.8 ttm-85 -134.99 129.68 34.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.389 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.02 135.23 51.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.947 0.403 . . . . 0.0 111.121 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.545 HD12 HG23 ' A' ' 58' ' ' ILE . 1.8 mp -93.32 115.0 27.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.628 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -107.87 141.02 40.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.951 0.405 . . . . 0.0 110.89 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.432 ' O ' HG12 ' A' ' 25' ' ' VAL . 1.4 t-80 -67.6 163.89 20.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.602 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.518 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -58.7 -45.05 95.32 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.699 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.45 -43.28 27.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.985 0.422 . . . . 0.0 110.91 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.77 ' O ' HG23 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -62.01 -32.79 73.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.508 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.698 HG22 HG13 ' A' ' 29' ' ' ILE . 9.8 p -76.95 -31.22 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.474 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.36 -42.71 99.7 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.441 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.9 m -75.87 -37.24 59.12 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.669 0.271 . . . . 0.0 111.605 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.77 HG23 ' O ' ' A' ' 24' ' ' GLU . 1.7 pp -76.29 -32.7 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 120.787 0.327 . . . . 0.0 111.879 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.769 ' HA ' HG13 ' A' ' 36' ' ' VAL . 10.9 mm -70.68 -54.74 16.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.253 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.406 ' HA3' ' CB ' ' A' ' 35' ' ' SER . . . 99.56 150.29 25.13 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-O 121.769 0.649 . . . . 0.0 113.026 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.58 ' HB3' ' HD3' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -67.13 146.37 54.33 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.413 -0.893 . . . . 0.0 111.113 179.606 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.58 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER 63.71 6.82 2.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.37 -179.603 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.444 ' O ' HG23 ' A' ' 36' ' ' VAL . . . 57.71 12.67 10.5 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 119.84 -1.171 . . . . 0.0 111.648 -178.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -76.78 -28.93 55.84 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.918 0.39 . . . . 0.0 110.091 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.406 ' CB ' ' HA3' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -73.33 -41.5 63.43 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.184 179.567 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.769 HG13 ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.16 -26.38 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.552 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.98 -36.87 75.53 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.49 -37.45 86.04 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.776 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.483 ' HE3' ' HA ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -62.14 -52.45 63.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.432 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.515 ' HG2' HD12 ' A' ' 47' ' ' ILE . 39.9 mtm180 -50.56 -51.21 50.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.206 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -57.98 -38.04 75.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.72 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -75.11 -36.11 61.68 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.862 ' HB2' ' HB2' ' A' ' 71' ' ' ALA . 79.6 p -82.69 -55.75 4.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.846 0.355 . . . . 0.0 111.66 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.9 -5.62 66.46 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.426 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.753 ' HB3' HD21 ' A' ' 61' ' ' LEU . . . -110.67 128.83 55.86 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.688 0.28 . . . . 0.0 111.138 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 47.8 ttm-85 -27.16 137.84 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.339 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.515 HD12 ' HG2' ' A' ' 40' ' ' ARG . 12.2 mt -142.27 100.43 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.705 0.288 . . . . 0.0 110.471 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.95 171.38 7.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.724 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 58' ' ' ILE . 6.0 mt -126.7 149.78 31.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.954 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.88 -169.3 1.96 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.911 0.386 . . . . 0.0 111.302 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.029 -179.884 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.429 ' HB2' ' N ' ' A' ' 22' ' ' GLY . 2.7 mt-10 . . . . . 0 N--CA 1.47 0.533 0 CA-C-O 120.657 0.265 . . . . 0.0 110.577 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.548 ' HB2' HG11 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -145.88 142.15 28.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.987 0.422 . . . . 0.0 111.626 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.545 HG23 HD12 ' A' ' 19' ' ' LEU . 25.5 mt -123.25 131.16 73.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.127 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.714 HD11 HD11 ' A' ' 28' ' ' ILE . 30.0 mt -109.24 106.12 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.87 0.367 . . . . 0.0 111.766 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 66.9 m -93.05 139.17 30.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.805 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.753 HD21 ' HB3' ' A' ' 45' ' ' ALA . 6.3 tt -131.5 137.26 48.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.726 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.719 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -135.55 132.37 37.13 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.563 0.22 . . . . 0.0 110.851 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.421 ' HA3' ' HB1' ' A' ' 45' ' ' ALA . . . 157.19 164.83 14.11 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.261 -0.971 . . . . 0.0 112.928 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 95.7 Cg_exo -42.47 159.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.986 2.457 . . . . 0.0 113.041 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.472 ' O ' HG22 ' A' ' 68' ' ' ILE . 35.8 m -60.28 -35.69 76.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.981 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -66.34 -52.02 51.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.15 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.77 -37.64 71.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.691 HD11 HG22 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -66.36 -39.24 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.157 -179.643 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.43 -51.9 67.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.842 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -43.83 88.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.587 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.862 ' HB2' ' HB2' ' A' ' 43' ' ' SER . . . -55.48 -45.54 76.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.22 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.464 ' CE1' HD13 ' A' ' 16' ' ' ILE . 1.2 m-85 -58.46 -50.3 74.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.207 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.0 -36.99 68.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.599 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.85 -40.0 49.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.23 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 72' ' ' PHE . 12.1 mt -62.42 -51.46 72.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.652 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.22 -38.54 80.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.991 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.26 -29.59 65.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.416 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -35.33 80.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.054 0.454 . . . . 0.0 109.81 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.9 tp -76.65 -31.69 57.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.172 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -76.79 -32.85 57.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.769 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -72.25 -36.85 69.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.783 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.992 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo . . . . . 0 C--O 1.231 0.133 0 CA-C-O 120.895 0.289 . . . . 0.0 112.198 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.4 t -126.21 103.36 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.95 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 11.0 t -113.26 133.49 55.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.01 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.76 ' HB3' HD11 ' A' ' 155' ' ' ILE . 6.6 tp -139.94 117.86 11.77 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.722 ' HB3' HG23 ' A' ' 147' ' ' THR . 0.0 OUTLIER -107.62 112.67 25.51 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.631 -178.684 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.616 HD21 HD21 ' A' ' 100' ' ' LEU . 28.5 mt -102.64 155.38 18.33 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.903 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.465 HG13 ' O ' ' A' ' 144' ' ' ARG . 17.0 t -106.71 141.15 22.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.17 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.405 ' HB ' ' CB ' ' A' ' 108' ' ' GLN . 6.4 m -145.44 155.94 53.47 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.124 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.64 162.86 35.23 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.552 2.168 . . . . 0.0 112.583 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.63 -34.51 69.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.502 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.1 m -67.24 -30.71 70.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.151 0.501 . . . . 0.0 109.823 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.405 ' CB ' ' HB ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -67.58 -45.4 75.65 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.525 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.509 ' SG ' HD11 ' A' ' 113' ' ' ILE . 42.7 t -66.68 -49.32 66.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.63 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -49.29 -51.96 24.68 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.522 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.9 p -71.84 -40.21 69.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.765 0.317 . . . . 0.0 110.545 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.723 HD21 HD12 ' A' ' 162' ' ' ILE . 7.4 mt -54.93 -28.72 53.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.045 0.45 . . . . 0.0 110.246 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.509 HD11 ' SG ' ' A' ' 109' ' ' CYS . 17.9 mt -80.02 -44.6 22.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.552 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 76.94 -173.25 54.88 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.588 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.5 tptp -64.56 118.98 9.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.894 0.378 . . . . 0.0 111.197 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 56.85 20.32 32.65 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.987 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.459 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 71.8 6.98 64.62 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.988 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 30.9 p -53.1 -40.12 63.9 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 120.826 0.346 . . . . 0.0 111.707 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.84 ' HD2' HD11 ' A' ' 123' ' ' ILE . 0.7 OUTLIER -65.26 -65.29 0.69 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.5 -179.474 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.884 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.6 OUTLIER -55.1 -34.29 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.581 -179.509 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -60.64 -45.09 95.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.011 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -73.11 -32.37 64.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.101 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.884 HD12 ' HA ' ' A' ' 120' ' ' ILE . 26.7 mt -64.24 -43.38 97.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.184 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.84 -42.7 60.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.92 0.391 . . . . 0.0 111.017 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -58.83 -35.37 72.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.733 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.8 t -93.45 -45.55 7.73 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.675 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.1 m -48.37 -25.64 1.7 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.874 0.368 . . . . 0.0 110.275 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.48 -9.49 41.94 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.048 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.569 ' HB1' ' O ' ' A' ' 149' ' ' ALA . . . -108.29 153.72 22.84 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.932 0.366 . . . . 0.0 111.201 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -99.7 141.29 32.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.732 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.709 ' HB ' HD11 ' A' ' 146' ' ' ILE . 11.4 m -99.22 157.9 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.356 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.789 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 0.1 OUTLIER -128.78 158.45 38.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.447 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.511 HG22 HH21 ' A' ' 144' ' ' ARG . 21.0 t -129.39 118.87 47.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.967 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.242 -179.862 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.835 0.35 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.9 t -115.49 -41.82 3.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.699 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.487 ' OE2' ' NH2' ' A' ' 17' ' ' ARG . 15.2 pt-20 -118.17 139.13 51.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.703 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.511 HH21 HG22 ' A' ' 133' ' ' VAL . 5.4 ptm180 -109.91 168.2 9.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.938 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.56 134.33 54.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.303 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.789 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 1.5 tt -116.37 131.94 67.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.519 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.722 HG23 ' HB3' ' A' ' 101' ' ' ARG . 1.0 OUTLIER -109.45 116.05 31.08 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.715 -179.554 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.58 HG23 HD12 ' A' ' 155' ' ' ILE . 4.7 tp -104.89 121.99 57.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.742 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.569 ' O ' ' HB1' ' A' ' 129' ' ' ALA . . . -118.39 140.41 49.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.204 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 166.14 -154.29 24.76 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.355 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.553 HD12 ' HB2' ' A' ' 153' ' ' GLN . 1.2 pt -87.06 161.96 45.17 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.59 0.234 . . . . 0.0 110.839 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.509 ' O ' HG22 ' A' ' 156' ' ' ILE . 73.7 Cg_exo -49.51 -34.96 35.31 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.315 2.01 . . . . 0.0 112.209 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.553 ' HB2' HD12 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -72.06 -34.74 68.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.817 179.736 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 53.1 p -74.25 -41.15 61.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.971 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.76 HD11 ' HB3' ' A' ' 100' ' ' LEU . 0.7 OUTLIER -68.73 -41.28 82.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.175 -179.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.509 HG22 ' O ' ' A' ' 152' ' ' PRO . 1.1 tp -69.68 -32.83 53.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.141 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -69.84 -49.22 54.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.894 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -58.61 -53.1 62.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.097 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.744 HG23 ' O ' ' A' ' 155' ' ' ILE . 30.1 t -57.35 -35.53 49.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.296 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 10.5 tptp -68.32 -32.91 73.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.978 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.645 ' O ' HG13 ' A' ' 165' ' ' VAL . 29.6 mt-30 -72.06 -38.32 69.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.033 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.723 HD12 HD21 ' A' ' 112' ' ' LEU . 36.0 mm -74.01 -34.48 39.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.2 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.17 -37.47 69.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.099 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 14.0 p -74.36 -39.68 48.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.456 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.645 HG13 ' O ' ' A' ' 161' ' ' GLN . 36.0 m -69.5 -45.59 78.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.418 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.477 ' N ' HG23 ' A' ' 165' ' ' VAL . 5.6 ptm -62.01 -45.93 91.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.928 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.13 -51.11 41.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.931 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -74.02 -2.53 24.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.959 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.93 0.395 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.642 HG21 HD21 ' A' ' 167' ' ' LEU . 21.5 t -126.28 152.65 33.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.97 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 1.4 m -103.25 146.91 27.73 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.682 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.57 HD21 ' HA ' ' A' ' 65' ' ' THR . 2.3 pp -158.21 139.77 13.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.531 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.588 HG23 ' O ' ' A' ' 61' ' ' LEU . 58.3 m -113.12 129.92 56.35 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.31 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.616 HG12 HD11 ' A' ' 68' ' ' ILE . 2.0 pt -112.13 163.98 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.223 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.493 ' NH2' ' OE2' ' A' ' 143' ' ' GLU . 0.9 OUTLIER -133.96 123.06 23.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.834 179.765 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.472 HD21 ' CZ ' ' A' ' 72' ' ' PHE . 67.5 mt -114.58 119.87 38.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.201 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.856 HD12 ' O ' ' A' ' 101' ' ' ARG . 0.2 OUTLIER -115.8 128.1 55.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.723 179.699 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.79 ' HB2' HG12 ' A' ' 25' ' ' VAL . 0.9 OUTLIER -142.11 162.38 35.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.835 0.35 . . . . 0.0 111.208 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.811 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.9 OUTLIER -70.2 163.45 26.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.888 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.415 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -49.19 -35.83 20.56 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.659 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -51.4 10.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.922 0.361 . . . . 0.0 111.958 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.4 ' HB3' ' HB3' ' A' ' 20' ' ' MET . 0.3 OUTLIER -61.93 -33.56 74.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.818 0.342 . . . . 0.0 110.991 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.811 HG13 ' O ' ' A' ' 21' ' ' HIS . 15.4 m -71.54 -39.96 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.083 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.01 -35.16 91.02 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.635 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 p -75.45 -33.55 60.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.668 0.271 . . . . 0.0 111.388 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.812 HD11 HG22 ' A' ' 75' ' ' ILE . 1.7 tp -79.21 -47.09 22.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.451 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.733 ' HA ' HG13 ' A' ' 36' ' ' VAL . 8.1 mm -57.25 -50.25 77.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.872 0.368 . . . . 0.0 110.204 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.41 ' HA3' ' HB3' ' A' ' 35' ' ' SER . . . 97.9 150.32 26.18 Favored Glycine 0 N--CA 1.437 -1.278 0 CA-C-O 121.747 0.637 . . . . 0.0 113.012 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.401 ' O ' ' CD ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -62.42 145.9 52.84 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.528 -0.836 . . . . 0.0 111.321 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.465 ' HG2' ' HB2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 51.36 18.89 0.69 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.461 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.491 ' O ' HG23 ' A' ' 36' ' ' VAL . . . 53.69 11.32 1.91 Allowed Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.936 -0.65 . . . . 0.0 114.26 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.465 ' HB2' ' HG2' ' A' ' 32' ' ' LYS . 4.0 tp10 -74.69 -27.2 60.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.536 0.668 . . . . 0.0 109.735 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.41 ' HB3' ' HA3' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -75.39 -39.84 58.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.514 179.434 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.733 HG13 ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.28 -26.34 35.91 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.588 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -70.66 -36.73 73.52 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -62.61 -34.73 77.62 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.936 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -43.05 81.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.711 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 44.9 mtp85 -58.1 -51.15 70.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.846 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -63.86 -38.02 89.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.037 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.84 -35.7 62.4 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.507 ' CB ' ' HB2' ' A' ' 71' ' ' ALA . 53.2 p -88.34 -55.79 3.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.937 0.399 . . . . 0.0 110.879 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.14 4.76 62.74 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.193 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.49 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -110.77 127.31 55.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.077 0.438 . . . . 0.0 111.317 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.789 ' HB2' ' HB3' ' A' ' 62' ' ' ALA . 1.8 mpt_? -27.75 104.3 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.275 0.63 . . . . 0.0 112.551 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.8 mt -107.45 100.58 11.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.832 0.348 . . . . 0.0 110.935 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.39 169.94 8.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.256 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.567 HG21 ' HD2' ' A' ' 57' ' ' ARG . 13.9 mt -126.46 152.13 33.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.144 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.451 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . 33.1 t -92.12 -161.4 0.82 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.738 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 . . . . . 0 N--CA 1.463 0.189 0 CA-C-O 121.2 0.524 . . . . 0.0 112.144 -179.046 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.224 -0.246 0 CA-C-O 120.624 0.25 . . . . 0.0 110.659 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.567 ' HD2' HG21 ' A' ' 49' ' ' ILE . 3.0 mmt180 -144.5 136.55 26.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.874 0.368 . . . . 0.0 110.992 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.845 HD12 HD23 ' A' ' 19' ' ' LEU . 4.5 mm -115.64 106.8 21.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.555 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.1 mt -85.98 94.05 4.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.882 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.0 m -80.04 101.87 8.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.138 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.588 ' O ' HG23 ' A' ' 15' ' ' THR . 0.1 OUTLIER -91.28 144.79 25.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.908 179.322 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.789 ' HB3' ' HB2' ' A' ' 46' ' ' ARG . . . -143.76 124.71 14.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.777 0.323 . . . . 0.0 111.051 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.57 164.0 13.28 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.159 -1.02 . . . . 0.0 113.104 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.563 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 78.6 Cg_exo -41.48 160.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 123.555 2.836 . . . . 0.0 113.798 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.57 ' HA ' HD21 ' A' ' 14' ' ' LEU . 13.6 t -57.89 -35.72 71.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.135 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.37 -52.48 46.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.917 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.35 -43.32 83.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.316 0.579 . . . . 0.0 110.429 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.616 HD11 HG12 ' A' ' 16' ' ' ILE . 0.5 OUTLIER -66.53 -39.4 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.842 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.85 -36.51 67.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.763 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.08 -38.94 63.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.691 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.507 ' HB2' ' CB ' ' A' ' 43' ' ' SER . . . -63.65 -48.25 77.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.149 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.575 ' CE2' HD13 ' A' ' 16' ' ' ILE . 1.2 m-85 -64.04 -43.06 96.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.473 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -68.78 -29.26 67.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.306 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.6 tpt -77.29 -48.3 17.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.688 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.812 HG22 HD11 ' A' ' 28' ' ' ILE . 2.2 pp -59.81 -42.98 90.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.252 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.597 HG23 ' CD1' ' A' ' 75' ' ' ILE . 18.6 pt -68.76 -36.01 72.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.852 0.358 . . . . 0.0 111.017 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -62.35 -47.63 83.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.024 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.486 ' HG3' ' N ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -62.39 -35.22 78.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.967 0.413 . . . . 0.0 110.149 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.486 ' N ' ' HG3' ' A' ' 78' ' ' LYS . 16.2 tp -77.53 -26.18 50.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.069 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -76.95 -35.71 57.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.597 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -72.07 -38.09 69.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.778 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.863 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 N--CA 1.465 -0.164 0 CA-C-O 120.83 0.263 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.751 ' HB ' HD11 ' A' ' 155' ' ' ILE . 21.2 t -140.32 113.19 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.654 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.588 ' CG2' HG22 ' A' ' 147' ' ' THR . 0.7 OUTLIER -103.22 140.21 37.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.271 -179.556 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.623 HD12 HG21 ' A' ' 155' ' ' ILE . 1.1 tt -139.83 117.76 11.76 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.856 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -105.22 112.7 25.91 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.788 -178.266 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.538 HD23 ' N ' ' A' ' 103' ' ' VAL . 0.8 OUTLIER -106.37 147.53 29.13 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.741 179.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.836 ' CG2' HD11 ' A' ' 19' ' ' LEU . 11.1 t -100.6 138.04 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.273 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.445 HG23 ' SG ' ' A' ' 109' ' ' CYS . 2.6 m -144.87 157.54 54.4 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.001 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -65.89 157.63 58.15 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.596 2.197 . . . . 0.0 112.143 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 142' ' ' THR . . . -68.86 -34.84 76.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.391 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.1 m -70.55 -30.3 66.99 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -70.94 -46.54 62.25 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.628 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.445 ' SG ' HG23 ' A' ' 104' ' ' VAL . 21.6 m -61.8 -40.03 93.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.389 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.75 -50.12 71.14 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.21 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.1 m -67.59 -38.7 84.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 0.0 110.724 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.8 mt -57.3 -27.77 62.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.476 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.568 HG22 ' HA2' ' A' ' 117' ' ' GLY . 12.6 mt -83.14 -34.28 11.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.786 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.63 178.55 6.27 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.558 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -67.49 132.53 47.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.818 0.342 . . . . 0.0 110.882 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.73 16.77 59.52 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.633 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.568 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 63.1 15.74 56.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.871 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 95.9 m -52.88 -43.64 66.29 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.869 0.366 . . . . 0.0 111.401 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -63.68 -58.56 6.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.129 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.499 ' HA ' HD12 ' A' ' 123' ' ' ILE . 1.6 tt -54.22 -31.44 22.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.315 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.16 -41.93 89.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.856 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -73.23 -40.2 64.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.082 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.499 HD12 ' HA ' ' A' ' 120' ' ' ILE . 50.2 mt -58.61 -53.42 47.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.297 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.794 ' HG3' HG22 ' A' ' 131' ' ' VAL . 0.2 OUTLIER -67.27 -40.42 86.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.969 0.414 . . . . 0.0 111.077 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -54.54 -48.36 72.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.881 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.48 -39.02 17.94 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.466 HG21 HD11 ' A' ' 148' ' ' ILE . 18.2 m -49.37 -26.38 3.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.845 0.355 . . . . 0.0 110.333 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.42 -21.85 4.17 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.333 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.713 ' HB1' ' O ' ' A' ' 149' ' ' ALA . . . -108.27 170.89 7.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.949 0.374 . . . . 0.0 111.149 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.7 130.45 44.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.705 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.794 HG22 ' HG3' ' A' ' 124' ' ' ARG . 36.0 m -99.26 140.52 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.164 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.786 ' O ' HG23 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -109.11 158.39 17.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.197 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.5 t -137.53 134.99 46.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.181 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.401 ' HB3' ' H ' ' A' ' 145' ' ' ALA . . . . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.077 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.792 0.33 . . . . 0.0 110.815 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.669 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 13.2 t -118.57 -46.56 2.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.887 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.493 ' OE2' ' NH2' ' A' ' 17' ' ' ARG . 3.0 mt-10 -104.07 137.74 41.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.7 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -109.97 140.84 43.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.93 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.401 ' H ' ' HB3' ' A' ' 134' ' ' ALA . . . -96.42 153.46 17.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.17 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.786 HG23 ' O ' ' A' ' 132' ' ' GLN . 74.9 mt -125.18 140.05 49.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.667 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.588 HG22 ' CG2' ' A' ' 99' ' ' THR . 0.2 OUTLIER -119.07 114.93 23.26 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.409 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.52 HD13 ' HB2' ' A' ' 158' ' ' CYS . 0.6 OUTLIER -104.1 121.47 55.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.109 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.713 ' O ' ' HB1' ' A' ' 129' ' ' ALA . . . -118.39 134.71 54.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.13 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 162.13 -151.91 22.09 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.532 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.814 ' O ' HD12 ' A' ' 155' ' ' ILE . 2.9 pt -87.0 162.06 45.07 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.57 0.224 . . . . 0.0 110.962 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 151' ' ' ILE . 72.7 Cg_exo -49.62 -32.84 29.3 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.517 2.144 . . . . 0.0 112.218 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.517 ' HB2' HD12 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -71.91 -34.65 69.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.757 179.662 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.617 ' HB2' ' HB2' ' A' ' 129' ' ' ALA . 10.6 p -67.92 -50.29 56.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.039 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.814 HD12 ' O ' ' A' ' 151' ' ' ILE . 2.7 mp -59.33 -51.52 71.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.157 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -55.84 -30.7 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.135 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -69.26 -48.0 63.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.834 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . 0.52 ' HB2' HD13 ' A' ' 148' ' ' ILE . 17.7 t -61.58 -44.06 97.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.96 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 155' ' ' ILE . 59.9 t -59.49 -38.95 77.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.956 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -32.86 74.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.711 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.779 ' O ' HG23 ' A' ' 165' ' ' VAL . 2.0 tt0 -71.71 -45.67 61.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 30.5 mm -69.92 -34.41 59.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.044 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 47.7 t -65.42 -52.4 53.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.117 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.471 HG13 ' N ' ' A' ' 165' ' ' VAL . 12.3 p -61.49 -45.14 99.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.225 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.779 HG23 ' O ' ' A' ' 161' ' ' GLN . 54.8 t -63.82 -40.28 88.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.914 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 32.4 mtt -56.98 -45.63 82.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.808 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.642 HD21 HG21 ' A' ' 12' ' ' VAL . 7.8 tt -65.11 -45.19 86.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.804 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.96 -2.72 25.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.902 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 165' ' ' VAL . 39.1 p . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.887 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.717 0.294 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.827 HG21 HD11 ' A' ' 167' ' ' LEU . 11.5 t -115.09 154.98 16.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.812 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.767 ' C ' HD22 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -109.21 131.36 55.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.693 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.767 HD22 ' C ' ' A' ' 13' ' ' THR . 4.3 mm? -130.44 158.49 39.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.148 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.2 m -141.97 133.59 26.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.749 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.629 HG22 HD11 ' A' ' 68' ' ' ILE . 3.8 tt -137.36 148.03 26.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.354 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.487 ' NH2' ' OE1' ' A' ' 143' ' ' GLU . 0.0 OUTLIER -129.35 131.1 46.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.709 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.411 ' O ' HG23 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -121.58 139.22 53.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.103 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.732 HD23 HG13 ' A' ' 103' ' ' VAL . 2.6 pp -108.72 136.02 48.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.758 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.11 162.4 33.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.827 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.73 ' O ' HG12 ' A' ' 25' ' ' VAL . 3.8 m-70 -67.58 169.63 8.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.536 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.65 -44.77 96.59 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.103 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.5 -38.51 40.58 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.69 -50.74 56.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.925 0.393 . . . . 0.0 110.655 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.747 HG23 HD11 ' A' ' 59' ' ' ILE . 9.8 p -63.44 -35.02 70.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.841 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.16 -34.92 90.63 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.32 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.3 m -75.38 -28.2 59.39 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.802 0.334 . . . . 0.0 110.68 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.431 ' N ' HD13 ' A' ' 28' ' ' ILE . 3.6 mm -78.84 -45.61 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.08 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.754 ' HA ' HG13 ' A' ' 36' ' ' VAL . 13.0 mt -60.59 -42.56 92.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.385 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.65 150.34 16.68 Favored Glycine 0 N--CA 1.435 -1.427 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.611 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.567 ' HG2' ' HG3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -58.15 145.75 35.88 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.593 -0.804 . . . . 0.0 111.588 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.571 ' HE3' ' HB3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 45.98 27.93 0.56 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.248 -178.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.436 ' O ' HG23 ' A' ' 36' ' ' VAL . . . 47.29 17.92 0.45 Allowed Glycine 0 CA--C 1.522 0.507 0 N-CA-C 114.784 0.673 . . . . 0.0 114.784 178.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.571 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 2.7 tm-20 -75.27 -25.46 58.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.752 0.776 . . . . 0.0 109.856 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -41.87 59.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.415 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.754 HG13 ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.24 -26.21 35.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 178.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.6 -36.75 70.94 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -62.94 -35.82 81.38 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.852 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.401 ' HA ' ' CE ' ' A' ' 39' ' ' MET . 0.0 OUTLIER -65.96 -43.46 87.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.392 179.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -56.63 -51.05 70.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.131 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -61.55 -37.5 84.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.778 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -74.62 -36.48 62.94 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.897 ' CB ' ' HB2' ' A' ' 71' ' ' ALA . 94.5 p -92.57 -55.86 3.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.862 0.363 . . . . 0.0 111.145 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.33 0.78 50.62 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.041 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.491 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . . . -110.76 128.16 55.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.877 0.338 . . . . 0.0 111.654 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 2.6 ttt180 -27.44 141.07 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.061 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.416 HG12 HD12 ' A' ' 61' ' ' LEU . 13.6 mt -142.32 100.44 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.76 0.314 . . . . 0.0 111.301 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -116.09 173.46 6.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.724 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.824 HG21 ' NE ' ' A' ' 57' ' ' ARG . 4.8 mt -126.5 151.97 33.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.121 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 94.3 p -83.74 -171.28 3.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.199 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.382 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 120.894 0.378 . . . . 0.0 110.782 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.824 ' NE ' HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -145.87 135.37 23.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.54 179.266 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.411 HG23 ' O ' ' A' ' 18' ' ' LEU . 26.1 mt -98.44 115.96 40.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.804 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.747 HD11 HG23 ' A' ' 25' ' ' VAL . 3.2 mt -86.62 101.21 10.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.285 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.405 ' CG2' ' HD3' ' A' ' 17' ' ' ARG . 89.2 m -90.01 138.25 31.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.94 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.675 HD22 HG13 ' A' ' 68' ' ' ILE . 7.3 tt -131.51 132.9 44.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.264 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.463 ' O ' ' HB1' ' A' ' 45' ' ' ALA . . . -128.68 133.85 48.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.742 0.306 . . . . 0.0 111.12 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.28 164.46 13.72 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.754 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.424 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 82.4 Cg_exo -39.58 162.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.147 2.565 . . . . 0.0 113.29 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.514 ' O ' HG22 ' A' ' 68' ' ' ILE . 73.5 m -59.69 -35.66 74.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.29 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -64.2 -51.96 61.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.782 0.325 . . . . 0.0 111.319 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.491 ' CB ' ' HB2' ' A' ' 45' ' ' ALA . . . -57.04 -37.98 72.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.351 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.675 HG13 HD22 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -66.16 -39.48 84.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.538 -179.231 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.26 -49.3 74.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.366 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.67 -47.23 82.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.117 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.897 ' HB2' ' CB ' ' A' ' 43' ' ' SER . . . -58.04 -56.3 23.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.316 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.412 ' HA ' HD12 ' A' ' 75' ' ' ILE . 0.4 OUTLIER -53.35 -42.52 66.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.339 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.27 -48.05 81.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.48 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 20.7 mmm -70.45 -33.88 71.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.178 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 72' ' ' PHE . 17.6 mt -68.09 -38.26 79.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.473 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.415 HG13 ' N ' ' A' ' 77' ' ' ASP . 36.6 pt -71.47 -38.44 68.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.071 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.415 ' N ' HG13 ' A' ' 76' ' ' ILE . 0.7 OUTLIER -63.39 -47.41 82.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.659 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.31 -36.39 83.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.947 0.403 . . . . 0.0 110.058 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.5 tp -77.58 -23.08 50.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.47 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -76.4 -49.31 17.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.99 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -72.27 -32.32 66.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.862 0.363 . . . . 0.0 111.067 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.0 t70 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.824 -179.438 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.837 0.265 . . . . 0.0 112.124 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.54 HG21 ' HG3' ' A' ' 152' ' ' PRO . 24.9 t -140.81 115.45 6.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.813 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 50.2 p -103.08 142.32 34.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.899 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.446 HD23 HD21 ' A' ' 102' ' ' LEU . 0.5 OUTLIER -139.96 117.55 11.52 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 178.656 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.534 ' HD2' HG23 ' A' ' 147' ' ' THR . 0.1 OUTLIER -103.67 112.4 25.32 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.36 -178.579 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.446 HD21 HD23 ' A' ' 100' ' ' LEU . 4.5 mm? -102.14 143.17 32.3 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.928 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.732 HG13 HD23 ' A' ' 19' ' ' LEU . 31.2 m -107.82 142.93 19.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.07 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.556 HG13 ' O ' ' A' ' 103' ' ' VAL . 4.4 m -159.53 157.16 26.39 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.33 172.08 9.48 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.559 2.173 . . . . 0.0 112.308 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.15 -34.64 78.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.517 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.21 -30.48 68.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.151 0.501 . . . . 0.0 109.848 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.41 ' CB ' ' HB ' ' A' ' 104' ' ' VAL . 2.2 mm100 -72.64 -49.78 29.57 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.724 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.5 m -62.94 -37.98 89.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.365 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.25 -43.25 99.62 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.249 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 83.6 p -74.49 -38.48 62.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.741 0.305 . . . . 0.0 110.655 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.7 mt -57.25 -27.95 62.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.563 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.606 HG22 ' HA2' ' A' ' 117' ' ' GLY . 10.4 mt -85.6 -36.74 11.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.847 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.59 -178.98 30.88 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.461 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.0 ttmm -66.99 123.68 20.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 0.0 111.204 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.6 15.29 57.21 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.012 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.606 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 73.58 5.1 67.28 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.955 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 31.9 p -52.92 -35.64 58.57 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.848 0.356 . . . . 0.0 111.631 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -65.53 -65.29 0.69 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.155 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.877 HD11 HG21 ' A' ' 131' ' ' VAL . 0.5 OUTLIER -54.75 -30.05 22.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.297 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -50.4 71.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.812 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -61.22 -40.55 94.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.203 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.775 HG23 ' OE1' ' A' ' 161' ' ' GLN . 44.4 mm -57.09 -53.94 36.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.807 0.337 . . . . 0.0 110.907 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.62 -32.91 74.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.822 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -57.14 -52.65 64.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.569 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.02 -46.99 8.43 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.583 HG21 ' SG ' ' A' ' 158' ' ' CYS . 92.3 m -47.39 -25.92 1.17 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.944 0.402 . . . . 0.0 110.485 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.11 -7.54 21.9 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.355 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -108.3 141.39 40.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.996 0.398 . . . . 0.0 111.209 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -79.14 141.08 37.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.877 HG21 HD11 ' A' ' 120' ' ' ILE . 34.8 m -107.39 143.17 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.157 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.805 ' O ' HG23 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -113.84 158.41 21.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.278 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.8 m -137.41 128.2 39.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.08 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.116 -179.955 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.974 0.416 . . . . 0.0 111.07 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.546 HG23 ' HG3' ' A' ' 143' ' ' GLU . 15.0 t -121.41 -40.49 2.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.567 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.546 ' HG3' HG23 ' A' ' 142' ' ' THR . 9.9 mt-10 -107.27 145.76 32.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.416 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -109.86 161.48 15.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.904 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -118.51 155.0 31.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.329 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.805 HG23 ' O ' ' A' ' 132' ' ' GLN . 69.7 mt -129.66 141.01 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.401 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 132' ' ' GLN . 0.4 OUTLIER -116.41 117.42 29.9 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.432 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.834 HD12 HG12 ' A' ' 131' ' ' VAL . 8.1 mm -104.08 120.54 54.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.793 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.31 137.22 53.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.128 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 160.77 -151.68 22.19 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.593 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.529 ' CG2' ' HD2' ' A' ' 152' ' ' PRO . 15.4 mt -85.48 144.52 40.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.54 ' HG3' HG21 ' A' ' 98' ' ' VAL . 72.3 Cg_exo -48.96 -32.51 23.35 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.98 1.787 . . . . 0.0 111.552 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -72.08 -34.83 68.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.62 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 57.9 m -70.94 -39.31 72.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.61 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.406 ' O ' HG23 ' A' ' 159' ' ' VAL . 40.5 mm -64.53 -50.06 77.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.909 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.9 mt -57.19 -38.39 61.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.7 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -66.24 -38.8 88.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.497 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . 0.583 ' SG ' HG21 ' A' ' 127' ' ' THR . 0.9 OUTLIER -61.57 -45.63 93.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.591 179.669 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.472 ' HA ' HD12 ' A' ' 162' ' ' ILE . 32.9 t -59.97 -36.09 64.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.796 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.437 ' O ' HG12 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -64.41 -32.98 74.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.62 179.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.775 ' OE1' HG23 ' A' ' 123' ' ' ILE . 47.4 mt-30 -72.19 -31.82 66.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.887 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 159' ' ' VAL . 29.8 mt -74.01 -36.34 44.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.077 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 1.3 m -74.01 -43.29 58.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.939 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.496 HG13 ' N ' ' A' ' 165' ' ' VAL . 11.2 p -66.29 -45.76 88.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.32 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 161' ' ' GLN . 11.8 p -61.76 -42.54 94.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.021 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.437 ' N ' HG13 ' A' ' 165' ' ' VAL . 0.3 OUTLIER -59.17 -40.03 84.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.796 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.827 HD11 HG21 ' A' ' 12' ' ' VAL . 1.2 tt -72.64 -43.99 62.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.78 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -73.97 -2.64 24.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.034 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 165' ' ' VAL . 32.5 p . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.895 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.5 m120 . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.824 0.345 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.82 ' CG1' HD13 ' A' ' 167' ' ' LEU . 6.8 p -107.34 159.87 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.029 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.524 ' N ' HG22 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -103.65 140.65 37.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.804 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.441 ' HA ' HD23 ' A' ' 14' ' ' LEU . 3.5 mt -131.24 171.32 13.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.027 0.441 . . . . 0.0 111.297 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.623 HG23 ' HB2' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -142.63 117.91 10.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.615 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.823 HG22 HD11 ' A' ' 68' ' ' ILE . 15.5 tt -121.51 156.66 25.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.908 0.385 . . . . 0.0 111.283 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.637 ' HG3' HG23 ' A' ' 60' ' ' THR . 1.9 mtp85 -134.46 111.92 10.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.643 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.543 HD13 HD12 ' A' ' 102' ' ' LEU . 0.6 OUTLIER -89.38 145.3 25.43 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.749 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.0 tt -122.51 121.1 35.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.544 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.409 ' CB ' ' HB ' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -148.07 163.19 37.67 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.374 0.607 . . . . 0.0 112.121 -179.515 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.93 ' O ' HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -76.48 134.72 39.44 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.542 179.545 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -45.7 -25.47 1.5 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 121.024 -0.608 . . . . 0.0 113.556 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.38 -52.46 9.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.942 0.371 . . . . 0.0 111.609 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -71.09 -51.0 27.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.993 0.425 . . . . 0.0 110.402 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.93 HG12 ' O ' ' A' ' 21' ' ' HIS . 10.0 p -62.8 -33.9 62.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.296 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.52 -37.75 94.66 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.641 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.3 t -68.38 -28.42 67.1 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.421 ' N ' HD13 ' A' ' 28' ' ' ILE . 4.6 mm -80.59 -32.55 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.567 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.617 HD11 HG22 ' A' ' 25' ' ' VAL . 3.2 mm -60.59 -45.22 97.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.902 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.46 ' HA3' ' CB ' ' A' ' 35' ' ' SER . . . 94.69 150.57 27.23 Favored Glycine 0 N--CA 1.436 -1.347 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.812 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.419 ' C ' ' HD3' ' A' ' 32' ' ' LYS . 8.0 tttm -64.4 146.31 54.68 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.571 -0.814 . . . . 0.0 111.659 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.419 ' HD3' ' C ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER 63.01 6.74 2.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.847 179.635 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.529 ' O ' HG23 ' A' ' 36' ' ' VAL . . . 59.9 7.07 5.94 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 119.822 -1.18 . . . . 0.0 111.795 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.402 ' HB2' ' CE ' ' A' ' 32' ' ' LYS . 1.5 tm-20 -71.8 -28.21 63.45 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.025 0.44 . . . . 0.0 109.878 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.46 ' CB ' ' HA3' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -75.03 -36.34 61.9 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.265 179.496 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -67.32 -26.56 36.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -69.88 -36.81 75.76 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -65.04 -34.78 79.25 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.844 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.409 ' HE3' ' HA ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -64.16 -46.44 84.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.616 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.479 ' HA ' HD12 ' A' ' 47' ' ' ILE . 53.5 mtt180 -58.26 -51.18 70.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.289 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.02 -38.16 90.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.203 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -74.85 -36.06 62.35 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.713 ' HB2' ' HB2' ' A' ' 71' ' ' ALA . 12.1 t -77.9 -47.23 19.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.898 0.38 . . . . 0.0 111.116 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.89 -8.42 76.11 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.398 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.665 ' HB3' HD21 ' A' ' 61' ' ' LEU . . . -110.79 128.75 55.88 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.493 0.187 . . . . 0.0 111.108 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 4.5 mtt-85 -26.99 139.37 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.058 0.543 . . . . 0.0 112.038 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 40' ' ' ARG . 11.1 mt -142.13 116.31 4.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.714 0.292 . . . . 0.0 111.317 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -133.68 122.07 22.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.059 0.456 . . . . 0.0 110.907 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.887 ' HB ' HD13 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -108.15 130.78 60.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.902 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.5 t 168.6 169.8 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.067 0.46 . . . . 0.0 111.383 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.4 ' HB3' HD12 ' A' ' 58' ' ' ILE . 3.9 tt0 . . . . . 0 C--N 1.333 -0.141 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.894 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 . . . . . 0 N--CA 1.465 0.301 0 CA-C-O 120.304 0.097 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.822 ' CB ' HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -133.89 130.76 38.27 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.034 0.445 . . . . 0.0 111.605 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 47.6 mt -129.46 109.93 19.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.491 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.887 HD13 ' HB ' ' A' ' 49' ' ' ILE . 7.1 mm -85.96 94.99 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.951 0.405 . . . . 0.0 111.537 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.637 HG23 ' HG3' ' A' ' 17' ' ' ARG . 50.0 m -88.82 105.85 17.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.841 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.753 HD22 HG13 ' A' ' 68' ' ' ILE . 9.1 tt -107.85 136.71 47.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.621 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.623 ' HB2' HG23 ' A' ' 15' ' ' THR . . . -133.51 133.74 42.58 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.541 0.21 . . . . 0.0 110.864 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.16 164.92 14.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.894 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 92.6 Cg_exo -41.35 162.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.04 2.494 . . . . 0.0 113.161 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.469 ' O ' HG22 ' A' ' 68' ' ' ILE . 4.1 t -60.19 -35.56 75.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.206 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -63.88 -51.81 62.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.228 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.458 ' CB ' ' HB2' ' A' ' 45' ' ' ALA . . . -57.26 -44.67 84.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.0 0.428 . . . . 0.0 111.003 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.823 HD11 HG22 ' A' ' 16' ' ' ILE . 1.5 tt -66.43 -39.42 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.666 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.27 -48.38 76.7 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.108 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.88 -48.02 78.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.899 0.38 . . . . 0.0 110.832 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.713 ' HB2' ' HB2' ' A' ' 43' ' ' SER . . . -57.72 -40.64 80.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.423 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.477 ' O ' HG23 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -61.47 -48.29 81.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.218 -179.663 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.406 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -68.72 -29.28 67.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.94 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.8 mmm -77.46 -48.43 17.15 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 72' ' ' PHE . 1.2 pp -61.34 -41.43 89.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.311 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.477 HG23 ' O ' ' A' ' 72' ' ' PHE . 26.0 pt -67.8 -38.91 81.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.808 0.337 . . . . 0.0 110.907 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.22 -32.16 73.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.399 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -40.42 86.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.174 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.7 tp -77.49 -25.62 50.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.492 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -77.06 -41.48 42.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -72.11 -36.64 69.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.904 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 179.948 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.432 ' HG2' ' CA ' ' A' ' 150' ' ' GLY . 35.9 Cg_endo . . . . . 0 CA--C 1.527 0.163 0 N-CA-C 112.642 0.208 . . . . 0.0 112.642 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.6 t -137.25 111.67 9.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.913 0.387 . . . . 0.0 111.022 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.641 HG22 ' HB2' ' A' ' 149' ' ' ALA . 38.8 p -103.24 138.36 40.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.982 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.94 117.79 11.72 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.409 ' HB3' HG23 ' A' ' 147' ' ' THR . 4.1 ptp180 -102.26 112.5 25.22 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.367 -178.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.543 HD12 HD13 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -110.63 145.53 37.74 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.032 -179.646 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.419 ' CG1' ' HB3' ' A' ' 17' ' ' ARG . 11.9 p -95.98 131.47 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.72 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.473 HG23 ' HD2' ' A' ' 105' ' ' PRO . 7.5 p -130.22 145.78 58.79 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.171 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.473 ' HD2' HG23 ' A' ' 104' ' ' VAL . 22.5 Cg_exo -65.62 163.4 30.34 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.537 2.158 . . . . 0.0 111.987 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 142' ' ' THR . . . -69.25 -39.69 78.31 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 25.8 m -69.72 -30.48 68.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.289 0.566 . . . . 0.0 109.626 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.471 ' HB3' HG22 ' A' ' 104' ' ' VAL . 0.9 OUTLIER -74.58 -49.48 21.61 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.53 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.478 ' O ' HD12 ' A' ' 113' ' ' ILE . 1.8 t -65.47 -37.42 86.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.935 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.38 -51.46 57.56 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.041 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.3 m -72.88 -34.87 66.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.806 0.336 . . . . 0.0 110.438 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.516 ' CD2' HD12 ' A' ' 162' ' ' ILE . 9.7 mt -60.88 -29.07 69.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.129 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.532 HG22 ' HA2' ' A' ' 117' ' ' GLY . 12.4 mt -80.41 -37.95 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.623 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.76 -179.26 44.53 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.458 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.05 122.23 17.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.867 0.365 . . . . 0.0 111.012 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.08 11.91 56.33 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.927 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.532 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 72.15 6.17 64.08 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.02 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -53.16 -39.98 63.99 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.691 ' HD2' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -63.23 -65.33 0.7 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.762 -179.234 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.813 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.9 OUTLIER -58.03 -37.65 62.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.634 -179.356 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.3 -44.75 80.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.332 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -73.12 -39.29 65.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.313 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.813 HD12 ' HA ' ' A' ' 120' ' ' ILE . 24.3 mt -58.13 -53.88 39.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.264 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.0 ptt85 -67.97 -35.02 77.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.879 0.371 . . . . 0.0 111.071 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -54.92 -50.63 68.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.177 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 53.3 p -83.86 -36.1 23.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.374 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.515 HG21 ' SG ' ' A' ' 158' ' ' CYS . 18.2 m -50.28 -26.13 4.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.807 0.337 . . . . 0.0 110.256 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 88.84 -21.75 25.27 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.981 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -102.49 155.82 18.01 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.823 0.344 . . . . 0.0 111.152 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -105.17 132.85 50.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.023 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.523 HG12 HG13 ' A' ' 148' ' ' ILE . 5.6 m -99.18 138.78 22.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.895 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.697 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 0.1 OUTLIER -116.94 116.67 27.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.107 0.479 . . . . 0.0 112.04 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.9 p -100.67 140.28 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.543 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.928 179.699 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.0 p . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.796 0.331 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.471 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 1.5 m -117.73 -46.22 2.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.82 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.498 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 43.9 mt-10 -108.54 138.01 45.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.762 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -109.9 148.84 30.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.833 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -105.98 128.82 54.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.218 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.697 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 28.5 mm -108.6 127.25 65.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.866 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' A' ' 132' ' ' GLN . 0.2 OUTLIER -108.06 114.67 28.76 Favored 'General case' 0 N--CA 1.46 0.07 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.711 179.76 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.523 HG13 HG12 ' A' ' 131' ' ' VAL . 3.2 mp -104.1 117.53 49.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.409 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.641 ' HB2' HG22 ' A' ' 99' ' ' THR . . . -118.91 126.07 50.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.856 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.432 ' CA ' ' HG2' ' A' ' 97' ' ' PRO . . . 171.26 -153.04 19.61 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.693 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.532 HG23 ' HD2' ' A' ' 152' ' ' PRO . 4.4 mt -86.98 143.3 34.86 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 110.569 -0.16 . . . . 0.0 110.569 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.876 ' HA ' HD12 ' A' ' 155' ' ' ILE . 6.0 Cg_endo -48.63 -34.18 26.18 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.258 1.972 . . . . 0.0 111.609 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.436 ' O ' HG22 ' A' ' 156' ' ' ILE . 4.0 pp0? -72.09 -34.65 68.82 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 19.2 m -68.84 -44.48 73.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.648 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.876 HD12 ' HA ' ' A' ' 152' ' ' PRO . 4.2 mt -60.64 -52.49 60.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.806 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 153' ' ' GLN . 7.8 tp -56.02 -31.06 30.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.861 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -70.08 -37.07 75.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.706 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . 0.515 ' SG ' HG21 ' A' ' 127' ' ' THR . 0.5 OUTLIER -64.01 -52.91 57.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.643 179.724 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 34.3 t -59.37 -31.97 47.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.773 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 7.4 ttmt -67.46 -34.45 77.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.748 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.79 ' O ' HG23 ' A' ' 165' ' ' VAL . 0.3 OUTLIER -70.45 -35.1 73.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.712 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.516 HD12 ' CD2' ' A' ' 112' ' ' LEU . 34.2 mm -73.4 -34.42 43.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.951 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 4.2 t -73.91 -46.39 44.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.043 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.24 -41.38 86.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.126 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' ' 161' ' ' GLN . 59.5 t -69.28 -47.54 73.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.797 0.332 . . . . 0.0 110.859 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -32.77 65.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.82 HD13 ' CG1' ' A' ' 12' ' ' VAL . 62.3 tp -71.91 -47.35 53.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.762 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -73.86 -2.72 24.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.081 0.467 . . . . 0.0 112.027 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 72.6 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.803 -179.994 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.761 0.315 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 64' ' ' PRO . 5.6 t -105.62 146.87 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.772 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 7.1 m -103.64 151.38 23.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.158 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' A' ' 14' ' ' LEU . 4.6 mt -138.32 176.21 8.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.984 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.41 125.32 16.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.901 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 1.043 HG22 HD11 ' A' ' 68' ' ' ILE . 7.4 tt -140.82 133.52 31.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.318 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.496 ' NH2' ' OE1' ' A' ' 143' ' ' GLU . 16.6 mtt180 -112.58 139.06 48.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.703 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.419 HD23 HD11 ' A' ' 100' ' ' LEU . 3.5 mp -113.74 138.82 49.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.938 0.399 . . . . 0.0 111.091 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.05 114.22 23.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.703 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.87 161.92 26.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.072 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.579 ' O ' HG12 ' A' ' 25' ' ' VAL . 27.6 m170 -74.69 175.0 8.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.899 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.57 -40.77 99.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.666 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.48 -44.23 25.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.829 0.347 . . . . 0.0 111.123 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.42 ' O ' HG23 ' A' ' 28' ' ' ILE . 42.4 mt-10 -61.92 -43.98 97.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.081 0.467 . . . . 0.0 110.281 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.758 HG21 ' CB ' ' A' ' 57' ' ' ARG . 9.8 p -68.66 -30.34 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.561 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.28 -39.32 97.56 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.538 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.87 -36.2 59.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.732 0.301 . . . . 0.0 111.474 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 25' ' ' VAL . 2.0 pp -78.5 -32.47 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.683 ' HA ' HG13 ' A' ' 36' ' ' VAL . 7.6 mm -70.62 -52.88 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.464 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.426 ' HA3' ' CB ' ' A' ' 35' ' ' SER . . . 99.69 150.33 25.07 Favored Glycine 0 N--CA 1.437 -1.297 0 CA-C-O 121.791 0.662 . . . . 0.0 112.967 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.49 ' C ' ' HD3' ' A' ' 32' ' ' LYS . 6.6 mttt -66.09 146.39 54.72 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.398 -0.901 . . . . 0.0 111.348 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.529 ' HE3' ' HB2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 61.59 6.9 1.65 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.583 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.52 ' O ' HG23 ' A' ' 36' ' ' VAL . . . 59.16 8.22 6.08 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.304 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.529 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 3.7 mt-10 -75.58 -30.56 59.68 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 122.402 -0.47 . . . . 0.0 109.915 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.526 ' HA ' ' HG2' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -67.91 -42.67 80.75 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.26 179.462 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.683 HG13 ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -66.86 -26.16 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.548 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.18 -36.63 83.58 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.526 ' HG2' ' HA ' ' A' ' 35' ' ' SER . 41.5 mmtt -59.96 -43.3 95.13 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.579 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.42 -47.14 82.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.914 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.25 -51.05 71.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.226 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -64.35 -37.79 88.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.98 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -74.59 -36.61 63.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.872 ' HB2' ' HB2' ' A' ' 71' ' ' ALA . 46.9 t -90.55 -55.79 3.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.946 0.403 . . . . 0.0 110.753 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.7 10.78 61.3 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.915 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.649 ' HB3' HD21 ' A' ' 61' ' ' LEU . . . -109.21 127.63 54.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 117.048 0.424 . . . . 0.0 111.554 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.545 ' HB2' ' HB3' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -27.94 104.08 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.294 178.869 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 60' ' ' THR . 3.3 mt -116.02 100.62 10.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.777 0.322 . . . . 0.0 110.419 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.483 ' O ' ' HB ' ' A' ' 60' ' ' THR . 2.4 p30 -121.61 125.83 47.64 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.617 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.7 mt -100.0 142.27 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.73 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.6 m -161.68 -177.81 6.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.024 0.44 . . . . 0.0 111.552 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.799 ' CB ' HD13 ' A' ' 58' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.306 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.758 ' CB ' HG21 ' A' ' 25' ' ' VAL . 6.3 mtt180 -145.77 127.61 15.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.926 0.393 . . . . 0.0 111.207 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.799 HD13 ' CB ' ' A' ' 51' ' ' GLU . 2.4 mp -101.04 104.72 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.612 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.1 mp -86.43 95.1 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.411 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 47' ' ' ILE . 27.7 m -73.8 131.0 41.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.688 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.649 HD21 ' HB3' ' A' ' 45' ' ' ALA . 1.5 tt -131.59 129.64 41.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.652 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.553 ' O ' ' HB1' ' A' ' 45' ' ' ALA . . . -139.45 130.45 26.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.699 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.35 165.18 14.68 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.116 -1.04 . . . . 0.0 112.783 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 80.6 Cg_exo -39.37 154.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.135 2.557 . . . . 0.0 113.216 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.425 ' O ' HG22 ' A' ' 68' ' ' ILE . 3.8 m -59.04 -35.35 73.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.864 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -67.03 -52.02 47.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.186 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.26 -42.93 82.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.058 0.456 . . . . 0.0 110.795 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 1.043 HD11 HG22 ' A' ' 16' ' ' ILE . 1.0 OUTLIER -66.44 -39.46 84.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.172 -179.515 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.52 -47.01 87.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.065 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -50.59 73.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.938 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.872 ' HB2' ' HB2' ' A' ' 43' ' ' SER . . . -58.72 -40.68 84.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.153 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.78 -42.69 99.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.093 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.79 -39.31 88.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.167 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.9 mtt -78.04 -32.49 50.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.841 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.14 -46.15 81.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.002 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.1 pp -68.14 -37.85 78.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.223 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -65.48 -46.2 80.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.504 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -35.4 75.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.111 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.0 tp -77.57 -25.17 49.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.523 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -76.88 -43.01 37.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.912 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -72.1 -32.33 66.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.828 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.3 t70 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.983 -179.948 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo . . . . . 0 N--CA 1.461 -0.408 0 CA-C-O 120.791 0.246 . . . . 0.0 112.606 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.653 HG21 ' HD3' ' A' ' 152' ' ' PRO . 24.3 t -137.2 106.77 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.482 HG22 ' HB2' ' A' ' 149' ' ' ALA . 40.7 p -103.4 139.22 39.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.04 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.419 HD11 HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -139.86 117.61 11.63 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.681 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.91 112.44 25.41 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.527 -178.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.708 HD22 HD11 ' A' ' 16' ' ' ILE . 40.7 mt -111.85 153.76 26.16 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.956 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 104' ' ' VAL . 21.2 t -114.32 149.23 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.062 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.963 HG11 HD11 ' A' ' 162' ' ' ILE . 6.0 m -156.14 164.46 21.35 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.335 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -66.03 160.74 43.02 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.744 2.296 . . . . 0.0 112.113 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.98 -34.9 76.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.358 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.9 t -70.17 -30.28 67.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.201 0.524 . . . . 0.0 109.667 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.559 ' NE2' HD23 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -70.72 -41.8 71.43 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.63 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.6 ' HA ' HD21 ' A' ' 112' ' ' LEU . 5.1 t -65.85 -40.8 92.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.706 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.17 -33.47 87.32 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.885 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.6 p -77.32 -50.78 12.07 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 121.115 -0.234 . . . . 0.0 111.312 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.625 HD12 HG13 ' A' ' 113' ' ' ILE . 2.7 pp -55.66 -25.78 41.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.054 0.455 . . . . 0.0 110.009 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.625 HG13 HD12 ' A' ' 112' ' ' LEU . 51.2 mt -77.03 -39.31 29.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.224 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.41 -177.86 39.37 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.527 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.53 121.73 16.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.857 0.361 . . . . 0.0 111.128 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.85 12.37 56.88 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.08 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.415 ' HA2' ' CG2' ' A' ' 113' ' ' ILE . . . 72.99 4.97 63.95 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.034 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 2.2 m -52.94 -42.64 65.65 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 120.791 0.329 . . . . 0.0 111.828 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -65.34 0.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.564 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.2 tt -58.99 -30.59 43.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.647 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 7.6 tppt? -60.07 -44.83 94.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.105 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -73.28 -41.66 63.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.464 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.409 HD12 ' NE2' ' A' ' 161' ' ' GLN . 34.5 mm -62.7 -53.78 42.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.583 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.4 mmt85 -67.82 -42.72 81.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.398 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.61 -40.77 69.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.222 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 91.3 p -85.32 -36.75 20.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.758 0.313 . . . . 0.0 111.101 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 31.0 m -50.49 -26.09 4.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.929 0.395 . . . . 0.0 110.249 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.48 -9.15 62.49 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.026 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -108.03 154.32 21.83 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.857 0.36 . . . . 0.0 111.212 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 1.9 mt-30 -105.14 139.75 39.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.41 ' HB ' ' CG2' ' A' ' 146' ' ' ILE . 1.2 m -99.16 157.96 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.035 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.593 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 3.4 tp60 -138.59 116.81 11.84 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.269 0.557 . . . . 0.0 112.347 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.65 131.22 45.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.305 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.079 179.915 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.869 0.366 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 24.5 m -118.91 -41.87 2.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.614 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.496 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 37.5 mt-10 -134.15 138.9 45.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.76 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.24 165.29 13.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.952 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.28 138.98 53.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.233 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.593 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 35.5 mt -114.21 131.63 65.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.824 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.435 ' HB ' ' CB ' ' A' ' 132' ' ' GLN . 1.0 OUTLIER -106.17 115.06 29.58 Favored 'General case' 0 N--CA 1.46 0.065 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.689 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 130' ' ' GLN . 3.2 mp -103.89 118.7 51.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.452 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.482 ' HB2' HG22 ' A' ' 99' ' ' THR . . . -118.55 134.5 55.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.758 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 163.35 -151.58 21.22 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.777 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.578 HG23 ' HD2' ' A' ' 152' ' ' PRO . 3.7 mt -78.2 144.74 67.5 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.653 ' HD3' HG21 ' A' ' 98' ' ' VAL . 5.7 Cg_endo -48.4 -39.87 36.06 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.134 1.889 . . . . 0.0 111.322 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -66.63 -34.68 78.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 18.3 m -68.44 -32.26 72.16 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.625 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 29.5 mm -76.35 -49.0 25.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.119 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.42 ' O ' HG12 ' A' ' 159' ' ' VAL . 33.4 mm -55.81 -36.38 43.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.989 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -75.03 -36.72 61.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.826 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 4.8 t -68.16 -38.45 82.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.905 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.445 ' HA ' HG22 ' A' ' 162' ' ' ILE . 10.3 p -70.82 -32.17 48.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.065 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.76 ' O ' HG23 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -69.3 -34.68 75.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.872 179.869 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.59 ' O ' HG23 ' A' ' 165' ' ' VAL . 0.8 OUTLIER -72.41 -49.37 34.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.776 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.963 HD11 HG11 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -63.15 -44.08 99.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.947 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' CYS . . . . . 0.477 ' N ' HG23 ' A' ' 162' ' ' ILE . 1.7 m -58.95 -44.61 91.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.831 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 160' ' ' LYS . 53.4 t -58.48 -52.59 57.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.02 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 161' ' ' GLN . 21.8 t -57.9 -41.25 79.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.18 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -59.69 -37.48 78.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.971 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 7.6 tt -67.46 -55.87 11.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.88 -2.63 24.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.01 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 18.4 p . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.372 -0.823 . . . . 0.0 111.152 179.999 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.722 0.296 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.563 HG22 ' N ' ' A' ' 13' ' ' THR . 12.0 p -118.08 163.97 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.97 0.414 . . . . 0.0 111.347 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.638 ' O ' HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -104.74 128.31 52.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.288 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.638 HD22 ' O ' ' A' ' 13' ' ' THR . 1.9 mm? -124.26 151.43 44.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.237 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.2 m -141.66 118.78 11.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.519 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.838 HD11 HD23 ' A' ' 102' ' ' LEU . 12.4 tt -119.96 147.21 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.931 0.396 . . . . 0.0 111.408 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.658 ' HG3' HG23 ' A' ' 60' ' ' THR . 2.4 mpp_? -131.04 112.08 12.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.524 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.685 HD12 ' CE ' ' A' ' 20' ' ' MET . 0.5 OUTLIER -109.51 134.74 51.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.224 -179.605 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.563 HD23 HG23 ' A' ' 103' ' ' VAL . 1.0 OUTLIER -104.36 122.36 45.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.562 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.685 ' CE ' HD12 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -124.71 159.51 30.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.144 0.497 . . . . 0.0 111.436 -179.621 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.86 ' O ' HG12 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -71.89 142.15 49.52 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.427 179.659 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.415 ' HA2' ' HG3' ' A' ' 57' ' ' ARG . . . -43.98 -32.2 2.26 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 121.018 -0.611 . . . . 0.0 113.801 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.41 ' HG3' ' HB3' ' A' ' 21' ' ' HIS . 0.0 OUTLIER -78.37 -52.03 9.2 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -179.255 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.18 -50.55 67.69 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.027 0.442 . . . . 0.0 110.309 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.86 HG12 ' O ' ' A' ' 21' ' ' HIS . 11.6 p -58.88 -36.04 59.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.956 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.701 ' HA2' HD12 ' A' ' 29' ' ' ILE . . . -62.37 -36.13 92.66 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.39 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.1 m -72.48 -29.53 63.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.96 0.41 . . . . 0.0 110.212 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.402 HD13 ' N ' ' A' ' 28' ' ' ILE . 4.9 mm -81.14 -32.59 12.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.699 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.735 HD11 HG22 ' A' ' 25' ' ' VAL . 14.2 mt -64.14 -42.59 96.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.156 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.4 150.96 26.14 Favored Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.293 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.431 ' C ' ' HG3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -58.08 146.39 33.28 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.772 -0.714 . . . . 0.0 111.259 179.824 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.496 ' HD2' ' HB2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 44.58 26.75 0.2 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.221 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.52 ' O ' HG23 ' A' ' 36' ' ' VAL . . . 49.25 16.17 0.8 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 114.391 0.517 . . . . 0.0 114.391 178.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.546 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 4.0 mt-10 -72.09 -35.01 69.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.677 0.739 . . . . 0.0 109.872 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.9 t -68.41 -39.86 81.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.102 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.684 HG13 ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -66.8 -26.1 36.26 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -36.45 79.91 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.546 ' HG2' ' O ' ' A' ' 34' ' ' GLU . 8.8 mmtt -63.28 -41.22 98.98 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.597 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.54 -49.48 76.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.169 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.583 ' HG2' HD12 ' A' ' 47' ' ' ILE . 1.7 mtt180 -58.34 -51.66 68.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.682 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -64.91 -38.4 90.84 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -75.06 -35.97 61.83 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.798 ' CB ' ' HB2' ' A' ' 71' ' ' ALA . 83.5 p -82.27 -55.33 4.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.83 0.347 . . . . 0.0 111.041 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.41 -7.89 64.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.544 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.565 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . . . -104.28 127.94 51.99 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 122.781 -0.246 . . . . 0.0 111.012 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 4.5 mmt180 -27.36 139.39 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.101 0.56 . . . . 0.0 112.213 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.583 HD12 ' HG2' ' A' ' 40' ' ' ARG . 11.6 mt -142.24 100.59 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.723 0.297 . . . . 0.0 111.008 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.34 132.6 50.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.04 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.9 mt -90.24 151.77 3.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.081 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.87 -175.12 3.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.043 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.055 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 . . . . . 0 N--CA 1.467 0.415 0 CA-C-O 120.593 0.235 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.697 ' HB2' HG11 ' A' ' 25' ' ' VAL . 3.3 mtp180 -140.24 143.61 36.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.008 0.432 . . . . 0.0 111.375 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.2 mt -140.53 115.45 6.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.599 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.5 mt -86.18 110.13 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.976 0.417 . . . . 0.0 111.43 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.658 HG23 ' HG3' ' A' ' 17' ' ' ARG . 49.6 m -103.15 101.84 11.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.64 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.57 HD22 HG13 ' A' ' 68' ' ' ILE . 6.5 tt -104.69 133.85 48.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.753 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.478 ' O ' ' HB1' ' A' ' 45' ' ' ALA . . . -125.55 137.42 53.93 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.45 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.49 165.57 15.44 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 119.847 -1.168 . . . . 0.0 113.007 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -50.5 161.96 1.07 Allowed 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.906 2.404 . . . . 0.0 112.337 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.496 ' O ' HG22 ' A' ' 68' ' ' ILE . 18.2 m -56.85 -35.96 69.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.559 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -63.8 -51.81 63.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.788 0.328 . . . . 0.0 111.3 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.565 ' CB ' ' HB2' ' A' ' 45' ' ' ALA . . . -57.24 -37.47 72.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.198 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.57 HG13 HD22 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -66.21 -39.34 84.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.376 -179.301 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.67 -50.91 70.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.032 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.76 -49.71 76.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.886 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.798 ' HB2' ' CB ' ' A' ' 43' ' ' SER . . . -56.31 -50.85 70.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.27 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.454 ' HA ' HD12 ' A' ' 75' ' ' ILE . 0.7 OUTLIER -52.78 -42.51 65.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.095 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.98 -37.13 78.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.108 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -76.32 -37.63 57.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.949 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 72' ' ' PHE . 46.0 mt -64.11 -50.6 76.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.846 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -62.17 -37.42 78.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.143 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -65.0 -47.64 76.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.741 0.305 . . . . 0.0 110.513 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.36 -35.42 80.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.174 0.511 . . . . 0.0 109.781 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.0 tp -77.67 -22.99 49.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.486 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -76.08 -41.75 49.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.841 0.353 . . . . 0.0 110.9 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.23 -45.44 60.22 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.036 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.681 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo . . . . . 0 N--CA 1.463 -0.315 0 CA-C-O 120.937 0.307 . . . . 0.0 112.701 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.839 HG12 ' O ' ' A' ' 150' ' ' GLY . 7.2 p -140.92 116.21 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.505 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.664 ' O ' HD23 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -103.08 131.85 49.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.133 -179.556 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.664 HD23 ' O ' ' A' ' 99' ' ' THR . 27.6 mt -139.92 117.67 11.63 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.54 ' HG2' ' HB1' ' A' ' 145' ' ' ALA . 28.2 ttm180 -103.09 112.57 25.48 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.567 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.838 HD23 HD11 ' A' ' 16' ' ' ILE . 1.4 mp -99.46 151.01 21.6 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.842 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.563 HG23 HD23 ' A' ' 19' ' ' LEU . 25.9 t -107.26 149.28 10.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.241 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.8 m -156.01 161.69 28.96 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.133 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.432 ' HD2' ' HB2' ' A' ' 108' ' ' GLN . 21.4 Cg_exo -65.69 162.15 35.75 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.748 2.298 . . . . 0.0 112.216 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.13 -34.64 76.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.639 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.25 -30.52 69.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.086 0.469 . . . . 0.0 109.823 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.432 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -68.85 -46.19 69.15 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.678 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.405 ' O ' HG12 ' A' ' 113' ' ' ILE . 0.8 OUTLIER -67.57 -37.48 82.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.419 179.554 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.22 -49.68 70.48 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.312 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.9 m -77.28 -35.22 55.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.839 0.352 . . . . 0.0 110.803 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.71 HD21 ' CD1' ' A' ' 162' ' ' ILE . 9.9 mt -57.66 -29.67 64.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.62 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.408 ' HA ' ' HB ' ' A' ' 120' ' ' ILE . 27.7 mm -87.12 -38.71 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.807 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.4 -179.38 36.66 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.453 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.34 124.73 23.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.874 0.369 . . . . 0.0 111.054 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.41 16.07 57.85 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.882 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.407 ' HA2' ' CG2' ' A' ' 113' ' ' ILE . . . 68.16 10.6 59.77 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.965 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -52.93 -39.86 63.16 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.823 0.344 . . . . 0.0 111.547 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.67 -65.27 0.7 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.224 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.891 HD11 HG21 ' A' ' 131' ' ' VAL . 0.0 OUTLIER -55.13 -28.86 21.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.437 -179.668 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -64.69 -49.36 71.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.094 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.5 -38.99 74.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.34 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 120' ' ' ILE . 27.8 mt -57.52 -53.93 37.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.116 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.435 ' HG2' HD13 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -72.47 -30.52 64.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.912 0.387 . . . . 0.0 110.998 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.97 -44.73 82.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.131 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.4 m -93.12 -37.53 12.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.506 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.5 m -49.83 -26.25 3.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.809 0.337 . . . . 0.0 110.234 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 82.9 -16.55 26.56 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.229 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.801 ' HB2' ' HB3' ' A' ' 154' ' ' SER . . . -100.87 166.54 10.79 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.937 0.368 . . . . 0.0 111.195 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -105.23 133.82 49.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.952 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.891 HG21 HD11 ' A' ' 120' ' ' ILE . 14.0 m -101.93 139.48 22.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.905 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.633 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 0.4 OUTLIER -129.47 116.72 19.39 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.6 m -99.26 132.74 44.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.277 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.995 179.92 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 56.1 p . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.84 0.353 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 28.3 m -115.59 -47.17 2.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.811 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.486 ' OE2' ' NH2' ' A' ' 17' ' ' ARG . 10.9 mt-10 -116.2 147.03 41.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.792 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.03 174.43 5.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.893 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.54 ' HB1' ' HG2' ' A' ' 101' ' ' ARG . . . -136.44 129.9 31.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.402 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.633 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 3.9 mp -100.13 125.4 53.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.741 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.566 HG22 HG22 ' A' ' 99' ' ' THR . 0.3 OUTLIER -96.92 114.82 26.47 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.743 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 148' ' ' ILE . 1.0 OUTLIER -106.04 113.48 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.183 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.611 ' HB2' HG23 ' A' ' 99' ' ' THR . . . -118.44 131.16 56.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.086 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.839 ' O ' HG12 ' A' ' 98' ' ' VAL . . . 165.49 -158.4 31.25 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.49 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.598 HG22 ' HD2' ' A' ' 152' ' ' PRO . 0.7 OUTLIER -87.76 163.74 37.09 Favored Pre-proline 0 C--N 1.33 -0.272 0 O-C-N 122.858 -0.201 . . . . 0.0 110.637 179.534 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.598 ' HD2' HG22 ' A' ' 151' ' ' ILE . 6.9 Cg_endo -49.59 -36.59 40.92 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.428 2.085 . . . . 0.0 111.77 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.44 ' HB2' HD13 ' A' ' 151' ' ' ILE . 7.8 mm100 -63.54 -34.61 78.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.038 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.801 ' HB3' ' HB2' ' A' ' 129' ' ' ALA . 4.2 m -70.45 -37.14 74.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.591 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.491 ' O ' HG12 ' A' ' 159' ' ' VAL . 36.8 mm -67.53 -51.72 48.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.937 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.9 mm -58.85 -28.24 37.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.056 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -70.6 -57.02 5.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.521 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 6.8 p -61.01 -47.54 86.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.519 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 155' ' ' ILE . 13.4 p -57.01 -36.56 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.809 0.338 . . . . 0.0 111.166 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.413 ' O ' HG12 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -71.48 -33.05 68.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.827 179.914 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.623 ' O ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -72.56 -39.81 67.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.978 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.71 ' CD1' HD21 ' A' ' 112' ' ' LEU . 6.4 tp -74.05 -34.51 38.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.032 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 2.3 t -70.81 -47.35 59.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.071 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.483 HG13 ' N ' ' A' ' 165' ' ' VAL . 12.4 p -61.81 -45.36 98.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.08 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.623 HG22 ' O ' ' A' ' 161' ' ' GLN . 28.5 m -69.27 -42.64 81.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.062 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.473 ' HG2' HD11 ' A' ' 14' ' ' LEU . 4.5 tpp -64.53 -37.43 87.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.958 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.44 -57.5 7.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.92 -2.49 24.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.029 0.442 . . . . 0.0 112.026 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.875 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.763 0.316 . . . . 0.0 111.307 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -113.03 -70.65 0.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.952 0.406 . . . . 0.0 110.649 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.7 t -136.92 150.06 26.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.748 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 2.5 t -103.51 157.7 16.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.871 0.367 . . . . 0.0 111.305 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.44 ' HA ' HD23 ' A' ' 14' ' ' LEU . 4.0 mt -152.33 174.46 13.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.993 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.9 m -142.5 133.62 25.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.776 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.887 HG22 HD11 ' A' ' 68' ' ' ILE . 1.1 tt -136.92 123.58 29.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.161 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.493 ' NH2' ' OE1' ' A' ' 143' ' ' GLU . 2.3 mpp_? -101.24 117.07 34.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.746 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.513 ' O ' HG23 ' A' ' 58' ' ' ILE . 96.0 mt -94.75 128.51 41.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.862 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.503 HD21 ' HB3' ' A' ' 55' ' ' PRO . 6.8 tt -123.05 120.85 34.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.496 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.446 ' HB3' ' HB ' ' A' ' 25' ' ' VAL . 0.8 OUTLIER -147.91 168.65 21.69 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.288 0.566 . . . . 0.0 111.9 -179.46 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.906 ' O ' HG12 ' A' ' 25' ' ' VAL . 29.0 m-70 -74.64 140.95 44.64 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.844 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -45.48 -30.89 3.29 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.962 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.536 ' HG2' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -78.45 -49.5 13.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 117.354 0.577 . . . . 0.0 111.95 -179.077 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.536 ' N ' ' HG2' ' A' ' 23' ' ' LYS . 4.8 mt-10 -65.14 -50.78 64.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.207 0.527 . . . . 0.0 109.999 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.907 HG11 ' CB ' ' A' ' 57' ' ' ARG . 7.3 p -58.72 -34.25 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.572 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.38 -41.9 98.69 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.924 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.1 p -65.88 -27.92 68.57 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.4 mm -81.21 -32.36 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.899 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.77 HD11 HG22 ' A' ' 25' ' ' VAL . 3.0 mm -60.43 -42.75 92.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.342 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.08 150.39 26.8 Favored Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.317 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.401 ' O ' ' CD ' ' A' ' 32' ' ' LYS . 1.3 tppm? -61.71 145.72 51.48 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.723 -0.739 . . . . 0.0 111.34 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.435 ' HG2' ' HB2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 50.79 20.22 0.73 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.442 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 51.24 13.88 1.19 Allowed Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.936 -0.649 . . . . 0.0 113.919 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.435 ' HB2' ' HG2' ' A' ' 32' ' ' LYS . 10.1 tt0 -76.79 -26.09 54.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.213 0.53 . . . . 0.0 109.808 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.13 -42.33 56.55 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.401 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.603 HG13 ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.38 -26.57 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.93 -36.69 67.27 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.54 -34.57 72.41 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.839 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -53.46 57.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.489 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.09 -51.48 69.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.989 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -51.9 -38.43 56.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.947 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -85.95 -27.38 24.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.697 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.938 ' HB2' ' HB2' ' A' ' 71' ' ' ALA . 1.5 p -73.25 -55.26 6.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.809 0.338 . . . . 0.0 111.21 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.36 -5.27 85.36 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.443 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.507 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -110.71 127.4 55.3 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.63 0.253 . . . . 0.0 111.197 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 9.1 tpp180 -28.19 104.3 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.452 ' CG1' ' O ' ' A' ' 45' ' ' ALA . 2.9 mt -114.73 120.37 64.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.688 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -137.01 173.82 11.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.041 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.9 mt -126.51 151.73 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.947 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.5 t -135.73 -175.28 3.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.08 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -81.73 -165.85 1.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.791 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . 166.72 83.24 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.75 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -52.97 -23.02 6.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.105 0.478 . . . . 0.0 110.301 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.489 ' CB ' ' HD3' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -93.48 -64.24 0.14 Allowed Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.549 -179.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.546 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 61.3 Cg_endo -82.82 -34.73 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.576 2.184 . . . . 0.0 112.349 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 52' ' ' GLY . 3.1 mm-40 93.56 -33.13 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.163 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.907 ' CB ' HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -136.29 133.98 37.5 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.035 0.445 . . . . 0.0 111.624 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.513 HG23 ' O ' ' A' ' 18' ' ' LEU . 31.0 mt -140.48 119.09 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.718 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.5 mt -97.01 109.66 23.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.442 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.7 m -87.2 108.7 19.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.033 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -106.67 138.52 42.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.506 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.507 ' O ' ' HB1' ' A' ' 45' ' ' ALA . . . -145.41 132.25 20.11 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.45 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.53 166.38 16.85 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 119.549 -1.31 . . . . 0.0 113.3 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 1.9 Cg_endo -46.09 159.21 0.26 Allowed 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 123.174 2.583 . . . . 0.0 112.472 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.43 ' O ' HG22 ' A' ' 68' ' ' ILE . 13.2 t -55.99 -35.94 67.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.429 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -65.37 -51.88 57.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.093 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.476 ' CB ' ' HB2' ' A' ' 45' ' ' ALA . . . -57.28 -44.54 84.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.041 0.448 . . . . 0.0 110.872 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.887 HD11 HG22 ' A' ' 16' ' ' ILE . 1.2 tt -66.45 -39.39 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.878 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.53 -45.13 77.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.041 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -45.4 68.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.746 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.938 ' HB2' ' HB2' ' A' ' 43' ' ' SER . . . -54.78 -56.16 22.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.323 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.558 ' O ' HG23 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -56.27 -40.09 73.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.998 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.45 -32.26 72.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.185 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.2 mtm -74.27 -46.55 40.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.196 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.451 HG13 ' N ' ' A' ' 76' ' ' ILE . 29.0 pt -61.56 -42.83 95.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.229 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 72' ' ' PHE . 41.0 pt -64.91 -36.45 77.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.82 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.401 ' N ' HG13 ' A' ' 76' ' ' ILE . 0.9 OUTLIER -67.9 -37.7 82.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.321 179.578 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -35.45 77.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.01 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.6 tp -76.34 -28.11 56.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.383 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.9 -35.98 56.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.682 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -72.39 -33.45 67.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.909 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -68.78 -55.3 11.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.237 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -55.53 -39.42 53.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.321 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.51 38.94 1.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.847 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.82 17.12 11.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.236 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.1 m 63.87 80.77 0.22 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.815 0.34 . . . . 0.0 110.777 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 5.4 tpt -58.82 121.25 10.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.946 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.56 33.87 2.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -160.64 178.01 9.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.84 165.99 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.509 ' O ' HG23 ' A' ' 91' ' ' THR . 5.2 t -126.15 93.83 3.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.951 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 62.23 148.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.08 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.65 -38.16 3.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.205 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 62.4 29.33 17.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.96 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.14 71.59 79.28 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.9 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.571 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 50.6 Cg_exo -52.98 -47.27 28.44 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.709 2.273 . . . . 0.0 112.91 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 96' ' ' PRO . 45.7 Cg_endo -69.31 -167.66 0.22 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.095 1.863 . . . . 0.0 112.641 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 150' ' ' GLY . 4.5 m -140.97 119.87 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.464 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.7 HG22 ' HB2' ' A' ' 149' ' ' ALA . 14.9 p -102.81 141.96 34.74 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.957 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.473 HD12 ' CD1' ' A' ' 102' ' ' LEU . 0.2 OUTLIER -139.85 117.75 11.75 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -100.87 112.62 25.09 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.499 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.577 HD12 ' N ' ' A' ' 102' ' ' LEU . 5.6 mp -99.35 162.82 12.82 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.835 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.571 ' O ' HG13 ' A' ' 104' ' ' VAL . 21.4 t -115.76 147.75 18.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.215 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 103' ' ' VAL . 4.3 m -160.38 154.36 19.46 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.046 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.37 167.53 18.39 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.386 2.057 . . . . 0.0 112.238 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.52 -34.58 78.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.479 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.1 t -69.59 -30.35 68.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.134 0.492 . . . . 0.0 109.837 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -71.92 -46.24 58.33 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.79 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.403 ' O ' HD12 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -66.62 -46.65 75.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.756 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -54.84 -51.79 50.73 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.57 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.3 m -70.76 -40.03 72.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.771 0.32 . . . . 0.0 110.757 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.7 mt -55.27 -26.99 43.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.645 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.589 HG22 ' HA2' ' A' ' 117' ' ' GLY . 9.8 mt -84.29 -40.76 15.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.799 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.48 -177.19 49.47 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.497 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.5 mttp -66.36 124.13 21.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.827 0.346 . . . . 0.0 111.056 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 58.47 19.96 43.28 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.766 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.589 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 66.78 11.57 57.91 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.904 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 29.1 p -53.01 -38.55 62.43 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.589 ' HD2' HD11 ' A' ' 123' ' ' ILE . 4.8 tmtt? -67.78 -65.39 0.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.641 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.822 ' HA ' HD12 ' A' ' 123' ' ' ILE . 1.0 OUTLIER -55.87 -34.66 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.728 -179.327 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -62.3 -50.4 71.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.306 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 123' ' ' ILE . 5.8 pt-20 -64.36 -34.39 78.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.303 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.822 HD12 ' HA ' ' A' ' 120' ' ' ILE . 15.7 mt -65.87 -53.97 32.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.226 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.47 -30.31 65.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.036 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -59.04 -45.22 91.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.982 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.2 -39.34 14.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.12 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 36.5 m -49.93 -25.84 3.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.832 0.349 . . . . 0.0 110.16 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.6 -9.25 65.58 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.929 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.678 ' HB1' ' O ' ' A' ' 149' ' ' ALA . . . -108.14 164.25 12.46 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.83 0.348 . . . . 0.0 111.204 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -104.81 133.15 50.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.708 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.897 ' HB ' HD11 ' A' ' 146' ' ' ILE . 6.3 m -99.19 139.07 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.137 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.622 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 0.0 OUTLIER -109.2 158.17 18.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.608 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.8 t -137.66 132.58 44.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.883 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.74 161.14 26.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.11 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -78.66 -156.49 9.56 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.479 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -177.16 66.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.95 0.405 . . . . 0.0 110.915 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -63.77 108.18 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.826 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.7 mp 61.03 166.7 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.852 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.02 76.54 0.85 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.563 2.176 . . . . 0.0 112.227 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -135.41 -45.77 0.69 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.0 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.7 p -64.0 143.17 58.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.963 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.81 -48.68 2.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.698 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.493 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 16.7 mm-40 -99.45 140.39 33.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.689 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -109.97 136.79 48.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.964 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -104.3 125.93 50.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.118 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.897 HD11 ' HB ' ' A' ' 131' ' ' VAL . 0.5 OUTLIER -105.91 139.86 25.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.518 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.531 ' HB ' ' HB2' ' A' ' 132' ' ' GLN . 2.3 m -121.12 115.1 22.45 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.473 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.8 mp -104.39 121.78 56.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.104 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.7 ' HB2' HG22 ' A' ' 99' ' ' THR . . . -118.35 145.93 44.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.021 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.644 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 154.49 -151.62 23.28 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.651 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.506 ' CG2' ' HD2' ' A' ' 152' ' ' PRO . 1.5 mp -82.41 143.85 48.75 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.506 ' HD2' ' CG2' ' A' ' 151' ' ' ILE . 79.5 Cg_exo -48.98 -34.09 28.1 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 121.933 1.756 . . . . 0.0 111.589 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -72.17 -34.64 68.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.645 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 50.7 m -69.81 -39.04 76.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.902 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.47 ' O ' HG23 ' A' ' 159' ' ' VAL . 39.2 mm -66.26 -53.47 36.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.073 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.554 HD11 HD13 ' A' ' 76' ' ' ILE . 32.6 mm -57.51 -29.0 32.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.873 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -72.32 -40.82 67.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.837 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . 0.422 ' O ' HG22 ' A' ' 162' ' ' ILE . 0.5 OUTLIER -65.73 -35.03 79.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.855 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 155' ' ' ILE . 24.7 t -73.99 -37.73 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.169 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -71.55 -34.82 70.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.93 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.78 ' O ' HG23 ' A' ' 165' ' ' VAL . 7.0 mm100 -73.77 -40.65 63.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.958 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.422 HG22 ' O ' ' A' ' 158' ' ' CYS . 14.8 tt -71.43 -34.46 53.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.152 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 1.5 m -68.27 -51.92 39.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.137 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 10.8 p -58.83 -40.13 79.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.273 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 161' ' ' GLN . 50.5 t -70.62 -32.33 49.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.007 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -45.78 90.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.874 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -71.36 -47.32 57.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.89 -2.65 24.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.209 -0.451 . . . . 0.0 112.015 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.166 -0.921 . . . . 0.0 111.385 179.957 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.903 0.382 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -109.94 -71.22 0.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.837 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.65 HG11 HD21 ' A' ' 167' ' ' LEU . 7.7 p -108.7 161.1 7.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.003 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.54 ' N ' HG22 ' A' ' 12' ' ' VAL . 3.1 t -103.57 160.78 14.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.012 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.478 ' HA ' HD23 ' A' ' 14' ' ' LEU . 4.3 mt -150.61 173.75 13.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.163 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.7 m -142.47 113.23 7.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.756 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.805 HG22 HD11 ' A' ' 68' ' ' ILE . 16.7 tt -132.61 129.01 58.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.319 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.75 ' O ' HD23 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -117.98 148.61 42.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.693 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 pp -129.38 146.67 51.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.895 0.379 . . . . 0.0 111.248 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.648 HD23 ' N ' ' A' ' 20' ' ' MET . 7.3 tt -123.05 134.62 54.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.795 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.648 ' N ' HD23 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -138.47 165.81 25.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.983 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.557 ' O ' HG12 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -67.78 166.25 15.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.676 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.2 -36.93 94.1 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.705 -0.76 . . . . 0.0 113.022 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -78.36 -50.08 12.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.901 0.381 . . . . 0.0 111.34 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.95 -44.81 95.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.335 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.796 HG22 HD11 ' A' ' 29' ' ' ILE . 6.4 p -62.97 -35.98 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.794 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.16 -34.87 90.47 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.5 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.6 t -75.52 -30.17 59.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.768 0.318 . . . . 0.0 110.846 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.524 ' CG2' HG23 ' A' ' 75' ' ' ILE . 4.1 mm -81.12 -36.87 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.258 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.796 HD11 HG22 ' A' ' 25' ' ' VAL . 30.5 mt -65.75 -42.48 92.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.337 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.42 ' HA3' ' HB2' ' A' ' 35' ' ' SER . . . 88.58 150.9 22.29 Favored Glycine 0 N--CA 1.434 -1.489 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.122 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.433 ' O ' ' CD ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -51.22 146.61 6.47 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.739 -0.731 . . . . 0.0 111.242 179.599 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.503 ' HE3' ' HB3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 44.43 27.1 0.21 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.119 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 45.37 20.2 0.31 Allowed Glycine 0 CA--C 1.522 0.529 0 C-N-CA 121.353 -0.451 . . . . 0.0 113.967 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.503 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -73.14 -25.3 60.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.327 0.564 . . . . 0.0 110.086 179.263 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.42 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -72.58 -42.75 64.26 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.539 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.663 HG13 ' HA ' ' A' ' 29' ' ' ILE . 0.9 OUTLIER -67.02 -26.62 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -71.03 -36.9 72.54 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.04 -37.09 86.45 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.586 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -59.01 -53.74 54.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.419 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.402 ' HA ' HD12 ' A' ' 47' ' ' ILE . 17.9 mtm-85 -52.86 -51.14 62.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.956 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.6 -37.5 84.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.914 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.52 -35.84 63.16 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.426 ' CB ' ' HB2' ' A' ' 71' ' ' ALA . 0.3 OUTLIER -93.28 -55.74 3.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.978 0.418 . . . . 0.0 111.08 -179.644 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.37 10.03 54.5 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.882 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.483 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -110.77 128.38 55.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.89 0.345 . . . . 0.0 111.221 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -27.49 134.5 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.243 179.439 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.406 HG13 ' HG ' ' A' ' 61' ' ' LEU . 10.4 mt -142.22 100.57 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.705 0.288 . . . . 0.0 110.522 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -112.98 167.43 10.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.886 0.374 . . . . 0.0 111.056 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.541 HG21 ' NE ' ' A' ' 57' ' ' ARG . 3.4 mt -126.52 152.04 33.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.155 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 63.9 m -91.03 -175.05 4.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.218 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -62.43 -168.45 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.16 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.85 -72.84 2.19 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.386 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 44.12 29.37 0.34 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.052 0.453 . . . . 0.0 110.558 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.508 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -151.25 -68.48 0.02 OUTLIER Pre-proline 0 N--CA 1.454 -0.266 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.09 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' A' ' 54' ' ' CYS . 86.5 Cg_endo -77.4 -35.41 1.64 Allowed 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.037 1.825 . . . . 0.0 110.937 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -146.34 161.05 41.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.583 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.791 ' HB2' HG21 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -146.32 127.53 14.78 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.288 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.639 HG12 HD12 ' A' ' 19' ' ' LEU . 17.3 mt -115.0 104.58 17.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.375 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.3 mt -92.92 103.55 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.522 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 91.1 m -83.02 129.1 35.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.459 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.794 HD22 HG13 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -118.21 131.3 56.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.085 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.483 ' O ' ' HB1' ' A' ' 45' ' ' ALA . . . -131.29 130.92 43.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.759 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.2 164.8 14.07 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.961 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 86.9 Cg_exo -40.31 162.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.169 2.58 . . . . 0.0 113.041 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.453 ' O ' HG22 ' A' ' 68' ' ' ILE . 9.6 m -60.17 -35.73 76.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.009 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -69.84 -51.86 29.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.081 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.04 -39.64 75.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.97 0.414 . . . . 0.0 110.85 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.805 HD11 HG22 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -66.23 -39.54 84.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.34 -179.469 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.74 -43.13 89.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.01 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.29 -49.92 75.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.955 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.426 ' HB2' ' CB ' ' A' ' 43' ' ' SER . . . -58.04 -56.47 21.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.27 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.933 ' HA ' HD12 ' A' ' 75' ' ' ILE . 2.6 m-85 -57.39 -34.57 69.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.113 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.27 -42.09 99.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.124 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.06 -36.55 72.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.951 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.933 HD12 ' HA ' ' A' ' 72' ' ' PHE . 14.9 mt -62.77 -49.26 84.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.4 HG13 ' N ' ' A' ' 77' ' ' ASP . 24.5 pt -61.21 -40.51 86.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.027 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.4 ' N ' HG13 ' A' ' 76' ' ' ILE . 1.1 t0 -61.22 -39.87 91.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.685 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.43 -41.67 97.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.29 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.411 HD21 HG11 ' A' ' 98' ' ' VAL . 18.1 tp -74.61 -26.62 60.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.472 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.689 ' HA ' HD12 ' A' ' 83' ' ' ILE . 1.7 mt-10 -76.89 -34.62 57.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.703 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -72.21 -37.38 69.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.729 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -59.33 -33.36 71.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.914 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.689 HD12 ' HA ' ' A' ' 80' ' ' GLU . 12.3 mt -68.36 -41.32 83.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.993 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.6 t -99.69 31.52 3.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.912 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.97 -31.51 11.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.5 p -164.83 141.56 5.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 2.7 ptm -154.14 115.02 4.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.945 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.1 m -71.32 -66.0 0.68 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.003 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -143.01 166.58 24.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.89 -79.05 0.43 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.92 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 47.76 88.62 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.188 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 61.62 -165.31 0.23 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.069 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -157.89 92.02 1.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.032 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.0 p -72.22 -28.23 63.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.132 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.4 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -135.1 64.07 59.68 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.03 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.479 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 33.9 Cg_exo -58.56 -46.33 24.71 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.55 2.167 . . . . 0.0 112.884 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 96' ' ' PRO . 84.6 Cg_endo -79.12 -163.81 0.24 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.371 2.047 . . . . 0.0 112.839 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.411 HG11 HD21 ' A' ' 79' ' ' LEU . 21.2 t -140.77 122.12 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.987 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.855 HG22 ' CB ' ' A' ' 149' ' ' ALA . 5.0 p -102.62 141.13 35.95 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.461 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 147' ' ' THR . 4.6 mp -139.84 158.58 43.85 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.139 -1.801 . . . . 0.0 106.139 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.584 ' HG2' ' HB1' ' A' ' 145' ' ' ALA . 8.3 ttp-105 -122.84 113.33 19.0 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.912 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.75 HD23 ' O ' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -101.09 144.6 29.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.933 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.5 t -104.43 139.08 26.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.061 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.3 m -149.06 157.22 40.17 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.04 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.24 166.56 20.84 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.421 2.081 . . . . 0.0 112.324 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.68 -34.57 75.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.384 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 p -68.97 -30.28 68.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.978 0.418 . . . . 0.0 109.926 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -50.6 52.71 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.793 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.474 ' O ' HD12 ' A' ' 113' ' ' ILE . 30.9 p -70.67 -38.21 73.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.677 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -54.7 -50.45 57.67 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.475 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.2 p -77.43 -47.45 19.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.671 0.272 . . . . 0.0 111.011 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.872 ' CD2' HD12 ' A' ' 162' ' ' ILE . 29.0 mt -52.66 -26.46 13.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.925 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.487 HG22 ' HA2' ' A' ' 117' ' ' GLY . 41.0 mt -92.33 -37.37 8.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.943 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.93 179.47 32.83 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.423 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -67.39 124.18 22.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.873 0.368 . . . . 0.0 111.008 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.0 19.1 63.14 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.816 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.487 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 64.41 13.26 54.25 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.887 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -52.9 -50.6 63.57 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 120.775 0.322 . . . . 0.0 111.728 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.734 ' HD2' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -57.1 -60.83 3.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.178 -179.763 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.645 HD13 ' O ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -56.1 -26.92 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.456 -179.766 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.6 tptp -65.06 -47.0 78.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.796 0.332 . . . . 0.0 110.892 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -73.13 -45.8 54.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.136 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.734 HD11 ' HD2' ' A' ' 119' ' ' LYS . 50.6 mt -62.17 -50.89 78.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.998 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -63.78 -40.55 96.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.151 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -54.99 -57.38 11.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.818 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.3 m -75.83 -43.68 44.77 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.422 HG21 ' HB3' ' A' ' 158' ' ' CYS . 25.0 m -47.95 -25.94 1.55 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.866 0.365 . . . . 0.0 110.432 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.24 -7.05 58.24 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.049 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -105.66 137.11 44.06 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.951 0.375 . . . . 0.0 110.953 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.41 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 0.0 OUTLIER -95.58 144.59 25.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.209 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.465 ' CG2' HD11 ' A' ' 120' ' ' ILE . 4.8 m -99.31 147.17 7.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.045 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 7.0 tp60 -140.22 117.77 11.52 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.555 HG23 ' CG ' ' A' ' 144' ' ' ARG . 11.6 p -96.59 116.47 38.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.051 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.22 135.01 35.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.795 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 49.78 -178.69 0.02 OUTLIER Glycine 0 CA--C 1.518 0.228 0 CA-C-N 115.968 -0.56 . . . . 0.0 113.387 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.3 p30 174.37 41.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.926 0.393 . . . . 0.0 110.484 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 19.6 mtp -56.09 166.87 0.7 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.127 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.52 164.59 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.837 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -50.78 -25.21 14.84 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.483 2.122 . . . . 0.0 112.189 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 177.29 104.72 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.639 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 88.3 p -57.77 -174.09 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.997 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 25.7 m -106.42 -64.56 1.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.359 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.494 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 10.5 mm-40 -93.92 135.73 34.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.171 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.555 ' CG ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -121.75 166.41 14.35 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.241 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.584 ' HB1' ' HG2' ' A' ' 101' ' ' ARG . . . -130.2 115.75 17.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.791 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 30.5 mt -100.77 129.24 51.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.696 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.457 ' HB ' ' CB ' ' A' ' 132' ' ' GLN . 2.6 m -97.67 123.06 41.43 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.519 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.795 ' O ' HD12 ' A' ' 148' ' ' ILE . 2.1 pp -106.72 117.97 53.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.935 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.855 ' CB ' HG22 ' A' ' 99' ' ' THR . . . -118.34 126.43 52.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.121 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 171.28 -153.28 20.08 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.592 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.518 HG22 ' HD2' ' A' ' 152' ' ' PRO . 1.3 mp -87.32 143.59 34.65 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 110.624 -0.139 . . . . 0.0 110.624 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.518 ' HD2' HG22 ' A' ' 151' ' ' ILE . 71.3 Cg_exo -49.33 -31.03 21.62 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 121.966 1.777 . . . . 0.0 111.447 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.13 -34.65 68.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.674 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 22.2 t -68.79 -50.08 53.3 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.795 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.612 HD13 ' C ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -58.39 -45.07 89.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.451 HD12 ' O ' ' A' ' 152' ' ' PRO . 27.9 mt -63.88 -29.98 48.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.845 0.355 . . . . 0.0 110.842 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -73.65 -43.02 60.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.238 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . 0.422 ' HB3' HG21 ' A' ' 127' ' ' THR . 21.4 p -72.42 -42.87 64.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.277 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.423 HG12 ' HA ' ' A' ' 156' ' ' ILE . 13.3 p -60.83 -37.9 77.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.927 0.394 . . . . 0.0 111.01 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.97 -32.91 69.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.756 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.874 ' O ' HG23 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -67.86 -49.56 61.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.0 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.872 HD12 ' CD2' ' A' ' 112' ' ' LEU . 37.7 mm -66.41 -34.48 70.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.015 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 1.7 m -64.58 -48.1 76.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.978 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 161' ' ' GLN . 11.1 p -65.48 -33.53 64.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.187 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 161' ' ' GLN . 50.8 t -70.64 -45.14 75.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.878 0.371 . . . . 0.0 110.972 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 27.2 mtm -58.98 -33.57 70.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.847 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.65 HD21 HG11 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -72.56 -48.22 41.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.818 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.02 -2.55 24.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.93 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 41.2 p . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.876 -179.979 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 120.762 0.315 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 -104.54 -77.88 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.854 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.44 151.68 16.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.986 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 0.9 OUTLIER -103.66 142.75 33.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.039 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.494 ' HA ' HD23 ' A' ' 14' ' ' LEU . 4.2 mt -137.11 175.23 9.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.991 0.424 . . . . 0.0 111.211 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.7 m -142.4 135.97 29.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.841 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.558 HG22 HD11 ' A' ' 68' ' ' ILE . 14.1 tt -140.87 154.67 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.164 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.496 ' NH2' ' OE1' ' A' ' 143' ' ' GLU . 25.0 mtp180 -134.79 127.63 31.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.867 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.474 HD11 ' CZ ' ' A' ' 72' ' ' PHE . 52.5 mt -113.96 147.58 38.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.595 HD21 ' HB3' ' A' ' 55' ' ' PRO . 6.8 tt -102.35 106.04 16.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.762 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.2 144.14 40.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.044 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.547 ' O ' HG12 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -76.61 167.82 21.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.752 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.424 ' C ' HG12 ' A' ' 25' ' ' VAL . . . -59.8 -34.66 83.49 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.769 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.86 -52.02 8.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 0.0 111.354 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -34.12 76.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.849 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.685 ' O ' HG12 ' A' ' 29' ' ' ILE . 7.4 p -71.03 -38.97 74.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.664 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.08 -35.08 90.95 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.683 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.26 -34.96 61.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.594 0.235 . . . . 0.0 111.07 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.638 HD12 ' N ' ' A' ' 29' ' ' ILE . 2.9 pp -80.15 -32.53 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.355 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.768 ' HA ' HG13 ' A' ' 36' ' ' VAL . 12.4 mm -65.06 -58.87 5.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.7 150.54 25.29 Favored Glycine 0 N--CA 1.436 -1.354 0 CA-C-O 121.635 0.575 . . . . 0.0 112.664 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.443 ' O ' ' CD ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -61.52 146.34 48.98 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.501 -0.85 . . . . 0.0 111.441 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.454 ' HG2' ' H ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER 52.56 18.89 1.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.277 179.482 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.412 ' O ' HG23 ' A' ' 36' ' ' VAL . . . 51.7 13.79 1.5 Allowed Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.956 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.454 ' H ' ' HG2' ' A' ' 32' ' ' LYS . 5.4 tp10 -76.88 -26.27 54.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.322 0.561 . . . . 0.0 109.748 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.445 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -75.19 -40.95 58.93 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.246 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.768 HG13 ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.3 -26.51 36.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.243 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.57 -36.61 81.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 177.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 35' ' ' SER . 22.2 ttmm -60.36 -40.9 92.43 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.778 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.502 ' HE2' HG21 ' A' ' 47' ' ' ILE . 3.0 ttp -59.2 -48.46 81.55 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.38 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.2 ttp85 -55.3 -50.63 69.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.101 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -64.64 -38.51 91.25 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 39' ' ' MET . 3.1 pp20? -75.03 -35.88 61.92 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.742 ' HB3' ' HB2' ' A' ' 71' ' ' ALA . 37.0 p -91.04 -55.4 3.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.911 0.386 . . . . 0.0 111.105 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.12 5.86 65.45 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.248 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.832 ' HB3' HD11 ' A' ' 61' ' ' LEU . . . -110.65 128.43 55.69 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.44 0.162 . . . . 0.0 110.799 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.572 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -27.61 136.91 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.001 0.521 . . . . 0.0 112.057 178.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.502 HG21 ' HE2' ' A' ' 39' ' ' MET . 20.6 mt -142.19 100.68 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.73 0.3 . . . . 0.0 110.578 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -121.41 121.57 37.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.919 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -107.53 127.61 63.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.374 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.404 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER 178.92 -174.04 0.18 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 61.44 173.25 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.044 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.47 ' HA2' HD11 ' A' ' 58' ' ' ILE . . . 149.76 -76.94 0.24 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.942 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.4 m120 53.97 24.61 4.76 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.476 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -164.41 -65.16 0.01 OUTLIER Pre-proline 0 N--CA 1.453 -0.295 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.562 -179.494 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.595 ' HB3' HD21 ' A' ' 19' ' ' LEU . 78.0 Cg_endo -79.58 -33.21 1.35 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.395 2.063 . . . . 0.0 111.254 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.553 ' CB ' ' O ' ' A' ' 55' ' ' PRO . 1.8 mt-10 113.14 -35.42 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.739 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.616 ' CD ' HG11 ' A' ' 25' ' ' VAL . 2.0 mpt_? -145.82 155.89 43.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.006 0.431 . . . . 0.0 111.525 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.47 HD11 ' HA2' ' A' ' 52' ' ' GLY . 19.7 mt -140.64 118.7 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.339 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 mt -85.94 117.93 31.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.985 0.422 . . . . 0.0 111.622 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.9 m -108.57 101.75 10.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.467 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.832 HD11 ' HB3' ' A' ' 45' ' ' ALA . 15.9 tp -104.41 124.29 48.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.812 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.508 ' HB3' ' HB2' ' A' ' 46' ' ' ARG . . . -126.78 131.71 51.22 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.495 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.39 166.19 16.43 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 119.686 -1.245 . . . . 0.0 113.297 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 2.9 Cg_endo -41.85 159.48 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 123.396 2.731 . . . . 0.0 112.669 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.466 ' O ' HG22 ' A' ' 68' ' ' ILE . 57.0 m -60.11 -35.97 76.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.48 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -68.72 -52.07 34.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.239 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.07 -38.04 72.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.071 0.462 . . . . 0.0 110.882 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.558 HD11 HG22 ' A' ' 16' ' ' ILE . 0.5 OUTLIER -65.18 -39.34 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.275 -179.376 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.44 -45.09 92.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.886 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.2 -53.41 58.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.614 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.742 ' HB2' ' HB3' ' A' ' 43' ' ' SER . . . -60.72 -43.74 97.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.177 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.474 ' CZ ' HD11 ' A' ' 18' ' ' LEU . 0.7 OUTLIER -62.02 -35.51 78.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.078 -179.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.87 -38.78 83.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.262 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.36 -39.21 54.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.984 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 88.6 mt -62.06 -50.58 79.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.661 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.499 HD12 ' N ' ' A' ' 77' ' ' ASP . 2.3 pp -63.87 -40.69 89.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.969 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.499 ' N ' HD12 ' A' ' 76' ' ' ILE . 3.0 m-20 -69.65 -29.69 67.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.455 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -35.64 81.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.076 0.465 . . . . 0.0 109.91 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.9 tp -77.39 -30.52 53.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.386 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.94 -34.05 57.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.776 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.408 ' HA ' ' HB2' ' A' ' 85' ' ' SER . 0.0 OUTLIER -72.54 -37.84 68.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.032 179.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -71.71 -51.17 24.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.446 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.7 pp -53.79 -42.97 54.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.55 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.48 112.29 1.94 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.935 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.408 ' HB2' ' HA ' ' A' ' 81' ' ' GLU . 0.3 OUTLIER 179.12 -51.17 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.819 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.07 30.19 3.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.955 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 1.3 mtt -126.91 -43.17 1.7 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.901 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.404 ' O ' HG22 ' A' ' 91' ' ' THR . 0.9 OUTLIER -83.2 -22.74 33.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.063 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 70.0 -65.8 0.3 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.955 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.94 56.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.838 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 88' ' ' THR . 9.0 t -138.24 36.71 2.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.937 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -158.35 154.4 26.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.038 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -171.4 36.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.192 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.3 m -119.84 -48.43 2.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.911 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.1 ttp180 63.9 119.49 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.879 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -74.31 170.48 20.1 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.423 2.082 . . . . 0.0 112.339 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.71 -166.71 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.597 2.198 . . . . 0.0 112.078 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.422 HG21 ' HG3' ' A' ' 152' ' ' PRO . 21.3 t -125.17 103.32 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.903 0.383 . . . . 0.0 111.418 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.0 t -107.53 127.0 53.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.383 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 mt -140.03 117.76 11.63 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -103.18 112.39 25.23 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.788 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.64 149.77 26.89 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.403 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.24 145.08 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.652 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.653 HG23 HD13 ' A' ' 146' ' ' ILE . 40.1 t -142.88 144.75 30.66 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.225 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.446 ' HD2' ' CG1' ' A' ' 104' ' ' VAL . 22.2 Cg_exo -65.36 165.51 22.16 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.507 2.138 . . . . 0.0 112.154 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' A' ' 142' ' ' THR . . . -69.04 -44.22 73.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.135 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.5 m -66.7 -30.48 70.72 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.419 ' HB3' ' CG1' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -74.61 -41.42 60.46 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.434 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 55.6 m -66.28 -40.9 90.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.102 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.57 -50.71 64.79 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.161 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.3 t -70.4 -36.2 73.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.783 0.325 . . . . 0.0 110.615 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.52 HD21 HG23 ' A' ' 162' ' ' ILE . 10.7 mt -58.49 -28.32 65.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.272 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.585 HG22 ' HA2' ' A' ' 117' ' ' GLY . 10.9 mt -81.71 -40.29 17.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.717 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.1 -176.83 53.81 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.521 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -66.47 118.15 9.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.896 0.379 . . . . 0.0 111.185 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.99 15.38 56.0 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.015 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.585 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 73.06 5.08 64.6 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.006 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 1.5 m -53.13 -39.65 63.64 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 120.727 0.299 . . . . 0.0 111.719 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -64.87 -65.33 0.69 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.438 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.405 ' HB ' ' HA ' ' A' ' 113' ' ' ILE . 0.5 OUTLIER -54.4 -35.51 31.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.393 -179.674 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.5 tptm -59.26 -44.18 92.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.08 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -73.24 -40.21 64.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.329 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 88.2 mt -54.97 -53.9 29.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.216 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -31.95 69.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.892 0.377 . . . . 0.0 110.938 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -49.74 72.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.31 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.2 m -90.08 -36.94 14.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.546 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.6 m -49.89 -26.05 3.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.848 0.356 . . . . 0.0 110.364 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.3 -12.04 52.59 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.093 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -103.8 155.24 18.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.844 0.354 . . . . 0.0 111.038 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.31 127.94 53.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.054 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 147' ' ' THR . 14.4 m -99.2 138.64 23.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.861 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.69 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 5.4 tm0? -123.38 116.59 23.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.167 0.508 . . . . 0.0 112.032 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.484 HG12 HG13 ' A' ' 146' ' ' ILE . 30.8 m -103.46 130.97 52.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.363 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.2 160.71 30.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.929 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.97 173.27 35.36 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.6 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -150.47 -46.6 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.865 0.364 . . . . 0.0 110.76 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 2.4 tpt 62.65 92.49 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.081 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.8 mp 58.81 163.34 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.964 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -55.93 91.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.57 2.18 . . . . 0.0 112.249 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -134.02 -68.05 0.57 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.887 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 79.0 p -62.76 166.19 5.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.882 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.419 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.2 OUTLIER -112.01 -47.32 3.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.496 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 29.5 mt-10 -121.98 139.88 53.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.825 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.04 173.07 6.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -122.54 126.33 47.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.232 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.69 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 3.4 mp -105.48 125.0 60.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.618 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 131' ' ' VAL . 2.1 m -99.59 114.69 27.87 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.678 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.923 HD12 HG12 ' A' ' 155' ' ' ILE . 4.6 pt -106.9 114.72 46.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.411 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -119.38 132.33 55.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.768 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 167.06 -151.61 19.67 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.815 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.532 ' CG2' ' HD2' ' A' ' 152' ' ' PRO . 15.9 mt -84.85 144.46 42.02 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.532 ' HD2' ' CG2' ' A' ' 151' ' ' ILE . 73.5 Cg_exo -48.89 -33.77 26.57 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 121.988 1.792 . . . . 0.0 111.689 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -72.05 -34.75 69.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.845 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.3 m -67.97 -50.46 55.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.992 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.923 HG12 HD12 ' A' ' 148' ' ' ILE . 0.0 OUTLIER -59.26 -47.45 90.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.134 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.472 ' N ' HG23 ' A' ' 155' ' ' ILE . 33.6 mt -60.69 -45.9 96.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.819 0.342 . . . . 0.0 110.759 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -60.46 -35.17 75.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.663 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 9.0 t -67.03 -42.99 83.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.774 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 155' ' ' ILE . 21.6 t -59.03 -37.96 71.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.022 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.97 -33.01 73.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.777 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.893 ' O ' HG23 ' A' ' 165' ' ' VAL . 26.1 tp60 -71.47 -46.23 60.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.827 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.631 HG22 ' SD ' ' A' ' 166' ' ' MET . 50.3 mt -67.25 -34.51 69.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.979 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 1.6 m -63.93 -52.37 60.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.017 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 161' ' ' GLN . 10.7 p -59.56 -33.3 51.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.172 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 161' ' ' GLN . 44.0 t -70.69 -44.03 76.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.849 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.631 ' SD ' HG22 ' A' ' 162' ' ' ILE . 0.0 OUTLIER -59.85 -33.09 71.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.855 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.59 -50.56 35.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.76 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -73.97 -2.56 24.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.069 0.461 . . . . 0.0 111.948 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 169' ' ' THR . 60.2 m . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.864 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.4 tttm . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.839 0.352 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -55.07 -84.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.15 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.613 HG11 ' CD1' ' A' ' 167' ' ' LEU . 7.5 p -114.27 159.18 14.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.115 0.483 . . . . 0.0 111.373 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.522 ' N ' HG22 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -109.52 154.05 23.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.787 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' A' ' 14' ' ' LEU . 1.1 mt -144.36 169.28 18.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.054 0.454 . . . . 0.0 111.229 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.2 m -142.72 132.13 23.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.673 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.808 HG22 HD11 ' A' ' 68' ' ' ILE . 2.4 tt -140.83 140.05 33.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.948 0.404 . . . . 0.0 111.326 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.712 ' HG3' HG23 ' A' ' 60' ' ' THR . 1.1 mpp_? -124.48 120.32 31.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.686 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.572 HD21 ' CZ ' ' A' ' 72' ' ' PHE . 14.1 mt -99.8 119.63 38.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.118 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.567 ' C ' HD23 ' A' ' 19' ' ' LEU . 8.3 tt -102.71 105.43 15.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.702 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.6 tpp -120.21 161.48 20.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.902 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.618 ' O ' HG12 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -67.7 172.57 5.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.452 179.807 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.08 -40.79 99.39 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.913 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.93 -45.27 24.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.771 0.32 . . . . 0.0 111.547 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.13 -48.39 78.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.944 0.402 . . . . 0.0 110.283 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.755 HG22 HD11 ' A' ' 29' ' ' ILE . 9.8 p -61.66 -35.2 65.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.852 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.94 -34.92 90.46 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.187 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 m -75.24 -26.76 59.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.879 0.371 . . . . 0.0 110.723 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.456 HG23 HG23 ' A' ' 75' ' ' ILE . 3.9 mm -79.11 -51.48 16.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.123 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.755 HD11 HG22 ' A' ' 25' ' ' VAL . 8.7 mt -57.31 -42.27 79.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.514 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.03 150.84 27.3 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.137 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.416 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -51.59 146.05 8.16 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.058 -0.571 . . . . 0.0 111.143 179.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.454 ' HE3' ' HB3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 43.36 27.07 0.12 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.834 -179.65 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.45 ' O ' HG12 ' A' ' 36' ' ' VAL . . . 45.17 21.75 0.43 Allowed Glycine 0 CA--C 1.52 0.4 0 C-N-CA 121.273 -0.489 . . . . 0.0 113.852 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.454 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -76.23 -28.84 57.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.209 0.504 . . . . 0.0 110.314 179.574 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.1 t -73.71 -41.75 62.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.488 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 33' ' ' GLY . 2.3 p -67.42 -27.34 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.2 -36.67 79.91 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 176.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.414 ' HA ' ' CG ' ' A' ' 41' ' ' GLU . 1.8 tttm -70.91 -31.8 68.53 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.241 177.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.409 ' HB2' ' HA ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -63.21 -51.04 67.89 Favored 'General case' 0 C--O 1.228 -0.047 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.463 179.52 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.0 ttt-85 -58.38 -51.57 69.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.581 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.414 ' CG ' ' HA ' ' A' ' 38' ' ' LYS . 1.4 pp20? -64.33 -37.94 89.27 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -74.69 -36.75 62.76 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.853 ' CB ' ' HB2' ' A' ' 71' ' ' ALA . 83.1 p -81.37 -55.65 4.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.906 0.384 . . . . 0.0 111.018 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.93 1.12 56.15 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.736 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -110.66 128.17 55.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.842 0.321 . . . . 0.0 111.304 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.566 ' HB3' ' HB3' ' A' ' 62' ' ' ALA . 8.3 ttm180 -27.27 140.6 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.257 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 60' ' ' THR . 12.0 mt -142.52 101.1 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.696 0.284 . . . . 0.0 110.817 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -118.38 128.77 54.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.781 0.324 . . . . 0.0 111.248 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.61 HG21 ' HD3' ' A' ' 57' ' ' ARG . 9.6 mm -92.11 151.86 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.97 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.7 m -87.16 -177.06 5.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.915 0.388 . . . . 0.0 111.268 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.15 -166.01 0.28 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.111 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.62 -76.94 1.38 Allowed Glycine 0 CA--C 1.51 -0.231 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.296 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 48.67 27.6 1.56 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.982 0.42 . . . . 0.0 110.348 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.507 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -149.96 -68.37 0.02 OUTLIER Pre-proline 0 N--CA 1.454 -0.241 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.378 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.507 ' HD3' ' HB3' ' A' ' 54' ' ' CYS . 92.0 Cg_endo -73.22 -32.35 8.46 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.838 1.692 . . . . 0.0 110.323 178.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.34 170.29 2.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.855 -178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.741 ' HB2' HG21 ' A' ' 25' ' ' VAL . 1.5 mtt180 -145.79 139.3 26.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.825 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.419 ' CD1' HD12 ' A' ' 19' ' ' LEU . 6.8 mm -105.62 109.71 28.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.024 0.44 . . . . 0.0 110.892 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.672 HD11 HG23 ' A' ' 25' ' ' VAL . 3.8 mt -86.49 92.83 3.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.094 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.712 HG23 ' HG3' ' A' ' 17' ' ' ARG . 8.0 m -81.1 134.08 35.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.985 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -131.39 134.65 46.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.285 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.566 ' HB3' ' HB3' ' A' ' 46' ' ' ARG . . . -135.47 130.52 34.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.66 0.267 . . . . 0.0 110.862 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.407 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.22 164.61 13.87 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.919 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.475 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 83.6 Cg_exo -39.93 158.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 123.21 2.607 . . . . 0.0 113.238 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.46 ' O ' HG22 ' A' ' 68' ' ' ILE . 29.9 m -60.04 -35.69 75.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.87 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -63.48 -51.83 63.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.262 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.21 -40.7 77.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.057 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.808 HD11 HG22 ' A' ' 16' ' ' ILE . 0.5 OUTLIER -66.19 -39.37 84.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.18 -179.44 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.38 -48.92 79.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.227 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.73 -48.8 79.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.977 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.853 ' HB2' ' CB ' ' A' ' 43' ' ' SER . . . -57.41 -58.75 6.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.286 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.838 ' HA ' HD12 ' A' ' 75' ' ' ILE . 2.7 m-85 -51.84 -39.24 58.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.305 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.61 -43.93 93.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.109 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.0 ttp -72.21 -34.82 68.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.838 HD12 ' HA ' ' A' ' 72' ' ' PHE . 20.9 mt -64.29 -48.7 84.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.965 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.3 pt -62.65 -39.35 84.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.93 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.19 -36.52 82.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.718 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -42.27 93.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.335 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.5 tp -77.34 -24.94 50.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.624 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -76.86 -39.96 49.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.779 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.1 -34.01 68.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.834 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.77 -55.23 35.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.917 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.575 HD12 ' H ' ' A' ' 85' ' ' SER . 0.8 OUTLIER -66.08 -39.87 85.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.222 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.5 t 54.39 24.14 4.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.268 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.575 ' H ' HD12 ' A' ' 83' ' ' ILE . 0.2 OUTLIER 57.94 46.64 16.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.97 0.414 . . . . 0.0 110.873 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.8 m 63.66 93.68 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.651 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -54.58 -26.84 34.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.207 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.459 HG23 ' H ' ' A' ' 89' ' ' ASN . 1.3 t -135.83 -55.19 0.77 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.13 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.459 ' H ' HG23 ' A' ' 88' ' ' THR . 0.6 OUTLIER 177.76 174.35 0.52 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.94 0.4 . . . . 0.0 110.87 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.0 149.29 51.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.864 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.7 p -100.49 39.1 1.4 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.891 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -96.09 -69.0 0.77 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.093 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -165.38 -58.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.165 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.1 m -160.52 -70.78 0.07 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.959 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.8 139.54 20.25 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.403 ' HA ' ' HD2' ' A' ' 97' ' ' PRO . 77.2 Cg_endo -77.38 114.02 3.66 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.514 2.143 . . . . 0.0 112.399 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 96' ' ' PRO . 43.2 Cg_endo -67.91 164.37 31.96 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.419 2.08 . . . . 0.0 112.114 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.497 HG21 ' HD3' ' A' ' 152' ' ' PRO . 19.3 t -134.81 107.04 7.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.197 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.1 p -104.0 135.53 45.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.785 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.585 ' O ' HG22 ' A' ' 148' ' ' ILE . 0.5 OUTLIER -139.98 117.59 11.53 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 178.812 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.485 ' HE ' HD22 ' A' ' 19' ' ' LEU . 18.9 ttp180 -105.2 112.56 25.73 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.291 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.3 mt -99.37 129.97 45.61 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.049 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.893 HG12 ' HB2' ' A' ' 145' ' ' ALA . 21.3 m -103.85 143.99 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.058 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 103' ' ' VAL . 12.7 m -157.94 166.2 17.04 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.09 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.402 ' CD ' ' HB ' ' A' ' 104' ' ' VAL . 21.8 Cg_exo -65.97 171.32 10.17 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.609 2.206 . . . . 0.0 112.356 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 142' ' ' THR . . . -63.58 -34.6 78.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.623 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.3 m -67.34 -30.52 70.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.11 0.481 . . . . 0.0 109.874 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.402 ' CB ' ' HB ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -69.41 -50.53 45.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.772 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.18 -41.52 99.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.646 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -56.55 -47.47 83.8 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.375 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.0 t -71.99 -40.5 68.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.795 0.331 . . . . 0.0 110.815 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.876 HD21 HG23 ' A' ' 162' ' ' ILE . 12.6 mt -54.36 -26.82 32.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.978 0.418 . . . . 0.0 110.598 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.641 HG22 ' HA2' ' A' ' 117' ' ' GLY . 8.2 mt -84.86 -43.18 17.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.791 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.98 -176.74 54.58 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.569 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -67.29 116.89 8.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.896 0.379 . . . . 0.0 111.079 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.57 11.82 57.7 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.999 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.641 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 75.64 2.58 69.88 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.995 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -52.83 -36.79 59.14 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 120.701 0.286 . . . . 0.0 111.609 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.9 mmtp -63.87 -65.27 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.192 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.39 -31.05 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.373 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.98 -46.55 88.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.038 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -73.21 -46.25 51.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.307 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.55 HG23 ' HG2' ' A' ' 161' ' ' GLN . 40.4 mm -54.84 -53.68 30.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.204 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -63.74 -39.92 95.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.26 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.33 -53.93 47.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.33 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.8 m -76.99 -33.47 57.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.294 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.441 HG22 ' H ' ' A' ' 129' ' ' ALA . 17.8 m -52.34 -26.61 12.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.974 0.416 . . . . 0.0 110.125 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.84 -22.09 5.14 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.247 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.643 ' HB3' HD11 ' A' ' 148' ' ' ILE . . . -96.44 165.4 12.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.919 0.36 . . . . 0.0 111.073 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 11.2 mm100 -105.16 138.01 42.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.694 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 27.6 m -99.11 145.07 10.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.16 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.708 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 0.7 OUTLIER -119.57 158.43 26.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.767 -179.685 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 133' ' ' VAL . 11.5 p -120.74 122.13 67.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.792 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -73.33 148.83 43.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.382 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -72.28 97.65 0.77 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.421 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -150.17 -45.15 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.873 0.368 . . . . 0.0 110.79 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 6.3 ttm 61.12 160.32 0.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.487 ' N ' ' CD ' ' A' ' 139' ' ' PRO . 0.3 OUTLIER -80.26 -46.14 1.38 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.172 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 138' ' ' LEU . 49.3 Cg_exo -55.8 -27.88 64.4 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.413 2.076 . . . . 0.0 112.26 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.85 -77.86 0.49 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.858 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.5 t -83.02 -168.69 2.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.834 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.568 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 15.7 m -123.35 -48.56 1.95 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.497 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 7.9 mt-10 -98.67 136.87 38.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.812 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 11.1 mtm-85 -115.6 155.3 27.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.93 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.893 ' HB2' HG12 ' A' ' 103' ' ' VAL . . . -122.43 135.98 54.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.988 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.708 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 21.9 mt -108.91 143.79 18.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.73 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' A' ' 132' ' ' GLN . 0.2 OUTLIER -113.62 116.84 30.12 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.178 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.674 HD13 ' SG ' ' A' ' 158' ' ' CYS . 1.0 OUTLIER -103.78 124.5 58.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.143 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.613 ' O ' ' HB1' ' A' ' 129' ' ' ALA . . . -118.46 146.32 44.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.171 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 149.52 -153.22 25.01 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.255 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.745 HD12 ' HB2' ' A' ' 153' ' ' GLN . 1.3 pt -87.12 156.39 54.64 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.642 0.258 . . . . 0.0 110.863 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.497 ' HD3' HG21 ' A' ' 98' ' ' VAL . 7.4 Cg_endo -49.53 -34.65 34.49 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.621 2.214 . . . . 0.0 111.907 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.745 ' HB2' HD12 ' A' ' 151' ' ' ILE . 0.3 OUTLIER -71.98 -34.66 69.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.391 179.457 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.574 ' HB3' ' HB2' ' A' ' 129' ' ' ALA . 18.6 m -70.37 -39.14 74.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.946 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.533 HD12 HG23 ' A' ' 148' ' ' ILE . 22.7 mm -72.64 -48.59 45.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.214 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.491 HG23 ' N ' ' A' ' 157' ' ' GLU . 20.2 tt -58.21 -45.15 88.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.141 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.491 ' N ' HG23 ' A' ' 156' ' ' ILE . 10.7 pt-20 -62.73 -36.67 83.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.707 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . 0.674 ' SG ' HD13 ' A' ' 148' ' ' ILE . 3.9 t -58.22 -47.22 84.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.642 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 30.3 t -61.2 -42.09 92.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.979 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.415 ' O ' HG12 ' A' ' 164' ' ' VAL . 0.2 OUTLIER -60.05 -35.59 75.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.78 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.561 ' O ' HG22 ' A' ' 165' ' ' VAL . 1.1 mp0 -67.24 -37.1 82.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.776 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.876 HG23 HD21 ' A' ' 112' ' ' LEU . 41.3 mt -74.02 -34.38 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.15 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 77.1 m -73.91 -45.15 52.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.076 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.489 HG13 ' N ' ' A' ' 165' ' ' VAL . 11.6 p -62.36 -45.36 98.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.062 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.621 ' O ' HG23 ' A' ' 169' ' ' THR . 28.0 m -65.85 -45.6 90.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.058 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.49 ' N ' HG23 ' A' ' 165' ' ' VAL . 50.8 mtp -57.6 -42.71 83.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.841 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.613 ' CD1' HG11 ' A' ' 12' ' ' VAL . 7.9 tt -72.55 -41.76 65.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.819 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.91 -2.67 24.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.977 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 165' ' ' VAL . 52.6 p . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.838 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.807 0.337 . . . . 0.0 111.182 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -134.44 76.66 1.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.921 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.495 HG11 HD11 ' A' ' 167' ' ' LEU . 21.6 t -145.39 158.35 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.144 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.706 ' O ' HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -109.14 129.49 55.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.506 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.706 HD22 ' O ' ' A' ' 13' ' ' THR . 4.3 mm? -128.84 153.4 47.48 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.175 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 61' ' ' LEU . 25.5 m -135.91 112.76 10.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.502 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.904 HG22 HD11 ' A' ' 68' ' ' ILE . 1.6 tt -111.48 142.97 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.453 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.496 ' NH2' ' OE1' ' A' ' 143' ' ' GLU . 1.1 mpp_? -132.08 126.14 33.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.657 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.452 ' O ' HD12 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -125.13 132.0 53.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.247 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.738 HD21 ' HB2' ' A' ' 56' ' ' GLU . 7.0 tt -102.23 136.32 42.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.632 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.636 ' N ' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -129.99 155.39 46.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.892 0.377 . . . . 0.0 111.135 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.649 ' O ' HG12 ' A' ' 25' ' ' VAL . 11.6 m170 -67.75 175.18 3.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.641 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.01 -41.96 96.69 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.91 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.66 -42.83 27.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.742 0.305 . . . . 0.0 111.677 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.56 -40.99 98.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.986 0.422 . . . . 0.0 110.537 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.724 HG22 HG13 ' A' ' 29' ' ' ILE . 8.6 p -70.89 -32.44 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.657 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.42 -39.86 98.33 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.371 -0.919 . . . . 0.0 112.822 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.5 p -76.06 -35.49 59.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 25' ' ' VAL . 2.1 pp -79.83 -32.61 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.724 HG13 HG22 ' A' ' 25' ' ' VAL . 9.8 mm -71.92 -54.58 16.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.916 0.388 . . . . 0.0 110.427 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.411 ' HA3' ' CB ' ' A' ' 35' ' ' SER . . . 99.65 150.64 25.45 Favored Glycine 0 N--CA 1.436 -1.327 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.945 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.427 ' O ' ' CD ' ' A' ' 32' ' ' LYS . 8.3 mttm -59.67 146.54 40.77 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.478 -0.861 . . . . 0.0 111.214 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.461 ' HE3' ' HB3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 44.2 26.25 0.15 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.997 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.405 ' O ' HG23 ' A' ' 36' ' ' VAL . . . 50.88 18.63 2.91 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.685 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.461 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -75.44 -29.77 59.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.228 0.514 . . . . 0.0 109.992 179.308 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.411 ' CB ' ' HA3' ' A' ' 30' ' ' GLY . 0.3 OUTLIER -75.39 -40.3 58.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.584 179.589 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.709 HG13 ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.09 -26.25 36.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.23 -36.97 74.89 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -63.15 -37.43 87.18 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.396 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.684 ' HE3' HG12 ' A' ' 36' ' ' VAL . 2.5 ttm -59.33 -51.29 70.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.487 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.503 ' HA ' HD12 ' A' ' 47' ' ' ILE . 6.0 mtp180 -53.81 -51.35 63.79 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.159 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -59.27 -38.41 80.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.693 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.27 -20.42 34.51 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.71 ' HB2' ' HB2' ' A' ' 71' ' ' ALA . 11.1 t -90.44 -55.48 3.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.757 0.313 . . . . 0.0 111.554 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.53 -10.93 73.27 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.401 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.81 ' HB3' HD21 ' A' ' 61' ' ' LEU . . . -110.73 128.91 55.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.588 0.232 . . . . 0.0 111.112 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.8 OUTLIER -27.01 140.12 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.204 0.602 . . . . 0.0 112.386 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 40' ' ' ARG . 25.6 mt -142.32 100.55 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.558 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.47 129.99 52.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.751 0.31 . . . . 0.0 111.011 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 3.4 mp -108.4 142.47 20.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.197 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.8 p -161.64 -170.73 2.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.922 0.392 . . . . 0.0 111.317 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.648 ' HG3' HD12 ' A' ' 58' ' ' ILE . 0.3 OUTLIER 66.29 131.15 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.035 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.76 -66.38 0.63 Allowed Glycine 0 CA--C 1.508 -0.375 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.69 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 45.48 25.92 0.27 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.93 0.395 . . . . 0.0 110.565 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.535 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -151.47 -70.13 0.02 OUTLIER Pre-proline 0 N--CA 1.452 -0.375 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.868 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 54' ' ' CYS . 66.5 Cg_endo -81.12 -33.14 0.81 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.157 1.905 . . . . 0.0 110.954 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.738 ' HB2' HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -147.64 170.22 17.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.297 -179.552 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.668 ' HB2' HG21 ' A' ' 25' ' ' VAL . 4.3 mtm180 -145.75 132.71 20.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.851 0.357 . . . . 0.0 110.885 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.648 HD12 ' HG3' ' A' ' 51' ' ' GLU . 46.4 mt -98.05 105.91 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.756 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.452 HD12 ' O ' ' A' ' 18' ' ' LEU . 3.7 mp -86.07 97.61 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.212 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.443 HG23 ' HG3' ' A' ' 17' ' ' ARG . 62.5 m -87.49 136.83 32.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.925 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.81 HD21 ' HB3' ' A' ' 45' ' ' ALA . 2.1 tt -131.42 134.24 46.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.486 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.412 ' O ' ' HB1' ' A' ' 45' ' ' ALA . . . -133.12 130.71 39.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.685 0.278 . . . . 0.0 111.158 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.426 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.26 164.41 13.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.707 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 86.7 Cg_exo -40.75 161.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.019 2.479 . . . . 0.0 113.179 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.456 ' O ' HG22 ' A' ' 68' ' ' ILE . 8.5 m -60.21 -35.64 75.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.115 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 -64.73 -51.88 60.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.362 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.46 ' CB ' ' HB2' ' A' ' 45' ' ' ALA . . . -56.97 -42.4 80.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.957 0.408 . . . . 0.0 110.974 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.904 HD11 HG22 ' A' ' 16' ' ' ILE . 0.5 OUTLIER -66.3 -39.65 84.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.335 -179.334 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -46.12 90.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.061 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -51.2 70.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.991 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.71 ' HB2' ' HB2' ' A' ' 43' ' ' SER . . . -57.37 -41.64 80.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.29 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.439 ' O ' HG13 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -60.37 -39.43 87.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.912 0.387 . . . . 0.0 110.889 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.92 -29.86 68.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.312 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -48.46 14.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.699 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 72' ' ' PHE . 0.7 OUTLIER -59.78 -39.08 78.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.288 -179.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 pp -72.48 -37.03 56.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.853 0.359 . . . . 0.0 111.012 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -65.48 -46.94 77.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.498 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.04 -35.3 74.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.012 0.434 . . . . 0.0 110.018 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.7 tp -76.58 -27.27 55.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.141 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.84 -34.13 57.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.696 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.23 -44.28 63.13 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.758 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.3 -51.38 69.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.868 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 28.8 mm -72.11 -30.62 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.939 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.2 t -107.34 48.0 0.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.758 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 m -91.22 14.36 14.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.233 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.83 -14.68 13.04 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.239 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 12.8 mmt 61.41 75.33 0.41 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.846 0.355 . . . . 0.0 110.9 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.2 m -152.77 164.66 37.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.845 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -127.75 162.75 25.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.1 -178.08 3.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.913 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 m -103.72 -58.85 1.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.904 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -148.16 31.19 0.84 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.026 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.33 -72.15 0.72 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.074 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 63.88 35.14 11.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.909 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.7 ptt-85 -141.34 71.17 26.99 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.891 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.05 147.33 54.37 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.611 2.207 . . . . 0.0 112.24 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.14 116.55 4.2 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.51 2.14 . . . . 0.0 112.546 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.873 HG23 HD11 ' A' ' 155' ' ' ILE . 3.6 m -141.02 117.08 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.739 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 148' ' ' ILE . 17.8 m -103.01 141.51 35.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.808 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.97 117.78 11.69 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -100.91 112.64 25.12 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.166 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.701 HD11 HD11 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -109.51 137.37 47.45 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.229 -179.524 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.74 148.93 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.447 HG12 ' HB2' ' A' ' 108' ' ' GLN . 23.4 t -152.81 143.67 15.81 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.227 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.419 ' HD2' ' CG1' ' A' ' 104' ' ' VAL . 20.9 Cg_exo -65.78 163.16 31.65 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.45 2.1 . . . . 0.0 112.192 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.94 -34.96 76.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.666 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.4 m -70.46 -30.48 67.33 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.447 ' HB2' HG12 ' A' ' 104' ' ' VAL . 26.4 mm-40 -71.79 -49.48 38.37 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.435 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.449 ' O ' HD12 ' A' ' 113' ' ' ILE . 2.9 t -64.49 -41.46 96.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.307 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -54.66 -51.81 49.91 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.219 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.9 -35.43 69.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.908 0.385 . . . . 0.0 110.405 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.67 -25.86 66.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.35 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.504 HG22 ' HA2' ' A' ' 117' ' ' GLY . 9.3 mt -84.68 -36.9 12.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.776 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.17 -178.73 16.2 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.505 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.46 129.63 40.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.883 0.373 . . . . 0.0 111.128 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 60.44 17.1 46.34 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.938 -0.648 . . . . 0.0 113.008 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.504 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 67.65 9.53 55.93 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.991 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 4.6 t -53.14 -35.53 59.82 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.801 0.334 . . . . 0.0 111.493 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.422 ' HG3' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -67.95 -64.09 0.93 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.274 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.4 ' HB ' ' HA ' ' A' ' 113' ' ' ILE . 9.1 tt -54.11 -26.94 15.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.822 0.344 . . . . 0.0 111.253 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -48.24 66.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.943 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -73.09 -36.11 66.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.177 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.422 HD11 ' HG3' ' A' ' 119' ' ' LYS . 16.4 mt -67.93 -48.29 75.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.217 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.04 -48.18 59.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.303 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -54.46 -35.29 62.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.46 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 99.9 p -90.21 -35.41 15.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.706 0.289 . . . . 0.0 111.329 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.4 m -52.14 -26.09 10.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.889 0.376 . . . . 0.0 110.106 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.11 -20.18 22.39 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.936 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -108.17 167.75 9.78 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.809 0.338 . . . . 0.0 111.132 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -105.08 129.95 53.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.892 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 147' ' ' THR . 13.2 m -99.29 139.14 21.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.067 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.627 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 1.1 tt0 -125.61 116.61 22.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.174 0.511 . . . . 0.0 112.178 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.3 p -97.46 136.75 27.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.408 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.55 161.11 10.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.056 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.59 155.58 53.37 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.635 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -170.67 32.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.1 mtt -101.8 26.39 7.52 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.298 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.427 ' CB ' ' HD3' ' A' ' 139' ' ' PRO . 0.2 OUTLIER -177.71 -53.48 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.043 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.427 ' HD3' ' CB ' ' A' ' 138' ' ' LEU . 35.9 Cg_exo -59.83 -35.89 92.67 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.341 2.028 . . . . 0.0 112.094 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 63.98 103.19 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.85 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.6 m -120.48 -170.67 2.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.928 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 10.9 t -115.96 -39.77 3.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.84 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.496 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 18.3 mt-10 -127.56 136.91 52.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.826 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.5 mtt180 -113.49 171.74 7.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.73 136.41 53.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.086 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.627 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 40.0 mt -105.86 124.32 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.736 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.452 ' HB ' ' CB ' ' A' ' 132' ' ' GLN . 4.4 m -97.77 114.76 26.85 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.523 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 99' ' ' THR . 23.6 mt -106.34 110.47 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.421 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.36 122.7 43.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.646 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 171.09 -151.38 15.6 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.543 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.527 ' CG2' ' HD2' ' A' ' 152' ' ' PRO . 1.4 mp -80.99 144.72 55.5 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.683 ' HA ' HD12 ' A' ' 155' ' ' ILE . 82.6 Cg_exo -49.02 -31.04 19.52 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 121.987 1.792 . . . . 0.0 111.587 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -72.03 -34.68 69.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.727 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 66.9 m -65.08 -44.81 87.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.734 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.873 HD11 HG23 ' A' ' 98' ' ' VAL . 4.3 mt -66.03 -51.32 61.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.195 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 23.0 mt -55.89 -28.49 24.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.991 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -73.39 -41.24 63.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.942 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . 0.512 ' O ' HG22 ' A' ' 162' ' ' ILE . 0.6 OUTLIER -67.09 -48.48 68.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.014 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 11.5 p -60.53 -38.19 77.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.248 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.646 ' O ' HG23 ' A' ' 164' ' ' VAL . 0.5 OUTLIER -69.33 -42.83 74.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.032 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.77 ' O ' HG23 ' A' ' 165' ' ' VAL . 1.8 mt-30 -65.83 -49.39 68.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.036 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.512 HG22 ' O ' ' A' ' 158' ' ' CYS . 17.2 tt -64.15 -45.07 97.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.197 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . 0.485 ' N ' HG23 ' A' ' 162' ' ' ILE . 12.6 t -62.54 -48.52 79.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.991 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 160' ' ' LYS . 53.2 t -60.0 -52.69 58.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.094 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 161' ' ' GLN . 33.2 t -62.05 -34.72 64.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.233 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 9.5 tmm? -59.9 -51.89 67.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.994 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.505 HD12 HD21 ' A' ' 14' ' ' LEU . 4.9 tt -58.94 -55.73 31.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.992 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.89 -2.62 24.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.072 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.901 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.806 0.336 . . . . 0.0 111.202 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -89.51 77.17 7.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.584 HG22 ' N ' ' A' ' 13' ' ' THR . 12.5 p -116.77 166.04 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.052 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.584 ' N ' HG22 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -103.13 141.96 34.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.595 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.5 mt -136.14 177.24 7.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.171 0.51 . . . . 0.0 111.447 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.2 m -141.71 113.07 7.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.557 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.777 HG22 HD11 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -111.63 126.47 69.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.976 0.417 . . . . 0.0 111.471 -179.601 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.711 ' CG ' HG23 ' A' ' 60' ' ' THR . 81.9 mtm-85 -112.57 116.31 30.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.446 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.52 HD12 ' CE ' ' A' ' 20' ' ' MET . 0.4 OUTLIER -114.59 119.6 37.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.237 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.428 HD11 ' HE ' ' A' ' 101' ' ' ARG . 1.8 pp -113.38 133.96 54.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.825 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.541 ' HB2' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -135.23 177.02 8.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.959 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.836 ' O ' HG22 ' A' ' 25' ' ' VAL . 6.8 m-70 -67.57 166.0 15.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.61 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.73 -31.96 72.9 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.925 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -78.37 -42.27 30.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.806 0.336 . . . . 0.0 111.335 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.58 ' O ' HG22 ' A' ' 28' ' ' ILE . 14.6 mt-10 -67.79 -43.11 80.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.917 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 21' ' ' HIS . 18.2 m -65.48 -40.39 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.314 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.91 -41.35 99.9 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.892 -0.67 . . . . 0.0 113.229 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.6 m -75.96 -35.64 59.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.721 0.296 . . . . 0.0 111.63 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.58 HG22 ' O ' ' A' ' 24' ' ' GLU . 2.7 tp -76.73 -50.52 21.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.746 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.538 ' N ' HG23 ' A' ' 28' ' ' ILE . 31.4 mt -60.19 -42.43 90.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.914 0.388 . . . . 0.0 110.752 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.422 ' HA3' ' CB ' ' A' ' 35' ' ' SER . . . 99.82 150.84 25.53 Favored Glycine 0 N--CA 1.435 -1.399 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.556 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.409 ' O ' ' CD ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -57.98 146.42 32.59 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.825 -0.688 . . . . 0.0 111.378 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.532 ' HD2' ' HB2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 44.01 27.04 0.17 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.956 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 50.6 19.64 3.32 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 114.512 0.565 . . . . 0.0 114.512 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.532 ' HB2' ' HD2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -76.98 -35.44 57.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.755 0.778 . . . . 0.0 109.966 179.095 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -68.81 -43.14 76.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.65 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.7 p -67.36 -27.04 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.91 -36.7 82.85 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 176.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 35' ' ' SER . 0.5 OUTLIER -69.71 -34.66 74.2 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.517 -1.219 . . . . 0.0 108.948 177.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -67.34 -41.22 85.56 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.101 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.476 ' HA ' HD12 ' A' ' 47' ' ' ILE . 4.4 ttp-105 -58.48 -51.35 70.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.194 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -59.76 -38.51 81.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.807 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -75.27 -36.27 61.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.693 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.691 ' HB2' ' HB2' ' A' ' 71' ' ' ALA . 19.7 t -73.02 -49.27 29.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.28 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.18 -8.96 78.66 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.292 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.46 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . . . -110.91 128.48 55.82 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.6 0.238 . . . . 0.0 111.156 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.616 ' HB2' ' HB3' ' A' ' 62' ' ' ALA . 0.8 OUTLIER -27.23 136.74 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.221 179.356 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 40' ' ' ARG . 4.2 mt -142.7 100.47 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.979 178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -115.88 165.84 12.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.916 0.389 . . . . 0.0 111.421 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.617 HG23 HD13 ' A' ' 59' ' ' ILE . 3.2 mp -126.47 151.74 33.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.798 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.59 -178.64 0.75 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.983 0.42 . . . . 0.0 111.4 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.663 ' CB ' HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER 66.12 134.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.12 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.39 -75.67 0.14 Allowed Glycine 0 CA--C 1.508 -0.351 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.675 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.3 m120 54.62 21.86 3.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.874 0.368 . . . . 0.0 110.038 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.502 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -148.31 -68.66 0.02 OUTLIER Pre-proline 0 N--CA 1.452 -0.356 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.937 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.502 ' HD3' ' HB3' ' A' ' 54' ' ' CYS . 80.5 Cg_endo -80.23 -34.55 0.81 Allowed 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.096 1.864 . . . . 0.0 111.158 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.82 176.96 8.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.516 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.518 ' HB2' HG21 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -145.71 127.59 15.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.857 179.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.663 HD12 ' CB ' ' A' ' 51' ' ' GLU . 19.1 mt -102.22 110.67 29.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.617 HD13 HG23 ' A' ' 49' ' ' ILE . 26.3 mm -94.62 96.38 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.088 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.711 HG23 ' CG ' ' A' ' 17' ' ' ARG . 6.0 m -76.33 139.14 40.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.795 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -131.29 133.27 45.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.267 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.616 ' HB3' ' HB2' ' A' ' 46' ' ' ARG . . . -133.03 129.31 37.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.79 0.328 . . . . 0.0 111.109 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.431 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.15 164.18 13.35 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.726 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 94.6 Cg_exo -42.2 161.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.106 2.537 . . . . 0.0 113.07 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.496 ' O ' HG22 ' A' ' 68' ' ' ILE . 34.1 m -59.97 -35.72 75.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.974 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -62.42 -51.88 65.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.224 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.46 ' CB ' ' HB2' ' A' ' 45' ' ' ALA . . . -56.99 -37.64 71.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.008 0.432 . . . . 0.0 110.989 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.777 HD11 HG22 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -66.21 -39.36 84.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.194 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -47.28 81.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.888 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.74 -51.91 67.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.745 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.691 ' HB2' ' HB2' ' A' ' 43' ' ' SER . . . -56.11 -58.37 8.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.315 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.624 ' HA ' HD12 ' A' ' 75' ' ' ILE . 0.9 OUTLIER -49.2 -32.53 10.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.33 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.21 -41.59 81.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.11 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -75.91 -32.84 59.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.055 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.624 HD12 ' HA ' ' A' ' 72' ' ' PHE . 18.2 mt -68.11 -43.63 85.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.963 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 72' ' ' PHE . 23.1 pt -67.88 -40.34 83.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.971 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.401 ' N ' HG13 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -65.03 -41.04 95.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.443 179.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.3 tptt -61.87 -35.92 79.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.055 0.455 . . . . 0.0 110.048 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.7 tp -77.39 -28.15 52.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.435 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -76.69 -35.11 58.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.649 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.29 -42.75 65.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.824 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.81 -50.14 75.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.041 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.526 HG23 ' HA ' ' A' ' 86' ' ' SER . 41.4 mt -62.05 -52.89 54.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.935 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.9 t 61.29 -80.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.109 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.3 p -101.52 -22.32 14.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.087 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.526 ' HA ' HG23 ' A' ' 83' ' ' ILE . 0.2 OUTLIER 70.66 95.57 0.07 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.879 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -68.62 -29.84 68.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.904 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.06 87.48 3.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.867 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -121.69 143.47 49.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.914 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.5 t -152.48 -46.9 0.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.813 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.3 p -150.78 -47.03 0.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.865 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -148.35 98.36 2.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.194 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -165.33 75.21 0.24 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.927 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.6 p -138.08 -43.7 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.29 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.471 ' CB ' ' HD3' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -157.48 -59.8 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.516 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.568 ' HA ' HG22 ' A' ' 151' ' ' ILE . 58.9 Cg_exo -50.44 -45.88 32.13 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.087 1.858 . . . . 0.0 112.632 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 10.2 Cg_exo -71.62 116.6 4.76 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.465 2.11 . . . . 0.0 111.938 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.685 HG12 HD11 ' A' ' 100' ' ' LEU . 19.7 t -140.88 111.87 3.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.347 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 16.0 m -103.41 134.28 47.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.634 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.685 HD11 HG12 ' A' ' 98' ' ' VAL . 5.4 mp -139.91 117.76 11.71 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.428 ' HE ' HD11 ' A' ' 19' ' ' LEU . 6.3 ttp180 -101.98 112.5 25.16 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.132 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.505 ' O ' HG22 ' A' ' 146' ' ' ILE . 8.1 mp -113.47 162.32 16.28 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.935 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.407 HG12 ' CB ' ' A' ' 17' ' ' ARG . 11.3 p -98.73 136.42 29.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.022 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.457 ' CG1' ' HD2' ' A' ' 105' ' ' PRO . 25.4 t -138.66 145.37 45.93 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.104 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.457 ' HD2' ' CG1' ' A' ' 104' ' ' VAL . 21.6 Cg_exo -65.99 159.92 46.85 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.475 2.116 . . . . 0.0 112.146 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.99 -34.64 75.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.5 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 m -69.48 -30.45 68.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.168 0.508 . . . . 0.0 109.771 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.411 ' HB3' ' CG1' ' A' ' 104' ' ' VAL . 0.7 OUTLIER -70.34 -50.54 38.02 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.463 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.411 ' O ' HG12 ' A' ' 113' ' ' ILE . 53.5 t -62.19 -43.48 98.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.381 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -53.89 -47.52 65.46 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.395 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.85 -40.31 69.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.804 0.335 . . . . 0.0 110.644 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 112' ' ' LEU . 19.1 mt -55.97 -27.82 54.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.0 0.428 . . . . 0.0 110.486 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.431 ' CG2' ' HA2' ' A' ' 117' ' ' GLY . 28.0 mm -82.07 -39.89 16.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.582 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.66 -177.67 26.02 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.501 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -67.54 125.15 25.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.894 0.378 . . . . 0.0 111.129 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.72 13.1 58.46 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.989 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.431 ' HA2' ' CG2' ' A' ' 113' ' ' ILE . . . 70.84 7.31 61.6 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.974 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 5.2 t -53.0 -39.64 63.24 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.786 0.326 . . . . 0.0 111.695 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.863 ' HD2' HD11 ' A' ' 123' ' ' ILE . 0.6 OUTLIER -61.33 -65.36 0.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.286 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.73 HD11 HG21 ' A' ' 131' ' ' VAL . 1.6 tp -55.83 -32.22 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.356 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.26 -52.3 66.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.157 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -73.08 -40.95 64.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.432 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.863 HD11 ' HD2' ' A' ' 119' ' ' LYS . 53.8 mt -57.24 -53.65 40.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.362 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.03 -38.25 72.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.353 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -54.84 -39.95 69.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.615 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.07 -37.55 11.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.602 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 17.2 m -49.73 -26.14 3.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.887 0.375 . . . . 0.0 110.265 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.46 -12.14 28.37 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.825 -0.702 . . . . 0.0 113.224 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.589 ' HB2' ' HB3' ' A' ' 154' ' ' SER . . . -108.27 146.3 33.08 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.953 0.377 . . . . 0.0 111.299 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.16 129.52 43.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.597 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.986 HG12 HG22 ' A' ' 148' ' ' ILE . 6.7 m -99.28 150.38 5.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.351 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.66 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 11.4 tt0 -122.65 158.55 29.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.01 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.6 m -137.45 140.89 40.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.227 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.75 161.14 24.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.125 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -78.62 -166.38 30.0 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.642 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -139.29 -42.35 0.46 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.706 0.289 . . . . 0.0 110.982 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 16.9 mtp 69.6 -167.57 0.17 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.817 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.547 ' N ' ' HD2' ' A' ' 139' ' ' PRO . 1.3 tp -50.63 -53.69 43.63 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.25 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 138' ' ' LEU . 35.5 Cg_endo -64.21 -160.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.214 1.943 . . . . 0.0 111.904 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -163.1 99.02 0.95 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.116 0.484 . . . . 0.0 110.768 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.1 -169.05 0.25 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.93 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.57 -50.56 2.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.639 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.483 ' OE2' ' NH2' ' A' ' 17' ' ' ARG . 10.1 mt-10 -115.09 137.92 51.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.679 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -109.88 176.99 4.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.909 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -110.41 130.7 55.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.166 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.859 HD11 ' HB ' ' A' ' 131' ' ' VAL . 0.5 OUTLIER -113.55 140.03 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.772 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.503 ' HB ' ' HB2' ' A' ' 132' ' ' GLN . 0.7 OUTLIER -115.98 114.99 25.37 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.304 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.986 HG22 HG12 ' A' ' 131' ' ' VAL . 1.6 pt -106.78 123.43 61.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.11 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.48 136.2 53.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.101 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 160.87 -162.88 33.88 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.513 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.8 HD12 ' HB2' ' A' ' 153' ' ' GLN . 2.7 pt -87.02 161.49 46.71 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.61 0.243 . . . . 0.0 110.95 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.476 ' HA ' HD12 ' A' ' 155' ' ' ILE . 74.8 Cg_exo -49.4 -40.0 44.4 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.431 2.087 . . . . 0.0 112.041 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.8 ' HB2' HD12 ' A' ' 151' ' ' ILE . 3.1 mm-40 -64.69 -34.7 78.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.301 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.589 ' HB3' ' HB2' ' A' ' 129' ' ' ALA . 61.8 m -69.4 -34.02 73.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.71 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 152' ' ' PRO . 26.6 mt -73.09 -53.34 18.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.945 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.447 ' HA ' HG12 ' A' ' 159' ' ' VAL . 37.7 mm -59.15 -28.63 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.061 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -75.17 -40.16 59.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.033 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -72.14 -38.91 69.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.183 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.447 HG12 ' HA ' ' A' ' 156' ' ' ILE . 12.1 p -69.98 -41.96 79.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.393 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.614 ' O ' HG23 ' A' ' 164' ' ' VAL . 8.3 pttt -65.54 -38.58 90.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.039 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -64.42 -49.41 71.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.768 HD13 ' O ' ' A' ' 162' ' ' ILE . 0.0 OUTLIER -64.78 -34.52 70.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.977 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 34.1 m -67.76 -43.4 79.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 160' ' ' LYS . 54.0 t -59.6 -52.68 58.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.9 p -64.26 -30.4 50.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.021 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -59.31 -51.57 69.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.951 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.557 HD22 HG21 ' A' ' 12' ' ' VAL . 9.6 mt -70.03 -45.91 66.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.949 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -73.99 -2.48 24.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.052 0.454 . . . . 0.0 112.018 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.848 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 120.822 0.344 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 43.04 60.64 2.43 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.554 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 13' ' ' THR . 20.3 t -120.56 158.26 22.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.913 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -103.77 139.34 39.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.029 -179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 14' ' ' LEU . 2.0 mt -143.02 166.1 25.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.008 0.433 . . . . 0.0 111.188 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 m -142.73 140.65 31.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.632 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.691 HG22 HD11 ' A' ' 68' ' ' ILE . 17.8 tt -140.87 152.51 20.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.972 0.415 . . . . 0.0 111.479 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.487 ' NH2' ' OE2' ' A' ' 143' ' ' GLU . 2.8 ttm-85 -134.99 129.68 34.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.389 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.02 135.23 51.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.947 0.403 . . . . 0.0 111.121 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.545 HD12 HG23 ' A' ' 58' ' ' ILE . 1.8 mp -93.32 115.0 27.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.628 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -107.87 141.02 40.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.951 0.405 . . . . 0.0 110.89 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.437 ' HA ' ' O ' ' A' ' 55' ' ' PRO . 1.4 t-80 -67.6 163.89 20.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.602 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.518 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -58.7 -45.05 95.32 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.699 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.45 -43.28 27.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.985 0.422 . . . . 0.0 110.91 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.77 ' O ' HG23 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -62.01 -32.79 73.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.508 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.698 HG22 HG13 ' A' ' 29' ' ' ILE . 9.8 p -76.95 -31.22 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.474 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.36 -42.71 99.7 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.441 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.9 m -75.87 -37.24 59.12 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.669 0.271 . . . . 0.0 111.605 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.77 HG23 ' O ' ' A' ' 24' ' ' GLU . 1.7 pp -76.29 -32.7 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 120.787 0.327 . . . . 0.0 111.879 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.769 ' HA ' HG13 ' A' ' 36' ' ' VAL . 10.9 mm -70.68 -54.74 16.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.253 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.406 ' HA3' ' CB ' ' A' ' 35' ' ' SER . . . 99.56 150.29 25.13 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-O 121.769 0.649 . . . . 0.0 113.026 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.58 ' HB3' ' HD3' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -67.13 146.37 54.33 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.413 -0.893 . . . . 0.0 111.113 179.606 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.58 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER 63.71 6.82 2.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.37 -179.603 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.444 ' O ' HG23 ' A' ' 36' ' ' VAL . . . 57.71 12.67 10.5 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 119.84 -1.171 . . . . 0.0 111.648 -178.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -76.78 -28.93 55.84 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.918 0.39 . . . . 0.0 110.091 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.406 ' CB ' ' HA3' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -73.33 -41.5 63.43 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.184 179.567 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.769 HG13 ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.16 -26.38 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.552 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.98 -36.87 75.53 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.49 -37.45 86.04 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.776 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.483 ' HE3' ' HA ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -62.14 -52.45 63.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.432 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.515 ' HG2' HD12 ' A' ' 47' ' ' ILE . 39.9 mtm180 -50.56 -51.21 50.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.206 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -57.98 -38.04 75.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.72 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -75.11 -36.11 61.68 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.862 ' HB2' ' HB2' ' A' ' 71' ' ' ALA . 79.6 p -82.69 -55.75 4.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.846 0.355 . . . . 0.0 111.66 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.9 -5.62 66.46 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.426 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.753 ' HB3' HD21 ' A' ' 61' ' ' LEU . . . -110.67 128.83 55.86 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.688 0.28 . . . . 0.0 111.138 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 47.8 ttm-85 -27.16 137.84 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.339 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.515 HD12 ' HG2' ' A' ' 40' ' ' ARG . 12.2 mt -142.27 100.43 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.705 0.288 . . . . 0.0 110.471 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.95 171.38 7.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.724 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 58' ' ' ILE . 6.0 mt -126.7 149.78 31.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.954 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.88 -169.3 1.96 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.911 0.386 . . . . 0.0 111.302 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -75.41 -160.21 0.12 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.029 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -151.64 -71.92 0.01 OUTLIER Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.021 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.3 m120 58.39 19.07 6.07 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.529 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -167.4 -66.26 0.01 OUTLIER Pre-proline 0 N--CA 1.452 -0.351 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.475 -179.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.558 ' O ' ' CB ' ' A' ' 56' ' ' GLU . 64.0 Cg_endo -81.75 -33.18 0.68 Allowed 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.384 2.056 . . . . 0.0 111.493 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.558 ' CB ' ' O ' ' A' ' 55' ' ' PRO . 2.7 mt-10 110.48 -43.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.577 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.548 ' HB2' HG11 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -145.88 142.15 28.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.987 0.422 . . . . 0.0 111.626 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.545 HG23 HD12 ' A' ' 19' ' ' LEU . 25.5 mt -123.25 131.16 73.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.127 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.714 HD11 HD11 ' A' ' 28' ' ' ILE . 30.0 mt -109.24 106.12 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.87 0.367 . . . . 0.0 111.766 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 66.9 m -93.05 139.17 30.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.805 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.753 HD21 ' HB3' ' A' ' 45' ' ' ALA . 6.3 tt -131.5 137.26 48.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.726 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.719 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -135.55 132.37 37.13 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.563 0.22 . . . . 0.0 110.851 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.421 ' HA3' ' HB1' ' A' ' 45' ' ' ALA . . . 157.19 164.83 14.11 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.261 -0.971 . . . . 0.0 112.928 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 95.7 Cg_exo -42.47 159.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.986 2.457 . . . . 0.0 113.041 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.472 ' O ' HG22 ' A' ' 68' ' ' ILE . 35.8 m -60.28 -35.69 76.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.981 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -66.34 -52.02 51.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.15 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.77 -37.64 71.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.691 HD11 HG22 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -66.36 -39.24 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.157 -179.643 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.43 -51.9 67.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.842 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -43.83 88.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.587 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.862 ' HB2' ' HB2' ' A' ' 43' ' ' SER . . . -55.48 -45.54 76.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.22 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.464 ' CE1' HD13 ' A' ' 16' ' ' ILE . 1.2 m-85 -58.46 -50.3 74.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.207 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.0 -36.99 68.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.599 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.85 -40.0 49.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.23 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 72' ' ' PHE . 12.1 mt -62.42 -51.46 72.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.652 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.22 -38.54 80.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.991 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.26 -29.59 65.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.416 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -35.33 80.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.054 0.454 . . . . 0.0 109.81 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.9 tp -76.65 -31.69 57.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.172 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -76.79 -32.85 57.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.769 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -72.25 -36.85 69.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.783 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.98 -54.97 31.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.992 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 15.9 pt -56.83 -42.7 78.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.195 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.24 -176.03 6.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.962 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.9 p 79.88 -55.81 0.38 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.941 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.2 114.27 6.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.939 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.54 -177.81 4.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.866 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.9 m -114.92 157.06 23.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.926 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -60.95 -32.8 72.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.902 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.7 m -65.42 155.56 35.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.06 153.88 19.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.848 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -90.12 -61.53 1.66 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.102 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -160.51 -78.48 0.05 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.166 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.18 97.42 0.27 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.864 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.6 tpp85 63.92 126.11 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.92 107.94 0.84 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.463 2.108 . . . . 0.0 112.167 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -69.82 162.96 40.09 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.672 2.248 . . . . 0.0 112.198 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.4 t -126.21 103.36 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.95 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 11.0 t -113.26 133.49 55.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.01 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.76 ' HB3' HD11 ' A' ' 155' ' ' ILE . 6.6 tp -139.94 117.86 11.77 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.722 ' HB3' HG23 ' A' ' 147' ' ' THR . 0.0 OUTLIER -107.62 112.67 25.51 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.631 -178.684 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.616 HD21 HD21 ' A' ' 100' ' ' LEU . 28.5 mt -102.64 155.38 18.33 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.903 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.465 HG13 ' O ' ' A' ' 144' ' ' ARG . 17.0 t -106.71 141.15 22.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.17 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.405 ' HB ' ' CB ' ' A' ' 108' ' ' GLN . 6.4 m -145.44 155.94 53.47 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.124 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.64 162.86 35.23 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.552 2.168 . . . . 0.0 112.583 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.63 -34.51 69.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.502 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.1 m -67.24 -30.71 70.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.151 0.501 . . . . 0.0 109.823 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.405 ' CB ' ' HB ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -67.58 -45.4 75.65 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.525 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.509 ' SG ' HD11 ' A' ' 113' ' ' ILE . 42.7 t -66.68 -49.32 66.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.63 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -49.29 -51.96 24.68 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.522 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.9 p -71.84 -40.21 69.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.765 0.317 . . . . 0.0 110.545 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.723 HD21 HD12 ' A' ' 162' ' ' ILE . 7.4 mt -54.93 -28.72 53.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.045 0.45 . . . . 0.0 110.246 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.509 HD11 ' SG ' ' A' ' 109' ' ' CYS . 17.9 mt -80.02 -44.6 22.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.552 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 76.94 -173.25 54.88 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.588 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.5 tptp -64.56 118.98 9.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.894 0.378 . . . . 0.0 111.197 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 56.85 20.32 32.65 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.987 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.459 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 71.8 6.98 64.62 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.988 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 30.9 p -53.1 -40.12 63.9 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 120.826 0.346 . . . . 0.0 111.707 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.84 ' HD2' HD11 ' A' ' 123' ' ' ILE . 0.7 OUTLIER -65.26 -65.29 0.69 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.5 -179.474 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.884 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.6 OUTLIER -55.1 -34.29 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.581 -179.509 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -60.64 -45.09 95.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.011 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -73.11 -32.37 64.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.101 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.884 HD12 ' HA ' ' A' ' 120' ' ' ILE . 26.7 mt -64.24 -43.38 97.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.184 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.84 -42.7 60.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.92 0.391 . . . . 0.0 111.017 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -58.83 -35.37 72.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.733 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.8 t -93.45 -45.55 7.73 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.675 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.1 m -48.37 -25.64 1.7 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.874 0.368 . . . . 0.0 110.275 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.48 -9.49 41.94 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.048 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.569 ' HB1' ' O ' ' A' ' 149' ' ' ALA . . . -108.29 153.72 22.84 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.932 0.366 . . . . 0.0 111.201 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -99.7 141.29 32.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.732 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.709 ' HB ' HD11 ' A' ' 146' ' ' ILE . 11.4 m -99.22 157.9 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.356 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.789 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 0.1 OUTLIER -128.78 158.45 38.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.447 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.511 HG22 HH21 ' A' ' 144' ' ' ARG . 21.0 t -129.39 118.87 47.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.967 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.69 161.11 29.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.242 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -78.43 105.59 2.2 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.454 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -156.53 -44.3 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.823 0.344 . . . . 0.0 111.024 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 65.65 172.1 0.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.808 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.527 ' N ' HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -88.06 -51.15 0.41 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.974 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 138' ' ' LEU . 33.5 Cg_exo -57.87 -28.86 84.24 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.495 2.13 . . . . 0.0 112.327 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -85.82 -80.71 0.22 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.999 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.28 -168.75 2.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.913 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.9 t -115.49 -41.82 3.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.699 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.487 ' OE2' ' NH2' ' A' ' 17' ' ' ARG . 15.2 pt-20 -118.17 139.13 51.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.703 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.511 HH21 HG22 ' A' ' 133' ' ' VAL . 5.4 ptm180 -109.91 168.2 9.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.938 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.56 134.33 54.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.303 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.789 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 1.5 tt -116.37 131.94 67.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.519 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.722 HG23 ' HB3' ' A' ' 101' ' ' ARG . 1.0 OUTLIER -109.45 116.05 31.08 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.715 -179.554 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.58 HG23 HD12 ' A' ' 155' ' ' ILE . 4.7 tp -104.89 121.99 57.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.742 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.569 ' O ' ' HB1' ' A' ' 129' ' ' ALA . . . -118.39 140.41 49.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.204 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 166.14 -154.29 24.76 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.355 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.553 HD12 ' HB2' ' A' ' 153' ' ' GLN . 1.2 pt -87.06 161.96 45.17 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.59 0.234 . . . . 0.0 110.839 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.509 ' O ' HG22 ' A' ' 156' ' ' ILE . 73.7 Cg_exo -49.51 -34.96 35.31 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.315 2.01 . . . . 0.0 112.209 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.553 ' HB2' HD12 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -72.06 -34.74 68.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.817 179.736 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 53.1 p -74.25 -41.15 61.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.971 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.76 HD11 ' HB3' ' A' ' 100' ' ' LEU . 0.7 OUTLIER -68.73 -41.28 82.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.175 -179.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.509 HG22 ' O ' ' A' ' 152' ' ' PRO . 1.1 tp -69.68 -32.83 53.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.141 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -69.84 -49.22 54.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.894 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -58.61 -53.1 62.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.097 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.744 HG23 ' O ' ' A' ' 155' ' ' ILE . 30.1 t -57.35 -35.53 49.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.296 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 10.5 tptp -68.32 -32.91 73.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.978 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.645 ' O ' HG13 ' A' ' 165' ' ' VAL . 29.6 mt-30 -72.06 -38.32 69.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.033 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.723 HD12 HD21 ' A' ' 112' ' ' LEU . 36.0 mm -74.01 -34.48 39.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.2 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.17 -37.47 69.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.099 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 14.0 p -74.36 -39.68 48.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.456 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.645 HG13 ' O ' ' A' ' 161' ' ' GLN . 36.0 m -69.5 -45.59 78.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.418 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.477 ' N ' HG23 ' A' ' 165' ' ' VAL . 5.6 ptm -62.01 -45.93 91.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.928 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.13 -51.11 41.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.931 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -74.02 -2.53 24.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.959 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.591 ' HD2' HG21 ' A' ' 65' ' ' THR . 8.0 mmtt . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.855 0.359 . . . . 0.0 111.236 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -142.63 50.46 1.46 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.642 HG21 HD21 ' A' ' 167' ' ' LEU . 21.5 t -126.28 152.65 33.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.97 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 1.4 m -103.25 146.91 27.73 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.682 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.57 HD21 ' HA ' ' A' ' 65' ' ' THR . 2.3 pp -158.21 139.77 13.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.531 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.588 HG23 ' O ' ' A' ' 61' ' ' LEU . 58.3 m -113.12 129.92 56.35 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.31 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.616 HG12 HD11 ' A' ' 68' ' ' ILE . 2.0 pt -112.13 163.98 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.223 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.493 ' NH2' ' OE2' ' A' ' 143' ' ' GLU . 0.9 OUTLIER -133.96 123.06 23.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.834 179.765 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.472 HD21 ' CZ ' ' A' ' 72' ' ' PHE . 67.5 mt -114.58 119.87 38.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.201 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.856 HD12 ' O ' ' A' ' 101' ' ' ARG . 0.2 OUTLIER -115.8 128.1 55.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.723 179.699 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.79 ' HB2' HG12 ' A' ' 25' ' ' VAL . 0.9 OUTLIER -142.11 162.38 35.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.835 0.35 . . . . 0.0 111.208 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.811 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.9 OUTLIER -70.2 163.45 26.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.888 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.415 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -49.19 -35.83 20.56 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.659 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -51.4 10.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.922 0.361 . . . . 0.0 111.958 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.4 ' HB3' ' HB3' ' A' ' 20' ' ' MET . 0.3 OUTLIER -61.93 -33.56 74.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.818 0.342 . . . . 0.0 110.991 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.811 HG13 ' O ' ' A' ' 21' ' ' HIS . 15.4 m -71.54 -39.96 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.083 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.01 -35.16 91.02 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.635 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 p -75.45 -33.55 60.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.668 0.271 . . . . 0.0 111.388 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.812 HD11 HG22 ' A' ' 75' ' ' ILE . 1.7 tp -79.21 -47.09 22.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.451 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.733 ' HA ' HG13 ' A' ' 36' ' ' VAL . 8.1 mm -57.25 -50.25 77.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.872 0.368 . . . . 0.0 110.204 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.41 ' HA3' ' HB3' ' A' ' 35' ' ' SER . . . 97.9 150.32 26.18 Favored Glycine 0 N--CA 1.437 -1.278 0 CA-C-O 121.747 0.637 . . . . 0.0 113.012 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.401 ' O ' ' CD ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -62.42 145.9 52.84 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.528 -0.836 . . . . 0.0 111.321 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.465 ' HG2' ' HB2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 51.36 18.89 0.69 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.461 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.491 ' O ' HG23 ' A' ' 36' ' ' VAL . . . 53.69 11.32 1.91 Allowed Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.936 -0.65 . . . . 0.0 114.26 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.465 ' HB2' ' HG2' ' A' ' 32' ' ' LYS . 4.0 tp10 -74.69 -27.2 60.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.536 0.668 . . . . 0.0 109.735 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.41 ' HB3' ' HA3' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -75.39 -39.84 58.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.514 179.434 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.733 HG13 ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.28 -26.34 35.91 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.588 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -70.66 -36.73 73.52 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -62.61 -34.73 77.62 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.936 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -43.05 81.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.711 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 44.9 mtp85 -58.1 -51.15 70.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.846 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -63.86 -38.02 89.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.037 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.84 -35.7 62.4 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.507 ' CB ' ' HB2' ' A' ' 71' ' ' ALA . 53.2 p -88.34 -55.79 3.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.937 0.399 . . . . 0.0 110.879 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.14 4.76 62.74 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.193 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.49 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -110.77 127.31 55.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.077 0.438 . . . . 0.0 111.317 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.789 ' HB2' ' HB3' ' A' ' 62' ' ' ALA . 1.8 mpt_? -27.75 104.3 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.275 0.63 . . . . 0.0 112.551 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.8 mt -107.45 100.58 11.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.832 0.348 . . . . 0.0 110.935 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.39 169.94 8.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.256 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.567 HG21 ' HD2' ' A' ' 57' ' ' ARG . 13.9 mt -126.46 152.13 33.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.144 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.451 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . 33.1 t -92.12 -161.4 0.82 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.738 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -69.3 176.84 3.09 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.2 0.524 . . . . 0.0 112.144 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.598 ' O ' ' O ' ' A' ' 56' ' ' GLU . . . 51.79 109.65 0.01 OUTLIER Glycine 0 CA--C 1.505 -0.546 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.311 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.418 ' HA ' ' CD ' ' A' ' 57' ' ' ARG . 7.6 p-10 -105.2 37.54 2.16 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 176.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.496 ' CB ' ' CD ' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -154.58 -66.26 0.02 OUTLIER Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 115.08 -0.964 . . . . 0.0 113.303 -177.361 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 54' ' ' CYS . 36.8 Cg_endo -59.45 -34.74 97.22 Favored 'Trans proline' 0 CA--C 1.508 -0.819 0 C-N-CA 122.427 2.085 . . . . 0.0 110.446 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.598 ' O ' ' O ' ' A' ' 52' ' ' GLY . 0.2 OUTLIER -174.52 167.17 3.9 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.659 -178.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.567 ' HD2' HG21 ' A' ' 49' ' ' ILE . 3.0 mmt180 -144.5 136.55 26.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.874 0.368 . . . . 0.0 110.992 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.845 HD12 HD23 ' A' ' 19' ' ' LEU . 4.5 mm -115.64 106.8 21.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.555 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.1 mt -85.98 94.05 4.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.882 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.0 m -80.04 101.87 8.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.138 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.588 ' O ' HG23 ' A' ' 15' ' ' THR . 0.1 OUTLIER -91.28 144.79 25.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.908 179.322 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.789 ' HB3' ' HB2' ' A' ' 46' ' ' ARG . . . -143.76 124.71 14.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.777 0.323 . . . . 0.0 111.051 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.57 164.0 13.28 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.159 -1.02 . . . . 0.0 113.104 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.563 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 78.6 Cg_exo -41.48 160.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 123.555 2.836 . . . . 0.0 113.798 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.591 HG21 ' HD2' ' A' ' 10' ' ' LYS . 13.6 t -57.89 -35.72 71.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.135 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.37 -52.48 46.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.917 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.35 -43.32 83.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.316 0.579 . . . . 0.0 110.429 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.616 HD11 HG12 ' A' ' 16' ' ' ILE . 0.5 OUTLIER -66.53 -39.4 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.842 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.85 -36.51 67.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.763 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.08 -38.94 63.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.691 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.507 ' HB2' ' CB ' ' A' ' 43' ' ' SER . . . -63.65 -48.25 77.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.149 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.575 ' CE2' HD13 ' A' ' 16' ' ' ILE . 1.2 m-85 -64.04 -43.06 96.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.473 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -68.78 -29.26 67.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.306 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.6 tpt -77.29 -48.3 17.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.688 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.812 HG22 HD11 ' A' ' 28' ' ' ILE . 2.2 pp -59.81 -42.98 90.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.252 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.597 HG23 ' CD1' ' A' ' 75' ' ' ILE . 18.6 pt -68.76 -36.01 72.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.852 0.358 . . . . 0.0 111.017 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -62.35 -47.63 83.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.024 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.486 ' HG3' ' N ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -62.39 -35.22 78.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.967 0.413 . . . . 0.0 110.149 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.486 ' N ' ' HG3' ' A' ' 78' ' ' LYS . 16.2 tp -77.53 -26.18 50.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.069 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -76.95 -35.71 57.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.597 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -72.07 -38.09 69.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.778 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.89 -35.87 71.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.863 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.6 mt -74.01 -34.99 40.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.082 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.5 m -97.49 38.02 1.31 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.935 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 m -89.41 5.07 46.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.352 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 70.43 39.02 1.27 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.91 0.386 . . . . 0.0 110.533 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 4.2 mtp -68.93 71.31 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.983 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.3 t -96.83 73.56 2.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.8 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -163.4 -49.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 64.6 p -69.48 -169.85 0.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.906 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.1 p -129.01 173.3 10.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.945 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -146.19 -175.77 4.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.054 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -99.34 -42.52 6.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.131 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 m 179.88 -71.08 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.898 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.22 95.23 9.38 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.08 110.97 2.32 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.541 2.16 . . . . 0.0 112.189 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.19 -167.5 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.514 2.143 . . . . 0.0 112.521 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.751 ' HB ' HD11 ' A' ' 155' ' ' ILE . 21.2 t -140.32 113.19 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.654 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.588 ' CG2' HG22 ' A' ' 147' ' ' THR . 0.7 OUTLIER -103.22 140.21 37.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.271 -179.556 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.623 HD12 HG21 ' A' ' 155' ' ' ILE . 1.1 tt -139.83 117.76 11.76 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.856 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -105.22 112.7 25.91 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.788 -178.266 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.538 HD23 ' N ' ' A' ' 103' ' ' VAL . 0.8 OUTLIER -106.37 147.53 29.13 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.741 179.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.836 ' CG2' HD11 ' A' ' 19' ' ' LEU . 11.1 t -100.6 138.04 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.273 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.445 HG23 ' SG ' ' A' ' 109' ' ' CYS . 2.6 m -144.87 157.54 54.4 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.001 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -65.89 157.63 58.15 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.596 2.197 . . . . 0.0 112.143 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 142' ' ' THR . . . -68.86 -34.84 76.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.391 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.1 m -70.55 -30.3 66.99 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -70.94 -46.54 62.25 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.628 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.445 ' SG ' HG23 ' A' ' 104' ' ' VAL . 21.6 m -61.8 -40.03 93.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.389 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.75 -50.12 71.14 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.21 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.1 m -67.59 -38.7 84.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 0.0 110.724 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.8 mt -57.3 -27.77 62.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.476 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.568 HG22 ' HA2' ' A' ' 117' ' ' GLY . 12.6 mt -83.14 -34.28 11.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.786 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.63 178.55 6.27 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.558 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -67.49 132.53 47.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.818 0.342 . . . . 0.0 110.882 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.73 16.77 59.52 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.633 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.568 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 63.1 15.74 56.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.871 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 95.9 m -52.88 -43.64 66.29 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.869 0.366 . . . . 0.0 111.401 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -63.68 -58.56 6.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.129 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.499 ' HA ' HD12 ' A' ' 123' ' ' ILE . 1.6 tt -54.22 -31.44 22.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.315 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.16 -41.93 89.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.856 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -73.23 -40.2 64.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.082 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.499 HD12 ' HA ' ' A' ' 120' ' ' ILE . 50.2 mt -58.61 -53.42 47.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.297 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.794 ' HG3' HG22 ' A' ' 131' ' ' VAL . 0.2 OUTLIER -67.27 -40.42 86.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.969 0.414 . . . . 0.0 111.077 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -54.54 -48.36 72.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.881 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.48 -39.02 17.94 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.466 HG21 HD11 ' A' ' 148' ' ' ILE . 18.2 m -49.37 -26.38 3.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.845 0.355 . . . . 0.0 110.333 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.42 -21.85 4.17 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.333 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.713 ' HB1' ' O ' ' A' ' 149' ' ' ALA . . . -108.27 170.89 7.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.949 0.374 . . . . 0.0 111.149 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.7 130.45 44.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.705 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.794 HG22 ' HG3' ' A' ' 124' ' ' ARG . 36.0 m -99.26 140.52 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.164 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.786 ' O ' HG23 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -109.11 158.39 17.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.197 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.5 t -137.53 134.99 46.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.181 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.401 ' HB3' ' H ' ' A' ' 145' ' ' ALA . . . -79.99 134.27 36.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.077 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -80.32 131.49 10.55 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.562 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.401 ' HB3' ' CB ' ' A' ' 141' ' ' SER . 46.5 m-20 -157.93 26.75 0.27 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.049 0.452 . . . . 0.0 109.788 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 35.1 mtm -93.96 52.22 1.62 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.97 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.443 ' N ' ' HD2' ' A' ' 139' ' ' PRO . 0.2 OUTLIER -176.13 -61.19 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.519 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 138' ' ' LEU . 15.0 Cg_endo -55.58 -90.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.392 2.061 . . . . 0.0 112.391 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -178.95 15.62 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.401 ' CB ' ' HB3' ' A' ' 136' ' ' ASP . 0.1 OUTLIER -62.29 163.02 8.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.792 0.33 . . . . 0.0 110.815 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.669 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 13.2 t -118.57 -46.56 2.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.887 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.493 ' OE2' ' NH2' ' A' ' 17' ' ' ARG . 3.0 mt-10 -104.07 137.74 41.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.7 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -109.97 140.84 43.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.93 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.401 ' H ' ' HB3' ' A' ' 134' ' ' ALA . . . -96.42 153.46 17.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.17 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.786 HG23 ' O ' ' A' ' 132' ' ' GLN . 74.9 mt -125.18 140.05 49.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.667 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.588 HG22 ' CG2' ' A' ' 99' ' ' THR . 0.2 OUTLIER -119.07 114.93 23.26 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.409 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.52 HD13 ' HB2' ' A' ' 158' ' ' CYS . 0.6 OUTLIER -104.1 121.47 55.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.109 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.713 ' O ' ' HB1' ' A' ' 129' ' ' ALA . . . -118.39 134.71 54.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.13 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 162.13 -151.91 22.09 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.532 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.814 ' O ' HD12 ' A' ' 155' ' ' ILE . 2.9 pt -87.0 162.06 45.07 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.57 0.224 . . . . 0.0 110.962 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 151' ' ' ILE . 72.7 Cg_exo -49.62 -32.84 29.3 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.517 2.144 . . . . 0.0 112.218 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.517 ' HB2' HD12 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -71.91 -34.65 69.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.757 179.662 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.617 ' HB2' ' HB2' ' A' ' 129' ' ' ALA . 10.6 p -67.92 -50.29 56.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.039 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.814 HD12 ' O ' ' A' ' 151' ' ' ILE . 2.7 mp -59.33 -51.52 71.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.157 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -55.84 -30.7 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.135 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -69.26 -48.0 63.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.834 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . 0.52 ' HB2' HD13 ' A' ' 148' ' ' ILE . 17.7 t -61.58 -44.06 97.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.96 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 155' ' ' ILE . 59.9 t -59.49 -38.95 77.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.956 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -32.86 74.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.711 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.779 ' O ' HG23 ' A' ' 165' ' ' VAL . 2.0 tt0 -71.71 -45.67 61.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 30.5 mm -69.92 -34.41 59.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.044 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 47.7 t -65.42 -52.4 53.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.117 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.471 HG13 ' N ' ' A' ' 165' ' ' VAL . 12.3 p -61.49 -45.14 99.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.225 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.779 HG23 ' O ' ' A' ' 161' ' ' GLN . 54.8 t -63.82 -40.28 88.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.914 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 32.4 mtt -56.98 -45.63 82.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.808 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.642 HD21 HG21 ' A' ' 12' ' ' VAL . 7.8 tt -65.11 -45.19 86.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.804 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.96 -2.72 25.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.902 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 165' ' ' VAL . 39.1 p . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.887 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.949 0.404 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -156.64 -78.81 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.819 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.827 HG21 HD11 ' A' ' 167' ' ' LEU . 11.5 t -115.09 154.98 16.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.812 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.767 ' C ' HD22 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -109.21 131.36 55.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.693 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.767 HD22 ' C ' ' A' ' 13' ' ' THR . 4.3 mm? -130.44 158.49 39.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.148 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.2 m -141.97 133.59 26.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.749 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.629 HG22 HD11 ' A' ' 68' ' ' ILE . 3.8 tt -137.36 148.03 26.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.354 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.487 ' NH2' ' OE1' ' A' ' 143' ' ' GLU . 0.0 OUTLIER -129.35 131.1 46.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.709 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.411 ' O ' HG23 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -121.58 139.22 53.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.103 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.732 HD23 HG13 ' A' ' 103' ' ' VAL . 2.6 pp -108.72 136.02 48.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.758 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.11 162.4 33.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.827 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.73 ' O ' HG12 ' A' ' 25' ' ' VAL . 3.8 m-70 -67.58 169.63 8.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.536 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.65 -44.77 96.59 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.103 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.5 -38.51 40.58 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.69 -50.74 56.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.925 0.393 . . . . 0.0 110.655 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.747 HG23 HD11 ' A' ' 59' ' ' ILE . 9.8 p -63.44 -35.02 70.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.841 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.16 -34.92 90.63 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.32 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.3 m -75.38 -28.2 59.39 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.802 0.334 . . . . 0.0 110.68 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.431 ' N ' HD13 ' A' ' 28' ' ' ILE . 3.6 mm -78.84 -45.61 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.08 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.754 ' HA ' HG13 ' A' ' 36' ' ' VAL . 13.0 mt -60.59 -42.56 92.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.385 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.65 150.34 16.68 Favored Glycine 0 N--CA 1.435 -1.427 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.611 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.567 ' HG2' ' HG3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -58.15 145.75 35.88 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.593 -0.804 . . . . 0.0 111.588 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.571 ' HE3' ' HB3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 45.98 27.93 0.56 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.248 -178.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.436 ' O ' HG23 ' A' ' 36' ' ' VAL . . . 47.29 17.92 0.45 Allowed Glycine 0 CA--C 1.522 0.507 0 N-CA-C 114.784 0.673 . . . . 0.0 114.784 178.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.571 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 2.7 tm-20 -75.27 -25.46 58.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.752 0.776 . . . . 0.0 109.856 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -41.87 59.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.415 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.754 HG13 ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -67.24 -26.21 35.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 178.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.6 -36.75 70.94 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -62.94 -35.82 81.38 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.852 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.401 ' HA ' ' CE ' ' A' ' 39' ' ' MET . 0.0 OUTLIER -65.96 -43.46 87.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.392 179.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -56.63 -51.05 70.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.131 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -61.55 -37.5 84.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.778 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -74.62 -36.48 62.94 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.897 ' CB ' ' HB2' ' A' ' 71' ' ' ALA . 94.5 p -92.57 -55.86 3.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.862 0.363 . . . . 0.0 111.145 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.33 0.78 50.62 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.041 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.491 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . . . -110.76 128.16 55.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.877 0.338 . . . . 0.0 111.654 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 2.6 ttt180 -27.44 141.07 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.061 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.416 HG12 HD12 ' A' ' 61' ' ' LEU . 13.6 mt -142.32 100.44 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.76 0.314 . . . . 0.0 111.301 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -116.09 173.46 6.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.724 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.824 HG21 ' NE ' ' A' ' 57' ' ' ARG . 4.8 mt -126.5 151.97 33.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.121 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 94.3 p -83.74 -171.28 3.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.199 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.07 -167.51 0.51 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.382 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.56 -77.29 0.83 Allowed Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.313 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 48.79 27.47 1.58 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.828 0.346 . . . . 0.0 110.397 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.515 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -150.47 -68.17 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.571 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.515 ' HD3' ' HB3' ' A' ' 54' ' ' CYS . 91.2 Cg_endo -74.46 -32.07 6.61 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.809 1.673 . . . . 0.0 110.366 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.71 172.18 1.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.782 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.824 ' NE ' HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -145.87 135.37 23.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.54 179.266 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.411 HG23 ' O ' ' A' ' 18' ' ' LEU . 26.1 mt -98.44 115.96 40.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.804 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.747 HD11 HG23 ' A' ' 25' ' ' VAL . 3.2 mt -86.62 101.21 10.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.285 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.405 ' CG2' ' HD3' ' A' ' 17' ' ' ARG . 89.2 m -90.01 138.25 31.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.94 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.675 HD22 HG13 ' A' ' 68' ' ' ILE . 7.3 tt -131.51 132.9 44.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.264 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.463 ' O ' ' HB1' ' A' ' 45' ' ' ALA . . . -128.68 133.85 48.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.742 0.306 . . . . 0.0 111.12 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.28 164.46 13.72 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.754 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.424 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 82.4 Cg_exo -39.58 162.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.147 2.565 . . . . 0.0 113.29 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.514 ' O ' HG22 ' A' ' 68' ' ' ILE . 73.5 m -59.69 -35.66 74.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.29 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -64.2 -51.96 61.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.782 0.325 . . . . 0.0 111.319 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.491 ' CB ' ' HB2' ' A' ' 45' ' ' ALA . . . -57.04 -37.98 72.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.351 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.675 HG13 HD22 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -66.16 -39.48 84.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.538 -179.231 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.26 -49.3 74.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.366 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.67 -47.23 82.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.117 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.897 ' HB2' ' CB ' ' A' ' 43' ' ' SER . . . -58.04 -56.3 23.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.316 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.412 ' HA ' HD12 ' A' ' 75' ' ' ILE . 0.4 OUTLIER -53.35 -42.52 66.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.339 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.27 -48.05 81.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.48 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 20.7 mmm -70.45 -33.88 71.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.178 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 72' ' ' PHE . 17.6 mt -68.09 -38.26 79.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.473 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.415 HG13 ' N ' ' A' ' 77' ' ' ASP . 36.6 pt -71.47 -38.44 68.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.071 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.415 ' N ' HG13 ' A' ' 76' ' ' ILE . 0.7 OUTLIER -63.39 -47.41 82.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.659 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.31 -36.39 83.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.947 0.403 . . . . 0.0 110.058 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.5 tp -77.58 -23.08 50.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.47 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.535 ' O ' HG22 ' A' ' 83' ' ' ILE . 21.0 tt0 -76.4 -49.31 17.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.99 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -72.27 -32.32 66.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.862 0.363 . . . . 0.0 111.067 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -57.96 -32.72 68.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.824 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 80' ' ' GLU . 0.6 OUTLIER -53.5 -49.6 53.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.938 0.399 . . . . 0.0 111.631 -179.214 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.51 ' N ' HG23 ' A' ' 83' ' ' ILE . 0.3 OUTLIER 177.93 -155.28 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.625 -179.662 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.4 p -139.55 30.82 2.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.876 0.37 . . . . 0.0 110.898 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.34 -169.26 0.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.839 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 10.0 mtp -80.19 -177.96 6.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.935 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.2 t -84.5 -169.84 2.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.931 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -121.31 -176.53 3.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 t -92.78 80.85 4.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.913 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.0 m -121.18 -46.61 2.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.85 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -144.69 175.17 10.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.102 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.29 -39.42 90.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.081 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.4 t 56.02 73.26 0.44 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.954 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.411 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 0.7 OUTLIER -72.27 -60.91 2.0 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.951 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.455 ' HB3' ' HB1' ' A' ' 149' ' ' ALA . 59.8 Cg_endo -72.29 109.79 2.81 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.585 2.19 . . . . 0.0 112.353 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.7 -41.88 3.95 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.671 2.247 . . . . 0.0 112.124 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.54 HG21 ' HG3' ' A' ' 152' ' ' PRO . 24.9 t -140.81 115.45 6.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.813 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 50.2 p -103.08 142.32 34.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.899 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.446 HD23 HD21 ' A' ' 102' ' ' LEU . 0.5 OUTLIER -139.96 117.55 11.52 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 178.656 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.534 ' HD2' HG23 ' A' ' 147' ' ' THR . 0.1 OUTLIER -103.67 112.4 25.32 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.36 -178.579 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.446 HD21 HD23 ' A' ' 100' ' ' LEU . 4.5 mm? -102.14 143.17 32.3 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.928 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.732 HG13 HD23 ' A' ' 19' ' ' LEU . 31.2 m -107.82 142.93 19.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.07 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.556 HG13 ' O ' ' A' ' 103' ' ' VAL . 4.4 m -159.53 157.16 26.39 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.33 172.08 9.48 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.559 2.173 . . . . 0.0 112.308 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.15 -34.64 78.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.517 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.21 -30.48 68.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.151 0.501 . . . . 0.0 109.848 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.41 ' CB ' ' HB ' ' A' ' 104' ' ' VAL . 2.2 mm100 -72.64 -49.78 29.57 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.724 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.5 m -62.94 -37.98 89.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.365 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.25 -43.25 99.62 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.249 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 83.6 p -74.49 -38.48 62.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.741 0.305 . . . . 0.0 110.655 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.7 mt -57.25 -27.95 62.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.563 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.606 HG22 ' HA2' ' A' ' 117' ' ' GLY . 10.4 mt -85.6 -36.74 11.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.847 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.59 -178.98 30.88 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.461 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.0 ttmm -66.99 123.68 20.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 0.0 111.204 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.6 15.29 57.21 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.012 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.606 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 73.58 5.1 67.28 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.955 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 31.9 p -52.92 -35.64 58.57 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.848 0.356 . . . . 0.0 111.631 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -65.53 -65.29 0.69 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.155 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.877 HD11 HG21 ' A' ' 131' ' ' VAL . 0.5 OUTLIER -54.75 -30.05 22.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.297 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -50.4 71.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.812 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -61.22 -40.55 94.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.203 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.775 HG23 ' OE1' ' A' ' 161' ' ' GLN . 44.4 mm -57.09 -53.94 36.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.807 0.337 . . . . 0.0 110.907 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.62 -32.91 74.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.822 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -57.14 -52.65 64.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.569 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.02 -46.99 8.43 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.583 HG21 ' SG ' ' A' ' 158' ' ' CYS . 92.3 m -47.39 -25.92 1.17 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.944 0.402 . . . . 0.0 110.485 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.11 -7.54 21.9 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.355 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -108.3 141.39 40.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.996 0.398 . . . . 0.0 111.209 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -79.14 141.08 37.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.877 HG21 HD11 ' A' ' 120' ' ' ILE . 34.8 m -107.39 143.17 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.157 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.805 ' O ' HG23 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -113.84 158.41 21.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.278 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.8 m -137.41 128.2 39.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.08 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.79 161.06 31.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.116 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -84.25 -142.76 5.52 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.607 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -126.34 -20.86 4.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.696 0.284 . . . . 0.0 111.145 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 9.2 mtp 66.14 -177.89 0.19 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.844 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.477 ' HB2' ' HD3' ' A' ' 139' ' ' PRO . 1.1 mp -83.5 -49.52 0.71 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.178 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.477 ' HD3' ' HB2' ' A' ' 138' ' ' LEU . 37.6 Cg_exo -60.06 -20.06 59.06 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.375 2.05 . . . . 0.0 112.387 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 71.19 105.37 0.06 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.052 0.453 . . . . 0.0 110.692 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.93 -171.5 3.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.07 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.546 HG23 ' HG3' ' A' ' 143' ' ' GLU . 15.0 t -121.41 -40.49 2.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.567 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.546 ' HG3' HG23 ' A' ' 142' ' ' THR . 9.9 mt-10 -107.27 145.76 32.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.416 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -109.86 161.48 15.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.904 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -118.51 155.0 31.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.329 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.805 HG23 ' O ' ' A' ' 132' ' ' GLN . 69.7 mt -129.66 141.01 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.401 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 132' ' ' GLN . 0.4 OUTLIER -116.41 117.42 29.9 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.432 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.834 HD12 HG12 ' A' ' 131' ' ' VAL . 8.1 mm -104.08 120.54 54.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.793 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.455 ' HB1' ' HB3' ' A' ' 96' ' ' PRO . . . -118.31 137.22 53.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.128 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 160.77 -151.68 22.19 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.593 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.529 ' CG2' ' HD2' ' A' ' 152' ' ' PRO . 15.4 mt -85.48 144.52 40.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.54 ' HG3' HG21 ' A' ' 98' ' ' VAL . 72.3 Cg_exo -48.96 -32.51 23.35 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.98 1.787 . . . . 0.0 111.552 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -72.08 -34.83 68.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.62 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 57.9 m -70.94 -39.31 72.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.61 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.406 ' O ' HG23 ' A' ' 159' ' ' VAL . 40.5 mm -64.53 -50.06 77.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.909 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.9 mt -57.19 -38.39 61.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.7 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -66.24 -38.8 88.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.497 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . 0.583 ' SG ' HG21 ' A' ' 127' ' ' THR . 0.9 OUTLIER -61.57 -45.63 93.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.591 179.669 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.472 ' HA ' HD12 ' A' ' 162' ' ' ILE . 32.9 t -59.97 -36.09 64.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.796 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.437 ' O ' HG12 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -64.41 -32.98 74.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.62 179.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.775 ' OE1' HG23 ' A' ' 123' ' ' ILE . 47.4 mt-30 -72.19 -31.82 66.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.887 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 159' ' ' VAL . 29.8 mt -74.01 -36.34 44.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.077 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 1.3 m -74.01 -43.29 58.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.939 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.496 HG13 ' N ' ' A' ' 165' ' ' VAL . 11.2 p -66.29 -45.76 88.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.32 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 161' ' ' GLN . 11.8 p -61.76 -42.54 94.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.021 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.437 ' N ' HG13 ' A' ' 165' ' ' VAL . 0.3 OUTLIER -59.17 -40.03 84.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.796 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.827 HD11 HG21 ' A' ' 12' ' ' VAL . 1.2 tt -72.64 -43.99 62.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.78 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -73.97 -2.64 24.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.034 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 165' ' ' VAL . 32.5 p . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.895 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.827 0.346 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -101.78 -76.64 0.57 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.842 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.82 ' CG1' HD13 ' A' ' 167' ' ' LEU . 6.8 p -107.34 159.87 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.029 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.524 ' N ' HG22 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -103.65 140.65 37.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.804 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.441 ' HA ' HD23 ' A' ' 14' ' ' LEU . 3.5 mt -131.24 171.32 13.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.027 0.441 . . . . 0.0 111.297 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.623 HG23 ' HB2' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -142.63 117.91 10.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.615 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.823 HG22 HD11 ' A' ' 68' ' ' ILE . 15.5 tt -121.51 156.66 25.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.908 0.385 . . . . 0.0 111.283 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.637 ' HG3' HG23 ' A' ' 60' ' ' THR . 1.9 mtp85 -134.46 111.92 10.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.643 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.543 HD13 HD12 ' A' ' 102' ' ' LEU . 0.6 OUTLIER -89.38 145.3 25.43 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.749 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.443 ' HG ' ' CB ' ' A' ' 55' ' ' PRO . 7.0 tt -122.51 121.1 35.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.544 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.409 ' CB ' ' HB ' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -148.07 163.19 37.67 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.374 0.607 . . . . 0.0 112.121 -179.515 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.93 ' O ' HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -76.48 134.72 39.44 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.542 179.545 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -45.7 -25.47 1.5 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 121.024 -0.608 . . . . 0.0 113.556 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.38 -52.46 9.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.942 0.371 . . . . 0.0 111.609 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -71.09 -51.0 27.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.993 0.425 . . . . 0.0 110.402 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.93 HG12 ' O ' ' A' ' 21' ' ' HIS . 10.0 p -62.8 -33.9 62.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.296 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.52 -37.75 94.66 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.641 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.3 t -68.38 -28.42 67.1 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.421 ' N ' HD13 ' A' ' 28' ' ' ILE . 4.6 mm -80.59 -32.55 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.567 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.617 HD11 HG22 ' A' ' 25' ' ' VAL . 3.2 mm -60.59 -45.22 97.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.902 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.46 ' HA3' ' CB ' ' A' ' 35' ' ' SER . . . 94.69 150.57 27.23 Favored Glycine 0 N--CA 1.436 -1.347 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.812 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.419 ' C ' ' HD3' ' A' ' 32' ' ' LYS . 8.0 tttm -64.4 146.31 54.68 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.571 -0.814 . . . . 0.0 111.659 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.419 ' HD3' ' C ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER 63.01 6.74 2.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.847 179.635 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.529 ' O ' HG23 ' A' ' 36' ' ' VAL . . . 59.9 7.07 5.94 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 119.822 -1.18 . . . . 0.0 111.795 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.402 ' HB2' ' CE ' ' A' ' 32' ' ' LYS . 1.5 tm-20 -71.8 -28.21 63.45 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.025 0.44 . . . . 0.0 109.878 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.46 ' CB ' ' HA3' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -75.03 -36.34 61.9 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.265 179.496 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -67.32 -26.56 36.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -69.88 -36.81 75.76 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -65.04 -34.78 79.25 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.844 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.409 ' HE3' ' HA ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -64.16 -46.44 84.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.616 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.479 ' HA ' HD12 ' A' ' 47' ' ' ILE . 53.5 mtt180 -58.26 -51.18 70.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.289 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.02 -38.16 90.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.203 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -74.85 -36.06 62.35 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.713 ' HB2' ' HB2' ' A' ' 71' ' ' ALA . 12.1 t -77.9 -47.23 19.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.898 0.38 . . . . 0.0 111.116 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.89 -8.42 76.11 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.398 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.665 ' HB3' HD21 ' A' ' 61' ' ' LEU . . . -110.79 128.75 55.88 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.493 0.187 . . . . 0.0 111.108 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 4.5 mtt-85 -26.99 139.37 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.058 0.543 . . . . 0.0 112.038 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 40' ' ' ARG . 11.1 mt -142.13 116.31 4.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.714 0.292 . . . . 0.0 111.317 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -133.68 122.07 22.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.059 0.456 . . . . 0.0 110.907 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.887 ' HB ' HD13 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -108.15 130.78 60.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.902 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.5 t 168.6 169.8 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.067 0.46 . . . . 0.0 111.383 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.4 ' HB3' HD12 ' A' ' 58' ' ' ILE . 3.9 tt0 67.06 162.33 0.17 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.894 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 54' ' ' CYS . . . 128.4 84.7 0.44 Allowed Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.812 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.37 41.5 0.47 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.498 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -162.59 -63.95 0.01 OUTLIER Pre-proline 0 N--CA 1.449 -0.507 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.835 -179.016 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.527 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 76.7 Cg_endo -78.84 -32.41 1.99 Allowed 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.522 2.148 . . . . 0.0 111.252 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 55' ' ' PRO . 1.9 mt-10 92.21 -31.75 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.204 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.822 ' CB ' HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -133.89 130.76 38.27 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.034 0.445 . . . . 0.0 111.605 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 47.6 mt -129.46 109.93 19.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.491 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.887 HD13 ' HB ' ' A' ' 49' ' ' ILE . 7.1 mm -85.96 94.99 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.951 0.405 . . . . 0.0 111.537 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.637 HG23 ' HG3' ' A' ' 17' ' ' ARG . 50.0 m -88.82 105.85 17.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.841 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.753 HD22 HG13 ' A' ' 68' ' ' ILE . 9.1 tt -107.85 136.71 47.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.621 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.623 ' HB2' HG23 ' A' ' 15' ' ' THR . . . -133.51 133.74 42.58 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.541 0.21 . . . . 0.0 110.864 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.16 164.92 14.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.894 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 92.6 Cg_exo -41.35 162.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.04 2.494 . . . . 0.0 113.161 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.469 ' O ' HG22 ' A' ' 68' ' ' ILE . 4.1 t -60.19 -35.56 75.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.206 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -63.88 -51.81 62.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.228 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.458 ' CB ' ' HB2' ' A' ' 45' ' ' ALA . . . -57.26 -44.67 84.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.0 0.428 . . . . 0.0 111.003 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.823 HD11 HG22 ' A' ' 16' ' ' ILE . 1.5 tt -66.43 -39.42 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.666 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.27 -48.38 76.7 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.108 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.88 -48.02 78.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.899 0.38 . . . . 0.0 110.832 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.713 ' HB2' ' HB2' ' A' ' 43' ' ' SER . . . -57.72 -40.64 80.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.423 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.477 ' O ' HG23 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -61.47 -48.29 81.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.218 -179.663 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.406 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -68.72 -29.28 67.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.94 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.8 mmm -77.46 -48.43 17.15 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 72' ' ' PHE . 1.2 pp -61.34 -41.43 89.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.311 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.477 HG23 ' O ' ' A' ' 72' ' ' PHE . 26.0 pt -67.8 -38.91 81.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.808 0.337 . . . . 0.0 110.907 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.22 -32.16 73.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.399 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -40.42 86.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.174 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.7 tp -77.49 -25.62 50.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.492 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -77.06 -41.48 42.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -72.11 -36.64 69.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.904 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.2 -53.4 57.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 15.0 pt -54.27 -43.61 62.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.358 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.69 -30.98 71.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.939 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 35.9 t -118.59 37.75 3.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.896 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.8 t -162.14 126.13 3.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.959 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 2.0 mtt -86.38 -178.01 6.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 95.3 m 57.07 85.34 0.08 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.936 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.688 ' OD1' HG22 ' A' ' 91' ' ' THR . 1.4 p30 -156.57 -45.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.896 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.4 m 63.31 85.29 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.688 HG22 ' OD1' ' A' ' 89' ' ' ASN . 6.1 t -143.17 128.54 18.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.894 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 60.84 39.87 16.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.025 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -111.61 31.02 6.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.064 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -172.94 -41.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.889 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.439 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -173.9 -63.64 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.181 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 95' ' ' ARG . 10.2 Cg_endo -51.61 104.37 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.718 2.279 . . . . 0.0 112.438 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.432 ' HG2' ' CA ' ' A' ' 150' ' ' GLY . 35.9 Cg_endo -68.08 -68.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.324 2.016 . . . . 0.0 112.642 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.6 t -137.25 111.67 9.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.913 0.387 . . . . 0.0 111.022 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.641 HG22 ' HB2' ' A' ' 149' ' ' ALA . 38.8 p -103.24 138.36 40.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.982 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.94 117.79 11.72 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.409 ' HB3' HG23 ' A' ' 147' ' ' THR . 4.1 ptp180 -102.26 112.5 25.22 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.367 -178.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.543 HD12 HD13 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -110.63 145.53 37.74 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.032 -179.646 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.419 ' CG1' ' HB3' ' A' ' 17' ' ' ARG . 11.9 p -95.98 131.47 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.72 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.473 HG23 ' HD2' ' A' ' 105' ' ' PRO . 7.5 p -130.22 145.78 58.79 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.171 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.473 ' HD2' HG23 ' A' ' 104' ' ' VAL . 22.5 Cg_exo -65.62 163.4 30.34 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.537 2.158 . . . . 0.0 111.987 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 142' ' ' THR . . . -69.25 -39.69 78.31 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 25.8 m -69.72 -30.48 68.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.289 0.566 . . . . 0.0 109.626 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.471 ' HB3' HG22 ' A' ' 104' ' ' VAL . 0.9 OUTLIER -74.58 -49.48 21.61 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.53 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.478 ' O ' HD12 ' A' ' 113' ' ' ILE . 1.8 t -65.47 -37.42 86.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.935 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.38 -51.46 57.56 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.041 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.3 m -72.88 -34.87 66.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.806 0.336 . . . . 0.0 110.438 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.516 ' CD2' HD12 ' A' ' 162' ' ' ILE . 9.7 mt -60.88 -29.07 69.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.129 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.532 HG22 ' HA2' ' A' ' 117' ' ' GLY . 12.4 mt -80.41 -37.95 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.623 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.76 -179.26 44.53 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.458 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.05 122.23 17.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.867 0.365 . . . . 0.0 111.012 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.08 11.91 56.33 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.927 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.532 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 72.15 6.17 64.08 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.02 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -53.16 -39.98 63.99 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.691 ' HD2' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -63.23 -65.33 0.7 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.762 -179.234 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.813 ' HA ' HD12 ' A' ' 123' ' ' ILE . 0.9 OUTLIER -58.03 -37.65 62.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.634 -179.356 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.3 -44.75 80.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.332 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -73.12 -39.29 65.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.313 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.813 HD12 ' HA ' ' A' ' 120' ' ' ILE . 24.3 mt -58.13 -53.88 39.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.264 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.0 ptt85 -67.97 -35.02 77.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.879 0.371 . . . . 0.0 111.071 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -54.92 -50.63 68.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.177 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 53.3 p -83.86 -36.1 23.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.374 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.515 HG21 ' SG ' ' A' ' 158' ' ' CYS . 18.2 m -50.28 -26.13 4.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.807 0.337 . . . . 0.0 110.256 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 88.84 -21.75 25.27 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.981 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -102.49 155.82 18.01 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.823 0.344 . . . . 0.0 111.152 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -105.17 132.85 50.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.023 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.523 HG12 HG13 ' A' ' 148' ' ' ILE . 5.6 m -99.18 138.78 22.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.895 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.697 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 0.1 OUTLIER -116.94 116.67 27.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.107 0.479 . . . . 0.0 112.04 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.9 p -100.67 140.28 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.543 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.21 161.36 30.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.928 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.98 -123.34 0.01 OUTLIER Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.721 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.93 20.79 1.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.686 0.279 . . . . 0.0 111.188 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 5.7 mmt 51.83 179.79 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.911 0.386 . . . . 0.0 111.212 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.413 ' N ' ' CD ' ' A' ' 139' ' ' PRO . 0.2 OUTLIER -92.14 -50.79 0.29 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.26 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 138' ' ' LEU . 2.0 Cg_endo -84.96 39.36 0.73 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.039 2.493 . . . . 0.0 112.699 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 63.27 103.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.079 0.466 . . . . 0.0 110.861 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.0 p -77.06 159.37 29.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.828 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.471 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 1.5 m -117.73 -46.22 2.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.82 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.498 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 43.9 mt-10 -108.54 138.01 45.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.762 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -109.9 148.84 30.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.833 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -105.98 128.82 54.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.218 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.697 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 28.5 mm -108.6 127.25 65.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.866 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' A' ' 132' ' ' GLN . 0.2 OUTLIER -108.06 114.67 28.76 Favored 'General case' 0 N--CA 1.46 0.07 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.711 179.76 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.523 HG13 HG12 ' A' ' 131' ' ' VAL . 3.2 mp -104.1 117.53 49.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.409 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.641 ' HB2' HG22 ' A' ' 99' ' ' THR . . . -118.91 126.07 50.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.856 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.432 ' CA ' ' HG2' ' A' ' 97' ' ' PRO . . . 171.26 -153.04 19.61 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.693 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.532 HG23 ' HD2' ' A' ' 152' ' ' PRO . 4.4 mt -86.98 143.3 34.86 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 110.569 -0.16 . . . . 0.0 110.569 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.876 ' HA ' HD12 ' A' ' 155' ' ' ILE . 6.0 Cg_endo -48.63 -34.18 26.18 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.258 1.972 . . . . 0.0 111.609 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.436 ' O ' HG22 ' A' ' 156' ' ' ILE . 4.0 pp0? -72.09 -34.65 68.82 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 19.2 m -68.84 -44.48 73.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.648 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.876 HD12 ' HA ' ' A' ' 152' ' ' PRO . 4.2 mt -60.64 -52.49 60.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.806 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 153' ' ' GLN . 7.8 tp -56.02 -31.06 30.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.861 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -70.08 -37.07 75.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.706 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . 0.515 ' SG ' HG21 ' A' ' 127' ' ' THR . 0.5 OUTLIER -64.01 -52.91 57.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.643 179.724 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 34.3 t -59.37 -31.97 47.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.773 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 7.4 ttmt -67.46 -34.45 77.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.748 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.79 ' O ' HG23 ' A' ' 165' ' ' VAL . 0.3 OUTLIER -70.45 -35.1 73.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.712 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.516 HD12 ' CD2' ' A' ' 112' ' ' LEU . 34.2 mm -73.4 -34.42 43.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.951 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 4.2 t -73.91 -46.39 44.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.043 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.24 -41.38 86.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.126 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' ' 161' ' ' GLN . 59.5 t -69.28 -47.54 73.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.797 0.332 . . . . 0.0 110.859 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -32.77 65.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.82 HD13 ' CG1' ' A' ' 12' ' ' VAL . 62.3 tp -71.91 -47.35 53.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.762 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -73.86 -2.72 24.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.081 0.467 . . . . 0.0 112.027 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 72.6 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.803 -179.994 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.816 0.341 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -176.31 83.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.95 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 64' ' ' PRO . 5.6 t -105.62 146.87 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.772 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 7.1 m -103.64 151.38 23.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.158 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' A' ' 14' ' ' LEU . 4.6 mt -138.32 176.21 8.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.984 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.41 125.32 16.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.901 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 1.043 HG22 HD11 ' A' ' 68' ' ' ILE . 7.4 tt -140.82 133.52 31.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.318 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.496 ' NH2' ' OE1' ' A' ' 143' ' ' GLU . 16.6 mtt180 -112.58 139.06 48.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.703 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.419 HD23 HD11 ' A' ' 100' ' ' LEU . 3.5 mp -113.74 138.82 49.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.938 0.399 . . . . 0.0 111.091 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.05 114.22 23.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.703 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.87 161.92 26.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.072 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.579 ' O ' HG12 ' A' ' 25' ' ' VAL . 27.6 m170 -74.69 175.0 8.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.899 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.57 -40.77 99.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.666 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.48 -44.23 25.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.829 0.347 . . . . 0.0 111.123 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.42 ' O ' HG23 ' A' ' 28' ' ' ILE . 42.4 mt-10 -61.92 -43.98 97.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.081 0.467 . . . . 0.0 110.281 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.758 HG21 ' CB ' ' A' ' 57' ' ' ARG . 9.8 p -68.66 -30.34 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.561 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.28 -39.32 97.56 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.538 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.87 -36.2 59.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.732 0.301 . . . . 0.0 111.474 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 25' ' ' VAL . 2.0 pp -78.5 -32.47 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.683 ' HA ' HG13 ' A' ' 36' ' ' VAL . 7.6 mm -70.62 -52.88 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.464 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.426 ' HA3' ' CB ' ' A' ' 35' ' ' SER . . . 99.69 150.33 25.07 Favored Glycine 0 N--CA 1.437 -1.297 0 CA-C-O 121.791 0.662 . . . . 0.0 112.967 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.49 ' C ' ' HD3' ' A' ' 32' ' ' LYS . 6.6 mttt -66.09 146.39 54.72 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.398 -0.901 . . . . 0.0 111.348 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.529 ' HE3' ' HB2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 61.59 6.9 1.65 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.583 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.52 ' O ' HG23 ' A' ' 36' ' ' VAL . . . 59.16 8.22 6.08 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.304 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.529 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 3.7 mt-10 -75.58 -30.56 59.68 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 122.402 -0.47 . . . . 0.0 109.915 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.526 ' HA ' ' HG2' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -67.91 -42.67 80.75 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.26 179.462 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.683 HG13 ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -66.86 -26.16 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.548 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.18 -36.63 83.58 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.526 ' HG2' ' HA ' ' A' ' 35' ' ' SER . 41.5 mmtt -59.96 -43.3 95.13 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.579 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.42 -47.14 82.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.914 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.25 -51.05 71.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.226 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -64.35 -37.79 88.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.98 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -74.59 -36.61 63.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.872 ' HB2' ' HB2' ' A' ' 71' ' ' ALA . 46.9 t -90.55 -55.79 3.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.946 0.403 . . . . 0.0 110.753 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.7 10.78 61.3 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.915 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.649 ' HB3' HD21 ' A' ' 61' ' ' LEU . . . -109.21 127.63 54.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 117.048 0.424 . . . . 0.0 111.554 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.545 ' HB2' ' HB3' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -27.94 104.08 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.294 178.869 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 60' ' ' THR . 3.3 mt -116.02 100.62 10.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.777 0.322 . . . . 0.0 110.419 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.483 ' O ' ' HB ' ' A' ' 60' ' ' THR . 2.4 p30 -121.61 125.83 47.64 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.617 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.7 mt -100.0 142.27 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.73 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.6 m -161.68 -177.81 6.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.024 0.44 . . . . 0.0 111.552 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.799 ' CB ' HD13 ' A' ' 58' ' ' ILE . 0.4 OUTLIER 64.68 134.81 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.306 179.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.56 -77.09 0.09 OUTLIER Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.929 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.7 m120 57.9 19.02 5.42 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -178.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.548 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -148.01 -69.16 0.02 OUTLIER Pre-proline 0 N--CA 1.452 -0.37 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.871 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 54' ' ' CYS . 68.1 Cg_endo -81.5 -34.88 0.48 Allowed 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.128 1.885 . . . . 0.0 111.255 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.16 167.25 22.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.247 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.758 ' CB ' HG21 ' A' ' 25' ' ' VAL . 6.3 mtt180 -145.77 127.61 15.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.926 0.393 . . . . 0.0 111.207 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.799 HD13 ' CB ' ' A' ' 51' ' ' GLU . 2.4 mp -101.04 104.72 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.612 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.1 mp -86.43 95.1 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.411 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 47' ' ' ILE . 27.7 m -73.8 131.0 41.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.688 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.649 HD21 ' HB3' ' A' ' 45' ' ' ALA . 1.5 tt -131.59 129.64 41.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.652 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.553 ' O ' ' HB1' ' A' ' 45' ' ' ALA . . . -139.45 130.45 26.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.699 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.35 165.18 14.68 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.116 -1.04 . . . . 0.0 112.783 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 80.6 Cg_exo -39.37 154.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.135 2.557 . . . . 0.0 113.216 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.425 ' O ' HG22 ' A' ' 68' ' ' ILE . 3.8 m -59.04 -35.35 73.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.864 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -67.03 -52.02 47.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.186 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.26 -42.93 82.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.058 0.456 . . . . 0.0 110.795 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 1.043 HD11 HG22 ' A' ' 16' ' ' ILE . 1.0 OUTLIER -66.44 -39.46 84.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.172 -179.515 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.52 -47.01 87.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.065 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -50.59 73.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.938 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.872 ' HB2' ' HB2' ' A' ' 43' ' ' SER . . . -58.72 -40.68 84.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.153 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.78 -42.69 99.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.093 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.79 -39.31 88.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.167 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.9 mtt -78.04 -32.49 50.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.841 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.14 -46.15 81.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.002 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.1 pp -68.14 -37.85 78.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.223 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -65.48 -46.2 80.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.504 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -35.4 75.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.111 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.0 tp -77.57 -25.17 49.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.523 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -76.88 -43.01 37.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.912 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -72.1 -32.33 66.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.828 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -59.95 -42.4 93.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.983 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 22.6 mt -64.37 -30.89 51.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.043 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.95 55.36 0.93 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.923 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.6 p -161.43 -45.9 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.97 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 84.3 p -85.55 -31.07 22.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.926 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 9.4 mtt -75.07 -175.81 2.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 51.8 m -107.37 70.09 0.77 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -156.09 126.8 6.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.867 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.25 -50.19 2.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.7 m -88.34 -66.35 0.92 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.984 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.59 102.63 5.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.045 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -167.96 80.66 0.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.216 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.4 t -96.43 13.51 27.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.168 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.486 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 5.4 mpt_? 49.04 58.06 18.08 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.476 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.486 ' HD3' ' N ' ' A' ' 95' ' ' ARG . 36.6 Cg_exo -58.75 -48.3 15.32 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.357 2.038 . . . . 0.0 112.403 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 83.1 Cg_endo -85.88 117.76 1.7 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.719 2.279 . . . . 0.0 112.606 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.653 HG21 ' HD3' ' A' ' 152' ' ' PRO . 24.3 t -137.2 106.77 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.482 HG22 ' HB2' ' A' ' 149' ' ' ALA . 40.7 p -103.4 139.22 39.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.04 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.419 HD11 HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -139.86 117.61 11.63 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.681 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.91 112.44 25.41 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.527 -178.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.708 HD22 HD11 ' A' ' 16' ' ' ILE . 40.7 mt -111.85 153.76 26.16 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.956 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 104' ' ' VAL . 21.2 t -114.32 149.23 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.062 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.963 HG11 HD11 ' A' ' 162' ' ' ILE . 6.0 m -156.14 164.46 21.35 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.335 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -66.03 160.74 43.02 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.744 2.296 . . . . 0.0 112.113 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.98 -34.9 76.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.358 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.9 t -70.17 -30.28 67.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.201 0.524 . . . . 0.0 109.667 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.559 ' NE2' HD23 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -70.72 -41.8 71.43 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.63 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.6 ' HA ' HD21 ' A' ' 112' ' ' LEU . 5.1 t -65.85 -40.8 92.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.706 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.17 -33.47 87.32 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.885 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.6 p -77.32 -50.78 12.07 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 121.115 -0.234 . . . . 0.0 111.312 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.625 HD12 HG13 ' A' ' 113' ' ' ILE . 2.7 pp -55.66 -25.78 41.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.054 0.455 . . . . 0.0 110.009 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.625 HG13 HD12 ' A' ' 112' ' ' LEU . 51.2 mt -77.03 -39.31 29.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.224 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.41 -177.86 39.37 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.527 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.53 121.73 16.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.857 0.361 . . . . 0.0 111.128 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.85 12.37 56.88 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.08 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.415 ' HA2' ' CG2' ' A' ' 113' ' ' ILE . . . 72.99 4.97 63.95 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.034 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 2.2 m -52.94 -42.64 65.65 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 120.791 0.329 . . . . 0.0 111.828 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -65.34 0.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.564 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.2 tt -58.99 -30.59 43.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.647 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 7.6 tppt? -60.07 -44.83 94.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.105 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -73.28 -41.66 63.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.464 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.409 HD12 ' NE2' ' A' ' 161' ' ' GLN . 34.5 mm -62.7 -53.78 42.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.583 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.4 mmt85 -67.82 -42.72 81.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.398 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.61 -40.77 69.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.222 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 91.3 p -85.32 -36.75 20.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.758 0.313 . . . . 0.0 111.101 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 31.0 m -50.49 -26.09 4.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.929 0.395 . . . . 0.0 110.249 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.48 -9.15 62.49 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.026 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -108.03 154.32 21.83 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.857 0.36 . . . . 0.0 111.212 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 1.9 mt-30 -105.14 139.75 39.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.41 ' HB ' ' CG2' ' A' ' 146' ' ' ILE . 1.2 m -99.16 157.96 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.035 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.593 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 3.4 tp60 -138.59 116.81 11.84 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.269 0.557 . . . . 0.0 112.347 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.65 131.22 45.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.305 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.08 161.22 13.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.079 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -58.68 -111.51 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.633 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.86 28.6 0.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.72 ' O ' HD12 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -93.72 12.45 25.56 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.499 -179.504 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.72 HD12 ' O ' ' A' ' 137' ' ' MET . 0.0 OUTLIER 165.32 -60.8 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.34 179.784 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.443 ' HD3' ' CB ' ' A' ' 138' ' ' LEU . 86.1 Cg_endo -80.58 68.48 8.31 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.707 2.272 . . . . 0.0 112.434 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -174.42 -40.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.886 0.374 . . . . 0.0 111.082 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.6 t -48.58 -53.63 17.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.951 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 24.5 m -118.91 -41.87 2.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.614 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.496 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 37.5 mt-10 -134.15 138.9 45.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.76 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.24 165.29 13.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.952 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.28 138.98 53.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.233 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.593 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 35.5 mt -114.21 131.63 65.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.824 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.435 ' HB ' ' CB ' ' A' ' 132' ' ' GLN . 1.0 OUTLIER -106.17 115.06 29.58 Favored 'General case' 0 N--CA 1.46 0.065 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.689 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 130' ' ' GLN . 3.2 mp -103.89 118.7 51.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.452 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.482 ' HB2' HG22 ' A' ' 99' ' ' THR . . . -118.55 134.5 55.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.758 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 163.35 -151.58 21.22 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.777 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.578 HG23 ' HD2' ' A' ' 152' ' ' PRO . 3.7 mt -78.2 144.74 67.5 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.653 ' HD3' HG21 ' A' ' 98' ' ' VAL . 5.7 Cg_endo -48.4 -39.87 36.06 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.134 1.889 . . . . 0.0 111.322 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -66.63 -34.68 78.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 18.3 m -68.44 -32.26 72.16 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.625 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 29.5 mm -76.35 -49.0 25.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.119 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.42 ' O ' HG12 ' A' ' 159' ' ' VAL . 33.4 mm -55.81 -36.38 43.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.989 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -75.03 -36.72 61.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.826 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 4.8 t -68.16 -38.45 82.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.905 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.445 ' HA ' HG22 ' A' ' 162' ' ' ILE . 10.3 p -70.82 -32.17 48.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.065 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.76 ' O ' HG23 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -69.3 -34.68 75.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.872 179.869 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.59 ' O ' HG23 ' A' ' 165' ' ' VAL . 0.8 OUTLIER -72.41 -49.37 34.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.776 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.963 HD11 HG11 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -63.15 -44.08 99.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.947 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . 0.477 ' N ' HG23 ' A' ' 162' ' ' ILE . 1.7 m -58.95 -44.61 91.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.831 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 160' ' ' LYS . 53.4 t -58.48 -52.59 57.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.02 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 161' ' ' GLN . 21.8 t -57.9 -41.25 79.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.18 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -59.69 -37.48 78.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.971 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 7.6 tt -67.46 -55.87 11.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.88 -2.63 24.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.01 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 18.4 p . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.372 -0.823 . . . . 0.0 111.152 179.999 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.801 0.334 . . . . 0.0 111.195 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -158.49 -78.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.937 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.563 HG22 ' N ' ' A' ' 13' ' ' THR . 12.0 p -118.08 163.97 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.97 0.414 . . . . 0.0 111.347 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.638 ' O ' HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -104.74 128.31 52.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.288 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.638 HD22 ' O ' ' A' ' 13' ' ' THR . 1.9 mm? -124.26 151.43 44.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.237 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.2 m -141.66 118.78 11.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.519 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.838 HD11 HD23 ' A' ' 102' ' ' LEU . 12.4 tt -119.96 147.21 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.931 0.396 . . . . 0.0 111.408 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.658 ' HG3' HG23 ' A' ' 60' ' ' THR . 2.4 mpp_? -131.04 112.08 12.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.524 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.685 HD12 ' CE ' ' A' ' 20' ' ' MET . 0.5 OUTLIER -109.51 134.74 51.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.224 -179.605 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.563 HD23 HG23 ' A' ' 103' ' ' VAL . 1.0 OUTLIER -104.36 122.36 45.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.562 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.685 ' CE ' HD12 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -124.71 159.51 30.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.144 0.497 . . . . 0.0 111.436 -179.621 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.86 ' O ' HG12 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -71.89 142.15 49.52 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.427 179.659 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.415 ' HA2' ' HG3' ' A' ' 57' ' ' ARG . . . -43.98 -32.2 2.26 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 121.018 -0.611 . . . . 0.0 113.801 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.41 ' HG3' ' HB3' ' A' ' 21' ' ' HIS . 0.0 OUTLIER -78.37 -52.03 9.2 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -179.255 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.18 -50.55 67.69 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.027 0.442 . . . . 0.0 110.309 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.86 HG12 ' O ' ' A' ' 21' ' ' HIS . 11.6 p -58.88 -36.04 59.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.956 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.701 ' HA2' HD12 ' A' ' 29' ' ' ILE . . . -62.37 -36.13 92.66 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.39 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.1 m -72.48 -29.53 63.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.96 0.41 . . . . 0.0 110.212 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.402 HD13 ' N ' ' A' ' 28' ' ' ILE . 4.9 mm -81.14 -32.59 12.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.699 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.735 HD11 HG22 ' A' ' 25' ' ' VAL . 14.2 mt -64.14 -42.59 96.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.156 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.4 150.96 26.14 Favored Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.293 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.431 ' C ' ' HG3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -58.08 146.39 33.28 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.772 -0.714 . . . . 0.0 111.259 179.824 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.496 ' HD2' ' HB2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 44.58 26.75 0.2 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.221 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.52 ' O ' HG23 ' A' ' 36' ' ' VAL . . . 49.25 16.17 0.8 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 114.391 0.517 . . . . 0.0 114.391 178.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.546 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 4.0 mt-10 -72.09 -35.01 69.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.677 0.739 . . . . 0.0 109.872 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.9 t -68.41 -39.86 81.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.102 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.684 HG13 ' HA ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -66.8 -26.1 36.26 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -36.45 79.91 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.546 ' HG2' ' O ' ' A' ' 34' ' ' GLU . 8.8 mmtt -63.28 -41.22 98.98 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.597 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.54 -49.48 76.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.169 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.583 ' HG2' HD12 ' A' ' 47' ' ' ILE . 1.7 mtt180 -58.34 -51.66 68.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.682 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -64.91 -38.4 90.84 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -75.06 -35.97 61.83 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.798 ' CB ' ' HB2' ' A' ' 71' ' ' ALA . 83.5 p -82.27 -55.33 4.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.83 0.347 . . . . 0.0 111.041 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.41 -7.89 64.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.544 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.565 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . . . -104.28 127.94 51.99 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 122.781 -0.246 . . . . 0.0 111.012 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 4.5 mmt180 -27.36 139.39 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.101 0.56 . . . . 0.0 112.213 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.583 HD12 ' HG2' ' A' ' 40' ' ' ARG . 11.6 mt -142.24 100.59 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.723 0.297 . . . . 0.0 111.008 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.34 132.6 50.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.04 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.9 mt -90.24 151.77 3.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.081 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.87 -175.12 3.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.043 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.62 -166.41 0.98 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.055 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.469 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . 162.25 84.75 0.05 OUTLIER Glycine 0 C--O 1.227 -0.315 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.653 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -55.14 -21.6 13.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.069 0.461 . . . . 0.0 110.339 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.461 ' CB ' ' HD3' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -93.16 -63.52 0.16 Allowed Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.675 -179.664 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.533 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 64.5 Cg_endo -81.79 -33.48 0.63 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.635 2.223 . . . . 0.0 112.321 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.505 ' CB ' ' O ' ' A' ' 55' ' ' PRO . 2.6 mt-10 95.83 -35.0 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.85 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.697 ' HB2' HG11 ' A' ' 25' ' ' VAL . 3.3 mtp180 -140.24 143.61 36.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.008 0.432 . . . . 0.0 111.375 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.2 mt -140.53 115.45 6.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.599 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.5 mt -86.18 110.13 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.976 0.417 . . . . 0.0 111.43 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.658 HG23 ' HG3' ' A' ' 17' ' ' ARG . 49.6 m -103.15 101.84 11.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.64 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.57 HD22 HG13 ' A' ' 68' ' ' ILE . 6.5 tt -104.69 133.85 48.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.753 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.478 ' O ' ' HB1' ' A' ' 45' ' ' ALA . . . -125.55 137.42 53.93 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.45 ' HA3' ' CB ' ' A' ' 45' ' ' ALA . . . 157.49 165.57 15.44 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 119.847 -1.168 . . . . 0.0 113.007 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -50.5 161.96 1.07 Allowed 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.906 2.404 . . . . 0.0 112.337 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.496 ' O ' HG22 ' A' ' 68' ' ' ILE . 18.2 m -56.85 -35.96 69.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.559 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -63.8 -51.81 63.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.788 0.328 . . . . 0.0 111.3 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.565 ' CB ' ' HB2' ' A' ' 45' ' ' ALA . . . -57.24 -37.47 72.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.198 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.57 HG13 HD22 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -66.21 -39.34 84.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.376 -179.301 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.67 -50.91 70.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.032 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.76 -49.71 76.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.886 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.798 ' HB2' ' CB ' ' A' ' 43' ' ' SER . . . -56.31 -50.85 70.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.27 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.454 ' HA ' HD12 ' A' ' 75' ' ' ILE . 0.7 OUTLIER -52.78 -42.51 65.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.095 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.98 -37.13 78.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.108 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -76.32 -37.63 57.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.949 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 72' ' ' PHE . 46.0 mt -64.11 -50.6 76.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.846 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -62.17 -37.42 78.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.143 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -65.0 -47.64 76.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.741 0.305 . . . . 0.0 110.513 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.36 -35.42 80.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.174 0.511 . . . . 0.0 109.781 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.481 ' O ' ' HB ' ' A' ' 83' ' ' ILE . 13.0 tp -77.67 -22.99 49.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.486 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -76.08 -41.75 49.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.841 0.353 . . . . 0.0 110.9 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.23 -45.44 60.22 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.036 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.9 -50.39 64.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.681 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 79' ' ' LEU . 2.6 tt -53.63 -47.22 61.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.128 0.489 . . . . 0.0 111.261 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.468 ' N ' ' CG2' ' A' ' 83' ' ' ILE . 28.8 t 62.96 -79.35 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.302 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.99 11.04 9.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.656 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.451 ' HA ' ' CG1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER 74.01 -64.59 0.38 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.831 0.348 . . . . 0.0 110.818 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 1.2 mtp -166.6 138.72 3.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.921 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.77 80.76 1.85 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.798 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -57.4 -30.35 64.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.019 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 94.0 p -166.74 -60.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.83 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.16 102.03 2.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -151.61 110.24 3.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.071 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -149.07 33.63 0.74 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.08 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 60.5 m -88.04 -44.17 11.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.953 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -168.57 88.36 0.65 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.74 110.73 1.96 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.615 2.21 . . . . 0.0 112.12 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -83.48 170.02 12.0 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.661 2.24 . . . . 0.0 112.701 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.839 HG12 ' O ' ' A' ' 150' ' ' GLY . 7.2 p -140.92 116.21 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.505 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.664 ' O ' HD23 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -103.08 131.85 49.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.133 -179.556 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.664 HD23 ' O ' ' A' ' 99' ' ' THR . 27.6 mt -139.92 117.67 11.63 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.54 ' HG2' ' HB1' ' A' ' 145' ' ' ALA . 28.2 ttm180 -103.09 112.57 25.48 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.567 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.838 HD23 HD11 ' A' ' 16' ' ' ILE . 1.4 mp -99.46 151.01 21.6 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.842 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.563 HG23 HD23 ' A' ' 19' ' ' LEU . 25.9 t -107.26 149.28 10.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.241 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.8 m -156.01 161.69 28.96 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.133 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.432 ' HD2' ' HB2' ' A' ' 108' ' ' GLN . 21.4 Cg_exo -65.69 162.15 35.75 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.748 2.298 . . . . 0.0 112.216 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.13 -34.64 76.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.639 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.25 -30.52 69.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.086 0.469 . . . . 0.0 109.823 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.432 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -68.85 -46.19 69.15 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.678 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.405 ' O ' HG12 ' A' ' 113' ' ' ILE . 0.8 OUTLIER -67.57 -37.48 82.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.419 179.554 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.22 -49.68 70.48 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.312 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.9 m -77.28 -35.22 55.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.839 0.352 . . . . 0.0 110.803 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.71 HD21 ' CD1' ' A' ' 162' ' ' ILE . 9.9 mt -57.66 -29.67 64.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.62 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.408 ' HA ' ' HB ' ' A' ' 120' ' ' ILE . 27.7 mm -87.12 -38.71 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.807 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.4 -179.38 36.66 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.453 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.34 124.73 23.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.874 0.369 . . . . 0.0 111.054 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.41 16.07 57.85 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.882 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.407 ' HA2' ' CG2' ' A' ' 113' ' ' ILE . . . 68.16 10.6 59.77 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.965 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -52.93 -39.86 63.16 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.823 0.344 . . . . 0.0 111.547 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.67 -65.27 0.7 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.224 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.891 HD11 HG21 ' A' ' 131' ' ' VAL . 0.0 OUTLIER -55.13 -28.86 21.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.437 -179.668 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -64.69 -49.36 71.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.094 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.5 -38.99 74.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.34 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 120' ' ' ILE . 27.8 mt -57.52 -53.93 37.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.116 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.435 ' HG2' HD13 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -72.47 -30.52 64.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.912 0.387 . . . . 0.0 110.998 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.97 -44.73 82.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.131 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.4 m -93.12 -37.53 12.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.506 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.5 m -49.83 -26.25 3.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.809 0.337 . . . . 0.0 110.234 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 82.9 -16.55 26.56 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.229 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.801 ' HB2' ' HB3' ' A' ' 154' ' ' SER . . . -100.87 166.54 10.79 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.937 0.368 . . . . 0.0 111.195 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -105.23 133.82 49.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.952 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.891 HG21 HD11 ' A' ' 120' ' ' ILE . 14.0 m -101.93 139.48 22.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.905 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.633 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 0.4 OUTLIER -129.47 116.72 19.39 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.6 m -99.26 132.74 44.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.277 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.25 160.05 5.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.995 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -89.08 -117.03 1.51 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.537 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 32.7 p-10 -161.71 31.03 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.822 0.344 . . . . 0.0 110.416 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.544 ' O ' HD12 ' A' ' 138' ' ' LEU . 3.7 ptp -72.42 64.06 0.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.855 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.544 HD12 ' O ' ' A' ' 137' ' ' MET . 0.2 OUTLIER -173.04 172.05 1.66 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.598 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.64 63.27 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.72 2.28 . . . . 0.0 112.323 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 64.69 103.73 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 56.1 p -80.4 165.52 22.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.787 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 28.3 m -115.59 -47.17 2.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.811 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.486 ' OE2' ' NH2' ' A' ' 17' ' ' ARG . 10.9 mt-10 -116.2 147.03 41.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.792 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.03 174.43 5.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.893 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.54 ' HB1' ' HG2' ' A' ' 101' ' ' ARG . . . -136.44 129.9 31.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.402 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.633 ' HA ' ' O ' ' A' ' 132' ' ' GLN . 3.9 mp -100.13 125.4 53.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.741 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.566 HG22 HG22 ' A' ' 99' ' ' THR . 0.3 OUTLIER -96.92 114.82 26.47 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.743 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 148' ' ' ILE . 1.0 OUTLIER -106.04 113.48 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.183 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.611 ' HB2' HG23 ' A' ' 99' ' ' THR . . . -118.44 131.16 56.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.086 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.839 ' O ' HG12 ' A' ' 98' ' ' VAL . . . 165.49 -158.4 31.25 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.49 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.598 HG22 ' HD2' ' A' ' 152' ' ' PRO . 0.7 OUTLIER -87.76 163.74 37.09 Favored Pre-proline 0 C--N 1.33 -0.272 0 O-C-N 122.858 -0.201 . . . . 0.0 110.637 179.534 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.598 ' HD2' HG22 ' A' ' 151' ' ' ILE . 6.9 Cg_endo -49.59 -36.59 40.92 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.428 2.085 . . . . 0.0 111.77 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.44 ' HB2' HD13 ' A' ' 151' ' ' ILE . 7.8 mm100 -63.54 -34.61 78.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.038 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.801 ' HB3' ' HB2' ' A' ' 129' ' ' ALA . 4.2 m -70.45 -37.14 74.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.591 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.491 ' O ' HG12 ' A' ' 159' ' ' VAL . 36.8 mm -67.53 -51.72 48.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.937 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.9 mm -58.85 -28.24 37.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.056 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -70.6 -57.02 5.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.521 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 6.8 p -61.01 -47.54 86.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.519 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 155' ' ' ILE . 13.4 p -57.01 -36.56 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.809 0.338 . . . . 0.0 111.166 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.413 ' O ' HG12 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -71.48 -33.05 68.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.827 179.914 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.623 ' O ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -72.56 -39.81 67.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.978 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.71 ' CD1' HD21 ' A' ' 112' ' ' LEU . 6.4 tp -74.05 -34.51 38.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.032 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 2.3 t -70.81 -47.35 59.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.071 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.483 HG13 ' N ' ' A' ' 165' ' ' VAL . 12.4 p -61.81 -45.36 98.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.08 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.623 HG22 ' O ' ' A' ' 161' ' ' GLN . 28.5 m -69.27 -42.64 81.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.062 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.473 ' HG2' HD11 ' A' ' 14' ' ' LEU . 4.5 tpp -64.53 -37.43 87.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.958 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.44 -57.5 7.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.92 -2.49 24.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.029 0.442 . . . . 0.0 112.026 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.875 179.949 . . . . . . . . 1 1 . 1 stop_ save_